data_1x0f_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1x0f _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.535 HG11 ' N ' ' A' ' 182' ' ' LYS . 45.5 t . . . . . 0 CA--C 1.503 -0.85 0 CA-C-O 121.243 0.544 . . . . 0.0 111.612 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.541 ' CE ' ' HB3' ' A' ' 233' ' ' GLU . 0.5 OUTLIER -149.97 112.6 4.75 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.883 177.769 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.824 ' HD2' ' HB2' ' A' ' 257' ' ' ALA . 0.0 OUTLIER -135.46 155.85 49.86 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.55 179.242 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.611 HG12 ' HB ' ' A' ' 228' ' ' ILE . 0.4 OUTLIER -131.15 121.19 48.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 115.452 -0.794 . . . . 0.0 108.858 178.973 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.553 ' CA ' ' HB1' ' A' ' 257' ' ' ALA . 0.3 OUTLIER -93.82 109.25 20.94 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.287 0.565 . . . . 0.0 110.826 -178.981 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.585 ' CG1' ' HB2' ' A' ' 252' ' ' CYS . 2.5 t -86.08 126.4 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.586 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.551 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . -114.76 126.4 7.22 Favored Glycine 0 N--CA 1.452 -0.274 0 N-CA-C 114.602 0.601 . . . . 0.0 114.602 -176.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.478 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . 80.59 83.13 0.74 Allowed Glycine 0 CA--C 1.519 0.285 0 C-N-CA 121.245 -0.502 . . . . 0.0 113.361 179.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . 0.534 HD12 ' N ' ' A' ' 190' ' ' SER . 0.6 OUTLIER -117.25 157.77 25.47 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.816 0.341 . . . . 0.0 111.384 -179.394 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' SER . . . . . 0.555 ' CB ' ' CD ' ' A' ' 191' ' ' PRO . 0.1 OUTLIER -45.4 -177.41 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.197 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.557 179.503 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . 0.555 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 11.4 Cg_exo -70.62 6.54 1.55 Allowed 'Trans proline' 0 CA--C 1.532 0.406 0 C-N-CA 123.255 2.637 . . . . 0.0 113.514 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.516 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 2.8 p30 160.55 77.65 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.013 0.435 . . . . 0.0 110.812 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.57 ' HB ' ' CD2' ' A' ' 213' ' ' LEU . 51.8 m -73.02 131.76 83.4 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.003 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.534 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 68.6 Cg_endo -80.96 114.34 2.88 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 122.945 2.43 . . . . 0.0 111.632 179.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.568 ' HA ' ' CD1' ' A' ' 198' ' ' ILE . 1.6 pm0 -48.1 -17.81 0.15 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.357 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . 0.468 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 27.4 mm-40 -61.36 -44.02 97.89 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -179.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.534 ' CD ' ' HG2' ' A' ' 194' ' ' PRO . 0.9 OUTLIER -76.38 -46.39 27.57 Favored 'General case' 0 CA--C 1.494 -1.207 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 178.826 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.617 HG21 ' CE1' ' A' ' 202' ' ' PHE . 0.2 OUTLIER -48.34 -29.01 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.373 0 CA-C-N 113.862 -1.517 . . . . 0.0 108.736 177.245 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.545 ' HG3' ' O ' ' A' ' 195' ' ' GLU . 2.3 mtt180 -76.12 -31.73 58.79 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-N 115.294 -0.867 . . . . 0.0 110.029 178.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . 0.58 ' CG ' ' N ' ' A' ' 201' ' ' TYR . 4.2 pt-20 -82.01 -55.17 4.74 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.098 0.475 . . . . 0.0 110.293 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.58 ' N ' ' CG ' ' A' ' 200' ' ' GLU . 0.3 OUTLIER -50.11 -53.88 24.4 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.484 0.659 . . . . 0.0 109.67 178.797 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.652 ' O ' ' HB2' ' A' ' 205' ' ' PHE . 0.5 OUTLIER -79.66 -32.69 41.58 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.7 -179.836 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.529 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -62.82 -55.05 29.13 Favored Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 107.359 -2.296 . . . . 0.0 107.359 176.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -51.39 -27.84 18.36 Favored Glycine 0 N--CA 1.442 -0.949 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 176.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . 0.742 ' CE2' HG13 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -59.17 -44.89 92.16 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 122.129 0.966 . . . . 0.0 108.601 177.849 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.493 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 172.42 -132.41 2.38 Favored Glycine 0 N--CA 1.442 -0.938 0 CA-C-N 113.698 -1.592 . . . . 0.0 110.482 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.476 ' HB3' ' HE2' ' A' ' 231' ' ' LYS . 1.8 mt-10 -97.22 97.13 8.92 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.21 0.529 . . . . 0.0 111.456 178.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 2.5 t -72.56 137.63 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.544 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 5.8 tp10 -89.54 -50.7 5.93 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 178.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.447 ' OG ' ' OE2' ' A' ' 212' ' ' GLU . 0.9 OUTLIER -165.15 159.02 17.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.31 0.576 . . . . 0.0 111.913 179.263 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.608 ' CG2' HD12 ' A' ' 228' ' ' ILE . 0.1 OUTLIER -131.59 120.72 46.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.212 179.156 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . 0.447 ' OE2' ' OG ' ' A' ' 210' ' ' SER . 0.0 OUTLIER -123.43 102.64 8.01 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -179.066 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.57 ' CD2' ' HB ' ' A' ' 193' ' ' THR . 1.7 mp . . . . . 0 C--N 1.329 -0.284 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 177.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.676 0 CA-C-O 121.16 0.311 . . . . 0.0 112.812 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . 0.536 ' CE2' ' CE2' ' A' ' 185' ' ' PHE . 0.1 OUTLIER -157.15 176.93 12.08 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -178.29 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . 0.53 ' HB3' ' CD2' ' A' ' 213' ' ' LEU . 1.4 p -141.42 149.18 40.69 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.258 -0.577 . . . . 0.0 112.433 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.664 ' CE2' ' CB ' ' A' ' 257' ' ' ALA . 5.7 m-85 -107.21 146.45 31.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.351 178.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.651 HD13 ' CD2' ' A' ' 202' ' ' PHE . 1.8 mt -141.12 121.22 12.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.287 0.565 . . . . 0.0 111.667 179.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' THR . . . . . 0.54 ' OG1' ' CG ' ' A' ' 183' ' ' LYS . 31.2 m -102.39 137.91 40.01 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.235 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 0.666 ' CE1' ' CB ' ' A' ' 235' ' ' PRO . 72.4 m-85 -113.58 126.41 55.26 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.078 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.544 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -51.79 -37.31 51.03 Favored 'General case' 0 CA--C 1.505 -0.769 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 178.328 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . 0.483 ' O ' ' HG3' ' A' ' 182' ' ' LYS . 1.6 mm-40 -93.37 -175.28 3.76 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 113.39 -1.732 . . . . 0.0 109.3 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . 0.541 ' HB3' ' CE ' ' A' ' 182' ' ' LYS . 0.1 OUTLIER -124.67 11.37 8.49 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.912 -179.631 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.551 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.2 OUTLIER -80.74 -59.79 0.47 Allowed Pre-proline 0 C--N 1.328 -0.327 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.813 179.926 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.666 ' CB ' ' CE1' ' A' ' 230' ' ' PHE . 84.0 Cg_exo -49.71 -31.87 26.92 Favored 'Trans proline' 0 CA--C 1.502 -1.087 0 N-CA-C 108.785 -1.275 . . . . 0.0 108.785 177.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.59 HG21 ' CD2' ' A' ' 230' ' ' PHE . 12.8 t -72.1 -44.93 64.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 114.059 -1.428 . . . . 0.0 110.566 178.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . 0.551 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 19.4 pttt -62.33 -37.85 87.2 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.987 -179.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.462 ' HA ' ' HG3' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -82.05 -49.99 9.6 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.856 0.36 . . . . 0.0 111.052 179.351 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.742 HG13 ' CE2' ' A' ' 205' ' ' PHE . 1.4 mt -42.88 -53.08 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 24.7 mtp -56.23 -32.2 64.24 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.027 -179.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.477 ' CG ' ' O ' ' A' ' 237' ' ' LYS . 1.1 mt-10 -75.4 -21.19 58.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.13 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -79.57 109.92 14.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.849 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.18 -47.57 35.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.755 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . 0.569 ' CE1' ' HG3' ' A' ' 253' ' ' GLU . 8.5 m-85 -138.31 151.75 47.86 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.903 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' HIS . . . . . 0.64 ' CG ' ' CD1' ' A' ' 254' ' ' ILE . 29.7 m-70 -116.67 154.91 29.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.25 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . 0.406 ' O ' ' CE2' ' A' ' 201' ' ' TYR . 2.4 m-80 -134.34 105.23 6.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.276 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.545 ' N ' ' O ' ' A' ' 250' ' ' SER . 2.2 t -103.57 106.88 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.292 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 52.04 -83.06 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.186 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.54 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -111.11 -38.34 5.08 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.586 0.707 . . . . 0.0 110.267 179.727 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' SER . . . . . 0.545 ' O ' ' N ' ' A' ' 247' ' ' VAL . 0.6 OUTLIER -77.16 153.21 34.41 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.747 -1.115 . . . . 0.0 112.014 -178.627 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.471 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -146.97 107.08 4.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.959 179.159 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' CYS . . . . . 0.585 ' HB2' ' CG1' ' A' ' 186' ' ' VAL . 0.0 OUTLIER -128.2 153.41 46.94 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -176.933 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . 0.569 ' HG3' ' CE1' ' A' ' 244' ' ' TYR . 29.2 tt0 -76.02 109.56 9.77 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.194 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . 0.64 ' CD1' ' CG ' ' A' ' 245' ' ' HIS . 21.4 mt -96.54 115.23 35.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 -178.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . 0.517 ' O ' ' C ' ' A' ' 256' ' ' VAL . 0.0 OUTLIER -121.01 131.8 54.51 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 106.144 -1.799 . . . . 0.0 106.144 176.628 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . 0.517 ' C ' ' O ' ' A' ' 255' ' ' LYS . 3.9 p -32.87 121.76 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.513 -0.472 0 CA-C-O 122.398 1.095 . . . . 0.0 111.446 -177.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.824 ' HB2' ' HD2' ' A' ' 183' ' ' LYS . . . -75.77 155.49 35.46 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 113.117 -1.856 . . . . 0.0 111.909 -178.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.91 125.16 27.71 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.426 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' SER . . . . . 0.561 ' HB3' ' CE ' ' A' ' 183' ' ' LYS . 83.3 p . . . . . 0 C--N 1.324 -0.516 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.232 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.508 HG12 ' N ' ' A' ' 182' ' ' LYS . 45.8 t . . . . . 0 CA--C 1.502 -0.891 0 CA-C-O 121.46 0.648 . . . . 0.0 112.051 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.508 ' N ' HG12 ' A' ' 181' ' ' VAL . 0.0 OUTLIER -148.91 111.56 4.78 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.117 176.733 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.609 ' HD3' ' HB1' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -138.57 146.1 41.44 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 114.979 -1.01 . . . . 0.0 109.623 179.39 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.58 HG12 ' HB ' ' A' ' 228' ' ' ILE . 0.4 OUTLIER -125.38 120.32 57.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.528 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.542 ' CA ' ' HB3' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -93.33 109.09 20.63 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.423 0.63 . . . . 0.0 110.459 -178.738 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.608 ' CG1' HG12 ' A' ' 254' ' ' ILE . 1.9 t -88.14 122.58 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.023 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.558 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . -108.23 125.79 8.0 Favored Glycine 0 N--CA 1.452 -0.239 0 CA-C-N 115.893 -0.594 . . . . 0.0 114.535 -176.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.476 ' O ' ' CB ' ' A' ' 252' ' ' CYS . . . 81.33 86.86 0.66 Allowed Glycine 0 C--N 1.333 0.414 0 C-N-CA 121.025 -0.607 . . . . 0.0 113.026 179.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . 0.528 HD12 ' N ' ' A' ' 190' ' ' SER . 0.7 OUTLIER -116.87 156.64 26.98 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.835 0.35 . . . . 0.0 111.258 -179.657 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' SER . . . . . 0.53 ' OG ' ' CD ' ' A' ' 191' ' ' PRO . 0.2 OUTLIER -45.31 179.65 0.01 OUTLIER Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.16 179.56 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . 0.53 ' CD ' ' OG ' ' A' ' 190' ' ' SER . 15.5 Cg_exo -68.33 4.98 1.35 Allowed 'Trans proline' 0 CA--C 1.531 0.346 0 C-N-CA 123.138 2.559 . . . . 0.0 113.575 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.505 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 0.3 OUTLIER 161.4 76.25 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.877 0.37 . . . . 0.0 110.954 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.574 HG21 ' CD1' ' A' ' 198' ' ' ILE . 35.7 m -70.86 132.41 86.88 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.469 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.581 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 83.9 Cg_endo -77.25 115.21 3.91 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.77 2.313 . . . . 0.0 110.955 178.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.795 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -51.61 -13.7 0.27 Allowed 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -179.36 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . 0.505 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 25.9 mt-10 -68.17 -41.34 81.63 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -179.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.581 ' CD ' ' HG2' ' A' ' 194' ' ' PRO . 1.5 mttp -72.5 -47.37 49.07 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.795 ' CG1' ' HA ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -47.05 -31.02 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.118 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.562 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 4.1 mtp85 -71.71 -33.46 68.77 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.247 179.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . 0.525 ' CG ' ' N ' ' A' ' 201' ' ' TYR . 3.1 pt-20 -82.49 -51.55 7.7 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.005 0.431 . . . . 0.0 110.601 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.525 ' N ' ' CG ' ' A' ' 200' ' ' GLU . 0.2 OUTLIER -54.84 -54.6 40.29 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.497 0.665 . . . . 0.0 109.835 178.964 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.683 ' CD2' HD11 ' A' ' 228' ' ' ILE . 0.4 OUTLIER -79.29 -31.0 43.19 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.079 -179.784 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.562 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -63.41 -55.47 25.43 Favored Glycine 0 CA--C 1.501 -0.841 0 N-CA-C 106.812 -2.515 . . . . 0.0 106.812 176.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -49.05 -29.35 8.62 Favored Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 176.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . 0.721 ' CE2' HG13 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -59.18 -42.56 91.11 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 122.046 0.927 . . . . 0.0 108.587 177.704 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 203' ' ' GLY . . . 167.69 -130.44 2.1 Favored Glycine 0 N--CA 1.442 -0.923 0 CA-C-N 113.666 -1.606 . . . . 0.0 110.318 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.502 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 13.1 mt-10 -97.02 101.91 13.58 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.157 0.503 . . . . 0.0 110.923 178.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 2.4 t -77.14 143.97 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 CA-C-N 115.449 -0.796 . . . . 0.0 108.931 178.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.544 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 18.8 tp10 -91.8 -55.13 3.58 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 178.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 3.3 m -170.55 150.88 3.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.765 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.626 HG22 HG12 ' A' ' 228' ' ' ILE . 0.4 OUTLIER -117.53 133.33 64.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.752 179.088 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -123.21 103.35 8.48 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -178.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.471 HD13 ' HB3' ' A' ' 226' ' ' CYS . 2.4 mm? . . . . . 0 CA--C 1.531 0.226 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 177.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.458 0 N-CA-C 112.252 -0.339 . . . . 0.0 112.252 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . 0.519 ' HB2' ' O ' ' A' ' 186' ' ' VAL . 0.0 OUTLIER -157.36 176.67 12.37 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.924 -0.638 . . . . 0.0 110.017 -177.773 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . 0.471 ' HB3' HD13 ' A' ' 213' ' ' LEU . 4.0 p -136.04 148.63 48.44 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.115 -0.634 . . . . 0.0 112.428 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.683 ' CE2' ' CB ' ' A' ' 257' ' ' ALA . 3.4 m-85 -109.81 132.79 53.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.111 -0.95 . . . . 0.0 108.446 178.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.683 HD11 ' CD2' ' A' ' 202' ' ' PHE . 1.8 mt -129.09 122.2 55.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.213 0.53 . . . . 0.0 111.785 -179.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' THR . . . . . 0.476 ' OG1' ' HG2' ' A' ' 183' ' ' LYS . 24.4 m -103.62 138.24 40.57 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.241 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 0.654 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 65.3 m-85 -110.97 126.38 54.71 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.55 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.544 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -48.22 -38.93 19.63 Favored 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 178.442 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . 0.452 ' O ' ' O ' ' A' ' 230' ' ' PHE . 0.3 OUTLIER -92.1 -166.18 1.5 Allowed 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 113.121 -1.854 . . . . 0.0 109.14 178.586 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . 0.514 ' O ' ' HG3' ' A' ' 237' ' ' LYS . 0.3 OUTLIER -131.27 -0.13 4.08 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.581 179.86 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.509 ' O ' ' N ' ' A' ' 237' ' ' LYS . 0.6 OUTLIER -72.57 -58.99 2.64 Favored Pre-proline 0 C--N 1.331 -0.234 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.835 -179.422 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.618 ' CB ' ' CE2' ' A' ' 230' ' ' PHE . 96.5 Cg_exo -48.98 -32.91 24.59 Favored 'Trans proline' 0 CA--C 1.497 -1.373 0 N-CA-C 108.949 -1.212 . . . . 0.0 108.949 178.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.587 HG21 ' CD1' ' A' ' 230' ' ' PHE . 21.6 t -69.87 -40.84 79.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 113.834 -1.53 . . . . 0.0 109.075 178.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . 0.514 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 8.7 mttt -58.81 -45.93 88.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.877 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.446 ' O ' ' HD3' ' A' ' 242' ' ' LYS . 0.0 OUTLIER -80.25 -47.42 14.63 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.064 -179.703 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.721 HG13 ' CE2' ' A' ' 205' ' ' PHE . 1.6 mt -45.15 -50.82 2.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.7 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' MET . . . . . 0.431 ' SD ' HG11 ' A' ' 236' ' ' VAL . 23.0 mtp -58.13 -28.22 64.47 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.192 -179.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.465 ' N ' ' OE1' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -82.48 -20.76 36.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.224 0.535 . . . . 0.0 109.824 179.408 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.446 ' HD3' ' O ' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -80.55 100.13 8.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.019 179.729 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.58 ' HE2' ' CG ' ' A' ' 244' ' ' TYR . 1.8 ttpt -40.7 -67.43 0.24 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.24 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . 0.58 ' CG ' ' HE2' ' A' ' 243' ' ' LYS . 7.1 m-30 -113.94 154.4 27.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.197 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' HIS . . . . . 0.608 ' CD2' ' CG1' ' A' ' 254' ' ' ILE . 24.3 m-70 -123.12 147.85 46.33 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.338 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . 0.44 ' HB3' ' HD2' ' A' ' 251' ' ' LYS . 0.4 OUTLIER -125.73 105.24 8.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.989 0.424 . . . . 0.0 110.938 179.712 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.556 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.9 t -102.64 108.98 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.235 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 48.76 -83.93 0.01 OUTLIER Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.271 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.556 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -110.48 -38.64 5.15 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.402 0.62 . . . . 0.0 110.497 179.639 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' SER . . . . . 0.501 ' HB3' ' HB2' ' A' ' 190' ' ' SER . 1.6 p -77.06 150.44 35.73 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.011 -0.995 . . . . 0.0 112.068 -178.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.499 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -144.88 108.05 4.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.307 178.984 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' CYS . . . . . 0.563 ' HB2' ' CG1' ' A' ' 186' ' ' VAL . 0.0 OUTLIER -128.04 153.01 47.25 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -177.436 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . 0.495 ' HB2' ' CE1' ' A' ' 244' ' ' TYR . 51.5 tt0 -76.17 113.14 13.38 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.221 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . 0.62 ' CG2' ' CG2' ' A' ' 239' ' ' ILE . 10.1 mt -96.53 113.05 29.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 114.66 1.355 . . . . 0.0 114.66 -178.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . 0.518 ' O ' ' C ' ' A' ' 256' ' ' VAL . 0.0 OUTLIER -119.5 129.57 54.77 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 176.207 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . 0.544 ' CG2' ' O ' ' A' ' 183' ' ' LYS . 6.3 p -32.84 121.46 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.433 0 CA-C-O 122.264 1.031 . . . . 0.0 111.42 -177.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.683 ' CB ' ' CE2' ' A' ' 227' ' ' PHE . . . -76.01 154.1 36.0 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 113.207 -1.815 . . . . 0.0 112.132 -178.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.32 117.16 19.36 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.174 179.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.323 -0.558 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.716 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.533 ' CA ' ' HE3' ' A' ' 182' ' ' LYS . 55.7 t . . . . . 0 CA--C 1.506 -0.74 0 CA-C-O 121.02 0.438 . . . . 0.0 111.502 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.549 ' CD ' ' HB3' ' A' ' 233' ' ' GLU . 0.0 OUTLIER -154.37 112.41 3.52 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.185 177.293 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.692 ' HD3' ' HB3' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -134.62 153.72 51.84 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.76 179.207 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.655 HG12 ' HB ' ' A' ' 228' ' ' ILE . 0.1 OUTLIER -133.1 120.49 40.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 177.991 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.664 ' CE2' ' CE2' ' A' ' 225' ' ' PHE . 0.2 OUTLIER -92.51 109.94 21.35 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 121.341 0.591 . . . . 0.0 110.309 -179.434 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.546 ' O ' ' HB2' ' A' ' 225' ' ' PHE . 39.2 t -88.08 131.0 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.968 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.487 ' O ' ' HB3' ' A' ' 252' ' ' CYS . . . -85.16 -146.56 8.45 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 114.597 0.599 . . . . 0.0 114.597 -177.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.487 ' HA2' ' O ' ' A' ' 224' ' ' GLY . . . -35.56 103.29 0.02 OUTLIER Glycine 0 C--N 1.336 0.569 0 N-CA-C 114.505 0.562 . . . . 0.0 114.505 -179.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . 0.521 ' CD1' ' O ' ' A' ' 190' ' ' SER . 1.7 pp -117.78 157.07 27.22 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 122.453 0.301 . . . . 0.0 110.893 179.099 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' SER . . . . . 0.529 ' HB3' ' HB3' ' A' ' 250' ' ' SER . 0.0 OUTLIER -42.27 172.64 0.03 OUTLIER Pre-proline 0 N--CA 1.463 0.191 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.32 179.806 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . 0.503 ' HD2' ' OG ' ' A' ' 190' ' ' SER . 31.7 Cg_exo -60.37 -5.24 3.92 Favored 'Trans proline' 0 CA--C 1.532 0.395 0 C-N-CA 122.891 2.394 . . . . 0.0 113.466 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 191' ' ' PRO . 0.1 OUTLIER 172.78 73.19 0.0 OUTLIER 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.924 0.392 . . . . 0.0 111.503 -179.943 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.561 ' HB ' ' CD1' ' A' ' 213' ' ' LEU . 57.4 m -61.36 114.31 10.51 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.471 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.502 ' HG2' ' HG2' ' A' ' 197' ' ' LYS . 13.3 Cg_endo -58.19 114.26 1.89 Allowed 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.166 1.911 . . . . 0.0 111.013 178.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.82 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 6.5 pt-20 -53.4 -14.67 0.81 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.501 -179.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . 0.503 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 51.7 mt-10 -68.34 -38.51 81.55 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.534 ' O ' ' N ' ' A' ' 200' ' ' GLU . 0.1 OUTLIER -73.85 -49.2 26.2 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.309 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.82 ' CG1' ' HA ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -48.48 -30.91 3.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.062 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.583 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 11.0 mtp180 -69.18 -33.43 73.35 Favored 'General case' 0 C--O 1.22 -0.494 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.639 178.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . 0.534 ' N ' ' O ' ' A' ' 197' ' ' LYS . 4.3 mt-10 -82.42 -59.58 2.49 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.422 178.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.548 ' OH ' ' ND1' ' A' ' 245' ' ' HIS . 0.4 OUTLIER -49.0 -54.27 16.37 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.498 0.666 . . . . 0.0 109.839 179.119 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.68 ' CD2' HD11 ' A' ' 228' ' ' ILE . 0.6 OUTLIER -79.36 -30.83 42.76 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 114.92 -1.037 . . . . 0.0 110.244 -179.863 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.583 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -62.2 -57.53 16.58 Favored Glycine 0 N--CA 1.443 -0.879 0 N-CA-C 106.959 -2.456 . . . . 0.0 106.959 176.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -48.64 -28.49 6.92 Favored Glycine 0 N--CA 1.442 -0.919 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 176.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . 0.727 ' CE2' HG13 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -58.65 -45.26 89.7 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 177.866 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.494 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 171.83 -132.75 2.51 Favored Glycine 0 N--CA 1.441 -0.975 0 CA-C-N 113.614 -1.63 . . . . 0.0 110.25 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.461 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 0.5 OUTLIER -96.87 98.02 9.77 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.278 0.561 . . . . 0.0 111.079 178.815 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 2.8 t -74.32 142.24 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.524 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 5.0 tp10 -94.13 -54.12 3.7 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.747 178.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.8 m -166.25 152.74 9.17 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.228 0.537 . . . . 0.0 112.073 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.613 HG22 HG12 ' A' ' 228' ' ' ILE . 0.4 OUTLIER -122.06 124.49 71.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.23 178.433 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -123.34 107.29 11.48 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -177.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.612 ' N ' ' CD2' ' A' ' 213' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 177.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . 0.487 ' O ' ' HA2' ' A' ' 188' ' ' GLY . . . . . . . . 0 C--O 1.224 -0.518 0 CA-C-O 120.818 0.121 . . . . 0.0 113.207 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . 0.664 ' CE2' ' CE2' ' A' ' 185' ' ' PHE . 1.1 p90 -156.24 176.38 12.76 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -179.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . 0.474 ' O ' ' HB ' ' A' ' 186' ' ' VAL . 7.9 p -146.43 154.66 41.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.178 0.513 . . . . 0.0 112.118 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.67 ' CE2' ' CB ' ' A' ' 257' ' ' ALA . 7.3 m-85 -105.85 147.45 28.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.761 179.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.68 HD11 ' CD2' ' A' ' 202' ' ' PHE . 2.0 mt -139.51 131.18 34.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.042 0.448 . . . . 0.0 110.646 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' THR . . . . . 0.432 HG23 ' HB3' ' A' ' 209' ' ' GLU . 38.2 m -113.18 137.99 50.63 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.752 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 0.662 ' CE2' ' CB ' ' A' ' 235' ' ' PRO . 80.4 m-85 -113.92 126.51 55.24 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.719 -0.393 . . . . 0.0 110.187 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.524 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -48.88 -39.05 24.4 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 178.243 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . 0.474 ' O ' ' HG3' ' A' ' 182' ' ' LYS . 35.9 mm-40 -98.63 169.46 9.49 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 113.528 -1.669 . . . . 0.0 109.381 178.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . 0.549 ' HB3' ' CD ' ' A' ' 182' ' ' LYS . 1.4 pm0 -108.67 17.75 21.6 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.542 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.3 OUTLIER -83.73 -61.58 0.3 Allowed Pre-proline 0 C--N 1.33 -0.25 0 C-N-CA 120.059 -0.657 . . . . 0.0 110.847 179.918 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.662 ' CB ' ' CE2' ' A' ' 230' ' ' PHE . 96.7 Cg_exo -49.18 -30.87 20.15 Favored 'Trans proline' 0 CA--C 1.498 -1.306 0 N-CA-C 108.982 -1.199 . . . . 0.0 108.982 177.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.588 HG22 ' CD1' ' A' ' 230' ' ' PHE . 15.7 t -72.25 -45.31 61.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 113.884 -1.507 . . . . 0.0 109.95 178.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . 0.542 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 33.5 pttt -63.35 -35.86 81.78 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.921 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.485 ' HA ' ' HG3' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -81.01 -49.72 10.57 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.093 0.473 . . . . 0.0 110.729 179.293 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.727 HG13 ' CE2' ' A' ' 205' ' ' PHE . 1.5 mt -46.67 -45.19 7.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.65 -0.704 . . . . 0.0 112.066 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' MET . . . . . 0.459 ' HG2' ' HB ' ' A' ' 256' ' ' VAL . 2.2 mtp -66.47 -20.03 65.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.766 -178.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.485 ' HG3' ' HA ' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -88.78 -27.32 21.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.909 0.385 . . . . 0.0 110.555 -179.883 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.538 ' N ' ' HD2' ' A' ' 242' ' ' LYS . 2.4 mmmm -80.36 106.8 12.65 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.316 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.414 ' C ' ' O ' ' A' ' 242' ' ' LYS . 0.0 OUTLIER -36.31 -62.37 0.45 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.221 -179.491 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . 0.522 ' CE1' ' CG ' ' A' ' 253' ' ' GLU . 73.9 m-85 -125.57 170.13 11.78 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.633 -179.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' HIS . . . . . 0.609 ' CG ' ' CD1' ' A' ' 254' ' ' ILE . 37.4 m-70 -130.16 156.98 43.68 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.288 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -134.66 104.8 6.19 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.215 0.531 . . . . 0.0 110.059 178.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.494 ' O ' ' C ' ' A' ' 248' ' ' GLY . 1.5 t -95.68 -179.63 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.992 -179.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . 0.494 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . -24.67 -58.06 0.05 OUTLIER Glycine 0 C--N 1.337 0.594 0 C-N-CA 121.377 -0.439 . . . . 0.0 112.991 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.37 -40.72 1.94 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.273 0.559 . . . . 0.0 111.063 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' SER . . . . . 0.529 ' HB3' ' HB3' ' A' ' 190' ' ' SER . 61.5 p -78.77 147.79 33.21 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.12 -0.945 . . . . 0.0 113.082 -178.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.466 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.1 OUTLIER -136.54 104.01 5.43 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 177.454 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' CYS . . . . . 0.526 ' HB2' ' CG1' ' A' ' 186' ' ' VAL . 0.0 OUTLIER -128.49 153.89 46.68 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -175.684 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . 0.522 ' CG ' ' CE1' ' A' ' 244' ' ' TYR . 51.1 tt0 -76.01 109.54 9.73 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.27 179.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . 0.609 ' CD1' ' CG ' ' A' ' 245' ' ' HIS . 21.7 mt -97.36 112.15 28.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -178.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . 0.508 ' O ' ' C ' ' A' ' 256' ' ' VAL . 0.0 OUTLIER -117.02 131.74 56.87 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 177.016 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . 0.532 ' CG2' ' O ' ' A' ' 183' ' ' LYS . 4.0 p -33.38 123.52 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.485 0 CA-C-O 122.307 1.051 . . . . 0.0 111.225 -177.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.692 ' HB3' ' HD3' ' A' ' 183' ' ' LYS . . . -76.11 154.29 35.65 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 113.28 -1.782 . . . . 0.0 111.915 -178.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.44 112.23 15.37 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.012 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.507 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.432 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.529 HG11 ' N ' ' A' ' 182' ' ' LYS . 47.7 t . . . . . 0 CA--C 1.503 -0.848 0 CA-C-O 121.229 0.538 . . . . 0.0 111.305 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.536 ' HG2' ' CB ' ' A' ' 233' ' ' GLU . 0.0 OUTLIER -151.38 112.31 4.27 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.481 177.463 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.638 ' HD3' ' HB3' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -132.35 152.01 51.61 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.607 179.228 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.684 HG12 ' HB ' ' A' ' 228' ' ' ILE . 0.2 OUTLIER -130.31 120.29 48.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.224 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.65 ' CE2' ' CE2' ' A' ' 225' ' ' PHE . 0.2 OUTLIER -92.67 109.53 20.95 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 121.576 0.703 . . . . 0.0 109.814 -179.544 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.579 ' CG1' ' HB2' ' A' ' 252' ' ' CYS . 24.0 t -85.68 126.6 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.244 -179.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.518 ' O ' ' N ' ' A' ' 253' ' ' GLU . . . -114.36 129.48 8.74 Favored Glycine 0 N--CA 1.453 -0.225 0 N-CA-C 115.014 0.766 . . . . 0.0 115.014 -177.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.481 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . 78.04 78.33 0.8 Allowed Glycine 0 C--N 1.331 0.264 0 C-N-CA 121.44 -0.409 . . . . 0.0 113.428 178.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . 0.526 HD12 ' N ' ' A' ' 190' ' ' SER . 0.6 OUTLIER -117.54 157.41 26.37 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 122.431 0.293 . . . . 0.0 110.726 -179.897 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' SER . . . . . 0.588 ' CB ' ' CD ' ' A' ' 191' ' ' PRO . 0.1 OUTLIER -46.7 -175.17 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.249 0 CA-C-O 121.102 0.477 . . . . 0.0 111.428 179.761 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . 0.588 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 11.8 Cg_exo -70.83 -1.7 9.77 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 123.149 2.566 . . . . 0.0 113.707 -179.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.505 ' HB2' ' O ' ' A' ' 191' ' ' PRO . 25.9 t70 169.58 74.21 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.982 0.42 . . . . 0.0 111.24 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.521 ' CB ' HD11 ' A' ' 189' ' ' LEU . 55.1 m -66.3 114.58 17.6 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.939 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.509 ' HG2' ' HG2' ' A' ' 197' ' ' LYS . 12.6 Cg_endo -56.72 115.41 2.46 Favored 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 122.478 2.119 . . . . 0.0 111.467 179.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.802 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.1 OUTLIER -53.11 -15.13 0.76 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.343 -179.641 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . 0.483 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 3.6 mt-10 -68.61 -38.96 81.0 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' A' ' 200' ' ' GLU . 19.0 mmmt -73.18 -48.93 31.1 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.802 ' CG1' ' HA ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -48.49 -30.8 3.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.222 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.564 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 2.3 mtt180 -70.56 -32.52 69.97 Favored 'General case' 0 C--O 1.221 -0.447 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.662 178.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . 0.577 ' CG ' ' N ' ' A' ' 201' ' ' TYR . 4.2 pt-20 -83.03 -56.38 3.83 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.664 179.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.577 ' N ' ' CG ' ' A' ' 200' ' ' GLU . 0.4 OUTLIER -50.31 -53.93 25.15 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.62 0.724 . . . . 0.0 109.791 179.049 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.661 ' CD2' HD12 ' A' ' 228' ' ' ILE . 0.4 OUTLIER -79.43 -29.77 42.02 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.875 -179.915 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.564 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -62.72 -57.99 13.98 Favored Glycine 0 CA--C 1.499 -0.946 0 N-CA-C 107.044 -2.422 . . . . 0.0 107.044 176.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -48.81 -29.21 7.83 Favored Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 176.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . 0.695 ' CE2' HG13 ' A' ' 239' ' ' ILE . 0.0 OUTLIER -58.36 -42.3 86.65 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.017 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.501 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 168.1 -131.1 2.23 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 113.733 -1.576 . . . . 0.0 110.212 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.516 ' HG3' ' CG ' ' A' ' 232' ' ' GLU . 1.3 mm-40 -96.8 100.64 12.17 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.239 0.542 . . . . 0.0 111.074 178.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.445 HG21 ' HB2' ' A' ' 202' ' ' PHE . 2.7 t -79.36 138.86 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 CA-C-N 115.336 -0.847 . . . . 0.0 108.813 178.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.488 ' CG ' HG21 ' A' ' 229' ' ' THR . 3.0 tp10 -89.9 -56.94 3.04 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.766 178.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 3.5 m -166.39 150.86 7.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.278 0.561 . . . . 0.0 112.245 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.651 HG22 HG12 ' A' ' 228' ' ' ILE . 0.5 OUTLIER -119.04 123.36 71.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.561 178.638 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.73 103.19 8.49 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -178.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.522 HD21 ' CB ' ' A' ' 226' ' ' CYS . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.362 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.226 -0.4 0 CA-C-O 120.756 0.087 . . . . 0.0 113.245 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . 0.65 ' CE2' ' CE2' ' A' ' 185' ' ' PHE . 1.4 p90 -156.83 176.77 12.3 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . 0.522 ' CB ' HD21 ' A' ' 213' ' ' LEU . 30.5 p -145.78 156.38 43.55 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.505 -0.478 . . . . 0.0 112.255 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.669 ' CE2' ' CB ' ' A' ' 257' ' ' ALA . 5.4 m-85 -107.94 143.55 36.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.642 179.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.684 ' HB ' HG12 ' A' ' 184' ' ' ILE . 2.0 mt -137.13 128.34 41.26 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.401 0 CA-C-O 121.175 0.512 . . . . 0.0 111.495 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' THR . . . . . 0.488 HG21 ' CG ' ' A' ' 209' ' ' GLU . 54.9 m -110.88 138.15 47.63 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.834 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 0.649 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 67.9 m-85 -111.64 126.1 54.66 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.766 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.479 ' HG3' ' O ' ' A' ' 207' ' ' GLU . 0.1 OUTLIER -49.81 -38.52 34.95 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 177.711 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . 0.516 ' CG ' ' HG3' ' A' ' 207' ' ' GLU . 60.5 mm-40 -89.86 -167.8 1.95 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 113.154 -1.839 . . . . 0.0 109.274 178.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . 0.536 ' CB ' ' HG2' ' A' ' 182' ' ' LYS . 0.8 OUTLIER -131.32 -1.28 3.99 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -179.876 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.504 ' HB2' ' HD3' ' A' ' 235' ' ' PRO . 2.0 mt-10 -73.69 -58.14 2.32 Favored Pre-proline 0 C--N 1.329 -0.29 0 C-N-CA 120.433 -0.507 . . . . 0.0 112.141 -179.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.595 ' CB ' ' CE2' ' A' ' 230' ' ' PHE . 79.8 Cg_exo -49.22 -31.07 20.96 Favored 'Trans proline' 0 CA--C 1.498 -1.303 0 N-CA-C 109.066 -1.167 . . . . 0.0 109.066 178.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.596 HG22 ' CD1' ' A' ' 230' ' ' PHE . 17.6 t -72.22 -44.07 64.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 114.019 -1.446 . . . . 0.0 109.189 178.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . 0.5 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 2.1 mtpp -52.74 -47.95 67.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.396 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.646 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -80.61 -52.79 7.18 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.926 -179.268 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.695 HG13 ' CE2' ' A' ' 205' ' ' PHE . 1.9 mt -38.49 -51.51 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.917 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' MET . . . . . 0.404 ' HG3' ' O ' ' A' ' 236' ' ' VAL . 22.7 mtp -59.17 -26.78 65.08 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.052 -179.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.515 ' HG3' ' CD ' ' A' ' 242' ' ' LYS . 0.2 OUTLIER -81.56 -27.91 34.13 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.676 179.89 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.515 ' CD ' ' HG3' ' A' ' 241' ' ' GLU . 0.6 OUTLIER -81.32 96.79 7.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.616 179.688 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.474 ' O ' ' HG3' ' A' ' 253' ' ' GLU . 0.0 OUTLIER -36.17 -55.0 0.8 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.867 -179.971 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . 0.53 ' CE1' ' HG3' ' A' ' 253' ' ' GLU . 32.7 m-85 -126.26 158.4 35.82 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.299 0.571 . . . . 0.0 111.836 -179.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' HIS . . . . . 0.585 ' CE1' HG12 ' A' ' 239' ' ' ILE . 32.2 m-70 -127.85 157.46 40.42 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.531 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . 0.462 ' O ' ' CE2' ' A' ' 201' ' ' TYR . 2.2 m-80 -127.82 104.69 7.97 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.211 0.529 . . . . 0.0 110.423 178.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.523 ' O ' ' C ' ' A' ' 248' ' ' GLY . 1.4 t -95.31 174.92 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.253 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . 0.523 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . -14.66 -57.16 0.01 OUTLIER Glycine 0 C--N 1.34 0.759 0 O-C-N 123.662 0.601 . . . . 0.0 113.316 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.486 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -133.39 -39.8 0.91 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.959 -0.621 . . . . 0.0 110.939 -179.883 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' SER . . . . . 0.498 ' HB3' ' HB2' ' A' ' 190' ' ' SER . 6.0 p -78.24 152.2 32.7 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.159 -0.928 . . . . 0.0 113.192 -178.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.517 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -137.19 108.6 6.89 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.419 178.211 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' CYS . . . . . 0.579 ' HB2' ' CG1' ' A' ' 186' ' ' VAL . 0.0 OUTLIER -128.63 153.73 46.97 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -176.357 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . 0.53 ' HG3' ' CE1' ' A' ' 244' ' ' TYR . 59.4 tt0 -76.08 108.11 8.75 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.832 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . 0.607 ' CG2' ' CG2' ' A' ' 239' ' ' ILE . 13.2 mt -96.47 112.24 28.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 -178.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . 0.514 ' O ' ' C ' ' A' ' 256' ' ' VAL . 0.0 OUTLIER -116.15 130.16 56.66 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 176.568 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . 0.549 ' CG2' ' O ' ' A' ' 183' ' ' LYS . 3.6 p -32.78 123.54 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 122.136 0.969 . . . . 0.0 111.372 -177.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.669 ' CB ' ' CE2' ' A' ' 227' ' ' PHE . . . -76.67 153.71 34.92 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 113.522 -1.672 . . . . 0.0 111.716 -178.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.48 112.92 14.87 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.354 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.518 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.08 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.535 HG11 ' N ' ' A' ' 182' ' ' LYS . 42.8 t . . . . . 0 CA--C 1.504 -0.802 0 CA-C-O 121.181 0.515 . . . . 0.0 111.615 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.535 ' N ' HG11 ' A' ' 181' ' ' VAL . 0.7 OUTLIER -149.99 112.67 4.76 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.488 177.731 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.643 ' HD3' ' HB3' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -134.15 142.57 47.51 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.747 179.838 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.621 HG12 ' HB ' ' A' ' 228' ' ' ILE . 0.2 OUTLIER -122.59 120.08 59.93 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.445 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.606 ' CB ' ' HA ' ' A' ' 257' ' ' ALA . 0.3 OUTLIER -91.73 109.44 20.76 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.68 0.752 . . . . 0.0 110.054 -179.135 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.6 ' CG1' ' HB2' ' A' ' 252' ' ' CYS . 48.7 t -85.53 126.43 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 CA-C-N 114.689 -1.141 . . . . 0.0 109.373 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.542 ' O ' ' HB3' ' A' ' 252' ' ' CYS . . . -112.99 134.8 12.18 Favored Glycine 0 C--N 1.331 0.288 0 N-CA-C 115.276 0.87 . . . . 0.0 115.276 -176.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.492 ' O ' ' HB3' ' A' ' 252' ' ' CYS . . . 64.51 84.09 0.08 OUTLIER Glycine 0 C--N 1.333 0.396 0 CA-C-N 115.516 -0.342 . . . . 0.0 112.675 178.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . 0.527 ' CD2' ' C ' ' A' ' 225' ' ' PHE . 1.1 pp -117.36 157.83 25.46 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.045 0.45 . . . . 0.0 112.039 -178.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' SER . . . . . 0.588 ' CB ' ' CD ' ' A' ' 191' ' ' PRO . 0.3 OUTLIER -44.68 -173.91 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.227 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.965 179.815 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . 0.588 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 6.4 Cg_exo -74.75 9.48 1.93 Allowed 'Trans proline' 0 CA--C 1.53 0.289 0 C-N-CA 123.125 2.55 . . . . 0.0 113.507 -179.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.54 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 1.1 m-20 158.2 78.24 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 120.842 0.353 . . . . 0.0 111.534 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.534 HG22 ' CD1' ' A' ' 198' ' ' ILE . 19.2 m -68.78 112.17 10.55 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.633 179.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.549 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 54.9 Cg_endo -67.3 107.04 1.31 Allowed 'Trans proline' 0 N--CA 1.465 -0.158 0 C-N-CA 122.668 2.245 . . . . 0.0 111.767 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.58 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -41.06 -21.51 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.32 -0.4 . . . . 0.0 112.016 -179.964 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 11.0 mt-10 -59.37 -43.71 92.84 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -178.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.549 ' CD ' ' HG2' ' A' ' 194' ' ' PRO . 0.6 OUTLIER -79.15 -46.21 18.42 Favored 'General case' 0 CA--C 1.494 -1.208 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 178.68 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.617 HG23 ' CE1' ' A' ' 202' ' ' PHE . 0.2 OUTLIER -49.07 -29.58 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-N 114.191 -1.368 . . . . 0.0 108.396 176.86 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.534 ' HG3' ' O ' ' A' ' 195' ' ' GLU . 4.6 mtp85 -74.16 -32.56 63.17 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.845 178.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . 0.528 ' N ' ' O ' ' A' ' 197' ' ' LYS . 5.4 mt-10 -82.61 -59.13 2.62 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.57 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.514 ' OH ' ' ND1' ' A' ' 245' ' ' HIS . 0.4 OUTLIER -47.96 -52.16 20.77 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.136 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.67 ' O ' ' HB2' ' A' ' 205' ' ' PHE . 0.4 OUTLIER -79.7 -31.69 41.26 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.301 179.459 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.53 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -61.84 -58.07 14.61 Favored Glycine 0 N--CA 1.442 -0.906 0 N-CA-C 107.613 -2.195 . . . . 0.0 107.613 176.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -49.76 -27.91 10.28 Favored Glycine 0 N--CA 1.441 -1.003 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 176.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . 0.735 ' CE2' HG13 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -57.76 -46.05 85.08 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 177.826 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.505 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 173.56 -132.28 2.27 Favored Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 113.639 -1.618 . . . . 0.0 110.25 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.486 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 3.1 mm-40 -97.19 99.84 11.32 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.134 0.492 . . . . 0.0 111.08 178.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 2.6 t -74.76 139.08 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.535 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 60.0 tt0 -91.03 -56.03 3.32 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 178.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -161.88 153.96 19.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.861 179.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.58 ' CG2' HD13 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -122.97 123.95 69.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.488 178.725 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -123.57 104.75 9.23 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -177.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.478 HD11 ' CD1' ' A' ' 198' ' ' ILE . 0.7 OUTLIER . . . . . 0 CA--C 1.531 0.233 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 176.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.598 0 CA-C-O 121.264 0.369 . . . . 0.0 112.863 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . 0.571 ' CE2' ' CE2' ' A' ' 185' ' ' PHE . 0.2 OUTLIER -156.49 176.48 12.65 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.985 -0.608 . . . . 0.0 109.406 -178.311 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . 0.525 ' O ' ' HB ' ' A' ' 186' ' ' VAL . 0.5 OUTLIER -139.77 156.89 46.52 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.033 -0.667 . . . . 0.0 112.225 -179.339 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.673 ' CE2' ' CB ' ' A' ' 257' ' ' ALA . 4.7 m-85 -114.24 132.26 56.2 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.428 -0.806 . . . . 0.0 108.968 179.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.646 HD11 ' CD2' ' A' ' 202' ' ' PHE . 2.2 mt -126.13 124.8 66.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.16 0.505 . . . . 0.0 111.41 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' THR . . . . . 0.461 HG22 ' HB3' ' A' ' 209' ' ' GLU . 85.1 m -106.1 138.08 42.9 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.496 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 0.677 ' CE1' ' CB ' ' A' ' 235' ' ' PRO . 74.7 m-85 -113.05 126.47 55.52 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.377 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.535 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -49.28 -38.4 27.03 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 178.334 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . 0.455 ' HB3' ' OE2' ' A' ' 234' ' ' GLU . 49.1 mt-10 -91.49 -168.57 2.07 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 113.399 -1.728 . . . . 0.0 109.673 179.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . 0.496 ' CB ' ' HG2' ' A' ' 182' ' ' LYS . 0.6 OUTLIER -131.34 14.04 5.06 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.834 -0.347 . . . . 0.0 111.372 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.566 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.4 OUTLIER -84.55 -60.06 0.32 Allowed Pre-proline 0 C--N 1.33 -0.263 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.702 179.873 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.677 ' CB ' ' CE1' ' A' ' 230' ' ' PHE . 87.1 Cg_exo -49.31 -32.59 26.21 Favored 'Trans proline' 0 CA--C 1.502 -1.103 0 N-CA-C 109.089 -1.158 . . . . 0.0 109.089 178.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.521 ' CG2' ' HB2' ' A' ' 230' ' ' PHE . 21.7 t -72.51 -43.44 63.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 113.938 -1.483 . . . . 0.0 110.429 179.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . 0.566 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 1.8 ptpt -64.07 -36.18 83.17 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.789 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.485 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 0.0 OUTLIER -82.19 -50.15 9.33 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.9 0.381 . . . . 0.0 111.269 179.279 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.735 HG13 ' CE2' ' A' ' 205' ' ' PHE . 1.5 mt -44.6 -48.77 2.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.252 -179.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' MET . . . . . 0.469 ' HG2' ' HB ' ' A' ' 256' ' ' VAL . 22.3 mtp -61.97 -26.51 68.26 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.944 -178.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.45 ' CG ' ' O ' ' A' ' 237' ' ' LYS . 1.1 mt-10 -86.99 -16.73 34.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.826 0.346 . . . . 0.0 111.248 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.47 ' HG2' ' O ' ' A' ' 238' ' ' LYS . 2.9 mmmt -80.55 118.42 22.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.138 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.464 ' HG2' ' N ' ' A' ' 244' ' ' TYR . 13.8 ttpt -41.9 -81.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . 0.486 ' CD1' ' HG3' ' A' ' 253' ' ' GLU . 12.1 m-85 -114.74 157.15 23.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.407 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' HIS . . . . . 0.586 ' CE1' HG12 ' A' ' 239' ' ' ILE . 24.2 m-70 -113.68 150.23 33.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.241 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . 0.417 ' O ' ' CE2' ' A' ' 201' ' ' TYR . 0.2 OUTLIER -127.85 105.35 8.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.859 179.704 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.533 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.7 t -110.35 110.22 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.985 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 45.61 -87.71 0.01 OUTLIER Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.407 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.533 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -106.49 -39.97 5.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.363 0.601 . . . . 0.0 110.546 179.639 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' SER . . . . . 0.455 ' OG ' ' OG1' ' A' ' 193' ' ' THR . 1.5 m -77.43 147.42 35.98 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.033 -178.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -143.97 106.24 4.39 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.463 179.162 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' CYS . . . . . 0.6 ' HB2' ' CG1' ' A' ' 186' ' ' VAL . 0.0 OUTLIER -128.21 153.12 47.27 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -176.541 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . 0.486 ' HG3' ' CD1' ' A' ' 244' ' ' TYR . 50.1 tt0 -76.29 107.57 8.62 Favored 'General case' 0 C--O 1.224 -0.27 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.172 178.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . 0.592 ' CG2' ' CG2' ' A' ' 239' ' ' ILE . 29.2 mt -96.39 113.3 30.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -177.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . 0.51 ' O ' ' C ' ' A' ' 256' ' ' VAL . 0.0 OUTLIER -117.25 133.09 56.4 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 176.677 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . 0.55 ' CG2' ' O ' ' A' ' 183' ' ' LYS . 5.5 p -33.23 124.94 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-O 122.251 1.024 . . . . 0.0 111.304 -177.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.673 ' CB ' ' CE2' ' A' ' 227' ' ' PHE . . . -78.27 152.95 32.24 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 113.423 -1.717 . . . . 0.0 112.48 -178.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.73 113.85 15.86 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.511 -1.222 . . . . 0.0 110.081 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 83.6 p . . . . . 0 C--N 1.323 -0.586 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.859 -179.828 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.525 HG13 ' N ' ' A' ' 182' ' ' LYS . 43.5 t . . . . . 0 CA--C 1.505 -0.765 0 CA-C-O 121.362 0.601 . . . . 0.0 112.328 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.528 ' CB ' HG23 ' A' ' 236' ' ' VAL . 8.0 mmtt -145.76 112.38 5.91 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.243 176.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.684 ' HD3' ' HB2' ' A' ' 257' ' ' ALA . 0.0 OUTLIER -130.62 162.45 29.33 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.965 179.775 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.643 HG12 ' HB ' ' A' ' 228' ' ' ILE . 0.3 OUTLIER -138.55 119.74 16.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 177.532 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.568 ' CE2' ' CE2' ' A' ' 225' ' ' PHE . 0.2 OUTLIER -92.52 109.49 20.89 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.587 0.708 . . . . 0.0 110.195 -178.914 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.584 ' CG1' ' HB2' ' A' ' 252' ' ' CYS . 40.6 t -84.29 128.07 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.894 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.529 ' O ' ' N ' ' A' ' 253' ' ' GLU . . . -116.5 132.76 10.32 Favored Glycine 0 N--CA 1.451 -0.319 0 N-CA-C 115.053 0.781 . . . . 0.0 115.053 -176.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.486 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . 71.39 80.11 0.36 Allowed Glycine 0 N--CA 1.452 -0.292 0 CA-C-N 115.442 -0.379 . . . . 0.0 113.397 178.171 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . 0.525 ' CD2' ' C ' ' A' ' 225' ' ' PHE . 0.8 OUTLIER -117.26 157.57 25.82 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.701 0.286 . . . . 0.0 110.958 -179.796 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' SER . . . . . 0.593 ' CB ' ' CD ' ' A' ' 191' ' ' PRO . 0.2 OUTLIER -47.71 -173.66 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.934 179.585 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . 0.593 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 5.7 Cg_exo -78.36 17.09 1.12 Allowed 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.956 2.437 . . . . 0.0 113.272 -179.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.538 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 1.2 m-20 159.73 76.89 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.117 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.635 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.541 HG23 ' CD1' ' A' ' 198' ' ' ILE . 50.1 m -71.45 114.55 28.94 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 120.855 0.36 . . . . 0.0 110.432 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.487 ' HG2' ' HG2' ' A' ' 197' ' ' LYS . 16.3 Cg_endo -58.52 110.05 0.6 Allowed 'Trans proline' 0 N--CA 1.464 -0.243 0 C-N-CA 122.369 2.046 . . . . 0.0 111.748 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.798 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -50.9 -15.69 0.33 Allowed 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.143 -179.875 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . 0.477 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 23.1 mm-40 -71.94 -36.89 70.03 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' A' ' 200' ' ' GLU . 0.0 OUTLIER -73.92 -48.01 33.72 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.186 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.798 ' CG1' ' HA ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -47.68 -30.73 2.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.225 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.589 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 6.5 mtt180 -71.72 -32.4 67.73 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.189 179.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . 0.53 ' N ' ' O ' ' A' ' 197' ' ' LYS . 0.4 OUTLIER -82.83 -46.19 13.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.023 0.44 . . . . 0.0 110.646 179.292 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.56 ' OH ' ' ND1' ' A' ' 245' ' ' HIS . 0.5 OUTLIER -63.04 -53.55 52.11 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.004 179.407 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.665 ' CD2' HD13 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -79.88 -31.41 40.33 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 114.845 -1.07 . . . . 0.0 110.339 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.589 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -64.85 -54.36 28.7 Favored Glycine 0 CA--C 1.497 -1.071 0 N-CA-C 106.535 -2.626 . . . . 0.0 106.535 176.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -50.23 -29.3 15.54 Favored Glycine 0 N--CA 1.442 -0.928 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 175.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . 0.723 ' CE2' HG13 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -58.34 -44.76 88.86 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 177.783 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 170.55 -129.89 1.89 Allowed Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 113.717 -1.583 . . . . 0.0 110.616 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.454 ' HB3' ' HE2' ' A' ' 231' ' ' LYS . 2.9 mm-40 -97.01 99.69 11.21 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.289 0.566 . . . . 0.0 111.321 178.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 2.6 t -77.5 143.39 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 CA-C-N 115.324 -0.853 . . . . 0.0 108.845 178.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.508 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 5.8 tp10 -93.7 -56.78 2.78 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 4.4 m -166.94 149.92 6.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.959 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.636 HG23 HG12 ' A' ' 228' ' ' ILE . 0.4 OUTLIER -117.19 126.37 74.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.664 178.922 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -123.09 103.07 8.34 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -178.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.46 HD23 ' HB ' ' A' ' 193' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.241 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 177.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.615 0 CA-C-O 121.242 0.357 . . . . 0.0 112.701 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . 0.568 ' CE2' ' CE2' ' A' ' 185' ' ' PHE . 0.1 OUTLIER -156.79 176.7 12.39 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -178.339 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . 0.504 ' O ' ' HB ' ' A' ' 186' ' ' VAL . 1.3 p -139.48 156.32 47.01 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.016 -0.674 . . . . 0.0 112.544 -179.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.67 ' CE2' ' CB ' ' A' ' 257' ' ' ALA . 3.8 m-85 -113.95 133.44 55.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.495 -0.775 . . . . 0.0 108.965 178.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.665 HD13 ' CD2' ' A' ' 202' ' ' PHE . 2.0 mt -128.55 133.26 66.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.142 0.496 . . . . 0.0 111.475 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' THR . . . . . 0.471 HG23 ' CB ' ' A' ' 209' ' ' GLU . 97.7 m -113.03 138.05 50.48 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.155 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 0.66 ' CE1' ' CB ' ' A' ' 235' ' ' PRO . 67.9 m-85 -112.8 126.44 55.43 Favored 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.053 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.508 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -50.52 -37.83 41.25 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 177.737 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -90.1 -165.86 1.45 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 113.152 -1.84 . . . . 0.0 109.691 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . 0.499 ' HB2' ' HD2' ' A' ' 182' ' ' LYS . 0.4 OUTLIER -134.64 8.53 3.6 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.667 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.531 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.3 OUTLIER -82.14 -59.92 0.41 Allowed Pre-proline 0 C--N 1.328 -0.369 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.755 179.939 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.66 ' CB ' ' CE1' ' A' ' 230' ' ' PHE . 80.2 Cg_exo -49.48 -30.91 22.27 Favored 'Trans proline' 0 CA--C 1.499 -1.27 0 N-CA-C 108.986 -1.198 . . . . 0.0 108.986 178.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.536 ' CG2' ' HB2' ' A' ' 230' ' ' PHE . 21.1 t -73.92 -45.69 48.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 114.473 -1.239 . . . . 0.0 110.272 178.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . 0.531 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 1.2 ptpt -61.74 -36.23 80.38 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.606 -179.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.635 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -82.29 -54.89 4.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.172 178.918 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.723 HG13 ' CE2' ' A' ' 205' ' ' PHE . 1.7 mt -40.33 -50.69 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.951 -179.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' MET . . . . . 0.484 ' HG2' ' HB ' ' A' ' 256' ' ' VAL . 17.3 mtp -60.06 -24.68 64.76 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.787 -178.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.487 ' CG ' ' O ' ' A' ' 237' ' ' LYS . 1.0 OUTLIER -87.91 -17.08 32.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.798 0.333 . . . . 0.0 111.261 -179.715 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.461 ' HD3' ' O ' ' A' ' 238' ' ' LYS . 0.1 OUTLIER -79.68 123.77 27.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.352 -179.742 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.461 ' HE3' ' HB2' ' A' ' 244' ' ' TYR . 7.7 ttpt -50.38 -75.53 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 178.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . 0.532 ' CD1' ' HG3' ' A' ' 253' ' ' GLU . 17.3 m-85 -121.02 144.81 48.33 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.932 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' HIS . . . . . 0.638 ' CG ' ' CD1' ' A' ' 254' ' ' ILE . 30.1 m-70 -104.55 150.63 24.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.096 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . 0.446 ' O ' ' CE2' ' A' ' 201' ' ' TYR . 0.0 OUTLIER -129.58 104.68 7.59 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.221 0.534 . . . . 0.0 110.493 179.164 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.556 ' O ' ' C ' ' A' ' 248' ' ' GLY . 1.7 t -95.29 170.24 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.737 -179.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . 0.556 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . -8.3 -64.66 0.01 OUTLIER Glycine 0 C--N 1.341 0.825 0 O-C-N 123.669 0.606 . . . . 0.0 113.797 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.467 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -126.0 -39.82 2.07 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.509 0.671 . . . . 0.0 110.501 -179.282 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' SER . . . . . 0.525 ' HB3' ' HB2' ' A' ' 190' ' ' SER . 0.2 OUTLIER -77.3 157.33 30.79 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.745 -1.116 . . . . 0.0 112.734 -178.197 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -142.42 107.97 5.07 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.182 179.27 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' CYS . . . . . 0.584 ' HB2' ' CG1' ' A' ' 186' ' ' VAL . 0.0 OUTLIER -128.67 152.96 47.79 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -177.255 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . 0.532 ' HG3' ' CD1' ' A' ' 244' ' ' TYR . 49.3 tt0 -76.61 108.48 9.64 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.581 179.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . 0.638 ' CD1' ' CG ' ' A' ' 245' ' ' HIS . 30.6 mt -96.8 113.44 31.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 -178.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . 0.509 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -115.94 133.25 56.22 Favored 'General case' 0 C--O 1.22 -0.448 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 176.508 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . 0.514 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.4 p -33.2 124.51 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-O 122.096 0.95 . . . . 0.0 111.324 -177.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.684 ' HB2' ' HD3' ' A' ' 183' ' ' LYS . . . -79.56 151.18 30.82 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 113.633 -1.621 . . . . 0.0 112.37 -178.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.62 115.85 19.41 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.089 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 29.7 p . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.057 -179.676 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.527 HG11 ' N ' ' A' ' 182' ' ' LYS . 45.3 t . . . . . 0 CA--C 1.503 -0.855 0 CA-C-O 121.044 0.449 . . . . 0.0 111.204 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.527 ' N ' HG11 ' A' ' 181' ' ' VAL . 0.0 OUTLIER -151.14 112.34 4.34 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.103 177.66 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.635 ' HD3' ' HB1' ' A' ' 257' ' ' ALA . 0.0 OUTLIER -135.64 142.6 45.21 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.978 178.863 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.652 HG12 ' HB ' ' A' ' 228' ' ' ILE . 0.4 OUTLIER -122.04 120.91 62.7 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.183 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.666 ' CE2' ' CE2' ' A' ' 225' ' ' PHE . 0.2 OUTLIER -94.14 109.34 21.13 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 121.553 0.692 . . . . 0.0 110.23 -179.195 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.586 ' CG1' ' HB2' ' A' ' 252' ' ' CYS . 4.9 t -85.03 128.86 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.802 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.532 ' O ' ' N ' ' A' ' 253' ' ' GLU . . . -115.6 127.87 7.78 Favored Glycine 0 C--N 1.332 0.316 0 N-CA-C 115.124 0.809 . . . . 0.0 115.124 -176.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.484 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . 76.26 82.04 0.53 Allowed Glycine 0 C--N 1.332 0.312 0 C-N-CA 121.354 -0.45 . . . . 0.0 113.419 178.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . 0.524 ' CD1' ' OG1' ' A' ' 193' ' ' THR . 1.2 pp -117.43 157.18 26.67 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.778 0.323 . . . . 0.0 111.168 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' SER . . . . . 0.574 ' CB ' ' CD ' ' A' ' 191' ' ' PRO . 0.2 OUTLIER -46.67 -177.45 0.01 OUTLIER Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.256 0.551 . . . . 0.0 111.592 -179.927 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . 0.574 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 19.6 Cg_exo -67.31 -2.73 8.68 Favored 'Trans proline' 0 CA--C 1.53 0.291 0 C-N-CA 123.395 2.73 . . . . 0.0 113.908 -179.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 191' ' ' PRO . 0.8 OUTLIER 171.76 73.0 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.905 0.383 . . . . 0.0 111.667 -179.811 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.528 HG21 ' CD1' ' A' ' 198' ' ' ILE . 93.7 m -61.52 122.32 70.03 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.998 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.439 ' C ' HD12 ' A' ' 198' ' ' ILE . 55.7 Cg_endo -70.09 114.62 3.82 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.157 1.905 . . . . 0.0 111.103 178.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.813 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -51.61 -15.16 0.41 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 121.056 -0.257 . . . . 0.0 111.265 -179.439 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . 0.498 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 4.9 mt-10 -67.91 -40.42 83.41 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.521 ' O ' ' N ' ' A' ' 200' ' ' GLU . 0.4 OUTLIER -70.71 -50.95 30.92 Favored 'General case' 0 CA--C 1.5 -0.98 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.222 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.813 ' CG1' ' HA ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -47.59 -32.43 2.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 115.297 -0.865 . . . . 0.0 108.751 178.717 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.555 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 16.7 mtt85 -69.92 -33.4 72.12 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.975 178.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . 0.521 ' N ' ' O ' ' A' ' 197' ' ' LYS . 8.5 mm-40 -81.87 -60.13 2.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.278 0.561 . . . . 0.0 109.928 179.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.532 ' OH ' ' ND1' ' A' ' 245' ' ' HIS . 0.3 OUTLIER -49.31 -54.19 18.29 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.025 178.932 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.675 ' CD2' HD13 ' A' ' 228' ' ' ILE . 0.2 OUTLIER -79.74 -31.5 41.04 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.991 -179.589 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.555 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -63.77 -56.47 18.81 Favored Glycine 0 CA--C 1.499 -0.95 0 N-CA-C 107.037 -2.425 . . . . 0.0 107.037 176.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -49.4 -28.44 9.47 Favored Glycine 0 N--CA 1.442 -0.937 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 176.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . 0.75 ' CE2' HG13 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -57.19 -48.56 78.45 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 177.769 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 175.62 -130.15 1.67 Allowed Glycine 0 N--CA 1.44 -1.078 0 CA-C-N 113.65 -1.614 . . . . 0.0 110.31 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.484 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 20.7 mm-40 -96.96 100.96 12.45 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.144 0.497 . . . . 0.0 110.861 178.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 2.8 t -77.93 141.37 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.515 ' CG ' HG23 ' A' ' 229' ' ' THR . 5.8 tp10 -91.9 -55.7 3.36 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 8.0 m -167.69 148.78 5.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.874 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.624 HG22 HG12 ' A' ' 228' ' ' ILE . 0.4 OUTLIER -115.72 125.67 72.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.882 178.931 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.28 105.01 9.49 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.334 -178.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.456 HD22 ' O ' ' A' ' 193' ' ' THR . 0.1 OUTLIER . . . . . 0 CA--C 1.534 0.349 0 CA-C-O 120.841 0.353 . . . . 0.0 110.822 178.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.407 0 N-CA-C 112.922 -0.071 . . . . 0.0 112.922 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . 0.666 ' CE2' ' CE2' ' A' ' 185' ' ' PHE . 1.5 p90 -156.79 176.47 12.69 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . 0.465 ' O ' ' HB ' ' A' ' 186' ' ' VAL . 27.7 p -146.0 152.22 39.02 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.658 ' CE2' ' CB ' ' A' ' 257' ' ' ALA . 6.1 m-85 -106.21 139.43 40.74 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.082 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.675 HD13 ' CD2' ' A' ' 202' ' ' PHE . 2.0 mt -133.58 129.84 56.01 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.386 0 CA-C-O 120.879 0.371 . . . . 0.0 110.985 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' THR . . . . . 0.515 HG23 ' CG ' ' A' ' 209' ' ' GLU . 53.5 m -111.17 138.22 47.88 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.897 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 0.66 ' CE1' ' CB ' ' A' ' 235' ' ' PRO . 81.4 m-85 -114.51 126.44 54.94 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.445 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.484 ' HG3' ' O ' ' A' ' 207' ' ' GLU . 0.0 OUTLIER -47.77 -39.63 18.49 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 178.134 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . 0.472 ' O ' ' HG3' ' A' ' 182' ' ' LYS . 5.9 mm-40 -99.29 171.29 8.08 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 113.452 -1.704 . . . . 0.0 109.684 179.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . 0.447 ' HB3' ' CE ' ' A' ' 182' ' ' LYS . 0.0 OUTLIER -110.21 21.07 17.17 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.307 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.561 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.0 OUTLIER -85.18 -62.16 0.26 Allowed Pre-proline 0 C--N 1.331 -0.221 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.699 179.619 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.66 ' CB ' ' CE1' ' A' ' 230' ' ' PHE . 87.3 Cg_exo -50.37 -29.69 24.54 Favored 'Trans proline' 0 CA--C 1.502 -1.101 0 N-CA-C 108.811 -1.265 . . . . 0.0 108.811 177.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.58 HG22 ' CD2' ' A' ' 230' ' ' PHE . 20.9 t -72.66 -42.96 62.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 113.768 -1.56 . . . . 0.0 110.324 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . 0.561 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 9.3 pttp -64.26 -36.41 84.0 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.738 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.541 ' O ' ' CG ' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -81.43 -50.37 9.52 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.16 0.505 . . . . 0.0 110.92 179.183 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.75 HG13 ' CE2' ' A' ' 205' ' ' PHE . 1.6 mt -45.53 -53.04 2.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.847 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' MET . . . . . 0.458 ' HG2' ' HB ' ' A' ' 256' ' ' VAL . 11.5 mtp -60.46 -17.1 42.59 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.263 -178.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.541 ' CG ' ' O ' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -88.37 -26.29 22.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.893 0.377 . . . . 0.0 111.0 -179.813 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.506 ' CD ' ' HG3' ' A' ' 241' ' ' GLU . 5.3 mmmt -79.58 109.8 14.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.01 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.468 ' HD3' ' CD1' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -40.18 -62.42 0.75 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.34 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . 0.555 ' CD1' ' HG3' ' A' ' 253' ' ' GLU . 12.9 m-30 -122.01 161.7 22.48 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.897 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' HIS . . . . . 0.646 ' CG ' ' CD1' ' A' ' 254' ' ' ILE . 20.5 m-70 -122.82 156.76 33.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.822 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . 0.416 ' O ' ' CE2' ' A' ' 201' ' ' TYR . 1.3 m-80 -133.24 105.15 6.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.172 0.511 . . . . 0.0 110.581 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.55 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.5 t -108.52 138.71 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.556 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . 0.479 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . 26.65 -87.57 0.01 OUTLIER Glycine 0 C--N 1.337 0.619 0 C-N-CA 121.163 -0.541 . . . . 0.0 113.017 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.55 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.1 OUTLIER -108.87 -34.63 6.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.774 0.797 . . . . 0.0 109.845 -179.861 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' SER . . . . . 0.516 ' O ' ' N ' ' A' ' 247' ' ' VAL . 3.0 p -77.25 152.92 34.46 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.248 -1.342 . . . . 0.0 113.176 -177.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -143.31 104.66 4.29 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 114.739 -1.118 . . . . 0.0 108.361 178.464 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' CYS . . . . . 0.586 ' HB2' ' CG1' ' A' ' 186' ' ' VAL . 0.0 OUTLIER -128.34 152.77 47.76 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -176.399 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . 0.555 ' HG3' ' CD1' ' A' ' 244' ' ' TYR . 50.7 tt0 -76.93 107.79 9.52 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.982 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . 0.646 ' CD1' ' CG ' ' A' ' 245' ' ' HIS . 26.1 mt -96.46 112.84 29.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -178.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . 0.521 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -115.02 130.98 57.06 Favored 'General case' 0 C--O 1.221 -0.41 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 176.418 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . 0.551 ' CG2' ' O ' ' A' ' 183' ' ' LYS . 10.0 p -33.16 124.46 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 122.156 0.979 . . . . 0.0 111.475 -177.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.658 ' CB ' ' CE2' ' A' ' 227' ' ' PHE . . . -76.68 153.93 34.68 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 113.501 -1.681 . . . . 0.0 111.448 -178.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.1 111.82 13.9 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.046 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' SER . . . . . 0.44 ' HB2' ' HD2' ' A' ' 183' ' ' LYS . 0.2 OUTLIER . . . . . 0 C--N 1.325 -0.459 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.7 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.527 HG12 ' N ' ' A' ' 182' ' ' LYS . 40.6 t . . . . . 0 CA--C 1.506 -0.745 0 CA-C-O 121.261 0.553 . . . . 0.0 111.77 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.527 ' N ' HG12 ' A' ' 181' ' ' VAL . 0.2 OUTLIER -148.02 112.5 5.31 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.029 177.442 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.609 ' HD3' ' HB1' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -130.5 145.45 51.86 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.382 179.271 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.672 HG12 ' HB ' ' A' ' 228' ' ' ILE . 0.3 OUTLIER -125.35 120.43 57.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.113 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.545 ' CA ' ' HB3' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -93.86 109.22 20.93 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.475 -178.875 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.56 ' CG1' HG12 ' A' ' 254' ' ' ILE . 2.8 t -84.44 124.65 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.196 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.515 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . -112.07 126.69 7.73 Favored Glycine 0 N--CA 1.451 -0.337 0 N-CA-C 114.932 0.733 . . . . 0.0 114.932 -176.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.478 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . 76.69 84.05 0.47 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 121.418 -0.42 . . . . 0.0 113.286 178.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . 0.528 HD11 ' N ' ' A' ' 190' ' ' SER . 0.9 OUTLIER -117.07 157.01 26.58 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.657 0.265 . . . . 0.0 110.788 179.843 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' SER . . . . . 0.586 ' CB ' ' CD ' ' A' ' 191' ' ' PRO . 0.1 OUTLIER -46.72 -175.15 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.061 179.818 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . 0.586 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 4.0 Cg_exo -79.79 17.76 1.24 Allowed 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 123.024 2.483 . . . . 0.0 112.949 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.494 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 1.0 OUTLIER 161.86 74.72 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.126 0 CA-C-O 120.621 0.248 . . . . 0.0 111.363 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.515 ' CB ' HD13 ' A' ' 189' ' ' LEU . 55.2 m -74.59 112.86 19.27 Favored Pre-proline 0 C--N 1.332 -0.169 0 CA-C-O 120.912 0.387 . . . . 0.0 110.919 179.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.532 ' HG2' ' CG ' ' A' ' 197' ' ' LYS . 26.6 Cg_endo -62.65 109.03 0.8 Allowed 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 122.3 2.0 . . . . 0.0 111.485 179.163 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.834 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -48.0 -15.4 0.06 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 111.849 0.314 . . . . 0.0 111.849 -179.658 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . 0.444 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 6.8 mm-40 -65.98 -37.06 84.99 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.532 ' CG ' ' HG2' ' A' ' 194' ' ' PRO . 0.8 OUTLIER -75.54 -50.95 14.08 Favored 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.258 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.834 ' CG1' ' HA ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -46.63 -31.19 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.314 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.54 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 5.2 mtp85 -70.16 -35.31 73.92 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.523 178.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . 0.513 ' N ' ' O ' ' A' ' 197' ' ' LYS . 12.1 mm-40 -82.4 -58.63 2.84 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.275 0.559 . . . . 0.0 110.233 179.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.526 ' OH ' ' ND1' ' A' ' 245' ' ' HIS . 0.4 OUTLIER -48.28 -53.45 17.21 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.677 179.144 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.677 ' CD2' HD13 ' A' ' 228' ' ' ILE . 0.2 OUTLIER -79.78 -31.17 40.82 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.177 179.688 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.54 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -60.2 -57.88 16.92 Favored Glycine 0 CA--C 1.499 -0.91 0 N-CA-C 107.221 -2.352 . . . . 0.0 107.221 176.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -50.15 -27.65 11.32 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 176.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . 0.724 ' CE2' HG13 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -58.24 -44.13 88.14 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 122.158 0.98 . . . . 0.0 108.383 178.003 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 169.49 -130.5 2.06 Favored Glycine 0 N--CA 1.442 -0.926 0 CA-C-N 113.465 -1.698 . . . . 0.0 110.26 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.479 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 46.1 mm-40 -96.72 101.64 13.28 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.258 0.551 . . . . 0.0 110.973 178.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 3.0 t -79.45 136.77 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 CA-C-N 115.25 -0.886 . . . . 0.0 108.814 178.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.419 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 6.1 tp10 -88.45 -56.56 3.26 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 3.4 m -166.29 150.37 7.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.342 0.591 . . . . 0.0 112.436 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.63 HG21 HG12 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -118.38 126.45 75.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.466 178.593 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -123.24 102.86 8.18 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -178.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.257 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 177.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.421 0 N-CA-C 112.232 -0.347 . . . . 0.0 112.232 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . 0.555 ' HB2' ' O ' ' A' ' 186' ' ' VAL . 0.1 OUTLIER -157.47 176.93 12.01 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.024 -0.588 . . . . 0.0 109.986 -177.879 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . 0.476 ' O ' ' HB ' ' A' ' 186' ' ' VAL . 1.6 p -138.66 147.43 42.82 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.138 -0.625 . . . . 0.0 112.389 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.675 ' CE2' ' CB ' ' A' ' 257' ' ' ALA . 4.6 m-85 -107.44 133.49 51.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.161 178.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.677 HD13 ' CD2' ' A' ' 202' ' ' PHE . 1.8 mt -128.06 133.0 68.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.13 0.49 . . . . 0.0 111.686 -179.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' THR . . . . . 0.455 ' OG1' ' NZ ' ' A' ' 183' ' ' LYS . 40.8 m -113.44 137.99 50.73 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.51 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 0.647 ' CE1' ' CB ' ' A' ' 235' ' ' PRO . 75.4 m-85 -113.62 126.3 55.12 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.298 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.483 ' O ' ' NZ ' ' A' ' 182' ' ' LYS . 0.3 OUTLIER -47.94 -39.19 18.51 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 178.051 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . 0.454 ' O ' ' HD3' ' A' ' 182' ' ' LYS . 0.0 OUTLIER -91.47 -166.05 1.48 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 113.443 -1.708 . . . . 0.0 110.036 179.119 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . 0.503 ' HB3' ' HG2' ' A' ' 182' ' ' LYS . 0.6 OUTLIER -133.7 13.88 4.04 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.51 -179.92 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.566 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.3 OUTLIER -85.14 -59.52 0.32 Allowed Pre-proline 0 N--CA 1.452 -0.37 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 179.752 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.647 ' CB ' ' CE1' ' A' ' 230' ' ' PHE . 83.4 Cg_exo -49.9 -31.0 25.39 Favored 'Trans proline' 0 CA--C 1.5 -1.214 0 N-CA-C 108.888 -1.235 . . . . 0.0 108.888 177.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.599 HG22 ' CD2' ' A' ' 230' ' ' PHE . 14.7 t -72.74 -45.16 57.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 113.892 -1.504 . . . . 0.0 110.179 179.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . 0.566 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 1.6 ptpt -62.81 -36.36 82.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.721 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 0.0 OUTLIER -81.62 -50.3 9.49 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.903 0.382 . . . . 0.0 110.92 179.194 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.724 HG13 ' CE2' ' A' ' 205' ' ' PHE . 1.6 mt -46.33 -49.84 5.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.54 -179.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' MET . . . . . 0.457 ' HG3' ' O ' ' A' ' 236' ' ' VAL . 15.4 mtp -60.27 -28.33 67.98 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.877 -178.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.531 ' CG ' ' O ' ' A' ' 237' ' ' LYS . 0.0 OUTLIER -88.67 -9.67 51.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.752 0.31 . . . . 0.0 110.976 -179.927 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' A' ' 238' ' ' LYS . 4.5 mmmm -79.81 116.19 19.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.363 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.503 ' HG2' ' N ' ' A' ' 244' ' ' TYR . 5.0 ttpt -39.98 -74.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . 0.56 ' CE1' ' HG3' ' A' ' 253' ' ' GLU . 21.6 m-85 -129.09 151.49 49.72 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.399 179.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' HIS . . . . . 0.623 ' CG ' ' CD1' ' A' ' 254' ' ' ILE . 45.0 m-70 -105.65 149.14 26.61 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.376 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . 0.414 ' N ' ' ND2' ' A' ' 246' ' ' ASN . 0.0 OUTLIER -123.55 105.4 9.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.543 179.503 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.511 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.8 t -110.05 116.55 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.961 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 41.16 -90.67 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.676 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.511 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.1 OUTLIER -105.03 -35.99 7.46 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.747 0.784 . . . . 0.0 109.914 -179.538 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' SER . . . . . 0.493 ' OG ' HG23 ' A' ' 193' ' ' THR . 0.8 OUTLIER -77.87 153.61 32.5 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.317 -1.311 . . . . 0.0 112.633 -178.363 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.467 ' HD3' ' O ' ' A' ' 249' ' ' LEU . 0.0 OUTLIER -148.18 104.81 3.57 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.868 -1.06 . . . . 0.0 108.545 178.942 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' CYS . . . . . 0.55 ' HB2' ' CG1' ' A' ' 186' ' ' VAL . 0.0 OUTLIER -127.59 152.32 47.8 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -177.074 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . 0.56 ' HG3' ' CE1' ' A' ' 244' ' ' TYR . 29.3 tt0 -77.17 110.05 11.54 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.047 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . 0.623 ' CD1' ' CG ' ' A' ' 245' ' ' HIS . 25.3 mt -96.52 111.29 26.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 -178.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . 0.514 ' O ' ' C ' ' A' ' 256' ' ' VAL . 0.0 OUTLIER -115.72 132.28 56.68 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 176.439 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . 0.559 ' CG2' ' O ' ' A' ' 183' ' ' LYS . 5.2 p -32.8 121.78 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 CA-C-O 122.254 1.025 . . . . 0.0 111.356 -177.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.675 ' CB ' ' CE2' ' A' ' 227' ' ' PHE . . . -76.54 153.91 35.01 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 113.315 -1.766 . . . . 0.0 111.774 -178.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 2.0 mtm -128.81 113.6 15.49 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.761 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 86.9 p . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.537 179.898 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.536 HG13 ' N ' ' A' ' 182' ' ' LYS . 55.6 t . . . . . 0 CA--C 1.502 -0.865 0 CA-C-O 121.377 0.608 . . . . 0.0 111.961 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.536 ' N ' HG13 ' A' ' 181' ' ' VAL . 0.0 OUTLIER -148.0 112.57 5.33 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.928 177.467 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.651 ' HD3' ' HB1' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -130.96 137.47 49.27 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.382 179.436 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.655 HG12 ' HB ' ' A' ' 228' ' ' ILE . 0.5 OUTLIER -119.67 120.73 64.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.814 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.703 ' CE2' ' CE2' ' A' ' 225' ' ' PHE . 0.3 OUTLIER -94.57 109.56 21.45 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.242 0.544 . . . . 0.0 111.003 -178.597 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.585 ' CG1' HG12 ' A' ' 254' ' ' ILE . 2.3 t -87.44 114.11 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.564 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.56 ' O ' ' N ' ' A' ' 253' ' ' GLU . . . -101.33 130.35 10.2 Favored Glycine 0 C--O 1.227 -0.288 0 N-CA-C 115.081 0.793 . . . . 0.0 115.081 -177.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.457 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . 78.36 79.73 0.75 Allowed Glycine 0 C--N 1.331 0.271 0 C-N-CA 121.01 -0.614 . . . . 0.0 113.472 178.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . 0.519 ' CB ' ' SG ' ' A' ' 252' ' ' CYS . 0.6 OUTLIER -117.69 157.56 26.26 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.693 0.282 . . . . 0.0 111.016 -179.916 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' SER . . . . . 0.585 ' CB ' ' CD ' ' A' ' 191' ' ' PRO . 0.1 OUTLIER -48.5 -173.48 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.792 179.305 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . 0.585 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 5.5 Cg_exo -77.59 15.96 1.16 Allowed 'Trans proline' 0 CA--C 1.531 0.36 0 C-N-CA 122.965 2.444 . . . . 0.0 113.409 -179.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.553 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 0.6 OUTLIER 157.58 78.19 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.667 0.27 . . . . 0.0 111.482 179.84 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.592 ' CG2' ' CD1' ' A' ' 198' ' ' ILE . 76.1 m -71.89 115.44 38.14 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.095 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.573 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 21.0 Cg_endo -61.02 112.31 1.33 Allowed 'Trans proline' 0 C--N 1.332 -0.325 0 C-N-CA 122.226 1.95 . . . . 0.0 111.519 178.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.794 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -50.63 -14.92 0.22 Allowed 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.872 -179.668 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . 0.478 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 9.3 mm-40 -66.94 -40.32 87.52 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -179.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.573 ' CD ' ' HG2' ' A' ' 194' ' ' PRO . 1.4 mttp -75.29 -46.42 33.61 Favored 'General case' 0 CA--C 1.498 -1.055 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.794 ' CG1' ' HA ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -47.74 -32.11 2.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.003 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.579 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 9.6 mtp180 -69.48 -33.48 72.94 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.091 178.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . 0.528 ' N ' ' O ' ' A' ' 197' ' ' LYS . 9.3 mm-40 -82.47 -59.06 2.66 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.207 0.527 . . . . 0.0 110.206 178.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.533 ' OH ' ' ND1' ' A' ' 245' ' ' HIS . 0.2 OUTLIER -48.76 -54.67 14.07 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.797 179.005 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.661 ' O ' ' HB2' ' A' ' 205' ' ' PHE . 0.2 OUTLIER -79.57 -30.69 41.74 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.376 -179.864 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.579 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -62.7 -57.1 17.64 Favored Glycine 0 CA--C 1.499 -0.931 0 N-CA-C 107.036 -2.426 . . . . 0.0 107.036 176.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -48.62 -29.33 7.6 Favored Glycine 0 N--CA 1.441 -1.022 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 176.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . 0.732 ' CE2' HG13 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -58.22 -43.45 87.71 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 177.764 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.491 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 169.06 -130.81 2.14 Favored Glycine 0 N--CA 1.441 -1.02 0 CA-C-N 113.725 -1.579 . . . . 0.0 110.423 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.486 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 4.3 mt-10 -96.97 101.31 12.86 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.208 0.528 . . . . 0.0 111.027 178.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 2.9 t -78.77 138.22 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 178.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.487 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 13.7 tp10 -91.46 -57.62 2.71 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.616 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 25.1 p -157.7 154.95 29.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.285 0.565 . . . . 0.0 112.207 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.619 ' CD1' ' HB ' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -129.64 124.3 59.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.411 179.516 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.15 112.96 18.34 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -179.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 193' ' ' THR . 1.7 mm? . . . . . 0 CA--C 1.532 0.277 0 CA-C-O 120.836 0.35 . . . . 0.0 111.424 178.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.437 0 CA-C-O 120.837 0.132 . . . . 0.0 113.052 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . 0.703 ' CE2' ' CE2' ' A' ' 185' ' ' PHE . 5.0 p90 -156.42 176.26 12.93 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -179.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . 0.531 ' CB ' HD12 ' A' ' 213' ' ' LEU . 7.2 p -143.87 154.89 43.83 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -179.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.663 ' CE2' ' CB ' ' A' ' 257' ' ' ALA . 6.1 m-85 -107.14 153.48 22.6 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.138 178.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.655 ' HB ' HG12 ' A' ' 184' ' ' ILE . 2.4 mt -147.87 135.11 13.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.869 0.366 . . . . 0.0 110.841 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' THR . . . . . 0.536 ' OG1' ' NZ ' ' A' ' 183' ' ' LYS . 92.3 m -117.35 138.41 51.8 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 0.637 ' CE1' ' CB ' ' A' ' 235' ' ' PRO . 70.6 m-85 -111.89 126.25 54.9 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.564 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.487 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -49.55 -38.78 32.24 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 177.829 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . 0.482 ' O ' ' HD3' ' A' ' 182' ' ' LYS . 22.4 mt-10 -90.41 -171.49 3.1 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 113.276 -1.784 . . . . 0.0 109.019 178.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . 0.524 ' O ' ' HG3' ' A' ' 237' ' ' LYS . 0.0 OUTLIER -127.47 0.5 6.26 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.55 179.965 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.485 ' O ' ' N ' ' A' ' 237' ' ' LYS . 0.2 OUTLIER -73.45 -57.61 2.63 Favored Pre-proline 0 C--N 1.329 -0.294 0 N-CA-C 112.0 0.371 . . . . 0.0 112.0 -179.075 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.637 ' CB ' ' CE1' ' A' ' 230' ' ' PHE . 99.8 Cg_exo -49.24 -32.97 26.78 Favored 'Trans proline' 0 CA--C 1.498 -1.3 0 C-N-CA 121.124 1.216 . . . . 0.0 108.985 178.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.587 HG22 ' CD2' ' A' ' 230' ' ' PHE . 19.5 t -70.84 -41.62 77.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 113.646 -1.615 . . . . 0.0 109.189 178.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . 0.524 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 23.5 mttm -57.18 -45.27 83.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.83 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.481 ' O ' ' HG3' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -81.03 -50.38 9.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.313 -179.396 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.732 HG13 ' CE2' ' A' ' 205' ' ' PHE . 1.4 mt -41.78 -51.42 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.99 -179.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' MET . . . . . 0.455 ' SD ' HG13 ' A' ' 236' ' ' VAL . 4.9 mtp -64.23 -19.37 65.32 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.43 -178.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.481 ' HG3' ' O ' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -86.78 -22.1 26.12 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.063 0.458 . . . . 0.0 110.666 -179.916 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -78.49 118.26 20.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.667 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.424 ' HD3' ' CD2' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -48.68 -49.86 35.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.611 179.911 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . 0.54 ' CE1' ' HG3' ' A' ' 253' ' ' GLU . 17.2 m-85 -138.74 163.91 30.96 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.945 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' HIS . . . . . 0.644 ' CG ' ' CD1' ' A' ' 254' ' ' ILE . 31.6 m-70 -125.07 156.05 38.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.028 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . 0.47 ' HA ' ' HA ' ' A' ' 251' ' ' LYS . 0.0 OUTLIER -137.99 105.08 5.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.093 0.473 . . . . 0.0 110.057 178.768 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.527 ' N ' ' O ' ' A' ' 250' ' ' SER . 1.8 t -103.09 106.7 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.424 -178.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 54.84 -81.22 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.482 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.527 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -114.38 -39.23 3.88 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.424 0.631 . . . . 0.0 110.346 -179.983 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' SER . . . . . 0.527 ' O ' ' N ' ' A' ' 247' ' ' VAL . 0.2 OUTLIER -77.42 153.24 33.82 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.736 -178.952 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -145.12 108.7 4.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.408 -0.815 . . . . 0.0 108.869 179.143 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' CYS . . . . . 0.571 ' HB2' ' CG1' ' A' ' 186' ' ' VAL . 0.0 OUTLIER -128.3 153.3 47.15 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -176.951 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . 0.56 ' N ' ' O ' ' A' ' 187' ' ' GLY . 39.0 tt0 -76.03 107.22 8.08 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.978 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . 0.644 ' CD1' ' CG ' ' A' ' 245' ' ' HIS . 23.5 mt -95.76 113.7 30.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -178.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . 0.519 ' O ' ' C ' ' A' ' 256' ' ' VAL . 0.0 OUTLIER -118.84 133.2 56.0 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 176.608 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . 0.537 ' CG2' ' O ' ' A' ' 183' ' ' LYS . 6.8 p -33.37 123.8 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 CA-C-O 122.252 1.025 . . . . 0.0 111.294 -177.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.663 ' CB ' ' CE2' ' A' ' 227' ' ' PHE . . . -76.01 153.36 36.55 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 113.337 -1.756 . . . . 0.0 111.444 -178.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.33 113.54 15.09 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.52 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.323 -0.559 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.995 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.531 HG11 ' N ' ' A' ' 182' ' ' LYS . 55.0 t . . . . . 0 CA--C 1.502 -0.871 0 CA-C-O 121.099 0.476 . . . . 0.0 111.356 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.533 ' HB2' ' CG2' ' A' ' 236' ' ' VAL . 0.0 OUTLIER -155.0 112.43 3.37 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.328 177.601 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.587 ' HD3' ' HB1' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -136.68 144.13 43.77 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 115.113 -0.948 . . . . 0.0 109.345 178.84 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.636 HG12 ' HB ' ' A' ' 228' ' ' ILE . 0.2 OUTLIER -123.9 120.07 58.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.827 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.689 ' CE2' ' CE2' ' A' ' 225' ' ' PHE . 0.9 OUTLIER -91.03 109.39 20.63 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.434 0.635 . . . . 0.0 109.748 -179.709 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.559 ' CG1' ' HB2' ' A' ' 252' ' ' CYS . 4.1 t -88.75 104.9 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.484 -179.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 253' ' ' GLU . . . -92.82 127.39 8.97 Favored Glycine 0 C--O 1.228 -0.28 0 CA-C-N 115.165 -0.925 . . . . 0.0 115.065 -177.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.522 ' O ' ' CB ' ' A' ' 252' ' ' CYS . . . 83.29 81.43 0.97 Allowed Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.893 -0.67 . . . . 0.0 113.531 178.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . 0.525 HD12 ' N ' ' A' ' 190' ' ' SER . 0.6 OUTLIER -117.26 156.96 26.86 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.803 0.335 . . . . 0.0 110.865 179.68 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' SER . . . . . 0.548 ' CB ' ' HD2' ' A' ' 191' ' ' PRO . 0.2 OUTLIER -46.52 -178.16 0.01 OUTLIER Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.812 179.811 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . 0.548 ' HD2' ' CB ' ' A' ' 190' ' ' SER . 72.1 Cg_endo -78.79 17.59 1.12 Allowed 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.563 2.175 . . . . 0.0 113.092 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.528 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 0.6 OUTLIER 159.86 66.17 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.497 0.189 . . . . 0.0 111.392 179.749 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.551 ' O ' ' CD1' ' A' ' 213' ' ' LEU . 94.9 m -69.8 127.37 92.58 Favored Pre-proline 0 CA--C 1.518 -0.271 0 CA-C-O 120.963 0.411 . . . . 0.0 110.69 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.585 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 71.1 Cg_endo -71.15 109.49 2.58 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.378 2.052 . . . . 0.0 111.146 178.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.788 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -48.29 -14.07 0.05 Allowed 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -179.77 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . 0.513 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 2.9 mt-10 -67.44 -41.05 85.37 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.585 ' CD ' ' HG2' ' A' ' 194' ' ' PRO . 1.6 mttp -73.22 -46.87 47.84 Favored 'General case' 0 CA--C 1.503 -0.854 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.788 ' CG1' ' HA ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -47.5 -29.94 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.978 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 177.947 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.531 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 7.5 mtt180 -72.96 -32.69 65.38 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.294 178.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . 0.572 ' CG ' ' N ' ' A' ' 201' ' ' TYR . 3.6 pt-20 -83.0 -55.35 4.43 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.01 0.433 . . . . 0.0 110.337 179.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.572 ' N ' ' CG ' ' A' ' 200' ' ' GLU . 0.3 OUTLIER -50.01 -53.31 27.54 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.575 0.702 . . . . 0.0 109.511 178.761 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.657 ' HB3' ' CZ ' ' A' ' 230' ' ' PHE . 0.3 OUTLIER -79.64 -30.91 41.47 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.2 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.531 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -62.41 -56.72 20.14 Favored Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 107.048 -2.421 . . . . 0.0 107.048 176.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -50.67 -28.13 14.79 Favored Glycine 0 N--CA 1.443 -0.895 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 176.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . 0.722 ' CE2' HG13 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -58.48 -43.9 89.13 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 177.805 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.502 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 170.69 -131.5 2.24 Favored Glycine 0 N--CA 1.441 -1.007 0 CA-C-N 113.615 -1.629 . . . . 0.0 110.271 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.489 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 2.1 mm-40 -97.1 100.82 12.3 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.238 0.542 . . . . 0.0 110.946 178.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 2.5 t -78.69 140.5 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.13 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.011 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.527 ' CG ' HG23 ' A' ' 229' ' ' THR . 7.4 tp10 -89.53 -53.49 4.51 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 178.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.466 ' HB3' ' OE2' ' A' ' 212' ' ' GLU . 0.4 OUTLIER -170.89 156.69 5.09 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.451 179.256 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.618 HG23 HG12 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -125.1 117.28 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.611 179.375 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . 0.487 ' N ' ' CD ' ' A' ' 212' ' ' GLU . 0.5 OUTLIER -123.5 104.43 9.06 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -179.422 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.584 ' N ' ' CD2' ' A' ' 213' ' ' LEU . 0.1 OUTLIER . . . . . 0 CA--C 1.533 0.31 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 179.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . 0.475 ' O ' ' HG ' ' A' ' 189' ' ' LEU . . . . . . . . 0 N--CA 1.447 -0.617 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . 0.689 ' CE2' ' CE2' ' A' ' 185' ' ' PHE . 15.9 p90 -135.75 177.2 8.01 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -178.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . 0.532 ' CB ' HD22 ' A' ' 213' ' ' LEU . 1.5 p -135.9 149.69 49.07 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -178.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.655 ' CE1' ' CB ' ' A' ' 257' ' ' ALA . 3.9 m-85 -106.08 132.58 51.98 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.651 HD12 ' CD2' ' A' ' 202' ' ' PHE . 1.8 mt -128.61 118.54 47.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.292 0.567 . . . . 0.0 111.472 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' THR . . . . . 0.527 HG23 ' CG ' ' A' ' 209' ' ' GLU . 22.1 m -101.58 138.03 39.12 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.562 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 0.657 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 74.4 m-85 -114.87 126.46 54.83 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.095 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.489 ' HG3' ' O ' ' A' ' 207' ' ' GLU . 0.0 OUTLIER -48.17 -39.13 19.87 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 177.992 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . 0.483 ' O ' ' HG3' ' A' ' 182' ' ' LYS . 3.1 mt-10 -98.81 165.22 11.88 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 113.413 -1.721 . . . . 0.0 109.478 178.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . 0.473 ' HA ' HG22 ' A' ' 236' ' ' VAL . 0.9 OUTLIER -106.14 19.64 20.21 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -179.393 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.541 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.7 OUTLIER -85.34 -61.44 0.27 Allowed Pre-proline 0 C--N 1.334 -0.086 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.955 179.67 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.617 ' CB ' ' CE1' ' A' ' 230' ' ' PHE . 85.5 Cg_exo -49.51 -29.53 18.85 Favored 'Trans proline' 0 CA--C 1.499 -1.256 0 N-CA-C 108.88 -1.238 . . . . 0.0 108.88 177.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.612 HG23 ' CD2' ' A' ' 230' ' ' PHE . 12.9 t -73.31 -46.15 50.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 113.786 -1.552 . . . . 0.0 110.719 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . 0.541 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 13.6 pttt -59.94 -37.18 78.8 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.42 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.621 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.6 OUTLIER -80.75 -56.1 4.37 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.201 0.524 . . . . 0.0 110.753 178.858 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.722 HG13 ' CE2' ' A' ' 205' ' ' PHE . 1.6 mt -39.28 -47.74 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.605 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' MET . . . . . 0.456 ' SD ' ' O ' ' A' ' 236' ' ' VAL . 3.8 mtp -62.63 -27.7 69.39 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.782 -178.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.479 ' CG ' ' O ' ' A' ' 237' ' ' LYS . 1.8 mt-10 -83.41 -24.92 31.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.631 0.253 . . . . 0.0 111.553 -179.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.568 ' HD3' ' CE1' ' A' ' 245' ' ' HIS . 0.8 OUTLIER -79.22 109.31 13.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.019 0.437 . . . . 0.0 111.118 -179.461 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.479 ' HD2' ' CE2' ' A' ' 244' ' ' TYR . 0.6 OUTLIER -35.49 -61.19 0.46 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.094 -179.747 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . 0.558 ' CE1' ' HG3' ' A' ' 253' ' ' GLU . 44.5 m-85 -129.28 167.72 17.28 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.583 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' HIS . . . . . 0.591 ' CG ' ' CD1' ' A' ' 254' ' ' ILE . 38.1 m-70 -128.47 153.36 47.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.758 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -127.93 105.57 8.51 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.001 0.429 . . . . 0.0 111.031 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.551 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.5 t -106.36 107.91 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.241 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 44.06 -86.67 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.582 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -101.41 -41.37 6.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.256 0.55 . . . . 0.0 110.829 179.75 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' SER . . . . . 0.479 ' HB3' ' HB2' ' A' ' 190' ' ' SER . 5.2 p -78.34 155.79 29.9 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.363 -0.835 . . . . 0.0 113.096 -178.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.1 OUTLIER -147.47 105.86 3.78 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 114.365 -1.288 . . . . 0.0 107.868 178.473 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' CYS . . . . . 0.559 ' HB2' ' CG1' ' A' ' 186' ' ' VAL . 0.0 OUTLIER -127.52 153.32 46.49 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -176.199 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . 0.558 ' HG3' ' CE1' ' A' ' 244' ' ' TYR . 40.6 tt0 -76.21 107.03 8.16 Favored 'General case' 0 C--O 1.22 -0.464 0 CA-C-N 114.832 -1.076 . . . . 0.0 110.607 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . 0.618 ' CG2' ' CG2' ' A' ' 239' ' ' ILE . 22.2 mt -95.62 111.85 26.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -178.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . 0.526 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -116.42 130.24 56.65 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 113.349 -1.751 . . . . 0.0 106.327 177.035 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . 0.547 ' CG2' ' O ' ' A' ' 183' ' ' LYS . 4.2 p -32.75 123.01 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.488 0 CA-C-O 122.265 1.031 . . . . 0.0 111.341 -177.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.655 ' CB ' ' CE1' ' A' ' 227' ' ' PHE . . . -76.31 153.98 35.44 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 113.39 -1.732 . . . . 0.0 110.974 -178.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.56 113.4 14.19 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.717 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.504 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.854 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.532 HG13 ' N ' ' A' ' 182' ' ' LYS . 47.4 t . . . . . 0 CA--C 1.504 -0.808 0 CA-C-O 121.338 0.59 . . . . 0.0 111.608 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.532 ' N ' HG13 ' A' ' 181' ' ' VAL . 0.0 OUTLIER -149.98 112.54 4.74 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.934 177.452 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.643 ' HD3' ' HB3' ' A' ' 257' ' ' ALA . 0.0 OUTLIER -133.21 141.78 48.25 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.444 179.254 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.645 HG12 ' HB ' ' A' ' 228' ' ' ILE . 0.5 OUTLIER -120.8 120.63 63.01 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 178.735 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.574 ' CE2' ' CE2' ' A' ' 225' ' ' PHE . 0.2 OUTLIER -93.35 109.32 20.87 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.29 0.567 . . . . 0.0 110.327 -179.172 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.565 ' O ' ' HB2' ' A' ' 225' ' ' PHE . 11.7 t -85.9 120.0 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.753 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.55 ' O ' ' N ' ' A' ' 253' ' ' GLU . . . -109.87 131.4 10.45 Favored Glycine 0 C--N 1.331 0.265 0 N-CA-C 115.221 0.849 . . . . 0.0 115.221 -176.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.486 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . 76.41 79.44 0.65 Allowed Glycine 0 C--N 1.331 0.255 0 C-N-CA 121.378 -0.439 . . . . 0.0 113.334 178.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . 0.539 HD13 ' N ' ' A' ' 190' ' ' SER . 0.6 OUTLIER -117.54 157.48 26.26 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.605 0.241 . . . . 0.0 111.049 -179.776 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' SER . . . . . 0.597 ' CB ' ' CD ' ' A' ' 191' ' ' PRO . 0.2 OUTLIER -46.88 -175.3 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.203 0 CA-C-O 121.046 0.45 . . . . 0.0 111.58 179.92 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . 0.597 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 13.2 Cg_exo -70.59 6.35 1.63 Allowed 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 123.319 2.68 . . . . 0.0 113.721 -179.119 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.54 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 3.5 m-20 159.6 78.76 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.153 0.502 . . . . 0.0 110.834 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.577 HG21 ' CD1' ' A' ' 198' ' ' ILE . 52.8 m -71.01 116.0 42.02 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.999 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.564 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 20.5 Cg_endo -58.16 110.54 0.66 Allowed 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.319 2.013 . . . . 0.0 111.127 178.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.793 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.4 OUTLIER -50.77 -14.98 0.23 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.524 -179.56 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . 0.47 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 74.1 mt-10 -65.15 -41.14 95.0 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -179.28 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.564 ' CD ' ' HG2' ' A' ' 194' ' ' PRO . 1.4 mttp -73.79 -48.07 34.24 Favored 'General case' 0 CA--C 1.498 -1.048 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.793 ' CG1' ' HA ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -47.69 -31.85 2.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.207 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.534 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 2.3 mtp-105 -69.82 -33.31 72.15 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.083 178.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . 0.514 ' N ' ' O ' ' A' ' 197' ' ' LYS . 7.9 mt-10 -82.49 -58.5 2.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.244 0.545 . . . . 0.0 110.095 178.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.555 ' CD1' ' CD1' ' A' ' 202' ' ' PHE . 0.2 OUTLIER -49.02 -53.54 19.65 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.677 178.895 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.675 ' O ' ' HB2' ' A' ' 205' ' ' PHE . 0.1 OUTLIER -79.74 -31.39 41.02 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.583 -179.787 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.534 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -62.77 -55.25 28.02 Favored Glycine 0 CA--C 1.5 -0.896 0 N-CA-C 107.051 -2.42 . . . . 0.0 107.051 176.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -50.25 -27.6 11.58 Favored Glycine 0 N--CA 1.444 -0.815 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 176.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . 0.728 ' CE2' HG13 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -59.2 -47.76 84.14 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 122.137 0.97 . . . . 0.0 108.528 177.984 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.493 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 176.5 -132.29 2.04 Favored Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 113.602 -1.635 . . . . 0.0 110.172 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.47 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 2.2 mt-10 -97.19 99.87 11.35 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.142 0.496 . . . . 0.0 111.128 178.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 2.7 t -76.17 138.71 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.47 ' HB3' HG23 ' A' ' 229' ' ' THR . 3.7 tp10 -92.45 -54.66 3.7 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.062 178.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 3.3 m -161.5 151.92 17.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.248 0.547 . . . . 0.0 112.272 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.629 ' CD1' ' HB ' ' A' ' 198' ' ' ILE . 0.1 OUTLIER -126.39 119.19 53.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.809 179.037 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.46 103.71 8.63 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -177.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.527 ' CD1' ' O ' ' A' ' 193' ' ' THR . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.225 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 176.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.58 0 N-CA-C 112.542 -0.223 . . . . 0.0 112.542 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . 0.574 ' CE2' ' CE2' ' A' ' 185' ' ' PHE . 0.5 OUTLIER -156.21 177.06 11.87 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.407 -0.396 . . . . 0.0 110.095 -177.852 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . 0.476 ' O ' ' HB ' ' A' ' 186' ' ' VAL . 1.7 p -138.59 155.17 48.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.367 0.603 . . . . 0.0 112.609 -179.014 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.666 ' CE2' ' CB ' ' A' ' 257' ' ' ALA . 4.6 m-85 -111.17 133.3 53.63 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.338 178.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.653 HD13 ' CD2' ' A' ' 202' ' ' PHE . 2.0 mt -128.33 120.48 53.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.293 0.568 . . . . 0.0 111.679 -179.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' THR . . . . . 0.47 HG23 ' HB3' ' A' ' 209' ' ' GLU . 73.6 m -103.44 138.1 40.63 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.404 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 0.683 ' CE1' ' CB ' ' A' ' 235' ' ' PRO . 82.7 m-85 -114.12 126.59 55.26 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.514 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.47 ' HG3' ' O ' ' A' ' 207' ' ' GLU . 0.0 OUTLIER -49.19 -38.53 26.22 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 177.914 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . 0.456 ' O ' ' HD3' ' A' ' 182' ' ' LYS . 2.0 mm-40 -90.85 -166.79 1.66 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 113.42 -1.718 . . . . 0.0 109.923 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . 0.483 ' HA ' HG21 ' A' ' 236' ' ' VAL . 0.6 OUTLIER -132.64 13.09 4.47 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.689 -179.852 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.526 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.8 OUTLIER -85.12 -58.04 0.36 Allowed Pre-proline 0 N--CA 1.451 -0.39 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.609 179.829 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.683 ' CB ' ' CE1' ' A' ' 230' ' ' PHE . 81.4 Cg_exo -50.65 -28.8 23.43 Favored 'Trans proline' 0 CA--C 1.502 -1.116 0 N-CA-C 109.238 -1.101 . . . . 0.0 109.238 178.139 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.544 HG22 ' CD2' ' A' ' 230' ' ' PHE . 13.9 t -73.14 -44.05 56.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 113.795 -1.548 . . . . 0.0 109.978 178.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . 0.541 ' O ' ' CG ' ' A' ' 241' ' ' GLU . 0.5 OUTLIER -67.95 -30.25 69.5 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.301 179.538 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.502 ' HD2' ' HG2' ' A' ' 237' ' ' LYS . 0.6 OUTLIER -78.74 -54.34 6.2 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.766 0.793 . . . . 0.0 110.369 179.36 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.728 HG13 ' CE2' ' A' ' 205' ' ' PHE . 1.9 mt -51.67 -49.65 33.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 114.357 -1.292 . . . . 0.0 112.645 -178.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 8.1 mtp -59.35 -17.69 31.91 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.598 -178.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.541 ' CG ' ' O ' ' A' ' 237' ' ' LYS . 0.1 OUTLIER -84.25 -40.66 17.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.084 179.952 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.454 ' O ' ' C ' ' A' ' 243' ' ' LYS . 0.0 OUTLIER -80.3 87.15 5.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.722 179.898 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.556 ' N ' ' HD3' ' A' ' 243' ' ' LYS . 0.0 OUTLIER -31.48 -46.48 0.1 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.907 179.757 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . 0.583 ' CE1' ' HG3' ' A' ' 253' ' ' GLU . 18.9 m-85 -120.62 148.94 43.23 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.799 -179.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' HIS . . . . . 0.644 ' CG ' ' CD1' ' A' ' 254' ' ' ILE . 24.7 m-70 -122.97 157.75 31.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.278 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . 0.404 ' O ' ' CE2' ' A' ' 201' ' ' TYR . 0.0 OUTLIER -129.54 104.8 7.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.114 178.815 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.525 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.6 t -106.89 111.02 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.069 -179.378 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 48.0 -86.48 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.248 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.525 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.1 OUTLIER -108.57 -39.56 5.36 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.436 0.636 . . . . 0.0 110.391 -179.722 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 250' ' ' SER . . . . . 0.523 ' OG ' HG23 ' A' ' 193' ' ' THR . 0.2 OUTLIER -77.75 154.96 31.52 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.85 -1.068 . . . . 0.0 112.626 -178.3 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.488 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.1 OUTLIER -146.61 108.87 4.45 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.065 178.86 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 252' ' ' CYS . . . . . 0.559 ' HB2' ' CG1' ' A' ' 186' ' ' VAL . 0.0 OUTLIER -128.17 152.79 47.62 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -177.015 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . 0.583 ' HG3' ' CE1' ' A' ' 244' ' ' TYR . 29.6 tt0 -76.44 107.12 8.49 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.523 179.282 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . 0.644 ' CD1' ' CG ' ' A' ' 245' ' ' HIS . 31.0 mt -96.15 111.07 25.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -178.291 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . 0.512 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -113.63 133.36 55.34 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 176.656 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . 0.537 ' CG2' ' O ' ' A' ' 183' ' ' LYS . 4.1 p -33.55 124.34 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-O 122.207 1.004 . . . . 0.0 111.26 -177.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.666 ' CB ' ' CE2' ' A' ' 227' ' ' PHE . . . -77.35 153.25 33.96 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 113.466 -1.697 . . . . 0.0 112.037 -178.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.18 117.56 19.21 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.298 179.186 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.322 -0.624 0 CA-C-O 121.254 0.55 . . . . 0.0 111.45 -178.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.541 HG13 ' N ' ' A' ' 182' ' ' LYS . 46.3 t . . . . . 0 CA--C 1.5 -0.949 0 CA-C-O 121.206 0.527 . . . . 0.0 111.422 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.541 ' N ' HG13 ' A' ' 181' ' ' VAL . 0.1 OUTLIER -150.45 112.02 4.47 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.247 178.0 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.65 ' HD3' ' HB3' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -133.73 144.95 49.42 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-N 114.432 -1.258 . . . . 0.0 108.814 178.896 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.623 HG12 ' HB ' ' A' ' 228' ' ' ILE . 1.8 pt -124.37 119.86 57.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 178.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.578 ' CB ' ' HA ' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -93.92 109.02 20.75 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 121.471 0.653 . . . . 0.0 110.687 -178.574 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.633 ' CG1' HG12 ' A' ' 254' ' ' ILE . 1.9 t -86.34 126.67 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.135 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.525 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . -113.4 133.99 11.6 Favored Glycine 0 C--N 1.333 0.412 0 N-CA-C 114.313 0.485 . . . . 0.0 114.313 -176.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.468 ' O ' ' HB3' ' A' ' 252' ' ' CYS . . . 71.41 87.64 0.14 Allowed Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.692 -0.766 . . . . 0.0 111.893 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . 0.536 ' CB ' ' SG ' ' A' ' 252' ' ' CYS . 0.6 OUTLIER -115.86 156.56 25.9 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.026 0.441 . . . . 0.0 111.655 -178.469 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' SER . . . . . 0.604 ' CB ' ' CD ' ' A' ' 191' ' ' PRO . 0.3 OUTLIER -49.31 -172.64 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.888 179.77 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . 0.604 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 3.1 Cg_exo -77.21 13.09 1.62 Allowed 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 123.004 2.469 . . . . 0.0 113.182 -179.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.535 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 1.6 p30 157.43 77.24 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 120.758 0.313 . . . . 0.0 111.375 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.531 HG21 ' CD1' ' A' ' 198' ' ' ILE . 16.8 m -70.91 114.24 25.4 Favored Pre-proline 0 CA--C 1.517 -0.309 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.258 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.566 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 97.6 Cg_endo -73.38 109.32 2.82 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.589 2.193 . . . . 0.0 111.211 178.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.586 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.3 OUTLIER -43.9 -19.69 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.831 -0.168 . . . . 0.0 111.447 -179.911 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' A' ' 194' ' ' PRO . 66.6 mt-10 -57.24 -43.14 82.64 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -179.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.566 ' CD ' ' HG2' ' A' ' 194' ' ' PRO . 0.5 OUTLIER -80.36 -47.11 14.96 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 178.619 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.634 HG22 ' CE1' ' A' ' 202' ' ' PHE . 0.3 OUTLIER -49.0 -29.68 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 CA-C-N 114.382 -1.281 . . . . 0.0 108.445 176.728 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.552 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 0.0 OUTLIER -73.22 -32.54 64.82 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.656 178.104 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . 0.539 ' N ' ' O ' ' A' ' 197' ' ' LYS . 2.7 mt-10 -82.15 -58.33 3.0 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.642 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.492 ' C ' ' CD1' ' A' ' 201' ' ' TYR . 0.5 OUTLIER -48.43 -53.9 16.11 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.801 179.318 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.657 ' CD2' HD12 ' A' ' 228' ' ' ILE . 0.4 OUTLIER -79.59 -31.67 41.83 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.36 179.827 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.552 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -61.99 -57.12 18.71 Favored Glycine 0 CA--C 1.498 -1.001 0 N-CA-C 107.563 -2.215 . . . . 0.0 107.563 176.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -51.33 -28.12 18.84 Favored Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 176.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . 0.749 ' CE2' HG13 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -57.07 -44.24 82.88 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.01 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.486 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 170.06 -129.11 1.76 Allowed Glycine 0 N--CA 1.441 -0.992 0 CA-C-N 113.518 -1.674 . . . . 0.0 110.221 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.492 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 21.8 mm-40 -97.16 101.52 13.1 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.153 0.502 . . . . 0.0 111.298 178.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 2.9 t -76.75 137.27 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 177.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.495 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 5.7 tp10 -89.43 -56.58 3.2 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.954 179.078 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 15.5 m -164.38 149.49 10.11 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.278 0.561 . . . . 0.0 111.921 179.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.583 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -117.66 126.47 74.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.669 179.078 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -123.18 105.18 9.67 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -178.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.526 ' CD1' ' O ' ' A' ' 193' ' ' THR . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.267 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 177.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.66 0 CA-C-O 121.041 0.245 . . . . 0.0 112.706 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . 0.565 ' CE2' ' CE2' ' A' ' 185' ' ' PHE . 0.1 OUTLIER -157.36 177.07 11.86 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -178.403 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . 0.441 ' SG ' ' HB ' ' A' ' 186' ' ' VAL . 6.0 p -139.75 151.35 45.74 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.661 ' CE2' ' CB ' ' A' ' 257' ' ' ALA . 4.6 m-85 -110.43 133.07 53.62 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.711 178.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.657 HD12 ' CD2' ' A' ' 202' ' ' PHE . 2.3 mt -127.68 131.75 69.69 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.342 0 CA-C-O 121.121 0.486 . . . . 0.0 111.245 179.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' THR . . . . . 0.474 HG21 ' HB3' ' A' ' 209' ' ' GLU . 87.9 m -111.61 138.23 48.43 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.388 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 0.634 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 62.8 m-85 -112.8 126.29 55.27 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.686 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.495 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -50.85 -38.15 47.4 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 177.612 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . 0.505 ' O ' ' HG3' ' A' ' 182' ' ' LYS . 10.1 mt-10 -93.83 178.22 5.74 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 113.051 -1.886 . . . . 0.0 108.951 178.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . 0.553 ' O ' ' HG3' ' A' ' 237' ' ' LYS . 0.7 OUTLIER -117.7 1.98 12.24 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.878 -179.509 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.496 ' O ' ' N ' ' A' ' 237' ' ' LYS . 0.4 OUTLIER -73.06 -58.83 2.38 Favored Pre-proline 0 C--N 1.326 -0.435 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.864 -179.177 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.633 ' CB ' ' CE1' ' A' ' 230' ' ' PHE . 82.2 Cg_exo -48.97 -32.72 23.97 Favored 'Trans proline' 0 CA--C 1.501 -1.134 0 N-CA-C 108.851 -1.25 . . . . 0.0 108.851 178.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.563 HG22 ' CD2' ' A' ' 230' ' ' PHE . 21.3 t -70.57 -42.05 78.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 113.928 -1.487 . . . . 0.0 109.034 178.068 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . 0.553 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 13.5 mtpt -56.43 -45.93 80.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.798 179.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.473 ' HA ' ' HG3' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -81.25 -49.97 10.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.701 -179.163 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.749 HG13 ' CE2' ' A' ' 205' ' ' PHE . 1.6 mt -42.74 -50.1 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.427 -178.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' MET . . . . . 0.457 ' SD ' ' O ' ' A' ' 236' ' ' VAL . 12.2 mtp -62.42 -24.18 67.27 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.695 -178.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.473 ' HG3' ' HA ' ' A' ' 238' ' ' LYS . 0.7 OUTLIER -87.88 -16.66 33.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.534 -179.437 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.442 ' CD ' ' O ' ' A' ' 238' ' ' LYS . 8.1 mmmt -83.93 116.3 22.72 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.57 -0.287 . . . . 0.0 111.153 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.525 ' HG2' ' N ' ' A' ' 244' ' ' TYR . 1.8 ttpm? -36.77 -80.7 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.082 0.468 . . . . 0.0 110.013 179.263 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . 0.525 ' N ' ' HG2' ' A' ' 243' ' ' LYS . 10.3 m-85 -113.24 169.43 8.95 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.876 178.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' HIS . . . . . 0.599 ' CG ' ' CD1' ' A' ' 254' ' ' ILE . 17.0 m-70 -123.46 146.35 48.1 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.784 0.326 . . . . 0.0 110.935 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . 0.441 ' O ' ' CD2' ' A' ' 201' ' ' TYR . 0.2 OUTLIER -122.42 105.47 10.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.042 0.449 . . . . 0.0 110.519 179.595 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.469 HG11 HG21 ' A' ' 198' ' ' ILE . 2.4 t -111.6 102.41 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.824 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 51.2 -90.57 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.321 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.436 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.1 OUTLIER -104.06 -40.36 6.21 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 121.594 0.711 . . . . 0.0 109.957 -179.931 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 250' ' ' SER . . . . . 0.494 ' CB ' ' OG1' ' A' ' 193' ' ' THR . 1.4 m -78.61 150.27 32.76 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.604 -1.18 . . . . 0.0 112.165 -178.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -149.98 107.61 3.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.47 179.36 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 252' ' ' CYS . . . . . 0.596 ' HB2' ' CG1' ' A' ' 186' ' ' VAL . 0.0 OUTLIER -128.19 153.46 46.88 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -177.326 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 187' ' ' GLY . 71.4 tt0 -75.58 110.87 10.33 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.301 -178.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . 0.633 HG12 ' CG1' ' A' ' 186' ' ' VAL . 11.5 mt -96.59 112.14 28.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 -178.036 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . 0.526 ' O ' ' C ' ' A' ' 256' ' ' VAL . 0.0 OUTLIER -119.14 131.24 55.86 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 176.009 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . 0.535 ' CG2' ' O ' ' A' ' 183' ' ' LYS . 6.0 p -32.32 122.58 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.586 0 CA-C-O 122.285 1.04 . . . . 0.0 111.551 -176.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.661 ' CB ' ' CE2' ' A' ' 227' ' ' PHE . . . -75.85 152.62 37.2 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 113.366 -1.743 . . . . 0.0 111.614 -178.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.86 110.18 12.33 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.717 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 259' ' ' SER . . . . . 0.496 ' HB2' ' HD2' ' A' ' 183' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--N 1.32 -0.677 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.805 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.526 HG12 ' N ' ' A' ' 182' ' ' LYS . 53.0 t . . . . . 0 CA--C 1.5 -0.946 0 CA-C-O 121.184 0.516 . . . . 0.0 111.314 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.526 ' N ' HG12 ' A' ' 181' ' ' VAL . 0.0 OUTLIER -153.76 111.69 3.55 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.89 177.142 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.642 ' HD3' ' HB2' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -138.25 137.52 37.58 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 114.561 -1.199 . . . . 0.0 108.795 178.953 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.693 HG12 ' HB ' ' A' ' 228' ' ' ILE . 1.1 pt -117.99 120.37 64.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.65 ' CE2' ' CE2' ' A' ' 225' ' ' PHE . 0.1 OUTLIER -94.59 109.77 21.65 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 121.543 0.687 . . . . 0.0 110.196 -179.026 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.563 ' O ' ' HB2' ' A' ' 225' ' ' PHE . 45.5 t -84.44 133.89 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.036 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.517 ' O ' ' HB3' ' A' ' 252' ' ' CYS . . . -92.0 -149.74 24.64 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.961 -0.638 . . . . 0.0 114.686 -177.128 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.485 ' O ' ' HB3' ' A' ' 252' ' ' CYS . . . -33.15 102.31 0.01 OUTLIER Glycine 0 C--N 1.334 0.469 0 CA-C-N 114.971 -0.614 . . . . 0.0 113.564 -179.428 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . 0.545 ' CD1' ' OG1' ' A' ' 193' ' ' THR . 1.4 pp -117.48 157.89 25.48 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 122.753 0.421 . . . . 0.0 111.186 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' SER . . . . . 0.535 ' CB ' ' CD ' ' A' ' 191' ' ' PRO . 0.5 OUTLIER -43.84 -178.9 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.539 179.65 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . 0.535 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 17.4 Cg_exo -67.62 4.05 1.54 Allowed 'Trans proline' 0 CA--C 1.533 0.458 0 C-N-CA 123.185 2.59 . . . . 0.0 114.019 -179.107 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.526 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 4.3 t0 161.76 76.04 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.896 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.547 HG21 ' CD1' ' A' ' 198' ' ' ILE . 17.6 m -64.65 109.78 3.25 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.483 179.156 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.474 ' HG2' ' HG2' ' A' ' 197' ' ' LYS . 11.5 Cg_endo -56.9 110.23 0.56 Allowed 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.243 1.962 . . . . 0.0 111.215 179.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.77 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.1 OUTLIER -47.23 -16.93 0.05 Allowed 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -179.278 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . 0.457 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 62.6 mt-10 -68.15 -38.05 81.71 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -179.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.501 ' O ' ' N ' ' A' ' 200' ' ' GLU . 1.5 mmmm -75.04 -47.78 27.23 Favored 'General case' 0 CA--C 1.5 -0.969 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.77 ' CG1' ' HA ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -48.1 -30.9 2.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 115.1 -0.955 . . . . 0.0 108.679 178.326 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.57 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 12.9 mtp180 -71.47 -32.09 67.88 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.238 179.02 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . 0.501 ' N ' ' O ' ' A' ' 197' ' ' LYS . 0.4 OUTLIER -82.51 -45.66 14.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.086 0.469 . . . . 0.0 110.65 179.424 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.504 ' C ' ' CD1' ' A' ' 201' ' ' TYR . 0.2 OUTLIER -63.92 -52.91 57.67 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.006 179.2 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.668 ' CE1' HG23 ' A' ' 198' ' ' ILE . 0.3 OUTLIER -79.68 -32.57 41.44 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.222 -179.799 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.57 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -64.98 -53.42 34.01 Favored Glycine 0 CA--C 1.498 -1.002 0 N-CA-C 106.579 -2.608 . . . . 0.0 106.579 175.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -51.18 -28.81 19.96 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 176.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . 0.738 ' CE2' HG13 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -57.45 -47.69 81.15 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 122.268 1.033 . . . . 0.0 108.341 177.856 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.481 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 174.04 -129.25 1.6 Allowed Glycine 0 N--CA 1.441 -0.98 0 CA-C-N 113.36 -1.745 . . . . 0.0 110.12 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.495 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 5.0 mm-40 -97.14 100.42 11.9 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.274 0.559 . . . . 0.0 111.424 178.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 2.6 t -76.98 139.47 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.151 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 177.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.509 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 21.0 tp10 -91.73 -49.84 6.06 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 178.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 9.8 p -166.93 152.84 8.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.187 0.518 . . . . 0.0 112.09 179.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.606 HG22 HG12 ' A' ' 228' ' ' ILE . 0.1 OUTLIER -125.43 120.22 57.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.114 178.956 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -123.63 103.65 8.55 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -178.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.455 HD13 ' O ' ' A' ' 193' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.332 -0.193 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 177.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.424 0 CA-C-O 120.892 0.162 . . . . 0.0 113.405 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . 0.65 ' CE2' ' CE2' ' A' ' 185' ' ' PHE . 1.1 p90 -156.13 176.24 12.93 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 -179.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . 0.514 ' SG ' ' CD2' ' A' ' 189' ' ' LEU . 0.8 OUTLIER -144.46 154.62 43.13 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.439 -0.504 . . . . 0.0 112.137 -179.08 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.666 ' CE2' ' CB ' ' A' ' 257' ' ' ALA . 6.3 m-85 -108.52 139.91 42.61 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.167 179.289 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.693 ' HB ' HG12 ' A' ' 184' ' ' ILE . 2.2 mt -135.51 122.08 33.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.959 0.409 . . . . 0.0 110.923 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' THR . . . . . 0.487 HG23 ' CG ' ' A' ' 209' ' ' GLU . 28.8 m -103.33 138.32 40.25 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.674 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 0.651 ' CE1' ' CB ' ' A' ' 235' ' ' PRO . 71.4 m-85 -113.34 126.25 55.16 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.265 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.509 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -47.96 -39.11 18.4 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 178.404 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . 0.461 ' O ' ' HG3' ' A' ' 182' ' ' LYS . 3.3 mm-40 -100.95 171.43 7.65 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 113.414 -1.721 . . . . 0.0 109.202 178.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . 0.547 ' O ' ' HG3' ' A' ' 237' ' ' LYS . 4.2 pt-20 -107.97 12.01 27.38 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -179.099 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.538 ' O ' ' N ' ' A' ' 237' ' ' LYS . 0.1 OUTLIER -77.54 -60.71 0.7 Allowed Pre-proline 0 N--CA 1.465 0.283 0 C-N-CA 120.479 -0.488 . . . . 0.0 111.38 -179.787 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.651 ' CB ' ' CE1' ' A' ' 230' ' ' PHE . 90.7 Cg_exo -49.45 -31.26 23.1 Favored 'Trans proline' 0 CA--C 1.499 -1.246 0 N-CA-C 108.671 -1.319 . . . . 0.0 108.671 178.279 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.57 HG23 ' CD2' ' A' ' 230' ' ' PHE . 21.5 t -69.25 -42.58 81.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 113.856 -1.52 . . . . 0.0 108.381 177.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . 0.547 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 2.8 mtpt -58.11 -45.4 87.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.529 178.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.537 ' CD ' ' O ' ' A' ' 234' ' ' GLU . 0.0 OUTLIER -73.47 -51.91 15.48 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.398 0.618 . . . . 0.0 111.22 -179.535 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.738 HG13 ' CE2' ' A' ' 205' ' ' PHE . 1.9 mt -48.66 -49.46 14.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 114.79 -1.095 . . . . 0.0 112.911 -178.329 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 54.2 mtp -61.1 -29.03 69.51 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.699 -178.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.543 ' CG ' ' O ' ' A' ' 237' ' ' LYS . 0.3 OUTLIER -84.75 -13.15 52.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.87 0.367 . . . . 0.0 110.563 179.696 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.484 ' N ' ' HD3' ' A' ' 242' ' ' LYS . 0.7 OUTLIER -87.17 99.22 11.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.049 -179.934 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.574 ' HE3' ' CG ' ' A' ' 244' ' ' TYR . 8.1 ttpt -37.89 -73.51 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . 0.575 ' CE1' ' HB2' ' A' ' 253' ' ' GLU . 8.7 m-30 -111.68 150.8 29.66 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.599 179.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' HIS . . . . . 0.629 ' CG ' ' CD1' ' A' ' 254' ' ' ILE . 17.6 m-70 -113.66 154.09 27.83 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.847 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -134.91 104.69 6.08 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.215 0.531 . . . . 0.0 110.01 178.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.504 ' O ' ' C ' ' A' ' 248' ' ' GLY . 1.6 t -96.94 -173.42 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.728 -179.067 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . 0.504 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . -25.17 -62.27 0.06 OUTLIER Glycine 0 C--N 1.337 0.635 0 C-N-CA 121.2 -0.524 . . . . 0.0 112.964 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.89 -38.69 2.01 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.399 0.619 . . . . 0.0 110.726 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 250' ' ' SER . . . . . 0.467 ' OG ' ' OG1' ' A' ' 193' ' ' THR . 1.2 m -77.54 151.08 34.68 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.919 -1.037 . . . . 0.0 112.567 -178.183 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -140.01 105.89 5.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.922 -1.035 . . . . 0.0 108.722 179.135 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 252' ' ' CYS . . . . . 0.525 ' SG ' ' CG1' ' A' ' 186' ' ' VAL . 0.0 OUTLIER -128.12 153.54 46.74 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -176.624 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . 0.575 ' HB2' ' CE1' ' A' ' 244' ' ' TYR . 64.1 tt0 -75.98 109.96 10.05 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.674 178.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . 0.629 ' CD1' ' CG ' ' A' ' 245' ' ' HIS . 37.0 mt -97.02 113.03 30.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -178.089 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . 0.515 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -114.1 131.94 56.23 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 176.89 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . 0.537 ' CG2' ' O ' ' A' ' 183' ' ' LYS . 9.8 p -33.59 127.56 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-O 122.084 0.945 . . . . 0.0 111.328 -178.079 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.666 ' CB ' ' CE2' ' A' ' 227' ' ' PHE . . . -80.18 152.82 28.98 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 113.656 -1.611 . . . . 0.0 112.268 -178.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.47 116.8 16.43 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.595 -1.184 . . . . 0.0 110.416 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.323 -0.547 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.114 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.536 HG12 ' N ' ' A' ' 182' ' ' LYS . 38.4 t . . . . . 0 CA--C 1.503 -0.84 0 CA-C-O 121.268 0.556 . . . . 0.0 112.04 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.536 ' N ' HG12 ' A' ' 181' ' ' VAL . 4.6 mmtt -143.62 112.89 6.82 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.362 177.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.663 ' HD3' ' HB1' ' A' ' 257' ' ' ALA . 0.7 OUTLIER -130.59 152.44 49.96 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.343 179.438 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.62 HG12 ' HB ' ' A' ' 228' ' ' ILE . 0.5 OUTLIER -127.37 119.83 53.35 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.096 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.561 ' CB ' ' HA ' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -92.35 108.96 20.35 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.614 0.721 . . . . 0.0 110.156 -178.842 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.576 ' CG1' HG12 ' A' ' 254' ' ' ILE . 2.4 t -85.53 118.74 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.254 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.52 ' O ' ' HB3' ' A' ' 252' ' ' CYS . . . -104.97 131.14 10.52 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.271 -0.877 . . . . 0.0 115.026 -176.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.476 ' O ' ' HB3' ' A' ' 252' ' ' CYS . . . 71.73 85.15 0.2 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 121.352 -0.451 . . . . 0.0 112.764 178.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . 0.538 ' CB ' ' SG ' ' A' ' 252' ' ' CYS . 0.5 OUTLIER -115.47 157.29 24.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.941 0.401 . . . . 0.0 111.268 -179.534 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' SER . . . . . 0.619 ' CB ' ' CD ' ' A' ' 191' ' ' PRO . 0.1 OUTLIER -48.0 -169.26 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.751 179.347 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . 0.619 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 17.7 Cg_endo -87.38 22.64 0.89 Allowed 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.403 2.068 . . . . 0.0 112.755 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.542 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 1.9 p30 157.05 76.26 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 111.623 0.231 . . . . 0.0 111.623 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.525 HG22 ' CD1' ' A' ' 198' ' ' ILE . 92.0 m -74.79 111.21 12.22 Favored Pre-proline 0 N--CA 1.464 0.236 0 CA-C-O 120.891 0.377 . . . . 0.0 110.908 179.31 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.558 ' HG2' ' CG ' ' A' ' 197' ' ' LYS . 16.6 Cg_endo -59.51 109.59 0.59 Allowed 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.367 2.045 . . . . 0.0 111.642 179.189 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.814 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.3 OUTLIER -50.84 -15.91 0.35 Allowed 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.754 -179.449 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . 0.499 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 5.6 mt-10 -69.0 -38.16 79.13 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.558 ' CG ' ' HG2' ' A' ' 194' ' ' PRO . 0.2 OUTLIER -73.25 -50.87 19.95 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.209 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.814 ' CG1' ' HA ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -46.77 -31.0 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.727 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.555 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 2.6 mtt180 -70.96 -33.9 70.92 Favored 'General case' 0 C--O 1.221 -0.441 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.373 178.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . 0.583 ' CG ' ' N ' ' A' ' 201' ' ' TYR . 3.2 pt-20 -82.14 -54.66 5.1 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.284 0.564 . . . . 0.0 110.162 179.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.583 ' N ' ' CG ' ' A' ' 200' ' ' GLU . 0.5 OUTLIER -53.69 -53.12 56.47 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.966 178.905 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.68 ' CD2' HD13 ' A' ' 228' ' ' ILE . 0.2 OUTLIER -79.84 -31.8 40.55 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.664 -179.933 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.555 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -63.81 -55.47 24.5 Favored Glycine 0 CA--C 1.498 -1.003 0 N-CA-C 106.799 -2.52 . . . . 0.0 106.799 176.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -50.16 -29.2 14.94 Favored Glycine 0 N--CA 1.443 -0.882 0 N-CA-C 109.694 -1.363 . . . . 0.0 109.694 176.076 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . 0.737 ' CE2' HG13 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -57.18 -45.28 83.84 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 122.157 0.98 . . . . 0.0 108.456 177.849 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 171.02 -129.71 1.84 Allowed Glycine 0 N--CA 1.441 -0.976 0 CA-C-N 113.567 -1.651 . . . . 0.0 110.31 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.509 ' HB3' ' CE ' ' A' ' 231' ' ' LYS . 20.9 mm-40 -96.99 101.52 13.12 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.148 0.499 . . . . 0.0 111.081 178.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 2.5 t -77.94 142.54 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.5 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 5.5 tp10 -91.66 -52.23 4.86 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 178.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 2.6 m -175.16 149.72 1.1 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.985 178.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.622 HG22 HG12 ' A' ' 228' ' ' ILE . 0.4 OUTLIER -113.96 129.55 69.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.147 178.656 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.35 104.79 9.33 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -178.126 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.471 HD11 ' HB ' ' A' ' 193' ' ' THR . 0.1 OUTLIER . . . . . 0 CA--C 1.531 0.238 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 177.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.801 0 CA-C-O 121.375 0.431 . . . . 0.0 112.219 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . 0.528 ' HB2' ' O ' ' A' ' 186' ' ' VAL . 0.1 OUTLIER -156.85 176.71 12.39 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.703 -0.748 . . . . 0.0 109.652 -177.43 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . 0.485 ' O ' ' HB ' ' A' ' 186' ' ' VAL . 31.7 p -138.56 147.65 43.28 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.059 -0.656 . . . . 0.0 112.567 -179.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.693 ' CE2' ' CB ' ' A' ' 257' ' ' ALA . 4.0 m-85 -107.26 133.06 52.38 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.098 -0.956 . . . . 0.0 109.412 178.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.68 HD13 ' CD2' ' A' ' 202' ' ' PHE . 1.8 mt -127.32 123.91 62.89 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 CA-C-O 121.23 0.538 . . . . 0.0 111.395 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' THR . . . . . 0.48 ' CG2' ' HB3' ' A' ' 209' ' ' GLU . 19.8 m -105.15 138.39 41.43 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.344 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 0.669 ' CE2' ' CB ' ' A' ' 235' ' ' PRO . 72.6 m-85 -114.11 126.32 54.95 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.471 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.509 ' CE ' ' HB3' ' A' ' 207' ' ' GLU . 0.0 OUTLIER -47.7 -39.12 16.67 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 178.139 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -94.34 -168.18 1.8 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 113.325 -1.762 . . . . 0.0 109.995 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . 0.524 ' CB ' ' HD2' ' A' ' 182' ' ' LYS . 1.1 pm0 -129.79 10.12 5.5 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.536 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.4 OUTLIER -80.0 -60.22 0.51 Allowed Pre-proline 0 C--N 1.328 -0.338 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.42 179.895 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.669 ' CB ' ' CE2' ' A' ' 230' ' ' PHE . 87.5 Cg_exo -50.32 -29.67 24.19 Favored 'Trans proline' 0 CA--C 1.5 -1.19 0 N-CA-C 108.909 -1.227 . . . . 0.0 108.909 177.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.521 HG23 ' CD1' ' A' ' 230' ' ' PHE . 15.9 t -72.4 -44.7 62.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 113.971 -1.468 . . . . 0.0 109.905 178.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . 0.536 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 0.2 OUTLIER -65.51 -35.52 81.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.84 -179.707 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.498 ' O ' ' CG ' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -80.99 -47.86 13.05 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.928 0.394 . . . . 0.0 110.857 179.14 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.737 HG13 ' CE2' ' A' ' 205' ' ' PHE . 1.6 mt -49.33 -50.93 15.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.468 -179.392 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' MET . . . . . 0.436 ' SD ' ' O ' ' A' ' 236' ' ' VAL . 10.3 mtp -59.09 -29.1 67.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.795 0.331 . . . . 0.0 111.246 -178.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.498 ' CG ' ' O ' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -79.54 -21.26 45.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.063 0.459 . . . . 0.0 111.241 -179.734 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.425 ' HD3' ' HG3' ' A' ' 241' ' ' GLU . 5.5 mmtp -78.77 118.5 20.9 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.371 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.541 ' HE3' ' CD2' ' A' ' 244' ' ' TYR . 2.9 ttpt -44.81 -74.58 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . 0.552 ' CE1' ' HB2' ' A' ' 253' ' ' GLU . 16.2 m-30 -121.95 153.92 37.85 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.072 178.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' HIS . . . . . 0.603 ' CE1' HG12 ' A' ' 239' ' ' ILE . 34.8 m-70 -109.9 146.56 34.94 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.03 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -122.11 105.03 9.9 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.102 0.477 . . . . 0.0 110.149 178.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.557 ' O ' ' N ' ' A' ' 249' ' ' LEU . 2.2 t -107.71 127.42 63.73 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.631 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . 0.436 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . 34.77 -89.89 0.01 OUTLIER Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.431 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.557 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.1 OUTLIER -108.67 -37.77 5.82 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 121.706 0.765 . . . . 0.0 110.269 -179.887 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 250' ' ' SER . . . . . 0.428 ' O ' ' N ' ' A' ' 247' ' ' VAL . 1.4 m -77.8 154.17 32.15 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.494 -1.23 . . . . 0.0 112.547 -178.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.468 ' O ' ' HD3' ' A' ' 251' ' ' LYS . 0.0 OUTLIER -149.37 110.63 4.41 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.824 179.375 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 252' ' ' CYS . . . . . 0.571 ' HB2' ' CG1' ' A' ' 186' ' ' VAL . 0.0 OUTLIER -129.38 152.84 48.49 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -177.619 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . 0.552 ' HB2' ' CE1' ' A' ' 244' ' ' TYR . 52.4 tt0 -76.41 110.86 11.29 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.917 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . 0.616 ' CG2' ' CG2' ' A' ' 239' ' ' ILE . 14.9 mt -96.12 112.7 28.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 -177.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . 0.513 ' O ' ' C ' ' A' ' 256' ' ' VAL . 0.0 OUTLIER -116.3 131.96 56.8 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 176.179 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . 0.54 ' CG2' ' O ' ' A' ' 183' ' ' LYS . 3.4 p -32.87 123.07 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 CA-C-O 122.235 1.017 . . . . 0.0 111.555 -177.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.693 ' CB ' ' CE2' ' A' ' 227' ' ' PHE . . . -78.35 152.41 32.36 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 113.34 -1.755 . . . . 0.0 112.28 -178.402 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.84 110.48 15.49 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.7 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 259' ' ' SER . . . . . 0.504 ' HB3' ' HD2' ' A' ' 183' ' ' LYS . 69.5 p . . . . . 0 C--N 1.327 -0.395 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.771 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.519 HG12 ' N ' ' A' ' 182' ' ' LYS . 40.0 t . . . . . 0 CA--C 1.503 -0.852 0 CA-C-O 121.35 0.595 . . . . 0.0 112.036 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.519 ' HD2' ' CB ' ' A' ' 233' ' ' GLU . 0.0 OUTLIER -144.89 112.17 6.06 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.841 177.36 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.618 ' HD3' ' HB2' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -130.85 151.51 51.19 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.954 178.973 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.642 HG12 ' HB ' ' A' ' 228' ' ' ILE . 0.4 OUTLIER -128.09 120.21 52.97 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.408 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.564 ' CB ' ' HA ' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -92.67 109.03 20.44 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.35 0.595 . . . . 0.0 110.57 -178.806 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.576 ' CG1' ' HB2' ' A' ' 252' ' ' CYS . 2.4 t -85.4 124.47 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 CA-C-N 114.781 -1.1 . . . . 0.0 109.327 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.551 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . -113.01 126.06 7.3 Favored Glycine 0 C--N 1.331 0.296 0 N-CA-C 114.555 0.582 . . . . 0.0 114.555 -176.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.471 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . 80.37 84.66 0.67 Allowed Glycine 0 C--N 1.331 0.266 0 C-N-CA 121.337 -0.458 . . . . 0.0 113.151 179.356 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . 0.513 ' CD2' ' C ' ' A' ' 225' ' ' PHE . 0.7 OUTLIER -117.31 157.32 26.31 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.831 0.348 . . . . 0.0 111.154 -179.573 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' SER . . . . . 0.583 ' CB ' ' CD ' ' A' ' 191' ' ' PRO . 0.1 OUTLIER -49.34 -172.07 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.765 179.537 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . 0.583 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 94.7 Cg_endo -81.61 25.44 0.65 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.293 1.995 . . . . 0.0 113.598 -179.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.575 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 8.0 t70 150.78 79.77 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.778 0.323 . . . . 0.0 110.974 179.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.561 ' CG2' ' CD1' ' A' ' 198' ' ' ILE . 62.0 m -75.28 111.98 16.44 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.759 179.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.546 ' HG2' ' CG ' ' A' ' 197' ' ' LYS . 18.8 Cg_endo -60.1 112.2 1.22 Allowed 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.097 1.864 . . . . 0.0 110.812 178.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.803 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 7.4 pt-20 -51.85 -14.84 0.41 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.438 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 1.3 mm-40 -67.12 -37.21 83.48 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.546 ' CG ' ' HG2' ' A' ' 194' ' ' PRO . 0.4 OUTLIER -74.97 -49.8 18.78 Favored 'General case' 0 CA--C 1.495 -1.139 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.193 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.803 ' CG1' ' HA ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -47.26 -31.81 2.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.594 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.566 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 16.0 mtp180 -69.13 -33.61 73.73 Favored 'General case' 0 C--O 1.221 -0.44 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.177 178.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . 0.529 ' N ' ' O ' ' A' ' 197' ' ' LYS . 3.2 mt-10 -82.57 -59.35 2.55 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.452 0.644 . . . . 0.0 109.903 178.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.535 ' OH ' ' ND1' ' A' ' 245' ' ' HIS . 0.6 OUTLIER -49.07 -54.36 16.33 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.931 179.083 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.673 ' O ' ' HB2' ' A' ' 205' ' ' PHE . 0.2 OUTLIER -79.85 -30.99 40.45 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.597 -179.962 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.566 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -62.52 -56.79 19.54 Favored Glycine 0 CA--C 1.499 -0.965 0 N-CA-C 107.202 -2.359 . . . . 0.0 107.202 176.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -49.08 -28.93 8.37 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 176.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . 0.741 ' CE2' HG13 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -58.38 -44.28 88.82 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 177.788 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 203' ' ' GLY . . . 169.65 -130.58 2.07 Favored Glycine 0 N--CA 1.443 -0.837 0 CA-C-N 113.708 -1.587 . . . . 0.0 110.579 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.454 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 54.8 mm-40 -97.05 100.2 11.7 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.27 0.557 . . . . 0.0 111.256 178.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.445 HG13 HD12 ' A' ' 211' ' ' ILE . 2.9 t -77.64 137.64 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.056 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.514 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 25.3 tp10 -92.84 -54.37 3.78 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 120.686 0.279 . . . . 0.0 110.341 178.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.426 ' C ' HG12 ' A' ' 211' ' ' ILE . 1.4 p -157.46 158.03 35.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.306 0.574 . . . . 0.0 112.182 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.618 ' CD1' ' HB ' ' A' ' 198' ' ' ILE . 0.1 OUTLIER -133.2 126.06 52.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.366 179.108 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -123.49 108.68 12.93 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 114.147 1.165 . . . . 0.0 114.147 -177.45 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.528 ' N ' ' CD2' ' A' ' 213' ' ' LEU . 1.3 mm? . . . . . 0 CA--C 1.531 0.249 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 176.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.61 0 CA-C-O 121.003 0.224 . . . . 0.0 112.921 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . 0.56 ' CE2' ' CE2' ' A' ' 185' ' ' PHE . 0.1 OUTLIER -157.27 176.62 12.46 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -178.5 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . 0.51 ' HB2' ' CD1' ' A' ' 213' ' ' LEU . 2.7 p -140.22 151.91 45.56 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.336 -0.546 . . . . 0.0 112.154 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.672 ' CE2' ' CB ' ' A' ' 257' ' ' ALA . 4.2 m-85 -111.11 137.43 48.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.472 178.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.671 HD13 ' CD2' ' A' ' 202' ' ' PHE . 2.1 mt -131.32 141.84 44.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.131 0.491 . . . . 0.0 111.146 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' THR . . . . . 0.453 ' N ' HG22 ' A' ' 228' ' ' ILE . 97.5 m -122.6 137.94 54.74 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 0.653 ' CE1' ' CB ' ' A' ' 235' ' ' PRO . 66.2 m-85 -111.83 126.44 55.09 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.93 -179.468 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.514 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -50.51 -37.77 40.74 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 106.622 -1.622 . . . . 0.0 106.622 177.696 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . 0.491 ' O ' ' HG3' ' A' ' 182' ' ' LYS . 15.2 mt-10 -89.86 -168.96 2.28 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 112.929 -1.941 . . . . 0.0 108.914 178.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . 0.519 ' CB ' ' HD2' ' A' ' 182' ' ' LYS . 2.3 pm0 -131.07 1.02 4.23 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.246 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.515 ' O ' ' N ' ' A' ' 237' ' ' LYS . 0.4 OUTLIER -75.13 -57.62 1.71 Allowed Pre-proline 0 C--N 1.331 -0.222 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -179.415 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.653 ' CB ' ' CE1' ' A' ' 230' ' ' PHE . 98.5 Cg_exo -49.09 -31.83 22.3 Favored 'Trans proline' 0 CA--C 1.498 -1.275 0 N-CA-C 109.027 -1.182 . . . . 0.0 109.027 178.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.532 HG22 ' CD2' ' A' ' 230' ' ' PHE . 17.5 t -69.52 -41.57 80.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 113.883 -1.508 . . . . 0.0 108.855 178.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . 0.515 ' N ' ' O ' ' A' ' 234' ' ' GLU . 22.7 mttt -59.47 -48.15 82.75 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.916 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.494 ' O ' ' CG ' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -76.86 -46.16 25.69 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.169 -179.238 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.741 HG13 ' CE2' ' A' ' 205' ' ' PHE . 1.8 mt -49.04 -47.12 17.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.213 -0.449 . . . . 0.0 112.051 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 44.4 mtp -63.92 -17.73 63.52 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.022 -178.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.494 ' CG ' ' O ' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -86.97 -27.73 23.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.686 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.465 ' HG2' ' O ' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -86.79 92.7 9.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.438 179.503 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.508 ' N ' ' HD3' ' A' ' 243' ' ' LYS . 0.0 OUTLIER -36.28 -48.9 0.66 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.996 0.427 . . . . 0.0 110.31 -179.947 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . 0.587 ' CE1' ' HG3' ' A' ' 253' ' ' GLU . 22.1 m-85 -122.3 157.56 31.47 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.836 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' HIS . . . . . 0.633 ' CG ' ' CD1' ' A' ' 254' ' ' ILE . 29.8 m-70 -127.79 156.83 41.86 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.917 -179.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . 0.4 ' O ' ' CE2' ' A' ' 201' ' ' TYR . 2.1 m-80 -129.15 105.15 7.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.124 0.487 . . . . 0.0 110.602 179.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.563 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.5 t -109.7 125.98 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.677 -179.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . 35.46 -89.19 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.504 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.563 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.1 OUTLIER -108.15 -35.88 6.45 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.777 0.798 . . . . 0.0 110.085 -179.679 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 250' ' ' SER . . . . . 0.49 ' OG ' HG23 ' A' ' 193' ' ' THR . 0.8 OUTLIER -77.92 154.46 31.63 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.322 -1.308 . . . . 0.0 112.959 -177.836 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -149.95 107.88 3.71 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.063 -0.972 . . . . 0.0 108.973 179.069 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 252' ' ' CYS . . . . . 0.576 ' HB2' ' CG1' ' A' ' 186' ' ' VAL . 0.0 OUTLIER -128.78 153.33 47.5 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 -176.762 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . 0.587 ' HG3' ' CE1' ' A' ' 244' ' ' TYR . 31.7 tt0 -75.93 108.91 9.13 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.033 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . 0.633 ' CD1' ' CG ' ' A' ' 245' ' ' HIS . 19.1 mt -96.48 113.1 30.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 -178.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . 0.516 ' O ' ' C ' ' A' ' 256' ' ' VAL . 0.0 OUTLIER -119.6 133.37 55.69 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 176.516 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . 0.527 ' CG2' ' O ' ' A' ' 183' ' ' LYS . 3.1 p -32.69 121.47 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 CA-C-O 122.218 1.009 . . . . 0.0 111.557 -177.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.672 ' CB ' ' CE2' ' A' ' 227' ' ' PHE . . . -76.52 153.71 35.23 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 113.353 -1.748 . . . . 0.0 112.07 -178.371 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -127.88 113.67 16.2 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.898 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 259' ' ' SER . . . . . 0.426 ' HB2' ' HD2' ' A' ' 183' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.519 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.073 -179.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.532 HG12 ' N ' ' A' ' 182' ' ' LYS . 55.2 t . . . . . 0 CA--C 1.501 -0.936 0 CA-C-O 121.11 0.481 . . . . 0.0 111.47 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.532 ' N ' HG12 ' A' ' 181' ' ' VAL . 0.0 OUTLIER -152.68 111.78 3.83 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.088 177.346 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.648 ' HD3' ' HB1' ' A' ' 257' ' ' ALA . 0.5 OUTLIER -136.36 167.86 20.52 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.693 179.04 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.672 HG12 ' HB ' ' A' ' 228' ' ' ILE . 0.3 OUTLIER -144.1 121.66 5.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.09 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.545 ' CE2' ' CE2' ' A' ' 225' ' ' PHE . 0.3 OUTLIER -96.36 108.97 21.57 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.454 -0.898 . . . . 0.0 109.679 -179.734 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.582 ' CG1' HG12 ' A' ' 254' ' ' ILE . 1.7 t -87.7 127.23 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.729 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.554 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . -114.71 124.54 6.42 Favored Glycine 0 C--N 1.331 0.282 0 N-CA-C 114.647 0.619 . . . . 0.0 114.647 -176.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.468 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . 82.12 85.83 0.75 Allowed Glycine 0 CA--C 1.518 0.28 0 C-N-CA 121.277 -0.487 . . . . 0.0 113.108 179.282 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . 0.507 HD13 ' N ' ' A' ' 190' ' ' SER . 0.8 OUTLIER -117.46 157.27 26.53 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.742 0.306 . . . . 0.0 111.367 -179.564 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' SER . . . . . 0.607 ' CB ' ' CD ' ' A' ' 191' ' ' PRO . 0.1 OUTLIER -49.83 -170.84 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.228 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.843 179.615 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . 0.607 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 95.7 Cg_endo -83.46 24.07 0.78 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.44 2.093 . . . . 0.0 113.381 -179.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.546 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 4.3 t0 154.67 77.19 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.72 0.295 . . . . 0.0 111.201 179.508 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.527 ' HB ' ' CD1' ' A' ' 213' ' ' LEU . 86.4 m -74.26 111.39 12.48 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 120.869 0.366 . . . . 0.0 110.957 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.504 ' HG2' ' HG2' ' A' ' 197' ' ' LYS . 19.3 Cg_endo -61.04 112.58 1.42 Allowed 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.248 1.965 . . . . 0.0 111.144 179.011 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.821 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 1.6 pm0 -51.9 -15.27 0.49 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.434 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . 0.488 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 40.6 mm-40 -66.94 -38.27 85.83 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.549 ' O ' ' N ' ' A' ' 200' ' ' GLU . 0.1 OUTLIER -74.04 -51.09 16.91 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.214 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.821 ' CG1' ' HA ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -47.52 -29.88 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.338 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.57 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 0.1 OUTLIER -70.9 -33.79 70.92 Favored 'General case' 0 C--O 1.22 -0.448 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.876 178.559 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . 0.578 ' CG ' ' N ' ' A' ' 201' ' ' TYR . 2.3 pt-20 -83.17 -56.47 3.76 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.857 0.361 . . . . 0.0 110.662 179.221 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.578 ' N ' ' CG ' ' A' ' 200' ' ' GLU . 0.2 OUTLIER -51.07 -53.5 33.31 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.427 0.632 . . . . 0.0 109.52 178.964 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.686 ' CD2' HD13 ' A' ' 228' ' ' ILE . 0.4 OUTLIER -79.65 -30.23 41.19 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.232 -179.913 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.57 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -62.11 -56.9 19.61 Favored Glycine 0 CA--C 1.498 -0.987 0 N-CA-C 106.763 -2.535 . . . . 0.0 106.763 176.234 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -49.41 -28.62 9.76 Favored Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 176.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . 0.682 ' CE2' ' CD1' ' A' ' 239' ' ' ILE . 0.1 OUTLIER -58.28 -42.4 86.5 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 177.99 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.493 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 166.96 -130.2 2.07 Favored Glycine 0 N--CA 1.441 -1.019 0 CA-C-N 113.709 -1.587 . . . . 0.0 109.895 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.509 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 9.4 mm-40 -96.82 100.85 12.37 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.322 0.582 . . . . 0.0 110.609 178.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.413 HG23 ' HB2' ' A' ' 202' ' ' PHE . 2.7 t -77.92 139.67 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.354 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.508 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 7.4 tp10 -89.75 -55.9 3.45 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 178.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 3.8 m -169.52 151.26 4.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.338 0.589 . . . . 0.0 112.069 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.635 HG22 HG12 ' A' ' 228' ' ' ILE . 0.4 OUTLIER -116.26 132.12 66.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.416 178.879 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -123.18 109.44 14.01 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -178.07 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.527 ' CD1' ' HB ' ' A' ' 193' ' ' THR . 1.6 mm? . . . . . 0 C--N 1.331 -0.231 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.873 177.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.554 0 CA-C-O 121.098 0.277 . . . . 0.0 112.744 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . 0.555 ' HB2' ' O ' ' A' ' 186' ' ' VAL . 0.1 OUTLIER -157.38 176.63 12.42 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.054 -0.573 . . . . 0.0 109.781 -178.309 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . 0.462 ' SG ' ' HB ' ' A' ' 186' ' ' VAL . 30.5 p -140.96 146.86 37.88 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.276 -0.57 . . . . 0.0 112.425 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.674 ' CE2' ' CB ' ' A' ' 257' ' ' ALA . 4.7 m-85 -106.76 134.91 49.19 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.355 178.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.686 HD13 ' CD2' ' A' ' 202' ' ' PHE . 1.8 mt -128.66 136.35 60.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.146 0.498 . . . . 0.0 111.374 -179.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' THR . . . . . 0.52 ' OG1' ' NZ ' ' A' ' 183' ' ' LYS . 52.5 m -117.02 138.02 51.85 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.529 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 0.608 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 75.6 m-85 -111.83 126.29 54.93 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.394 179.587 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.509 ' HG3' ' O ' ' A' ' 207' ' ' GLU . 0.0 OUTLIER -45.0 -40.33 6.37 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 178.56 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . 0.458 ' O ' ' HG3' ' A' ' 182' ' ' LYS . 69.5 mt-10 -99.12 173.05 7.0 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 113.442 -1.708 . . . . 0.0 108.779 178.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . 0.523 ' O ' ' HG3' ' A' ' 237' ' ' LYS . 0.8 OUTLIER -112.0 13.17 20.74 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.58 -179.633 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.538 ' O ' ' HB2' ' A' ' 237' ' ' LYS . 0.6 OUTLIER -80.84 -60.38 0.44 Allowed Pre-proline 0 C--N 1.331 -0.213 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.7 -179.628 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.638 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 90.8 Cg_exo -48.7 -36.76 33.56 Favored 'Trans proline' 0 CA--C 1.495 -1.456 0 N-CA-C 108.61 -1.342 . . . . 0.0 108.61 178.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.512 ' CG2' ' HB2' ' A' ' 230' ' ' PHE . 17.2 t -62.66 -40.27 87.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 114.204 -1.362 . . . . 0.0 109.773 178.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . 0.538 ' HB2' ' O ' ' A' ' 234' ' ' GLU . 8.3 mtpt -54.24 -49.21 70.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.957 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.488 ' HA ' ' HG3' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -80.91 -45.83 16.13 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.615 -179.236 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.682 ' CD1' ' CE2' ' A' ' 205' ' ' PHE . 0.7 OUTLIER -39.48 -59.11 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.256 -0.883 . . . . 0.0 111.818 -179.549 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' MET . . . . . 0.467 ' HG2' ' HB ' ' A' ' 256' ' ' VAL . 2.6 mtp -55.53 -27.68 50.27 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.435 -178.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.488 ' HG3' ' HA ' ' A' ' 238' ' ' LYS . 1.1 mt-10 -84.43 -13.87 50.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.937 0.399 . . . . 0.0 110.642 179.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.451 ' HB2' ' O ' ' A' ' 239' ' ' ILE . 1.9 mptt -79.42 105.86 11.04 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.725 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.487 ' HD3' ' CD2' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -37.52 -67.18 0.2 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.05 -179.869 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . 0.487 ' CD2' ' HD3' ' A' ' 243' ' ' LYS . 29.3 m-85 -132.71 143.28 49.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.971 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' HIS . . . . . 0.594 ' CD2' HG13 ' A' ' 254' ' ' ILE . 45.5 m-70 -108.81 127.93 54.45 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.354 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -102.25 105.28 15.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.034 0.445 . . . . 0.0 110.905 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.555 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.1 t -103.85 130.0 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.701 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . 0.451 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . 32.78 -89.91 0.01 OUTLIER Glycine 0 C--N 1.334 0.442 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.412 -179.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.555 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.1 OUTLIER -109.9 -34.74 6.34 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.843 0.83 . . . . 0.0 109.642 179.748 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 250' ' ' SER . . . . . 0.503 ' OG ' HG21 ' A' ' 193' ' ' THR . 1.9 p -77.16 152.44 34.85 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.172 -1.376 . . . . 0.0 112.65 -178.252 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -150.26 108.48 3.76 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.254 179.246 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 252' ' ' CYS . . . . . 0.554 ' HB3' ' C ' ' A' ' 187' ' ' GLY . 0.0 OUTLIER -127.54 153.15 46.71 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -177.381 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' A' ' 187' ' ' GLY . 48.8 tt0 -76.07 113.68 13.87 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.552 -179.266 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . 0.594 HG13 ' CD2' ' A' ' 245' ' ' HIS . 6.3 mt -96.75 113.33 30.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 -178.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . 0.53 ' O ' ' C ' ' A' ' 256' ' ' VAL . 0.0 OUTLIER -122.67 128.15 50.22 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 105.569 -2.012 . . . . 0.0 105.569 176.346 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . 0.53 ' C ' ' O ' ' A' ' 255' ' ' LYS . 1.4 p -31.9 121.71 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 CA-C-O 122.244 1.021 . . . . 0.0 111.37 -176.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.674 ' CB ' ' CE2' ' A' ' 227' ' ' PHE . . . -75.85 153.85 36.53 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 113.27 -1.786 . . . . 0.0 111.768 -178.307 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.03 118.64 19.04 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.969 179.451 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 90.6 p . . . . . 0 C--N 1.326 -0.432 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.192 -179.514 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.551 HG13 ' N ' ' A' ' 182' ' ' LYS . 47.8 t . . . . . 0 CA--C 1.504 -0.805 0 CA-C-O 121.156 0.503 . . . . 0.0 111.671 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.551 ' N ' HG13 ' A' ' 181' ' ' VAL . 0.0 OUTLIER -150.33 112.63 4.65 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.676 177.621 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.69 ' HD2' ' HB1' ' A' ' 257' ' ' ALA . 0.0 OUTLIER -138.51 148.27 44.08 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.218 178.484 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.633 HG12 ' HB ' ' A' ' 228' ' ' ILE . 0.3 OUTLIER -126.58 120.06 55.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.679 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.674 ' CE2' ' CE2' ' A' ' 225' ' ' PHE . 0.3 OUTLIER -92.98 109.6 21.06 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 121.44 0.638 . . . . 0.0 110.111 -179.164 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.54 ' CG2' HD11 ' A' ' 254' ' ' ILE . 5.8 t -88.72 118.49 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.161 -179.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.535 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . -62.11 -150.9 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 115.76 -0.654 . . . . 0.0 114.609 -178.004 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.504 ' O ' ' HB3' ' A' ' 252' ' ' CYS . . . -47.03 111.74 0.8 Allowed Glycine 0 C--N 1.33 0.234 0 CA-C-N 114.823 -0.688 . . . . 0.0 114.435 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . 0.537 ' CD1' ' OG1' ' A' ' 193' ' ' THR . 3.3 pp -109.11 157.35 18.82 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.98 -0.61 . . . . 0.0 110.255 178.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' SER . . . . . 0.529 ' O ' ' O ' ' A' ' 189' ' ' LEU . 0.1 OUTLIER -42.74 178.13 0.01 OUTLIER Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 121.084 0.469 . . . . 0.0 111.034 179.726 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . 0.543 ' O ' ' CB ' ' A' ' 192' ' ' ASP . 74.5 Cg_endo -76.37 26.65 0.42 Allowed 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 122.637 2.225 . . . . 0.0 113.544 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.543 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 4.6 p30 157.48 73.88 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.113 0 N-CA-C 111.528 0.196 . . . . 0.0 111.528 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.571 HG23 ' CD1' ' A' ' 198' ' ' ILE . 87.6 m -77.93 111.22 16.58 Favored Pre-proline 0 CA--C 1.518 -0.26 0 CA-C-O 121.055 0.455 . . . . 0.0 110.742 179.268 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.57 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 57.7 Cg_endo -68.47 109.62 2.09 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.525 2.15 . . . . 0.0 111.686 179.27 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.596 ' HA ' ' CD1' ' A' ' 198' ' ' ILE . 0.6 OUTLIER -43.42 -19.81 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.47 179.752 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . 0.499 ' O ' ' HG2' ' A' ' 200' ' ' GLU . 0.1 OUTLIER -61.02 -44.49 97.33 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -179.158 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.57 ' CD ' ' HG2' ' A' ' 194' ' ' PRO . 1.4 mttp -76.17 -46.18 29.8 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 178.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.617 HG22 ' CE1' ' A' ' 202' ' ' PHE . 0.2 OUTLIER -48.56 -28.94 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-N 114.048 -1.433 . . . . 0.0 108.717 177.014 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.54 ' HG3' ' O ' ' A' ' 195' ' ' GLU . 12.9 mtp180 -75.75 -32.11 59.83 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.955 178.233 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . 0.521 ' N ' ' O ' ' A' ' 197' ' ' LYS . 4.1 mm-40 -81.91 -57.48 3.4 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.226 0.536 . . . . 0.0 110.536 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.524 ' OH ' ' ND1' ' A' ' 245' ' ' HIS . 0.3 OUTLIER -48.03 -53.94 14.65 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.678 179.308 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.688 ' CD2' HD12 ' A' ' 228' ' ' ILE . 0.9 OUTLIER -79.73 -31.95 41.12 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.571 179.93 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.517 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -61.88 -57.78 15.86 Favored Glycine 0 N--CA 1.444 -0.824 0 N-CA-C 107.378 -2.289 . . . . 0.0 107.378 176.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -49.33 -29.28 10.21 Favored Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 176.264 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . 0.741 ' CE2' HG13 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -58.53 -43.49 89.25 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 122.115 0.959 . . . . 0.0 108.423 177.787 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 169.14 -131.29 2.25 Favored Glycine 0 N--CA 1.441 -1.002 0 CA-C-N 113.714 -1.584 . . . . 0.0 110.417 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.49 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 4.1 mt-10 -97.11 102.94 14.82 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.231 0.539 . . . . 0.0 111.364 178.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.503 ' O ' ' NZ ' ' A' ' 231' ' ' LYS . 2.5 t -77.84 138.9 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.049 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.555 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 70.8 tt0 -93.35 -53.15 4.2 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.5 178.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.446 ' OG ' ' OE2' ' A' ' 212' ' ' GLU . 37.2 p -160.51 151.65 19.08 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.606 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -129.55 122.36 55.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.923 178.905 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . 0.446 ' OE2' ' OG ' ' A' ' 210' ' ' SER . 0.0 OUTLIER -123.86 115.29 21.07 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 -177.962 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.484 ' N ' ' CD2' ' A' ' 213' ' ' LEU . 0.3 OUTLIER . . . . . 0 CA--C 1.537 0.452 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 176.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . 0.448 ' O ' ' HG ' ' A' ' 189' ' ' LEU . . . . . . . . 0 N--CA 1.449 -0.488 0 N-CA-C 112.411 -0.276 . . . . 0.0 112.411 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . 0.674 ' CE2' ' CE2' ' A' ' 185' ' ' PHE . 6.7 p90 -132.87 176.68 8.26 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . 0.517 ' HB3' ' CD2' ' A' ' 189' ' ' LEU . 23.1 p -136.06 149.15 48.64 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 119.495 -0.882 . . . . 0.0 112.709 -179.311 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.675 ' CE2' ' CB ' ' A' ' 257' ' ' ALA . 3.1 m-85 -105.65 139.0 40.91 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 115.586 -0.733 . . . . 0.0 109.119 178.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.688 HD12 ' CD2' ' A' ' 202' ' ' PHE . 1.7 mt -133.83 118.29 29.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.414 0.626 . . . . 0.0 111.015 179.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' THR . . . . . 0.473 ' OG1' ' HG3' ' A' ' 183' ' ' LYS . 63.4 m -100.67 137.99 38.32 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 0.645 ' CE1' ' CB ' ' A' ' 235' ' ' PRO . 58.1 m-85 -111.8 126.49 55.14 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.465 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.555 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -49.46 -38.31 29.23 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 178.302 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . 0.419 ' OE1' ' CD ' ' A' ' 234' ' ' GLU . 0.7 OUTLIER -92.06 -165.37 1.33 Allowed 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 113.049 -1.887 . . . . 0.0 109.483 178.873 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . 0.54 ' CG ' ' HG2' ' A' ' 182' ' ' LYS . 0.5 OUTLIER -132.96 1.75 3.59 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.443 -179.914 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.493 ' O ' ' N ' ' A' ' 237' ' ' LYS . 0.2 OUTLIER -73.91 -59.53 1.79 Allowed Pre-proline 0 C--N 1.33 -0.264 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.622 -179.415 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.645 ' CB ' ' CE1' ' A' ' 230' ' ' PHE . 98.5 Cg_exo -48.65 -33.61 24.74 Favored 'Trans proline' 0 CA--C 1.498 -1.299 0 N-CA-C 108.851 -1.25 . . . . 0.0 108.851 178.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.512 HG11 HG22 ' A' ' 184' ' ' ILE . 21.7 t -70.43 -40.74 77.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 113.856 -1.52 . . . . 0.0 109.502 178.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . 0.531 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 19.9 mttt -56.68 -46.89 80.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.915 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.529 ' O ' ' CG ' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -81.14 -50.09 10.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.277 -179.754 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.741 HG13 ' CE2' ' A' ' 205' ' ' PHE . 1.5 mt -40.74 -52.58 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.632 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' MET . . . . . 0.456 ' SD ' ' HB ' ' A' ' 256' ' ' VAL . 6.7 mtp -61.32 -21.92 64.42 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.025 -179.024 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.529 ' CG ' ' O ' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -80.05 -23.96 41.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.844 -179.834 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.425 ' N ' ' HG3' ' A' ' 241' ' ' GLU . 2.9 mmtp -79.11 137.59 37.56 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.034 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.543 ' HD2' ' CG ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -76.55 -41.96 44.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.447 179.588 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . 0.632 ' CD1' ' HB3' ' A' ' 253' ' ' GLU . 2.5 m-85 -140.51 140.88 35.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.277 178.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' HIS . . . . . 0.638 ' CG ' ' CD1' ' A' ' 254' ' ' ILE . 17.3 m-70 -106.39 157.8 17.36 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.675 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . 0.404 ' ND2' ' N ' ' A' ' 246' ' ' ASN . 0.1 OUTLIER -133.77 105.27 6.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.97 0.414 . . . . 0.0 110.87 179.541 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.538 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.6 t -108.61 105.63 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.112 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 50.17 -85.21 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.421 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.538 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -107.1 -38.99 5.85 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.405 0.621 . . . . 0.0 110.602 179.806 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 250' ' ' SER . . . . . 0.495 ' O ' ' N ' ' A' ' 247' ' ' VAL . 4.4 p -77.63 150.28 34.64 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.984 -1.007 . . . . 0.0 112.105 -178.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -150.5 103.58 3.14 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.588 178.994 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 252' ' ' CYS . . . . . 0.535 ' HB3' ' C ' ' A' ' 187' ' ' GLY . 0.0 OUTLIER -130.59 154.69 47.59 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -177.515 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . 0.632 ' HB3' ' CD1' ' A' ' 244' ' ' TYR . 7.8 pt-20 -74.94 118.54 18.01 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.24 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . 0.638 ' CD1' ' CG ' ' A' ' 245' ' ' HIS . 24.0 mt -96.76 102.12 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 CA-C-O 121.809 0.814 . . . . 0.0 112.657 -178.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . 0.558 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -104.0 128.99 51.58 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 177.627 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . 0.513 ' C ' ' O ' ' A' ' 255' ' ' LYS . 3.8 p -32.41 125.06 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-O 122.15 0.976 . . . . 0.0 111.206 -176.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.69 ' HB1' ' HD2' ' A' ' 183' ' ' LYS . . . -76.23 152.82 36.46 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 113.522 -1.672 . . . . 0.0 112.166 -178.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.15 126.65 26.89 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.469 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 259' ' ' SER . . . . . 0.531 ' HB3' ' NZ ' ' A' ' 183' ' ' LYS . 53.9 p . . . . . 0 C--N 1.324 -0.508 0 CA-C-O 120.866 0.365 . . . . 0.0 111.097 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.533 HG12 ' N ' ' A' ' 182' ' ' LYS . 36.1 t . . . . . 0 CA--C 1.504 -0.808 0 CA-C-O 121.115 0.483 . . . . 0.0 111.247 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.568 ' HG2' ' CB ' ' A' ' 233' ' ' GLU . 2.8 mptt -148.45 112.95 5.32 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.447 178.038 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.64 ' HD3' ' HB2' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -134.14 143.88 48.2 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.846 179.08 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.647 HG12 ' HB ' ' A' ' 228' ' ' ILE . 1.0 OUTLIER -123.4 120.05 59.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.411 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.655 ' CE2' ' CE2' ' A' ' 225' ' ' PHE . 0.2 OUTLIER -92.11 109.49 20.85 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.423 0.63 . . . . 0.0 109.992 -179.337 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.527 ' CG2' HD11 ' A' ' 254' ' ' ILE . 11.0 t -87.03 123.59 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.303 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.515 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . -68.67 -159.07 1.56 Allowed Glycine 0 CA--C 1.521 0.452 0 CA-C-N 115.743 -0.662 . . . . 0.0 114.477 -178.098 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.532 ' HA2' ' O ' ' A' ' 224' ' ' GLY . . . -39.13 107.55 0.07 OUTLIER Glycine 0 C--N 1.332 0.355 0 CA-C-N 114.918 -0.641 . . . . 0.0 114.37 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . 0.526 ' CD1' ' O ' ' A' ' 190' ' ' SER . 3.2 pp -107.98 157.14 18.47 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 122.537 0.335 . . . . 0.0 110.802 179.182 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' SER . . . . . 0.526 ' O ' ' CD1' ' A' ' 189' ' ' LEU . 0.1 OUTLIER -40.28 173.44 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.392 0.615 . . . . 0.0 111.921 -179.947 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . 0.471 ' O ' ' HB2' ' A' ' 192' ' ' ASP . 32.9 Cg_exo -60.34 -3.65 2.62 Favored 'Trans proline' 0 CA--C 1.529 0.27 0 C-N-CA 123.293 2.662 . . . . 0.0 114.126 -179.373 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 191' ' ' PRO . 0.5 OUTLIER 172.01 74.02 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.69 -179.933 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.544 ' HB ' ' CD1' ' A' ' 213' ' ' LEU . 57.7 m -64.29 125.29 87.99 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.826 179.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.578 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 83.5 Cg_endo -76.55 117.71 4.65 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.405 2.07 . . . . 0.0 110.381 178.37 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.789 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 12.4 pt-20 -51.62 -14.0 0.29 Allowed 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -178.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . 0.506 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 33.7 mt-10 -68.51 -44.0 75.6 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -179.397 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.578 ' CD ' ' HG2' ' A' ' 194' ' ' PRO . 0.9 OUTLIER -70.58 -47.41 60.34 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.444 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.789 ' CG1' ' HA ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -47.85 -30.84 2.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.423 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.565 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 1.5 mtp-105 -72.31 -32.35 66.48 Favored 'General case' 0 C--O 1.22 -0.456 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.105 178.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . 0.522 ' N ' ' O ' ' A' ' 197' ' ' LYS . 25.2 mt-10 -82.71 -59.16 2.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.137 0.494 . . . . 0.0 110.397 179.329 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.504 ' C ' ' CD1' ' A' ' 201' ' ' TYR . 0.4 OUTLIER -48.72 -53.61 18.21 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.767 -0.652 . . . . 0.0 109.718 179.118 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.671 ' CD2' HD12 ' A' ' 228' ' ' ILE . 0.5 OUTLIER -79.7 -31.36 41.26 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.538 -179.963 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.565 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -62.14 -56.34 22.78 Favored Glycine 0 CA--C 1.5 -0.855 0 N-CA-C 107.104 -2.398 . . . . 0.0 107.104 176.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -49.76 -28.4 11.15 Favored Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 176.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . 0.742 ' CE2' HG13 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -58.64 -44.21 89.98 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 177.885 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 169.87 -130.66 2.07 Favored Glycine 0 N--CA 1.441 -0.985 0 CA-C-N 113.663 -1.608 . . . . 0.0 110.473 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.463 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 5.0 mt-10 -96.89 98.77 10.38 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.228 0.537 . . . . 0.0 110.923 178.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.429 ' O ' ' HE3' ' A' ' 231' ' ' LYS . 2.7 t -75.76 141.26 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 CA-C-N 115.384 -0.825 . . . . 0.0 108.984 178.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.497 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 45.6 tt0 -89.75 -57.72 2.77 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.141 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 10.4 p -167.58 151.41 6.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.298 0.571 . . . . 0.0 112.375 179.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.628 HG22 HG12 ' A' ' 228' ' ' ILE . 0.4 OUTLIER -117.71 132.29 67.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.497 178.657 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.45 111.46 16.35 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -178.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.544 ' CD1' ' HB ' ' A' ' 193' ' ' THR . 2.7 mm? . . . . . 0 CA--C 1.533 0.315 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.922 177.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . 0.532 ' O ' ' HA2' ' A' ' 188' ' ' GLY . . . . . . . . 0 C--O 1.222 -0.637 0 N-CA-C 113.635 0.214 . . . . 0.0 113.635 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . 0.655 ' CE2' ' CE2' ' A' ' 185' ' ' PHE . 0.6 OUTLIER -156.05 176.08 13.12 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.743 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . 0.516 ' HB3' ' CD2' ' A' ' 189' ' ' LEU . 27.3 p -140.7 150.92 44.08 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -179.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.669 ' CE2' ' CB ' ' A' ' 257' ' ' ALA . 4.5 m-85 -106.29 133.49 50.9 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.657 178.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.671 HD12 ' CD2' ' A' ' 202' ' ' PHE . 1.9 mt -127.75 128.05 68.99 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.393 0 CA-C-O 120.904 0.383 . . . . 0.0 111.108 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' THR . . . . . 0.488 ' CG2' ' CD ' ' A' ' 209' ' ' GLU . 51.5 m -111.62 137.95 48.81 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.214 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 0.661 ' CE2' ' CB ' ' A' ' 235' ' ' PRO . 83.2 m-85 -112.42 126.38 55.23 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.387 179.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.497 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -47.96 -38.38 16.66 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 178.018 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -91.0 -165.33 1.33 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 113.397 -1.728 . . . . 0.0 110.186 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . 0.568 ' CB ' ' HG2' ' A' ' 182' ' ' LYS . 9.5 pt-20 -133.25 10.91 4.16 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.486 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.53 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.0 OUTLIER -83.43 -60.38 0.34 Allowed Pre-proline 0 C--N 1.326 -0.419 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.649 179.951 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.661 ' CB ' ' CE2' ' A' ' 230' ' ' PHE . 80.2 Cg_exo -49.51 -30.45 21.26 Favored 'Trans proline' 0 CA--C 1.501 -1.145 0 N-CA-C 108.942 -1.215 . . . . 0.0 108.942 177.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.582 HG21 ' CD1' ' A' ' 230' ' ' PHE . 17.9 t -72.68 -45.28 58.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 113.88 -1.509 . . . . 0.0 110.323 178.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . 0.53 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 1.5 ptpt -63.76 -35.09 79.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.791 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.495 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 0.0 OUTLIER -80.73 -50.39 9.94 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.128 0.489 . . . . 0.0 110.379 179.055 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.742 HG13 ' CE2' ' A' ' 205' ' ' PHE . 1.7 mt -47.96 -49.74 10.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.433 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' MET . . . . . 0.463 ' HG2' ' HB ' ' A' ' 256' ' ' VAL . 36.8 mtp -58.16 -29.27 65.46 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.353 -178.456 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.514 ' CG ' ' O ' ' A' ' 237' ' ' LYS . 0.1 OUTLIER -86.38 -10.61 54.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.918 0.39 . . . . 0.0 110.566 179.447 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 239' ' ' ILE . 0.0 OUTLIER -81.6 102.52 10.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.2 -179.865 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.476 ' HE2' ' HB2' ' A' ' 244' ' ' TYR . 1.9 ttpt -38.18 -76.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.212 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . 0.64 ' CD1' ' HB3' ' A' ' 253' ' ' GLU . 8.9 m-85 -118.16 144.75 45.45 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.661 179.062 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' HIS . . . . . 0.584 ' CD2' HG13 ' A' ' 254' ' ' ILE . 24.9 m-70 -105.51 157.94 17.02 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.041 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . 0.464 ' N ' ' ND2' ' A' ' 246' ' ' ASN . 0.0 OUTLIER -133.15 105.21 6.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.527 179.582 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.548 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.5 t -110.9 101.34 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.688 -179.186 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 53.5 -79.62 0.01 OUTLIER Glycine 0 C--N 1.331 0.274 0 C-N-CA 121.062 -0.589 . . . . 0.0 112.521 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.548 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -113.44 -40.2 3.92 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.476 0.655 . . . . 0.0 110.234 179.762 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 250' ' ' SER . . . . . 0.513 ' O ' ' N ' ' A' ' 247' ' ' VAL . 5.1 p -77.68 148.64 34.89 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.877 -179.021 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.505 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -151.25 103.22 2.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.84 178.807 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 252' ' ' CYS . . . . . 0.515 ' HB3' ' C ' ' A' ' 187' ' ' GLY . 0.0 OUTLIER -130.74 155.06 47.27 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -177.885 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . 0.64 ' HB3' ' CD1' ' A' ' 244' ' ' TYR . 8.4 pt-20 -74.69 119.51 18.98 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.196 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . 0.592 ' CG2' ' CG2' ' A' ' 239' ' ' ILE . 30.7 mt -96.97 102.59 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 CA-C-O 121.553 0.692 . . . . 0.0 112.385 -178.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . 0.539 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -103.52 130.36 50.89 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 177.812 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . 0.551 ' CG2' ' O ' ' A' ' 183' ' ' LYS . 4.0 p -32.67 122.74 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.561 0 CA-C-O 122.3 1.048 . . . . 0.0 111.513 -176.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.669 ' CB ' ' CE2' ' A' ' 227' ' ' PHE . . . -76.25 152.02 36.64 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 113.262 -1.79 . . . . 0.0 111.776 -178.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.43 118.82 21.74 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.026 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 54.4 p . . . . . 0 C--N 1.325 -0.46 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.106 -179.567 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.54 HG11 ' N ' ' A' ' 182' ' ' LYS . 39.8 t . . . . . 0 CA--C 1.504 -0.815 0 CA-C-O 121.276 0.56 . . . . 0.0 111.589 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.54 ' N ' HG11 ' A' ' 181' ' ' VAL . 0.0 OUTLIER -145.66 112.6 6.04 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.503 177.26 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.641 ' HD2' ' HB3' ' A' ' 257' ' ' ALA . 0.0 OUTLIER -133.62 164.82 26.34 Favored 'General case' 0 CA--C 1.507 -0.682 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.895 -179.891 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.702 HG12 ' HB ' ' A' ' 228' ' ' ILE . 1.4 pt -140.33 119.96 12.49 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 177.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.593 ' CE2' ' CE2' ' A' ' 225' ' ' PHE . 0.4 OUTLIER -95.94 108.77 21.19 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.424 -178.713 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.626 ' CG1' HG12 ' A' ' 254' ' ' ILE . 1.6 t -84.86 117.39 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.598 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 253' ' ' GLU . . . -104.7 134.14 11.87 Favored Glycine 0 N--CA 1.452 -0.248 0 N-CA-C 114.691 0.636 . . . . 0.0 114.691 -177.002 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.464 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . 72.73 84.48 0.24 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.147 -0.549 . . . . 0.0 112.746 179.178 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . 0.538 ' CD1' ' OG1' ' A' ' 193' ' ' THR . 0.6 OUTLIER -117.44 156.16 28.44 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.957 0.408 . . . . 0.0 111.085 -179.723 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' SER . . . . . 0.574 ' CB ' ' CD ' ' A' ' 191' ' ' PRO . 0.5 OUTLIER -47.25 -176.72 0.01 OUTLIER Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.316 179.917 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . 0.574 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 12.0 Cg_exo -71.86 5.73 2.4 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 123.391 2.727 . . . . 0.0 113.329 -179.286 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.464 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 0.8 OUTLIER 165.63 74.75 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.803 0.335 . . . . 0.0 111.43 -179.944 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.541 HG22 ' CD1' ' A' ' 198' ' ' ILE . 88.4 m -70.34 112.63 13.43 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.61 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.578 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 25.4 Cg_endo -60.32 107.38 0.41 Allowed 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.221 1.948 . . . . 0.0 111.163 179.098 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.802 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -48.53 -14.89 0.07 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.8 -179.618 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . 0.499 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 34.9 mt-10 -67.41 -40.46 85.57 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 -179.399 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.578 ' CD ' ' HG2' ' A' ' 194' ' ' PRO . 1.8 mttp -74.21 -47.51 34.97 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.802 ' CG1' ' HA ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -46.86 -30.2 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.104 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.554 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 7.1 mtp180 -71.5 -33.98 69.71 Favored 'General case' 0 C--O 1.221 -0.438 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.447 178.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . 0.518 ' N ' ' O ' ' A' ' 197' ' ' LYS . 0.4 OUTLIER -83.21 -46.3 12.86 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.157 0.503 . . . . 0.0 110.738 179.459 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.547 ' CD1' ' CD1' ' A' ' 202' ' ' PHE . 0.4 OUTLIER -61.25 -52.73 63.51 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.694 179.127 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.648 ' CD2' HD13 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -79.53 -31.25 42.06 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.663 179.483 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.554 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -63.86 -56.15 20.44 Favored Glycine 0 N--CA 1.443 -0.88 0 N-CA-C 106.73 -2.548 . . . . 0.0 106.73 175.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -50.25 -28.7 14.3 Favored Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 176.076 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . 0.72 ' CE2' HG13 ' A' ' 239' ' ' ILE . 0.0 OUTLIER -58.82 -44.49 90.86 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 177.68 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.503 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 170.77 -130.88 2.08 Favored Glycine 0 N--CA 1.442 -0.955 0 CA-C-N 113.664 -1.607 . . . . 0.0 110.389 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.492 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 0.4 OUTLIER -97.11 101.93 13.6 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.156 0.503 . . . . 0.0 111.439 178.805 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.441 HG12 ' N ' ' A' ' 209' ' ' GLU . 2.6 t -79.29 141.12 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 177.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.523 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 38.2 tt0 -98.05 -51.91 3.88 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.202 178.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.409 ' C ' HG12 ' A' ' 211' ' ' ILE . 5.1 p -157.66 154.32 28.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.392 0.615 . . . . 0.0 112.471 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.593 HG22 HG12 ' A' ' 228' ' ' ILE . 0.2 OUTLIER -137.26 116.3 14.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.144 178.548 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -124.1 114.47 19.74 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 113.853 1.056 . . . . 0.0 113.853 -177.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.454 ' CD1' ' O ' ' A' ' 193' ' ' THR . 0.1 OUTLIER . . . . . 0 CA--C 1.533 0.326 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 177.034 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . 0.523 ' O ' ' HG ' ' A' ' 189' ' ' LEU . . . . . . . . 0 N--CA 1.443 -0.881 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . 0.593 ' CE2' ' CE2' ' A' ' 185' ' ' PHE . 19.4 p90 -133.42 177.31 7.79 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 -178.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . 0.445 ' SG ' ' HB ' ' A' ' 186' ' ' VAL . 3.6 p -136.22 150.1 48.84 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 119.507 -0.877 . . . . 0.0 112.682 -179.144 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.686 ' CE2' ' CB ' ' A' ' 257' ' ' ALA . 3.1 m-85 -106.12 141.14 37.98 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.06 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.702 ' HB ' HG12 ' A' ' 184' ' ' ILE . 1.4 mt -138.0 114.42 11.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.458 0.647 . . . . 0.0 111.018 179.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 229' ' ' THR . . . . . 0.522 ' OG1' ' CG ' ' A' ' 183' ' ' LYS . 69.3 m -100.58 138.15 38.03 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.33 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 0.633 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 74.3 m-85 -112.51 126.42 55.31 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.221 -0.591 . . . . 0.0 111.335 -179.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.523 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -47.49 -38.89 14.72 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 177.52 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . 0.484 ' O ' ' HG3' ' A' ' 182' ' ' LYS . 17.5 mm-40 -91.2 -171.25 2.9 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 113.078 -1.874 . . . . 0.0 109.431 178.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . 0.487 ' HB3' ' HD2' ' A' ' 182' ' ' LYS . 0.0 OUTLIER -130.32 14.25 5.59 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.476 179.92 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.52 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.3 OUTLIER -84.89 -60.84 0.29 Allowed Pre-proline 0 CA--C 1.517 -0.318 0 C-N-CA 120.644 -0.423 . . . . 0.0 110.928 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.631 ' CB ' ' CE2' ' A' ' 230' ' ' PHE . 79.9 Cg_exo -49.3 -28.83 15.92 Favored 'Trans proline' 0 CA--C 1.499 -1.257 0 N-CA-C 108.719 -1.3 . . . . 0.0 108.719 178.208 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.582 HG22 ' CD1' ' A' ' 230' ' ' PHE . 14.5 t -73.29 -46.44 49.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 114.269 -1.332 . . . . 0.0 110.382 178.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . 0.52 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 2.1 pttp -62.12 -35.9 80.13 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.552 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.625 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.1 OUTLIER -81.38 -55.44 4.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.301 179.43 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.72 HG13 ' CE2' ' A' ' 205' ' ' PHE . 1.6 mt -42.04 -50.02 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.851 -179.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' MET . . . . . 0.425 ' CE ' ' HB ' ' A' ' 256' ' ' VAL . 46.7 mtp -59.82 -26.18 65.58 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.565 -178.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.5 ' CG ' ' O ' ' A' ' 237' ' ' LYS . 0.1 OUTLIER -82.24 -22.91 35.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.022 0.439 . . . . 0.0 110.742 179.875 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.413 ' HG2' ' O ' ' A' ' 238' ' ' LYS . 9.2 mmmt -79.11 107.06 11.59 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.662 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.572 ' HE2' ' CE1' ' A' ' 244' ' ' TYR . 0.3 OUTLIER -42.66 -46.66 5.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.997 -179.787 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . 0.572 ' CE1' ' HE2' ' A' ' 243' ' ' LYS . 14.0 m-85 -138.59 161.27 37.51 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.047 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 245' ' ' HIS . . . . . 0.616 ' CD2' ' CG1' ' A' ' 254' ' ' ILE . 39.2 m-70 -126.08 152.58 45.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.078 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -130.71 105.44 7.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.042 0.449 . . . . 0.0 110.579 179.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.498 HG13 HG23 ' A' ' 198' ' ' ILE . 2.6 t -106.14 105.74 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.189 -179.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 54.32 -86.84 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.229 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.465 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.1 OUTLIER -109.87 -39.19 5.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.697 0.761 . . . . 0.0 109.787 -179.829 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 250' ' ' SER . . . . . 0.522 ' CB ' ' OG1' ' A' ' 193' ' ' THR . 0.0 OUTLIER -77.82 153.97 32.29 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.373 -1.285 . . . . 0.0 112.349 -178.435 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.452 ' HD3' ' O ' ' A' ' 249' ' ' LEU . 0.0 OUTLIER -150.22 110.63 4.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.266 179.114 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 252' ' ' CYS . . . . . 0.544 ' HB2' ' CG1' ' A' ' 186' ' ' VAL . 0.0 OUTLIER -127.91 153.16 46.99 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -177.709 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . 0.569 ' HG3' ' CE1' ' A' ' 244' ' ' TYR . 39.5 tt0 -75.98 110.34 10.36 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.149 -179.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . 0.626 HG12 ' CG1' ' A' ' 186' ' ' VAL . 11.5 mt -95.62 108.51 21.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -177.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . 0.522 ' O ' ' C ' ' A' ' 256' ' ' VAL . 0.0 OUTLIER -112.03 129.86 56.06 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 105.488 -2.041 . . . . 0.0 105.488 176.066 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . 0.522 ' C ' ' O ' ' A' ' 255' ' ' LYS . 7.8 p -32.61 124.14 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 122.212 1.006 . . . . 0.0 111.459 -176.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.686 ' CB ' ' CE2' ' A' ' 227' ' ' PHE . . . -75.9 152.37 37.16 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 113.447 -1.706 . . . . 0.0 112.049 -177.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.5 123.59 21.62 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.216 179.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 259' ' ' SER . . . . . 0.485 ' OG ' ' NZ ' ' A' ' 183' ' ' LYS . 62.0 p . . . . . 0 C--N 1.326 -0.449 0 CA-C-O 120.903 0.382 . . . . 0.0 110.891 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.531 HG11 ' N ' ' A' ' 182' ' ' LYS . 40.9 t . . . . . 0 CA--C 1.502 -0.895 0 CA-C-O 121.217 0.532 . . . . 0.0 111.66 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.534 ' HG2' ' CB ' ' A' ' 233' ' ' GLU . 0.0 OUTLIER -149.18 112.52 4.97 Favored 'General case' 0 N--CA 1.432 -1.375 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.487 177.97 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.634 ' HD3' ' HB1' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -131.22 142.86 50.23 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-N 114.974 -1.012 . . . . 0.0 108.646 178.52 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.647 HG12 ' HB ' ' A' ' 228' ' ' ILE . 1.3 pt -123.85 119.75 57.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.656 ' CE2' ' CE2' ' A' ' 225' ' ' PHE . 0.2 OUTLIER -92.5 109.81 21.21 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.494 0.664 . . . . 0.0 110.404 -178.982 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.511 ' O ' ' HB2' ' A' ' 225' ' ' PHE . 6.3 t -85.97 129.84 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.886 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.568 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . -79.43 -153.73 8.07 Favored Glycine 0 CA--C 1.521 0.454 0 C-N-CA 121.034 -0.603 . . . . 0.0 114.209 -178.062 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.511 ' HA2' ' O ' ' A' ' 224' ' ' GLY . . . -34.56 109.61 0.06 OUTLIER Glycine 0 C--N 1.334 0.442 0 N-CA-C 114.255 0.462 . . . . 0.0 114.255 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . 0.537 ' O ' ' O ' ' A' ' 190' ' ' SER . 1.7 pp -117.05 157.48 25.78 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.687 0.28 . . . . 0.0 110.819 179.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' SER . . . . . 0.56 ' CB ' ' CD ' ' A' ' 191' ' ' PRO . 0.3 OUTLIER -42.25 -177.96 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.259 0 CA-C-O 121.463 0.649 . . . . 0.0 112.087 -179.709 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . 0.56 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 10.4 Cg_exo -70.82 1.52 5.05 Favored 'Trans proline' 0 CA--C 1.529 0.266 0 C-N-CA 123.232 2.621 . . . . 0.0 113.404 -179.403 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 192' ' ' ASP . 8.4 p-10 165.44 74.91 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.89 0.376 . . . . 0.0 111.415 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.531 HG21 ' CD1' ' A' ' 198' ' ' ILE . 11.9 m -68.9 116.85 45.6 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.125 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.489 ' HG2' ' HG2' ' A' ' 197' ' ' LYS . 36.5 Cg_endo -64.78 118.36 5.35 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.424 2.083 . . . . 0.0 111.438 179.037 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.767 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -52.06 -16.05 0.69 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.328 -179.607 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . 0.484 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 34.8 mt-10 -68.23 -37.85 81.24 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -179.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.516 ' NZ ' ' OE1' ' A' ' 200' ' ' GLU . 18.0 mmmt -74.44 -50.08 19.81 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.767 ' CG1' ' HA ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -48.13 -31.15 2.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 114.849 -1.069 . . . . 0.0 108.428 178.229 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.578 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 1.9 mtp85 -71.09 -32.73 69.44 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.296 178.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . 0.55 ' CG ' ' N ' ' A' ' 201' ' ' TYR . 4.2 pt-20 -81.71 -53.03 6.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.201 0.524 . . . . 0.0 109.894 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.56 ' OH ' ' ND1' ' A' ' 245' ' ' HIS . 0.3 OUTLIER -55.35 -54.05 48.52 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.98 178.87 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.658 ' CD2' HD12 ' A' ' 228' ' ' ILE . 0.2 OUTLIER -79.58 -31.15 41.79 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.069 -0.968 . . . . 0.0 110.424 -179.67 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.578 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -65.1 -55.47 21.48 Favored Glycine 0 CA--C 1.499 -0.927 0 N-CA-C 106.928 -2.469 . . . . 0.0 106.928 176.349 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -49.97 -28.82 13.08 Favored Glycine 0 N--CA 1.442 -0.936 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 176.128 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . 0.745 ' CE2' HG13 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -57.93 -46.18 85.44 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 122.145 0.974 . . . . 0.0 108.496 177.738 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 171.95 -130.89 2.03 Favored Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 113.542 -1.663 . . . . 0.0 110.247 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.464 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 5.2 mm-40 -97.01 100.7 12.2 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.245 0.545 . . . . 0.0 111.05 178.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 2.9 t -78.11 140.86 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.088 0 CA-C-N 115.235 -0.893 . . . . 0.0 108.653 178.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.487 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 10.1 tp10 -94.43 -53.83 3.76 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.771 0.32 . . . . 0.0 110.352 179.154 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.404 ' C ' HG12 ' A' ' 211' ' ' ILE . 24.0 p -159.83 156.85 28.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.21 0.528 . . . . 0.0 111.842 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.598 ' CD1' ' HB ' ' A' ' 198' ' ' ILE . 0.1 OUTLIER -131.84 124.57 53.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.528 178.959 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -123.07 103.26 8.46 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -178.16 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.52 HD13 ' N ' ' A' ' 195' ' ' GLU . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.323 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 177.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . 0.511 ' O ' ' HA2' ' A' ' 188' ' ' GLY . . . . . . . . 0 C--O 1.223 -0.583 0 N-CA-C 113.728 0.251 . . . . 0.0 113.728 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . 0.656 ' CE2' ' CE2' ' A' ' 185' ' ' PHE . 0.4 OUTLIER -156.47 176.48 12.65 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.712 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . 0.462 ' O ' ' HB ' ' A' ' 186' ' ' VAL . 11.9 p -142.14 149.56 39.95 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.028 -0.669 . . . . 0.0 112.538 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.668 ' CE2' ' CB ' ' A' ' 257' ' ' ALA . 4.7 m-85 -106.24 138.86 41.67 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.592 178.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.658 HD12 ' CD2' ' A' ' 202' ' ' PHE . 2.2 mt -133.87 135.09 55.57 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.35 0 CA-C-O 120.962 0.41 . . . . 0.0 111.133 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 229' ' ' THR . . . . . 0.431 ' OG1' ' HG2' ' A' ' 183' ' ' LYS . 52.3 m -116.26 138.08 51.6 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.719 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 0.653 ' CE1' ' CB ' ' A' ' 235' ' ' PRO . 75.4 m-85 -112.9 126.29 55.3 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.271 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.487 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -49.36 -38.93 30.0 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 177.981 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . 0.467 ' O ' ' HD3' ' A' ' 182' ' ' LYS . 63.9 mt-10 -92.59 -170.86 2.59 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 113.362 -1.745 . . . . 0.0 109.304 178.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . 0.541 ' O ' ' HG3' ' A' ' 237' ' ' LYS . 14.4 pt-20 -126.09 2.83 7.22 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.836 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.511 ' O ' ' N ' ' A' ' 237' ' ' LYS . 0.2 OUTLIER -74.33 -59.25 1.69 Allowed Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.809 -179.169 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.653 ' CB ' ' CE1' ' A' ' 230' ' ' PHE . 87.5 Cg_exo -49.15 -32.94 25.93 Favored 'Trans proline' 0 CA--C 1.5 -1.196 0 N-CA-C 108.814 -1.264 . . . . 0.0 108.814 178.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.569 HG21 ' CD2' ' A' ' 230' ' ' PHE . 22.9 t -70.41 -41.57 78.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 114.041 -1.436 . . . . 0.0 108.985 177.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . 0.541 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 20.6 mtpt -55.78 -46.91 77.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.799 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.476 ' HA ' ' HG3' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -81.01 -48.76 11.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.144 -179.501 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.745 HG13 ' CE2' ' A' ' 205' ' ' PHE . 1.7 mt -43.57 -49.49 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.841 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' MET . . . . . 0.428 ' SD ' HG13 ' A' ' 236' ' ' VAL . 52.9 mtp -61.22 -29.93 70.13 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.637 -178.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.476 ' HG3' ' HA ' ' A' ' 238' ' ' LYS . 0.2 OUTLIER -85.97 -12.17 51.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.794 0.33 . . . . 0.0 111.134 -179.56 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.425 ' O ' ' C ' ' A' ' 243' ' ' LYS . 11.5 mmmm -79.63 103.5 9.58 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.837 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.554 ' CD ' ' CD2' ' A' ' 244' ' ' TYR . 0.1 OUTLIER -37.46 -58.05 0.88 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.15 0.5 . . . . 0.0 110.325 179.75 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . 0.637 ' CD1' ' HB3' ' A' ' 253' ' ' GLU . 10.9 m-85 -135.51 153.27 51.78 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.239 179.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 245' ' ' HIS . . . . . 0.575 ' CD2' HG13 ' A' ' 254' ' ' ILE . 28.8 m-70 -111.91 157.43 20.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.116 -179.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . 0.447 ' ND2' ' C ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -139.79 104.3 4.86 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.299 0.571 . . . . 0.0 109.979 178.525 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.51 ' N ' ' O ' ' A' ' 250' ' ' SER . 1.4 t -95.67 -173.65 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.874 -179.468 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . 0.502 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . -26.51 -56.69 0.08 OUTLIER Glycine 0 C--N 1.337 0.619 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.761 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.47 -40.03 1.27 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.443 0.639 . . . . 0.0 111.033 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 250' ' ' SER . . . . . 0.51 ' O ' ' N ' ' A' ' 247' ' ' VAL . 57.2 p -77.59 150.01 34.75 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.094 -0.957 . . . . 0.0 112.794 -178.316 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.508 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -144.87 102.69 3.81 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.225 178.373 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 252' ' ' CYS . . . . . 0.568 ' HB3' ' C ' ' A' ' 187' ' ' GLY . 0.0 OUTLIER -130.11 154.86 47.05 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -177.448 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . 0.637 ' HB3' ' CD1' ' A' ' 244' ' ' TYR . 6.9 pt-20 -74.61 119.05 18.28 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . 0.596 ' CG2' ' CG2' ' A' ' 239' ' ' ILE . 39.8 mt -97.2 102.47 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 CA-C-O 121.621 0.724 . . . . 0.0 112.332 -178.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . 0.542 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -103.38 129.27 50.41 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 177.781 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . 0.55 ' CG2' ' O ' ' A' ' 183' ' ' LYS . 5.7 p -32.32 123.62 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.509 -0.599 0 CA-C-O 122.307 1.051 . . . . 0.0 111.491 -176.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.668 ' CB ' ' CE2' ' A' ' 227' ' ' PHE . . . -76.26 152.57 36.46 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 113.319 -1.764 . . . . 0.0 111.982 -178.257 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.35 114.93 14.27 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.354 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.326 -0.452 0 CA-C-O 121.082 0.468 . . . . 0.0 111.518 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.535 HG11 ' N ' ' A' ' 182' ' ' LYS . 45.5 t . . . . . 0 CA--C 1.503 -0.85 0 CA-C-O 121.243 0.544 . . . . 0.0 111.612 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.541 ' CE ' ' HB3' ' A' ' 233' ' ' GLU . 0.5 OUTLIER -149.97 112.6 4.75 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.883 177.769 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.824 ' HD2' ' HB2' ' A' ' 257' ' ' ALA . 0.0 OUTLIER -135.46 155.85 49.86 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.55 179.242 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.611 HG12 ' HB ' ' A' ' 228' ' ' ILE . 0.4 OUTLIER -131.15 121.19 48.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 115.452 -0.794 . . . . 0.0 108.858 178.973 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.553 ' CA ' ' HB1' ' A' ' 257' ' ' ALA . 0.3 OUTLIER -93.82 109.25 20.94 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.287 0.565 . . . . 0.0 110.826 -178.981 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.585 ' CG1' ' HB2' ' A' ' 252' ' ' CYS . 2.5 t -86.08 126.4 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.586 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.551 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . -114.76 126.4 7.22 Favored Glycine 0 N--CA 1.452 -0.274 0 N-CA-C 114.602 0.601 . . . . 0.0 114.602 -176.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.478 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . 80.59 83.13 0.74 Allowed Glycine 0 CA--C 1.519 0.285 0 C-N-CA 121.245 -0.502 . . . . 0.0 113.361 179.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.534 HD12 ' N ' ' A' ' 190' ' ' SER . 0.6 OUTLIER -117.25 157.77 25.47 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.816 0.341 . . . . 0.0 111.384 -179.394 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.555 ' CB ' ' CD ' ' A' ' 191' ' ' PRO . 0.1 OUTLIER -45.4 -177.41 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.197 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.557 179.503 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.555 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 11.4 Cg_exo -70.62 6.54 1.55 Allowed 'Trans proline' 0 CA--C 1.532 0.406 0 C-N-CA 123.255 2.637 . . . . 0.0 113.514 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.516 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 2.8 p30 160.55 77.65 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.013 0.435 . . . . 0.0 110.812 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.57 ' HB ' ' CD2' ' A' ' 213' ' ' LEU . 51.8 m -73.02 131.76 83.4 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.003 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.534 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 68.6 Cg_endo -80.96 114.34 2.88 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 122.945 2.43 . . . . 0.0 111.632 179.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.568 ' HA ' ' CD1' ' A' ' 198' ' ' ILE . 1.6 pm0 -48.1 -17.81 0.15 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.357 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . 0.468 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 27.4 mm-40 -61.36 -44.02 97.89 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -179.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.534 ' CD ' ' HG2' ' A' ' 194' ' ' PRO . 0.9 OUTLIER -76.38 -46.39 27.57 Favored 'General case' 0 CA--C 1.494 -1.207 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 178.826 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.617 HG21 ' CE1' ' A' ' 202' ' ' PHE . 0.2 OUTLIER -48.34 -29.01 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.373 0 CA-C-N 113.862 -1.517 . . . . 0.0 108.736 177.245 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.545 ' HG3' ' O ' ' A' ' 195' ' ' GLU . 2.3 mtt180 -76.12 -31.73 58.79 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-N 115.294 -0.867 . . . . 0.0 110.029 178.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . 0.58 ' CG ' ' N ' ' A' ' 201' ' ' TYR . 4.2 pt-20 -82.01 -55.17 4.74 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.098 0.475 . . . . 0.0 110.293 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.58 ' N ' ' CG ' ' A' ' 200' ' ' GLU . 0.3 OUTLIER -50.11 -53.88 24.4 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.484 0.659 . . . . 0.0 109.67 178.797 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.652 ' O ' ' HB2' ' A' ' 205' ' ' PHE . 0.5 OUTLIER -79.66 -32.69 41.58 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.7 -179.836 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.529 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -62.82 -55.05 29.13 Favored Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 107.359 -2.296 . . . . 0.0 107.359 176.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -51.39 -27.84 18.36 Favored Glycine 0 N--CA 1.442 -0.949 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 176.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . 0.742 ' CE2' HG13 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -59.17 -44.89 92.16 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 122.129 0.966 . . . . 0.0 108.601 177.849 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.493 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 172.42 -132.41 2.38 Favored Glycine 0 N--CA 1.442 -0.938 0 CA-C-N 113.698 -1.592 . . . . 0.0 110.482 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.476 ' HB3' ' HE2' ' A' ' 231' ' ' LYS . 1.8 mt-10 -97.22 97.13 8.92 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.21 0.529 . . . . 0.0 111.456 178.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 2.5 t -72.56 137.63 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.544 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 5.8 tp10 -89.54 -50.7 5.93 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 178.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.447 ' OG ' ' OE2' ' A' ' 212' ' ' GLU . 0.9 OUTLIER -165.15 159.02 17.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.31 0.576 . . . . 0.0 111.913 179.263 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.608 ' CG2' HD12 ' A' ' 228' ' ' ILE . 0.1 OUTLIER -131.59 120.72 46.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.212 179.156 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.447 ' OE2' ' OG ' ' A' ' 210' ' ' SER . 0.0 OUTLIER -123.43 102.64 8.01 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -179.066 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.57 ' CD2' ' HB ' ' A' ' 193' ' ' THR . 1.7 mp -96.83 104.86 20.01 Favored Pre-proline 0 C--N 1.329 -0.284 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 177.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.521 ' HD2' ' O ' ' A' ' 225' ' ' PHE . 64.3 Cg_endo -72.86 130.3 15.48 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.98 2.453 . . . . 0.0 113.321 -179.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 11.1 mtm -135.77 130.96 34.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.633 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.422 ' O ' ' HA ' ' A' ' 220' ' ' ASN . 0.5 OUTLIER -111.96 107.98 17.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.912 0.387 . . . . 0.0 110.666 179.849 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -81.97 -12.42 58.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.722 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.58 -47.29 12.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.671 0.272 . . . . 0.0 111.407 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 3.5 t -124.21 -19.74 5.47 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.664 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . 0.422 ' HA ' ' O ' ' A' ' 216' ' ' ASP . 13.8 m-80 51.74 58.45 5.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.746 0.308 . . . . 0.0 110.821 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 1.6 mtpp -51.92 -179.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.636 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.625 ' CD ' ' O ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -93.98 26.14 3.35 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 122.386 1.089 . . . . 0.0 109.957 179.992 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.583 ' O ' ' CD1' ' A' ' 225' ' ' PHE . 4.9 ptp85 -71.33 -25.96 62.63 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . 0.516 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . -8.3 73.83 0.0 OUTLIER Glycine 0 C--N 1.345 1.07 0 O-C-N 124.506 1.129 . . . . 0.0 112.812 178.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.588 ' CE1' H5'' ' B' ' 3' ' ' ' DA' . 0.1 OUTLIER -157.15 176.93 12.08 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -178.29 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . 0.53 ' HB3' ' CD2' ' A' ' 213' ' ' LEU . 1.4 p -141.42 149.18 40.69 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.258 -0.577 . . . . 0.0 112.433 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.664 ' CE2' ' CB ' ' A' ' 257' ' ' ALA . 5.7 m-85 -107.21 146.45 31.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.351 178.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.651 HD13 ' CD2' ' A' ' 202' ' ' PHE . 1.8 mt -141.12 121.22 12.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.287 0.565 . . . . 0.0 111.667 179.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.54 ' OG1' ' CG ' ' A' ' 183' ' ' LYS . 31.2 m -102.39 137.91 40.01 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.235 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.666 ' CE1' ' CB ' ' A' ' 235' ' ' PRO . 72.4 m-85 -113.58 126.41 55.26 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.078 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.544 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -51.79 -37.31 51.03 Favored 'General case' 0 CA--C 1.505 -0.769 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 178.328 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . 0.483 ' O ' ' HG3' ' A' ' 182' ' ' LYS . 1.6 mm-40 -93.37 -175.28 3.76 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 113.39 -1.732 . . . . 0.0 109.3 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . 0.541 ' HB3' ' CE ' ' A' ' 182' ' ' LYS . 0.1 OUTLIER -124.67 11.37 8.49 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.912 -179.631 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.551 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.2 OUTLIER -80.74 -59.79 0.47 Allowed Pre-proline 0 C--N 1.328 -0.327 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.813 179.926 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.666 ' CB ' ' CE1' ' A' ' 230' ' ' PHE . 84.0 Cg_exo -49.71 -31.87 26.92 Favored 'Trans proline' 0 CA--C 1.502 -1.087 0 N-CA-C 108.785 -1.275 . . . . 0.0 108.785 177.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.59 HG21 ' CD2' ' A' ' 230' ' ' PHE . 12.8 t -72.1 -44.93 64.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 114.059 -1.428 . . . . 0.0 110.566 178.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . 0.551 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 19.4 pttt -62.33 -37.85 87.2 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.987 -179.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.462 ' HA ' ' HG3' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -82.05 -49.99 9.6 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.856 0.36 . . . . 0.0 111.052 179.351 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.742 HG13 ' CE2' ' A' ' 205' ' ' PHE . 1.4 mt -42.88 -53.08 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 24.7 mtp -56.23 -32.2 64.24 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.027 -179.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.477 ' CG ' ' O ' ' A' ' 237' ' ' LYS . 1.1 mt-10 -75.4 -21.19 58.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.13 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -79.57 109.92 14.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.849 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.18 -47.57 35.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.755 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.569 ' CE1' ' HG3' ' A' ' 253' ' ' GLU . 8.5 m-85 -138.31 151.75 47.86 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.903 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' HIS . . . . . 0.64 ' CG ' ' CD1' ' A' ' 254' ' ' ILE . 29.7 m-70 -116.67 154.91 29.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.25 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . 0.406 ' O ' ' CE2' ' A' ' 201' ' ' TYR . 2.4 m-80 -134.34 105.23 6.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.276 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.545 ' N ' ' O ' ' A' ' 250' ' ' SER . 2.2 t -103.57 106.88 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.292 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 52.04 -83.06 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.186 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.54 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -111.11 -38.34 5.08 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.586 0.707 . . . . 0.0 110.267 179.727 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' SER . . . . . 0.545 ' O ' ' N ' ' A' ' 247' ' ' VAL . 0.6 OUTLIER -77.16 153.21 34.41 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.747 -1.115 . . . . 0.0 112.014 -178.627 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.471 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -146.97 107.08 4.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.959 179.159 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' CYS . . . . . 0.585 ' HB2' ' CG1' ' A' ' 186' ' ' VAL . 0.0 OUTLIER -128.2 153.41 46.94 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -176.933 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . 0.569 ' HG3' ' CE1' ' A' ' 244' ' ' TYR . 29.2 tt0 -76.02 109.56 9.77 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.194 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . 0.64 ' CD1' ' CG ' ' A' ' 245' ' ' HIS . 21.4 mt -96.54 115.23 35.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 -178.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.517 ' O ' ' C ' ' A' ' 256' ' ' VAL . 0.0 OUTLIER -121.01 131.8 54.51 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 106.144 -1.799 . . . . 0.0 106.144 176.628 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . 0.517 ' C ' ' O ' ' A' ' 255' ' ' LYS . 3.9 p -32.87 121.76 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.513 -0.472 0 CA-C-O 122.398 1.095 . . . . 0.0 111.446 -177.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.824 ' HB2' ' HD2' ' A' ' 183' ' ' LYS . . . -75.77 155.49 35.46 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 113.117 -1.856 . . . . 0.0 111.909 -178.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.91 125.16 27.71 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.426 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' SER . . . . . 0.561 ' HB3' ' CE ' ' A' ' 183' ' ' LYS . 83.3 p . . . . . 0 C--N 1.324 -0.516 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.232 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' ' DT' . . . . . 0.777 ' O2 ' " H2'" ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.427 -0.82 0 O4'-C1'-C2' 106.888 0.716 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' ' DA' . . . . . 0.588 H5'' ' CE1' ' A' ' 225' ' ' PHE . . . . . . . . 0 O4'--C1' 1.408 -0.954 0 C1'-O4'-C4' 107.639 -1.472 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' ' DG' . . . . . 0.647 H2'' " O5'" ' B' ' 5' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.428 -0.76 0 C4'-C3'-C2' 102.098 -1.102 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' ' DG' . . . . . 0.647 " O5'" H2'' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.428 -0.78 0 O4'-C1'-C2' 106.714 0.559 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.508 HG12 ' N ' ' A' ' 182' ' ' LYS . 45.8 t . . . . . 0 CA--C 1.502 -0.891 0 CA-C-O 121.46 0.648 . . . . 0.0 112.051 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.508 ' N ' HG12 ' A' ' 181' ' ' VAL . 0.0 OUTLIER -148.91 111.56 4.78 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.117 176.733 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.609 ' HD3' ' HB1' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -138.57 146.1 41.44 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 114.979 -1.01 . . . . 0.0 109.623 179.39 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.58 HG12 ' HB ' ' A' ' 228' ' ' ILE . 0.4 OUTLIER -125.38 120.32 57.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.528 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.542 ' CA ' ' HB3' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -93.33 109.09 20.63 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.423 0.63 . . . . 0.0 110.459 -178.738 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.608 ' CG1' HG12 ' A' ' 254' ' ' ILE . 1.9 t -88.14 122.58 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.023 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.558 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . -108.23 125.79 8.0 Favored Glycine 0 N--CA 1.452 -0.239 0 CA-C-N 115.893 -0.594 . . . . 0.0 114.535 -176.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.54 ' HA3' ' C7 ' ' B' ' 2' ' ' ' DT' . . . 81.33 86.86 0.66 Allowed Glycine 0 C--N 1.333 0.414 0 C-N-CA 121.025 -0.607 . . . . 0.0 113.026 179.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.528 HD12 ' N ' ' A' ' 190' ' ' SER . 0.7 OUTLIER -116.87 156.64 26.98 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.835 0.35 . . . . 0.0 111.258 -179.657 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.53 ' OG ' ' CD ' ' A' ' 191' ' ' PRO . 0.2 OUTLIER -45.31 179.65 0.01 OUTLIER Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.16 179.56 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.53 ' CD ' ' OG ' ' A' ' 190' ' ' SER . 15.5 Cg_exo -68.33 4.98 1.35 Allowed 'Trans proline' 0 CA--C 1.531 0.346 0 C-N-CA 123.138 2.559 . . . . 0.0 113.575 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.505 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 0.3 OUTLIER 161.4 76.25 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.877 0.37 . . . . 0.0 110.954 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.574 HG21 ' CD1' ' A' ' 198' ' ' ILE . 35.7 m -70.86 132.41 86.88 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.469 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.581 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 83.9 Cg_endo -77.25 115.21 3.91 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.77 2.313 . . . . 0.0 110.955 178.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.795 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -51.61 -13.7 0.27 Allowed 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -179.36 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . 0.505 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 25.9 mt-10 -68.17 -41.34 81.63 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -179.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.581 ' CD ' ' HG2' ' A' ' 194' ' ' PRO . 1.5 mttp -72.5 -47.37 49.07 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.795 ' CG1' ' HA ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -47.05 -31.02 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.118 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.562 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 4.1 mtp85 -71.71 -33.46 68.77 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.247 179.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . 0.525 ' CG ' ' N ' ' A' ' 201' ' ' TYR . 3.1 pt-20 -82.49 -51.55 7.7 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.005 0.431 . . . . 0.0 110.601 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.525 ' N ' ' CG ' ' A' ' 200' ' ' GLU . 0.2 OUTLIER -54.84 -54.6 40.29 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.497 0.665 . . . . 0.0 109.835 178.964 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.683 ' CD2' HD11 ' A' ' 228' ' ' ILE . 0.4 OUTLIER -79.29 -31.0 43.19 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.079 -179.784 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.562 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -63.41 -55.47 25.43 Favored Glycine 0 CA--C 1.501 -0.841 0 N-CA-C 106.812 -2.515 . . . . 0.0 106.812 176.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -49.05 -29.35 8.62 Favored Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 176.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . 0.721 ' CE2' HG13 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -59.18 -42.56 91.11 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 122.046 0.927 . . . . 0.0 108.587 177.704 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 203' ' ' GLY . . . 167.69 -130.44 2.1 Favored Glycine 0 N--CA 1.442 -0.923 0 CA-C-N 113.666 -1.606 . . . . 0.0 110.318 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.502 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 13.1 mt-10 -97.02 101.91 13.58 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.157 0.503 . . . . 0.0 110.923 178.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 2.4 t -77.14 143.97 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 CA-C-N 115.449 -0.796 . . . . 0.0 108.931 178.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.544 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 18.8 tp10 -91.8 -55.13 3.58 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 178.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 3.3 m -170.55 150.88 3.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.765 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.626 HG22 HG12 ' A' ' 228' ' ' ILE . 0.4 OUTLIER -117.53 133.33 64.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.752 179.088 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -123.21 103.35 8.48 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -178.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.471 HD13 ' HB3' ' A' ' 226' ' ' CYS . 2.4 mm? -96.33 109.08 45.73 Favored Pre-proline 0 CA--C 1.531 0.226 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 177.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.563 ' HD2' ' O ' ' A' ' 225' ' ' PHE . 26.8 Cg_endo -92.36 130.78 1.04 Allowed 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 123.225 2.617 . . . . 0.0 112.567 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' MET . . . . . 0.451 ' HE2' ' OD1' ' A' ' 192' ' ' ASP . 0.7 OUTLIER -134.88 130.89 36.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.587 179.649 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.503 ' O ' ' ND2' ' A' ' 220' ' ' ASN . 1.0 OUTLIER -115.22 106.51 14.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.979 -179.93 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -82.58 -12.79 57.46 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.994 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -87.67 -48.61 7.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.412 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 4.0 t -109.81 -26.89 9.58 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.348 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . 0.503 ' ND2' ' O ' ' A' ' 216' ' ' ASP . 9.5 m120 52.44 47.27 25.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.833 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 3.9 ttpt -49.99 -178.67 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.946 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.625 ' CD ' ' O ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -101.35 21.85 13.46 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 122.444 1.116 . . . . 0.0 109.716 179.77 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.598 ' O ' ' N ' ' A' ' 225' ' ' PHE . 1.6 ptm180 -71.43 -20.83 62.06 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.321 178.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . 0.514 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . -16.28 79.5 0.0 OUTLIER Glycine 0 C--N 1.343 0.964 0 O-C-N 124.4 1.062 . . . . 0.0 112.252 179.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.608 ' CZ ' H5'' ' B' ' 4' ' ' ' DG' . 0.0 OUTLIER -157.36 176.67 12.37 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.924 -0.638 . . . . 0.0 110.017 -177.773 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . 0.471 ' HB3' HD13 ' A' ' 213' ' ' LEU . 4.0 p -136.04 148.63 48.44 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.115 -0.634 . . . . 0.0 112.428 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.699 ' CE1' ' C2 ' ' B' ' 4' ' ' ' DG' . 3.4 m-85 -109.81 132.79 53.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.111 -0.95 . . . . 0.0 108.446 178.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.683 HD11 ' CD2' ' A' ' 202' ' ' PHE . 1.8 mt -129.09 122.2 55.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.213 0.53 . . . . 0.0 111.785 -179.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.476 ' OG1' ' HG2' ' A' ' 183' ' ' LYS . 24.4 m -103.62 138.24 40.57 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.241 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.654 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 65.3 m-85 -110.97 126.38 54.71 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.55 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.544 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -48.22 -38.93 19.63 Favored 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 178.442 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . 0.452 ' O ' ' O ' ' A' ' 230' ' ' PHE . 0.3 OUTLIER -92.1 -166.18 1.5 Allowed 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 113.121 -1.854 . . . . 0.0 109.14 178.586 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . 0.514 ' O ' ' HG3' ' A' ' 237' ' ' LYS . 0.3 OUTLIER -131.27 -0.13 4.08 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.581 179.86 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.509 ' O ' ' N ' ' A' ' 237' ' ' LYS . 0.6 OUTLIER -72.57 -58.99 2.64 Favored Pre-proline 0 C--N 1.331 -0.234 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.835 -179.422 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.618 ' CB ' ' CE2' ' A' ' 230' ' ' PHE . 96.5 Cg_exo -48.98 -32.91 24.59 Favored 'Trans proline' 0 CA--C 1.497 -1.373 0 N-CA-C 108.949 -1.212 . . . . 0.0 108.949 178.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.587 HG21 ' CD1' ' A' ' 230' ' ' PHE . 21.6 t -69.87 -40.84 79.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 113.834 -1.53 . . . . 0.0 109.075 178.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . 0.514 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 8.7 mttt -58.81 -45.93 88.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.877 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.446 ' O ' ' HD3' ' A' ' 242' ' ' LYS . 0.0 OUTLIER -80.25 -47.42 14.63 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.064 -179.703 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.721 HG13 ' CE2' ' A' ' 205' ' ' PHE . 1.6 mt -45.15 -50.82 2.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.7 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' MET . . . . . 0.431 ' SD ' HG11 ' A' ' 236' ' ' VAL . 23.0 mtp -58.13 -28.22 64.47 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.192 -179.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.465 ' N ' ' OE1' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -82.48 -20.76 36.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.224 0.535 . . . . 0.0 109.824 179.408 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.446 ' HD3' ' O ' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -80.55 100.13 8.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.019 179.729 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.58 ' HE2' ' CG ' ' A' ' 244' ' ' TYR . 1.8 ttpt -40.7 -67.43 0.24 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.24 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.58 ' CG ' ' HE2' ' A' ' 243' ' ' LYS . 7.1 m-30 -113.94 154.4 27.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.197 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' HIS . . . . . 0.608 ' CD2' ' CG1' ' A' ' 254' ' ' ILE . 24.3 m-70 -123.12 147.85 46.33 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.338 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . 0.44 ' HB3' ' HD2' ' A' ' 251' ' ' LYS . 0.4 OUTLIER -125.73 105.24 8.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.989 0.424 . . . . 0.0 110.938 179.712 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.556 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.9 t -102.64 108.98 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.235 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 48.76 -83.93 0.01 OUTLIER Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.271 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.556 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -110.48 -38.64 5.15 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.402 0.62 . . . . 0.0 110.497 179.639 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' SER . . . . . 0.501 ' HB3' ' HB2' ' A' ' 190' ' ' SER . 1.6 p -77.06 150.44 35.73 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.011 -0.995 . . . . 0.0 112.068 -178.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.499 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -144.88 108.05 4.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.307 178.984 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' CYS . . . . . 0.563 ' HB2' ' CG1' ' A' ' 186' ' ' VAL . 0.0 OUTLIER -128.04 153.01 47.25 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -177.436 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . 0.5 ' HB2' ' O4 ' ' B' ' 2' ' ' ' DT' . 51.5 tt0 -76.17 113.14 13.38 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.221 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . 0.62 ' CG2' ' CG2' ' A' ' 239' ' ' ILE . 10.1 mt -96.53 113.05 29.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 114.66 1.355 . . . . 0.0 114.66 -178.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.518 ' O ' ' C ' ' A' ' 256' ' ' VAL . 0.0 OUTLIER -119.5 129.57 54.77 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 176.207 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . 0.544 ' CG2' ' O ' ' A' ' 183' ' ' LYS . 6.3 p -32.84 121.46 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.433 0 CA-C-O 122.264 1.031 . . . . 0.0 111.42 -177.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.683 ' CB ' ' CE2' ' A' ' 227' ' ' PHE . . . -76.01 154.1 36.0 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 113.207 -1.815 . . . . 0.0 112.132 -178.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' MET . . . . . 0.62 ' CE ' ' N6 ' ' B' ' 3' ' ' ' DA' . 0.0 OUTLIER -130.32 117.16 19.36 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.174 179.451 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.323 -0.558 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.716 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' ' DT' . . . . . 0.745 ' O2 ' " H2'" ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.428 -0.772 0 O4'-C1'-C2' 106.716 0.56 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' ' DA' . . . . . 0.62 ' N6 ' ' CE ' ' A' ' 258' ' ' MET . . . . . . . . 0 O4'--C1' 1.405 -1.118 0 C4'-C3'-C2' 104.602 1.402 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' ' DG' . . . . . 0.699 ' C2 ' ' CE1' ' A' ' 227' ' ' PHE . . . . . . . . 0 O5'--C5' 1.427 -0.831 0 C4'-C3'-C2' 102.178 -1.022 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' ' DG' . . . . . 0.691 " O5'" H2'' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.425 -0.913 0 O4'-C1'-C2' 106.962 0.783 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.533 ' CA ' ' HE3' ' A' ' 182' ' ' LYS . 55.7 t . . . . . 0 CA--C 1.506 -0.74 0 CA-C-O 121.02 0.438 . . . . 0.0 111.502 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.549 ' CD ' ' HB3' ' A' ' 233' ' ' GLU . 0.0 OUTLIER -154.37 112.41 3.52 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.185 177.293 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.692 ' HD3' ' HB3' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -134.62 153.72 51.84 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.76 179.207 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.655 HG12 ' HB ' ' A' ' 228' ' ' ILE . 0.1 OUTLIER -133.1 120.49 40.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 177.991 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.664 ' CE2' ' CE2' ' A' ' 225' ' ' PHE . 0.2 OUTLIER -92.51 109.94 21.35 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 121.341 0.591 . . . . 0.0 110.309 -179.434 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.546 ' O ' ' HB2' ' A' ' 225' ' ' PHE . 39.2 t -88.08 131.0 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.968 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.487 ' O ' ' HB3' ' A' ' 252' ' ' CYS . . . -85.16 -146.56 8.45 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 114.597 0.599 . . . . 0.0 114.597 -177.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.487 ' HA2' ' O ' ' A' ' 224' ' ' GLY . . . -35.56 103.29 0.02 OUTLIER Glycine 0 C--N 1.336 0.569 0 N-CA-C 114.505 0.562 . . . . 0.0 114.505 -179.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.521 ' CD1' ' O ' ' A' ' 190' ' ' SER . 1.7 pp -117.78 157.07 27.22 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 122.453 0.301 . . . . 0.0 110.893 179.099 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.529 ' HB3' ' HB3' ' A' ' 250' ' ' SER . 0.0 OUTLIER -42.27 172.64 0.03 OUTLIER Pre-proline 0 N--CA 1.463 0.191 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.32 179.806 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.503 ' HD2' ' OG ' ' A' ' 190' ' ' SER . 31.7 Cg_exo -60.37 -5.24 3.92 Favored 'Trans proline' 0 CA--C 1.532 0.395 0 C-N-CA 122.891 2.394 . . . . 0.0 113.466 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 191' ' ' PRO . 0.1 OUTLIER 172.78 73.19 0.0 OUTLIER 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.924 0.392 . . . . 0.0 111.503 -179.943 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.561 ' HB ' ' CD1' ' A' ' 213' ' ' LEU . 57.4 m -61.36 114.31 10.51 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.471 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.502 ' HG2' ' HG2' ' A' ' 197' ' ' LYS . 13.3 Cg_endo -58.19 114.26 1.89 Allowed 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.166 1.911 . . . . 0.0 111.013 178.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.82 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 6.5 pt-20 -53.4 -14.67 0.81 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.501 -179.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . 0.503 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 51.7 mt-10 -68.34 -38.51 81.55 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.534 ' O ' ' N ' ' A' ' 200' ' ' GLU . 0.1 OUTLIER -73.85 -49.2 26.2 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.309 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.82 ' CG1' ' HA ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -48.48 -30.91 3.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.062 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.583 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 11.0 mtp180 -69.18 -33.43 73.35 Favored 'General case' 0 C--O 1.22 -0.494 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.639 178.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . 0.534 ' N ' ' O ' ' A' ' 197' ' ' LYS . 4.3 mt-10 -82.42 -59.58 2.49 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.422 178.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.548 ' OH ' ' ND1' ' A' ' 245' ' ' HIS . 0.4 OUTLIER -49.0 -54.27 16.37 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.498 0.666 . . . . 0.0 109.839 179.119 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.68 ' CD2' HD11 ' A' ' 228' ' ' ILE . 0.6 OUTLIER -79.36 -30.83 42.76 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 114.92 -1.037 . . . . 0.0 110.244 -179.863 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.583 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -62.2 -57.53 16.58 Favored Glycine 0 N--CA 1.443 -0.879 0 N-CA-C 106.959 -2.456 . . . . 0.0 106.959 176.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -48.64 -28.49 6.92 Favored Glycine 0 N--CA 1.442 -0.919 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 176.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . 0.727 ' CE2' HG13 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -58.65 -45.26 89.7 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 177.866 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.494 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 171.83 -132.75 2.51 Favored Glycine 0 N--CA 1.441 -0.975 0 CA-C-N 113.614 -1.63 . . . . 0.0 110.25 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.461 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 0.5 OUTLIER -96.87 98.02 9.77 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.278 0.561 . . . . 0.0 111.079 178.815 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 2.8 t -74.32 142.24 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.524 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 5.0 tp10 -94.13 -54.12 3.7 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.747 178.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.8 m -166.25 152.74 9.17 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.228 0.537 . . . . 0.0 112.073 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.613 HG22 HG12 ' A' ' 228' ' ' ILE . 0.4 OUTLIER -122.06 124.49 71.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.23 178.433 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.492 ' O ' ' HD3' ' A' ' 214' ' ' PRO . 0.9 OUTLIER -123.34 107.29 11.48 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -177.993 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.612 ' N ' ' CD2' ' A' ' 213' ' ' LEU . 0.1 OUTLIER -95.65 105.56 21.57 Favored Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 177.66 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.518 ' HD2' ' O ' ' A' ' 225' ' ' PHE . 11.4 Cg_exo -73.01 134.01 20.74 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.752 2.301 . . . . 0.0 112.521 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.87 130.94 38.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.358 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.427 ' OD2' ' CG2' ' A' ' 219' ' ' THR . 0.8 OUTLIER -113.75 107.19 15.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.963 0.411 . . . . 0.0 111.585 -179.356 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -82.62 -28.57 30.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.03 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.55 -42.72 9.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.928 -178.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.427 ' CG2' ' OD2' ' A' ' 216' ' ' ASP . 0.1 OUTLIER -91.51 -23.21 20.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.813 0.339 . . . . 0.0 111.279 -179.426 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . 0.403 ' HA ' ' O ' ' A' ' 216' ' ' ASP . 17.1 m120 38.17 46.74 0.89 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.398 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . 0.423 ' HB2' ' NH1' ' A' ' 223' ' ' ARG . 2.0 mtmt -69.78 166.32 19.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.561 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.649 ' O ' ' CG ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -93.66 46.7 1.2 Allowed 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 122.93 1.348 . . . . 0.0 109.573 179.816 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.541 ' CB ' H5'' ' B' ' 3' ' ' ' DA' . 2.4 ptp85 -71.76 -31.87 67.11 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 178.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . 0.498 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 13.56 60.57 0.01 OUTLIER Glycine 0 C--O 1.224 -0.518 0 CA-C-N 114.396 -1.275 . . . . 0.0 113.207 178.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.673 ' CE1' H5'' ' B' ' 4' ' ' ' DG' . 1.1 p90 -156.24 176.38 12.76 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -179.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . 0.474 ' O ' ' HB ' ' A' ' 186' ' ' VAL . 7.9 p -146.43 154.66 41.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.178 0.513 . . . . 0.0 112.118 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.67 ' CE2' ' CB ' ' A' ' 257' ' ' ALA . 7.3 m-85 -105.85 147.45 28.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.761 179.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.68 HD11 ' CD2' ' A' ' 202' ' ' PHE . 2.0 mt -139.51 131.18 34.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.042 0.448 . . . . 0.0 110.646 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.432 HG23 ' HB3' ' A' ' 209' ' ' GLU . 38.2 m -113.18 137.99 50.63 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.752 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.662 ' CE2' ' CB ' ' A' ' 235' ' ' PRO . 80.4 m-85 -113.92 126.51 55.24 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.719 -0.393 . . . . 0.0 110.187 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.524 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -48.88 -39.05 24.4 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 178.243 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . 0.474 ' O ' ' HG3' ' A' ' 182' ' ' LYS . 35.9 mm-40 -98.63 169.46 9.49 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 113.528 -1.669 . . . . 0.0 109.381 178.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . 0.549 ' HB3' ' CD ' ' A' ' 182' ' ' LYS . 1.4 pm0 -108.67 17.75 21.6 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.542 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.3 OUTLIER -83.73 -61.58 0.3 Allowed Pre-proline 0 C--N 1.33 -0.25 0 C-N-CA 120.059 -0.657 . . . . 0.0 110.847 179.918 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.662 ' CB ' ' CE2' ' A' ' 230' ' ' PHE . 96.7 Cg_exo -49.18 -30.87 20.15 Favored 'Trans proline' 0 CA--C 1.498 -1.306 0 N-CA-C 108.982 -1.199 . . . . 0.0 108.982 177.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.588 HG22 ' CD1' ' A' ' 230' ' ' PHE . 15.7 t -72.25 -45.31 61.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 113.884 -1.507 . . . . 0.0 109.95 178.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . 0.542 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 33.5 pttt -63.35 -35.86 81.78 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.921 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.485 ' HA ' ' HG3' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -81.01 -49.72 10.57 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.093 0.473 . . . . 0.0 110.729 179.293 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.727 HG13 ' CE2' ' A' ' 205' ' ' PHE . 1.5 mt -46.67 -45.19 7.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.65 -0.704 . . . . 0.0 112.066 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' MET . . . . . 0.459 ' HG2' ' HB ' ' A' ' 256' ' ' VAL . 2.2 mtp -66.47 -20.03 65.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.766 -178.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.485 ' HG3' ' HA ' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -88.78 -27.32 21.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.909 0.385 . . . . 0.0 110.555 -179.883 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.538 ' N ' ' HD2' ' A' ' 242' ' ' LYS . 2.4 mmmm -80.36 106.8 12.65 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.316 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.414 ' C ' ' O ' ' A' ' 242' ' ' LYS . 0.0 OUTLIER -36.31 -62.37 0.45 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.221 -179.491 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.522 ' CE1' ' CG ' ' A' ' 253' ' ' GLU . 73.9 m-85 -125.57 170.13 11.78 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.633 -179.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' HIS . . . . . 0.609 ' CG ' ' CD1' ' A' ' 254' ' ' ILE . 37.4 m-70 -130.16 156.98 43.68 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.288 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -134.66 104.8 6.19 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.215 0.531 . . . . 0.0 110.059 178.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.494 ' O ' ' C ' ' A' ' 248' ' ' GLY . 1.5 t -95.68 -179.63 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.992 -179.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . 0.494 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . -24.67 -58.06 0.05 OUTLIER Glycine 0 C--N 1.337 0.594 0 C-N-CA 121.377 -0.439 . . . . 0.0 112.991 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.37 -40.72 1.94 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.273 0.559 . . . . 0.0 111.063 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' SER . . . . . 0.529 ' HB3' ' HB3' ' A' ' 190' ' ' SER . 61.5 p -78.77 147.79 33.21 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.12 -0.945 . . . . 0.0 113.082 -178.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.466 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.1 OUTLIER -136.54 104.01 5.43 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 177.454 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' CYS . . . . . 0.526 ' HB2' ' CG1' ' A' ' 186' ' ' VAL . 0.0 OUTLIER -128.49 153.89 46.68 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -175.684 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . 0.522 ' CG ' ' CE1' ' A' ' 244' ' ' TYR . 51.1 tt0 -76.01 109.54 9.73 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.27 179.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . 0.609 ' CD1' ' CG ' ' A' ' 245' ' ' HIS . 21.7 mt -97.36 112.15 28.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -178.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.508 ' O ' ' C ' ' A' ' 256' ' ' VAL . 0.0 OUTLIER -117.02 131.74 56.87 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 177.016 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . 0.532 ' CG2' ' O ' ' A' ' 183' ' ' LYS . 4.0 p -33.38 123.52 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.485 0 CA-C-O 122.307 1.051 . . . . 0.0 111.225 -177.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.692 ' HB3' ' HD3' ' A' ' 183' ' ' LYS . . . -76.11 154.29 35.65 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 113.28 -1.782 . . . . 0.0 111.915 -178.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.44 112.23 15.37 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.012 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' SER . . . . . 0.494 ' OG ' ' O6 ' ' B' ' 4' ' ' ' DG' . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.507 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.432 -179.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' ' DT' . . . . . 0.599 ' O2 ' " H2'" ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.428 -0.73 0 O4'-C1'-C2' 106.856 0.687 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' ' DA' . . . . . 0.921 " H4'" " O5'" ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.426 -0.903 0 C5'-C4'-O4' 108.429 -0.607 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' ' DG' . . . . . 0.921 " O5'" " H4'" ' B' ' 3' ' ' ' DA' . . . . . . . . 0 O5'--C5' 1.426 -0.877 0 C4'-C3'-C2' 102.032 -1.168 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' ' DG' . . . . . 0.728 ' N7 ' ' C5 ' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.428 -0.768 0 O4'-C1'-C2' 106.964 0.786 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.529 HG11 ' N ' ' A' ' 182' ' ' LYS . 47.7 t . . . . . 0 CA--C 1.503 -0.848 0 CA-C-O 121.229 0.538 . . . . 0.0 111.305 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.536 ' HG2' ' CB ' ' A' ' 233' ' ' GLU . 0.0 OUTLIER -151.38 112.31 4.27 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.481 177.463 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.638 ' HD3' ' HB3' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -132.35 152.01 51.61 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.607 179.228 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.684 HG12 ' HB ' ' A' ' 228' ' ' ILE . 0.2 OUTLIER -130.31 120.29 48.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.224 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.68 ' CE2' ' C4 ' ' B' ' 3' ' ' ' DA' . 0.2 OUTLIER -92.67 109.53 20.95 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 121.576 0.703 . . . . 0.0 109.814 -179.544 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.579 ' CG1' ' HB2' ' A' ' 252' ' ' CYS . 24.0 t -85.68 126.6 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.244 -179.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.518 ' O ' ' N ' ' A' ' 253' ' ' GLU . . . -114.36 129.48 8.74 Favored Glycine 0 N--CA 1.453 -0.225 0 N-CA-C 115.014 0.766 . . . . 0.0 115.014 -177.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.54 ' HA3' ' C7 ' ' B' ' 2' ' ' ' DT' . . . 78.04 78.33 0.8 Allowed Glycine 0 C--N 1.331 0.264 0 C-N-CA 121.44 -0.409 . . . . 0.0 113.428 178.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.526 HD12 ' N ' ' A' ' 190' ' ' SER . 0.6 OUTLIER -117.54 157.41 26.37 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 122.431 0.293 . . . . 0.0 110.726 -179.897 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.588 ' CB ' ' CD ' ' A' ' 191' ' ' PRO . 0.1 OUTLIER -46.7 -175.17 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.249 0 CA-C-O 121.102 0.477 . . . . 0.0 111.428 179.761 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.588 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 11.8 Cg_exo -70.83 -1.7 9.77 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 123.149 2.566 . . . . 0.0 113.707 -179.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.505 ' HB2' ' O ' ' A' ' 191' ' ' PRO . 25.9 t70 169.58 74.21 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.982 0.42 . . . . 0.0 111.24 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.521 ' CB ' HD11 ' A' ' 189' ' ' LEU . 55.1 m -66.3 114.58 17.6 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.939 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.509 ' HG2' ' HG2' ' A' ' 197' ' ' LYS . 12.6 Cg_endo -56.72 115.41 2.46 Favored 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 122.478 2.119 . . . . 0.0 111.467 179.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.802 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.1 OUTLIER -53.11 -15.13 0.76 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.343 -179.641 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . 0.483 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 3.6 mt-10 -68.61 -38.96 81.0 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' A' ' 200' ' ' GLU . 19.0 mmmt -73.18 -48.93 31.1 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.802 ' CG1' ' HA ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -48.49 -30.8 3.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.222 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.564 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 2.3 mtt180 -70.56 -32.52 69.97 Favored 'General case' 0 C--O 1.221 -0.447 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.662 178.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . 0.577 ' CG ' ' N ' ' A' ' 201' ' ' TYR . 4.2 pt-20 -83.03 -56.38 3.83 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.664 179.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.577 ' N ' ' CG ' ' A' ' 200' ' ' GLU . 0.4 OUTLIER -50.31 -53.93 25.15 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.62 0.724 . . . . 0.0 109.791 179.049 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.661 ' CD2' HD12 ' A' ' 228' ' ' ILE . 0.4 OUTLIER -79.43 -29.77 42.02 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.875 -179.915 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.564 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -62.72 -57.99 13.98 Favored Glycine 0 CA--C 1.499 -0.946 0 N-CA-C 107.044 -2.422 . . . . 0.0 107.044 176.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -48.81 -29.21 7.83 Favored Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 176.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . 0.695 ' CE2' HG13 ' A' ' 239' ' ' ILE . 0.0 OUTLIER -58.36 -42.3 86.65 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.017 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.501 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 168.1 -131.1 2.23 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 113.733 -1.576 . . . . 0.0 110.212 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.516 ' HG3' ' CG ' ' A' ' 232' ' ' GLU . 1.3 mm-40 -96.8 100.64 12.17 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.239 0.542 . . . . 0.0 111.074 178.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.445 HG21 ' HB2' ' A' ' 202' ' ' PHE . 2.7 t -79.36 138.86 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 CA-C-N 115.336 -0.847 . . . . 0.0 108.813 178.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.488 ' CG ' HG21 ' A' ' 229' ' ' THR . 3.0 tp10 -89.9 -56.94 3.04 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.766 178.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 3.5 m -166.39 150.86 7.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.278 0.561 . . . . 0.0 112.245 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.651 HG22 HG12 ' A' ' 228' ' ' ILE . 0.5 OUTLIER -119.04 123.36 71.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.561 178.638 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.486 ' O ' ' HD3' ' A' ' 214' ' ' PRO . 0.0 OUTLIER -122.73 103.19 8.49 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -178.834 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.522 HD21 ' CB ' ' A' ' 226' ' ' CYS . 0.0 OUTLIER -95.89 106.14 25.9 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.347 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.514 ' HD2' ' O ' ' A' ' 225' ' ' PHE . 13.0 Cg_exo -72.21 130.91 17.06 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 123.299 2.666 . . . . 0.0 113.282 -178.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 4.3 ptp -135.3 130.84 35.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.307 179.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.48 ' O ' ' HA ' ' A' ' 220' ' ' ASN . 0.5 OUTLIER -110.59 107.98 17.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.038 0.447 . . . . 0.0 111.24 -179.735 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -81.98 -8.7 59.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.045 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 4.4 mtpt -88.27 -51.68 5.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.454 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.427 ' O ' ' C ' ' A' ' 220' ' ' ASN . 0.0 OUTLIER -118.6 -9.98 10.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.278 -179.762 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . 0.48 ' HA ' ' O ' ' A' ' 216' ' ' ASP . 4.4 m120 37.35 59.01 1.22 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.652 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -57.26 -179.62 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.627 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.636 ' O ' ' CG ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -99.48 40.17 1.24 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 122.791 1.282 . . . . 0.0 110.139 -179.909 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.533 ' CB ' H5'' ' B' ' 3' ' ' ' DA' . 1.8 ptp85 -71.54 -31.59 67.19 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . 0.498 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 11.94 63.7 0.01 OUTLIER Glycine 0 C--N 1.336 0.559 0 CA-C-N 114.292 -1.322 . . . . 0.0 113.245 178.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.676 ' CE1' " C5'" ' B' ' 3' ' ' ' DA' . 1.4 p90 -156.83 176.77 12.3 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . 0.522 ' CB ' HD21 ' A' ' 213' ' ' LEU . 30.5 p -145.78 156.38 43.55 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.505 -0.478 . . . . 0.0 112.255 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.669 ' CE2' ' CB ' ' A' ' 257' ' ' ALA . 5.4 m-85 -107.94 143.55 36.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.642 179.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.684 ' HB ' HG12 ' A' ' 184' ' ' ILE . 2.0 mt -137.13 128.34 41.26 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.401 0 CA-C-O 121.175 0.512 . . . . 0.0 111.495 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.488 HG21 ' CG ' ' A' ' 209' ' ' GLU . 54.9 m -110.88 138.15 47.63 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.834 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.649 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 67.9 m-85 -111.64 126.1 54.66 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.766 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.479 ' HG3' ' O ' ' A' ' 207' ' ' GLU . 0.1 OUTLIER -49.81 -38.52 34.95 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 177.711 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . 0.516 ' CG ' ' HG3' ' A' ' 207' ' ' GLU . 60.5 mm-40 -89.86 -167.8 1.95 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 113.154 -1.839 . . . . 0.0 109.274 178.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . 0.536 ' CB ' ' HG2' ' A' ' 182' ' ' LYS . 0.8 OUTLIER -131.32 -1.28 3.99 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -179.876 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.504 ' HB2' ' HD3' ' A' ' 235' ' ' PRO . 2.0 mt-10 -73.69 -58.14 2.32 Favored Pre-proline 0 C--N 1.329 -0.29 0 C-N-CA 120.433 -0.507 . . . . 0.0 112.141 -179.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.595 ' CB ' ' CE2' ' A' ' 230' ' ' PHE . 79.8 Cg_exo -49.22 -31.07 20.96 Favored 'Trans proline' 0 CA--C 1.498 -1.303 0 N-CA-C 109.066 -1.167 . . . . 0.0 109.066 178.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.596 HG22 ' CD1' ' A' ' 230' ' ' PHE . 17.6 t -72.22 -44.07 64.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 114.019 -1.446 . . . . 0.0 109.189 178.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . 0.5 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 2.1 mtpp -52.74 -47.95 67.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.396 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.646 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -80.61 -52.79 7.18 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.926 -179.268 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.695 HG13 ' CE2' ' A' ' 205' ' ' PHE . 1.9 mt -38.49 -51.51 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.917 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' MET . . . . . 0.404 ' HG3' ' O ' ' A' ' 236' ' ' VAL . 22.7 mtp -59.17 -26.78 65.08 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.052 -179.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.515 ' HG3' ' CD ' ' A' ' 242' ' ' LYS . 0.2 OUTLIER -81.56 -27.91 34.13 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.676 179.89 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.515 ' CD ' ' HG3' ' A' ' 241' ' ' GLU . 0.6 OUTLIER -81.32 96.79 7.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.616 179.688 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.474 ' O ' ' HG3' ' A' ' 253' ' ' GLU . 0.0 OUTLIER -36.17 -55.0 0.8 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.867 -179.971 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.53 ' CE1' ' HG3' ' A' ' 253' ' ' GLU . 32.7 m-85 -126.26 158.4 35.82 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.299 0.571 . . . . 0.0 111.836 -179.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' HIS . . . . . 0.585 ' CE1' HG12 ' A' ' 239' ' ' ILE . 32.2 m-70 -127.85 157.46 40.42 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.531 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . 0.462 ' O ' ' CE2' ' A' ' 201' ' ' TYR . 2.2 m-80 -127.82 104.69 7.97 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.211 0.529 . . . . 0.0 110.423 178.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.523 ' O ' ' C ' ' A' ' 248' ' ' GLY . 1.4 t -95.31 174.92 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.253 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . 0.523 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . -14.66 -57.16 0.01 OUTLIER Glycine 0 C--N 1.34 0.759 0 O-C-N 123.662 0.601 . . . . 0.0 113.316 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.486 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -133.39 -39.8 0.91 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.959 -0.621 . . . . 0.0 110.939 -179.883 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' SER . . . . . 0.498 ' HB3' ' HB2' ' A' ' 190' ' ' SER . 6.0 p -78.24 152.2 32.7 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.159 -0.928 . . . . 0.0 113.192 -178.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.517 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -137.19 108.6 6.89 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.419 178.211 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' CYS . . . . . 0.579 ' HB2' ' CG1' ' A' ' 186' ' ' VAL . 0.0 OUTLIER -128.63 153.73 46.97 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -176.357 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . 0.53 ' HG3' ' CE1' ' A' ' 244' ' ' TYR . 59.4 tt0 -76.08 108.11 8.75 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.832 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . 0.607 ' CG2' ' CG2' ' A' ' 239' ' ' ILE . 13.2 mt -96.47 112.24 28.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 -178.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.514 ' O ' ' C ' ' A' ' 256' ' ' VAL . 0.0 OUTLIER -116.15 130.16 56.66 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 176.568 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . 0.549 ' CG2' ' O ' ' A' ' 183' ' ' LYS . 3.6 p -32.78 123.54 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 122.136 0.969 . . . . 0.0 111.372 -177.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.669 ' CB ' ' CE2' ' A' ' 227' ' ' PHE . . . -76.67 153.71 34.92 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 113.522 -1.672 . . . . 0.0 111.716 -178.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.48 112.92 14.87 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.354 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' SER . . . . . 0.484 ' OG ' ' O6 ' ' B' ' 4' ' ' ' DG' . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.518 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.08 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' ' DT' . . . . . 0.823 ' O2 ' H5'' ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.427 -0.797 0 O4'-C1'-C2' 107.192 0.992 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' ' DA' . . . . . 0.905 " H4'" " O5'" ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.426 -0.854 0 C5'-C4'-O4' 108.251 -0.718 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' ' DG' . . . . . 0.905 " O5'" " H4'" ' B' ' 3' ' ' ' DA' . . . . . . . . 0 O5'--C5' 1.425 -0.908 0 C4'-C3'-C2' 101.493 -1.707 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' ' DG' . . . . . 0.643 ' C8 ' " H1'" ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.429 -0.667 0 C4'-C3'-C2' 102.571 -0.629 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.535 HG11 ' N ' ' A' ' 182' ' ' LYS . 42.8 t . . . . . 0 CA--C 1.504 -0.802 0 CA-C-O 121.181 0.515 . . . . 0.0 111.615 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.535 ' N ' HG11 ' A' ' 181' ' ' VAL . 0.7 OUTLIER -149.99 112.67 4.76 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.488 177.731 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.643 ' HD3' ' HB3' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -134.15 142.57 47.51 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.747 179.838 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.621 HG12 ' HB ' ' A' ' 228' ' ' ILE . 0.2 OUTLIER -122.59 120.08 59.93 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.445 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.699 ' CD2' ' C2 ' ' B' ' 3' ' ' ' DA' . 0.3 OUTLIER -91.73 109.44 20.76 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.68 0.752 . . . . 0.0 110.054 -179.135 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.6 ' CG1' ' HB2' ' A' ' 252' ' ' CYS . 48.7 t -85.53 126.43 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 CA-C-N 114.689 -1.141 . . . . 0.0 109.373 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.542 ' O ' ' HB3' ' A' ' 252' ' ' CYS . . . -112.99 134.8 12.18 Favored Glycine 0 C--N 1.331 0.288 0 N-CA-C 115.276 0.87 . . . . 0.0 115.276 -176.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.586 ' HA3' ' C5 ' ' B' ' 2' ' ' ' DT' . . . 64.51 84.09 0.08 OUTLIER Glycine 0 C--N 1.333 0.396 0 CA-C-N 115.516 -0.342 . . . . 0.0 112.675 178.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.527 ' CD2' ' C ' ' A' ' 225' ' ' PHE . 1.1 pp -117.36 157.83 25.46 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.045 0.45 . . . . 0.0 112.039 -178.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.588 ' CB ' ' CD ' ' A' ' 191' ' ' PRO . 0.3 OUTLIER -44.68 -173.91 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.227 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.965 179.815 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.588 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 6.4 Cg_exo -74.75 9.48 1.93 Allowed 'Trans proline' 0 CA--C 1.53 0.289 0 C-N-CA 123.125 2.55 . . . . 0.0 113.507 -179.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.54 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 1.1 m-20 158.2 78.24 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 120.842 0.353 . . . . 0.0 111.534 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.534 HG22 ' CD1' ' A' ' 198' ' ' ILE . 19.2 m -68.78 112.17 10.55 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.633 179.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.549 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 54.9 Cg_endo -67.3 107.04 1.31 Allowed 'Trans proline' 0 N--CA 1.465 -0.158 0 C-N-CA 122.668 2.245 . . . . 0.0 111.767 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.58 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -41.06 -21.51 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.32 -0.4 . . . . 0.0 112.016 -179.964 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 11.0 mt-10 -59.37 -43.71 92.84 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -178.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.549 ' CD ' ' HG2' ' A' ' 194' ' ' PRO . 0.6 OUTLIER -79.15 -46.21 18.42 Favored 'General case' 0 CA--C 1.494 -1.208 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 178.68 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.617 HG23 ' CE1' ' A' ' 202' ' ' PHE . 0.2 OUTLIER -49.07 -29.58 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-N 114.191 -1.368 . . . . 0.0 108.396 176.86 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.534 ' HG3' ' O ' ' A' ' 195' ' ' GLU . 4.6 mtp85 -74.16 -32.56 63.17 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.845 178.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . 0.528 ' N ' ' O ' ' A' ' 197' ' ' LYS . 5.4 mt-10 -82.61 -59.13 2.62 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.57 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.514 ' OH ' ' ND1' ' A' ' 245' ' ' HIS . 0.4 OUTLIER -47.96 -52.16 20.77 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.136 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.67 ' O ' ' HB2' ' A' ' 205' ' ' PHE . 0.4 OUTLIER -79.7 -31.69 41.26 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.301 179.459 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.53 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -61.84 -58.07 14.61 Favored Glycine 0 N--CA 1.442 -0.906 0 N-CA-C 107.613 -2.195 . . . . 0.0 107.613 176.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -49.76 -27.91 10.28 Favored Glycine 0 N--CA 1.441 -1.003 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 176.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . 0.735 ' CE2' HG13 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -57.76 -46.05 85.08 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 177.826 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.505 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 173.56 -132.28 2.27 Favored Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 113.639 -1.618 . . . . 0.0 110.25 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.486 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 3.1 mm-40 -97.19 99.84 11.32 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.134 0.492 . . . . 0.0 111.08 178.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 2.6 t -74.76 139.08 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.535 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 60.0 tt0 -91.03 -56.03 3.32 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 178.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -161.88 153.96 19.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.861 179.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.58 ' CG2' HD13 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -122.97 123.95 69.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.488 178.725 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.509 ' OE1' ' N7 ' ' B' ' 4' ' ' ' DG' . 1.0 OUTLIER -123.57 104.75 9.23 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -177.371 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.478 HD11 ' CD1' ' A' ' 198' ' ' ILE . 0.7 OUTLIER -95.69 106.69 28.89 Favored Pre-proline 0 CA--C 1.531 0.233 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 176.545 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.559 ' CG ' " O4'" ' B' ' 4' ' ' ' DG' . 5.1 Cg_endo -85.38 133.98 4.77 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 123.197 2.598 . . . . 0.0 113.885 -178.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.39 134.84 40.14 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.288 179.052 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.461 ' O ' ' HA ' ' A' ' 220' ' ' ASN . 0.2 OUTLIER -110.2 107.19 16.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.912 0.387 . . . . 0.0 111.174 -179.834 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -81.88 -6.48 59.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.608 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -88.7 -51.7 5.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.837 0.351 . . . . 0.0 111.432 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.77 -22.3 7.46 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.03 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . 0.461 ' HA ' ' O ' ' A' ' 216' ' ' ASP . 2.2 m-80 57.02 55.99 5.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.278 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.4 177.16 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.347 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.741 ' HG3' ' O ' ' A' ' 222' ' ' ARG . 0.7 OUTLIER -100.01 38.27 1.5 Allowed 'General case' 0 N--CA 1.439 -0.991 0 CA-C-O 122.458 1.123 . . . . 0.0 109.713 -179.762 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.613 ' HB2' ' CE1' ' A' ' 225' ' ' PHE . 6.6 ptp85 -70.98 -28.89 64.78 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 179.052 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . 0.535 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 4.99 64.77 0.01 OUTLIER Glycine 0 C--N 1.342 0.887 0 O-C-N 124.446 1.091 . . . . 0.0 112.863 177.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.613 ' CE1' ' HB2' ' A' ' 223' ' ' ARG . 0.2 OUTLIER -156.49 176.48 12.65 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.985 -0.608 . . . . 0.0 109.406 -178.311 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . 0.525 ' O ' ' HB ' ' A' ' 186' ' ' VAL . 0.5 OUTLIER -139.77 156.89 46.52 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.033 -0.667 . . . . 0.0 112.225 -179.339 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.709 ' CE1' ' C2 ' ' B' ' 4' ' ' ' DG' . 4.7 m-85 -114.24 132.26 56.2 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.428 -0.806 . . . . 0.0 108.968 179.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.646 HD11 ' CD2' ' A' ' 202' ' ' PHE . 2.2 mt -126.13 124.8 66.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.16 0.505 . . . . 0.0 111.41 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.461 HG22 ' HB3' ' A' ' 209' ' ' GLU . 85.1 m -106.1 138.08 42.9 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.496 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.677 ' CE1' ' CB ' ' A' ' 235' ' ' PRO . 74.7 m-85 -113.05 126.47 55.52 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.377 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.535 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -49.28 -38.4 27.03 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 178.334 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . 0.455 ' HB3' ' OE2' ' A' ' 234' ' ' GLU . 49.1 mt-10 -91.49 -168.57 2.07 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 113.399 -1.728 . . . . 0.0 109.673 179.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . 0.496 ' CB ' ' HG2' ' A' ' 182' ' ' LYS . 0.6 OUTLIER -131.34 14.04 5.06 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.834 -0.347 . . . . 0.0 111.372 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.566 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.4 OUTLIER -84.55 -60.06 0.32 Allowed Pre-proline 0 C--N 1.33 -0.263 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.702 179.873 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.677 ' CB ' ' CE1' ' A' ' 230' ' ' PHE . 87.1 Cg_exo -49.31 -32.59 26.21 Favored 'Trans proline' 0 CA--C 1.502 -1.103 0 N-CA-C 109.089 -1.158 . . . . 0.0 109.089 178.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.521 ' CG2' ' HB2' ' A' ' 230' ' ' PHE . 21.7 t -72.51 -43.44 63.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 113.938 -1.483 . . . . 0.0 110.429 179.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . 0.566 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 1.8 ptpt -64.07 -36.18 83.17 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.789 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.485 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 0.0 OUTLIER -82.19 -50.15 9.33 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.9 0.381 . . . . 0.0 111.269 179.279 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.735 HG13 ' CE2' ' A' ' 205' ' ' PHE . 1.5 mt -44.6 -48.77 2.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.252 -179.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' MET . . . . . 0.469 ' HG2' ' HB ' ' A' ' 256' ' ' VAL . 22.3 mtp -61.97 -26.51 68.26 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.944 -178.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.45 ' CG ' ' O ' ' A' ' 237' ' ' LYS . 1.1 mt-10 -86.99 -16.73 34.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.826 0.346 . . . . 0.0 111.248 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.47 ' HG2' ' O ' ' A' ' 238' ' ' LYS . 2.9 mmmt -80.55 118.42 22.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.138 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.464 ' HG2' ' N ' ' A' ' 244' ' ' TYR . 13.8 ttpt -41.9 -81.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.486 ' CD1' ' HG3' ' A' ' 253' ' ' GLU . 12.1 m-85 -114.74 157.15 23.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.407 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' HIS . . . . . 0.586 ' CE1' HG12 ' A' ' 239' ' ' ILE . 24.2 m-70 -113.68 150.23 33.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.241 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . 0.417 ' O ' ' CE2' ' A' ' 201' ' ' TYR . 0.2 OUTLIER -127.85 105.35 8.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.859 179.704 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.533 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.7 t -110.35 110.22 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.985 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 45.61 -87.71 0.01 OUTLIER Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.407 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.533 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -106.49 -39.97 5.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.363 0.601 . . . . 0.0 110.546 179.639 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' SER . . . . . 0.455 ' OG ' ' OG1' ' A' ' 193' ' ' THR . 1.5 m -77.43 147.42 35.98 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.033 -178.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -143.97 106.24 4.39 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.463 179.162 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' CYS . . . . . 0.6 ' HB2' ' CG1' ' A' ' 186' ' ' VAL . 0.0 OUTLIER -128.21 153.12 47.27 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -176.541 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . 0.486 ' HG3' ' CD1' ' A' ' 244' ' ' TYR . 50.1 tt0 -76.29 107.57 8.62 Favored 'General case' 0 C--O 1.224 -0.27 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.172 178.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . 0.592 ' CG2' ' CG2' ' A' ' 239' ' ' ILE . 29.2 mt -96.39 113.3 30.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -177.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.51 ' O ' ' C ' ' A' ' 256' ' ' VAL . 0.0 OUTLIER -117.25 133.09 56.4 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 176.677 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . 0.55 ' CG2' ' O ' ' A' ' 183' ' ' LYS . 5.5 p -33.23 124.94 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-O 122.251 1.024 . . . . 0.0 111.304 -177.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.673 ' CB ' ' CE2' ' A' ' 227' ' ' PHE . . . -78.27 152.95 32.24 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 113.423 -1.717 . . . . 0.0 112.48 -178.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.73 113.85 15.86 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.511 -1.222 . . . . 0.0 110.081 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' SER . . . . . 0.46 ' HB3' ' O6 ' ' B' ' 4' ' ' ' DG' . 83.6 p . . . . . 0 C--N 1.323 -0.586 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.859 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' ' DT' . . . . . 0.876 ' O2 ' " H2'" ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.427 -0.813 0 C4'-C3'-C2' 102.475 -0.725 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' ' DA' . . . . . 0.699 ' C2 ' ' CD2' ' A' ' 185' ' ' PHE . . . . . . . . 0 O5'--C5' 1.425 -0.947 0 C3'-C2'-C1' 99.718 -2.13 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' ' DG' . . . . . 0.717 ' N3 ' " H5'" ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.427 -0.834 0 C4'-C3'-C2' 102.045 -1.155 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' ' DG' . . . . . 0.64 ' N7 ' ' C5 ' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.427 -0.801 0 O4'-C1'-C2' 106.799 0.635 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.525 HG13 ' N ' ' A' ' 182' ' ' LYS . 43.5 t . . . . . 0 CA--C 1.505 -0.765 0 CA-C-O 121.362 0.601 . . . . 0.0 112.328 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.528 ' CB ' HG23 ' A' ' 236' ' ' VAL . 8.0 mmtt -145.76 112.38 5.91 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.243 176.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.684 ' HD3' ' HB2' ' A' ' 257' ' ' ALA . 0.0 OUTLIER -130.62 162.45 29.33 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.965 179.775 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.643 HG12 ' HB ' ' A' ' 228' ' ' ILE . 0.3 OUTLIER -138.55 119.74 16.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 177.532 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.568 ' CE2' ' CE2' ' A' ' 225' ' ' PHE . 0.2 OUTLIER -92.52 109.49 20.89 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.587 0.708 . . . . 0.0 110.195 -178.914 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.584 ' CG1' ' HB2' ' A' ' 252' ' ' CYS . 40.6 t -84.29 128.07 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.894 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.529 ' O ' ' N ' ' A' ' 253' ' ' GLU . . . -116.5 132.76 10.32 Favored Glycine 0 N--CA 1.451 -0.319 0 N-CA-C 115.053 0.781 . . . . 0.0 115.053 -176.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.529 ' HA3' ' C7 ' ' B' ' 2' ' ' ' DT' . . . 71.39 80.11 0.36 Allowed Glycine 0 N--CA 1.452 -0.292 0 CA-C-N 115.442 -0.379 . . . . 0.0 113.397 178.171 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.525 ' CD2' ' C ' ' A' ' 225' ' ' PHE . 0.8 OUTLIER -117.26 157.57 25.82 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.701 0.286 . . . . 0.0 110.958 -179.796 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.593 ' CB ' ' CD ' ' A' ' 191' ' ' PRO . 0.2 OUTLIER -47.71 -173.66 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.934 179.585 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.593 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 5.7 Cg_exo -78.36 17.09 1.12 Allowed 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.956 2.437 . . . . 0.0 113.272 -179.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.538 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 1.2 m-20 159.73 76.89 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.117 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.635 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.541 HG23 ' CD1' ' A' ' 198' ' ' ILE . 50.1 m -71.45 114.55 28.94 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 120.855 0.36 . . . . 0.0 110.432 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.487 ' HG2' ' HG2' ' A' ' 197' ' ' LYS . 16.3 Cg_endo -58.52 110.05 0.6 Allowed 'Trans proline' 0 N--CA 1.464 -0.243 0 C-N-CA 122.369 2.046 . . . . 0.0 111.748 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.798 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -50.9 -15.69 0.33 Allowed 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.143 -179.875 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . 0.477 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 23.1 mm-40 -71.94 -36.89 70.03 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' A' ' 200' ' ' GLU . 0.0 OUTLIER -73.92 -48.01 33.72 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.186 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.798 ' CG1' ' HA ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -47.68 -30.73 2.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.225 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.589 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 6.5 mtt180 -71.72 -32.4 67.73 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.189 179.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . 0.53 ' N ' ' O ' ' A' ' 197' ' ' LYS . 0.4 OUTLIER -82.83 -46.19 13.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.023 0.44 . . . . 0.0 110.646 179.292 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.56 ' OH ' ' ND1' ' A' ' 245' ' ' HIS . 0.5 OUTLIER -63.04 -53.55 52.11 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.004 179.407 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.665 ' CD2' HD13 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -79.88 -31.41 40.33 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 114.845 -1.07 . . . . 0.0 110.339 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.589 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -64.85 -54.36 28.7 Favored Glycine 0 CA--C 1.497 -1.071 0 N-CA-C 106.535 -2.626 . . . . 0.0 106.535 176.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -50.23 -29.3 15.54 Favored Glycine 0 N--CA 1.442 -0.928 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 175.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . 0.723 ' CE2' HG13 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -58.34 -44.76 88.86 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 177.783 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 170.55 -129.89 1.89 Allowed Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 113.717 -1.583 . . . . 0.0 110.616 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.454 ' HB3' ' HE2' ' A' ' 231' ' ' LYS . 2.9 mm-40 -97.01 99.69 11.21 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.289 0.566 . . . . 0.0 111.321 178.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 2.6 t -77.5 143.39 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 CA-C-N 115.324 -0.853 . . . . 0.0 108.845 178.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.508 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 5.8 tp10 -93.7 -56.78 2.78 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 4.4 m -166.94 149.92 6.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.959 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.636 HG23 HG12 ' A' ' 228' ' ' ILE . 0.4 OUTLIER -117.19 126.37 74.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.664 178.922 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -123.09 103.07 8.34 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -178.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.46 HD23 ' HB ' ' A' ' 193' ' ' THR . 0.1 OUTLIER -96.3 105.53 22.93 Favored Pre-proline 0 C--N 1.33 -0.241 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 177.917 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.51 ' HD2' ' O ' ' A' ' 225' ' ' PHE . 73.0 Cg_endo -75.31 127.44 10.47 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.75 2.3 . . . . 0.0 112.813 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.25 131.21 36.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.972 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.421 ' O ' ' OD1' ' A' ' 220' ' ' ASN . 0.3 OUTLIER -114.78 106.9 14.74 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.942 0.401 . . . . 0.0 110.945 179.931 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -82.02 -10.76 59.13 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.519 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.34 -50.89 9.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.867 0.365 . . . . 0.0 111.28 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.89 -30.17 5.12 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.171 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . 0.421 ' OD1' ' O ' ' A' ' 216' ' ' ASP . 39.6 m-20 62.47 71.72 0.52 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.956 0.407 . . . . 0.0 110.52 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.66 176.56 1.9 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.217 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.625 ' CD ' ' O ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -94.16 27.34 2.9 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 122.432 1.11 . . . . 0.0 110.104 179.993 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.572 ' O ' ' CD1' ' A' ' 225' ' ' PHE . 4.2 ptp85 -70.99 -28.47 64.45 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . 0.528 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . -1.08 68.89 0.0 OUTLIER Glycine 0 C--N 1.343 0.93 0 O-C-N 124.611 1.194 . . . . 0.0 112.701 178.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.573 ' CE1' H5'' ' B' ' 3' ' ' ' DA' . 0.1 OUTLIER -156.79 176.7 12.39 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -178.339 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . 0.504 ' O ' ' HB ' ' A' ' 186' ' ' VAL . 1.3 p -139.48 156.32 47.01 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.016 -0.674 . . . . 0.0 112.544 -179.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.67 ' CE2' ' CB ' ' A' ' 257' ' ' ALA . 3.8 m-85 -113.95 133.44 55.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.495 -0.775 . . . . 0.0 108.965 178.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.665 HD13 ' CD2' ' A' ' 202' ' ' PHE . 2.0 mt -128.55 133.26 66.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.142 0.496 . . . . 0.0 111.475 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.471 HG23 ' CB ' ' A' ' 209' ' ' GLU . 97.7 m -113.03 138.05 50.48 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.155 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.66 ' CE1' ' CB ' ' A' ' 235' ' ' PRO . 67.9 m-85 -112.8 126.44 55.43 Favored 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.053 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.508 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -50.52 -37.83 41.25 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 177.737 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -90.1 -165.86 1.45 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 113.152 -1.84 . . . . 0.0 109.691 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . 0.499 ' HB2' ' HD2' ' A' ' 182' ' ' LYS . 0.4 OUTLIER -134.64 8.53 3.6 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.667 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.531 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.3 OUTLIER -82.14 -59.92 0.41 Allowed Pre-proline 0 C--N 1.328 -0.369 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.755 179.939 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.66 ' CB ' ' CE1' ' A' ' 230' ' ' PHE . 80.2 Cg_exo -49.48 -30.91 22.27 Favored 'Trans proline' 0 CA--C 1.499 -1.27 0 N-CA-C 108.986 -1.198 . . . . 0.0 108.986 178.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.536 ' CG2' ' HB2' ' A' ' 230' ' ' PHE . 21.1 t -73.92 -45.69 48.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 114.473 -1.239 . . . . 0.0 110.272 178.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . 0.531 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 1.2 ptpt -61.74 -36.23 80.38 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.606 -179.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.635 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -82.29 -54.89 4.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.172 178.918 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.723 HG13 ' CE2' ' A' ' 205' ' ' PHE . 1.7 mt -40.33 -50.69 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.951 -179.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' MET . . . . . 0.484 ' HG2' ' HB ' ' A' ' 256' ' ' VAL . 17.3 mtp -60.06 -24.68 64.76 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.787 -178.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.487 ' CG ' ' O ' ' A' ' 237' ' ' LYS . 1.0 OUTLIER -87.91 -17.08 32.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.798 0.333 . . . . 0.0 111.261 -179.715 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.461 ' HD3' ' O ' ' A' ' 238' ' ' LYS . 0.1 OUTLIER -79.68 123.77 27.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.352 -179.742 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.461 ' HE3' ' HB2' ' A' ' 244' ' ' TYR . 7.7 ttpt -50.38 -75.53 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 178.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.532 ' CD1' ' HG3' ' A' ' 253' ' ' GLU . 17.3 m-85 -121.02 144.81 48.33 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.932 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' HIS . . . . . 0.638 ' CG ' ' CD1' ' A' ' 254' ' ' ILE . 30.1 m-70 -104.55 150.63 24.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.096 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . 0.446 ' O ' ' CE2' ' A' ' 201' ' ' TYR . 0.0 OUTLIER -129.58 104.68 7.59 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.221 0.534 . . . . 0.0 110.493 179.164 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.556 ' O ' ' C ' ' A' ' 248' ' ' GLY . 1.7 t -95.29 170.24 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.737 -179.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . 0.556 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . -8.3 -64.66 0.01 OUTLIER Glycine 0 C--N 1.341 0.825 0 O-C-N 123.669 0.606 . . . . 0.0 113.797 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.467 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -126.0 -39.82 2.07 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.509 0.671 . . . . 0.0 110.501 -179.282 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' SER . . . . . 0.525 ' HB3' ' HB2' ' A' ' 190' ' ' SER . 0.2 OUTLIER -77.3 157.33 30.79 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.745 -1.116 . . . . 0.0 112.734 -178.197 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -142.42 107.97 5.07 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.182 179.27 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' CYS . . . . . 0.584 ' HB2' ' CG1' ' A' ' 186' ' ' VAL . 0.0 OUTLIER -128.67 152.96 47.79 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -177.255 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . 0.532 ' HG3' ' CD1' ' A' ' 244' ' ' TYR . 49.3 tt0 -76.61 108.48 9.64 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.581 179.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . 0.638 ' CD1' ' CG ' ' A' ' 245' ' ' HIS . 30.6 mt -96.8 113.44 31.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 -178.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.509 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -115.94 133.25 56.22 Favored 'General case' 0 C--O 1.22 -0.448 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 176.508 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . 0.514 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.4 p -33.2 124.51 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-O 122.096 0.95 . . . . 0.0 111.324 -177.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.684 ' HB2' ' HD3' ' A' ' 183' ' ' LYS . . . -79.56 151.18 30.82 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 113.633 -1.621 . . . . 0.0 112.37 -178.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.62 115.85 19.41 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.089 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 29.7 p . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.057 -179.676 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' ' DT' . . . . . 0.631 ' O2 ' " H2'" ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.427 -0.803 0 O4'-C1'-C2' 106.874 0.703 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' ' DA' . . . . . 0.573 H5'' ' CE1' ' A' ' 225' ' ' PHE . . . . . . . . 0 O4'--C1' 1.407 -1.021 0 C4'-C3'-C2' 104.755 1.555 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' ' DG' . . . . . 0.966 H2'' " O5'" ' B' ' 5' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.428 -0.772 0 C4'-C3'-C2' 101.929 -1.271 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' ' DG' . . . . . 0.966 " O5'" H2'' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.427 -0.797 0 O4'-C1'-C2' 106.804 0.64 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.527 HG11 ' N ' ' A' ' 182' ' ' LYS . 45.3 t . . . . . 0 CA--C 1.503 -0.855 0 CA-C-O 121.044 0.449 . . . . 0.0 111.204 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.527 ' N ' HG11 ' A' ' 181' ' ' VAL . 0.0 OUTLIER -151.14 112.34 4.34 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.103 177.66 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.635 ' HD3' ' HB1' ' A' ' 257' ' ' ALA . 0.0 OUTLIER -135.64 142.6 45.21 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.978 178.863 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.652 HG12 ' HB ' ' A' ' 228' ' ' ILE . 0.4 OUTLIER -122.04 120.91 62.7 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.183 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.703 ' CE2' ' C4 ' ' B' ' 3' ' ' ' DA' . 0.2 OUTLIER -94.14 109.34 21.13 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 121.553 0.692 . . . . 0.0 110.23 -179.195 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.586 ' CG1' ' HB2' ' A' ' 252' ' ' CYS . 4.9 t -85.03 128.86 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.802 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.532 ' O ' ' N ' ' A' ' 253' ' ' GLU . . . -115.6 127.87 7.78 Favored Glycine 0 C--N 1.332 0.316 0 N-CA-C 115.124 0.809 . . . . 0.0 115.124 -176.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.484 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . 76.26 82.04 0.53 Allowed Glycine 0 C--N 1.332 0.312 0 C-N-CA 121.354 -0.45 . . . . 0.0 113.419 178.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.524 ' CD1' ' OG1' ' A' ' 193' ' ' THR . 1.2 pp -117.43 157.18 26.67 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.778 0.323 . . . . 0.0 111.168 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.574 ' CB ' ' CD ' ' A' ' 191' ' ' PRO . 0.2 OUTLIER -46.67 -177.45 0.01 OUTLIER Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.256 0.551 . . . . 0.0 111.592 -179.927 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.574 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 19.6 Cg_exo -67.31 -2.73 8.68 Favored 'Trans proline' 0 CA--C 1.53 0.291 0 C-N-CA 123.395 2.73 . . . . 0.0 113.908 -179.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 191' ' ' PRO . 0.8 OUTLIER 171.76 73.0 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.905 0.383 . . . . 0.0 111.667 -179.811 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.528 HG21 ' CD1' ' A' ' 198' ' ' ILE . 93.7 m -61.52 122.32 70.03 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.998 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.439 ' C ' HD12 ' A' ' 198' ' ' ILE . 55.7 Cg_endo -70.09 114.62 3.82 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.157 1.905 . . . . 0.0 111.103 178.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.813 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -51.61 -15.16 0.41 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 121.056 -0.257 . . . . 0.0 111.265 -179.439 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . 0.498 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 4.9 mt-10 -67.91 -40.42 83.41 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.521 ' O ' ' N ' ' A' ' 200' ' ' GLU . 0.4 OUTLIER -70.71 -50.95 30.92 Favored 'General case' 0 CA--C 1.5 -0.98 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.222 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.813 ' CG1' ' HA ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -47.59 -32.43 2.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 115.297 -0.865 . . . . 0.0 108.751 178.717 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.555 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 16.7 mtt85 -69.92 -33.4 72.12 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.975 178.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . 0.521 ' N ' ' O ' ' A' ' 197' ' ' LYS . 8.5 mm-40 -81.87 -60.13 2.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.278 0.561 . . . . 0.0 109.928 179.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.532 ' OH ' ' ND1' ' A' ' 245' ' ' HIS . 0.3 OUTLIER -49.31 -54.19 18.29 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.025 178.932 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.675 ' CD2' HD13 ' A' ' 228' ' ' ILE . 0.2 OUTLIER -79.74 -31.5 41.04 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.991 -179.589 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.555 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -63.77 -56.47 18.81 Favored Glycine 0 CA--C 1.499 -0.95 0 N-CA-C 107.037 -2.425 . . . . 0.0 107.037 176.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -49.4 -28.44 9.47 Favored Glycine 0 N--CA 1.442 -0.937 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 176.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . 0.75 ' CE2' HG13 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -57.19 -48.56 78.45 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 177.769 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 175.62 -130.15 1.67 Allowed Glycine 0 N--CA 1.44 -1.078 0 CA-C-N 113.65 -1.614 . . . . 0.0 110.31 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.484 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 20.7 mm-40 -96.96 100.96 12.45 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.144 0.497 . . . . 0.0 110.861 178.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 2.8 t -77.93 141.37 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.515 ' CG ' HG23 ' A' ' 229' ' ' THR . 5.8 tp10 -91.9 -55.7 3.36 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 8.0 m -167.69 148.78 5.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.874 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.624 HG22 HG12 ' A' ' 228' ' ' ILE . 0.4 OUTLIER -115.72 125.67 72.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.882 178.931 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.497 ' O ' ' HD3' ' A' ' 214' ' ' PRO . 0.0 OUTLIER -123.28 105.01 9.49 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.334 -178.753 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.467 ' O ' ' O ' ' A' ' 214' ' ' PRO . 0.1 OUTLIER -96.39 105.41 22.33 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-O 120.841 0.353 . . . . 0.0 110.822 178.55 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.571 ' HD2' ' O ' ' A' ' 225' ' ' PHE . 84.4 Cg_exo -49.72 -156.59 0.0 OUTLIER 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 123.444 2.762 . . . . 0.0 113.977 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' MET . . . . . 0.415 ' HB3' ' HB2' ' A' ' 220' ' ' ASN . 15.4 mmt -96.91 173.61 7.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.237 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.403 ' O ' ' N ' ' A' ' 220' ' ' ASN . 0.4 OUTLIER -112.01 149.98 31.26 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.341 -179.701 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . 0.578 ' N ' ' O ' ' A' ' 221' ' ' LYS . 13.6 t30 -56.97 -16.24 6.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.145 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.17 -27.08 69.12 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.155 0.502 . . . . 0.0 110.048 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 9.9 t -145.29 11.24 1.31 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.958 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . 0.482 ' HB3' ' NH1' ' A' ' 223' ' ' ARG . 3.6 m120 -148.8 -87.82 0.08 Allowed 'General case' 0 C--O 1.231 0.112 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . 0.578 ' O ' ' N ' ' A' ' 217' ' ' ASN . 34.7 mtpt -153.64 175.33 13.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.713 0.292 . . . . 0.0 111.299 -179.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.636 ' O ' ' CG ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -88.13 41.94 1.03 Allowed 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 122.928 1.347 . . . . 0.0 109.678 179.461 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.594 ' HB2' ' CE1' ' A' ' 225' ' ' PHE . 3.7 ptp85 -71.51 -31.12 66.73 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . 0.491 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 16.57 61.26 0.01 OUTLIER Glycine 0 C--N 1.335 0.504 0 CA-C-N 114.43 -1.259 . . . . 0.0 112.922 178.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.677 ' CE1' " C5'" ' B' ' 3' ' ' ' DA' . 1.5 p90 -156.79 176.47 12.69 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . 0.465 ' O ' ' HB ' ' A' ' 186' ' ' VAL . 27.7 p -146.0 152.22 39.02 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.658 ' CE2' ' CB ' ' A' ' 257' ' ' ALA . 6.1 m-85 -106.21 139.43 40.74 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.082 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.675 HD13 ' CD2' ' A' ' 202' ' ' PHE . 2.0 mt -133.58 129.84 56.01 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.386 0 CA-C-O 120.879 0.371 . . . . 0.0 110.985 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.515 HG23 ' CG ' ' A' ' 209' ' ' GLU . 53.5 m -111.17 138.22 47.88 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.897 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.66 ' CE1' ' CB ' ' A' ' 235' ' ' PRO . 81.4 m-85 -114.51 126.44 54.94 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.445 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.484 ' HG3' ' O ' ' A' ' 207' ' ' GLU . 0.0 OUTLIER -47.77 -39.63 18.49 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 178.134 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . 0.472 ' O ' ' HG3' ' A' ' 182' ' ' LYS . 5.9 mm-40 -99.29 171.29 8.08 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 113.452 -1.704 . . . . 0.0 109.684 179.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . 0.447 ' HB3' ' CE ' ' A' ' 182' ' ' LYS . 0.0 OUTLIER -110.21 21.07 17.17 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.307 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.561 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.0 OUTLIER -85.18 -62.16 0.26 Allowed Pre-proline 0 C--N 1.331 -0.221 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.699 179.619 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.66 ' CB ' ' CE1' ' A' ' 230' ' ' PHE . 87.3 Cg_exo -50.37 -29.69 24.54 Favored 'Trans proline' 0 CA--C 1.502 -1.101 0 N-CA-C 108.811 -1.265 . . . . 0.0 108.811 177.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.58 HG22 ' CD2' ' A' ' 230' ' ' PHE . 20.9 t -72.66 -42.96 62.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 113.768 -1.56 . . . . 0.0 110.324 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . 0.561 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 9.3 pttp -64.26 -36.41 84.0 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.738 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.541 ' O ' ' CG ' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -81.43 -50.37 9.52 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.16 0.505 . . . . 0.0 110.92 179.183 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.75 HG13 ' CE2' ' A' ' 205' ' ' PHE . 1.6 mt -45.53 -53.04 2.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.847 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' MET . . . . . 0.458 ' HG2' ' HB ' ' A' ' 256' ' ' VAL . 11.5 mtp -60.46 -17.1 42.59 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.263 -178.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.541 ' CG ' ' O ' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -88.37 -26.29 22.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.893 0.377 . . . . 0.0 111.0 -179.813 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.506 ' CD ' ' HG3' ' A' ' 241' ' ' GLU . 5.3 mmmt -79.58 109.8 14.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.01 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.468 ' HD3' ' CD1' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -40.18 -62.42 0.75 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.34 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.555 ' CD1' ' HG3' ' A' ' 253' ' ' GLU . 12.9 m-30 -122.01 161.7 22.48 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.897 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' HIS . . . . . 0.646 ' CG ' ' CD1' ' A' ' 254' ' ' ILE . 20.5 m-70 -122.82 156.76 33.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.822 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . 0.416 ' O ' ' CE2' ' A' ' 201' ' ' TYR . 1.3 m-80 -133.24 105.15 6.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.172 0.511 . . . . 0.0 110.581 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.55 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.5 t -108.52 138.71 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.556 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . 0.479 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . 26.65 -87.57 0.01 OUTLIER Glycine 0 C--N 1.337 0.619 0 C-N-CA 121.163 -0.541 . . . . 0.0 113.017 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.55 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.1 OUTLIER -108.87 -34.63 6.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.774 0.797 . . . . 0.0 109.845 -179.861 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' SER . . . . . 0.516 ' O ' ' N ' ' A' ' 247' ' ' VAL . 3.0 p -77.25 152.92 34.46 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.248 -1.342 . . . . 0.0 113.176 -177.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -143.31 104.66 4.29 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 114.739 -1.118 . . . . 0.0 108.361 178.464 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' CYS . . . . . 0.586 ' HB2' ' CG1' ' A' ' 186' ' ' VAL . 0.0 OUTLIER -128.34 152.77 47.76 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -176.399 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . 0.555 ' HG3' ' CD1' ' A' ' 244' ' ' TYR . 50.7 tt0 -76.93 107.79 9.52 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.982 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . 0.646 ' CD1' ' CG ' ' A' ' 245' ' ' HIS . 26.1 mt -96.46 112.84 29.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -178.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.521 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -115.02 130.98 57.06 Favored 'General case' 0 C--O 1.221 -0.41 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 176.418 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . 0.551 ' CG2' ' O ' ' A' ' 183' ' ' LYS . 10.0 p -33.16 124.46 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 122.156 0.979 . . . . 0.0 111.475 -177.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.658 ' CB ' ' CE2' ' A' ' 227' ' ' PHE . . . -76.68 153.93 34.68 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 113.501 -1.681 . . . . 0.0 111.448 -178.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.1 111.82 13.9 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.046 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' SER . . . . . 0.484 ' OG ' ' O6 ' ' B' ' 4' ' ' ' DG' . 0.2 OUTLIER . . . . . 0 C--N 1.325 -0.459 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.7 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' ' DT' . . . . . 0.548 " C5'" ' O2 ' ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.427 -0.843 0 O4'-C1'-C2' 107.344 1.131 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' ' DA' . . . . . 0.911 " H4'" " O5'" ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.426 -0.857 0 C5'-C4'-O4' 108.419 -0.613 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' ' DG' . . . . . 0.911 " O5'" " H4'" ' B' ' 3' ' ' ' DA' . . . . . . . . 0 O5'--C5' 1.426 -0.878 0 C4'-C3'-C2' 101.949 -1.251 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' ' DG' . . . . . 0.899 " O5'" H2'' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.426 -0.847 0 O4'-C1'-C2' 107.089 0.899 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.527 HG12 ' N ' ' A' ' 182' ' ' LYS . 40.6 t . . . . . 0 CA--C 1.506 -0.745 0 CA-C-O 121.261 0.553 . . . . 0.0 111.77 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.527 ' N ' HG12 ' A' ' 181' ' ' VAL . 0.2 OUTLIER -148.02 112.5 5.31 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.029 177.442 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.609 ' HD3' ' HB1' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -130.5 145.45 51.86 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.382 179.271 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.672 HG12 ' HB ' ' A' ' 228' ' ' ILE . 0.3 OUTLIER -125.35 120.43 57.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.113 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.545 ' CA ' ' HB3' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -93.86 109.22 20.93 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.475 -178.875 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.56 ' CG1' HG12 ' A' ' 254' ' ' ILE . 2.8 t -84.44 124.65 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.196 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.515 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . -112.07 126.69 7.73 Favored Glycine 0 N--CA 1.451 -0.337 0 N-CA-C 114.932 0.733 . . . . 0.0 114.932 -176.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.478 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . 76.69 84.05 0.47 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 121.418 -0.42 . . . . 0.0 113.286 178.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.528 HD11 ' N ' ' A' ' 190' ' ' SER . 0.9 OUTLIER -117.07 157.01 26.58 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.657 0.265 . . . . 0.0 110.788 179.843 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.586 ' CB ' ' CD ' ' A' ' 191' ' ' PRO . 0.1 OUTLIER -46.72 -175.15 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.061 179.818 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.586 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 4.0 Cg_exo -79.79 17.76 1.24 Allowed 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 123.024 2.483 . . . . 0.0 112.949 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.494 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 1.0 OUTLIER 161.86 74.72 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.126 0 CA-C-O 120.621 0.248 . . . . 0.0 111.363 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.515 ' CB ' HD13 ' A' ' 189' ' ' LEU . 55.2 m -74.59 112.86 19.27 Favored Pre-proline 0 C--N 1.332 -0.169 0 CA-C-O 120.912 0.387 . . . . 0.0 110.919 179.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.532 ' HG2' ' CG ' ' A' ' 197' ' ' LYS . 26.6 Cg_endo -62.65 109.03 0.8 Allowed 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 122.3 2.0 . . . . 0.0 111.485 179.163 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.834 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -48.0 -15.4 0.06 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 111.849 0.314 . . . . 0.0 111.849 -179.658 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . 0.444 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 6.8 mm-40 -65.98 -37.06 84.99 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.532 ' CG ' ' HG2' ' A' ' 194' ' ' PRO . 0.8 OUTLIER -75.54 -50.95 14.08 Favored 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.258 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.834 ' CG1' ' HA ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -46.63 -31.19 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.314 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.54 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 5.2 mtp85 -70.16 -35.31 73.92 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.523 178.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . 0.513 ' N ' ' O ' ' A' ' 197' ' ' LYS . 12.1 mm-40 -82.4 -58.63 2.84 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.275 0.559 . . . . 0.0 110.233 179.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.526 ' OH ' ' ND1' ' A' ' 245' ' ' HIS . 0.4 OUTLIER -48.28 -53.45 17.21 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.677 179.144 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.677 ' CD2' HD13 ' A' ' 228' ' ' ILE . 0.2 OUTLIER -79.78 -31.17 40.82 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.177 179.688 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.54 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -60.2 -57.88 16.92 Favored Glycine 0 CA--C 1.499 -0.91 0 N-CA-C 107.221 -2.352 . . . . 0.0 107.221 176.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -50.15 -27.65 11.32 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 176.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . 0.724 ' CE2' HG13 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -58.24 -44.13 88.14 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 122.158 0.98 . . . . 0.0 108.383 178.003 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 169.49 -130.5 2.06 Favored Glycine 0 N--CA 1.442 -0.926 0 CA-C-N 113.465 -1.698 . . . . 0.0 110.26 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.479 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 46.1 mm-40 -96.72 101.64 13.28 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.258 0.551 . . . . 0.0 110.973 178.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 3.0 t -79.45 136.77 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 CA-C-N 115.25 -0.886 . . . . 0.0 108.814 178.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.419 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 6.1 tp10 -88.45 -56.56 3.26 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 3.4 m -166.29 150.37 7.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.342 0.591 . . . . 0.0 112.436 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.63 HG21 HG12 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -118.38 126.45 75.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.466 178.593 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.473 ' O ' ' HD3' ' A' ' 214' ' ' PRO . 0.5 OUTLIER -123.24 102.86 8.18 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -178.905 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -97.18 105.13 22.5 Favored Pre-proline 0 C--N 1.33 -0.257 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 177.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.543 ' HB2' ' CZ ' ' A' ' 223' ' ' ARG . 6.3 Cg_exo -76.88 139.93 20.02 Favored 'Trans proline' 0 N--CA 1.465 -0.193 0 C-N-CA 123.022 2.481 . . . . 0.0 112.884 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.82 130.73 40.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.229 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.455 ' O ' ' OD1' ' A' ' 220' ' ' ASN . 0.7 OUTLIER -101.31 106.62 17.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.838 0.352 . . . . 0.0 111.132 -179.716 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -83.14 -21.31 33.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.366 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 7.4 mttm -66.02 -51.99 53.25 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.44 -179.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.448 ' O ' ' O ' ' A' ' 220' ' ' ASN . 11.9 t -150.24 14.88 0.8 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.199 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . 0.455 ' OD1' ' O ' ' A' ' 216' ' ' ASP . 2.5 m120 37.7 96.76 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.241 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . 0.469 ' HB3' ' HG2' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -78.13 174.22 11.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.415 179.407 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.6 ' CD ' ' O ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -88.47 16.48 6.43 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 122.197 0.998 . . . . 0.0 109.609 179.242 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.611 ' O ' ' CD1' ' A' ' 225' ' ' PHE . 0.1 OUTLIER -71.71 -11.02 60.62 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.269 178.469 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . 0.481 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . -23.67 82.46 0.0 OUTLIER Glycine 0 C--N 1.346 1.093 0 O-C-N 123.899 0.749 . . . . 0.0 112.232 179.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.618 ' CE1' H5'' ' B' ' 4' ' ' ' DG' . 0.1 OUTLIER -157.47 176.93 12.01 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.024 -0.588 . . . . 0.0 109.986 -177.879 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . 0.476 ' O ' ' HB ' ' A' ' 186' ' ' VAL . 1.6 p -138.66 147.43 42.82 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.138 -0.625 . . . . 0.0 112.389 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.675 ' CE2' ' CB ' ' A' ' 257' ' ' ALA . 4.6 m-85 -107.44 133.49 51.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.161 178.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.677 HD13 ' CD2' ' A' ' 202' ' ' PHE . 1.8 mt -128.06 133.0 68.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.13 0.49 . . . . 0.0 111.686 -179.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.455 ' OG1' ' NZ ' ' A' ' 183' ' ' LYS . 40.8 m -113.44 137.99 50.73 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.51 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.647 ' CE1' ' CB ' ' A' ' 235' ' ' PRO . 75.4 m-85 -113.62 126.3 55.12 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.298 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.483 ' O ' ' NZ ' ' A' ' 182' ' ' LYS . 0.3 OUTLIER -47.94 -39.19 18.51 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 178.051 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . 0.454 ' O ' ' HD3' ' A' ' 182' ' ' LYS . 0.0 OUTLIER -91.47 -166.05 1.48 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 113.443 -1.708 . . . . 0.0 110.036 179.119 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . 0.503 ' HB3' ' HG2' ' A' ' 182' ' ' LYS . 0.6 OUTLIER -133.7 13.88 4.04 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.51 -179.92 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.566 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.3 OUTLIER -85.14 -59.52 0.32 Allowed Pre-proline 0 N--CA 1.452 -0.37 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 179.752 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.647 ' CB ' ' CE1' ' A' ' 230' ' ' PHE . 83.4 Cg_exo -49.9 -31.0 25.39 Favored 'Trans proline' 0 CA--C 1.5 -1.214 0 N-CA-C 108.888 -1.235 . . . . 0.0 108.888 177.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.599 HG22 ' CD2' ' A' ' 230' ' ' PHE . 14.7 t -72.74 -45.16 57.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 113.892 -1.504 . . . . 0.0 110.179 179.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . 0.566 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 1.6 ptpt -62.81 -36.36 82.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.721 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 0.0 OUTLIER -81.62 -50.3 9.49 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.903 0.382 . . . . 0.0 110.92 179.194 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.724 HG13 ' CE2' ' A' ' 205' ' ' PHE . 1.6 mt -46.33 -49.84 5.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.54 -179.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' MET . . . . . 0.457 ' HG3' ' O ' ' A' ' 236' ' ' VAL . 15.4 mtp -60.27 -28.33 67.98 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.877 -178.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.531 ' CG ' ' O ' ' A' ' 237' ' ' LYS . 0.0 OUTLIER -88.67 -9.67 51.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.752 0.31 . . . . 0.0 110.976 -179.927 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' A' ' 238' ' ' LYS . 4.5 mmmm -79.81 116.19 19.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.363 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.503 ' HG2' ' N ' ' A' ' 244' ' ' TYR . 5.0 ttpt -39.98 -74.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.56 ' CE1' ' HG3' ' A' ' 253' ' ' GLU . 21.6 m-85 -129.09 151.49 49.72 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.399 179.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' HIS . . . . . 0.623 ' CG ' ' CD1' ' A' ' 254' ' ' ILE . 45.0 m-70 -105.65 149.14 26.61 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.376 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . 0.414 ' ND2' ' N ' ' A' ' 246' ' ' ASN . 0.0 OUTLIER -123.55 105.4 9.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.543 179.503 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.511 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.8 t -110.05 116.55 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.961 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 41.16 -90.67 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.676 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.511 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.1 OUTLIER -105.03 -35.99 7.46 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.747 0.784 . . . . 0.0 109.914 -179.538 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' SER . . . . . 0.493 ' OG ' HG23 ' A' ' 193' ' ' THR . 0.8 OUTLIER -77.87 153.61 32.5 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.317 -1.311 . . . . 0.0 112.633 -178.363 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.467 ' HD3' ' O ' ' A' ' 249' ' ' LEU . 0.0 OUTLIER -148.18 104.81 3.57 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.868 -1.06 . . . . 0.0 108.545 178.942 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' CYS . . . . . 0.55 ' HB2' ' CG1' ' A' ' 186' ' ' VAL . 0.0 OUTLIER -127.59 152.32 47.8 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -177.074 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . 0.56 ' HG3' ' CE1' ' A' ' 244' ' ' TYR . 29.3 tt0 -77.17 110.05 11.54 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.047 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . 0.623 ' CD1' ' CG ' ' A' ' 245' ' ' HIS . 25.3 mt -96.52 111.29 26.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 -178.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.514 ' O ' ' C ' ' A' ' 256' ' ' VAL . 0.0 OUTLIER -115.72 132.28 56.68 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 176.439 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . 0.559 ' CG2' ' O ' ' A' ' 183' ' ' LYS . 5.2 p -32.8 121.78 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 CA-C-O 122.254 1.025 . . . . 0.0 111.356 -177.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.675 ' CB ' ' CE2' ' A' ' 227' ' ' PHE . . . -76.54 153.91 35.01 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 113.315 -1.766 . . . . 0.0 111.774 -178.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 2.0 mtm -128.81 113.6 15.49 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.761 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 86.9 p . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.537 179.898 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' ' DT' . . . . . 0.768 ' O2 ' " H2'" ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.428 -0.766 0 C1'-O4'-C4' 110.27 0.407 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' ' DA' . . . . . 0.572 H5'' ' CE1' ' A' ' 225' ' ' PHE . . . . . . . . 0 O5'--C5' 1.426 -0.899 0 C3'-C2'-C1' 104.965 1.618 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' ' DG' . . . . . 0.671 ' N1 ' ' CZ ' ' A' ' 227' ' ' PHE . . . . . . . . 0 O5'--C5' 1.426 -0.856 0 C4'-C3'-C2' 101.304 -1.896 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' ' DG' . . . . . 0.511 ' N7 ' ' C5 ' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.426 -0.872 0 O4'-C1'-N19 108.214 0.517 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.536 HG13 ' N ' ' A' ' 182' ' ' LYS . 55.6 t . . . . . 0 CA--C 1.502 -0.865 0 CA-C-O 121.377 0.608 . . . . 0.0 111.961 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.536 ' N ' HG13 ' A' ' 181' ' ' VAL . 0.0 OUTLIER -148.0 112.57 5.33 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.928 177.467 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.651 ' HD3' ' HB1' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -130.96 137.47 49.27 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.382 179.436 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.655 HG12 ' HB ' ' A' ' 228' ' ' ILE . 0.5 OUTLIER -119.67 120.73 64.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.814 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.703 ' CE2' ' CE2' ' A' ' 225' ' ' PHE . 0.3 OUTLIER -94.57 109.56 21.45 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.242 0.544 . . . . 0.0 111.003 -178.597 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.585 ' CG1' HG12 ' A' ' 254' ' ' ILE . 2.3 t -87.44 114.11 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.564 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.56 ' O ' ' N ' ' A' ' 253' ' ' GLU . . . -101.33 130.35 10.2 Favored Glycine 0 C--O 1.227 -0.288 0 N-CA-C 115.081 0.793 . . . . 0.0 115.081 -177.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.457 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . 78.36 79.73 0.75 Allowed Glycine 0 C--N 1.331 0.271 0 C-N-CA 121.01 -0.614 . . . . 0.0 113.472 178.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.519 ' CB ' ' SG ' ' A' ' 252' ' ' CYS . 0.6 OUTLIER -117.69 157.56 26.26 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.693 0.282 . . . . 0.0 111.016 -179.916 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.585 ' CB ' ' CD ' ' A' ' 191' ' ' PRO . 0.1 OUTLIER -48.5 -173.48 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.792 179.305 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.585 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 5.5 Cg_exo -77.59 15.96 1.16 Allowed 'Trans proline' 0 CA--C 1.531 0.36 0 C-N-CA 122.965 2.444 . . . . 0.0 113.409 -179.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.553 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 0.6 OUTLIER 157.58 78.19 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.667 0.27 . . . . 0.0 111.482 179.84 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.592 ' CG2' ' CD1' ' A' ' 198' ' ' ILE . 76.1 m -71.89 115.44 38.14 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.095 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.573 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 21.0 Cg_endo -61.02 112.31 1.33 Allowed 'Trans proline' 0 C--N 1.332 -0.325 0 C-N-CA 122.226 1.95 . . . . 0.0 111.519 178.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.794 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -50.63 -14.92 0.22 Allowed 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.872 -179.668 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . 0.478 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 9.3 mm-40 -66.94 -40.32 87.52 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -179.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.573 ' CD ' ' HG2' ' A' ' 194' ' ' PRO . 1.4 mttp -75.29 -46.42 33.61 Favored 'General case' 0 CA--C 1.498 -1.055 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.794 ' CG1' ' HA ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -47.74 -32.11 2.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.003 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.579 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 9.6 mtp180 -69.48 -33.48 72.94 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.091 178.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . 0.528 ' N ' ' O ' ' A' ' 197' ' ' LYS . 9.3 mm-40 -82.47 -59.06 2.66 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.207 0.527 . . . . 0.0 110.206 178.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.533 ' OH ' ' ND1' ' A' ' 245' ' ' HIS . 0.2 OUTLIER -48.76 -54.67 14.07 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.797 179.005 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.661 ' O ' ' HB2' ' A' ' 205' ' ' PHE . 0.2 OUTLIER -79.57 -30.69 41.74 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.376 -179.864 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.579 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -62.7 -57.1 17.64 Favored Glycine 0 CA--C 1.499 -0.931 0 N-CA-C 107.036 -2.426 . . . . 0.0 107.036 176.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -48.62 -29.33 7.6 Favored Glycine 0 N--CA 1.441 -1.022 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 176.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . 0.732 ' CE2' HG13 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -58.22 -43.45 87.71 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 177.764 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.491 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 169.06 -130.81 2.14 Favored Glycine 0 N--CA 1.441 -1.02 0 CA-C-N 113.725 -1.579 . . . . 0.0 110.423 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.486 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 4.3 mt-10 -96.97 101.31 12.86 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.208 0.528 . . . . 0.0 111.027 178.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 2.9 t -78.77 138.22 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 178.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.487 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 13.7 tp10 -91.46 -57.62 2.71 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.616 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 25.1 p -157.7 154.95 29.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.285 0.565 . . . . 0.0 112.207 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.619 ' CD1' ' HB ' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -129.64 124.3 59.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.411 179.516 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.505 ' O ' ' HD3' ' A' ' 214' ' ' PRO . 0.0 OUTLIER -123.15 112.96 18.34 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -179.093 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 193' ' ' THR . 1.7 mm? -96.27 105.16 20.36 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-O 120.836 0.35 . . . . 0.0 111.424 178.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.632 ' HD2' ' O ' ' A' ' 225' ' ' PHE . 65.6 Cg_exo -48.45 -159.99 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 123.672 2.915 . . . . 0.0 113.286 179.217 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' MET . . . . . 0.492 ' SD ' ' ND2' ' A' ' 220' ' ' ASN . 0.0 OUTLIER -107.57 173.32 6.37 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.15 179.861 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -109.14 150.13 28.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.618 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . 0.533 ' N ' ' O ' ' A' ' 221' ' ' LYS . 2.1 t30 -56.77 -14.76 3.64 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.171 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 29.9 mttp -62.79 -27.85 69.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.119 0.485 . . . . 0.0 109.929 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 2.3 t -146.99 13.31 1.13 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.718 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . 0.492 ' ND2' ' SD ' ' A' ' 215' ' ' MET . 6.4 m120 -149.27 -91.75 0.07 Allowed 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 120.751 0.31 . . . . 0.0 111.653 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . 0.535 ' CD ' ' NH2' ' A' ' 223' ' ' ARG . 0.7 OUTLIER -154.18 172.07 18.17 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.27 -179.815 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.651 ' O ' ' CG ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -85.94 39.57 0.81 Allowed 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 122.673 1.225 . . . . 0.0 110.802 -179.431 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.586 ' CB ' H5'' ' B' ' 3' ' ' ' DA' . 8.7 ptp85 -71.46 -31.02 66.69 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 177.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . 0.51 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 16.01 64.18 0.01 OUTLIER Glycine 0 C--N 1.336 0.577 0 CA-C-N 114.501 -1.227 . . . . 0.0 113.052 178.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.715 ' CE1' H5'' ' B' ' 4' ' ' ' DG' . 5.0 p90 -156.42 176.26 12.93 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -179.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . 0.531 ' CB ' HD12 ' A' ' 213' ' ' LEU . 7.2 p -143.87 154.89 43.83 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -179.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.697 ' CE1' ' C2 ' ' B' ' 4' ' ' ' DG' . 6.1 m-85 -107.14 153.48 22.6 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.138 178.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.655 ' HB ' HG12 ' A' ' 184' ' ' ILE . 2.4 mt -147.87 135.11 13.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.869 0.366 . . . . 0.0 110.841 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.536 ' OG1' ' NZ ' ' A' ' 183' ' ' LYS . 92.3 m -117.35 138.41 51.8 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.637 ' CE1' ' CB ' ' A' ' 235' ' ' PRO . 70.6 m-85 -111.89 126.25 54.9 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.564 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.487 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -49.55 -38.78 32.24 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 177.829 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . 0.482 ' O ' ' HD3' ' A' ' 182' ' ' LYS . 22.4 mt-10 -90.41 -171.49 3.1 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 113.276 -1.784 . . . . 0.0 109.019 178.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . 0.524 ' O ' ' HG3' ' A' ' 237' ' ' LYS . 0.0 OUTLIER -127.47 0.5 6.26 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.55 179.965 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.485 ' O ' ' N ' ' A' ' 237' ' ' LYS . 0.2 OUTLIER -73.45 -57.61 2.63 Favored Pre-proline 0 C--N 1.329 -0.294 0 N-CA-C 112.0 0.371 . . . . 0.0 112.0 -179.075 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.637 ' CB ' ' CE1' ' A' ' 230' ' ' PHE . 99.8 Cg_exo -49.24 -32.97 26.78 Favored 'Trans proline' 0 CA--C 1.498 -1.3 0 C-N-CA 121.124 1.216 . . . . 0.0 108.985 178.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.587 HG22 ' CD2' ' A' ' 230' ' ' PHE . 19.5 t -70.84 -41.62 77.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 113.646 -1.615 . . . . 0.0 109.189 178.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . 0.524 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 23.5 mttm -57.18 -45.27 83.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.83 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.481 ' O ' ' HG3' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -81.03 -50.38 9.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.313 -179.396 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.732 HG13 ' CE2' ' A' ' 205' ' ' PHE . 1.4 mt -41.78 -51.42 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.99 -179.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' MET . . . . . 0.455 ' SD ' HG13 ' A' ' 236' ' ' VAL . 4.9 mtp -64.23 -19.37 65.32 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.43 -178.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.481 ' HG3' ' O ' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -86.78 -22.1 26.12 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.063 0.458 . . . . 0.0 110.666 -179.916 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -78.49 118.26 20.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.667 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.424 ' HD3' ' CD2' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -48.68 -49.86 35.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.611 179.911 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.54 ' CE1' ' HG3' ' A' ' 253' ' ' GLU . 17.2 m-85 -138.74 163.91 30.96 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.945 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' HIS . . . . . 0.644 ' CG ' ' CD1' ' A' ' 254' ' ' ILE . 31.6 m-70 -125.07 156.05 38.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.028 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . 0.47 ' HA ' ' HA ' ' A' ' 251' ' ' LYS . 0.0 OUTLIER -137.99 105.08 5.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.093 0.473 . . . . 0.0 110.057 178.768 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.527 ' N ' ' O ' ' A' ' 250' ' ' SER . 1.8 t -103.09 106.7 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.424 -178.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 54.84 -81.22 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.482 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.527 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -114.38 -39.23 3.88 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.424 0.631 . . . . 0.0 110.346 -179.983 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' SER . . . . . 0.527 ' O ' ' N ' ' A' ' 247' ' ' VAL . 0.2 OUTLIER -77.42 153.24 33.82 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.736 -178.952 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -145.12 108.7 4.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.408 -0.815 . . . . 0.0 108.869 179.143 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' CYS . . . . . 0.571 ' HB2' ' CG1' ' A' ' 186' ' ' VAL . 0.0 OUTLIER -128.3 153.3 47.15 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -176.951 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . 0.56 ' N ' ' O ' ' A' ' 187' ' ' GLY . 39.0 tt0 -76.03 107.22 8.08 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.978 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . 0.644 ' CD1' ' CG ' ' A' ' 245' ' ' HIS . 23.5 mt -95.76 113.7 30.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -178.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.519 ' O ' ' C ' ' A' ' 256' ' ' VAL . 0.0 OUTLIER -118.84 133.2 56.0 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 176.608 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . 0.537 ' CG2' ' O ' ' A' ' 183' ' ' LYS . 6.8 p -33.37 123.8 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 CA-C-O 122.252 1.025 . . . . 0.0 111.294 -177.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.663 ' CB ' ' CE2' ' A' ' 227' ' ' PHE . . . -76.01 153.36 36.55 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 113.337 -1.756 . . . . 0.0 111.444 -178.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.33 113.54 15.09 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.52 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' SER . . . . . 0.477 ' OG ' ' O6 ' ' B' ' 4' ' ' ' DG' . 0.1 OUTLIER . . . . . 0 C--N 1.323 -0.559 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.995 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' ' DT' . . . . . 0.885 ' O2 ' " H2'" ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O4'--C1' 1.409 -0.868 0 C3'-C2'-C1' 104.752 1.465 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' ' DA' . . . . . 0.998 " H4'" " O5'" ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.426 -0.9 0 O4'-C1'-C2' 106.721 0.565 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' ' DG' . . . . . 0.998 " O5'" " H4'" ' B' ' 3' ' ' ' DA' . . . . . . . . 0 C4'--C3' 1.52 -0.76 0 C4'-C3'-C2' 101.83 -1.37 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' ' DG' . . . . . 0.713 ' N7 ' ' C5 ' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 C2'--C1' 1.509 -0.828 0 C3'-C2'-C1' 101.461 -0.885 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.531 HG11 ' N ' ' A' ' 182' ' ' LYS . 55.0 t . . . . . 0 CA--C 1.502 -0.871 0 CA-C-O 121.099 0.476 . . . . 0.0 111.356 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.533 ' HB2' ' CG2' ' A' ' 236' ' ' VAL . 0.0 OUTLIER -155.0 112.43 3.37 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.328 177.601 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.587 ' HD3' ' HB1' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -136.68 144.13 43.77 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 115.113 -0.948 . . . . 0.0 109.345 178.84 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.636 HG12 ' HB ' ' A' ' 228' ' ' ILE . 0.2 OUTLIER -123.9 120.07 58.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.827 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.711 ' CE2' ' C4 ' ' B' ' 3' ' ' ' DA' . 0.9 OUTLIER -91.03 109.39 20.63 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.434 0.635 . . . . 0.0 109.748 -179.709 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.559 ' CG1' ' HB2' ' A' ' 252' ' ' CYS . 4.1 t -88.75 104.9 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.484 -179.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 253' ' ' GLU . . . -92.82 127.39 8.97 Favored Glycine 0 C--O 1.228 -0.28 0 CA-C-N 115.165 -0.925 . . . . 0.0 115.065 -177.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.608 ' HA3' ' C5 ' ' B' ' 2' ' ' ' DT' . . . 83.29 81.43 0.97 Allowed Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.893 -0.67 . . . . 0.0 113.531 178.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.525 HD12 ' N ' ' A' ' 190' ' ' SER . 0.6 OUTLIER -117.26 156.96 26.86 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.803 0.335 . . . . 0.0 110.865 179.68 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.548 ' CB ' ' HD2' ' A' ' 191' ' ' PRO . 0.2 OUTLIER -46.52 -178.16 0.01 OUTLIER Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.812 179.811 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.548 ' HD2' ' CB ' ' A' ' 190' ' ' SER . 72.1 Cg_endo -78.79 17.59 1.12 Allowed 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.563 2.175 . . . . 0.0 113.092 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.528 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 0.6 OUTLIER 159.86 66.17 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.497 0.189 . . . . 0.0 111.392 179.749 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.551 ' O ' ' CD1' ' A' ' 213' ' ' LEU . 94.9 m -69.8 127.37 92.58 Favored Pre-proline 0 CA--C 1.518 -0.271 0 CA-C-O 120.963 0.411 . . . . 0.0 110.69 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.585 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 71.1 Cg_endo -71.15 109.49 2.58 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.378 2.052 . . . . 0.0 111.146 178.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.788 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -48.29 -14.07 0.05 Allowed 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -179.77 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . 0.513 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 2.9 mt-10 -67.44 -41.05 85.37 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.585 ' CD ' ' HG2' ' A' ' 194' ' ' PRO . 1.6 mttp -73.22 -46.87 47.84 Favored 'General case' 0 CA--C 1.503 -0.854 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.788 ' CG1' ' HA ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -47.5 -29.94 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.978 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 177.947 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.531 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 7.5 mtt180 -72.96 -32.69 65.38 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.294 178.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . 0.572 ' CG ' ' N ' ' A' ' 201' ' ' TYR . 3.6 pt-20 -83.0 -55.35 4.43 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.01 0.433 . . . . 0.0 110.337 179.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.572 ' N ' ' CG ' ' A' ' 200' ' ' GLU . 0.3 OUTLIER -50.01 -53.31 27.54 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.575 0.702 . . . . 0.0 109.511 178.761 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.657 ' HB3' ' CZ ' ' A' ' 230' ' ' PHE . 0.3 OUTLIER -79.64 -30.91 41.47 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.2 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.531 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -62.41 -56.72 20.14 Favored Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 107.048 -2.421 . . . . 0.0 107.048 176.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -50.67 -28.13 14.79 Favored Glycine 0 N--CA 1.443 -0.895 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 176.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . 0.722 ' CE2' HG13 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -58.48 -43.9 89.13 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 177.805 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.502 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 170.69 -131.5 2.24 Favored Glycine 0 N--CA 1.441 -1.007 0 CA-C-N 113.615 -1.629 . . . . 0.0 110.271 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.489 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 2.1 mm-40 -97.1 100.82 12.3 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.238 0.542 . . . . 0.0 110.946 178.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 2.5 t -78.69 140.5 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.13 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.011 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.527 ' CG ' HG23 ' A' ' 229' ' ' THR . 7.4 tp10 -89.53 -53.49 4.51 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 178.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.466 ' HB3' ' OE2' ' A' ' 212' ' ' GLU . 0.4 OUTLIER -170.89 156.69 5.09 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.451 179.256 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.618 HG23 HG12 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -125.1 117.28 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.611 179.375 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.487 ' N ' ' CD ' ' A' ' 212' ' ' GLU . 0.5 OUTLIER -123.5 104.43 9.06 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -179.422 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.584 ' N ' ' CD2' ' A' ' 213' ' ' LEU . 0.1 OUTLIER -96.73 106.1 27.92 Favored Pre-proline 0 CA--C 1.533 0.31 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 179.207 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.593 ' CB ' " C4'" ' B' ' 4' ' ' ' DG' . 4.7 Cg_exo -79.65 135.28 11.47 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.121 2.548 . . . . 0.0 112.535 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 70.3 mtm -135.36 133.55 38.86 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.904 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.505 ' OD2' ' CG2' ' A' ' 219' ' ' THR . 0.7 OUTLIER -115.32 105.71 13.18 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.907 0.384 . . . . 0.0 110.936 179.781 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -84.73 -22.18 29.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.949 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 6.6 mttt -90.47 -51.7 5.28 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.505 ' CG2' ' OD2' ' A' ' 216' ' ' ASP . 3.4 t -90.78 -13.43 33.96 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -178.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . 0.411 ' C ' ' O ' ' A' ' 219' ' ' THR . 89.7 m-20 38.06 66.29 0.5 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.787 0.327 . . . . 0.0 110.812 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . 0.537 ' CD ' ' HB3' ' A' ' 223' ' ' ARG . 0.2 OUTLIER -95.01 31.45 1.87 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.032 0.444 . . . . 0.0 110.753 179.931 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.42 ' HD2' ' HA ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER 44.85 36.28 1.81 Allowed 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.179 -179.415 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.559 ' CD ' ' OP2' ' B' ' 5' ' ' ' DG' . 0.2 OUTLIER -87.83 17.33 4.9 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.684 178.794 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . 0.475 ' O ' ' HG ' ' A' ' 189' ' ' LEU . . . -67.25 61.32 0.25 Allowed Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 178.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.689 ' CE2' ' CE2' ' A' ' 185' ' ' PHE . 15.9 p90 -135.75 177.2 8.01 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -178.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . 0.532 ' CB ' HD22 ' A' ' 213' ' ' LEU . 1.5 p -135.9 149.69 49.07 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -178.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.7 ' CE2' ' C2 ' ' B' ' 4' ' ' ' DG' . 3.9 m-85 -106.08 132.58 51.98 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.651 HD12 ' CD2' ' A' ' 202' ' ' PHE . 1.8 mt -128.61 118.54 47.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.292 0.567 . . . . 0.0 111.472 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.527 HG23 ' CG ' ' A' ' 209' ' ' GLU . 22.1 m -101.58 138.03 39.12 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.562 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.657 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 74.4 m-85 -114.87 126.46 54.83 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.095 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.489 ' HG3' ' O ' ' A' ' 207' ' ' GLU . 0.0 OUTLIER -48.17 -39.13 19.87 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 177.992 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . 0.483 ' O ' ' HG3' ' A' ' 182' ' ' LYS . 3.1 mt-10 -98.81 165.22 11.88 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 113.413 -1.721 . . . . 0.0 109.478 178.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . 0.473 ' HA ' HG22 ' A' ' 236' ' ' VAL . 0.9 OUTLIER -106.14 19.64 20.21 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -179.393 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.541 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.7 OUTLIER -85.34 -61.44 0.27 Allowed Pre-proline 0 C--N 1.334 -0.086 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.955 179.67 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.617 ' CB ' ' CE1' ' A' ' 230' ' ' PHE . 85.5 Cg_exo -49.51 -29.53 18.85 Favored 'Trans proline' 0 CA--C 1.499 -1.256 0 N-CA-C 108.88 -1.238 . . . . 0.0 108.88 177.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.612 HG23 ' CD2' ' A' ' 230' ' ' PHE . 12.9 t -73.31 -46.15 50.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 113.786 -1.552 . . . . 0.0 110.719 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . 0.541 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 13.6 pttt -59.94 -37.18 78.8 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.42 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.621 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.6 OUTLIER -80.75 -56.1 4.37 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.201 0.524 . . . . 0.0 110.753 178.858 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.722 HG13 ' CE2' ' A' ' 205' ' ' PHE . 1.6 mt -39.28 -47.74 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.605 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' MET . . . . . 0.456 ' SD ' ' O ' ' A' ' 236' ' ' VAL . 3.8 mtp -62.63 -27.7 69.39 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.782 -178.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.479 ' CG ' ' O ' ' A' ' 237' ' ' LYS . 1.8 mt-10 -83.41 -24.92 31.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.631 0.253 . . . . 0.0 111.553 -179.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.568 ' HD3' ' CE1' ' A' ' 245' ' ' HIS . 0.8 OUTLIER -79.22 109.31 13.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.019 0.437 . . . . 0.0 111.118 -179.461 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.479 ' HD2' ' CE2' ' A' ' 244' ' ' TYR . 0.6 OUTLIER -35.49 -61.19 0.46 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.094 -179.747 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.558 ' CE1' ' HG3' ' A' ' 253' ' ' GLU . 44.5 m-85 -129.28 167.72 17.28 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.583 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' HIS . . . . . 0.591 ' CG ' ' CD1' ' A' ' 254' ' ' ILE . 38.1 m-70 -128.47 153.36 47.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.758 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -127.93 105.57 8.51 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.001 0.429 . . . . 0.0 111.031 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.551 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.5 t -106.36 107.91 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.241 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 44.06 -86.67 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.582 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -101.41 -41.37 6.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.256 0.55 . . . . 0.0 110.829 179.75 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' SER . . . . . 0.479 ' HB3' ' HB2' ' A' ' 190' ' ' SER . 5.2 p -78.34 155.79 29.9 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.363 -0.835 . . . . 0.0 113.096 -178.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.1 OUTLIER -147.47 105.86 3.78 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 114.365 -1.288 . . . . 0.0 107.868 178.473 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' CYS . . . . . 0.559 ' HB2' ' CG1' ' A' ' 186' ' ' VAL . 0.0 OUTLIER -127.52 153.32 46.49 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -176.199 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . 0.558 ' HG3' ' CE1' ' A' ' 244' ' ' TYR . 40.6 tt0 -76.21 107.03 8.16 Favored 'General case' 0 C--O 1.22 -0.464 0 CA-C-N 114.832 -1.076 . . . . 0.0 110.607 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . 0.618 ' CG2' ' CG2' ' A' ' 239' ' ' ILE . 22.2 mt -95.62 111.85 26.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -178.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.526 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -116.42 130.24 56.65 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 113.349 -1.751 . . . . 0.0 106.327 177.035 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . 0.547 ' CG2' ' O ' ' A' ' 183' ' ' LYS . 4.2 p -32.75 123.01 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.488 0 CA-C-O 122.265 1.031 . . . . 0.0 111.341 -177.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.655 ' CB ' ' CE1' ' A' ' 227' ' ' PHE . . . -76.31 153.98 35.44 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 113.39 -1.732 . . . . 0.0 110.974 -178.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.56 113.4 14.19 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.717 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' SER . . . . . 0.498 ' OG ' ' O6 ' ' B' ' 4' ' ' ' DG' . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.504 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.854 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' ' DT' . . . . . 0.615 ' O2 ' " H2'" ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.427 -0.82 0 C1'-O4'-C4' 110.625 0.66 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' ' DA' . . . . . 1.008 " H4'" " O5'" ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.424 -0.996 0 C3'-C2'-C1' 101.132 -1.12 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' ' DG' . . . . . 1.008 " O5'" " H4'" ' B' ' 3' ' ' ' DA' . . . . . . . . 0 O5'--C5' 1.427 -0.82 0 C4'-C3'-C2' 101.323 -1.877 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' ' DG' . . . . . 0.661 ' N7 ' ' C8 ' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.428 -0.773 0 O4'-C1'-C2' 106.847 0.679 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.532 HG13 ' N ' ' A' ' 182' ' ' LYS . 47.4 t . . . . . 0 CA--C 1.504 -0.808 0 CA-C-O 121.338 0.59 . . . . 0.0 111.608 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.532 ' N ' HG13 ' A' ' 181' ' ' VAL . 0.0 OUTLIER -149.98 112.54 4.74 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.934 177.452 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.643 ' HD3' ' HB3' ' A' ' 257' ' ' ALA . 0.0 OUTLIER -133.21 141.78 48.25 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.444 179.254 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.645 HG12 ' HB ' ' A' ' 228' ' ' ILE . 0.5 OUTLIER -120.8 120.63 63.01 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 178.735 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.602 ' CE2' ' OP2' ' B' ' 3' ' ' ' DA' . 0.2 OUTLIER -93.35 109.32 20.87 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.29 0.567 . . . . 0.0 110.327 -179.172 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.565 ' O ' ' HB2' ' A' ' 225' ' ' PHE . 11.7 t -85.9 120.0 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.753 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.55 ' O ' ' N ' ' A' ' 253' ' ' GLU . . . -109.87 131.4 10.45 Favored Glycine 0 C--N 1.331 0.265 0 N-CA-C 115.221 0.849 . . . . 0.0 115.221 -176.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.598 ' HA3' ' C6 ' ' B' ' 2' ' ' ' DT' . . . 76.41 79.44 0.65 Allowed Glycine 0 C--N 1.331 0.255 0 C-N-CA 121.378 -0.439 . . . . 0.0 113.334 178.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.539 HD13 ' N ' ' A' ' 190' ' ' SER . 0.6 OUTLIER -117.54 157.48 26.26 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.605 0.241 . . . . 0.0 111.049 -179.776 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.597 ' CB ' ' CD ' ' A' ' 191' ' ' PRO . 0.2 OUTLIER -46.88 -175.3 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.203 0 CA-C-O 121.046 0.45 . . . . 0.0 111.58 179.92 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.597 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 13.2 Cg_exo -70.59 6.35 1.63 Allowed 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 123.319 2.68 . . . . 0.0 113.721 -179.119 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.54 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 3.5 m-20 159.6 78.76 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.153 0.502 . . . . 0.0 110.834 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.577 HG21 ' CD1' ' A' ' 198' ' ' ILE . 52.8 m -71.01 116.0 42.02 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.999 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.564 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 20.5 Cg_endo -58.16 110.54 0.66 Allowed 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.319 2.013 . . . . 0.0 111.127 178.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.793 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.4 OUTLIER -50.77 -14.98 0.23 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.524 -179.56 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . 0.47 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 74.1 mt-10 -65.15 -41.14 95.0 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -179.28 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.564 ' CD ' ' HG2' ' A' ' 194' ' ' PRO . 1.4 mttp -73.79 -48.07 34.24 Favored 'General case' 0 CA--C 1.498 -1.048 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.793 ' CG1' ' HA ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -47.69 -31.85 2.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.207 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.534 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 2.3 mtp-105 -69.82 -33.31 72.15 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.083 178.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . 0.514 ' N ' ' O ' ' A' ' 197' ' ' LYS . 7.9 mt-10 -82.49 -58.5 2.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.244 0.545 . . . . 0.0 110.095 178.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.555 ' CD1' ' CD1' ' A' ' 202' ' ' PHE . 0.2 OUTLIER -49.02 -53.54 19.65 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.677 178.895 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.675 ' O ' ' HB2' ' A' ' 205' ' ' PHE . 0.1 OUTLIER -79.74 -31.39 41.02 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.583 -179.787 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.534 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -62.77 -55.25 28.02 Favored Glycine 0 CA--C 1.5 -0.896 0 N-CA-C 107.051 -2.42 . . . . 0.0 107.051 176.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -50.25 -27.6 11.58 Favored Glycine 0 N--CA 1.444 -0.815 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 176.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . 0.728 ' CE2' HG13 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -59.2 -47.76 84.14 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 122.137 0.97 . . . . 0.0 108.528 177.984 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.493 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 176.5 -132.29 2.04 Favored Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 113.602 -1.635 . . . . 0.0 110.172 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.47 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 2.2 mt-10 -97.19 99.87 11.35 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.142 0.496 . . . . 0.0 111.128 178.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 2.7 t -76.17 138.71 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.47 ' HB3' HG23 ' A' ' 229' ' ' THR . 3.7 tp10 -92.45 -54.66 3.7 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.062 178.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 3.3 m -161.5 151.92 17.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.248 0.547 . . . . 0.0 112.272 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.629 ' CD1' ' HB ' ' A' ' 198' ' ' ILE . 0.1 OUTLIER -126.39 119.19 53.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.809 179.037 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.476 ' O ' ' HD3' ' A' ' 214' ' ' PRO . 0.1 OUTLIER -123.46 103.71 8.63 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -177.895 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.527 ' CD1' ' O ' ' A' ' 193' ' ' THR . 0.0 OUTLIER -96.03 105.75 23.72 Favored Pre-proline 0 CA--C 1.531 0.225 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 176.84 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.582 ' HD2' ' O ' ' A' ' 225' ' ' PHE . 5.2 Cg_exo -77.63 131.77 11.63 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 123.041 2.494 . . . . 0.0 112.863 -178.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 2.8 ptm -132.12 130.57 41.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.027 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.479 ' O ' ' HA ' ' A' ' 220' ' ' ASN . 0.5 OUTLIER -110.94 106.73 15.94 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.866 0.365 . . . . 0.0 111.188 -179.577 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -81.9 -6.81 59.41 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.677 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 3.9 mttt -82.71 -48.82 10.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.158 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -127.8 -5.43 5.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.602 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . 0.479 ' HA ' ' O ' ' A' ' 216' ' ' ASP . 17.0 m120 40.58 61.03 1.73 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.823 0.344 . . . . 0.0 110.884 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.25 176.78 0.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.757 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.618 ' O ' ' CG ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -93.78 23.26 4.89 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 122.343 1.068 . . . . 0.0 109.792 179.755 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.589 ' O ' ' CD1' ' A' ' 225' ' ' PHE . 8.8 ptp85 -70.39 -31.64 68.96 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . 0.562 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 0.92 70.92 0.0 OUTLIER Glycine 0 C--N 1.341 0.818 0 O-C-N 124.322 1.013 . . . . 0.0 112.542 178.497 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.634 ' CD2' ' OP2' ' B' ' 3' ' ' ' DA' . 0.5 OUTLIER -156.21 177.06 11.87 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.407 -0.396 . . . . 0.0 110.095 -177.852 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . 0.476 ' O ' ' HB ' ' A' ' 186' ' ' VAL . 1.7 p -138.59 155.17 48.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.367 0.603 . . . . 0.0 112.609 -179.014 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.666 ' CE2' ' CB ' ' A' ' 257' ' ' ALA . 4.6 m-85 -111.17 133.3 53.63 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.338 178.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.653 HD13 ' CD2' ' A' ' 202' ' ' PHE . 2.0 mt -128.33 120.48 53.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.293 0.568 . . . . 0.0 111.679 -179.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.47 HG23 ' HB3' ' A' ' 209' ' ' GLU . 73.6 m -103.44 138.1 40.63 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.404 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.683 ' CE1' ' CB ' ' A' ' 235' ' ' PRO . 82.7 m-85 -114.12 126.59 55.26 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.514 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.47 ' HG3' ' O ' ' A' ' 207' ' ' GLU . 0.0 OUTLIER -49.19 -38.53 26.22 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 177.914 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . 0.456 ' O ' ' HD3' ' A' ' 182' ' ' LYS . 2.0 mm-40 -90.85 -166.79 1.66 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 113.42 -1.718 . . . . 0.0 109.923 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . 0.483 ' HA ' HG21 ' A' ' 236' ' ' VAL . 0.6 OUTLIER -132.64 13.09 4.47 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.689 -179.852 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.526 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.8 OUTLIER -85.12 -58.04 0.36 Allowed Pre-proline 0 N--CA 1.451 -0.39 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.609 179.829 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.683 ' CB ' ' CE1' ' A' ' 230' ' ' PHE . 81.4 Cg_exo -50.65 -28.8 23.43 Favored 'Trans proline' 0 CA--C 1.502 -1.116 0 N-CA-C 109.238 -1.101 . . . . 0.0 109.238 178.139 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.544 HG22 ' CD2' ' A' ' 230' ' ' PHE . 13.9 t -73.14 -44.05 56.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 113.795 -1.548 . . . . 0.0 109.978 178.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . 0.541 ' O ' ' CG ' ' A' ' 241' ' ' GLU . 0.5 OUTLIER -67.95 -30.25 69.5 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.301 179.538 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.502 ' HD2' ' HG2' ' A' ' 237' ' ' LYS . 0.6 OUTLIER -78.74 -54.34 6.2 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.766 0.793 . . . . 0.0 110.369 179.36 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.728 HG13 ' CE2' ' A' ' 205' ' ' PHE . 1.9 mt -51.67 -49.65 33.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 114.357 -1.292 . . . . 0.0 112.645 -178.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 8.1 mtp -59.35 -17.69 31.91 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.598 -178.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.541 ' CG ' ' O ' ' A' ' 237' ' ' LYS . 0.1 OUTLIER -84.25 -40.66 17.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.084 179.952 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.454 ' O ' ' C ' ' A' ' 243' ' ' LYS . 0.0 OUTLIER -80.3 87.15 5.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.722 179.898 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.556 ' N ' ' HD3' ' A' ' 243' ' ' LYS . 0.0 OUTLIER -31.48 -46.48 0.1 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.907 179.757 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.583 ' CE1' ' HG3' ' A' ' 253' ' ' GLU . 18.9 m-85 -120.62 148.94 43.23 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.799 -179.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' HIS . . . . . 0.644 ' CG ' ' CD1' ' A' ' 254' ' ' ILE . 24.7 m-70 -122.97 157.75 31.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.278 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . 0.404 ' O ' ' CE2' ' A' ' 201' ' ' TYR . 0.0 OUTLIER -129.54 104.8 7.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.114 178.815 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.525 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.6 t -106.89 111.02 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.069 -179.378 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 48.0 -86.48 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.248 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.525 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.1 OUTLIER -108.57 -39.56 5.36 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.436 0.636 . . . . 0.0 110.391 -179.722 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' SER . . . . . 0.523 ' OG ' HG23 ' A' ' 193' ' ' THR . 0.2 OUTLIER -77.75 154.96 31.52 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.85 -1.068 . . . . 0.0 112.626 -178.3 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.488 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.1 OUTLIER -146.61 108.87 4.45 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.065 178.86 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' CYS . . . . . 0.559 ' HB2' ' CG1' ' A' ' 186' ' ' VAL . 0.0 OUTLIER -128.17 152.79 47.62 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -177.015 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . 0.583 ' HG3' ' CE1' ' A' ' 244' ' ' TYR . 29.6 tt0 -76.44 107.12 8.49 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.523 179.282 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . 0.644 ' CD1' ' CG ' ' A' ' 245' ' ' HIS . 31.0 mt -96.15 111.07 25.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -178.291 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.512 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -113.63 133.36 55.34 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 176.656 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . 0.537 ' CG2' ' O ' ' A' ' 183' ' ' LYS . 4.1 p -33.55 124.34 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-O 122.207 1.004 . . . . 0.0 111.26 -177.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.666 ' CB ' ' CE2' ' A' ' 227' ' ' PHE . . . -77.35 153.25 33.96 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 113.466 -1.697 . . . . 0.0 112.037 -178.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' MET . . . . . 0.423 ' HG3' ' C2 ' ' B' ' 3' ' ' ' DA' . 0.0 OUTLIER -131.18 117.56 19.21 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.298 179.186 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' SER . . . . . 0.493 ' OG ' ' O6 ' ' B' ' 4' ' ' ' DG' . 0.1 OUTLIER . . . . . 0 C--N 1.322 -0.624 0 CA-C-O 121.254 0.55 . . . . 0.0 111.45 -178.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' ' DT' . . . . . 0.872 ' O2 ' " H2'" ' B' ' 2' ' ' ' DT' . . . . . . . . 0 C2'--C1' 1.51 -0.79 0 C4'-C3'-C2' 104.404 1.204 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' ' DA' . . . . . 0.64 ' C8 ' ' OP1' ' B' ' 3' ' ' ' DA' . . . . . . . . 0 O5'--C5' 1.426 -0.873 0 C4'-C3'-C2' 104.231 1.031 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' ' DG' . . . . . 0.935 H2'' " O5'" ' B' ' 5' ' ' ' DG' . . . . . . . . 0 C4'--C3' 1.52 -0.765 0 C4'-C3'-C2' 101.867 -1.333 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' ' DG' . . . . . 0.935 " O5'" H2'' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.427 -0.811 0 O4'-C1'-C2' 106.636 0.487 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.541 HG13 ' N ' ' A' ' 182' ' ' LYS . 46.3 t . . . . . 0 CA--C 1.5 -0.949 0 CA-C-O 121.206 0.527 . . . . 0.0 111.422 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.541 ' N ' HG13 ' A' ' 181' ' ' VAL . 0.1 OUTLIER -150.45 112.02 4.47 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.247 178.0 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.65 ' HD3' ' HB3' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -133.73 144.95 49.42 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-N 114.432 -1.258 . . . . 0.0 108.814 178.896 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.623 HG12 ' HB ' ' A' ' 228' ' ' ILE . 1.8 pt -124.37 119.86 57.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 178.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.578 ' CB ' ' HA ' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -93.92 109.02 20.75 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 121.471 0.653 . . . . 0.0 110.687 -178.574 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.633 ' CG1' HG12 ' A' ' 254' ' ' ILE . 1.9 t -86.34 126.67 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.135 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.525 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . -113.4 133.99 11.6 Favored Glycine 0 C--N 1.333 0.412 0 N-CA-C 114.313 0.485 . . . . 0.0 114.313 -176.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.53 ' HA3' ' C6 ' ' B' ' 2' ' ' ' DT' . . . 71.41 87.64 0.14 Allowed Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.692 -0.766 . . . . 0.0 111.893 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.536 ' CB ' ' SG ' ' A' ' 252' ' ' CYS . 0.6 OUTLIER -115.86 156.56 25.9 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.026 0.441 . . . . 0.0 111.655 -178.469 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.604 ' CB ' ' CD ' ' A' ' 191' ' ' PRO . 0.3 OUTLIER -49.31 -172.64 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.888 179.77 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.604 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 3.1 Cg_exo -77.21 13.09 1.62 Allowed 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 123.004 2.469 . . . . 0.0 113.182 -179.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.535 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 1.6 p30 157.43 77.24 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 120.758 0.313 . . . . 0.0 111.375 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.531 HG21 ' CD1' ' A' ' 198' ' ' ILE . 16.8 m -70.91 114.24 25.4 Favored Pre-proline 0 CA--C 1.517 -0.309 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.258 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.566 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 97.6 Cg_endo -73.38 109.32 2.82 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.589 2.193 . . . . 0.0 111.211 178.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.586 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.3 OUTLIER -43.9 -19.69 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.831 -0.168 . . . . 0.0 111.447 -179.911 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' A' ' 194' ' ' PRO . 66.6 mt-10 -57.24 -43.14 82.64 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -179.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.566 ' CD ' ' HG2' ' A' ' 194' ' ' PRO . 0.5 OUTLIER -80.36 -47.11 14.96 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 178.619 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.634 HG22 ' CE1' ' A' ' 202' ' ' PHE . 0.3 OUTLIER -49.0 -29.68 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 CA-C-N 114.382 -1.281 . . . . 0.0 108.445 176.728 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.552 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 0.0 OUTLIER -73.22 -32.54 64.82 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.656 178.104 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . 0.539 ' N ' ' O ' ' A' ' 197' ' ' LYS . 2.7 mt-10 -82.15 -58.33 3.0 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.642 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.492 ' C ' ' CD1' ' A' ' 201' ' ' TYR . 0.5 OUTLIER -48.43 -53.9 16.11 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.801 179.318 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.657 ' CD2' HD12 ' A' ' 228' ' ' ILE . 0.4 OUTLIER -79.59 -31.67 41.83 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.36 179.827 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.552 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -61.99 -57.12 18.71 Favored Glycine 0 CA--C 1.498 -1.001 0 N-CA-C 107.563 -2.215 . . . . 0.0 107.563 176.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -51.33 -28.12 18.84 Favored Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 176.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . 0.749 ' CE2' HG13 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -57.07 -44.24 82.88 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.01 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.486 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 170.06 -129.11 1.76 Allowed Glycine 0 N--CA 1.441 -0.992 0 CA-C-N 113.518 -1.674 . . . . 0.0 110.221 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.492 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 21.8 mm-40 -97.16 101.52 13.1 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.153 0.502 . . . . 0.0 111.298 178.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 2.9 t -76.75 137.27 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 177.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.495 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 5.7 tp10 -89.43 -56.58 3.2 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.954 179.078 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 15.5 m -164.38 149.49 10.11 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.278 0.561 . . . . 0.0 111.921 179.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.583 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -117.66 126.47 74.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.669 179.078 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -123.18 105.18 9.67 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -178.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.526 ' CD1' ' O ' ' A' ' 193' ' ' THR . 0.3 OUTLIER -96.34 105.85 25.13 Favored Pre-proline 0 C--N 1.33 -0.267 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 177.439 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.513 ' HD2' ' O ' ' A' ' 225' ' ' PHE . 96.0 Cg_endo -79.59 136.28 12.18 Favored 'Trans proline' 0 N--CA 1.464 -0.236 0 C-N-CA 122.746 2.297 . . . . 0.0 113.091 -179.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 25.1 mmm -130.2 135.1 47.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.963 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.52 ' HB2' ' N ' ' A' ' 220' ' ' ASN . 0.0 OUTLIER -113.74 106.5 14.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.224 -179.526 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -83.16 -42.21 17.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.335 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -91.05 -36.17 14.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.688 -179.242 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.436 ' O ' ' N ' ' A' ' 221' ' ' LYS . 0.7 OUTLIER -89.51 -21.95 22.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.841 0.353 . . . . 0.0 110.916 -179.741 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . 0.52 ' N ' ' HB2' ' A' ' 216' ' ' ASP . 0.6 OUTLIER 34.93 34.79 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.157 179.75 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . 0.436 ' N ' ' O ' ' A' ' 219' ' ' THR . 0.0 OUTLIER -57.41 168.28 0.82 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.795 0.331 . . . . 0.0 110.608 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.623 ' O ' ' CG ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -96.92 36.23 1.44 Allowed 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 122.526 1.155 . . . . 0.0 109.981 -179.758 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.536 ' O ' ' C ' ' A' ' 224' ' ' GLY . 8.0 ptp85 -71.87 -24.42 61.67 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.44 178.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . 0.536 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . -2.77 72.17 0.0 OUTLIER Glycine 0 C--N 1.344 1.019 0 O-C-N 124.274 0.984 . . . . 0.0 112.706 179.029 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.609 ' CE1' H5'' ' B' ' 4' ' ' ' DG' . 0.1 OUTLIER -157.36 177.07 11.86 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -178.403 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . 0.441 ' SG ' ' HB ' ' A' ' 186' ' ' VAL . 6.0 p -139.75 151.35 45.74 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.713 ' CE1' ' C2 ' ' B' ' 4' ' ' ' DG' . 4.6 m-85 -110.43 133.07 53.62 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.711 178.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.657 HD12 ' CD2' ' A' ' 202' ' ' PHE . 2.3 mt -127.68 131.75 69.69 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.342 0 CA-C-O 121.121 0.486 . . . . 0.0 111.245 179.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.474 HG21 ' HB3' ' A' ' 209' ' ' GLU . 87.9 m -111.61 138.23 48.43 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.388 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.634 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 62.8 m-85 -112.8 126.29 55.27 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.686 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.495 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -50.85 -38.15 47.4 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 177.612 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . 0.505 ' O ' ' HG3' ' A' ' 182' ' ' LYS . 10.1 mt-10 -93.83 178.22 5.74 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 113.051 -1.886 . . . . 0.0 108.951 178.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . 0.553 ' O ' ' HG3' ' A' ' 237' ' ' LYS . 0.7 OUTLIER -117.7 1.98 12.24 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.878 -179.509 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.496 ' O ' ' N ' ' A' ' 237' ' ' LYS . 0.4 OUTLIER -73.06 -58.83 2.38 Favored Pre-proline 0 C--N 1.326 -0.435 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.864 -179.177 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.633 ' CB ' ' CE1' ' A' ' 230' ' ' PHE . 82.2 Cg_exo -48.97 -32.72 23.97 Favored 'Trans proline' 0 CA--C 1.501 -1.134 0 N-CA-C 108.851 -1.25 . . . . 0.0 108.851 178.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.563 HG22 ' CD2' ' A' ' 230' ' ' PHE . 21.3 t -70.57 -42.05 78.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 113.928 -1.487 . . . . 0.0 109.034 178.068 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . 0.553 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 13.5 mtpt -56.43 -45.93 80.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.798 179.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.473 ' HA ' ' HG3' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -81.25 -49.97 10.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.701 -179.163 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.749 HG13 ' CE2' ' A' ' 205' ' ' PHE . 1.6 mt -42.74 -50.1 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.427 -178.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' MET . . . . . 0.457 ' SD ' ' O ' ' A' ' 236' ' ' VAL . 12.2 mtp -62.42 -24.18 67.27 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.695 -178.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.473 ' HG3' ' HA ' ' A' ' 238' ' ' LYS . 0.7 OUTLIER -87.88 -16.66 33.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.534 -179.437 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.442 ' CD ' ' O ' ' A' ' 238' ' ' LYS . 8.1 mmmt -83.93 116.3 22.72 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.57 -0.287 . . . . 0.0 111.153 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.525 ' HG2' ' N ' ' A' ' 244' ' ' TYR . 1.8 ttpm? -36.77 -80.7 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.082 0.468 . . . . 0.0 110.013 179.263 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.525 ' N ' ' HG2' ' A' ' 243' ' ' LYS . 10.3 m-85 -113.24 169.43 8.95 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.876 178.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' HIS . . . . . 0.599 ' CG ' ' CD1' ' A' ' 254' ' ' ILE . 17.0 m-70 -123.46 146.35 48.1 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.784 0.326 . . . . 0.0 110.935 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . 0.441 ' O ' ' CD2' ' A' ' 201' ' ' TYR . 0.2 OUTLIER -122.42 105.47 10.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.042 0.449 . . . . 0.0 110.519 179.595 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.469 HG11 HG21 ' A' ' 198' ' ' ILE . 2.4 t -111.6 102.41 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.824 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 51.2 -90.57 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.321 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.436 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.1 OUTLIER -104.06 -40.36 6.21 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 121.594 0.711 . . . . 0.0 109.957 -179.931 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' SER . . . . . 0.494 ' CB ' ' OG1' ' A' ' 193' ' ' THR . 1.4 m -78.61 150.27 32.76 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.604 -1.18 . . . . 0.0 112.165 -178.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -149.98 107.61 3.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.47 179.36 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' CYS . . . . . 0.596 ' HB2' ' CG1' ' A' ' 186' ' ' VAL . 0.0 OUTLIER -128.19 153.46 46.88 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -177.326 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . 0.513 ' HB2' ' O4 ' ' B' ' 2' ' ' ' DT' . 71.4 tt0 -75.58 110.87 10.33 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.301 -178.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . 0.633 HG12 ' CG1' ' A' ' 186' ' ' VAL . 11.5 mt -96.59 112.14 28.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 -178.036 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.526 ' O ' ' C ' ' A' ' 256' ' ' VAL . 0.0 OUTLIER -119.14 131.24 55.86 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 176.009 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . 0.535 ' CG2' ' O ' ' A' ' 183' ' ' LYS . 6.0 p -32.32 122.58 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.586 0 CA-C-O 122.285 1.04 . . . . 0.0 111.551 -176.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.661 ' CB ' ' CE2' ' A' ' 227' ' ' PHE . . . -75.85 152.62 37.2 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 113.366 -1.743 . . . . 0.0 111.614 -178.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.86 110.18 12.33 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.717 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' SER . . . . . 0.496 ' HB2' ' HD2' ' A' ' 183' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--N 1.32 -0.677 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.805 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' ' DT' . . . . . 0.894 ' O2 ' " H2'" ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.427 -0.824 0 C3'-C2'-C1' 105.218 1.799 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' ' DA' . . . . . 0.578 " H4'" ' CZ ' ' A' ' 225' ' ' PHE . . . . . . . . 0 C2'--C1' 1.508 -0.924 0 C3'-C2'-C1' 100.272 -1.734 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' ' DG' . . . . . 0.713 ' C2 ' ' CE1' ' A' ' 227' ' ' PHE . . . . . . . . 0 O5'--C5' 1.427 -0.815 0 C4'-C3'-C2' 101.958 -1.242 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' ' DG' . . . . . 0.578 ' N7 ' ' C5 ' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.427 -0.801 0 O4'-C1'-C2' 107.121 0.928 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.526 HG12 ' N ' ' A' ' 182' ' ' LYS . 53.0 t . . . . . 0 CA--C 1.5 -0.946 0 CA-C-O 121.184 0.516 . . . . 0.0 111.314 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.526 ' N ' HG12 ' A' ' 181' ' ' VAL . 0.0 OUTLIER -153.76 111.69 3.55 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.89 177.142 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.642 ' HD3' ' HB2' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -138.25 137.52 37.58 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 114.561 -1.199 . . . . 0.0 108.795 178.953 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.693 HG12 ' HB ' ' A' ' 228' ' ' ILE . 1.1 pt -117.99 120.37 64.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.65 ' CE2' ' CE2' ' A' ' 225' ' ' PHE . 0.1 OUTLIER -94.59 109.77 21.65 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 121.543 0.687 . . . . 0.0 110.196 -179.026 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.563 ' O ' ' HB2' ' A' ' 225' ' ' PHE . 45.5 t -84.44 133.89 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.036 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.517 ' O ' ' HB3' ' A' ' 252' ' ' CYS . . . -92.0 -149.74 24.64 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.961 -0.638 . . . . 0.0 114.686 -177.128 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.485 ' O ' ' HB3' ' A' ' 252' ' ' CYS . . . -33.15 102.31 0.01 OUTLIER Glycine 0 C--N 1.334 0.469 0 CA-C-N 114.971 -0.614 . . . . 0.0 113.564 -179.428 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.545 ' CD1' ' OG1' ' A' ' 193' ' ' THR . 1.4 pp -117.48 157.89 25.48 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 122.753 0.421 . . . . 0.0 111.186 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.535 ' CB ' ' CD ' ' A' ' 191' ' ' PRO . 0.5 OUTLIER -43.84 -178.9 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.539 179.65 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.535 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 17.4 Cg_exo -67.62 4.05 1.54 Allowed 'Trans proline' 0 CA--C 1.533 0.458 0 C-N-CA 123.185 2.59 . . . . 0.0 114.019 -179.107 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.526 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 4.3 t0 161.76 76.04 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.896 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.547 HG21 ' CD1' ' A' ' 198' ' ' ILE . 17.6 m -64.65 109.78 3.25 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.483 179.156 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.474 ' HG2' ' HG2' ' A' ' 197' ' ' LYS . 11.5 Cg_endo -56.9 110.23 0.56 Allowed 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.243 1.962 . . . . 0.0 111.215 179.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.77 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.1 OUTLIER -47.23 -16.93 0.05 Allowed 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -179.278 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . 0.457 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 62.6 mt-10 -68.15 -38.05 81.71 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -179.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.501 ' O ' ' N ' ' A' ' 200' ' ' GLU . 1.5 mmmm -75.04 -47.78 27.23 Favored 'General case' 0 CA--C 1.5 -0.969 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.77 ' CG1' ' HA ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -48.1 -30.9 2.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 115.1 -0.955 . . . . 0.0 108.679 178.326 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.57 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 12.9 mtp180 -71.47 -32.09 67.88 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.238 179.02 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . 0.501 ' N ' ' O ' ' A' ' 197' ' ' LYS . 0.4 OUTLIER -82.51 -45.66 14.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.086 0.469 . . . . 0.0 110.65 179.424 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.504 ' C ' ' CD1' ' A' ' 201' ' ' TYR . 0.2 OUTLIER -63.92 -52.91 57.67 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.006 179.2 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.668 ' CE1' HG23 ' A' ' 198' ' ' ILE . 0.3 OUTLIER -79.68 -32.57 41.44 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.222 -179.799 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.57 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -64.98 -53.42 34.01 Favored Glycine 0 CA--C 1.498 -1.002 0 N-CA-C 106.579 -2.608 . . . . 0.0 106.579 175.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -51.18 -28.81 19.96 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 176.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . 0.738 ' CE2' HG13 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -57.45 -47.69 81.15 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 122.268 1.033 . . . . 0.0 108.341 177.856 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.481 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 174.04 -129.25 1.6 Allowed Glycine 0 N--CA 1.441 -0.98 0 CA-C-N 113.36 -1.745 . . . . 0.0 110.12 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.495 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 5.0 mm-40 -97.14 100.42 11.9 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.274 0.559 . . . . 0.0 111.424 178.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 2.6 t -76.98 139.47 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.151 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 177.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.509 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 21.0 tp10 -91.73 -49.84 6.06 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 178.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 9.8 p -166.93 152.84 8.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.187 0.518 . . . . 0.0 112.09 179.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.606 HG22 HG12 ' A' ' 228' ' ' ILE . 0.1 OUTLIER -125.43 120.22 57.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.114 178.956 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.501 ' OE1' ' N7 ' ' B' ' 4' ' ' ' DG' . 0.4 OUTLIER -123.63 103.65 8.55 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -178.303 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.455 HD13 ' O ' ' A' ' 193' ' ' THR . 0.0 OUTLIER -95.67 105.78 22.99 Favored Pre-proline 0 C--N 1.332 -0.193 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 177.46 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.537 ' HD2' ' O ' ' A' ' 225' ' ' PHE . 7.0 Cg_exo -75.69 122.29 6.8 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 123.011 2.474 . . . . 0.0 112.968 -179.073 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 9.5 ptp -128.89 130.81 47.33 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.004 179.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.468 ' O ' ' HA ' ' A' ' 220' ' ' ASN . 2.1 t0 -111.42 106.01 14.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.974 0.416 . . . . 0.0 111.448 -179.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -83.43 -14.0 53.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.518 179.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -78.35 -50.88 10.95 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.435 -179.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.07 -28.46 6.6 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.375 -179.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . 0.468 ' HA ' ' O ' ' A' ' 216' ' ' ASP . 14.1 m-80 62.69 61.16 1.22 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.807 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -65.41 171.91 3.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.541 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.64 ' O ' ' CG ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -95.31 33.33 1.59 Allowed 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 122.684 1.231 . . . . 0.0 110.162 -179.899 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.565 ' CB ' " H5'" ' B' ' 3' ' ' ' DA' . 8.1 ptp85 -71.06 -30.38 66.52 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . 0.511 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 8.84 66.56 0.01 OUTLIER Glycine 0 C--N 1.335 0.496 0 CA-C-N 114.658 -1.156 . . . . 0.0 113.405 178.125 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.666 ' CE1' H5'' ' B' ' 4' ' ' ' DG' . 1.1 p90 -156.13 176.24 12.93 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 -179.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . 0.514 ' SG ' ' CD2' ' A' ' 189' ' ' LEU . 0.8 OUTLIER -144.46 154.62 43.13 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.439 -0.504 . . . . 0.0 112.137 -179.08 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.666 ' CE2' ' CB ' ' A' ' 257' ' ' ALA . 6.3 m-85 -108.52 139.91 42.61 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.167 179.289 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.693 ' HB ' HG12 ' A' ' 184' ' ' ILE . 2.2 mt -135.51 122.08 33.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.959 0.409 . . . . 0.0 110.923 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.487 HG23 ' CG ' ' A' ' 209' ' ' GLU . 28.8 m -103.33 138.32 40.25 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.674 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.651 ' CE1' ' CB ' ' A' ' 235' ' ' PRO . 71.4 m-85 -113.34 126.25 55.16 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.265 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.509 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -47.96 -39.11 18.4 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 178.404 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . 0.461 ' O ' ' HG3' ' A' ' 182' ' ' LYS . 3.3 mm-40 -100.95 171.43 7.65 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 113.414 -1.721 . . . . 0.0 109.202 178.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . 0.547 ' O ' ' HG3' ' A' ' 237' ' ' LYS . 4.2 pt-20 -107.97 12.01 27.38 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -179.099 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.538 ' O ' ' N ' ' A' ' 237' ' ' LYS . 0.1 OUTLIER -77.54 -60.71 0.7 Allowed Pre-proline 0 N--CA 1.465 0.283 0 C-N-CA 120.479 -0.488 . . . . 0.0 111.38 -179.787 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.651 ' CB ' ' CE1' ' A' ' 230' ' ' PHE . 90.7 Cg_exo -49.45 -31.26 23.1 Favored 'Trans proline' 0 CA--C 1.499 -1.246 0 N-CA-C 108.671 -1.319 . . . . 0.0 108.671 178.279 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.57 HG23 ' CD2' ' A' ' 230' ' ' PHE . 21.5 t -69.25 -42.58 81.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 113.856 -1.52 . . . . 0.0 108.381 177.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . 0.547 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 2.8 mtpt -58.11 -45.4 87.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.529 178.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.537 ' CD ' ' O ' ' A' ' 234' ' ' GLU . 0.0 OUTLIER -73.47 -51.91 15.48 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.398 0.618 . . . . 0.0 111.22 -179.535 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.738 HG13 ' CE2' ' A' ' 205' ' ' PHE . 1.9 mt -48.66 -49.46 14.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 114.79 -1.095 . . . . 0.0 112.911 -178.329 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 54.2 mtp -61.1 -29.03 69.51 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.699 -178.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.543 ' CG ' ' O ' ' A' ' 237' ' ' LYS . 0.3 OUTLIER -84.75 -13.15 52.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.87 0.367 . . . . 0.0 110.563 179.696 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.484 ' N ' ' HD3' ' A' ' 242' ' ' LYS . 0.7 OUTLIER -87.17 99.22 11.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.049 -179.934 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.574 ' HE3' ' CG ' ' A' ' 244' ' ' TYR . 8.1 ttpt -37.89 -73.51 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.575 ' CE1' ' HB2' ' A' ' 253' ' ' GLU . 8.7 m-30 -111.68 150.8 29.66 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.599 179.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' HIS . . . . . 0.629 ' CG ' ' CD1' ' A' ' 254' ' ' ILE . 17.6 m-70 -113.66 154.09 27.83 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.847 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -134.91 104.69 6.08 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.215 0.531 . . . . 0.0 110.01 178.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.504 ' O ' ' C ' ' A' ' 248' ' ' GLY . 1.6 t -96.94 -173.42 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.728 -179.067 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . 0.504 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . -25.17 -62.27 0.06 OUTLIER Glycine 0 C--N 1.337 0.635 0 C-N-CA 121.2 -0.524 . . . . 0.0 112.964 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.89 -38.69 2.01 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.399 0.619 . . . . 0.0 110.726 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' SER . . . . . 0.467 ' OG ' ' OG1' ' A' ' 193' ' ' THR . 1.2 m -77.54 151.08 34.68 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.919 -1.037 . . . . 0.0 112.567 -178.183 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -140.01 105.89 5.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.922 -1.035 . . . . 0.0 108.722 179.135 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' CYS . . . . . 0.525 ' SG ' ' CG1' ' A' ' 186' ' ' VAL . 0.0 OUTLIER -128.12 153.54 46.74 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -176.624 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . 0.575 ' HB2' ' CE1' ' A' ' 244' ' ' TYR . 64.1 tt0 -75.98 109.96 10.05 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.674 178.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . 0.629 ' CD1' ' CG ' ' A' ' 245' ' ' HIS . 37.0 mt -97.02 113.03 30.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -178.089 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.515 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -114.1 131.94 56.23 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 176.89 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . 0.537 ' CG2' ' O ' ' A' ' 183' ' ' LYS . 9.8 p -33.59 127.56 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-O 122.084 0.945 . . . . 0.0 111.328 -178.079 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.666 ' CB ' ' CE2' ' A' ' 227' ' ' PHE . . . -80.18 152.82 28.98 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 113.656 -1.611 . . . . 0.0 112.268 -178.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.47 116.8 16.43 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.595 -1.184 . . . . 0.0 110.416 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' SER . . . . . 0.492 ' OG ' ' O6 ' ' B' ' 4' ' ' ' DG' . 0.1 OUTLIER . . . . . 0 C--N 1.323 -0.547 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.114 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' ' DT' . . . . . 0.875 ' O2 ' " H2'" ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.429 -0.712 0 C1'-O4'-C4' 110.443 0.531 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' ' DA' . . . . . 0.984 " H4'" " O5'" ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.424 -0.997 0 C4'-C3'-C2' 104.517 1.317 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' ' DG' . . . . . 0.984 " O5'" " H4'" ' B' ' 3' ' ' ' DA' . . . . . . . . 0 C4'--C3' 1.52 -0.844 0 C4'-C3'-C2' 101.668 -1.532 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' ' DG' . . . . . 0.618 ' N7 ' ' C5 ' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 C2'--C1' 1.509 -0.876 0 O4'-C1'-N19 108.107 0.383 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.536 HG12 ' N ' ' A' ' 182' ' ' LYS . 38.4 t . . . . . 0 CA--C 1.503 -0.84 0 CA-C-O 121.268 0.556 . . . . 0.0 112.04 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.536 ' N ' HG12 ' A' ' 181' ' ' VAL . 4.6 mmtt -143.62 112.89 6.82 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.362 177.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.663 ' HD3' ' HB1' ' A' ' 257' ' ' ALA . 0.7 OUTLIER -130.59 152.44 49.96 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.343 179.438 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.62 HG12 ' HB ' ' A' ' 228' ' ' ILE . 0.5 OUTLIER -127.37 119.83 53.35 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.096 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.561 ' CB ' ' HA ' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -92.35 108.96 20.35 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.614 0.721 . . . . 0.0 110.156 -178.842 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.576 ' CG1' HG12 ' A' ' 254' ' ' ILE . 2.4 t -85.53 118.74 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.254 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.52 ' O ' ' HB3' ' A' ' 252' ' ' CYS . . . -104.97 131.14 10.52 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.271 -0.877 . . . . 0.0 115.026 -176.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.576 ' HA3' ' C6 ' ' B' ' 2' ' ' ' DT' . . . 71.73 85.15 0.2 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 121.352 -0.451 . . . . 0.0 112.764 178.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.538 ' CB ' ' SG ' ' A' ' 252' ' ' CYS . 0.5 OUTLIER -115.47 157.29 24.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.941 0.401 . . . . 0.0 111.268 -179.534 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.619 ' CB ' ' CD ' ' A' ' 191' ' ' PRO . 0.1 OUTLIER -48.0 -169.26 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.751 179.347 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.619 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 17.7 Cg_endo -87.38 22.64 0.89 Allowed 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.403 2.068 . . . . 0.0 112.755 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.542 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 1.9 p30 157.05 76.26 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 111.623 0.231 . . . . 0.0 111.623 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.525 HG22 ' CD1' ' A' ' 198' ' ' ILE . 92.0 m -74.79 111.21 12.22 Favored Pre-proline 0 N--CA 1.464 0.236 0 CA-C-O 120.891 0.377 . . . . 0.0 110.908 179.31 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.558 ' HG2' ' CG ' ' A' ' 197' ' ' LYS . 16.6 Cg_endo -59.51 109.59 0.59 Allowed 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.367 2.045 . . . . 0.0 111.642 179.189 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.814 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.3 OUTLIER -50.84 -15.91 0.35 Allowed 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.754 -179.449 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . 0.499 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 5.6 mt-10 -69.0 -38.16 79.13 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.558 ' CG ' ' HG2' ' A' ' 194' ' ' PRO . 0.2 OUTLIER -73.25 -50.87 19.95 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.209 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.814 ' CG1' ' HA ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -46.77 -31.0 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.727 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.555 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 2.6 mtt180 -70.96 -33.9 70.92 Favored 'General case' 0 C--O 1.221 -0.441 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.373 178.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . 0.583 ' CG ' ' N ' ' A' ' 201' ' ' TYR . 3.2 pt-20 -82.14 -54.66 5.1 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.284 0.564 . . . . 0.0 110.162 179.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.583 ' N ' ' CG ' ' A' ' 200' ' ' GLU . 0.5 OUTLIER -53.69 -53.12 56.47 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.966 178.905 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.68 ' CD2' HD13 ' A' ' 228' ' ' ILE . 0.2 OUTLIER -79.84 -31.8 40.55 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.664 -179.933 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.555 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -63.81 -55.47 24.5 Favored Glycine 0 CA--C 1.498 -1.003 0 N-CA-C 106.799 -2.52 . . . . 0.0 106.799 176.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -50.16 -29.2 14.94 Favored Glycine 0 N--CA 1.443 -0.882 0 N-CA-C 109.694 -1.363 . . . . 0.0 109.694 176.076 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . 0.737 ' CE2' HG13 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -57.18 -45.28 83.84 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 122.157 0.98 . . . . 0.0 108.456 177.849 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 171.02 -129.71 1.84 Allowed Glycine 0 N--CA 1.441 -0.976 0 CA-C-N 113.567 -1.651 . . . . 0.0 110.31 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.509 ' HB3' ' CE ' ' A' ' 231' ' ' LYS . 20.9 mm-40 -96.99 101.52 13.12 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.148 0.499 . . . . 0.0 111.081 178.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 2.5 t -77.94 142.54 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.5 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 5.5 tp10 -91.66 -52.23 4.86 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 178.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 2.6 m -175.16 149.72 1.1 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.985 178.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.622 HG22 HG12 ' A' ' 228' ' ' ILE . 0.4 OUTLIER -113.96 129.55 69.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.147 178.656 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.438 ' O ' ' HD3' ' A' ' 214' ' ' PRO . 0.0 OUTLIER -123.35 104.79 9.33 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -178.126 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.471 HD11 ' HB ' ' A' ' 193' ' ' THR . 0.1 OUTLIER -96.33 105.62 23.59 Favored Pre-proline 0 CA--C 1.531 0.238 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 177.634 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.569 ' HD2' ' O ' ' A' ' 225' ' ' PHE . 4.6 Cg_exo -82.93 131.1 5.92 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 123.362 2.708 . . . . 0.0 112.217 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 88.2 mmm -135.23 130.44 35.22 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.033 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.486 ' OD1' ' NH1' ' A' ' 223' ' ' ARG . 0.9 OUTLIER -114.94 105.86 13.48 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.981 0.419 . . . . 0.0 110.551 179.581 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -83.63 -14.63 51.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.548 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -90.03 -38.05 13.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.56 -179.283 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 5.0 t -112.35 -32.6 6.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.248 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 54.44 56.26 7.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.841 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 31.9 mtpt -63.88 173.66 1.74 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.98 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.633 ' CD ' ' O ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -92.21 22.23 4.59 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 122.271 1.034 . . . . 0.0 109.845 179.72 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.567 ' O ' ' N ' ' A' ' 225' ' ' PHE . 2.5 ptp85 -71.4 -25.09 62.2 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.36 178.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . 0.529 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . -10.32 77.16 0.0 OUTLIER Glycine 0 C--N 1.344 1.015 0 O-C-N 124.459 1.099 . . . . 0.0 112.219 179.097 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.594 ' CZ ' H5'' ' B' ' 4' ' ' ' DG' . 0.1 OUTLIER -156.85 176.71 12.39 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.703 -0.748 . . . . 0.0 109.652 -177.43 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . 0.485 ' O ' ' HB ' ' A' ' 186' ' ' VAL . 31.7 p -138.56 147.65 43.28 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.059 -0.656 . . . . 0.0 112.567 -179.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.762 ' CE1' ' C2 ' ' B' ' 4' ' ' ' DG' . 4.0 m-85 -107.26 133.06 52.38 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.098 -0.956 . . . . 0.0 109.412 178.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.68 HD13 ' CD2' ' A' ' 202' ' ' PHE . 1.8 mt -127.32 123.91 62.89 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 CA-C-O 121.23 0.538 . . . . 0.0 111.395 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.48 ' CG2' ' HB3' ' A' ' 209' ' ' GLU . 19.8 m -105.15 138.39 41.43 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.344 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.669 ' CE2' ' CB ' ' A' ' 235' ' ' PRO . 72.6 m-85 -114.11 126.32 54.95 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.471 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.509 ' CE ' ' HB3' ' A' ' 207' ' ' GLU . 0.0 OUTLIER -47.7 -39.12 16.67 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 178.139 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -94.34 -168.18 1.8 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 113.325 -1.762 . . . . 0.0 109.995 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . 0.524 ' CB ' ' HD2' ' A' ' 182' ' ' LYS . 1.1 pm0 -129.79 10.12 5.5 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.536 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.4 OUTLIER -80.0 -60.22 0.51 Allowed Pre-proline 0 C--N 1.328 -0.338 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.42 179.895 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.669 ' CB ' ' CE2' ' A' ' 230' ' ' PHE . 87.5 Cg_exo -50.32 -29.67 24.19 Favored 'Trans proline' 0 CA--C 1.5 -1.19 0 N-CA-C 108.909 -1.227 . . . . 0.0 108.909 177.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.521 HG23 ' CD1' ' A' ' 230' ' ' PHE . 15.9 t -72.4 -44.7 62.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 113.971 -1.468 . . . . 0.0 109.905 178.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . 0.536 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 0.2 OUTLIER -65.51 -35.52 81.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.84 -179.707 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.498 ' O ' ' CG ' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -80.99 -47.86 13.05 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.928 0.394 . . . . 0.0 110.857 179.14 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.737 HG13 ' CE2' ' A' ' 205' ' ' PHE . 1.6 mt -49.33 -50.93 15.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.468 -179.392 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' MET . . . . . 0.436 ' SD ' ' O ' ' A' ' 236' ' ' VAL . 10.3 mtp -59.09 -29.1 67.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.795 0.331 . . . . 0.0 111.246 -178.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.498 ' CG ' ' O ' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -79.54 -21.26 45.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.063 0.459 . . . . 0.0 111.241 -179.734 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.425 ' HD3' ' HG3' ' A' ' 241' ' ' GLU . 5.5 mmtp -78.77 118.5 20.9 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.371 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.541 ' HE3' ' CD2' ' A' ' 244' ' ' TYR . 2.9 ttpt -44.81 -74.58 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.552 ' CE1' ' HB2' ' A' ' 253' ' ' GLU . 16.2 m-30 -121.95 153.92 37.85 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.072 178.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' HIS . . . . . 0.603 ' CE1' HG12 ' A' ' 239' ' ' ILE . 34.8 m-70 -109.9 146.56 34.94 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.03 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -122.11 105.03 9.9 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.102 0.477 . . . . 0.0 110.149 178.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.557 ' O ' ' N ' ' A' ' 249' ' ' LEU . 2.2 t -107.71 127.42 63.73 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.631 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . 0.436 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . 34.77 -89.89 0.01 OUTLIER Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.431 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.557 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.1 OUTLIER -108.67 -37.77 5.82 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 121.706 0.765 . . . . 0.0 110.269 -179.887 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' SER . . . . . 0.428 ' O ' ' N ' ' A' ' 247' ' ' VAL . 1.4 m -77.8 154.17 32.15 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.494 -1.23 . . . . 0.0 112.547 -178.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.468 ' O ' ' HD3' ' A' ' 251' ' ' LYS . 0.0 OUTLIER -149.37 110.63 4.41 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.824 179.375 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' CYS . . . . . 0.571 ' HB2' ' CG1' ' A' ' 186' ' ' VAL . 0.0 OUTLIER -129.38 152.84 48.49 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -177.619 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . 0.552 ' HB2' ' CE1' ' A' ' 244' ' ' TYR . 52.4 tt0 -76.41 110.86 11.29 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.917 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . 0.616 ' CG2' ' CG2' ' A' ' 239' ' ' ILE . 14.9 mt -96.12 112.7 28.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 -177.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.513 ' O ' ' C ' ' A' ' 256' ' ' VAL . 0.0 OUTLIER -116.3 131.96 56.8 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 176.179 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . 0.54 ' CG2' ' O ' ' A' ' 183' ' ' LYS . 3.4 p -32.87 123.07 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 CA-C-O 122.235 1.017 . . . . 0.0 111.555 -177.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.693 ' CB ' ' CE2' ' A' ' 227' ' ' PHE . . . -78.35 152.41 32.36 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 113.34 -1.755 . . . . 0.0 112.28 -178.402 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.84 110.48 15.49 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.7 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' SER . . . . . 0.504 ' HB3' ' HD2' ' A' ' 183' ' ' LYS . 69.5 p . . . . . 0 C--N 1.327 -0.395 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.771 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' ' DT' . . . . . 0.68 ' O2 ' " H2'" ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.427 -0.803 0 O4'-C1'-C2' 106.646 0.497 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' ' DA' . . . . . 0.499 " H4'" H5'' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.428 -0.773 0 C3'-C2'-C1' 105.368 1.906 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' ' DG' . . . . . 1.032 H2'' " O5'" ' B' ' 5' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.427 -0.796 0 C4'-C3'-C2' 101.994 -1.206 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' ' DG' . . . . . 1.032 " O5'" H2'' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.424 -1.024 0 O4'-C1'-C2' 107.112 0.92 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.519 HG12 ' N ' ' A' ' 182' ' ' LYS . 40.0 t . . . . . 0 CA--C 1.503 -0.852 0 CA-C-O 121.35 0.595 . . . . 0.0 112.036 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.519 ' HD2' ' CB ' ' A' ' 233' ' ' GLU . 0.0 OUTLIER -144.89 112.17 6.06 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.841 177.36 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.618 ' HD3' ' HB2' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -130.85 151.51 51.19 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.954 178.973 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.642 HG12 ' HB ' ' A' ' 228' ' ' ILE . 0.4 OUTLIER -128.09 120.21 52.97 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.408 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.564 ' CB ' ' HA ' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -92.67 109.03 20.44 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.35 0.595 . . . . 0.0 110.57 -178.806 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.576 ' CG1' ' HB2' ' A' ' 252' ' ' CYS . 2.4 t -85.4 124.47 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 CA-C-N 114.781 -1.1 . . . . 0.0 109.327 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.551 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . -113.01 126.06 7.3 Favored Glycine 0 C--N 1.331 0.296 0 N-CA-C 114.555 0.582 . . . . 0.0 114.555 -176.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.471 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . 80.37 84.66 0.67 Allowed Glycine 0 C--N 1.331 0.266 0 C-N-CA 121.337 -0.458 . . . . 0.0 113.151 179.356 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.513 ' CD2' ' C ' ' A' ' 225' ' ' PHE . 0.7 OUTLIER -117.31 157.32 26.31 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.831 0.348 . . . . 0.0 111.154 -179.573 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.583 ' CB ' ' CD ' ' A' ' 191' ' ' PRO . 0.1 OUTLIER -49.34 -172.07 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.765 179.537 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.583 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 94.7 Cg_endo -81.61 25.44 0.65 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.293 1.995 . . . . 0.0 113.598 -179.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.575 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 8.0 t70 150.78 79.77 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.778 0.323 . . . . 0.0 110.974 179.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.561 ' CG2' ' CD1' ' A' ' 198' ' ' ILE . 62.0 m -75.28 111.98 16.44 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.759 179.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.546 ' HG2' ' CG ' ' A' ' 197' ' ' LYS . 18.8 Cg_endo -60.1 112.2 1.22 Allowed 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.097 1.864 . . . . 0.0 110.812 178.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.803 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 7.4 pt-20 -51.85 -14.84 0.41 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.438 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 1.3 mm-40 -67.12 -37.21 83.48 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.546 ' CG ' ' HG2' ' A' ' 194' ' ' PRO . 0.4 OUTLIER -74.97 -49.8 18.78 Favored 'General case' 0 CA--C 1.495 -1.139 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.193 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.803 ' CG1' ' HA ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -47.26 -31.81 2.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.594 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.566 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 16.0 mtp180 -69.13 -33.61 73.73 Favored 'General case' 0 C--O 1.221 -0.44 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.177 178.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . 0.529 ' N ' ' O ' ' A' ' 197' ' ' LYS . 3.2 mt-10 -82.57 -59.35 2.55 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.452 0.644 . . . . 0.0 109.903 178.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.535 ' OH ' ' ND1' ' A' ' 245' ' ' HIS . 0.6 OUTLIER -49.07 -54.36 16.33 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.931 179.083 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.673 ' O ' ' HB2' ' A' ' 205' ' ' PHE . 0.2 OUTLIER -79.85 -30.99 40.45 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.597 -179.962 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.566 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -62.52 -56.79 19.54 Favored Glycine 0 CA--C 1.499 -0.965 0 N-CA-C 107.202 -2.359 . . . . 0.0 107.202 176.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -49.08 -28.93 8.37 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 176.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . 0.741 ' CE2' HG13 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -58.38 -44.28 88.82 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 177.788 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 203' ' ' GLY . . . 169.65 -130.58 2.07 Favored Glycine 0 N--CA 1.443 -0.837 0 CA-C-N 113.708 -1.587 . . . . 0.0 110.579 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.454 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 54.8 mm-40 -97.05 100.2 11.7 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.27 0.557 . . . . 0.0 111.256 178.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.445 HG13 HD12 ' A' ' 211' ' ' ILE . 2.9 t -77.64 137.64 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.056 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.514 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 25.3 tp10 -92.84 -54.37 3.78 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 120.686 0.279 . . . . 0.0 110.341 178.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.426 ' C ' HG12 ' A' ' 211' ' ' ILE . 1.4 p -157.46 158.03 35.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.306 0.574 . . . . 0.0 112.182 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.618 ' CD1' ' HB ' ' A' ' 198' ' ' ILE . 0.1 OUTLIER -133.2 126.06 52.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.366 179.108 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.529 ' OE1' ' N7 ' ' B' ' 4' ' ' ' DG' . 0.7 OUTLIER -123.49 108.68 12.93 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 114.147 1.165 . . . . 0.0 114.147 -177.45 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.528 ' N ' ' CD2' ' A' ' 213' ' ' LEU . 1.3 mm? -96.49 105.9 25.86 Favored Pre-proline 0 CA--C 1.531 0.249 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 176.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.503 ' HD2' ' O ' ' A' ' 225' ' ' PHE . 84.5 Cg_endo -82.43 136.02 8.51 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.881 2.388 . . . . 0.0 113.502 -178.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 4.1 mtp -135.43 133.46 38.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.379 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.513 ' HB2' ' NH1' ' A' ' 223' ' ' ARG . 3.3 t0 -113.21 106.54 14.76 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.988 0.423 . . . . 0.0 111.425 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -83.35 -22.7 32.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.575 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 10.1 mttm -84.14 -51.68 6.87 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -178.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -106.96 -25.2 11.73 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.498 -179.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . 0.443 ' HA ' ' O ' ' A' ' 216' ' ' ASP . 0.5 OUTLIER 49.25 60.13 3.98 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.791 0.329 . . . . 0.0 110.821 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . 0.516 ' HD3' ' CZ ' ' A' ' 223' ' ' ARG . 0.1 OUTLIER -67.21 175.22 2.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.116 -179.886 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.626 ' O ' ' CG ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -93.42 37.8 1.05 Allowed 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 122.755 1.264 . . . . 0.0 110.041 180.0 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.569 ' O ' ' N ' ' A' ' 225' ' ' PHE . 5.9 ptp85 -71.65 -27.08 62.83 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 121.569 -0.707 . . . . 0.0 109.134 178.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . 0.521 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . -1.77 68.92 0.0 OUTLIER Glycine 0 C--N 1.341 0.834 0 O-C-N 124.619 1.199 . . . . 0.0 112.921 179.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.596 ' CE1' H5'' ' B' ' 3' ' ' ' DA' . 0.1 OUTLIER -157.27 176.62 12.46 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -178.5 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . 0.51 ' HB2' ' CD1' ' A' ' 213' ' ' LEU . 2.7 p -140.22 151.91 45.56 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.336 -0.546 . . . . 0.0 112.154 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.723 ' CE1' ' C2 ' ' B' ' 4' ' ' ' DG' . 4.2 m-85 -111.11 137.43 48.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.472 178.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.671 HD13 ' CD2' ' A' ' 202' ' ' PHE . 2.1 mt -131.32 141.84 44.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.131 0.491 . . . . 0.0 111.146 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.453 ' N ' HG22 ' A' ' 228' ' ' ILE . 97.5 m -122.6 137.94 54.74 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.653 ' CE1' ' CB ' ' A' ' 235' ' ' PRO . 66.2 m-85 -111.83 126.44 55.09 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.93 -179.468 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.514 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -50.51 -37.77 40.74 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 106.622 -1.622 . . . . 0.0 106.622 177.696 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . 0.491 ' O ' ' HG3' ' A' ' 182' ' ' LYS . 15.2 mt-10 -89.86 -168.96 2.28 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 112.929 -1.941 . . . . 0.0 108.914 178.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . 0.519 ' CB ' ' HD2' ' A' ' 182' ' ' LYS . 2.3 pm0 -131.07 1.02 4.23 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.246 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.515 ' O ' ' N ' ' A' ' 237' ' ' LYS . 0.4 OUTLIER -75.13 -57.62 1.71 Allowed Pre-proline 0 C--N 1.331 -0.222 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -179.415 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.653 ' CB ' ' CE1' ' A' ' 230' ' ' PHE . 98.5 Cg_exo -49.09 -31.83 22.3 Favored 'Trans proline' 0 CA--C 1.498 -1.275 0 N-CA-C 109.027 -1.182 . . . . 0.0 109.027 178.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.532 HG22 ' CD2' ' A' ' 230' ' ' PHE . 17.5 t -69.52 -41.57 80.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 113.883 -1.508 . . . . 0.0 108.855 178.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . 0.515 ' N ' ' O ' ' A' ' 234' ' ' GLU . 22.7 mttt -59.47 -48.15 82.75 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.916 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.494 ' O ' ' CG ' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -76.86 -46.16 25.69 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.169 -179.238 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.741 HG13 ' CE2' ' A' ' 205' ' ' PHE . 1.8 mt -49.04 -47.12 17.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.213 -0.449 . . . . 0.0 112.051 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 44.4 mtp -63.92 -17.73 63.52 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.022 -178.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.494 ' CG ' ' O ' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -86.97 -27.73 23.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.686 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.465 ' HG2' ' O ' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -86.79 92.7 9.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.438 179.503 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.508 ' N ' ' HD3' ' A' ' 243' ' ' LYS . 0.0 OUTLIER -36.28 -48.9 0.66 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.996 0.427 . . . . 0.0 110.31 -179.947 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.587 ' CE1' ' HG3' ' A' ' 253' ' ' GLU . 22.1 m-85 -122.3 157.56 31.47 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.836 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' HIS . . . . . 0.633 ' CG ' ' CD1' ' A' ' 254' ' ' ILE . 29.8 m-70 -127.79 156.83 41.86 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.917 -179.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . 0.4 ' O ' ' CE2' ' A' ' 201' ' ' TYR . 2.1 m-80 -129.15 105.15 7.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.124 0.487 . . . . 0.0 110.602 179.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.563 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.5 t -109.7 125.98 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.677 -179.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . 35.46 -89.19 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.504 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.563 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.1 OUTLIER -108.15 -35.88 6.45 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.777 0.798 . . . . 0.0 110.085 -179.679 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' SER . . . . . 0.49 ' OG ' HG23 ' A' ' 193' ' ' THR . 0.8 OUTLIER -77.92 154.46 31.63 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.322 -1.308 . . . . 0.0 112.959 -177.836 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -149.95 107.88 3.71 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.063 -0.972 . . . . 0.0 108.973 179.069 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' CYS . . . . . 0.576 ' HB2' ' CG1' ' A' ' 186' ' ' VAL . 0.0 OUTLIER -128.78 153.33 47.5 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 -176.762 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . 0.587 ' HG3' ' CE1' ' A' ' 244' ' ' TYR . 31.7 tt0 -75.93 108.91 9.13 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.033 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . 0.633 ' CD1' ' CG ' ' A' ' 245' ' ' HIS . 19.1 mt -96.48 113.1 30.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 -178.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.516 ' O ' ' C ' ' A' ' 256' ' ' VAL . 0.0 OUTLIER -119.6 133.37 55.69 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 176.516 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . 0.527 ' CG2' ' O ' ' A' ' 183' ' ' LYS . 3.1 p -32.69 121.47 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 CA-C-O 122.218 1.009 . . . . 0.0 111.557 -177.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.672 ' CB ' ' CE2' ' A' ' 227' ' ' PHE . . . -76.52 153.71 35.23 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 113.353 -1.748 . . . . 0.0 112.07 -178.371 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' MET . . . . . 0.41 ' HE2' ' N6 ' ' B' ' 3' ' ' ' DA' . 0.5 OUTLIER -127.88 113.67 16.2 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.898 179.519 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' SER . . . . . 0.487 ' OG ' ' O6 ' ' B' ' 4' ' ' ' DG' . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.519 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.073 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' ' DT' . . . . . 0.627 ' O2 ' " H2'" ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.427 -0.795 0 C1'-O4'-C4' 110.383 0.488 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' ' DA' . . . . . 0.596 H5'' ' CE1' ' A' ' 225' ' ' PHE . . . . . . . . 0 O4'--C1' 1.408 -0.949 0 C4'-C3'-C2' 104.736 1.536 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' ' DG' . . . . . 0.759 H2'' " O5'" ' B' ' 5' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.426 -0.874 0 C4'-C3'-C2' 101.976 -1.224 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' ' DG' . . . . . 0.759 " O5'" H2'' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.426 -0.871 0 O4'-C1'-C2' 106.934 0.758 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.532 HG12 ' N ' ' A' ' 182' ' ' LYS . 55.2 t . . . . . 0 CA--C 1.501 -0.936 0 CA-C-O 121.11 0.481 . . . . 0.0 111.47 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.532 ' N ' HG12 ' A' ' 181' ' ' VAL . 0.0 OUTLIER -152.68 111.78 3.83 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.088 177.346 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.648 ' HD3' ' HB1' ' A' ' 257' ' ' ALA . 0.5 OUTLIER -136.36 167.86 20.52 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.693 179.04 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.672 HG12 ' HB ' ' A' ' 228' ' ' ILE . 0.3 OUTLIER -144.1 121.66 5.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.09 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.545 ' CE2' ' CE2' ' A' ' 225' ' ' PHE . 0.3 OUTLIER -96.36 108.97 21.57 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.454 -0.898 . . . . 0.0 109.679 -179.734 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.582 ' CG1' HG12 ' A' ' 254' ' ' ILE . 1.7 t -87.7 127.23 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.729 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.554 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . -114.71 124.54 6.42 Favored Glycine 0 C--N 1.331 0.282 0 N-CA-C 114.647 0.619 . . . . 0.0 114.647 -176.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.468 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . 82.12 85.83 0.75 Allowed Glycine 0 CA--C 1.518 0.28 0 C-N-CA 121.277 -0.487 . . . . 0.0 113.108 179.282 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.507 HD13 ' N ' ' A' ' 190' ' ' SER . 0.8 OUTLIER -117.46 157.27 26.53 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.742 0.306 . . . . 0.0 111.367 -179.564 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.607 ' CB ' ' CD ' ' A' ' 191' ' ' PRO . 0.1 OUTLIER -49.83 -170.84 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.228 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.843 179.615 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.607 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 95.7 Cg_endo -83.46 24.07 0.78 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.44 2.093 . . . . 0.0 113.381 -179.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.546 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 4.3 t0 154.67 77.19 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.72 0.295 . . . . 0.0 111.201 179.508 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.527 ' HB ' ' CD1' ' A' ' 213' ' ' LEU . 86.4 m -74.26 111.39 12.48 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 120.869 0.366 . . . . 0.0 110.957 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.504 ' HG2' ' HG2' ' A' ' 197' ' ' LYS . 19.3 Cg_endo -61.04 112.58 1.42 Allowed 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.248 1.965 . . . . 0.0 111.144 179.011 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.821 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 1.6 pm0 -51.9 -15.27 0.49 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.434 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . 0.488 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 40.6 mm-40 -66.94 -38.27 85.83 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.549 ' O ' ' N ' ' A' ' 200' ' ' GLU . 0.1 OUTLIER -74.04 -51.09 16.91 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.214 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.821 ' CG1' ' HA ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -47.52 -29.88 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.338 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.57 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 0.1 OUTLIER -70.9 -33.79 70.92 Favored 'General case' 0 C--O 1.22 -0.448 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.876 178.559 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . 0.578 ' CG ' ' N ' ' A' ' 201' ' ' TYR . 2.3 pt-20 -83.17 -56.47 3.76 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.857 0.361 . . . . 0.0 110.662 179.221 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.578 ' N ' ' CG ' ' A' ' 200' ' ' GLU . 0.2 OUTLIER -51.07 -53.5 33.31 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.427 0.632 . . . . 0.0 109.52 178.964 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.686 ' CD2' HD13 ' A' ' 228' ' ' ILE . 0.4 OUTLIER -79.65 -30.23 41.19 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.232 -179.913 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.57 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -62.11 -56.9 19.61 Favored Glycine 0 CA--C 1.498 -0.987 0 N-CA-C 106.763 -2.535 . . . . 0.0 106.763 176.234 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -49.41 -28.62 9.76 Favored Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 176.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . 0.682 ' CE2' ' CD1' ' A' ' 239' ' ' ILE . 0.1 OUTLIER -58.28 -42.4 86.5 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 177.99 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.493 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 166.96 -130.2 2.07 Favored Glycine 0 N--CA 1.441 -1.019 0 CA-C-N 113.709 -1.587 . . . . 0.0 109.895 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.509 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 9.4 mm-40 -96.82 100.85 12.37 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.322 0.582 . . . . 0.0 110.609 178.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.413 HG23 ' HB2' ' A' ' 202' ' ' PHE . 2.7 t -77.92 139.67 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.354 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.508 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 7.4 tp10 -89.75 -55.9 3.45 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 178.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 3.8 m -169.52 151.26 4.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.338 0.589 . . . . 0.0 112.069 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.635 HG22 HG12 ' A' ' 228' ' ' ILE . 0.4 OUTLIER -116.26 132.12 66.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.416 178.879 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.4 ' OE1' ' N7 ' ' B' ' 4' ' ' ' DG' . 1.0 OUTLIER -123.18 109.44 14.01 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -178.07 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.527 ' CD1' ' HB ' ' A' ' 193' ' ' THR . 1.6 mm? -96.59 106.37 29.36 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.873 177.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.542 ' HD2' ' O ' ' A' ' 225' ' ' PHE . 95.1 Cg_endo -86.27 129.97 3.35 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.736 2.291 . . . . 0.0 112.808 -179.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 2.2 mmt -135.25 132.92 38.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.609 179.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.423 ' O ' ' HA ' ' A' ' 220' ' ' ASN . 1.2 m-20 -107.6 106.23 16.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.878 0.371 . . . . 0.0 110.943 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -83.16 -10.56 58.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.171 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.35 -51.37 8.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.299 -179.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.9 -31.58 4.17 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.946 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . 0.423 ' HA ' ' O ' ' A' ' 216' ' ' ASP . 1.0 OUTLIER 70.78 56.7 0.23 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.969 179.835 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.4 -179.77 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.048 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.613 ' CD ' ' O ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -102.17 33.99 2.88 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 122.74 1.257 . . . . 0.0 109.668 179.783 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.557 ' O ' ' N ' ' A' ' 225' ' ' PHE . 4.7 ptp85 -71.98 -24.53 61.6 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.149 178.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . 0.523 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . -4.29 72.35 0.0 OUTLIER Glycine 0 C--N 1.345 1.037 0 O-C-N 124.53 1.144 . . . . 0.0 112.744 179.327 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.587 ' CE1' H5'' ' B' ' 4' ' ' ' DG' . 0.1 OUTLIER -157.38 176.63 12.42 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.054 -0.573 . . . . 0.0 109.781 -178.309 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . 0.462 ' SG ' ' HB ' ' A' ' 186' ' ' VAL . 30.5 p -140.96 146.86 37.88 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.276 -0.57 . . . . 0.0 112.425 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.674 ' CE2' ' CB ' ' A' ' 257' ' ' ALA . 4.7 m-85 -106.76 134.91 49.19 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.355 178.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.686 HD13 ' CD2' ' A' ' 202' ' ' PHE . 1.8 mt -128.66 136.35 60.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.146 0.498 . . . . 0.0 111.374 -179.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.52 ' OG1' ' NZ ' ' A' ' 183' ' ' LYS . 52.5 m -117.02 138.02 51.85 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.529 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.608 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 75.6 m-85 -111.83 126.29 54.93 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.394 179.587 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.509 ' HG3' ' O ' ' A' ' 207' ' ' GLU . 0.0 OUTLIER -45.0 -40.33 6.37 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 178.56 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . 0.458 ' O ' ' HG3' ' A' ' 182' ' ' LYS . 69.5 mt-10 -99.12 173.05 7.0 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 113.442 -1.708 . . . . 0.0 108.779 178.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . 0.523 ' O ' ' HG3' ' A' ' 237' ' ' LYS . 0.8 OUTLIER -112.0 13.17 20.74 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.58 -179.633 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.538 ' O ' ' HB2' ' A' ' 237' ' ' LYS . 0.6 OUTLIER -80.84 -60.38 0.44 Allowed Pre-proline 0 C--N 1.331 -0.213 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.7 -179.628 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.638 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 90.8 Cg_exo -48.7 -36.76 33.56 Favored 'Trans proline' 0 CA--C 1.495 -1.456 0 N-CA-C 108.61 -1.342 . . . . 0.0 108.61 178.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.512 ' CG2' ' HB2' ' A' ' 230' ' ' PHE . 17.2 t -62.66 -40.27 87.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 114.204 -1.362 . . . . 0.0 109.773 178.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . 0.538 ' HB2' ' O ' ' A' ' 234' ' ' GLU . 8.3 mtpt -54.24 -49.21 70.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.957 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.488 ' HA ' ' HG3' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -80.91 -45.83 16.13 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.615 -179.236 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.682 ' CD1' ' CE2' ' A' ' 205' ' ' PHE . 0.7 OUTLIER -39.48 -59.11 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.256 -0.883 . . . . 0.0 111.818 -179.549 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' MET . . . . . 0.467 ' HG2' ' HB ' ' A' ' 256' ' ' VAL . 2.6 mtp -55.53 -27.68 50.27 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.435 -178.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.488 ' HG3' ' HA ' ' A' ' 238' ' ' LYS . 1.1 mt-10 -84.43 -13.87 50.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.937 0.399 . . . . 0.0 110.642 179.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.451 ' HB2' ' O ' ' A' ' 239' ' ' ILE . 1.9 mptt -79.42 105.86 11.04 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.725 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.487 ' HD3' ' CD2' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -37.52 -67.18 0.2 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.05 -179.869 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.487 ' CD2' ' HD3' ' A' ' 243' ' ' LYS . 29.3 m-85 -132.71 143.28 49.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.971 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' HIS . . . . . 0.594 ' CD2' HG13 ' A' ' 254' ' ' ILE . 45.5 m-70 -108.81 127.93 54.45 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.354 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -102.25 105.28 15.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.034 0.445 . . . . 0.0 110.905 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.555 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.1 t -103.85 130.0 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.701 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . 0.451 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . 32.78 -89.91 0.01 OUTLIER Glycine 0 C--N 1.334 0.442 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.412 -179.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.555 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.1 OUTLIER -109.9 -34.74 6.34 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.843 0.83 . . . . 0.0 109.642 179.748 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' SER . . . . . 0.503 ' OG ' HG21 ' A' ' 193' ' ' THR . 1.9 p -77.16 152.44 34.85 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.172 -1.376 . . . . 0.0 112.65 -178.252 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -150.26 108.48 3.76 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.254 179.246 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' CYS . . . . . 0.554 ' HB3' ' C ' ' A' ' 187' ' ' GLY . 0.0 OUTLIER -127.54 153.15 46.71 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -177.381 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' A' ' 187' ' ' GLY . 48.8 tt0 -76.07 113.68 13.87 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.552 -179.266 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . 0.594 HG13 ' CD2' ' A' ' 245' ' ' HIS . 6.3 mt -96.75 113.33 30.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 -178.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.53 ' O ' ' C ' ' A' ' 256' ' ' VAL . 0.0 OUTLIER -122.67 128.15 50.22 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 105.569 -2.012 . . . . 0.0 105.569 176.346 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . 0.53 ' C ' ' O ' ' A' ' 255' ' ' LYS . 1.4 p -31.9 121.71 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 CA-C-O 122.244 1.021 . . . . 0.0 111.37 -176.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.674 ' CB ' ' CE2' ' A' ' 227' ' ' PHE . . . -75.85 153.85 36.53 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 113.27 -1.786 . . . . 0.0 111.768 -178.307 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.03 118.64 19.04 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.969 179.451 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 90.6 p . . . . . 0 C--N 1.326 -0.432 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.192 -179.514 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 2' ' ' ' DT' . . . . . 0.695 ' O2 ' " H2'" ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.427 -0.804 0 C3'-C2'-C1' 102.103 -0.427 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 3' ' ' ' DA' . . . . . 0.58 H5'' ' CE1' ' A' ' 225' ' ' PHE . . . . . . . . 0 O5'--C5' 1.427 -0.828 0 C4'-C3'-C2' 104.757 1.557 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 4' ' ' ' DG' . . . . . 0.856 H2'' " O5'" ' B' ' 5' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.427 -0.813 0 C4'-C3'-C2' 102.05 -1.15 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 5' ' ' ' DG' . . . . . 0.856 " O5'" H2'' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 C2'--C1' 1.508 -0.924 0 O4'-C1'-N19 108.146 0.432 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.551 HG13 ' N ' ' A' ' 182' ' ' LYS . 47.8 t . . . . . 0 CA--C 1.504 -0.805 0 CA-C-O 121.156 0.503 . . . . 0.0 111.671 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.551 ' N ' HG13 ' A' ' 181' ' ' VAL . 0.0 OUTLIER -150.33 112.63 4.65 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.676 177.621 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.69 ' HD2' ' HB1' ' A' ' 257' ' ' ALA . 0.0 OUTLIER -138.51 148.27 44.08 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.218 178.484 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.633 HG12 ' HB ' ' A' ' 228' ' ' ILE . 0.3 OUTLIER -126.58 120.06 55.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.679 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.709 ' CE2' ' C4 ' ' B' ' 3' ' ' ' DA' . 0.3 OUTLIER -92.98 109.6 21.06 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 121.44 0.638 . . . . 0.0 110.111 -179.164 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.54 ' CG2' HD11 ' A' ' 254' ' ' ILE . 5.8 t -88.72 118.49 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.161 -179.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.535 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . -62.11 -150.9 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 115.76 -0.654 . . . . 0.0 114.609 -178.004 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.504 ' O ' ' HB3' ' A' ' 252' ' ' CYS . . . -47.03 111.74 0.8 Allowed Glycine 0 C--N 1.33 0.234 0 CA-C-N 114.823 -0.688 . . . . 0.0 114.435 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.537 ' CD1' ' OG1' ' A' ' 193' ' ' THR . 3.3 pp -109.11 157.35 18.82 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.98 -0.61 . . . . 0.0 110.255 178.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.529 ' O ' ' O ' ' A' ' 189' ' ' LEU . 0.1 OUTLIER -42.74 178.13 0.01 OUTLIER Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 121.084 0.469 . . . . 0.0 111.034 179.726 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.543 ' O ' ' CB ' ' A' ' 192' ' ' ASP . 74.5 Cg_endo -76.37 26.65 0.42 Allowed 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 122.637 2.225 . . . . 0.0 113.544 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.543 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 4.6 p30 157.48 73.88 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.113 0 N-CA-C 111.528 0.196 . . . . 0.0 111.528 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.571 HG23 ' CD1' ' A' ' 198' ' ' ILE . 87.6 m -77.93 111.22 16.58 Favored Pre-proline 0 CA--C 1.518 -0.26 0 CA-C-O 121.055 0.455 . . . . 0.0 110.742 179.268 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.57 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 57.7 Cg_endo -68.47 109.62 2.09 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.525 2.15 . . . . 0.0 111.686 179.27 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.596 ' HA ' ' CD1' ' A' ' 198' ' ' ILE . 0.6 OUTLIER -43.42 -19.81 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.47 179.752 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . 0.499 ' O ' ' HG2' ' A' ' 200' ' ' GLU . 0.1 OUTLIER -61.02 -44.49 97.33 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -179.158 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.57 ' CD ' ' HG2' ' A' ' 194' ' ' PRO . 1.4 mttp -76.17 -46.18 29.8 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 178.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.617 HG22 ' CE1' ' A' ' 202' ' ' PHE . 0.2 OUTLIER -48.56 -28.94 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-N 114.048 -1.433 . . . . 0.0 108.717 177.014 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.54 ' HG3' ' O ' ' A' ' 195' ' ' GLU . 12.9 mtp180 -75.75 -32.11 59.83 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.955 178.233 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . 0.521 ' N ' ' O ' ' A' ' 197' ' ' LYS . 4.1 mm-40 -81.91 -57.48 3.4 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.226 0.536 . . . . 0.0 110.536 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.524 ' OH ' ' ND1' ' A' ' 245' ' ' HIS . 0.3 OUTLIER -48.03 -53.94 14.65 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.678 179.308 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.688 ' CD2' HD12 ' A' ' 228' ' ' ILE . 0.9 OUTLIER -79.73 -31.95 41.12 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.571 179.93 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.517 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -61.88 -57.78 15.86 Favored Glycine 0 N--CA 1.444 -0.824 0 N-CA-C 107.378 -2.289 . . . . 0.0 107.378 176.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -49.33 -29.28 10.21 Favored Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 176.264 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . 0.741 ' CE2' HG13 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -58.53 -43.49 89.25 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 122.115 0.959 . . . . 0.0 108.423 177.787 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 169.14 -131.29 2.25 Favored Glycine 0 N--CA 1.441 -1.002 0 CA-C-N 113.714 -1.584 . . . . 0.0 110.417 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.49 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 4.1 mt-10 -97.11 102.94 14.82 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.231 0.539 . . . . 0.0 111.364 178.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.503 ' O ' ' NZ ' ' A' ' 231' ' ' LYS . 2.5 t -77.84 138.9 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.049 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.555 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 70.8 tt0 -93.35 -53.15 4.2 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.5 178.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.446 ' OG ' ' OE2' ' A' ' 212' ' ' GLU . 37.2 p -160.51 151.65 19.08 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.606 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -129.55 122.36 55.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.923 178.905 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.446 ' OE2' ' OG ' ' A' ' 210' ' ' SER . 0.0 OUTLIER -123.86 115.29 21.07 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 -177.962 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.484 ' N ' ' CD2' ' A' ' 213' ' ' LEU . 0.3 OUTLIER -97.02 105.72 26.0 Favored Pre-proline 0 CA--C 1.537 0.452 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 176.644 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.622 ' HD2' ' O ' ' A' ' 225' ' ' PHE . 2.4 Cg_endo -86.75 123.69 2.13 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 123.583 2.855 . . . . 0.0 113.299 -178.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -135.29 130.18 34.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.283 178.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.458 ' HB3' HG22 ' A' ' 219' ' ' THR . 1.2 m-20 -116.77 106.57 13.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.855 0.36 . . . . 0.0 111.407 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -82.82 -9.09 59.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.17 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 21.1 mmmt -91.18 -51.29 5.39 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.852 -179.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.458 HG22 ' HB3' ' A' ' 216' ' ' ASP . 0.8 OUTLIER -92.65 -35.13 13.68 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.321 -179.291 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 2.7 m120 70.07 36.9 1.81 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.91 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . 0.433 ' CD ' ' N ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -70.73 148.55 47.85 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.135 179.703 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.433 ' N ' ' CD ' ' A' ' 221' ' ' LYS . 0.0 OUTLIER -70.31 59.24 0.18 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.277 0.561 . . . . 0.0 110.568 179.632 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.429 ' NH1' ' CG ' ' A' ' 216' ' ' ASP . 4.0 ptp85 -102.13 18.94 19.57 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.651 179.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . 0.448 ' O ' ' HG ' ' A' ' 189' ' ' LEU . . . -68.53 53.82 0.48 Allowed Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 115.162 -0.926 . . . . 0.0 112.411 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.681 ' CE1' H5'' ' B' ' 4' ' ' ' DG' . 6.7 p90 -132.87 176.68 8.26 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . 0.517 ' HB3' ' CD2' ' A' ' 189' ' ' LEU . 23.1 p -136.06 149.15 48.64 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 119.495 -0.882 . . . . 0.0 112.709 -179.311 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.675 ' CE2' ' CB ' ' A' ' 257' ' ' ALA . 3.1 m-85 -105.65 139.0 40.91 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 115.586 -0.733 . . . . 0.0 109.119 178.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.688 HD12 ' CD2' ' A' ' 202' ' ' PHE . 1.7 mt -133.83 118.29 29.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.414 0.626 . . . . 0.0 111.015 179.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.473 ' OG1' ' HG3' ' A' ' 183' ' ' LYS . 63.4 m -100.67 137.99 38.32 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.645 ' CE1' ' CB ' ' A' ' 235' ' ' PRO . 58.1 m-85 -111.8 126.49 55.14 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.465 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.555 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -49.46 -38.31 29.23 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 178.302 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . 0.419 ' OE1' ' CD ' ' A' ' 234' ' ' GLU . 0.7 OUTLIER -92.06 -165.37 1.33 Allowed 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 113.049 -1.887 . . . . 0.0 109.483 178.873 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . 0.54 ' CG ' ' HG2' ' A' ' 182' ' ' LYS . 0.5 OUTLIER -132.96 1.75 3.59 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.443 -179.914 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.493 ' O ' ' N ' ' A' ' 237' ' ' LYS . 0.2 OUTLIER -73.91 -59.53 1.79 Allowed Pre-proline 0 C--N 1.33 -0.264 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.622 -179.415 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.645 ' CB ' ' CE1' ' A' ' 230' ' ' PHE . 98.5 Cg_exo -48.65 -33.61 24.74 Favored 'Trans proline' 0 CA--C 1.498 -1.299 0 N-CA-C 108.851 -1.25 . . . . 0.0 108.851 178.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.512 HG11 HG22 ' A' ' 184' ' ' ILE . 21.7 t -70.43 -40.74 77.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 113.856 -1.52 . . . . 0.0 109.502 178.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . 0.531 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 19.9 mttt -56.68 -46.89 80.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.915 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.529 ' O ' ' CG ' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -81.14 -50.09 10.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.277 -179.754 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.741 HG13 ' CE2' ' A' ' 205' ' ' PHE . 1.5 mt -40.74 -52.58 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.632 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' MET . . . . . 0.456 ' SD ' ' HB ' ' A' ' 256' ' ' VAL . 6.7 mtp -61.32 -21.92 64.42 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.025 -179.024 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.529 ' CG ' ' O ' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -80.05 -23.96 41.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.844 -179.834 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.425 ' N ' ' HG3' ' A' ' 241' ' ' GLU . 2.9 mmtp -79.11 137.59 37.56 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.034 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.543 ' HD2' ' CG ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -76.55 -41.96 44.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.447 179.588 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.632 ' CD1' ' HB3' ' A' ' 253' ' ' GLU . 2.5 m-85 -140.51 140.88 35.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.277 178.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' HIS . . . . . 0.638 ' CG ' ' CD1' ' A' ' 254' ' ' ILE . 17.3 m-70 -106.39 157.8 17.36 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.675 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . 0.404 ' ND2' ' N ' ' A' ' 246' ' ' ASN . 0.1 OUTLIER -133.77 105.27 6.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.97 0.414 . . . . 0.0 110.87 179.541 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.538 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.6 t -108.61 105.63 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.112 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 50.17 -85.21 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.421 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.538 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -107.1 -38.99 5.85 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.405 0.621 . . . . 0.0 110.602 179.806 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' SER . . . . . 0.495 ' O ' ' N ' ' A' ' 247' ' ' VAL . 4.4 p -77.63 150.28 34.64 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.984 -1.007 . . . . 0.0 112.105 -178.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -150.5 103.58 3.14 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.588 178.994 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' CYS . . . . . 0.535 ' HB3' ' C ' ' A' ' 187' ' ' GLY . 0.0 OUTLIER -130.59 154.69 47.59 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -177.515 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . 0.632 ' HB3' ' CD1' ' A' ' 244' ' ' TYR . 7.8 pt-20 -74.94 118.54 18.01 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.24 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . 0.638 ' CD1' ' CG ' ' A' ' 245' ' ' HIS . 24.0 mt -96.76 102.12 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 CA-C-O 121.809 0.814 . . . . 0.0 112.657 -178.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.558 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -104.0 128.99 51.58 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 177.627 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . 0.513 ' C ' ' O ' ' A' ' 255' ' ' LYS . 3.8 p -32.41 125.06 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-O 122.15 0.976 . . . . 0.0 111.206 -176.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.69 ' HB1' ' HD2' ' A' ' 183' ' ' LYS . . . -76.23 152.82 36.46 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 113.522 -1.672 . . . . 0.0 112.166 -178.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.15 126.65 26.89 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.469 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 259' ' ' SER . . . . . 0.531 ' HB3' ' NZ ' ' A' ' 183' ' ' LYS . 53.9 p . . . . . 0 C--N 1.324 -0.508 0 CA-C-O 120.866 0.365 . . . . 0.0 111.097 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 2' ' ' ' DT' . . . . . 0.871 ' O2 ' " H2'" ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.427 -0.81 0 O4'-C1'-C2' 107.067 0.879 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 3' ' ' ' DA' . . . . . 1.004 " H4'" " O5'" ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.426 -0.875 0 C4'-C3'-O3' 111.484 0.538 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 4' ' ' ' DG' . . . . . 1.004 " O5'" " H4'" ' B' ' 3' ' ' ' DA' . . . . . . . . 0 O5'--C5' 1.427 -0.826 0 C4'-C3'-C2' 102.194 -1.006 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 5' ' ' ' DG' . . . . . 0.731 ' N7 ' ' C5 ' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 C2'--C1' 1.507 -1.013 0 O4'-C1'-N19 108.182 0.478 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.533 HG12 ' N ' ' A' ' 182' ' ' LYS . 36.1 t . . . . . 0 CA--C 1.504 -0.808 0 CA-C-O 121.115 0.483 . . . . 0.0 111.247 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.568 ' HG2' ' CB ' ' A' ' 233' ' ' GLU . 2.8 mptt -148.45 112.95 5.32 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.447 178.038 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.64 ' HD3' ' HB2' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -134.14 143.88 48.2 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.846 179.08 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.647 HG12 ' HB ' ' A' ' 228' ' ' ILE . 1.0 OUTLIER -123.4 120.05 59.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.411 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.655 ' CE2' ' CE2' ' A' ' 225' ' ' PHE . 0.2 OUTLIER -92.11 109.49 20.85 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.423 0.63 . . . . 0.0 109.992 -179.337 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.527 ' CG2' HD11 ' A' ' 254' ' ' ILE . 11.0 t -87.03 123.59 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.303 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.515 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . -68.67 -159.07 1.56 Allowed Glycine 0 CA--C 1.521 0.452 0 CA-C-N 115.743 -0.662 . . . . 0.0 114.477 -178.098 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.532 ' HA2' ' O ' ' A' ' 224' ' ' GLY . . . -39.13 107.55 0.07 OUTLIER Glycine 0 C--N 1.332 0.355 0 CA-C-N 114.918 -0.641 . . . . 0.0 114.37 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.526 ' CD1' ' O ' ' A' ' 190' ' ' SER . 3.2 pp -107.98 157.14 18.47 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 122.537 0.335 . . . . 0.0 110.802 179.182 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.526 ' O ' ' CD1' ' A' ' 189' ' ' LEU . 0.1 OUTLIER -40.28 173.44 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.392 0.615 . . . . 0.0 111.921 -179.947 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.471 ' O ' ' HB2' ' A' ' 192' ' ' ASP . 32.9 Cg_exo -60.34 -3.65 2.62 Favored 'Trans proline' 0 CA--C 1.529 0.27 0 C-N-CA 123.293 2.662 . . . . 0.0 114.126 -179.373 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 191' ' ' PRO . 0.5 OUTLIER 172.01 74.02 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.69 -179.933 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.544 ' HB ' ' CD1' ' A' ' 213' ' ' LEU . 57.7 m -64.29 125.29 87.99 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.826 179.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.578 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 83.5 Cg_endo -76.55 117.71 4.65 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.405 2.07 . . . . 0.0 110.381 178.37 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.789 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 12.4 pt-20 -51.62 -14.0 0.29 Allowed 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -178.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . 0.506 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 33.7 mt-10 -68.51 -44.0 75.6 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -179.397 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.578 ' CD ' ' HG2' ' A' ' 194' ' ' PRO . 0.9 OUTLIER -70.58 -47.41 60.34 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.444 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.789 ' CG1' ' HA ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -47.85 -30.84 2.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.423 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.565 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 1.5 mtp-105 -72.31 -32.35 66.48 Favored 'General case' 0 C--O 1.22 -0.456 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.105 178.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . 0.522 ' N ' ' O ' ' A' ' 197' ' ' LYS . 25.2 mt-10 -82.71 -59.16 2.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.137 0.494 . . . . 0.0 110.397 179.329 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.504 ' C ' ' CD1' ' A' ' 201' ' ' TYR . 0.4 OUTLIER -48.72 -53.61 18.21 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.767 -0.652 . . . . 0.0 109.718 179.118 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.671 ' CD2' HD12 ' A' ' 228' ' ' ILE . 0.5 OUTLIER -79.7 -31.36 41.26 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.538 -179.963 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.565 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -62.14 -56.34 22.78 Favored Glycine 0 CA--C 1.5 -0.855 0 N-CA-C 107.104 -2.398 . . . . 0.0 107.104 176.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -49.76 -28.4 11.15 Favored Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 176.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . 0.742 ' CE2' HG13 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -58.64 -44.21 89.98 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 177.885 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 169.87 -130.66 2.07 Favored Glycine 0 N--CA 1.441 -0.985 0 CA-C-N 113.663 -1.608 . . . . 0.0 110.473 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.463 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 5.0 mt-10 -96.89 98.77 10.38 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.228 0.537 . . . . 0.0 110.923 178.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.429 ' O ' ' HE3' ' A' ' 231' ' ' LYS . 2.7 t -75.76 141.26 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 CA-C-N 115.384 -0.825 . . . . 0.0 108.984 178.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.497 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 45.6 tt0 -89.75 -57.72 2.77 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.141 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 10.4 p -167.58 151.41 6.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.298 0.571 . . . . 0.0 112.375 179.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.628 HG22 HG12 ' A' ' 228' ' ' ILE . 0.4 OUTLIER -117.71 132.29 67.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.497 178.657 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.493 ' OE1' ' N7 ' ' B' ' 4' ' ' ' DG' . 0.0 OUTLIER -123.45 111.46 16.35 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -178.293 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.544 ' CD1' ' HB ' ' A' ' 193' ' ' THR . 2.7 mm? -96.21 109.02 45.12 Favored Pre-proline 0 CA--C 1.533 0.315 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.922 177.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.582 ' HD2' ' O ' ' A' ' 225' ' ' PHE . 22.3 Cg_exo -65.87 -157.36 0.03 OUTLIER 'Trans proline' 0 N--CA 1.472 0.223 0 C-N-CA 123.458 2.772 . . . . 0.0 113.427 -179.412 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' MET . . . . . 0.436 ' HB3' ' CG ' ' A' ' 220' ' ' ASN . 0.0 OUTLIER -92.86 173.49 7.72 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.608 -179.65 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.458 ' O ' ' HB2' ' A' ' 220' ' ' ASN . 1.0 OUTLIER -109.6 149.85 29.07 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.541 -179.668 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . 0.541 ' N ' ' O ' ' A' ' 221' ' ' LYS . 9.4 t30 -64.93 -9.44 21.32 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.029 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 7.0 mttp -67.29 -26.6 66.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.144 0.497 . . . . 0.0 110.481 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 2.6 t -150.15 15.42 0.82 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.876 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 216' ' ' ASP . 16.6 m120 -148.71 -92.13 0.08 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.689 0.28 . . . . 0.0 111.635 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . 0.541 ' O ' ' N ' ' A' ' 217' ' ' ASN . 23.1 mtpp -148.44 173.2 13.34 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.832 0.348 . . . . 0.0 111.253 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.636 ' O ' ' CG ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -92.39 40.23 1.04 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 123.066 1.412 . . . . 0.0 110.057 -179.993 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.533 ' CB ' H5'' ' B' ' 3' ' ' ' DA' . 2.1 ptp85 -71.7 -31.26 66.56 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . 0.532 ' O ' ' HA2' ' A' ' 188' ' ' GLY . . . 10.98 62.36 0.01 OUTLIER Glycine 0 C--O 1.222 -0.637 0 CA-C-N 114.059 -1.428 . . . . 0.0 113.635 178.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.655 ' CE2' ' CE2' ' A' ' 185' ' ' PHE . 0.6 OUTLIER -156.05 176.08 13.12 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.743 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . 0.516 ' HB3' ' CD2' ' A' ' 189' ' ' LEU . 27.3 p -140.7 150.92 44.08 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -179.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.72 ' CE1' ' C2 ' ' B' ' 4' ' ' ' DG' . 4.5 m-85 -106.29 133.49 50.9 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.657 178.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.671 HD12 ' CD2' ' A' ' 202' ' ' PHE . 1.9 mt -127.75 128.05 68.99 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.393 0 CA-C-O 120.904 0.383 . . . . 0.0 111.108 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.488 ' CG2' ' CD ' ' A' ' 209' ' ' GLU . 51.5 m -111.62 137.95 48.81 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.214 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.661 ' CE2' ' CB ' ' A' ' 235' ' ' PRO . 83.2 m-85 -112.42 126.38 55.23 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.387 179.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.497 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -47.96 -38.38 16.66 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 178.018 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -91.0 -165.33 1.33 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 113.397 -1.728 . . . . 0.0 110.186 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . 0.568 ' CB ' ' HG2' ' A' ' 182' ' ' LYS . 9.5 pt-20 -133.25 10.91 4.16 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.486 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.53 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.0 OUTLIER -83.43 -60.38 0.34 Allowed Pre-proline 0 C--N 1.326 -0.419 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.649 179.951 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.661 ' CB ' ' CE2' ' A' ' 230' ' ' PHE . 80.2 Cg_exo -49.51 -30.45 21.26 Favored 'Trans proline' 0 CA--C 1.501 -1.145 0 N-CA-C 108.942 -1.215 . . . . 0.0 108.942 177.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.582 HG21 ' CD1' ' A' ' 230' ' ' PHE . 17.9 t -72.68 -45.28 58.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 113.88 -1.509 . . . . 0.0 110.323 178.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . 0.53 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 1.5 ptpt -63.76 -35.09 79.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.791 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.495 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 0.0 OUTLIER -80.73 -50.39 9.94 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.128 0.489 . . . . 0.0 110.379 179.055 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.742 HG13 ' CE2' ' A' ' 205' ' ' PHE . 1.7 mt -47.96 -49.74 10.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.433 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' MET . . . . . 0.463 ' HG2' ' HB ' ' A' ' 256' ' ' VAL . 36.8 mtp -58.16 -29.27 65.46 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.353 -178.456 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.514 ' CG ' ' O ' ' A' ' 237' ' ' LYS . 0.1 OUTLIER -86.38 -10.61 54.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.918 0.39 . . . . 0.0 110.566 179.447 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 239' ' ' ILE . 0.0 OUTLIER -81.6 102.52 10.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.2 -179.865 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.476 ' HE2' ' HB2' ' A' ' 244' ' ' TYR . 1.9 ttpt -38.18 -76.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.212 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.64 ' CD1' ' HB3' ' A' ' 253' ' ' GLU . 8.9 m-85 -118.16 144.75 45.45 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.661 179.062 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' HIS . . . . . 0.584 ' CD2' HG13 ' A' ' 254' ' ' ILE . 24.9 m-70 -105.51 157.94 17.02 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.041 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . 0.464 ' ND2' ' N ' ' A' ' 246' ' ' ASN . 0.0 OUTLIER -133.15 105.21 6.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.527 179.582 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.548 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.5 t -110.9 101.34 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.688 -179.186 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 53.5 -79.62 0.01 OUTLIER Glycine 0 C--N 1.331 0.274 0 C-N-CA 121.062 -0.589 . . . . 0.0 112.521 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.548 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -113.44 -40.2 3.92 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.476 0.655 . . . . 0.0 110.234 179.762 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' SER . . . . . 0.513 ' O ' ' N ' ' A' ' 247' ' ' VAL . 5.1 p -77.68 148.64 34.89 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.877 -179.021 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.505 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -151.25 103.22 2.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.84 178.807 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' CYS . . . . . 0.515 ' HB3' ' C ' ' A' ' 187' ' ' GLY . 0.0 OUTLIER -130.74 155.06 47.27 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -177.885 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . 0.64 ' HB3' ' CD1' ' A' ' 244' ' ' TYR . 8.4 pt-20 -74.69 119.51 18.98 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.196 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . 0.592 ' CG2' ' CG2' ' A' ' 239' ' ' ILE . 30.7 mt -96.97 102.59 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 CA-C-O 121.553 0.692 . . . . 0.0 112.385 -178.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.539 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -103.52 130.36 50.89 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 177.812 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . 0.551 ' CG2' ' O ' ' A' ' 183' ' ' LYS . 4.0 p -32.67 122.74 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.561 0 CA-C-O 122.3 1.048 . . . . 0.0 111.513 -176.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.669 ' CB ' ' CE2' ' A' ' 227' ' ' PHE . . . -76.25 152.02 36.64 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 113.262 -1.79 . . . . 0.0 111.776 -178.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 258' ' ' MET . . . . . 0.501 ' HE2' ' C6 ' ' B' ' 3' ' ' ' DA' . 0.0 OUTLIER -130.43 118.82 21.74 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.026 179.811 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 54.4 p . . . . . 0 C--N 1.325 -0.46 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.106 -179.567 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 2' ' ' ' DT' . . . . . 0.871 ' O2 ' " H2'" ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.428 -0.758 0 O4'-C1'-C2' 106.876 0.705 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 3' ' ' ' DA' . . . . . 0.608 " C5'" ' CE1' ' A' ' 225' ' ' PHE . . . . . . . . 0 O5'--C5' 1.426 -0.845 0 C4'-C3'-C2' 104.592 1.392 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 4' ' ' ' DG' . . . . . 0.72 ' C2 ' ' CE1' ' A' ' 227' ' ' PHE . . . . . . . . 0 O5'--C5' 1.428 -0.775 0 C4'-C3'-C2' 101.924 -1.276 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 5' ' ' ' DG' . . . . . 0.704 " O5'" H2'' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.426 -0.898 0 O4'-C1'-C2' 107.047 0.861 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.54 HG11 ' N ' ' A' ' 182' ' ' LYS . 39.8 t . . . . . 0 CA--C 1.504 -0.815 0 CA-C-O 121.276 0.56 . . . . 0.0 111.589 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.54 ' N ' HG11 ' A' ' 181' ' ' VAL . 0.0 OUTLIER -145.66 112.6 6.04 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.503 177.26 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.641 ' HD2' ' HB3' ' A' ' 257' ' ' ALA . 0.0 OUTLIER -133.62 164.82 26.34 Favored 'General case' 0 CA--C 1.507 -0.682 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.895 -179.891 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.702 HG12 ' HB ' ' A' ' 228' ' ' ILE . 1.4 pt -140.33 119.96 12.49 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 177.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.719 ' CD2' ' C2 ' ' B' ' 3' ' ' ' DA' . 0.4 OUTLIER -95.94 108.77 21.19 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.424 -178.713 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.626 ' CG1' HG12 ' A' ' 254' ' ' ILE . 1.6 t -84.86 117.39 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.598 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 253' ' ' GLU . . . -104.7 134.14 11.87 Favored Glycine 0 N--CA 1.452 -0.248 0 N-CA-C 114.691 0.636 . . . . 0.0 114.691 -177.002 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.591 ' HA3' ' C5 ' ' B' ' 2' ' ' ' DT' . . . 72.73 84.48 0.24 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.147 -0.549 . . . . 0.0 112.746 179.178 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.538 ' CD1' ' OG1' ' A' ' 193' ' ' THR . 0.6 OUTLIER -117.44 156.16 28.44 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.957 0.408 . . . . 0.0 111.085 -179.723 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.574 ' CB ' ' CD ' ' A' ' 191' ' ' PRO . 0.5 OUTLIER -47.25 -176.72 0.01 OUTLIER Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.316 179.917 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.574 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 12.0 Cg_exo -71.86 5.73 2.4 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 123.391 2.727 . . . . 0.0 113.329 -179.286 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.464 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 0.8 OUTLIER 165.63 74.75 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.803 0.335 . . . . 0.0 111.43 -179.944 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.541 HG22 ' CD1' ' A' ' 198' ' ' ILE . 88.4 m -70.34 112.63 13.43 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.61 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.578 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 25.4 Cg_endo -60.32 107.38 0.41 Allowed 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.221 1.948 . . . . 0.0 111.163 179.098 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.802 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -48.53 -14.89 0.07 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.8 -179.618 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . 0.499 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 34.9 mt-10 -67.41 -40.46 85.57 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 -179.399 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.578 ' CD ' ' HG2' ' A' ' 194' ' ' PRO . 1.8 mttp -74.21 -47.51 34.97 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.802 ' CG1' ' HA ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -46.86 -30.2 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.104 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.554 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 7.1 mtp180 -71.5 -33.98 69.71 Favored 'General case' 0 C--O 1.221 -0.438 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.447 178.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . 0.518 ' N ' ' O ' ' A' ' 197' ' ' LYS . 0.4 OUTLIER -83.21 -46.3 12.86 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.157 0.503 . . . . 0.0 110.738 179.459 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.547 ' CD1' ' CD1' ' A' ' 202' ' ' PHE . 0.4 OUTLIER -61.25 -52.73 63.51 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.694 179.127 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.648 ' CD2' HD13 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -79.53 -31.25 42.06 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.663 179.483 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.554 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -63.86 -56.15 20.44 Favored Glycine 0 N--CA 1.443 -0.88 0 N-CA-C 106.73 -2.548 . . . . 0.0 106.73 175.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -50.25 -28.7 14.3 Favored Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 176.076 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . 0.72 ' CE2' HG13 ' A' ' 239' ' ' ILE . 0.0 OUTLIER -58.82 -44.49 90.86 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 177.68 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.503 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 170.77 -130.88 2.08 Favored Glycine 0 N--CA 1.442 -0.955 0 CA-C-N 113.664 -1.607 . . . . 0.0 110.389 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.492 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 0.4 OUTLIER -97.11 101.93 13.6 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.156 0.503 . . . . 0.0 111.439 178.805 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.441 HG12 ' N ' ' A' ' 209' ' ' GLU . 2.6 t -79.29 141.12 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 177.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.523 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 38.2 tt0 -98.05 -51.91 3.88 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.202 178.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.409 ' C ' HG12 ' A' ' 211' ' ' ILE . 5.1 p -157.66 154.32 28.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.392 0.615 . . . . 0.0 112.471 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.593 HG22 HG12 ' A' ' 228' ' ' ILE . 0.2 OUTLIER -137.26 116.3 14.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.144 178.548 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.417 ' O ' ' HD3' ' A' ' 214' ' ' PRO . 0.3 OUTLIER -124.1 114.47 19.74 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 113.853 1.056 . . . . 0.0 113.853 -177.79 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.454 ' CD1' ' O ' ' A' ' 193' ' ' THR . 0.1 OUTLIER -96.45 105.97 26.28 Favored Pre-proline 0 CA--C 1.533 0.326 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 177.034 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.677 ' HD2' ' O ' ' A' ' 225' ' ' PHE . 13.4 Cg_exo -74.16 136.04 21.68 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 123.112 2.542 . . . . 0.0 113.181 -179.01 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -132.31 130.7 41.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.959 179.063 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.485 ' O ' ' HA ' ' A' ' 220' ' ' ASN . 3.7 t0 -116.32 106.64 13.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.819 0.342 . . . . 0.0 111.253 -179.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -82.89 -9.55 59.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.075 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.56 -51.18 20.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.251 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.432 ' O ' ' C ' ' A' ' 220' ' ' ASN . 0.0 OUTLIER -137.51 8.43 2.86 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.14 -179.676 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . 0.485 ' HA ' ' O ' ' A' ' 216' ' ' ASP . 72.4 m-80 33.01 58.73 0.45 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.634 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 1.9 mtpt -62.96 -174.5 0.07 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.464 ' O ' ' OP1' ' B' ' 3' ' ' ' DA' . 0.0 OUTLIER -85.0 33.87 0.54 Allowed 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 120.845 0.355 . . . . 0.0 111.123 179.17 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.457 ' HD3' ' HB2' ' A' ' 214' ' ' PRO . 1.9 ptp85 -86.75 17.33 4.06 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.722 178.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . 0.523 ' O ' ' HG ' ' A' ' 189' ' ' LEU . . . -71.67 61.78 1.22 Allowed Glycine 0 N--CA 1.443 -0.881 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 177.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.677 ' O ' ' HD2' ' A' ' 214' ' ' PRO . 19.4 p90 -133.42 177.31 7.79 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 -178.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . 0.445 ' SG ' ' HB ' ' A' ' 186' ' ' VAL . 3.6 p -136.22 150.1 48.84 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 119.507 -0.877 . . . . 0.0 112.682 -179.144 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.686 ' CE2' ' CB ' ' A' ' 257' ' ' ALA . 3.1 m-85 -106.12 141.14 37.98 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.06 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.702 ' HB ' HG12 ' A' ' 184' ' ' ILE . 1.4 mt -138.0 114.42 11.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.458 0.647 . . . . 0.0 111.018 179.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.522 ' OG1' ' CG ' ' A' ' 183' ' ' LYS . 69.3 m -100.58 138.15 38.03 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.33 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.633 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 74.3 m-85 -112.51 126.42 55.31 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.221 -0.591 . . . . 0.0 111.335 -179.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.523 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -47.49 -38.89 14.72 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 177.52 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . 0.484 ' O ' ' HG3' ' A' ' 182' ' ' LYS . 17.5 mm-40 -91.2 -171.25 2.9 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 113.078 -1.874 . . . . 0.0 109.431 178.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . 0.487 ' HB3' ' HD2' ' A' ' 182' ' ' LYS . 0.0 OUTLIER -130.32 14.25 5.59 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.476 179.92 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.52 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.3 OUTLIER -84.89 -60.84 0.29 Allowed Pre-proline 0 CA--C 1.517 -0.318 0 C-N-CA 120.644 -0.423 . . . . 0.0 110.928 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.631 ' CB ' ' CE2' ' A' ' 230' ' ' PHE . 79.9 Cg_exo -49.3 -28.83 15.92 Favored 'Trans proline' 0 CA--C 1.499 -1.257 0 N-CA-C 108.719 -1.3 . . . . 0.0 108.719 178.208 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.582 HG22 ' CD1' ' A' ' 230' ' ' PHE . 14.5 t -73.29 -46.44 49.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 114.269 -1.332 . . . . 0.0 110.382 178.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . 0.52 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 2.1 pttp -62.12 -35.9 80.13 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.552 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.625 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.1 OUTLIER -81.38 -55.44 4.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.301 179.43 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.72 HG13 ' CE2' ' A' ' 205' ' ' PHE . 1.6 mt -42.04 -50.02 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.851 -179.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' MET . . . . . 0.425 ' CE ' ' HB ' ' A' ' 256' ' ' VAL . 46.7 mtp -59.82 -26.18 65.58 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.565 -178.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.5 ' CG ' ' O ' ' A' ' 237' ' ' LYS . 0.1 OUTLIER -82.24 -22.91 35.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.022 0.439 . . . . 0.0 110.742 179.875 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.413 ' HG2' ' O ' ' A' ' 238' ' ' LYS . 9.2 mmmt -79.11 107.06 11.59 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.662 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.572 ' HE2' ' CE1' ' A' ' 244' ' ' TYR . 0.3 OUTLIER -42.66 -46.66 5.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.997 -179.787 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.572 ' CE1' ' HE2' ' A' ' 243' ' ' LYS . 14.0 m-85 -138.59 161.27 37.51 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.047 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' HIS . . . . . 0.616 ' CD2' ' CG1' ' A' ' 254' ' ' ILE . 39.2 m-70 -126.08 152.58 45.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.078 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -130.71 105.44 7.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.042 0.449 . . . . 0.0 110.579 179.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.498 HG13 HG23 ' A' ' 198' ' ' ILE . 2.6 t -106.14 105.74 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.189 -179.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 54.32 -86.84 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.229 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.465 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.1 OUTLIER -109.87 -39.19 5.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.697 0.761 . . . . 0.0 109.787 -179.829 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' SER . . . . . 0.522 ' CB ' ' OG1' ' A' ' 193' ' ' THR . 0.0 OUTLIER -77.82 153.97 32.29 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.373 -1.285 . . . . 0.0 112.349 -178.435 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.452 ' HD3' ' O ' ' A' ' 249' ' ' LEU . 0.0 OUTLIER -150.22 110.63 4.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.266 179.114 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' CYS . . . . . 0.544 ' HB2' ' CG1' ' A' ' 186' ' ' VAL . 0.0 OUTLIER -127.91 153.16 46.99 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -177.709 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . 0.569 ' HG3' ' CE1' ' A' ' 244' ' ' TYR . 39.5 tt0 -75.98 110.34 10.36 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.149 -179.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . 0.626 HG12 ' CG1' ' A' ' 186' ' ' VAL . 11.5 mt -95.62 108.51 21.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -177.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.522 ' O ' ' C ' ' A' ' 256' ' ' VAL . 0.0 OUTLIER -112.03 129.86 56.06 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 105.488 -2.041 . . . . 0.0 105.488 176.066 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . 0.522 ' C ' ' O ' ' A' ' 255' ' ' LYS . 7.8 p -32.61 124.14 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 122.212 1.006 . . . . 0.0 111.459 -176.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.686 ' CB ' ' CE2' ' A' ' 227' ' ' PHE . . . -75.9 152.37 37.16 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 113.447 -1.706 . . . . 0.0 112.049 -177.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.5 123.59 21.62 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.216 179.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 259' ' ' SER . . . . . 0.485 ' OG ' ' NZ ' ' A' ' 183' ' ' LYS . 62.0 p . . . . . 0 C--N 1.326 -0.449 0 CA-C-O 120.903 0.382 . . . . 0.0 110.891 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 2' ' ' ' DT' . . . . . 0.776 ' O2 ' " H2'" ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.428 -0.764 0 C3'-C2'-C1' 101.611 -0.778 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 3' ' ' ' DA' . . . . . 1.028 " H4'" " O5'" ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.424 -1.022 0 C3'-C2'-C1' 101.658 -0.744 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 4' ' ' ' DG' . . . . . 1.028 " O5'" " H4'" ' B' ' 3' ' ' ' DA' . . . . . . . . 0 O5'--C5' 1.426 -0.847 0 C4'-C3'-C2' 102.316 -0.884 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 5' ' ' ' DG' . . . . . 0.713 ' N7 ' ' C6 ' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 C2'--C1' 1.507 -0.976 0 C4'-C3'-C2' 104.812 1.612 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.531 HG11 ' N ' ' A' ' 182' ' ' LYS . 40.9 t . . . . . 0 CA--C 1.502 -0.895 0 CA-C-O 121.217 0.532 . . . . 0.0 111.66 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.534 ' HG2' ' CB ' ' A' ' 233' ' ' GLU . 0.0 OUTLIER -149.18 112.52 4.97 Favored 'General case' 0 N--CA 1.432 -1.375 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.487 177.97 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.634 ' HD3' ' HB1' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -131.22 142.86 50.23 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-N 114.974 -1.012 . . . . 0.0 108.646 178.52 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.647 HG12 ' HB ' ' A' ' 228' ' ' ILE . 1.3 pt -123.85 119.75 57.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.656 ' CE2' ' CE2' ' A' ' 225' ' ' PHE . 0.2 OUTLIER -92.5 109.81 21.21 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.494 0.664 . . . . 0.0 110.404 -178.982 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.511 ' O ' ' HB2' ' A' ' 225' ' ' PHE . 6.3 t -85.97 129.84 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.886 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.568 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . -79.43 -153.73 8.07 Favored Glycine 0 CA--C 1.521 0.454 0 C-N-CA 121.034 -0.603 . . . . 0.0 114.209 -178.062 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.511 ' HA2' ' O ' ' A' ' 224' ' ' GLY . . . -34.56 109.61 0.06 OUTLIER Glycine 0 C--N 1.334 0.442 0 N-CA-C 114.255 0.462 . . . . 0.0 114.255 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.537 ' O ' ' O ' ' A' ' 190' ' ' SER . 1.7 pp -117.05 157.48 25.78 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.687 0.28 . . . . 0.0 110.819 179.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.56 ' CB ' ' CD ' ' A' ' 191' ' ' PRO . 0.3 OUTLIER -42.25 -177.96 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.259 0 CA-C-O 121.463 0.649 . . . . 0.0 112.087 -179.709 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.56 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 10.4 Cg_exo -70.82 1.52 5.05 Favored 'Trans proline' 0 CA--C 1.529 0.266 0 C-N-CA 123.232 2.621 . . . . 0.0 113.404 -179.403 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 192' ' ' ASP . 8.4 p-10 165.44 74.91 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.89 0.376 . . . . 0.0 111.415 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.531 HG21 ' CD1' ' A' ' 198' ' ' ILE . 11.9 m -68.9 116.85 45.6 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.125 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.489 ' HG2' ' HG2' ' A' ' 197' ' ' LYS . 36.5 Cg_endo -64.78 118.36 5.35 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.424 2.083 . . . . 0.0 111.438 179.037 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.767 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -52.06 -16.05 0.69 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.328 -179.607 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . 0.484 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 34.8 mt-10 -68.23 -37.85 81.24 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -179.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.516 ' NZ ' ' OE1' ' A' ' 200' ' ' GLU . 18.0 mmmt -74.44 -50.08 19.81 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.767 ' CG1' ' HA ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -48.13 -31.15 2.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 114.849 -1.069 . . . . 0.0 108.428 178.229 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.578 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 1.9 mtp85 -71.09 -32.73 69.44 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.296 178.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . 0.55 ' CG ' ' N ' ' A' ' 201' ' ' TYR . 4.2 pt-20 -81.71 -53.03 6.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.201 0.524 . . . . 0.0 109.894 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.56 ' OH ' ' ND1' ' A' ' 245' ' ' HIS . 0.3 OUTLIER -55.35 -54.05 48.52 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.98 178.87 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.658 ' CD2' HD12 ' A' ' 228' ' ' ILE . 0.2 OUTLIER -79.58 -31.15 41.79 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.069 -0.968 . . . . 0.0 110.424 -179.67 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.578 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -65.1 -55.47 21.48 Favored Glycine 0 CA--C 1.499 -0.927 0 N-CA-C 106.928 -2.469 . . . . 0.0 106.928 176.349 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -49.97 -28.82 13.08 Favored Glycine 0 N--CA 1.442 -0.936 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 176.128 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . 0.745 ' CE2' HG13 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -57.93 -46.18 85.44 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 122.145 0.974 . . . . 0.0 108.496 177.738 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 171.95 -130.89 2.03 Favored Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 113.542 -1.663 . . . . 0.0 110.247 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.464 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 5.2 mm-40 -97.01 100.7 12.2 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.245 0.545 . . . . 0.0 111.05 178.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 2.9 t -78.11 140.86 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.088 0 CA-C-N 115.235 -0.893 . . . . 0.0 108.653 178.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.487 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 10.1 tp10 -94.43 -53.83 3.76 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.771 0.32 . . . . 0.0 110.352 179.154 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.404 ' C ' HG12 ' A' ' 211' ' ' ILE . 24.0 p -159.83 156.85 28.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.21 0.528 . . . . 0.0 111.842 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.598 ' CD1' ' HB ' ' A' ' 198' ' ' ILE . 0.1 OUTLIER -131.84 124.57 53.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.528 178.959 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.546 ' OE1' ' N7 ' ' B' ' 4' ' ' ' DG' . 0.6 OUTLIER -123.07 103.26 8.46 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -178.16 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.52 HD13 ' N ' ' A' ' 195' ' ' GLU . 0.1 OUTLIER -96.72 105.91 26.52 Favored Pre-proline 0 C--N 1.329 -0.323 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 177.357 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.588 ' HD2' ' O ' ' A' ' 225' ' ' PHE . 31.3 Cg_exo -61.41 -158.22 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 123.272 2.648 . . . . 0.0 113.494 -179.103 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' MET . . . . . 0.475 ' HB2' ' CB ' ' A' ' 220' ' ' ASN . 5.5 mmt -97.13 173.56 7.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.455 -179.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -106.65 150.66 26.0 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.461 -179.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . 0.556 ' N ' ' O ' ' A' ' 221' ' ' LYS . 21.8 t30 -52.92 -16.45 1.04 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.295 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.59 -32.37 73.35 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.47 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -137.76 5.5 2.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.155 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . 0.475 ' CB ' ' HB2' ' A' ' 215' ' ' MET . 6.8 m-80 -143.71 -85.79 0.14 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.642 0.258 . . . . 0.0 111.537 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . 0.556 ' O ' ' N ' ' A' ' 217' ' ' ASN . 0.2 OUTLIER -161.05 174.46 13.7 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.706 179.853 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.626 ' O ' ' CG ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -84.09 41.85 0.84 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 122.564 1.173 . . . . 0.0 111.102 -179.289 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.538 ' HB2' ' CE1' ' A' ' 225' ' ' PHE . 5.0 ptp85 -72.05 -29.05 63.76 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 177.44 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . 0.511 ' O ' ' HA2' ' A' ' 188' ' ' GLY . . . 9.11 62.72 0.01 OUTLIER Glycine 0 C--N 1.337 0.592 0 CA-C-N 114.334 -1.303 . . . . 0.0 113.728 178.29 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.656 ' CE2' ' CE2' ' A' ' 185' ' ' PHE . 0.4 OUTLIER -156.47 176.48 12.65 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.712 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . 0.462 ' O ' ' HB ' ' A' ' 186' ' ' VAL . 11.9 p -142.14 149.56 39.95 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.028 -0.669 . . . . 0.0 112.538 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.668 ' CE2' ' CB ' ' A' ' 257' ' ' ALA . 4.7 m-85 -106.24 138.86 41.67 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.592 178.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.658 HD12 ' CD2' ' A' ' 202' ' ' PHE . 2.2 mt -133.87 135.09 55.57 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.35 0 CA-C-O 120.962 0.41 . . . . 0.0 111.133 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.431 ' OG1' ' HG2' ' A' ' 183' ' ' LYS . 52.3 m -116.26 138.08 51.6 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.719 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.653 ' CE1' ' CB ' ' A' ' 235' ' ' PRO . 75.4 m-85 -112.9 126.29 55.3 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.271 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.487 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -49.36 -38.93 30.0 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 177.981 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . 0.467 ' O ' ' HD3' ' A' ' 182' ' ' LYS . 63.9 mt-10 -92.59 -170.86 2.59 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 113.362 -1.745 . . . . 0.0 109.304 178.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . 0.541 ' O ' ' HG3' ' A' ' 237' ' ' LYS . 14.4 pt-20 -126.09 2.83 7.22 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.836 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.511 ' O ' ' N ' ' A' ' 237' ' ' LYS . 0.2 OUTLIER -74.33 -59.25 1.69 Allowed Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.809 -179.169 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.653 ' CB ' ' CE1' ' A' ' 230' ' ' PHE . 87.5 Cg_exo -49.15 -32.94 25.93 Favored 'Trans proline' 0 CA--C 1.5 -1.196 0 N-CA-C 108.814 -1.264 . . . . 0.0 108.814 178.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.569 HG21 ' CD2' ' A' ' 230' ' ' PHE . 22.9 t -70.41 -41.57 78.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 114.041 -1.436 . . . . 0.0 108.985 177.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . 0.541 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 20.6 mtpt -55.78 -46.91 77.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.799 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.476 ' HA ' ' HG3' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -81.01 -48.76 11.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.144 -179.501 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.745 HG13 ' CE2' ' A' ' 205' ' ' PHE . 1.7 mt -43.57 -49.49 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.841 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' MET . . . . . 0.428 ' SD ' HG13 ' A' ' 236' ' ' VAL . 52.9 mtp -61.22 -29.93 70.13 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.637 -178.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.476 ' HG3' ' HA ' ' A' ' 238' ' ' LYS . 0.2 OUTLIER -85.97 -12.17 51.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.794 0.33 . . . . 0.0 111.134 -179.56 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.425 ' O ' ' C ' ' A' ' 243' ' ' LYS . 11.5 mmmm -79.63 103.5 9.58 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.837 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.554 ' CD ' ' CD2' ' A' ' 244' ' ' TYR . 0.1 OUTLIER -37.46 -58.05 0.88 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.15 0.5 . . . . 0.0 110.325 179.75 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.637 ' CD1' ' HB3' ' A' ' 253' ' ' GLU . 10.9 m-85 -135.51 153.27 51.78 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.239 179.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' HIS . . . . . 0.575 ' CD2' HG13 ' A' ' 254' ' ' ILE . 28.8 m-70 -111.91 157.43 20.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.116 -179.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . 0.447 ' ND2' ' C ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -139.79 104.3 4.86 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.299 0.571 . . . . 0.0 109.979 178.525 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.51 ' N ' ' O ' ' A' ' 250' ' ' SER . 1.4 t -95.67 -173.65 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.874 -179.468 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . 0.502 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . -26.51 -56.69 0.08 OUTLIER Glycine 0 C--N 1.337 0.619 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.761 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.47 -40.03 1.27 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.443 0.639 . . . . 0.0 111.033 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' SER . . . . . 0.51 ' O ' ' N ' ' A' ' 247' ' ' VAL . 57.2 p -77.59 150.01 34.75 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.094 -0.957 . . . . 0.0 112.794 -178.316 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.508 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -144.87 102.69 3.81 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.225 178.373 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' CYS . . . . . 0.568 ' HB3' ' C ' ' A' ' 187' ' ' GLY . 0.0 OUTLIER -130.11 154.86 47.05 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -177.448 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . 0.637 ' HB3' ' CD1' ' A' ' 244' ' ' TYR . 6.9 pt-20 -74.61 119.05 18.28 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . 0.596 ' CG2' ' CG2' ' A' ' 239' ' ' ILE . 39.8 mt -97.2 102.47 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 CA-C-O 121.621 0.724 . . . . 0.0 112.332 -178.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.542 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -103.38 129.27 50.41 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 177.781 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . 0.55 ' CG2' ' O ' ' A' ' 183' ' ' LYS . 5.7 p -32.32 123.62 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.509 -0.599 0 CA-C-O 122.307 1.051 . . . . 0.0 111.491 -176.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.668 ' CB ' ' CE2' ' A' ' 227' ' ' PHE . . . -76.26 152.57 36.46 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 113.319 -1.764 . . . . 0.0 111.982 -178.257 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.35 114.93 14.27 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.354 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 259' ' ' SER . . . . . 0.515 ' OG ' ' C6 ' ' B' ' 4' ' ' ' DG' . 0.1 OUTLIER . . . . . 0 C--N 1.326 -0.452 0 CA-C-O 121.082 0.468 . . . . 0.0 111.518 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 2' ' ' ' DT' . . . . . 0.864 ' O2 ' " H2'" ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.427 -0.821 0 O4'-C1'-C2' 106.93 0.754 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 3' ' ' ' DA' . . . . . 0.532 H5'' ' CB ' ' A' ' 223' ' ' ARG . . . . . . . . 0 O5'--C5' 1.426 -0.893 0 C4'-C3'-C2' 103.929 0.729 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 4' ' ' ' DG' . . . . . 0.608 ' C8 ' ' N7 ' ' B' ' 5' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.428 -0.755 0 C4'-C3'-C2' 101.193 -2.007 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 5' ' ' ' DG' . . . . . 0.608 ' N7 ' ' C8 ' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 C2'--C1' 1.511 -0.7 0 C4'-C3'-C2' 102.392 -0.808 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.511 ' CG1' ' N ' ' A' ' 182' ' ' LYS . 45.5 t . . . . . 0 CA--C 1.503 -0.85 0 CA-C-O 121.243 0.544 . . . . 0.0 111.612 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.879 ' HB2' HG21 ' A' ' 236' ' ' VAL . 0.5 OUTLIER -149.97 112.6 4.75 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.883 177.769 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.765 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.0 OUTLIER -135.46 155.85 49.86 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.55 179.242 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.87 HD13 ' HE2' ' A' ' 230' ' ' PHE . 0.4 OUTLIER -131.15 121.19 48.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 115.452 -0.794 . . . . 0.0 108.858 178.973 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.825 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.3 OUTLIER -93.82 109.25 20.94 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.287 0.565 . . . . 0.0 110.826 -178.981 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 1.012 HG12 ' HB2' ' A' ' 252' ' ' CYS . 2.5 t -86.08 126.4 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.586 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.589 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . -114.76 126.4 7.22 Favored Glycine 0 N--CA 1.452 -0.274 0 N-CA-C 114.602 0.601 . . . . 0.0 114.602 -176.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.464 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . 80.59 83.13 0.74 Allowed Glycine 0 CA--C 1.519 0.285 0 C-N-CA 121.245 -0.502 . . . . 0.0 113.361 179.119 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.966 HD23 ' C ' ' A' ' 225' ' ' PHE . 0.6 OUTLIER -117.25 157.77 25.47 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.816 0.341 . . . . 0.0 111.384 -179.394 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.615 ' N ' HD12 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -45.4 -177.41 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.197 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.557 179.503 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 191' ' ' PRO . . . . . 0.555 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 11.4 Cg_exo -70.62 6.54 1.55 Allowed 'Trans proline' 0 CA--C 1.532 0.406 0 C-N-CA 123.255 2.637 . . . . 0.0 113.514 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.516 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 2.8 p30 160.55 77.65 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.013 0.435 . . . . 0.0 110.812 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.891 HG22 HD11 ' A' ' 198' ' ' ILE . 51.8 m -73.02 131.76 83.4 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.003 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.575 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 68.6 Cg_endo -80.96 114.34 2.88 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 122.945 2.43 . . . . 0.0 111.632 179.155 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.583 ' HA ' ' CD1' ' A' ' 198' ' ' ILE . 1.6 pm0 -48.1 -17.81 0.15 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.357 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 196' ' ' GLU . . . . . 0.474 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 27.4 mm-40 -61.36 -44.02 97.89 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -179.027 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.575 ' CD ' ' HG2' ' A' ' 194' ' ' PRO . 0.9 OUTLIER -76.38 -46.39 27.57 Favored 'General case' 0 CA--C 1.494 -1.207 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 178.826 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.959 ' CD1' HD21 ' A' ' 213' ' ' LEU . 0.2 OUTLIER -48.34 -29.01 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.373 0 CA-C-N 113.862 -1.517 . . . . 0.0 108.736 177.245 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.57 ' HG3' ' O ' ' A' ' 195' ' ' GLU . 2.3 mtt180 -76.12 -31.73 58.79 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-N 115.294 -0.867 . . . . 0.0 110.029 178.262 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 200' ' ' GLU . . . . . 0.58 ' CG ' ' N ' ' A' ' 201' ' ' TYR . 4.2 pt-20 -82.01 -55.17 4.74 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.098 0.475 . . . . 0.0 110.293 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.58 ' N ' ' CG ' ' A' ' 200' ' ' GLU . 0.3 OUTLIER -50.11 -53.88 24.4 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.484 0.659 . . . . 0.0 109.67 178.797 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 1.011 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.5 OUTLIER -79.66 -32.69 41.58 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.7 -179.836 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.539 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -62.82 -55.05 29.13 Favored Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 107.359 -2.296 . . . . 0.0 107.359 176.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -51.39 -27.84 18.36 Favored Glycine 0 N--CA 1.442 -0.949 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 176.36 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.764 ' CE2' HG13 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -59.17 -44.89 92.16 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 122.129 0.966 . . . . 0.0 108.601 177.849 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.493 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 172.42 -132.41 2.38 Favored Glycine 0 N--CA 1.442 -0.938 0 CA-C-N 113.698 -1.592 . . . . 0.0 110.482 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.486 ' HB2' ' HG3' ' A' ' 232' ' ' GLU . 1.8 mt-10 -97.22 97.13 8.92 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.21 0.529 . . . . 0.0 111.456 178.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 2.5 t -72.56 137.63 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' GLU . . . . . 0.669 ' HB3' HG22 ' A' ' 229' ' ' THR . 5.8 tp10 -89.54 -50.7 5.93 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 178.581 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.438 ' OG ' ' OE2' ' A' ' 212' ' ' GLU . 0.9 OUTLIER -165.15 159.02 17.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.31 0.576 . . . . 0.0 111.913 179.263 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.533 HD11 ' HA ' ' A' ' 199' ' ' ARG . 0.1 OUTLIER -131.59 120.72 46.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.212 179.156 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 212' ' ' GLU . . . . . 0.438 ' OE2' ' OG ' ' A' ' 210' ' ' SER . 0.0 OUTLIER -123.43 102.64 8.01 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -179.066 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.959 HD21 ' CD1' ' A' ' 198' ' ' ILE . 1.7 mp . . . . . 0 C--N 1.329 -0.284 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 177.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.676 0 CA-C-O 121.16 0.311 . . . . 0.0 112.812 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 225' ' ' PHE . . . . . 0.966 ' C ' HD23 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -157.15 176.93 12.08 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -178.29 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 226' ' ' CYS . . . . . 0.808 ' HB3' HD23 ' A' ' 213' ' ' LEU . 1.4 p -141.42 149.18 40.69 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.258 -0.577 . . . . 0.0 112.433 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 1.104 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 5.7 m-85 -107.21 146.45 31.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.351 178.306 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 1.011 HD12 ' CE2' ' A' ' 202' ' ' PHE . 1.8 mt -141.12 121.22 12.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.287 0.565 . . . . 0.0 111.667 179.5 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 229' ' ' THR . . . . . 0.669 HG22 ' HB3' ' A' ' 209' ' ' GLU . 31.2 m -102.39 137.91 40.01 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.235 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.87 ' HE2' HD13 ' A' ' 184' ' ' ILE . 72.4 m-85 -113.58 126.41 55.26 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.078 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.558 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -51.79 -37.31 51.03 Favored 'General case' 0 CA--C 1.505 -0.769 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 178.328 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 232' ' ' GLU . . . . . 0.49 ' O ' ' HG3' ' A' ' 182' ' ' LYS . 1.6 mm-40 -93.37 -175.28 3.76 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 113.39 -1.732 . . . . 0.0 109.3 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 233' ' ' GLU . . . . . 0.553 ' HB3' ' CE ' ' A' ' 182' ' ' LYS . 0.1 OUTLIER -124.67 11.37 8.49 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.912 -179.631 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.562 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.2 OUTLIER -80.74 -59.79 0.47 Allowed Pre-proline 0 C--N 1.328 -0.327 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.813 179.926 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.92 ' O ' HD12 ' A' ' 239' ' ' ILE . 84.0 Cg_exo -49.71 -31.87 26.92 Favored 'Trans proline' 0 CA--C 1.502 -1.087 0 N-CA-C 108.785 -1.275 . . . . 0.0 108.785 177.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.879 HG21 ' HB2' ' A' ' 182' ' ' LYS . 12.8 t -72.1 -44.93 64.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 114.059 -1.428 . . . . 0.0 110.566 178.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.562 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 19.4 pttt -62.33 -37.85 87.2 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.987 -179.153 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.48 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 0.0 OUTLIER -82.05 -49.99 9.6 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.856 0.36 . . . . 0.0 111.052 179.351 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.92 HD12 ' O ' ' A' ' 235' ' ' PRO . 1.4 mt -42.88 -53.08 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 24.7 mtp -56.23 -32.2 64.24 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.027 -179.057 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.477 ' CG ' ' O ' ' A' ' 237' ' ' LYS . 1.1 mt-10 -75.4 -21.19 58.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.13 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -79.57 109.92 14.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.849 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.406 ' HE2' ' HG3' ' A' ' 253' ' ' GLU . 0.0 OUTLIER -48.18 -47.57 35.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.755 179.951 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 244' ' ' TYR . . . . . 0.561 ' CE1' ' HG3' ' A' ' 253' ' ' GLU . 8.5 m-85 -138.31 151.75 47.86 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.903 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 245' ' ' HIS . . . . . 0.807 ' CG ' HD12 ' A' ' 254' ' ' ILE . 29.7 m-70 -116.67 154.91 29.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.25 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 246' ' ' ASN . . . . . 0.406 ' O ' ' CE2' ' A' ' 201' ' ' TYR . 2.4 m-80 -134.34 105.23 6.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.276 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.545 ' N ' ' O ' ' A' ' 250' ' ' SER . 2.2 t -103.57 106.88 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.292 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 248' ' ' GLY . . . . . 0.457 ' C ' HD23 ' A' ' 249' ' ' LEU . . . 52.04 -83.06 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.186 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.544 HD23 ' N ' ' A' ' 249' ' ' LEU . 0.0 OUTLIER -111.11 -38.34 5.08 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.586 0.707 . . . . 0.0 110.267 179.727 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.545 ' O ' ' N ' ' A' ' 247' ' ' VAL . 0.6 OUTLIER -77.16 153.21 34.41 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.747 -1.115 . . . . 0.0 112.014 -178.627 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.498 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -146.97 107.08 4.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.959 179.159 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 252' ' ' CYS . . . . . 1.012 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -128.2 153.41 46.94 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -176.933 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 253' ' ' GLU . . . . . 0.561 ' HG3' ' CE1' ' A' ' 244' ' ' TYR . 29.2 tt0 -76.02 109.56 9.77 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.194 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 254' ' ' ILE . . . . . 0.861 HG12 HG13 ' A' ' 186' ' ' VAL . 21.4 mt -96.54 115.23 35.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 -178.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 255' ' ' LYS . . . . . 0.517 ' O ' ' C ' ' A' ' 256' ' ' VAL . 0.0 OUTLIER -121.01 131.8 54.51 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 106.144 -1.799 . . . . 0.0 106.144 176.628 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 183' ' ' LYS . 3.9 p -32.87 121.76 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.513 -0.472 0 CA-C-O 122.398 1.095 . . . . 0.0 111.446 -177.397 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 1.104 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -75.77 155.49 35.46 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 113.117 -1.856 . . . . 0.0 111.909 -178.53 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.91 125.16 27.71 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.426 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 259' ' ' SER . . . . . 0.568 ' HB3' ' CE ' ' A' ' 183' ' ' LYS . 83.3 p . . . . . 0 C--N 1.324 -0.516 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.232 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.46 ' CG1' ' N ' ' A' ' 182' ' ' LYS . 45.8 t . . . . . 0 CA--C 1.502 -0.891 0 CA-C-O 121.46 0.648 . . . . 0.0 112.051 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.559 ' HB3' HG21 ' A' ' 236' ' ' VAL . 0.0 OUTLIER -148.91 111.56 4.78 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.117 176.733 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.829 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -138.57 146.1 41.44 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 114.979 -1.01 . . . . 0.0 109.623 179.39 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.877 HD13 ' HE1' ' A' ' 230' ' ' PHE . 0.4 OUTLIER -125.38 120.32 57.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.528 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.854 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -93.33 109.09 20.63 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.423 0.63 . . . . 0.0 110.459 -178.738 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 1.12 HG12 ' HB2' ' A' ' 252' ' ' CYS . 1.9 t -88.14 122.58 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.023 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.597 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . -108.23 125.79 8.0 Favored Glycine 0 N--CA 1.452 -0.239 0 CA-C-N 115.893 -0.594 . . . . 0.0 114.535 -176.52 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.476 ' O ' ' CB ' ' A' ' 252' ' ' CYS . . . 81.33 86.86 0.66 Allowed Glycine 0 C--N 1.333 0.414 0 C-N-CA 121.025 -0.607 . . . . 0.0 113.026 179.251 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.934 HD23 ' C ' ' A' ' 225' ' ' PHE . 0.7 OUTLIER -116.87 156.64 26.98 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.835 0.35 . . . . 0.0 111.258 -179.657 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.605 ' O ' HD12 ' A' ' 189' ' ' LEU . 0.2 OUTLIER -45.31 179.65 0.01 OUTLIER Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.16 179.56 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 191' ' ' PRO . . . . . 0.53 ' CD ' ' OG ' ' A' ' 190' ' ' SER . 15.5 Cg_exo -68.33 4.98 1.35 Allowed 'Trans proline' 0 CA--C 1.531 0.346 0 C-N-CA 123.138 2.559 . . . . 0.0 113.575 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.505 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 0.3 OUTLIER 161.4 76.25 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.877 0.37 . . . . 0.0 110.954 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.847 ' OG1' HD13 ' A' ' 189' ' ' LEU . 35.7 m -70.86 132.41 86.88 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.469 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.626 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 83.9 Cg_endo -77.25 115.21 3.91 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.77 2.313 . . . . 0.0 110.955 178.324 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.803 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -51.61 -13.7 0.27 Allowed 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -179.36 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 196' ' ' GLU . . . . . 0.513 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 25.9 mt-10 -68.17 -41.34 81.63 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -179.411 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.626 ' CD ' ' HG2' ' A' ' 194' ' ' PRO . 1.5 mttp -72.5 -47.37 49.07 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.803 ' CG1' ' HA ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -47.05 -31.02 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.118 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.575 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 4.1 mtp85 -71.71 -33.46 68.77 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.247 179.121 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 200' ' ' GLU . . . . . 0.525 ' CG ' ' N ' ' A' ' 201' ' ' TYR . 3.1 pt-20 -82.49 -51.55 7.7 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.005 0.431 . . . . 0.0 110.601 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.525 ' N ' ' CG ' ' A' ' 200' ' ' GLU . 0.2 OUTLIER -54.84 -54.6 40.29 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.497 0.665 . . . . 0.0 109.835 178.964 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 1.107 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.4 OUTLIER -79.29 -31.0 43.19 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.079 -179.784 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.575 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -63.41 -55.47 25.43 Favored Glycine 0 CA--C 1.501 -0.841 0 N-CA-C 106.812 -2.515 . . . . 0.0 106.812 176.067 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -49.05 -29.35 8.62 Favored Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 176.009 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.803 ' CD2' HD11 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -59.18 -42.56 91.11 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 122.046 0.927 . . . . 0.0 108.587 177.704 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.489 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 167.69 -130.44 2.1 Favored Glycine 0 N--CA 1.442 -0.923 0 CA-C-N 113.666 -1.606 . . . . 0.0 110.318 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.526 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 13.1 mt-10 -97.02 101.91 13.58 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.157 0.503 . . . . 0.0 110.923 178.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.459 HG21 ' HB2' ' A' ' 202' ' ' PHE . 2.4 t -77.14 143.97 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 CA-C-N 115.449 -0.796 . . . . 0.0 108.931 178.362 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 209' ' ' GLU . . . . . 0.738 ' HB3' HG22 ' A' ' 229' ' ' THR . 18.8 tp10 -91.8 -55.13 3.58 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 178.412 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 3.3 m -170.55 150.88 3.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.765 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.959 HD13 HG23 ' A' ' 228' ' ' ILE . 0.4 OUTLIER -117.53 133.33 64.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.752 179.088 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -123.21 103.35 8.48 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -178.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.603 HD13 ' HB3' ' A' ' 226' ' ' CYS . 2.4 mm? . . . . . 0 CA--C 1.531 0.226 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 177.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.458 0 N-CA-C 112.252 -0.339 . . . . 0.0 112.252 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 225' ' ' PHE . . . . . 0.934 ' C ' HD23 ' A' ' 189' ' ' LEU . 0.0 OUTLIER -157.36 176.67 12.37 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.924 -0.638 . . . . 0.0 110.017 -177.773 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 226' ' ' CYS . . . . . 0.603 ' HB3' HD13 ' A' ' 213' ' ' LEU . 4.0 p -136.04 148.63 48.44 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.115 -0.634 . . . . 0.0 112.428 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 1.101 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 3.4 m-85 -109.81 132.79 53.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.111 -0.95 . . . . 0.0 108.446 178.254 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 1.107 HD12 ' CE2' ' A' ' 202' ' ' PHE . 1.8 mt -129.09 122.2 55.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.213 0.53 . . . . 0.0 111.785 -179.107 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 229' ' ' THR . . . . . 0.738 HG22 ' HB3' ' A' ' 209' ' ' GLU . 24.4 m -103.62 138.24 40.57 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.241 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.877 ' HE1' HD13 ' A' ' 184' ' ' ILE . 65.3 m-85 -110.97 126.38 54.71 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.55 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.559 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -48.22 -38.93 19.63 Favored 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 178.442 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 232' ' ' GLU . . . . . 0.452 ' O ' ' O ' ' A' ' 230' ' ' PHE . 0.3 OUTLIER -92.1 -166.18 1.5 Allowed 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 113.121 -1.854 . . . . 0.0 109.14 178.586 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 233' ' ' GLU . . . . . 0.517 ' O ' ' HG3' ' A' ' 237' ' ' LYS . 0.3 OUTLIER -131.27 -0.13 4.08 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.581 179.86 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.509 ' O ' ' N ' ' A' ' 237' ' ' LYS . 0.6 OUTLIER -72.57 -58.99 2.64 Favored Pre-proline 0 C--N 1.331 -0.234 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.835 -179.422 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.864 ' O ' HD12 ' A' ' 239' ' ' ILE . 96.5 Cg_exo -48.98 -32.91 24.59 Favored 'Trans proline' 0 CA--C 1.497 -1.373 0 N-CA-C 108.949 -1.212 . . . . 0.0 108.949 178.652 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.559 HG21 ' HB3' ' A' ' 182' ' ' LYS . 21.6 t -69.87 -40.84 79.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 113.834 -1.53 . . . . 0.0 109.075 178.118 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.517 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 8.7 mttt -58.81 -45.93 88.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.877 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.459 ' O ' ' HD3' ' A' ' 242' ' ' LYS . 0.0 OUTLIER -80.25 -47.42 14.63 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.064 -179.703 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.864 HD12 ' O ' ' A' ' 235' ' ' PRO . 1.6 mt -45.15 -50.82 2.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.7 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 240' ' ' MET . . . . . 0.501 ' SD ' HG12 ' A' ' 236' ' ' VAL . 23.0 mtp -58.13 -28.22 64.47 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.192 -179.073 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.465 ' N ' ' OE1' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -82.48 -20.76 36.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.224 0.535 . . . . 0.0 109.824 179.408 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.459 ' HD3' ' O ' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -80.55 100.13 8.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.019 179.729 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.61 ' HE2' ' CG ' ' A' ' 244' ' ' TYR . 1.8 ttpt -40.7 -67.43 0.24 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.24 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 244' ' ' TYR . . . . . 0.61 ' CG ' ' HE2' ' A' ' 243' ' ' LYS . 7.1 m-30 -113.94 154.4 27.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.197 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 245' ' ' HIS . . . . . 0.699 ' CG ' HD12 ' A' ' 254' ' ' ILE . 24.3 m-70 -123.12 147.85 46.33 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.338 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 246' ' ' ASN . . . . . 0.448 ' HB3' ' HD2' ' A' ' 251' ' ' LYS . 0.4 OUTLIER -125.73 105.24 8.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.989 0.424 . . . . 0.0 110.938 179.712 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.662 HG11 HG23 ' A' ' 198' ' ' ILE . 1.9 t -102.64 108.98 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.235 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 48.76 -83.93 0.01 OUTLIER Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.271 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.556 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -110.48 -38.64 5.15 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.402 0.62 . . . . 0.0 110.497 179.639 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.522 ' HB3' ' HB2' ' A' ' 190' ' ' SER . 1.6 p -77.06 150.44 35.73 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.011 -0.995 . . . . 0.0 112.068 -178.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -144.88 108.05 4.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.307 178.984 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 252' ' ' CYS . . . . . 1.12 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -128.04 153.01 47.25 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -177.436 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 253' ' ' GLU . . . . . 0.492 ' HB2' ' CE1' ' A' ' 244' ' ' TYR . 51.5 tt0 -76.17 113.14 13.38 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.221 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 254' ' ' ILE . . . . . 0.92 HG12 HG13 ' A' ' 186' ' ' VAL . 10.1 mt -96.53 113.05 29.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 114.66 1.355 . . . . 0.0 114.66 -178.183 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 255' ' ' LYS . . . . . 0.518 ' O ' ' C ' ' A' ' 256' ' ' VAL . 0.0 OUTLIER -119.5 129.57 54.77 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 176.207 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.674 HG23 ' O ' ' A' ' 183' ' ' LYS . 6.3 p -32.84 121.46 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.433 0 CA-C-O 122.264 1.031 . . . . 0.0 111.42 -177.157 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 1.101 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -76.01 154.1 36.0 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 113.207 -1.815 . . . . 0.0 112.132 -178.239 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.32 117.16 19.36 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.174 179.451 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.323 -0.558 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.716 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.543 ' CA ' ' HE3' ' A' ' 182' ' ' LYS . 55.7 t . . . . . 0 CA--C 1.506 -0.74 0 CA-C-O 121.02 0.438 . . . . 0.0 111.502 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 1.086 ' HB2' HG21 ' A' ' 236' ' ' VAL . 0.0 OUTLIER -154.37 112.41 3.52 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.185 177.293 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.829 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -134.62 153.72 51.84 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.76 179.207 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.783 HD13 ' HE1' ' A' ' 230' ' ' PHE . 0.1 OUTLIER -133.1 120.49 40.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 177.991 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.816 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -92.51 109.94 21.35 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 121.341 0.591 . . . . 0.0 110.309 -179.434 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.684 HG12 ' HB2' ' A' ' 252' ' ' CYS . 39.2 t -88.08 131.0 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.968 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.502 ' O ' ' HB3' ' A' ' 252' ' ' CYS . . . -85.16 -146.56 8.45 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 114.597 0.599 . . . . 0.0 114.597 -177.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.491 ' HA2' ' O ' ' A' ' 224' ' ' GLY . . . -35.56 103.29 0.02 OUTLIER Glycine 0 C--N 1.336 0.569 0 N-CA-C 114.505 0.562 . . . . 0.0 114.505 -179.25 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.924 HD13 ' OG1' ' A' ' 193' ' ' THR . 1.7 pp -117.78 157.07 27.22 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 122.453 0.301 . . . . 0.0 110.893 179.099 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.828 ' O ' HD12 ' A' ' 189' ' ' LEU . 0.0 OUTLIER -42.27 172.64 0.03 OUTLIER Pre-proline 0 N--CA 1.463 0.191 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.32 179.806 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 191' ' ' PRO . . . . . 0.515 ' HD2' ' OG ' ' A' ' 190' ' ' SER . 31.7 Cg_exo -60.37 -5.24 3.92 Favored 'Trans proline' 0 CA--C 1.532 0.395 0 C-N-CA 122.891 2.394 . . . . 0.0 113.466 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 191' ' ' PRO . 0.1 OUTLIER 172.78 73.19 0.0 OUTLIER 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.924 0.392 . . . . 0.0 111.503 -179.943 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.924 ' OG1' HD13 ' A' ' 189' ' ' LEU . 57.4 m -61.36 114.31 10.51 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.471 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.538 ' HG2' ' HG2' ' A' ' 197' ' ' LYS . 13.3 Cg_endo -58.19 114.26 1.89 Allowed 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.166 1.911 . . . . 0.0 111.013 178.612 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.836 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 6.5 pt-20 -53.4 -14.67 0.81 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.501 -179.287 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' GLU . . . . . 0.514 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 51.7 mt-10 -68.34 -38.51 81.55 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.538 ' HG2' ' HG2' ' A' ' 194' ' ' PRO . 0.1 OUTLIER -73.85 -49.2 26.2 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.309 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 1.022 HG22 ' CE1' ' A' ' 202' ' ' PHE . 0.0 OUTLIER -48.48 -30.91 3.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.062 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.598 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 11.0 mtp180 -69.18 -33.43 73.35 Favored 'General case' 0 C--O 1.22 -0.494 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.639 178.367 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 200' ' ' GLU . . . . . 0.534 ' N ' ' O ' ' A' ' 197' ' ' LYS . 4.3 mt-10 -82.42 -59.58 2.49 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.422 178.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.52 ' C ' ' CD1' ' A' ' 201' ' ' TYR . 0.4 OUTLIER -49.0 -54.27 16.37 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.498 0.666 . . . . 0.0 109.839 179.119 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 1.074 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.6 OUTLIER -79.36 -30.83 42.76 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 114.92 -1.037 . . . . 0.0 110.244 -179.863 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.598 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -62.2 -57.53 16.58 Favored Glycine 0 N--CA 1.443 -0.879 0 N-CA-C 106.959 -2.456 . . . . 0.0 106.959 176.395 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -48.64 -28.49 6.92 Favored Glycine 0 N--CA 1.442 -0.919 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 176.199 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.776 ' CD2' HD11 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -58.65 -45.26 89.7 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 177.866 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.494 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 171.83 -132.75 2.51 Favored Glycine 0 N--CA 1.441 -0.975 0 CA-C-N 113.614 -1.63 . . . . 0.0 110.25 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.484 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 0.5 OUTLIER -96.87 98.02 9.77 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.278 0.561 . . . . 0.0 111.079 178.815 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.495 HG21 ' HB2' ' A' ' 202' ' ' PHE . 2.8 t -74.32 142.24 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.337 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 209' ' ' GLU . . . . . 0.669 ' HB3' HG22 ' A' ' 229' ' ' THR . 5.0 tp10 -94.13 -54.12 3.7 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.747 178.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.8 m -166.25 152.74 9.17 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.228 0.537 . . . . 0.0 112.073 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.886 HD13 HG23 ' A' ' 228' ' ' ILE . 0.4 OUTLIER -122.06 124.49 71.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.23 178.433 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -123.34 107.29 11.48 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -177.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.768 HD11 ' HB ' ' A' ' 193' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 177.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 224' ' ' GLY . . . . . 0.491 ' O ' ' HA2' ' A' ' 188' ' ' GLY . . . . . . . . 0 C--O 1.224 -0.518 0 CA-C-O 120.818 0.121 . . . . 0.0 113.207 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 225' ' ' PHE . . . . . 0.802 ' C ' HD23 ' A' ' 189' ' ' LEU . 1.1 p90 -156.24 176.38 12.76 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -179.218 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 226' ' ' CYS . . . . . 0.702 ' SG ' HD22 ' A' ' 189' ' ' LEU . 7.9 p -146.43 154.66 41.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.178 0.513 . . . . 0.0 112.118 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 1.121 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 7.3 m-85 -105.85 147.45 28.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.761 179.027 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 1.074 HD12 ' CE2' ' A' ' 202' ' ' PHE . 2.0 mt -139.51 131.18 34.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.042 0.448 . . . . 0.0 110.646 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 229' ' ' THR . . . . . 0.669 HG22 ' HB3' ' A' ' 209' ' ' GLU . 38.2 m -113.18 137.99 50.63 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.752 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.783 ' HE1' HD13 ' A' ' 184' ' ' ILE . 80.4 m-85 -113.92 126.51 55.24 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.719 -0.393 . . . . 0.0 110.187 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.541 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -48.88 -39.05 24.4 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 178.243 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 232' ' ' GLU . . . . . 0.473 ' O ' ' HG3' ' A' ' 182' ' ' LYS . 35.9 mm-40 -98.63 169.46 9.49 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 113.528 -1.669 . . . . 0.0 109.381 178.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 233' ' ' GLU . . . . . 0.552 ' HB3' ' CD ' ' A' ' 182' ' ' LYS . 1.4 pm0 -108.67 17.75 21.6 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.557 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.3 OUTLIER -83.73 -61.58 0.3 Allowed Pre-proline 0 C--N 1.33 -0.25 0 C-N-CA 120.059 -0.657 . . . . 0.0 110.847 179.918 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.885 ' O ' HD12 ' A' ' 239' ' ' ILE . 96.7 Cg_exo -49.18 -30.87 20.15 Favored 'Trans proline' 0 CA--C 1.498 -1.306 0 N-CA-C 108.982 -1.199 . . . . 0.0 108.982 177.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 1.086 HG21 ' HB2' ' A' ' 182' ' ' LYS . 15.7 t -72.25 -45.31 61.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 113.884 -1.507 . . . . 0.0 109.95 178.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.557 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 33.5 pttt -63.35 -35.86 81.78 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.921 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.515 ' HA ' ' HG3' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -81.01 -49.72 10.57 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.093 0.473 . . . . 0.0 110.729 179.293 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.885 HD12 ' O ' ' A' ' 235' ' ' PRO . 1.5 mt -46.67 -45.19 7.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.65 -0.704 . . . . 0.0 112.066 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 240' ' ' MET . . . . . 0.441 ' HG2' ' HB ' ' A' ' 256' ' ' VAL . 2.2 mtp -66.47 -20.03 65.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.766 -178.451 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.515 ' HG3' ' HA ' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -88.78 -27.32 21.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.909 0.385 . . . . 0.0 110.555 -179.883 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.536 ' N ' ' HD2' ' A' ' 242' ' ' LYS . 2.4 mmmm -80.36 106.8 12.65 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.316 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.414 ' C ' ' O ' ' A' ' 242' ' ' LYS . 0.0 OUTLIER -36.31 -62.37 0.45 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.221 -179.491 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 244' ' ' TYR . . . . . 0.522 ' CE1' ' CG ' ' A' ' 253' ' ' GLU . 73.9 m-85 -125.57 170.13 11.78 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.633 -179.36 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 245' ' ' HIS . . . . . 0.796 ' CG ' HD12 ' A' ' 254' ' ' ILE . 37.4 m-70 -130.16 156.98 43.68 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.288 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -134.66 104.8 6.19 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.215 0.531 . . . . 0.0 110.059 178.692 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.635 HG12 ' H ' ' A' ' 248' ' ' GLY . 1.5 t -95.68 -179.63 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.992 -179.346 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 248' ' ' GLY . . . . . 0.635 ' H ' HG12 ' A' ' 247' ' ' VAL . . . -24.67 -58.06 0.05 OUTLIER Glycine 0 C--N 1.337 0.594 0 C-N-CA 121.377 -0.439 . . . . 0.0 112.991 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.37 -40.72 1.94 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.273 0.559 . . . . 0.0 111.063 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.555 ' HB3' ' HB3' ' A' ' 190' ' ' SER . 61.5 p -78.77 147.79 33.21 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.12 -0.945 . . . . 0.0 113.082 -178.148 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.1 OUTLIER -136.54 104.01 5.43 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 177.454 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 252' ' ' CYS . . . . . 0.684 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -128.49 153.89 46.68 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -175.684 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 253' ' ' GLU . . . . . 0.522 ' CG ' ' CE1' ' A' ' 244' ' ' TYR . 51.1 tt0 -76.01 109.54 9.73 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.27 179.311 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 254' ' ' ILE . . . . . 0.796 HD12 ' CG ' ' A' ' 245' ' ' HIS . 21.7 mt -97.36 112.15 28.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -178.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 255' ' ' LYS . . . . . 0.509 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -117.02 131.74 56.87 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 177.016 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.692 HG23 ' O ' ' A' ' 183' ' ' LYS . 4.0 p -33.38 123.52 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.485 0 CA-C-O 122.307 1.051 . . . . 0.0 111.225 -177.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 1.121 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -76.11 154.29 35.65 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 113.28 -1.782 . . . . 0.0 111.915 -178.447 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.44 112.23 15.37 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.012 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.507 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.432 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.483 ' CG1' ' N ' ' A' ' 182' ' ' LYS . 47.7 t . . . . . 0 CA--C 1.503 -0.848 0 CA-C-O 121.229 0.538 . . . . 0.0 111.305 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.653 ' CB ' HG21 ' A' ' 236' ' ' VAL . 0.0 OUTLIER -151.38 112.31 4.27 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.481 177.463 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.851 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -132.35 152.01 51.61 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.607 179.228 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.792 HD13 ' HE1' ' A' ' 230' ' ' PHE . 0.2 OUTLIER -130.31 120.29 48.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.224 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.833 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -92.67 109.53 20.95 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 121.576 0.703 . . . . 0.0 109.814 -179.544 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.797 HG12 ' HB2' ' A' ' 252' ' ' CYS . 24.0 t -85.68 126.6 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.244 -179.199 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.544 ' O ' ' HB3' ' A' ' 252' ' ' CYS . . . -114.36 129.48 8.74 Favored Glycine 0 N--CA 1.453 -0.225 0 N-CA-C 115.014 0.766 . . . . 0.0 115.014 -177.016 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.476 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . 78.04 78.33 0.8 Allowed Glycine 0 C--N 1.331 0.264 0 C-N-CA 121.44 -0.409 . . . . 0.0 113.428 178.322 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.906 HD23 ' C ' ' A' ' 225' ' ' PHE . 0.6 OUTLIER -117.54 157.41 26.37 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 122.431 0.293 . . . . 0.0 110.726 -179.897 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.612 ' N ' HD12 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -46.7 -175.17 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.249 0 CA-C-O 121.102 0.477 . . . . 0.0 111.428 179.761 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 191' ' ' PRO . . . . . 0.588 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 11.8 Cg_exo -70.83 -1.7 9.77 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 123.149 2.566 . . . . 0.0 113.707 -179.046 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.523 ' HB2' ' O ' ' A' ' 191' ' ' PRO . 25.9 t70 169.58 74.21 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.982 0.42 . . . . 0.0 111.24 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.854 ' OG1' HD13 ' A' ' 189' ' ' LEU . 55.1 m -66.3 114.58 17.6 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.939 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.583 ' O ' HD11 ' A' ' 198' ' ' ILE . 12.6 Cg_endo -56.72 115.41 2.46 Favored 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 122.478 2.119 . . . . 0.0 111.467 179.25 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.813 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.1 OUTLIER -53.11 -15.13 0.76 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.343 -179.641 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 196' ' ' GLU . . . . . 0.493 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 3.6 mt-10 -68.61 -38.96 81.0 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.552 ' HG2' ' HG2' ' A' ' 194' ' ' PRO . 19.0 mmmt -73.18 -48.93 31.1 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.406 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.843 ' CD1' HG22 ' A' ' 193' ' ' THR . 0.0 OUTLIER -48.49 -30.8 3.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.222 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.583 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 2.3 mtt180 -70.56 -32.52 69.97 Favored 'General case' 0 C--O 1.221 -0.447 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.662 178.646 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 200' ' ' GLU . . . . . 0.577 ' CG ' ' N ' ' A' ' 201' ' ' TYR . 4.2 pt-20 -83.03 -56.38 3.83 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.664 179.148 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.577 ' N ' ' CG ' ' A' ' 200' ' ' GLU . 0.4 OUTLIER -50.31 -53.93 25.15 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.62 0.724 . . . . 0.0 109.791 179.049 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 1.148 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.4 OUTLIER -79.43 -29.77 42.02 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.875 -179.915 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.583 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -62.72 -57.99 13.98 Favored Glycine 0 CA--C 1.499 -0.946 0 N-CA-C 107.044 -2.422 . . . . 0.0 107.044 176.511 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -48.81 -29.21 7.83 Favored Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 176.036 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.828 ' CD2' HD11 ' A' ' 239' ' ' ILE . 0.0 OUTLIER -58.36 -42.3 86.65 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.017 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.501 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 168.1 -131.1 2.23 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 113.733 -1.576 . . . . 0.0 110.212 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.529 ' HG3' ' CG ' ' A' ' 232' ' ' GLU . 1.3 mm-40 -96.8 100.64 12.17 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.239 0.542 . . . . 0.0 111.074 178.679 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.572 HG21 ' HB2' ' A' ' 202' ' ' PHE . 2.7 t -79.36 138.86 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 CA-C-N 115.336 -0.847 . . . . 0.0 108.813 178.229 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 209' ' ' GLU . . . . . 0.604 ' HB3' HG22 ' A' ' 229' ' ' THR . 3.0 tp10 -89.9 -56.94 3.04 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.766 178.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 3.5 m -166.39 150.86 7.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.278 0.561 . . . . 0.0 112.245 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 1.044 HD13 HG23 ' A' ' 228' ' ' ILE . 0.5 OUTLIER -119.04 123.36 71.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.561 178.638 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.73 103.19 8.49 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -178.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.527 HD23 ' CB ' ' A' ' 226' ' ' CYS . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.362 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.347 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.226 -0.4 0 CA-C-O 120.756 0.087 . . . . 0.0 113.245 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 225' ' ' PHE . . . . . 0.906 ' C ' HD23 ' A' ' 189' ' ' LEU . 1.4 p90 -156.83 176.77 12.3 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 226' ' ' CYS . . . . . 0.527 ' CB ' HD23 ' A' ' 213' ' ' LEU . 30.5 p -145.78 156.38 43.55 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.505 -0.478 . . . . 0.0 112.255 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 1.12 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 5.4 m-85 -107.94 143.55 36.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.642 179.309 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 1.148 HD12 ' CE2' ' A' ' 202' ' ' PHE . 2.0 mt -137.13 128.34 41.26 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.401 0 CA-C-O 121.175 0.512 . . . . 0.0 111.495 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 229' ' ' THR . . . . . 0.604 HG22 ' HB3' ' A' ' 209' ' ' GLU . 54.9 m -110.88 138.15 47.63 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.834 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.792 ' HE1' HD13 ' A' ' 184' ' ' ILE . 67.9 m-85 -111.64 126.1 54.66 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.766 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.5 ' HG3' ' O ' ' A' ' 207' ' ' GLU . 0.1 OUTLIER -49.81 -38.52 34.95 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 177.711 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 232' ' ' GLU . . . . . 0.529 ' CG ' ' HG3' ' A' ' 207' ' ' GLU . 60.5 mm-40 -89.86 -167.8 1.95 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 113.154 -1.839 . . . . 0.0 109.274 178.543 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 233' ' ' GLU . . . . . 0.555 ' CB ' ' HG2' ' A' ' 182' ' ' LYS . 0.8 OUTLIER -131.32 -1.28 3.99 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -179.876 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.514 ' HB2' ' HD3' ' A' ' 235' ' ' PRO . 2.0 mt-10 -73.69 -58.14 2.32 Favored Pre-proline 0 C--N 1.329 -0.29 0 C-N-CA 120.433 -0.507 . . . . 0.0 112.141 -179.093 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.851 ' O ' HD12 ' A' ' 239' ' ' ILE . 79.8 Cg_exo -49.22 -31.07 20.96 Favored 'Trans proline' 0 CA--C 1.498 -1.303 0 N-CA-C 109.066 -1.167 . . . . 0.0 109.066 178.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.653 HG21 ' CB ' ' A' ' 182' ' ' LYS . 17.6 t -72.22 -44.07 64.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 114.019 -1.446 . . . . 0.0 109.189 178.255 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.497 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 2.1 mtpp -52.74 -47.95 67.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.396 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.666 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -80.61 -52.79 7.18 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.926 -179.268 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.851 HD12 ' O ' ' A' ' 235' ' ' PRO . 1.9 mt -38.49 -51.51 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.917 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 22.7 mtp -59.17 -26.78 65.08 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.052 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.529 ' HG3' ' CD ' ' A' ' 242' ' ' LYS . 0.2 OUTLIER -81.56 -27.91 34.13 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.676 179.89 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.529 ' CD ' ' HG3' ' A' ' 241' ' ' GLU . 0.6 OUTLIER -81.32 96.79 7.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.616 179.688 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.498 ' O ' ' HG3' ' A' ' 253' ' ' GLU . 0.0 OUTLIER -36.17 -55.0 0.8 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.867 -179.971 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 244' ' ' TYR . . . . . 0.515 ' CE1' ' HG3' ' A' ' 253' ' ' GLU . 32.7 m-85 -126.26 158.4 35.82 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.299 0.571 . . . . 0.0 111.836 -179.127 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 245' ' ' HIS . . . . . 0.643 ' CG ' HD12 ' A' ' 254' ' ' ILE . 32.2 m-70 -127.85 157.46 40.42 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.531 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 246' ' ' ASN . . . . . 0.462 ' O ' ' CE2' ' A' ' 201' ' ' TYR . 5.6 m120 -127.82 104.69 7.97 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.211 0.529 . . . . 0.0 110.423 178.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.556 HG12 ' H ' ' A' ' 248' ' ' GLY . 1.4 t -95.31 174.92 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.253 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 248' ' ' GLY . . . . . 0.713 ' C ' HD23 ' A' ' 249' ' ' LEU . . . -14.66 -57.16 0.01 OUTLIER Glycine 0 C--N 1.34 0.759 0 O-C-N 123.662 0.601 . . . . 0.0 113.316 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.713 HD23 ' C ' ' A' ' 248' ' ' GLY . 0.0 OUTLIER -133.39 -39.8 0.91 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.959 -0.621 . . . . 0.0 110.939 -179.883 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.637 ' CB ' ' HG1' ' A' ' 193' ' ' THR . 6.0 p -78.24 152.2 32.7 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.159 -0.928 . . . . 0.0 113.192 -178.034 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -137.19 108.6 6.89 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.419 178.211 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 252' ' ' CYS . . . . . 0.797 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -128.63 153.73 46.97 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -176.357 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 253' ' ' GLU . . . . . 0.518 ' N ' ' O ' ' A' ' 187' ' ' GLY . 59.4 tt0 -76.08 108.11 8.75 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.832 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 254' ' ' ILE . . . . . 0.651 HG21 ' CG2' ' A' ' 239' ' ' ILE . 13.2 mt -96.47 112.24 28.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 -178.237 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 255' ' ' LYS . . . . . 0.514 ' O ' ' C ' ' A' ' 256' ' ' VAL . 0.0 OUTLIER -116.15 130.16 56.66 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 176.568 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 183' ' ' LYS . 3.6 p -32.78 123.54 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 122.136 0.969 . . . . 0.0 111.372 -177.529 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 1.12 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -76.67 153.71 34.92 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 113.522 -1.672 . . . . 0.0 111.716 -178.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.48 112.92 14.87 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.354 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.518 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.08 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.511 ' CG1' ' N ' ' A' ' 182' ' ' LYS . 42.8 t . . . . . 0 CA--C 1.504 -0.802 0 CA-C-O 121.181 0.515 . . . . 0.0 111.615 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.641 ' CB ' HG21 ' A' ' 236' ' ' VAL . 0.7 OUTLIER -149.99 112.67 4.76 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.488 177.731 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.818 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -134.15 142.57 47.51 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.747 179.838 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.789 HD12 HG21 ' A' ' 239' ' ' ILE . 0.2 OUTLIER -122.59 120.08 59.93 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.445 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.868 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.3 OUTLIER -91.73 109.44 20.76 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.68 0.752 . . . . 0.0 110.054 -179.135 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.706 HG22 HG12 ' A' ' 254' ' ' ILE . 48.7 t -85.53 126.43 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 CA-C-N 114.689 -1.141 . . . . 0.0 109.373 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.572 ' O ' ' HB3' ' A' ' 252' ' ' CYS . . . -112.99 134.8 12.18 Favored Glycine 0 C--N 1.331 0.288 0 N-CA-C 115.276 0.87 . . . . 0.0 115.276 -176.542 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.493 ' O ' ' HB3' ' A' ' 252' ' ' CYS . . . 64.51 84.09 0.08 OUTLIER Glycine 0 C--N 1.333 0.396 0 CA-C-N 115.516 -0.342 . . . . 0.0 112.675 178.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 1.016 HD13 ' OG1' ' A' ' 193' ' ' THR . 1.1 pp -117.36 157.83 25.46 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.045 0.45 . . . . 0.0 112.039 -178.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.643 ' O ' HD12 ' A' ' 189' ' ' LEU . 0.3 OUTLIER -44.68 -173.91 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.227 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.965 179.815 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 191' ' ' PRO . . . . . 0.588 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 6.4 Cg_exo -74.75 9.48 1.93 Allowed 'Trans proline' 0 CA--C 1.53 0.289 0 C-N-CA 123.125 2.55 . . . . 0.0 113.507 -179.173 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.54 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 1.1 m-20 158.2 78.24 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 120.842 0.353 . . . . 0.0 111.534 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 193' ' ' THR . . . . . 1.016 ' OG1' HD13 ' A' ' 189' ' ' LEU . 19.2 m -68.78 112.17 10.55 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.633 179.343 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.587 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 54.9 Cg_endo -67.3 107.04 1.31 Allowed 'Trans proline' 0 N--CA 1.465 -0.158 0 C-N-CA 122.668 2.245 . . . . 0.0 111.767 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.609 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -41.06 -21.51 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.32 -0.4 . . . . 0.0 112.016 -179.964 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 196' ' ' GLU . . . . . 0.462 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 11.0 mt-10 -59.37 -43.71 92.84 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -178.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.587 ' CD ' ' HG2' ' A' ' 194' ' ' PRO . 0.6 OUTLIER -79.15 -46.21 18.42 Favored 'General case' 0 CA--C 1.494 -1.208 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 178.68 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.833 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.2 OUTLIER -49.07 -29.58 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-N 114.191 -1.368 . . . . 0.0 108.396 176.86 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.553 ' HG3' ' O ' ' A' ' 195' ' ' GLU . 4.6 mtp85 -74.16 -32.56 63.17 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.845 178.044 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 200' ' ' GLU . . . . . 0.536 ' O ' ' N ' ' A' ' 204' ' ' GLY . 5.4 mt-10 -82.61 -59.13 2.62 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.57 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.493 ' C ' ' CD1' ' A' ' 201' ' ' TYR . 0.4 OUTLIER -47.96 -52.16 20.77 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.136 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 1.065 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.4 OUTLIER -79.7 -31.69 41.26 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.301 179.459 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.542 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -61.84 -58.07 14.61 Favored Glycine 0 N--CA 1.442 -0.906 0 N-CA-C 107.613 -2.195 . . . . 0.0 107.613 176.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -49.76 -27.91 10.28 Favored Glycine 0 N--CA 1.441 -1.003 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 176.425 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.761 ' CE2' HG13 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -57.76 -46.05 85.08 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 177.826 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.505 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 173.56 -132.28 2.27 Favored Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 113.639 -1.618 . . . . 0.0 110.25 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.509 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 3.1 mm-40 -97.19 99.84 11.32 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.134 0.492 . . . . 0.0 111.08 178.581 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 2.6 t -74.76 139.08 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.133 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' GLU . . . . . 0.55 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 60.0 tt0 -91.03 -56.03 3.32 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 178.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -161.88 153.96 19.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.861 179.447 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.567 HD12 ' HB ' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -122.97 123.95 69.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.488 178.725 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -123.57 104.75 9.23 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -177.371 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.614 HD21 ' HB ' ' A' ' 193' ' ' THR . 0.7 OUTLIER . . . . . 0 CA--C 1.531 0.233 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 176.545 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.598 0 CA-C-O 121.264 0.369 . . . . 0.0 112.863 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 225' ' ' PHE . . . . . 0.883 ' C ' HD23 ' A' ' 189' ' ' LEU . 0.2 OUTLIER -156.49 176.48 12.65 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.985 -0.608 . . . . 0.0 109.406 -178.311 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 226' ' ' CYS . . . . . 0.536 ' O ' ' HB ' ' A' ' 186' ' ' VAL . 0.5 OUTLIER -139.77 156.89 46.52 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.033 -0.667 . . . . 0.0 112.225 -179.339 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 1.099 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 4.7 m-85 -114.24 132.26 56.2 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.428 -0.806 . . . . 0.0 108.968 179.196 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 1.065 HD12 ' CE2' ' A' ' 202' ' ' PHE . 2.2 mt -126.13 124.8 66.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.16 0.505 . . . . 0.0 111.41 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 229' ' ' THR . . . . . 0.525 HG22 ' HB3' ' A' ' 209' ' ' GLU . 85.1 m -106.1 138.08 42.9 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.496 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.767 ' HE2' HD13 ' A' ' 184' ' ' ILE . 74.7 m-85 -113.05 126.47 55.52 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.377 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.55 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -49.28 -38.4 27.03 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 178.334 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 232' ' ' GLU . . . . . 0.458 ' HB3' ' OE2' ' A' ' 234' ' ' GLU . 49.1 mt-10 -91.49 -168.57 2.07 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 113.399 -1.728 . . . . 0.0 109.673 179.177 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 233' ' ' GLU . . . . . 0.515 ' CB ' ' HG2' ' A' ' 182' ' ' LYS . 0.6 OUTLIER -131.34 14.04 5.06 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.834 -0.347 . . . . 0.0 111.372 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.582 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.4 OUTLIER -84.55 -60.06 0.32 Allowed Pre-proline 0 C--N 1.33 -0.263 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.702 179.873 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.889 ' O ' HD12 ' A' ' 239' ' ' ILE . 87.1 Cg_exo -49.31 -32.59 26.21 Favored 'Trans proline' 0 CA--C 1.502 -1.103 0 N-CA-C 109.089 -1.158 . . . . 0.0 109.089 178.193 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.641 HG21 ' CB ' ' A' ' 182' ' ' LYS . 21.7 t -72.51 -43.44 63.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 113.938 -1.483 . . . . 0.0 110.429 179.006 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.582 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 1.8 ptpt -64.07 -36.18 83.17 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.789 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.517 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 0.0 OUTLIER -82.19 -50.15 9.33 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.9 0.381 . . . . 0.0 111.269 179.279 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.889 HD12 ' O ' ' A' ' 235' ' ' PRO . 1.5 mt -44.6 -48.77 2.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.252 -179.196 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 240' ' ' MET . . . . . 0.459 ' HG2' ' HB ' ' A' ' 256' ' ' VAL . 22.3 mtp -61.97 -26.51 68.26 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.944 -178.561 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.45 ' CG ' ' O ' ' A' ' 237' ' ' LYS . 1.1 mt-10 -86.99 -16.73 34.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.826 0.346 . . . . 0.0 111.248 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.487 ' HG2' ' HA ' ' A' ' 239' ' ' ILE . 2.9 mmmt -80.55 118.42 22.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.138 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.456 ' HG2' ' N ' ' A' ' 244' ' ' TYR . 13.8 ttpt -41.9 -81.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.18 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 244' ' ' TYR . . . . . 0.481 ' CD1' ' HG3' ' A' ' 253' ' ' GLU . 12.1 m-85 -114.74 157.15 23.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.407 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 245' ' ' HIS . . . . . 0.767 ' CG ' HD12 ' A' ' 254' ' ' ILE . 24.2 m-70 -113.68 150.23 33.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.241 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 246' ' ' ASN . . . . . 0.417 ' O ' ' CE2' ' A' ' 201' ' ' TYR . 0.2 OUTLIER -127.85 105.35 8.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.859 179.704 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.533 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.7 t -110.35 110.22 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.985 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 45.61 -87.71 0.01 OUTLIER Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.407 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.533 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -106.49 -39.97 5.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.363 0.601 . . . . 0.0 110.546 179.639 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.473 ' OG ' ' HB2' ' A' ' 190' ' ' SER . 1.5 m -77.43 147.42 35.98 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.033 -178.568 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -143.97 106.24 4.39 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.463 179.162 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 252' ' ' CYS . . . . . 0.68 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -128.21 153.12 47.27 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -176.541 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 253' ' ' GLU . . . . . 0.481 ' HG3' ' CD1' ' A' ' 244' ' ' TYR . 50.1 tt0 -76.29 107.57 8.62 Favored 'General case' 0 C--O 1.224 -0.27 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.172 178.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 254' ' ' ILE . . . . . 0.767 HD12 ' CG ' ' A' ' 245' ' ' HIS . 29.2 mt -96.39 113.3 30.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -177.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 255' ' ' LYS . . . . . 0.515 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -117.25 133.09 56.4 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 176.677 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 183' ' ' LYS . 5.5 p -33.23 124.94 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-O 122.251 1.024 . . . . 0.0 111.304 -177.628 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 1.099 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -78.27 152.95 32.24 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 113.423 -1.717 . . . . 0.0 112.48 -178.13 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.73 113.85 15.86 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.511 -1.222 . . . . 0.0 110.081 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 259' ' ' SER . . . . . 0.408 ' HB3' ' HD2' ' A' ' 183' ' ' LYS . 83.6 p . . . . . 0 C--N 1.323 -0.586 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.859 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.485 ' O ' ' HD3' ' A' ' 182' ' ' LYS . 43.5 t . . . . . 0 CA--C 1.505 -0.765 0 CA-C-O 121.362 0.601 . . . . 0.0 112.328 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.549 ' CB ' HG21 ' A' ' 236' ' ' VAL . 8.0 mmtt -145.76 112.38 5.91 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.243 176.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.883 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.0 OUTLIER -130.62 162.45 29.33 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.965 179.775 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.846 HD11 ' HE2' ' A' ' 202' ' ' PHE . 0.3 OUTLIER -138.55 119.74 16.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 177.532 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.854 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -92.52 109.49 20.89 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.587 0.708 . . . . 0.0 110.195 -178.914 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.707 HG12 ' HB2' ' A' ' 252' ' ' CYS . 40.6 t -84.29 128.07 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.894 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.553 ' O ' ' HB3' ' A' ' 252' ' ' CYS . . . -116.5 132.76 10.32 Favored Glycine 0 N--CA 1.451 -0.319 0 N-CA-C 115.053 0.781 . . . . 0.0 115.053 -176.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.483 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . 71.39 80.11 0.36 Allowed Glycine 0 N--CA 1.452 -0.292 0 CA-C-N 115.442 -0.379 . . . . 0.0 113.397 178.171 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.934 HD13 ' OG1' ' A' ' 193' ' ' THR . 0.8 OUTLIER -117.26 157.57 25.82 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.701 0.286 . . . . 0.0 110.958 -179.796 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.593 ' CB ' ' CD ' ' A' ' 191' ' ' PRO . 0.2 OUTLIER -47.71 -173.66 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.934 179.585 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 191' ' ' PRO . . . . . 0.593 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 5.7 Cg_exo -78.36 17.09 1.12 Allowed 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.956 2.437 . . . . 0.0 113.272 -179.373 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.538 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 1.2 m-20 159.73 76.89 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.117 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.635 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.934 ' OG1' HD13 ' A' ' 189' ' ' LEU . 50.1 m -71.45 114.55 28.94 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 120.855 0.36 . . . . 0.0 110.432 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.541 ' C ' HD11 ' A' ' 198' ' ' ILE . 16.3 Cg_endo -58.52 110.05 0.6 Allowed 'Trans proline' 0 N--CA 1.464 -0.243 0 C-N-CA 122.369 2.046 . . . . 0.0 111.748 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.803 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -50.9 -15.69 0.33 Allowed 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.143 -179.875 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 196' ' ' GLU . . . . . 0.482 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 23.1 mm-40 -71.94 -36.89 70.03 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' A' ' 200' ' ' GLU . 0.0 OUTLIER -73.92 -48.01 33.72 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.186 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.854 ' CD1' HG22 ' A' ' 193' ' ' THR . 0.0 OUTLIER -47.68 -30.73 2.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.225 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.603 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 6.5 mtt180 -71.72 -32.4 67.73 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.189 179.012 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 200' ' ' GLU . . . . . 0.53 ' N ' ' O ' ' A' ' 197' ' ' LYS . 0.4 OUTLIER -82.83 -46.19 13.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.023 0.44 . . . . 0.0 110.646 179.292 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.509 ' C ' ' CD1' ' A' ' 201' ' ' TYR . 0.5 OUTLIER -63.04 -53.55 52.11 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.004 179.407 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 1.122 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -79.88 -31.41 40.33 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 114.845 -1.07 . . . . 0.0 110.339 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.603 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -64.85 -54.36 28.7 Favored Glycine 0 CA--C 1.497 -1.071 0 N-CA-C 106.535 -2.626 . . . . 0.0 106.535 176.318 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -50.23 -29.3 15.54 Favored Glycine 0 N--CA 1.442 -0.928 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 175.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.811 ' CD2' HD11 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -58.34 -44.76 88.86 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 177.783 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 170.55 -129.89 1.89 Allowed Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 113.717 -1.583 . . . . 0.0 110.616 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.474 ' HB3' ' HE2' ' A' ' 231' ' ' LYS . 2.9 mm-40 -97.01 99.69 11.21 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.289 0.566 . . . . 0.0 111.321 178.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.413 HG22 ' CE1' ' A' ' 230' ' ' PHE . 2.6 t -77.5 143.39 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 CA-C-N 115.324 -0.853 . . . . 0.0 108.845 178.318 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 209' ' ' GLU . . . . . 0.525 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 5.8 tp10 -93.7 -56.78 2.78 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.646 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 4.4 m -166.94 149.92 6.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.959 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.903 HD13 HG23 ' A' ' 228' ' ' ILE . 0.4 OUTLIER -117.19 126.37 74.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.664 178.922 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -123.09 103.07 8.34 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -178.573 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.574 HD21 ' HB ' ' A' ' 193' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.241 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 177.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.615 0 CA-C-O 121.242 0.357 . . . . 0.0 112.701 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 225' ' ' PHE . . . . . 0.911 ' C ' HD23 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -156.79 176.7 12.39 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -178.339 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 226' ' ' CYS . . . . . 0.516 ' O ' ' HB ' ' A' ' 186' ' ' VAL . 1.3 p -139.48 156.32 47.01 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.016 -0.674 . . . . 0.0 112.544 -179.303 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 1.072 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 3.8 m-85 -113.95 133.44 55.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.495 -0.775 . . . . 0.0 108.965 178.438 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 1.122 HD12 ' CE2' ' A' ' 202' ' ' PHE . 2.0 mt -128.55 133.26 66.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.142 0.496 . . . . 0.0 111.475 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 229' ' ' THR . . . . . 0.457 HG22 ' HB3' ' A' ' 209' ' ' GLU . 97.7 m -113.03 138.05 50.48 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.155 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.817 ' HE2' HD13 ' A' ' 184' ' ' ILE . 67.9 m-85 -112.8 126.44 55.43 Favored 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.053 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.525 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -50.52 -37.83 41.25 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 177.737 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -90.1 -165.86 1.45 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 113.152 -1.84 . . . . 0.0 109.691 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 233' ' ' GLU . . . . . 0.528 ' HB2' ' HD2' ' A' ' 182' ' ' LYS . 0.4 OUTLIER -134.64 8.53 3.6 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.667 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.548 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.3 OUTLIER -82.14 -59.92 0.41 Allowed Pre-proline 0 C--N 1.328 -0.369 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.755 179.939 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.911 ' O ' HD12 ' A' ' 239' ' ' ILE . 80.2 Cg_exo -49.48 -30.91 22.27 Favored 'Trans proline' 0 CA--C 1.499 -1.27 0 N-CA-C 108.986 -1.198 . . . . 0.0 108.986 178.488 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.549 HG21 ' CB ' ' A' ' 182' ' ' LYS . 21.1 t -73.92 -45.69 48.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 114.473 -1.239 . . . . 0.0 110.272 178.681 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.548 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 1.2 ptpt -61.74 -36.23 80.38 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.606 -179.424 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.645 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -82.29 -54.89 4.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.172 178.918 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.911 HD12 ' O ' ' A' ' 235' ' ' PRO . 1.7 mt -40.33 -50.69 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.951 -179.132 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 240' ' ' MET . . . . . 0.472 ' HG2' ' HB ' ' A' ' 256' ' ' VAL . 17.3 mtp -60.06 -24.68 64.76 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.787 -178.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.487 ' CG ' ' O ' ' A' ' 237' ' ' LYS . 1.0 OUTLIER -87.91 -17.08 32.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.798 0.333 . . . . 0.0 111.261 -179.715 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.505 ' HG2' ' HA ' ' A' ' 239' ' ' ILE . 0.1 OUTLIER -79.68 123.77 27.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.352 -179.742 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.456 ' HE3' ' HB2' ' A' ' 244' ' ' TYR . 7.7 ttpt -50.38 -75.53 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 178.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 244' ' ' TYR . . . . . 0.526 ' CD1' ' HG3' ' A' ' 253' ' ' GLU . 17.3 m-85 -121.02 144.81 48.33 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.932 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 245' ' ' HIS . . . . . 0.866 ' CG ' HD12 ' A' ' 254' ' ' ILE . 30.1 m-70 -104.55 150.63 24.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.096 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 246' ' ' ASN . . . . . 0.457 ' HB3' ' HD2' ' A' ' 251' ' ' LYS . 0.1 OUTLIER -129.58 104.68 7.59 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.221 0.534 . . . . 0.0 110.493 179.164 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.556 ' O ' ' C ' ' A' ' 248' ' ' GLY . 1.7 t -95.29 170.24 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.737 -179.481 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 248' ' ' GLY . . . . . 0.556 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . -8.3 -64.66 0.01 OUTLIER Glycine 0 C--N 1.341 0.825 0 O-C-N 123.669 0.606 . . . . 0.0 113.797 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.467 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -126.0 -39.82 2.07 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.509 0.671 . . . . 0.0 110.501 -179.282 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.663 ' CB ' ' HG1' ' A' ' 193' ' ' THR . 0.2 OUTLIER -77.3 157.33 30.79 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.745 -1.116 . . . . 0.0 112.734 -178.197 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -142.42 107.97 5.07 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.182 179.27 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 252' ' ' CYS . . . . . 0.707 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -128.67 152.96 47.79 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -177.255 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 253' ' ' GLU . . . . . 0.529 ' N ' ' O ' ' A' ' 187' ' ' GLY . 49.3 tt0 -76.61 108.48 9.64 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.581 179.056 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 254' ' ' ILE . . . . . 0.866 HD12 ' CG ' ' A' ' 245' ' ' HIS . 30.6 mt -96.8 113.44 31.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 -178.261 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 255' ' ' LYS . . . . . 0.518 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -115.94 133.25 56.22 Favored 'General case' 0 C--O 1.22 -0.448 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 176.508 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.633 HG23 ' O ' ' A' ' 183' ' ' LYS . 2.4 p -33.2 124.51 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-O 122.096 0.95 . . . . 0.0 111.324 -177.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 1.072 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -79.56 151.18 30.82 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 113.633 -1.621 . . . . 0.0 112.37 -178.406 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.62 115.85 19.41 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.089 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 29.7 p . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.057 -179.676 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.507 ' C ' ' CD ' ' A' ' 182' ' ' LYS . 45.3 t . . . . . 0 CA--C 1.503 -0.855 0 CA-C-O 121.044 0.449 . . . . 0.0 111.204 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 1.028 ' HB2' HG21 ' A' ' 236' ' ' VAL . 0.0 OUTLIER -151.14 112.34 4.34 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.103 177.66 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.817 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.0 OUTLIER -135.64 142.6 45.21 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.978 178.863 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.891 HD13 ' HE2' ' A' ' 230' ' ' PHE . 0.4 OUTLIER -122.04 120.91 62.7 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.183 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.787 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -94.14 109.34 21.13 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 121.553 0.692 . . . . 0.0 110.23 -179.195 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.992 HG12 ' HB2' ' A' ' 252' ' ' CYS . 4.9 t -85.03 128.86 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.802 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.564 ' HA2' ' HB2' ' A' ' 225' ' ' PHE . . . -115.6 127.87 7.78 Favored Glycine 0 C--N 1.332 0.316 0 N-CA-C 115.124 0.809 . . . . 0.0 115.124 -176.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.476 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . 76.26 82.04 0.53 Allowed Glycine 0 C--N 1.332 0.312 0 C-N-CA 121.354 -0.45 . . . . 0.0 113.419 178.606 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.949 HD13 ' OG1' ' A' ' 193' ' ' THR . 1.2 pp -117.43 157.18 26.67 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.778 0.323 . . . . 0.0 111.168 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.653 ' O ' HD12 ' A' ' 189' ' ' LEU . 0.2 OUTLIER -46.67 -177.45 0.01 OUTLIER Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.256 0.551 . . . . 0.0 111.592 -179.927 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 191' ' ' PRO . . . . . 0.574 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 19.6 Cg_exo -67.31 -2.73 8.68 Favored 'Trans proline' 0 CA--C 1.53 0.291 0 C-N-CA 123.395 2.73 . . . . 0.0 113.908 -179.052 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 191' ' ' PRO . 0.8 OUTLIER 171.76 73.0 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.905 0.383 . . . . 0.0 111.667 -179.811 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.949 ' OG1' HD13 ' A' ' 189' ' ' LEU . 93.7 m -61.52 122.32 70.03 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.998 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.497 ' O ' HD11 ' A' ' 198' ' ' ILE . 55.7 Cg_endo -70.09 114.62 3.82 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.157 1.905 . . . . 0.0 111.103 178.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.817 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -51.61 -15.16 0.41 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 121.056 -0.257 . . . . 0.0 111.265 -179.439 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 196' ' ' GLU . . . . . 0.509 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 4.9 mt-10 -67.91 -40.42 83.41 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.521 ' O ' ' N ' ' A' ' 200' ' ' GLU . 0.4 OUTLIER -70.71 -50.95 30.92 Favored 'General case' 0 CA--C 1.5 -0.98 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.222 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.824 ' HB ' HD12 ' A' ' 211' ' ' ILE . 0.0 OUTLIER -47.59 -32.43 2.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 115.297 -0.865 . . . . 0.0 108.751 178.717 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.572 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 16.7 mtt85 -69.92 -33.4 72.12 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.975 178.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 200' ' ' GLU . . . . . 0.521 ' N ' ' O ' ' A' ' 197' ' ' LYS . 8.5 mm-40 -81.87 -60.13 2.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.278 0.561 . . . . 0.0 109.928 179.126 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.495 ' C ' ' CD1' ' A' ' 201' ' ' TYR . 0.3 OUTLIER -49.31 -54.19 18.29 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.025 178.932 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 1.104 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.2 OUTLIER -79.74 -31.5 41.04 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.991 -179.589 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.572 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -63.77 -56.47 18.81 Favored Glycine 0 CA--C 1.499 -0.95 0 N-CA-C 107.037 -2.425 . . . . 0.0 107.037 176.48 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -49.4 -28.44 9.47 Favored Glycine 0 N--CA 1.442 -0.937 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 176.237 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.771 ' CE2' HG13 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -57.19 -48.56 78.45 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 177.769 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 175.62 -130.15 1.67 Allowed Glycine 0 N--CA 1.44 -1.078 0 CA-C-N 113.65 -1.614 . . . . 0.0 110.31 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.505 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 20.7 mm-40 -96.96 100.96 12.45 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.144 0.497 . . . . 0.0 110.861 178.497 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.461 HG22 ' CE1' ' A' ' 230' ' ' PHE . 2.8 t -77.93 141.37 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.238 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 209' ' ' GLU . . . . . 0.588 ' HB3' HG22 ' A' ' 229' ' ' THR . 5.8 tp10 -91.9 -55.7 3.36 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.599 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 8.0 m -167.69 148.78 5.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.874 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.882 HD13 HG23 ' A' ' 228' ' ' ILE . 0.4 OUTLIER -115.72 125.67 72.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.882 178.931 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.28 105.01 9.49 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.334 -178.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.47 HD22 ' HB ' ' A' ' 193' ' ' THR . 0.1 OUTLIER . . . . . 0 CA--C 1.534 0.349 0 CA-C-O 120.841 0.353 . . . . 0.0 110.822 178.55 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.407 0 N-CA-C 112.922 -0.071 . . . . 0.0 112.922 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 225' ' ' PHE . . . . . 0.88 ' C ' HD23 ' A' ' 189' ' ' LEU . 1.5 p90 -156.79 176.47 12.69 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 226' ' ' CYS . . . . . 0.469 ' O ' ' HB ' ' A' ' 186' ' ' VAL . 27.7 p -146.0 152.22 39.02 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.393 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 1.11 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 6.1 m-85 -106.21 139.43 40.74 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.082 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 1.104 HD12 ' CE2' ' A' ' 202' ' ' PHE . 2.0 mt -133.58 129.84 56.01 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.386 0 CA-C-O 120.879 0.371 . . . . 0.0 110.985 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 229' ' ' THR . . . . . 0.588 HG22 ' HB3' ' A' ' 209' ' ' GLU . 53.5 m -111.17 138.22 47.88 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.897 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.891 ' HE2' HD13 ' A' ' 184' ' ' ILE . 81.4 m-85 -114.51 126.44 54.94 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.445 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.505 ' HG3' ' O ' ' A' ' 207' ' ' GLU . 0.0 OUTLIER -47.77 -39.63 18.49 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 178.134 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 232' ' ' GLU . . . . . 0.479 ' O ' ' HG3' ' A' ' 182' ' ' LYS . 5.9 mm-40 -99.29 171.29 8.08 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 113.452 -1.704 . . . . 0.0 109.684 179.078 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 233' ' ' GLU . . . . . 0.44 ' HB3' ' CE ' ' A' ' 182' ' ' LYS . 0.0 OUTLIER -110.21 21.07 17.17 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.307 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.562 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.0 OUTLIER -85.18 -62.16 0.26 Allowed Pre-proline 0 C--N 1.331 -0.221 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.699 179.619 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.916 ' O ' HD12 ' A' ' 239' ' ' ILE . 87.3 Cg_exo -50.37 -29.69 24.54 Favored 'Trans proline' 0 CA--C 1.502 -1.101 0 N-CA-C 108.811 -1.265 . . . . 0.0 108.811 177.582 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 1.028 HG21 ' HB2' ' A' ' 182' ' ' LYS . 20.9 t -72.66 -42.96 62.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 113.768 -1.56 . . . . 0.0 110.324 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.562 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 9.3 pttp -64.26 -36.41 84.0 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.738 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.541 ' O ' ' CG ' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -81.43 -50.37 9.52 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.16 0.505 . . . . 0.0 110.92 179.183 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.916 HD12 ' O ' ' A' ' 235' ' ' PRO . 1.6 mt -45.53 -53.04 2.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.847 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 240' ' ' MET . . . . . 0.582 ' SD ' HG12 ' A' ' 236' ' ' VAL . 11.5 mtp -60.46 -17.1 42.59 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.263 -178.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.541 ' CG ' ' O ' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -88.37 -26.29 22.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.893 0.377 . . . . 0.0 111.0 -179.813 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.516 ' CD ' ' HG3' ' A' ' 241' ' ' GLU . 5.3 mmmt -79.58 109.8 14.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.01 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.483 ' HD3' ' CD1' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -40.18 -62.42 0.75 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.34 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 244' ' ' TYR . . . . . 0.549 ' CD1' ' HG3' ' A' ' 253' ' ' GLU . 12.9 m-30 -122.01 161.7 22.48 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.897 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 245' ' ' HIS . . . . . 0.78 ' CE1' HD12 ' A' ' 254' ' ' ILE . 20.5 m-70 -122.82 156.76 33.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.822 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 246' ' ' ASN . . . . . 0.416 ' O ' ' CE2' ' A' ' 201' ' ' TYR . 6.0 m120 -133.24 105.15 6.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.172 0.511 . . . . 0.0 110.581 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.55 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.5 t -108.52 138.71 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.556 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 248' ' ' GLY . . . . . 0.479 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . 26.65 -87.57 0.01 OUTLIER Glycine 0 C--N 1.337 0.619 0 C-N-CA 121.163 -0.541 . . . . 0.0 113.017 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.55 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.1 OUTLIER -108.87 -34.63 6.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.774 0.797 . . . . 0.0 109.845 -179.861 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.516 ' O ' ' N ' ' A' ' 247' ' ' VAL . 3.0 p -77.25 152.92 34.46 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.248 -1.342 . . . . 0.0 113.176 -177.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -143.31 104.66 4.29 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 114.739 -1.118 . . . . 0.0 108.361 178.464 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 252' ' ' CYS . . . . . 0.992 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -128.34 152.77 47.76 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -176.399 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 253' ' ' GLU . . . . . 0.549 ' HG3' ' CD1' ' A' ' 244' ' ' TYR . 50.7 tt0 -76.93 107.79 9.52 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.982 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 254' ' ' ILE . . . . . 0.854 HG12 HG13 ' A' ' 186' ' ' VAL . 26.1 mt -96.46 112.84 29.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -178.606 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 255' ' ' LYS . . . . . 0.53 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -115.02 130.98 57.06 Favored 'General case' 0 C--O 1.221 -0.41 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 176.418 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.675 HG23 ' O ' ' A' ' 183' ' ' LYS . 10.0 p -33.16 124.46 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 122.156 0.979 . . . . 0.0 111.475 -177.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 1.11 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -76.68 153.93 34.68 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 113.501 -1.681 . . . . 0.0 111.448 -178.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.1 111.82 13.9 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.046 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 259' ' ' SER . . . . . 0.457 ' HB2' ' HD2' ' A' ' 183' ' ' LYS . 0.2 OUTLIER . . . . . 0 C--N 1.325 -0.459 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.7 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.501 ' CG1' ' N ' ' A' ' 182' ' ' LYS . 40.6 t . . . . . 0 CA--C 1.506 -0.745 0 CA-C-O 121.261 0.553 . . . . 0.0 111.77 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.685 ' CB ' HG21 ' A' ' 236' ' ' VAL . 0.2 OUTLIER -148.02 112.5 5.31 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.029 177.442 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.863 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -130.5 145.45 51.86 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.382 179.271 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.873 HD13 ' HE2' ' A' ' 230' ' ' PHE . 0.3 OUTLIER -125.35 120.43 57.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.113 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.844 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -93.86 109.22 20.93 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.475 -178.875 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.995 HG12 ' HB2' ' A' ' 252' ' ' CYS . 2.8 t -84.44 124.65 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.196 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.551 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . -112.07 126.69 7.73 Favored Glycine 0 N--CA 1.451 -0.337 0 N-CA-C 114.932 0.733 . . . . 0.0 114.932 -176.429 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.464 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . 76.69 84.05 0.47 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 121.418 -0.42 . . . . 0.0 113.286 178.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.951 HD23 ' C ' ' A' ' 225' ' ' PHE . 0.9 OUTLIER -117.07 157.01 26.58 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.657 0.265 . . . . 0.0 110.788 179.843 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.655 ' O ' HD12 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -46.72 -175.15 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.061 179.818 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 191' ' ' PRO . . . . . 0.586 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 4.0 Cg_exo -79.79 17.76 1.24 Allowed 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 123.024 2.483 . . . . 0.0 112.949 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.494 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 1.0 OUTLIER 161.86 74.72 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.126 0 CA-C-O 120.621 0.248 . . . . 0.0 111.363 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.933 ' OG1' HD13 ' A' ' 189' ' ' LEU . 55.2 m -74.59 112.86 19.27 Favored Pre-proline 0 C--N 1.332 -0.169 0 CA-C-O 120.912 0.387 . . . . 0.0 110.919 179.508 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.548 ' HG2' ' CG ' ' A' ' 197' ' ' LYS . 26.6 Cg_endo -62.65 109.03 0.8 Allowed 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 122.3 2.0 . . . . 0.0 111.485 179.163 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.851 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -48.0 -15.4 0.06 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 111.849 0.314 . . . . 0.0 111.849 -179.658 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 196' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 6.8 mm-40 -65.98 -37.06 84.99 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.548 ' CG ' ' HG2' ' A' ' 194' ' ' PRO . 0.8 OUTLIER -75.54 -50.95 14.08 Favored 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.258 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.851 ' CG1' ' HA ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -46.63 -31.19 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.314 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.552 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 5.2 mtp85 -70.16 -35.31 73.92 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.523 178.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 200' ' ' GLU . . . . . 0.513 ' N ' ' O ' ' A' ' 197' ' ' LYS . 12.1 mm-40 -82.4 -58.63 2.84 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.275 0.559 . . . . 0.0 110.233 179.187 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.497 ' C ' ' CD1' ' A' ' 201' ' ' TYR . 0.4 OUTLIER -48.28 -53.45 17.21 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.677 179.144 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 1.136 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.2 OUTLIER -79.78 -31.17 40.82 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.177 179.688 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.552 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -60.2 -57.88 16.92 Favored Glycine 0 CA--C 1.499 -0.91 0 N-CA-C 107.221 -2.352 . . . . 0.0 107.221 176.673 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -50.15 -27.65 11.32 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 176.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.814 ' CD2' HD11 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -58.24 -44.13 88.14 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 122.158 0.98 . . . . 0.0 108.383 178.003 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 169.49 -130.5 2.06 Favored Glycine 0 N--CA 1.442 -0.926 0 CA-C-N 113.465 -1.698 . . . . 0.0 110.26 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.5 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 46.1 mm-40 -96.72 101.64 13.28 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.258 0.551 . . . . 0.0 110.973 178.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.424 HG21 ' HB2' ' A' ' 202' ' ' PHE . 3.0 t -79.45 136.77 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 CA-C-N 115.25 -0.886 . . . . 0.0 108.814 178.343 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 209' ' ' GLU . . . . . 0.65 ' HB3' HG22 ' A' ' 229' ' ' THR . 6.1 tp10 -88.45 -56.56 3.26 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.399 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 3.4 m -166.29 150.37 7.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.342 0.591 . . . . 0.0 112.436 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.904 HD13 HG23 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -118.38 126.45 75.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.466 178.593 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -123.24 102.86 8.18 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -178.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.508 HD23 ' HB3' ' A' ' 226' ' ' CYS . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.257 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 177.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.421 0 N-CA-C 112.232 -0.347 . . . . 0.0 112.232 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 225' ' ' PHE . . . . . 0.951 ' C ' HD23 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -157.47 176.93 12.01 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.024 -0.588 . . . . 0.0 109.986 -177.879 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 226' ' ' CYS . . . . . 0.508 ' HB3' HD23 ' A' ' 213' ' ' LEU . 1.6 p -138.66 147.43 42.82 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.138 -0.625 . . . . 0.0 112.389 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 1.109 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 4.6 m-85 -107.44 133.49 51.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.161 178.571 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 1.136 HD12 ' CE2' ' A' ' 202' ' ' PHE . 1.8 mt -128.06 133.0 68.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.13 0.49 . . . . 0.0 111.686 -179.186 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 229' ' ' THR . . . . . 0.65 HG22 ' HB3' ' A' ' 209' ' ' GLU . 40.8 m -113.44 137.99 50.73 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.51 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.873 ' HE2' HD13 ' A' ' 184' ' ' ILE . 75.4 m-85 -113.62 126.3 55.12 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.298 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.5 ' HG3' ' O ' ' A' ' 207' ' ' GLU . 0.3 OUTLIER -47.94 -39.19 18.51 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 178.051 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 232' ' ' GLU . . . . . 0.44 ' O ' ' HD3' ' A' ' 182' ' ' LYS . 0.0 OUTLIER -91.47 -166.05 1.48 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 113.443 -1.708 . . . . 0.0 110.036 179.119 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 233' ' ' GLU . . . . . 0.544 ' HB3' ' HG2' ' A' ' 182' ' ' LYS . 0.6 OUTLIER -133.7 13.88 4.04 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.51 -179.92 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.578 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.3 OUTLIER -85.14 -59.52 0.32 Allowed Pre-proline 0 N--CA 1.452 -0.37 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 179.752 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.875 ' O ' HD12 ' A' ' 239' ' ' ILE . 83.4 Cg_exo -49.9 -31.0 25.39 Favored 'Trans proline' 0 CA--C 1.5 -1.214 0 N-CA-C 108.888 -1.235 . . . . 0.0 108.888 177.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.685 HG21 ' CB ' ' A' ' 182' ' ' LYS . 14.7 t -72.74 -45.16 57.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 113.892 -1.504 . . . . 0.0 110.179 179.001 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.578 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 1.6 ptpt -62.81 -36.36 82.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.721 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.503 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 0.0 OUTLIER -81.62 -50.3 9.49 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.903 0.382 . . . . 0.0 110.92 179.194 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.875 HD12 ' O ' ' A' ' 235' ' ' PRO . 1.6 mt -46.33 -49.84 5.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.54 -179.312 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 240' ' ' MET . . . . . 0.522 ' SD ' HG12 ' A' ' 236' ' ' VAL . 15.4 mtp -60.27 -28.33 67.98 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.877 -178.398 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.531 ' CG ' ' O ' ' A' ' 237' ' ' LYS . 0.0 OUTLIER -88.67 -9.67 51.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.752 0.31 . . . . 0.0 110.976 -179.927 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.484 ' HG2' ' HA ' ' A' ' 239' ' ' ILE . 4.5 mmmm -79.81 116.19 19.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.363 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.498 ' HG2' ' N ' ' A' ' 244' ' ' TYR . 5.0 ttpt -39.98 -74.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 244' ' ' TYR . . . . . 0.546 ' CE1' ' HG3' ' A' ' 253' ' ' GLU . 21.6 m-85 -129.09 151.49 49.72 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.399 179.277 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 245' ' ' HIS . . . . . 0.787 ' CG ' HD12 ' A' ' 254' ' ' ILE . 45.0 m-70 -105.65 149.14 26.61 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.376 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -123.55 105.4 9.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.543 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.529 HG12 ' HB2' ' A' ' 197' ' ' LYS . 1.8 t -110.05 116.55 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.961 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 41.16 -90.67 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.676 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.511 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.1 OUTLIER -105.03 -35.99 7.46 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.747 0.784 . . . . 0.0 109.914 -179.538 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.477 ' HB3' ' HB2' ' A' ' 190' ' ' SER . 0.8 OUTLIER -77.87 153.61 32.5 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.317 -1.311 . . . . 0.0 112.633 -178.363 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.488 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -148.18 104.81 3.57 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.868 -1.06 . . . . 0.0 108.545 178.942 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 252' ' ' CYS . . . . . 0.995 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -127.59 152.32 47.8 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -177.074 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 253' ' ' GLU . . . . . 0.546 ' HG3' ' CE1' ' A' ' 244' ' ' TYR . 29.3 tt0 -77.17 110.05 11.54 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.047 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 254' ' ' ILE . . . . . 0.877 HG12 HG13 ' A' ' 186' ' ' VAL . 25.3 mt -96.52 111.29 26.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 -178.497 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 255' ' ' LYS . . . . . 0.514 ' O ' ' C ' ' A' ' 256' ' ' VAL . 0.0 OUTLIER -115.72 132.28 56.68 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 176.439 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.66 HG23 ' O ' ' A' ' 183' ' ' LYS . 5.2 p -32.8 121.78 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 CA-C-O 122.254 1.025 . . . . 0.0 111.356 -177.59 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 1.109 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -76.54 153.91 35.01 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 113.315 -1.766 . . . . 0.0 111.774 -178.511 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 2.0 mtm -128.81 113.6 15.49 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.761 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 259' ' ' SER . . . . . 0.411 ' HB3' ' HD2' ' A' ' 183' ' ' LYS . 86.9 p . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.537 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.527 ' CG1' ' N ' ' A' ' 182' ' ' LYS . 55.6 t . . . . . 0 CA--C 1.502 -0.865 0 CA-C-O 121.377 0.608 . . . . 0.0 111.961 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.75 ' CB ' HG21 ' A' ' 236' ' ' VAL . 0.0 OUTLIER -148.0 112.57 5.33 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.928 177.467 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.852 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -130.96 137.47 49.27 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.382 179.436 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.875 HD13 ' HE2' ' A' ' 230' ' ' PHE . 0.5 OUTLIER -119.67 120.73 64.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.814 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.813 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.3 OUTLIER -94.57 109.56 21.45 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.242 0.544 . . . . 0.0 111.003 -178.597 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 1.087 HG12 ' HB2' ' A' ' 252' ' ' CYS . 2.3 t -87.44 114.11 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.564 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.58 ' HA2' ' HB2' ' A' ' 225' ' ' PHE . . . -101.33 130.35 10.2 Favored Glycine 0 C--O 1.227 -0.288 0 N-CA-C 115.081 0.793 . . . . 0.0 115.081 -177.266 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.441 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . 78.36 79.73 0.75 Allowed Glycine 0 C--N 1.331 0.271 0 C-N-CA 121.01 -0.614 . . . . 0.0 113.472 178.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.939 HD23 ' C ' ' A' ' 225' ' ' PHE . 0.6 OUTLIER -117.69 157.56 26.26 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.693 0.282 . . . . 0.0 111.016 -179.916 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.587 ' N ' HD12 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -48.5 -173.48 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.792 179.305 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 191' ' ' PRO . . . . . 0.585 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 5.5 Cg_exo -77.59 15.96 1.16 Allowed 'Trans proline' 0 CA--C 1.531 0.36 0 C-N-CA 122.965 2.444 . . . . 0.0 113.409 -179.429 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.553 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 0.6 OUTLIER 157.58 78.19 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.667 0.27 . . . . 0.0 111.482 179.84 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.93 ' OG1' HD13 ' A' ' 189' ' ' LEU . 76.1 m -71.89 115.44 38.14 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.095 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.602 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 21.0 Cg_endo -61.02 112.31 1.33 Allowed 'Trans proline' 0 C--N 1.332 -0.325 0 C-N-CA 122.226 1.95 . . . . 0.0 111.519 178.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.804 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -50.63 -14.92 0.22 Allowed 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.872 -179.668 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 196' ' ' GLU . . . . . 0.484 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 9.3 mm-40 -66.94 -40.32 87.52 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -179.167 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.602 ' CD ' ' HG2' ' A' ' 194' ' ' PRO . 1.4 mttp -75.29 -46.42 33.61 Favored 'General case' 0 CA--C 1.498 -1.055 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.269 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.891 ' CD1' HG22 ' A' ' 193' ' ' THR . 0.0 OUTLIER -47.74 -32.11 2.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.003 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.595 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 9.6 mtp180 -69.48 -33.48 72.94 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.091 178.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 200' ' ' GLU . . . . . 0.528 ' N ' ' O ' ' A' ' 197' ' ' LYS . 9.3 mm-40 -82.47 -59.06 2.66 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.207 0.527 . . . . 0.0 110.206 178.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.505 ' C ' ' CD1' ' A' ' 201' ' ' TYR . 0.2 OUTLIER -48.76 -54.67 14.07 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.797 179.005 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.965 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.2 OUTLIER -79.57 -30.69 41.74 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.376 -179.864 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.595 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -62.7 -57.1 17.64 Favored Glycine 0 CA--C 1.499 -0.931 0 N-CA-C 107.036 -2.426 . . . . 0.0 107.036 176.475 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -48.62 -29.33 7.6 Favored Glycine 0 N--CA 1.441 -1.022 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 176.165 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.805 ' CD2' HD11 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -58.22 -43.45 87.71 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 177.764 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.491 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 169.06 -130.81 2.14 Favored Glycine 0 N--CA 1.441 -1.02 0 CA-C-N 113.725 -1.579 . . . . 0.0 110.423 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.506 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 4.3 mt-10 -96.97 101.31 12.86 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.208 0.528 . . . . 0.0 111.027 178.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.433 HG21 ' HB2' ' A' ' 202' ' ' PHE . 2.9 t -78.77 138.22 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 178.404 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 209' ' ' GLU . . . . . 0.502 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 13.7 tp10 -91.46 -57.62 2.71 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.616 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 25.1 p -157.7 154.95 29.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.285 0.565 . . . . 0.0 112.207 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.742 HD12 ' HB ' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -129.64 124.3 59.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.411 179.516 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.15 112.96 18.34 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -179.093 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.903 HD13 ' HB2' ' A' ' 226' ' ' CYS . 1.7 mm? . . . . . 0 CA--C 1.532 0.277 0 CA-C-O 120.836 0.35 . . . . 0.0 111.424 178.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.437 0 CA-C-O 120.837 0.132 . . . . 0.0 113.052 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 225' ' ' PHE . . . . . 0.939 ' C ' HD23 ' A' ' 189' ' ' LEU . 5.0 p90 -156.42 176.26 12.93 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -179.579 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 226' ' ' CYS . . . . . 0.903 ' HB2' HD13 ' A' ' 213' ' ' LEU . 7.2 p -143.87 154.89 43.83 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -179.245 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 1.137 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 6.1 m-85 -107.14 153.48 22.6 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.138 178.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.965 HD12 ' CE2' ' A' ' 202' ' ' PHE . 2.4 mt -147.87 135.11 13.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.869 0.366 . . . . 0.0 110.841 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 229' ' ' THR . . . . . 0.438 ' OG1' ' HG2' ' A' ' 183' ' ' LYS . 92.3 m -117.35 138.41 51.8 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.875 ' HE2' HD13 ' A' ' 184' ' ' ILE . 70.6 m-85 -111.89 126.25 54.9 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.564 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.506 ' HG3' ' O ' ' A' ' 207' ' ' GLU . 0.0 OUTLIER -49.55 -38.78 32.24 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 177.829 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 232' ' ' GLU . . . . . 0.483 ' O ' ' HD3' ' A' ' 182' ' ' LYS . 22.4 mt-10 -90.41 -171.49 3.1 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 113.276 -1.784 . . . . 0.0 109.019 178.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 233' ' ' GLU . . . . . 0.539 ' CB ' ' HG2' ' A' ' 182' ' ' LYS . 0.0 OUTLIER -127.47 0.5 6.26 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.55 179.965 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.485 ' O ' ' N ' ' A' ' 237' ' ' LYS . 0.2 OUTLIER -73.45 -57.61 2.63 Favored Pre-proline 0 C--N 1.329 -0.294 0 N-CA-C 112.0 0.371 . . . . 0.0 112.0 -179.075 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.887 ' O ' HD12 ' A' ' 239' ' ' ILE . 99.8 Cg_exo -49.24 -32.97 26.78 Favored 'Trans proline' 0 CA--C 1.498 -1.3 0 C-N-CA 121.124 1.216 . . . . 0.0 108.985 178.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.75 HG21 ' CB ' ' A' ' 182' ' ' LYS . 19.5 t -70.84 -41.62 77.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 113.646 -1.615 . . . . 0.0 109.189 178.297 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.524 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 23.5 mttm -57.18 -45.27 83.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.83 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.502 ' O ' ' HG3' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -81.03 -50.38 9.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.313 -179.396 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.887 HD12 ' O ' ' A' ' 235' ' ' PRO . 1.4 mt -41.78 -51.42 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.99 -179.298 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 240' ' ' MET . . . . . 0.61 ' SD ' HG12 ' A' ' 236' ' ' VAL . 4.9 mtp -64.23 -19.37 65.32 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.43 -178.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.502 ' HG3' ' O ' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -86.78 -22.1 26.12 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.063 0.458 . . . . 0.0 110.666 -179.916 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -78.49 118.26 20.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.667 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.447 ' HD3' ' CD2' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -48.68 -49.86 35.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.611 179.911 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 244' ' ' TYR . . . . . 0.528 ' CD1' ' HG3' ' A' ' 253' ' ' GLU . 17.2 m-85 -138.74 163.91 30.96 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.945 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 245' ' ' HIS . . . . . 0.789 ' CE1' HD12 ' A' ' 254' ' ' ILE . 31.6 m-70 -125.07 156.05 38.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.028 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 246' ' ' ASN . . . . . 0.5 ' HA ' ' HA ' ' A' ' 251' ' ' LYS . 0.2 OUTLIER -137.99 105.08 5.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.093 0.473 . . . . 0.0 110.057 178.768 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.527 ' N ' ' O ' ' A' ' 250' ' ' SER . 1.8 t -103.09 106.7 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.424 -178.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 248' ' ' GLY . . . . . 0.407 ' HA3' ' HE3' ' A' ' 197' ' ' LYS . . . 54.84 -81.22 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.482 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.527 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -114.38 -39.23 3.88 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.424 0.631 . . . . 0.0 110.346 -179.983 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.527 ' O ' ' N ' ' A' ' 247' ' ' VAL . 0.2 OUTLIER -77.42 153.24 33.82 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.736 -178.952 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 246' ' ' ASN . 0.0 OUTLIER -145.12 108.7 4.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.408 -0.815 . . . . 0.0 108.869 179.143 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 252' ' ' CYS . . . . . 1.087 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -128.3 153.3 47.15 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -176.951 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 253' ' ' GLU . . . . . 0.56 ' N ' ' O ' ' A' ' 187' ' ' GLY . 39.0 tt0 -76.03 107.22 8.08 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.978 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 254' ' ' ILE . . . . . 0.861 HG12 HG13 ' A' ' 186' ' ' VAL . 23.5 mt -95.76 113.7 30.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -178.398 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 255' ' ' LYS . . . . . 0.519 ' O ' ' C ' ' A' ' 256' ' ' VAL . 0.0 OUTLIER -118.84 133.2 56.0 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 176.608 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 183' ' ' LYS . 6.8 p -33.37 123.8 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 CA-C-O 122.252 1.025 . . . . 0.0 111.294 -177.605 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 1.137 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -76.01 153.36 36.55 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 113.337 -1.756 . . . . 0.0 111.444 -178.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.33 113.54 15.09 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.52 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.323 -0.559 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.995 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.505 HG12 ' N ' ' A' ' 182' ' ' LYS . 55.0 t . . . . . 0 CA--C 1.502 -0.871 0 CA-C-O 121.099 0.476 . . . . 0.0 111.356 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 1.103 ' HB2' HG21 ' A' ' 236' ' ' VAL . 0.0 OUTLIER -155.0 112.43 3.37 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.328 177.601 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.817 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -136.68 144.13 43.77 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 115.113 -0.948 . . . . 0.0 109.345 178.84 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.866 HD13 ' HE2' ' A' ' 230' ' ' PHE . 0.2 OUTLIER -123.9 120.07 58.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.827 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.846 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.9 OUTLIER -91.03 109.39 20.63 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.434 0.635 . . . . 0.0 109.748 -179.709 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.954 HG12 ' HB2' ' A' ' 252' ' ' CYS . 4.1 t -88.75 104.9 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.484 -179.066 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.551 ' O ' ' N ' ' A' ' 253' ' ' GLU . . . -92.82 127.39 8.97 Favored Glycine 0 C--O 1.228 -0.28 0 CA-C-N 115.165 -0.925 . . . . 0.0 115.065 -177.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.522 ' O ' ' CB ' ' A' ' 252' ' ' CYS . . . 83.29 81.43 0.97 Allowed Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.893 -0.67 . . . . 0.0 113.531 178.3 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.951 HD23 ' C ' ' A' ' 225' ' ' PHE . 0.6 OUTLIER -117.26 156.96 26.86 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.803 0.335 . . . . 0.0 110.865 179.68 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.591 ' N ' HD12 ' A' ' 189' ' ' LEU . 0.2 OUTLIER -46.52 -178.16 0.01 OUTLIER Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.812 179.811 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 191' ' ' PRO . . . . . 0.568 ' HD2' ' CB ' ' A' ' 190' ' ' SER . 72.1 Cg_endo -78.79 17.59 1.12 Allowed 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.563 2.175 . . . . 0.0 113.092 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.528 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 0.6 OUTLIER 159.86 66.17 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.497 0.189 . . . . 0.0 111.392 179.749 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.78 ' OG1' HD13 ' A' ' 189' ' ' LEU . 94.9 m -69.8 127.37 92.58 Favored Pre-proline 0 CA--C 1.518 -0.271 0 CA-C-O 120.963 0.411 . . . . 0.0 110.69 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.628 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 71.1 Cg_endo -71.15 109.49 2.58 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.378 2.052 . . . . 0.0 111.146 178.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.806 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -48.29 -14.07 0.05 Allowed 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -179.77 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 196' ' ' GLU . . . . . 0.524 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 2.9 mt-10 -67.44 -41.05 85.37 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.628 ' CD ' ' HG2' ' A' ' 194' ' ' PRO . 1.6 mttp -73.22 -46.87 47.84 Favored 'General case' 0 CA--C 1.503 -0.854 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.806 ' CG1' ' HA ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -47.5 -29.94 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.978 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 177.947 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.544 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 7.5 mtt180 -72.96 -32.69 65.38 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.294 178.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 200' ' ' GLU . . . . . 0.572 ' CG ' ' N ' ' A' ' 201' ' ' TYR . 3.6 pt-20 -83.0 -55.35 4.43 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.01 0.433 . . . . 0.0 110.337 179.053 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.572 ' N ' ' CG ' ' A' ' 200' ' ' GLU . 0.3 OUTLIER -50.01 -53.31 27.54 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.575 0.702 . . . . 0.0 109.511 178.761 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 1.132 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -79.64 -30.91 41.47 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.2 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.544 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -62.41 -56.72 20.14 Favored Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 107.048 -2.421 . . . . 0.0 107.048 176.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -50.67 -28.13 14.79 Favored Glycine 0 N--CA 1.443 -0.895 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 176.14 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.809 ' CD2' HD11 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -58.48 -43.9 89.13 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 177.805 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.502 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 170.69 -131.5 2.24 Favored Glycine 0 N--CA 1.441 -1.007 0 CA-C-N 113.615 -1.629 . . . . 0.0 110.271 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.513 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 2.1 mm-40 -97.1 100.82 12.3 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.238 0.542 . . . . 0.0 110.946 178.615 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.469 HG21 ' HB2' ' A' ' 202' ' ' PHE . 2.5 t -78.69 140.5 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.13 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.011 178.506 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 209' ' ' GLU . . . . . 0.718 ' HB3' HG22 ' A' ' 229' ' ' THR . 7.4 tp10 -89.53 -53.49 4.51 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 178.056 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.481 ' HB3' ' OE2' ' A' ' 212' ' ' GLU . 0.4 OUTLIER -170.89 156.69 5.09 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.451 179.256 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 1.022 HD13 HG23 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -125.1 117.28 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.611 179.375 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 212' ' ' GLU . . . . . 0.556 ' C ' HD23 ' A' ' 213' ' ' LEU . 0.5 OUTLIER -123.5 104.43 9.06 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -179.422 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.987 HD22 ' CB ' ' A' ' 226' ' ' CYS . 0.1 OUTLIER . . . . . 0 CA--C 1.533 0.31 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 179.207 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 224' ' ' GLY . . . . . 0.485 ' O ' ' HG ' ' A' ' 189' ' ' LEU . . . . . . . . 0 N--CA 1.447 -0.617 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 225' ' ' PHE . . . . . 0.951 ' C ' HD23 ' A' ' 189' ' ' LEU . 15.9 p90 -135.75 177.2 8.01 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -178.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 226' ' ' CYS . . . . . 0.987 ' CB ' HD22 ' A' ' 213' ' ' LEU . 1.5 p -135.9 149.69 49.07 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -178.573 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 1.117 ' CE1' ' HB1' ' A' ' 257' ' ' ALA . 3.9 m-85 -106.08 132.58 51.98 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.168 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 1.132 HD12 ' CE2' ' A' ' 202' ' ' PHE . 1.8 mt -128.61 118.54 47.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.292 0.567 . . . . 0.0 111.472 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 229' ' ' THR . . . . . 0.718 HG22 ' HB3' ' A' ' 209' ' ' GLU . 22.1 m -101.58 138.03 39.12 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.562 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.866 ' HE2' HD13 ' A' ' 184' ' ' ILE . 74.4 m-85 -114.87 126.46 54.83 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.095 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.513 ' HG3' ' O ' ' A' ' 207' ' ' GLU . 0.0 OUTLIER -48.17 -39.13 19.87 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 177.992 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 232' ' ' GLU . . . . . 0.485 ' O ' ' HG3' ' A' ' 182' ' ' LYS . 3.1 mt-10 -98.81 165.22 11.88 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 113.413 -1.721 . . . . 0.0 109.478 178.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 233' ' ' GLU . . . . . 0.458 ' HB3' ' CD ' ' A' ' 182' ' ' LYS . 0.9 OUTLIER -106.14 19.64 20.21 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -179.393 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.548 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.7 OUTLIER -85.34 -61.44 0.27 Allowed Pre-proline 0 C--N 1.334 -0.086 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.955 179.67 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.888 ' O ' HD12 ' A' ' 239' ' ' ILE . 85.5 Cg_exo -49.51 -29.53 18.85 Favored 'Trans proline' 0 CA--C 1.499 -1.256 0 N-CA-C 108.88 -1.238 . . . . 0.0 108.88 177.538 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 1.103 HG21 ' HB2' ' A' ' 182' ' ' LYS . 12.9 t -73.31 -46.15 50.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 113.786 -1.552 . . . . 0.0 110.719 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.548 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 13.6 pttt -59.94 -37.18 78.8 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.42 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.624 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.6 OUTLIER -80.75 -56.1 4.37 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.201 0.524 . . . . 0.0 110.753 178.858 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.888 HD12 ' O ' ' A' ' 235' ' ' PRO . 1.6 mt -39.28 -47.74 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.605 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 240' ' ' MET . . . . . 0.51 ' SD ' HG12 ' A' ' 236' ' ' VAL . 3.8 mtp -62.63 -27.7 69.39 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.782 -178.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.479 ' CG ' ' O ' ' A' ' 237' ' ' LYS . 1.8 mt-10 -83.41 -24.92 31.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.631 0.253 . . . . 0.0 111.553 -179.355 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.575 ' HD3' ' CE1' ' A' ' 245' ' ' HIS . 0.8 OUTLIER -79.22 109.31 13.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.019 0.437 . . . . 0.0 111.118 -179.461 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.504 ' HD2' ' CE2' ' A' ' 244' ' ' TYR . 0.6 OUTLIER -35.49 -61.19 0.46 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.094 -179.747 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 244' ' ' TYR . . . . . 0.551 ' CE1' ' HG3' ' A' ' 253' ' ' GLU . 44.5 m-85 -129.28 167.72 17.28 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.583 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 245' ' ' HIS . . . . . 0.778 ' CG ' HD12 ' A' ' 254' ' ' ILE . 38.1 m-70 -128.47 153.36 47.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.758 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -127.93 105.57 8.51 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.001 0.429 . . . . 0.0 111.031 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.58 HG11 HG23 ' A' ' 198' ' ' ILE . 1.5 t -106.36 107.91 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.241 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 44.06 -86.67 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.582 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -101.41 -41.37 6.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.256 0.55 . . . . 0.0 110.829 179.75 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.504 ' HB3' ' HB2' ' A' ' 190' ' ' SER . 5.2 p -78.34 155.79 29.9 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.363 -0.835 . . . . 0.0 113.096 -178.054 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.508 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.1 OUTLIER -147.47 105.86 3.78 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 114.365 -1.288 . . . . 0.0 107.868 178.473 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 252' ' ' CYS . . . . . 0.954 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -127.52 153.32 46.49 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -176.199 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 253' ' ' GLU . . . . . 0.551 ' N ' ' O ' ' A' ' 187' ' ' GLY . 40.6 tt0 -76.21 107.03 8.16 Favored 'General case' 0 C--O 1.22 -0.464 0 CA-C-N 114.832 -1.076 . . . . 0.0 110.607 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 254' ' ' ILE . . . . . 0.835 HG12 HG13 ' A' ' 186' ' ' VAL . 22.2 mt -95.62 111.85 26.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -178.171 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 255' ' ' LYS . . . . . 0.537 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -116.42 130.24 56.65 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 113.349 -1.751 . . . . 0.0 106.327 177.035 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 183' ' ' LYS . 4.2 p -32.75 123.01 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.488 0 CA-C-O 122.265 1.031 . . . . 0.0 111.341 -177.386 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 1.117 ' HB1' ' CE1' ' A' ' 227' ' ' PHE . . . -76.31 153.98 35.44 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 113.39 -1.732 . . . . 0.0 110.974 -178.572 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.56 113.4 14.19 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.717 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.504 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.854 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.501 ' CG1' ' N ' ' A' ' 182' ' ' LYS . 47.4 t . . . . . 0 CA--C 1.504 -0.808 0 CA-C-O 121.338 0.59 . . . . 0.0 111.608 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.696 ' CB ' HG21 ' A' ' 236' ' ' VAL . 0.0 OUTLIER -149.98 112.54 4.74 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.934 177.452 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.815 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.0 OUTLIER -133.21 141.78 48.25 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.444 179.254 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.816 HD12 HG21 ' A' ' 239' ' ' ILE . 0.5 OUTLIER -120.8 120.63 63.01 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 178.735 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.841 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -93.35 109.32 20.87 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.29 0.567 . . . . 0.0 110.327 -179.172 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.879 HG12 ' HB2' ' A' ' 252' ' ' CYS . 11.7 t -85.9 120.0 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.753 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.55 ' O ' ' N ' ' A' ' 253' ' ' GLU . . . -109.87 131.4 10.45 Favored Glycine 0 C--N 1.331 0.265 0 N-CA-C 115.221 0.849 . . . . 0.0 115.221 -176.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.478 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . 76.41 79.44 0.65 Allowed Glycine 0 C--N 1.331 0.255 0 C-N-CA 121.378 -0.439 . . . . 0.0 113.334 178.451 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.952 HD23 ' CA ' ' A' ' 225' ' ' PHE . 0.6 OUTLIER -117.54 157.48 26.26 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.605 0.241 . . . . 0.0 111.049 -179.776 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.619 ' N ' HD12 ' A' ' 189' ' ' LEU . 0.2 OUTLIER -46.88 -175.3 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.203 0 CA-C-O 121.046 0.45 . . . . 0.0 111.58 179.92 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 191' ' ' PRO . . . . . 0.597 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 13.2 Cg_exo -70.59 6.35 1.63 Allowed 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 123.319 2.68 . . . . 0.0 113.721 -179.119 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.54 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 3.5 m-20 159.6 78.76 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.153 0.502 . . . . 0.0 110.834 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.911 ' OG1' HD13 ' A' ' 189' ' ' LEU . 52.8 m -71.01 116.0 42.02 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.999 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.603 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 20.5 Cg_endo -58.16 110.54 0.66 Allowed 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.319 2.013 . . . . 0.0 111.127 178.544 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.804 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.4 OUTLIER -50.77 -14.98 0.23 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.524 -179.56 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 196' ' ' GLU . . . . . 0.477 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 74.1 mt-10 -65.15 -41.14 95.0 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -179.28 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.603 ' CD ' ' HG2' ' A' ' 194' ' ' PRO . 1.4 mttp -73.79 -48.07 34.24 Favored 'General case' 0 CA--C 1.498 -1.048 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.41 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.855 ' CD1' HG22 ' A' ' 193' ' ' THR . 0.0 OUTLIER -47.69 -31.85 2.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.207 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.547 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 2.3 mtp-105 -69.82 -33.31 72.15 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.083 178.786 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 200' ' ' GLU . . . . . 0.514 ' N ' ' O ' ' A' ' 197' ' ' LYS . 7.9 mt-10 -82.49 -58.5 2.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.244 0.545 . . . . 0.0 110.095 178.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.555 ' CD1' ' CD1' ' A' ' 202' ' ' PHE . 0.2 OUTLIER -49.02 -53.54 19.65 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.677 178.895 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 1.094 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.1 OUTLIER -79.74 -31.39 41.02 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.583 -179.787 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.547 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -62.77 -55.25 28.02 Favored Glycine 0 CA--C 1.5 -0.896 0 N-CA-C 107.051 -2.42 . . . . 0.0 107.051 176.618 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -50.25 -27.6 11.58 Favored Glycine 0 N--CA 1.444 -0.815 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 176.163 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.75 ' CE2' HG13 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -59.2 -47.76 84.14 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 122.137 0.97 . . . . 0.0 108.528 177.984 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.493 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 176.5 -132.29 2.04 Favored Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 113.602 -1.635 . . . . 0.0 110.172 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.489 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 2.2 mt-10 -97.19 99.87 11.35 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.142 0.496 . . . . 0.0 111.128 178.515 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.464 HG22 ' CE1' ' A' ' 230' ' ' PHE . 2.7 t -76.17 138.71 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.274 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 209' ' ' GLU . . . . . 0.464 ' HB3' HG22 ' A' ' 229' ' ' THR . 3.7 tp10 -92.45 -54.66 3.7 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.062 178.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 3.3 m -161.5 151.92 17.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.248 0.547 . . . . 0.0 112.272 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.691 HD12 ' HB ' ' A' ' 198' ' ' ILE . 0.1 OUTLIER -126.39 119.19 53.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.809 179.037 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.46 103.71 8.63 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -177.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.773 HD23 ' CB ' ' A' ' 226' ' ' CYS . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.225 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 176.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.58 0 N-CA-C 112.542 -0.223 . . . . 0.0 112.542 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 225' ' ' PHE . . . . . 0.952 ' CA ' HD23 ' A' ' 189' ' ' LEU . 0.5 OUTLIER -156.21 177.06 11.87 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.407 -0.396 . . . . 0.0 110.095 -177.852 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 226' ' ' CYS . . . . . 0.773 ' CB ' HD23 ' A' ' 213' ' ' LEU . 1.7 p -138.59 155.17 48.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.367 0.603 . . . . 0.0 112.609 -179.014 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 1.084 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 4.6 m-85 -111.17 133.3 53.63 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.338 178.779 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 1.094 HD12 ' CE2' ' A' ' 202' ' ' PHE . 2.0 mt -128.33 120.48 53.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.293 0.568 . . . . 0.0 111.679 -179.42 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 229' ' ' THR . . . . . 0.48 ' OG1' ' HG2' ' A' ' 183' ' ' LYS . 73.6 m -103.44 138.1 40.63 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.404 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.809 ' HE2' HD13 ' A' ' 184' ' ' ILE . 82.7 m-85 -114.12 126.59 55.26 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.514 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.489 ' HG3' ' O ' ' A' ' 207' ' ' GLU . 0.0 OUTLIER -49.19 -38.53 26.22 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 177.914 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 232' ' ' GLU . . . . . 0.451 ' O ' ' HD3' ' A' ' 182' ' ' LYS . 2.0 mm-40 -90.85 -166.79 1.66 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 113.42 -1.718 . . . . 0.0 109.923 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 233' ' ' GLU . . . . . 0.471 ' CB ' ' HG2' ' A' ' 182' ' ' LYS . 0.6 OUTLIER -132.64 13.09 4.47 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.689 -179.852 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.538 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.8 OUTLIER -85.12 -58.04 0.36 Allowed Pre-proline 0 N--CA 1.451 -0.39 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.609 179.829 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.931 ' O ' HD12 ' A' ' 239' ' ' ILE . 81.4 Cg_exo -50.65 -28.8 23.43 Favored 'Trans proline' 0 CA--C 1.502 -1.116 0 N-CA-C 109.238 -1.101 . . . . 0.0 109.238 178.139 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.696 HG21 ' CB ' ' A' ' 182' ' ' LYS . 13.9 t -73.14 -44.05 56.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 113.795 -1.548 . . . . 0.0 109.978 178.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.542 ' HG2' ' HD2' ' A' ' 238' ' ' LYS . 0.5 OUTLIER -67.95 -30.25 69.5 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.301 179.538 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.542 ' HD2' ' HG2' ' A' ' 237' ' ' LYS . 0.6 OUTLIER -78.74 -54.34 6.2 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.766 0.793 . . . . 0.0 110.369 179.36 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.931 HD12 ' O ' ' A' ' 235' ' ' PRO . 1.9 mt -51.67 -49.65 33.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 114.357 -1.292 . . . . 0.0 112.645 -178.702 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 240' ' ' MET . . . . . 0.528 ' SD ' HG12 ' A' ' 236' ' ' VAL . 8.1 mtp -59.35 -17.69 31.91 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.598 -178.572 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.541 ' CG ' ' O ' ' A' ' 237' ' ' LYS . 0.1 OUTLIER -84.25 -40.66 17.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.084 179.952 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.454 ' O ' ' C ' ' A' ' 243' ' ' LYS . 0.0 OUTLIER -80.3 87.15 5.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.722 179.898 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.56 ' N ' ' HD3' ' A' ' 243' ' ' LYS . 0.0 OUTLIER -31.48 -46.48 0.1 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.907 179.757 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 244' ' ' TYR . . . . . 0.572 ' CE1' ' HG3' ' A' ' 253' ' ' GLU . 18.9 m-85 -120.62 148.94 43.23 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.799 -179.366 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 245' ' ' HIS . . . . . 0.875 ' CG ' HD12 ' A' ' 254' ' ' ILE . 24.7 m-70 -122.97 157.75 31.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.278 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 246' ' ' ASN . . . . . 0.404 ' O ' ' CE2' ' A' ' 201' ' ' TYR . 0.1 OUTLIER -129.54 104.8 7.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.114 178.815 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.575 HG11 HG23 ' A' ' 198' ' ' ILE . 1.6 t -106.89 111.02 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.069 -179.378 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 48.0 -86.48 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.248 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.525 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.1 OUTLIER -108.57 -39.56 5.36 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.436 0.636 . . . . 0.0 110.391 -179.722 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.509 ' HB3' ' HB2' ' A' ' 190' ' ' SER . 0.2 OUTLIER -77.75 154.96 31.52 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.85 -1.068 . . . . 0.0 112.626 -178.3 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.513 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.1 OUTLIER -146.61 108.87 4.45 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.065 178.86 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 252' ' ' CYS . . . . . 0.879 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -128.17 152.79 47.62 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -177.015 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 253' ' ' GLU . . . . . 0.572 ' HG3' ' CE1' ' A' ' 244' ' ' TYR . 29.6 tt0 -76.44 107.12 8.49 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.523 179.282 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 254' ' ' ILE . . . . . 0.875 HD12 ' CG ' ' A' ' 245' ' ' HIS . 31.0 mt -96.15 111.07 25.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -178.291 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 255' ' ' LYS . . . . . 0.521 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -113.63 133.36 55.34 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 176.656 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.537 ' CG2' ' O ' ' A' ' 183' ' ' LYS . 4.1 p -33.55 124.34 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-O 122.207 1.004 . . . . 0.0 111.26 -177.635 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 1.084 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -77.35 153.25 33.96 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 113.466 -1.697 . . . . 0.0 112.037 -178.538 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.18 117.56 19.21 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.298 179.186 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.322 -0.624 0 CA-C-O 121.254 0.55 . . . . 0.0 111.45 -178.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.476 ' CG1' ' N ' ' A' ' 182' ' ' LYS . 46.3 t . . . . . 0 CA--C 1.5 -0.949 0 CA-C-O 121.206 0.527 . . . . 0.0 111.422 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.873 ' HB2' HG21 ' A' ' 236' ' ' VAL . 0.1 OUTLIER -150.45 112.02 4.47 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.247 178.0 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.874 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -133.73 144.95 49.42 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-N 114.432 -1.258 . . . . 0.0 108.814 178.896 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.916 HD13 ' HE2' ' A' ' 230' ' ' PHE . 1.8 pt -124.37 119.86 57.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 178.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.837 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -93.92 109.02 20.75 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 121.471 0.653 . . . . 0.0 110.687 -178.574 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 1.131 HG12 ' HB2' ' A' ' 252' ' ' CYS . 1.9 t -86.34 126.67 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.135 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.566 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . -113.4 133.99 11.6 Favored Glycine 0 C--N 1.333 0.412 0 N-CA-C 114.313 0.485 . . . . 0.0 114.313 -176.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.455 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . 71.41 87.64 0.14 Allowed Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.692 -0.766 . . . . 0.0 111.893 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.938 HD13 ' OG1' ' A' ' 193' ' ' THR . 0.6 OUTLIER -115.86 156.56 25.9 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.026 0.441 . . . . 0.0 111.655 -178.469 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.604 ' CB ' ' CD ' ' A' ' 191' ' ' PRO . 0.3 OUTLIER -49.31 -172.64 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.888 179.77 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 191' ' ' PRO . . . . . 0.604 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 3.1 Cg_exo -77.21 13.09 1.62 Allowed 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 123.004 2.469 . . . . 0.0 113.182 -179.3 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.535 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 1.6 p30 157.43 77.24 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 120.758 0.313 . . . . 0.0 111.375 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.938 ' OG1' HD13 ' A' ' 189' ' ' LEU . 16.8 m -70.91 114.24 25.4 Favored Pre-proline 0 CA--C 1.517 -0.309 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.258 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.61 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 97.6 Cg_endo -73.38 109.32 2.82 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.589 2.193 . . . . 0.0 111.211 178.701 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.606 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.3 OUTLIER -43.9 -19.69 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.831 -0.168 . . . . 0.0 111.447 -179.911 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 196' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' A' ' 194' ' ' PRO . 66.6 mt-10 -57.24 -43.14 82.64 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -179.355 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.61 ' CD ' ' HG2' ' A' ' 194' ' ' PRO . 0.5 OUTLIER -80.36 -47.11 14.96 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 178.619 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.893 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -49.0 -29.68 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 CA-C-N 114.382 -1.281 . . . . 0.0 108.445 176.728 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.565 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 0.0 OUTLIER -73.22 -32.54 64.82 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.656 178.104 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 200' ' ' GLU . . . . . 0.539 ' N ' ' O ' ' A' ' 197' ' ' LYS . 2.7 mt-10 -82.15 -58.33 3.0 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.642 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.492 ' C ' ' CD1' ' A' ' 201' ' ' TYR . 0.5 OUTLIER -48.43 -53.9 16.11 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.801 179.318 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 1.058 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.4 OUTLIER -79.59 -31.67 41.83 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.36 179.827 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.565 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -61.99 -57.12 18.71 Favored Glycine 0 CA--C 1.498 -1.001 0 N-CA-C 107.563 -2.215 . . . . 0.0 107.563 176.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -51.33 -28.12 18.84 Favored Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 176.479 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.771 ' CD2' HD11 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -57.07 -44.24 82.88 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.01 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.486 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 170.06 -129.11 1.76 Allowed Glycine 0 N--CA 1.441 -0.992 0 CA-C-N 113.518 -1.674 . . . . 0.0 110.221 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.516 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 21.8 mm-40 -97.16 101.52 13.1 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.153 0.502 . . . . 0.0 111.298 178.769 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 2.9 t -76.75 137.27 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 177.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 209' ' ' GLU . . . . . 0.509 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 5.7 tp10 -89.43 -56.58 3.2 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.954 179.078 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 15.5 m -164.38 149.49 10.11 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.278 0.561 . . . . 0.0 111.921 179.478 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.493 HD12 ' HB ' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -117.66 126.47 74.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.669 179.078 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -123.18 105.18 9.67 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -178.128 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.752 HD13 ' O ' ' A' ' 193' ' ' THR . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.267 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 177.439 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.66 0 CA-C-O 121.041 0.245 . . . . 0.0 112.706 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 225' ' ' PHE . . . . . 0.92 ' C ' HD23 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -157.36 177.07 11.86 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -178.403 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 226' ' ' CYS . . . . . 0.425 ' SG ' ' HB ' ' A' ' 186' ' ' VAL . 6.0 p -139.75 151.35 45.74 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 1.095 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 4.6 m-85 -110.43 133.07 53.62 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.711 178.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 1.058 HD12 ' CE2' ' A' ' 202' ' ' PHE . 2.3 mt -127.68 131.75 69.69 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.342 0 CA-C-O 121.121 0.486 . . . . 0.0 111.245 179.592 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 229' ' ' THR . . . . . 0.482 ' HG1' ' HZ2' ' A' ' 183' ' ' LYS . 87.9 m -111.61 138.23 48.43 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.388 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.916 ' HE2' HD13 ' A' ' 184' ' ' ILE . 62.8 m-85 -112.8 126.29 55.27 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.686 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.516 ' HG3' ' O ' ' A' ' 207' ' ' GLU . 0.0 OUTLIER -50.85 -38.15 47.4 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 177.612 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 232' ' ' GLU . . . . . 0.511 ' O ' ' HG3' ' A' ' 182' ' ' LYS . 10.1 mt-10 -93.83 178.22 5.74 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 113.051 -1.886 . . . . 0.0 108.951 178.61 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 233' ' ' GLU . . . . . 0.547 ' O ' ' HG3' ' A' ' 237' ' ' LYS . 0.7 OUTLIER -117.7 1.98 12.24 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.878 -179.509 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.496 ' O ' ' N ' ' A' ' 237' ' ' LYS . 0.4 OUTLIER -73.06 -58.83 2.38 Favored Pre-proline 0 C--N 1.326 -0.435 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.864 -179.177 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.883 ' O ' HD12 ' A' ' 239' ' ' ILE . 82.2 Cg_exo -48.97 -32.72 23.97 Favored 'Trans proline' 0 CA--C 1.501 -1.134 0 N-CA-C 108.851 -1.25 . . . . 0.0 108.851 178.758 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.873 HG21 ' HB2' ' A' ' 182' ' ' LYS . 21.3 t -70.57 -42.05 78.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 113.928 -1.487 . . . . 0.0 109.034 178.068 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.547 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 13.5 mtpt -56.43 -45.93 80.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.798 179.619 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.489 ' HA ' ' HG3' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -81.25 -49.97 10.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.701 -179.163 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.883 HD12 ' O ' ' A' ' 235' ' ' PRO . 1.6 mt -42.74 -50.1 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.427 -178.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 240' ' ' MET . . . . . 0.543 ' SD ' HG12 ' A' ' 236' ' ' VAL . 12.2 mtp -62.42 -24.18 67.27 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.695 -178.613 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.489 ' HG3' ' HA ' ' A' ' 238' ' ' LYS . 0.7 OUTLIER -87.88 -16.66 33.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.534 -179.437 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.456 ' HG2' ' HA ' ' A' ' 239' ' ' ILE . 8.1 mmmt -83.93 116.3 22.72 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.57 -0.287 . . . . 0.0 111.153 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.518 ' HG2' ' N ' ' A' ' 244' ' ' TYR . 1.8 ttpm? -36.77 -80.7 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.082 0.468 . . . . 0.0 110.013 179.263 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 244' ' ' TYR . . . . . 0.518 ' N ' ' HG2' ' A' ' 243' ' ' LYS . 10.3 m-85 -113.24 169.43 8.95 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.876 178.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 245' ' ' HIS . . . . . 0.697 ' CG ' HD12 ' A' ' 254' ' ' ILE . 17.0 m-70 -123.46 146.35 48.1 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.784 0.326 . . . . 0.0 110.935 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 246' ' ' ASN . . . . . 0.441 ' O ' ' CD2' ' A' ' 201' ' ' TYR . 0.1 OUTLIER -122.42 105.47 10.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.042 0.449 . . . . 0.0 110.519 179.595 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.523 HG11 HG23 ' A' ' 198' ' ' ILE . 2.4 t -111.6 102.41 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.824 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 51.2 -90.57 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.321 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.474 HD11 ' OG ' ' A' ' 190' ' ' SER . 0.1 OUTLIER -104.06 -40.36 6.21 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 121.594 0.711 . . . . 0.0 109.957 -179.931 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.57 ' CB ' ' HG1' ' A' ' 193' ' ' THR . 1.4 m -78.61 150.27 32.76 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.604 -1.18 . . . . 0.0 112.165 -178.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.519 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -149.98 107.61 3.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.47 179.36 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 252' ' ' CYS . . . . . 1.131 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -128.19 153.46 46.88 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -177.326 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 253' ' ' GLU . . . . . 0.542 ' N ' ' O ' ' A' ' 187' ' ' GLY . 71.4 tt0 -75.58 110.87 10.33 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.301 -178.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 254' ' ' ILE . . . . . 0.964 HG12 HG13 ' A' ' 186' ' ' VAL . 11.5 mt -96.59 112.14 28.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 -178.036 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 255' ' ' LYS . . . . . 0.526 ' O ' ' C ' ' A' ' 256' ' ' VAL . 0.0 OUTLIER -119.14 131.24 55.86 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 176.009 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.654 HG23 ' O ' ' A' ' 183' ' ' LYS . 6.0 p -32.32 122.58 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.586 0 CA-C-O 122.285 1.04 . . . . 0.0 111.551 -176.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 1.095 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -75.85 152.62 37.2 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 113.366 -1.743 . . . . 0.0 111.614 -178.425 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.86 110.18 12.33 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.717 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 259' ' ' SER . . . . . 0.525 ' HB2' ' HD2' ' A' ' 183' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--N 1.32 -0.677 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.805 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.416 ' CG1' ' N ' ' A' ' 182' ' ' LYS . 53.0 t . . . . . 0 CA--C 1.5 -0.946 0 CA-C-O 121.184 0.516 . . . . 0.0 111.314 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.963 ' HB2' HG21 ' A' ' 236' ' ' VAL . 0.0 OUTLIER -153.76 111.69 3.55 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.89 177.142 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.806 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -138.25 137.52 37.58 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 114.561 -1.199 . . . . 0.0 108.795 178.953 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.835 HD13 ' HE2' ' A' ' 230' ' ' PHE . 1.1 pt -117.99 120.37 64.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.064 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.824 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -94.59 109.77 21.65 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 121.543 0.687 . . . . 0.0 110.196 -179.026 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.692 HG22 ' CD1' ' A' ' 254' ' ' ILE . 45.5 t -84.44 133.89 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.036 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.536 ' O ' ' HB3' ' A' ' 252' ' ' CYS . . . -92.0 -149.74 24.64 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.961 -0.638 . . . . 0.0 114.686 -177.128 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.477 ' O ' ' HB3' ' A' ' 252' ' ' CYS . . . -33.15 102.31 0.01 OUTLIER Glycine 0 C--N 1.334 0.469 0 CA-C-N 114.971 -0.614 . . . . 0.0 113.564 -179.428 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 1.026 HD13 ' OG1' ' A' ' 193' ' ' THR . 1.4 pp -117.48 157.89 25.48 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 122.753 0.421 . . . . 0.0 111.186 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.63 ' O ' HD12 ' A' ' 189' ' ' LEU . 0.5 OUTLIER -43.84 -178.9 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.539 179.65 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 191' ' ' PRO . . . . . 0.535 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 17.4 Cg_exo -67.62 4.05 1.54 Allowed 'Trans proline' 0 CA--C 1.533 0.458 0 C-N-CA 123.185 2.59 . . . . 0.0 114.019 -179.107 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.526 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 4.3 t0 161.76 76.04 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.896 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 193' ' ' THR . . . . . 1.026 ' OG1' HD13 ' A' ' 189' ' ' LEU . 17.6 m -64.65 109.78 3.25 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.483 179.156 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.505 ' HG2' ' HG2' ' A' ' 197' ' ' LYS . 11.5 Cg_endo -56.9 110.23 0.56 Allowed 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.243 1.962 . . . . 0.0 111.215 179.517 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.787 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.1 OUTLIER -47.23 -16.93 0.05 Allowed 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -179.278 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 196' ' ' GLU . . . . . 0.462 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 62.6 mt-10 -68.15 -38.05 81.71 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -179.584 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.505 ' HG2' ' HG2' ' A' ' 194' ' ' PRO . 1.5 mmmm -75.04 -47.78 27.23 Favored 'General case' 0 CA--C 1.5 -0.969 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.605 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.901 ' CD1' HG22 ' A' ' 193' ' ' THR . 0.0 OUTLIER -48.1 -30.9 2.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 115.1 -0.955 . . . . 0.0 108.679 178.326 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.579 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 12.9 mtp180 -71.47 -32.09 67.88 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.238 179.02 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 200' ' ' GLU . . . . . 0.501 ' N ' ' O ' ' A' ' 197' ' ' LYS . 0.4 OUTLIER -82.51 -45.66 14.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.086 0.469 . . . . 0.0 110.65 179.424 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.504 ' C ' ' CD1' ' A' ' 201' ' ' TYR . 0.2 OUTLIER -63.92 -52.91 57.67 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.006 179.2 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 1.029 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -79.68 -32.57 41.44 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.222 -179.799 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.579 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -64.98 -53.42 34.01 Favored Glycine 0 CA--C 1.498 -1.002 0 N-CA-C 106.579 -2.608 . . . . 0.0 106.579 175.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -51.18 -28.81 19.96 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 176.035 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.761 ' CE2' HG13 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -57.45 -47.69 81.15 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 122.268 1.033 . . . . 0.0 108.341 177.856 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.481 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 174.04 -129.25 1.6 Allowed Glycine 0 N--CA 1.441 -0.98 0 CA-C-N 113.36 -1.745 . . . . 0.0 110.12 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.518 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 5.0 mm-40 -97.14 100.42 11.9 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.274 0.559 . . . . 0.0 111.424 178.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.408 HG22 ' CE1' ' A' ' 230' ' ' PHE . 2.6 t -76.98 139.47 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.151 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 177.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 209' ' ' GLU . . . . . 0.765 ' HB3' HG22 ' A' ' 229' ' ' THR . 21.0 tp10 -91.73 -49.84 6.06 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 178.776 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 9.8 p -166.93 152.84 8.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.187 0.518 . . . . 0.0 112.09 179.407 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.736 HD12 ' HB ' ' A' ' 198' ' ' ILE . 0.1 OUTLIER -125.43 120.22 57.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.114 178.956 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -123.63 103.65 8.55 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -178.303 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.528 HD13 ' O ' ' A' ' 193' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.332 -0.193 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 177.46 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.424 0 CA-C-O 120.892 0.162 . . . . 0.0 113.405 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 225' ' ' PHE . . . . . 0.859 ' CA ' HD23 ' A' ' 189' ' ' LEU . 1.1 p90 -156.13 176.24 12.93 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 -179.484 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 226' ' ' CYS . . . . . 0.875 ' SG ' HD22 ' A' ' 189' ' ' LEU . 0.8 OUTLIER -144.46 154.62 43.13 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.439 -0.504 . . . . 0.0 112.137 -179.08 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 1.108 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 6.3 m-85 -108.52 139.91 42.61 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.167 179.289 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 1.029 HD12 ' CE2' ' A' ' 202' ' ' PHE . 2.2 mt -135.51 122.08 33.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.959 0.409 . . . . 0.0 110.923 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 229' ' ' THR . . . . . 0.765 HG22 ' HB3' ' A' ' 209' ' ' GLU . 28.8 m -103.33 138.32 40.25 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.674 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.835 ' HE2' HD13 ' A' ' 184' ' ' ILE . 71.4 m-85 -113.34 126.25 55.16 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.265 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.524 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -47.96 -39.11 18.4 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 178.404 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 232' ' ' GLU . . . . . 0.462 ' O ' ' HG3' ' A' ' 182' ' ' LYS . 3.3 mm-40 -100.95 171.43 7.65 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 113.414 -1.721 . . . . 0.0 109.202 178.76 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 233' ' ' GLU . . . . . 0.541 ' O ' ' HG3' ' A' ' 237' ' ' LYS . 4.2 pt-20 -107.97 12.01 27.38 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -179.099 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.538 ' O ' ' N ' ' A' ' 237' ' ' LYS . 0.1 OUTLIER -77.54 -60.71 0.7 Allowed Pre-proline 0 N--CA 1.465 0.283 0 C-N-CA 120.479 -0.488 . . . . 0.0 111.38 -179.787 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.914 ' O ' HD12 ' A' ' 239' ' ' ILE . 90.7 Cg_exo -49.45 -31.26 23.1 Favored 'Trans proline' 0 CA--C 1.499 -1.246 0 N-CA-C 108.671 -1.319 . . . . 0.0 108.671 178.279 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.963 HG21 ' HB2' ' A' ' 182' ' ' LYS . 21.5 t -69.25 -42.58 81.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 113.856 -1.52 . . . . 0.0 108.381 177.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.543 ' O ' ' CG ' ' A' ' 241' ' ' GLU . 2.8 mtpt -58.11 -45.4 87.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.529 178.473 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.537 ' CD ' ' O ' ' A' ' 234' ' ' GLU . 0.0 OUTLIER -73.47 -51.91 15.48 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.398 0.618 . . . . 0.0 111.22 -179.535 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.914 HD12 ' O ' ' A' ' 235' ' ' PRO . 1.9 mt -48.66 -49.46 14.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 114.79 -1.095 . . . . 0.0 112.911 -178.329 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 240' ' ' MET . . . . . 0.473 ' SD ' HG12 ' A' ' 236' ' ' VAL . 54.2 mtp -61.1 -29.03 69.51 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.699 -178.152 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.543 ' CG ' ' O ' ' A' ' 237' ' ' LYS . 0.3 OUTLIER -84.75 -13.15 52.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.87 0.367 . . . . 0.0 110.563 179.696 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.497 ' N ' ' HD3' ' A' ' 242' ' ' LYS . 0.7 OUTLIER -87.17 99.22 11.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.049 -179.934 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.593 ' HE3' ' CG ' ' A' ' 244' ' ' TYR . 8.1 ttpt -37.89 -73.51 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.23 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 244' ' ' TYR . . . . . 0.593 ' CG ' ' HE3' ' A' ' 243' ' ' LYS . 8.7 m-30 -111.68 150.8 29.66 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.599 179.153 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 245' ' ' HIS . . . . . 0.803 ' CG ' HD12 ' A' ' 254' ' ' ILE . 17.6 m-70 -113.66 154.09 27.83 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.847 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -134.91 104.69 6.08 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.215 0.531 . . . . 0.0 110.01 178.588 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.694 HG12 ' H ' ' A' ' 248' ' ' GLY . 1.6 t -96.94 -173.42 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.728 -179.067 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 248' ' ' GLY . . . . . 0.694 ' H ' HG12 ' A' ' 247' ' ' VAL . . . -25.17 -62.27 0.06 OUTLIER Glycine 0 C--N 1.337 0.635 0 C-N-CA 121.2 -0.524 . . . . 0.0 112.964 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.633 HD23 ' C ' ' A' ' 248' ' ' GLY . 0.0 OUTLIER -126.89 -38.69 2.01 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.399 0.619 . . . . 0.0 110.726 179.796 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.467 ' OG ' ' OG1' ' A' ' 193' ' ' THR . 1.2 m -77.54 151.08 34.68 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.919 -1.037 . . . . 0.0 112.567 -178.183 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.5 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -140.01 105.89 5.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.922 -1.035 . . . . 0.0 108.722 179.135 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 252' ' ' CYS . . . . . 0.595 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -128.12 153.54 46.74 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -176.624 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 253' ' ' GLU . . . . . 0.581 ' HB2' ' CE1' ' A' ' 244' ' ' TYR . 64.1 tt0 -75.98 109.96 10.05 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.674 178.698 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 254' ' ' ILE . . . . . 0.803 HD12 ' CG ' ' A' ' 245' ' ' HIS . 37.0 mt -97.02 113.03 30.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -178.089 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 255' ' ' LYS . . . . . 0.519 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -114.1 131.94 56.23 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 176.89 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 183' ' ' LYS . 9.8 p -33.59 127.56 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-O 122.084 0.945 . . . . 0.0 111.328 -178.079 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 1.108 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -80.18 152.82 28.98 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 113.656 -1.611 . . . . 0.0 112.268 -178.446 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.47 116.8 16.43 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.595 -1.184 . . . . 0.0 110.416 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.323 -0.547 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.114 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.508 ' CG1' ' N ' ' A' ' 182' ' ' LYS . 38.4 t . . . . . 0 CA--C 1.503 -0.84 0 CA-C-O 121.268 0.556 . . . . 0.0 112.04 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.595 ' CB ' HG21 ' A' ' 236' ' ' VAL . 4.6 mmtt -143.62 112.89 6.82 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.362 177.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.84 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.7 OUTLIER -130.59 152.44 49.96 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.343 179.438 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.904 HD13 ' HE1' ' A' ' 230' ' ' PHE . 0.5 OUTLIER -127.37 119.83 53.35 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.096 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.868 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -92.35 108.96 20.35 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.614 0.721 . . . . 0.0 110.156 -178.842 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 1.031 HG12 ' HB2' ' A' ' 252' ' ' CYS . 2.4 t -85.53 118.74 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.254 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.55 ' O ' ' HB3' ' A' ' 252' ' ' CYS . . . -104.97 131.14 10.52 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.271 -0.877 . . . . 0.0 115.026 -176.33 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.458 ' O ' ' HB3' ' A' ' 252' ' ' CYS . . . 71.73 85.15 0.2 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 121.352 -0.451 . . . . 0.0 112.764 178.736 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.963 HD13 ' OG1' ' A' ' 193' ' ' THR . 0.5 OUTLIER -115.47 157.29 24.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.941 0.401 . . . . 0.0 111.268 -179.534 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.625 ' N ' HD12 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -48.0 -169.26 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.751 179.347 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 191' ' ' PRO . . . . . 0.619 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 17.7 Cg_endo -87.38 22.64 0.89 Allowed 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.403 2.068 . . . . 0.0 112.755 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.542 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 1.9 p30 157.05 76.26 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 111.623 0.231 . . . . 0.0 111.623 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.963 ' OG1' HD13 ' A' ' 189' ' ' LEU . 92.0 m -74.79 111.21 12.22 Favored Pre-proline 0 N--CA 1.464 0.236 0 CA-C-O 120.891 0.377 . . . . 0.0 110.908 179.31 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.572 ' HG2' ' CG ' ' A' ' 197' ' ' LYS . 16.6 Cg_endo -59.51 109.59 0.59 Allowed 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.367 2.045 . . . . 0.0 111.642 179.189 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.825 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.3 OUTLIER -50.84 -15.91 0.35 Allowed 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.754 -179.449 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 196' ' ' GLU . . . . . 0.512 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 5.6 mt-10 -69.0 -38.16 79.13 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.572 ' CG ' ' HG2' ' A' ' 194' ' ' PRO . 0.2 OUTLIER -73.25 -50.87 19.95 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.209 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.825 ' CG1' ' HA ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -46.77 -31.0 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.727 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.571 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 2.6 mtt180 -70.96 -33.9 70.92 Favored 'General case' 0 C--O 1.221 -0.441 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.373 178.768 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 200' ' ' GLU . . . . . 0.583 ' CG ' ' N ' ' A' ' 201' ' ' TYR . 3.2 pt-20 -82.14 -54.66 5.1 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.284 0.564 . . . . 0.0 110.162 179.421 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.583 ' N ' ' CG ' ' A' ' 200' ' ' GLU . 0.5 OUTLIER -53.69 -53.12 56.47 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.966 178.905 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 1.147 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.2 OUTLIER -79.84 -31.8 40.55 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.664 -179.933 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.571 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -63.81 -55.47 24.5 Favored Glycine 0 CA--C 1.498 -1.003 0 N-CA-C 106.799 -2.52 . . . . 0.0 106.799 176.441 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -50.16 -29.2 14.94 Favored Glycine 0 N--CA 1.443 -0.882 0 N-CA-C 109.694 -1.363 . . . . 0.0 109.694 176.076 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.765 ' CE2' HG13 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -57.18 -45.28 83.84 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 122.157 0.98 . . . . 0.0 108.456 177.849 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 171.02 -129.71 1.84 Allowed Glycine 0 N--CA 1.441 -0.976 0 CA-C-N 113.567 -1.651 . . . . 0.0 110.31 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.526 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 20.9 mm-40 -96.99 101.52 13.12 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.148 0.499 . . . . 0.0 111.081 178.722 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 2.5 t -77.94 142.54 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.25 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 209' ' ' GLU . . . . . 0.81 ' HB3' HG22 ' A' ' 229' ' ' THR . 5.5 tp10 -91.66 -52.23 4.86 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 178.403 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 2.6 m -175.16 149.72 1.1 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.985 178.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.901 HD13 HG23 ' A' ' 228' ' ' ILE . 0.4 OUTLIER -113.96 129.55 69.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.147 178.656 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.35 104.79 9.33 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -178.126 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.667 HD21 ' HB ' ' A' ' 193' ' ' THR . 0.1 OUTLIER . . . . . 0 CA--C 1.531 0.238 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 177.634 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.801 0 CA-C-O 121.375 0.431 . . . . 0.0 112.219 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 225' ' ' PHE . . . . . 0.948 ' C ' HD23 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -156.85 176.71 12.39 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.703 -0.748 . . . . 0.0 109.652 -177.43 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 226' ' ' CYS . . . . . 0.483 ' O ' ' HB ' ' A' ' 186' ' ' VAL . 31.7 p -138.56 147.65 43.28 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.059 -0.656 . . . . 0.0 112.567 -179.32 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 1.122 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 4.0 m-85 -107.26 133.06 52.38 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.098 -0.956 . . . . 0.0 109.412 178.779 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 1.147 HD12 ' CE2' ' A' ' 202' ' ' PHE . 1.8 mt -127.32 123.91 62.89 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 CA-C-O 121.23 0.538 . . . . 0.0 111.395 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 229' ' ' THR . . . . . 0.81 HG22 ' HB3' ' A' ' 209' ' ' GLU . 19.8 m -105.15 138.39 41.43 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.344 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.904 ' HE1' HD13 ' A' ' 184' ' ' ILE . 72.6 m-85 -114.11 126.32 54.95 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.471 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.526 ' HG3' ' O ' ' A' ' 207' ' ' GLU . 0.0 OUTLIER -47.7 -39.12 16.67 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 178.139 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -94.34 -168.18 1.8 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 113.325 -1.762 . . . . 0.0 109.995 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 233' ' ' GLU . . . . . 0.539 ' HB3' ' CD ' ' A' ' 182' ' ' LYS . 1.1 pm0 -129.79 10.12 5.5 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.55 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.4 OUTLIER -80.0 -60.22 0.51 Allowed Pre-proline 0 C--N 1.328 -0.338 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.42 179.895 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.911 ' O ' HD12 ' A' ' 239' ' ' ILE . 87.5 Cg_exo -50.32 -29.67 24.19 Favored 'Trans proline' 0 CA--C 1.5 -1.19 0 N-CA-C 108.909 -1.227 . . . . 0.0 108.909 177.731 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.595 HG21 ' CB ' ' A' ' 182' ' ' LYS . 15.9 t -72.4 -44.7 62.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 113.971 -1.468 . . . . 0.0 109.905 178.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.55 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 0.2 OUTLIER -65.51 -35.52 81.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.84 -179.707 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.498 ' O ' ' CG ' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -80.99 -47.86 13.05 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.928 0.394 . . . . 0.0 110.857 179.14 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.911 HD12 ' O ' ' A' ' 235' ' ' PRO . 1.6 mt -49.33 -50.93 15.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.468 -179.392 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 240' ' ' MET . . . . . 0.436 ' SD ' ' O ' ' A' ' 236' ' ' VAL . 10.3 mtp -59.09 -29.1 67.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.795 0.331 . . . . 0.0 111.246 -178.76 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.498 ' CG ' ' O ' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -79.54 -21.26 45.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.063 0.459 . . . . 0.0 111.241 -179.734 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.411 ' HD3' ' HG3' ' A' ' 241' ' ' GLU . 5.5 mmtp -78.77 118.5 20.9 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.371 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.56 ' HE3' ' CD2' ' A' ' 244' ' ' TYR . 2.9 ttpt -44.81 -74.58 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 244' ' ' TYR . . . . . 0.56 ' CD2' ' HE3' ' A' ' 243' ' ' LYS . 16.2 m-30 -121.95 153.92 37.85 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.072 178.586 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 245' ' ' HIS . . . . . 0.702 ' CD2' HD12 ' A' ' 254' ' ' ILE . 34.8 m-70 -109.9 146.56 34.94 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.03 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 34.0 m-20 -122.11 105.03 9.9 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.102 0.477 . . . . 0.0 110.149 178.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.557 ' O ' ' N ' ' A' ' 249' ' ' LEU . 2.2 t -107.71 127.42 63.73 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.631 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 248' ' ' GLY . . . . . 0.436 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . 34.77 -89.89 0.01 OUTLIER Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.431 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.557 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.1 OUTLIER -108.67 -37.77 5.82 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 121.706 0.765 . . . . 0.0 110.269 -179.887 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.433 ' HB3' ' H ' ' A' ' 190' ' ' SER . 1.4 m -77.8 154.17 32.15 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.494 -1.23 . . . . 0.0 112.547 -178.242 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -149.37 110.63 4.41 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.824 179.375 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 252' ' ' CYS . . . . . 1.031 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -129.38 152.84 48.49 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -177.619 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 253' ' ' GLU . . . . . 0.551 ' HB2' ' CE1' ' A' ' 244' ' ' TYR . 52.4 tt0 -76.41 110.86 11.29 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.917 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 254' ' ' ILE . . . . . 0.919 HG12 HG13 ' A' ' 186' ' ' VAL . 14.9 mt -96.12 112.7 28.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 -177.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 255' ' ' LYS . . . . . 0.513 ' O ' ' C ' ' A' ' 256' ' ' VAL . 0.0 OUTLIER -116.3 131.96 56.8 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 176.179 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 183' ' ' LYS . 3.4 p -32.87 123.07 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 CA-C-O 122.235 1.017 . . . . 0.0 111.555 -177.475 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 1.122 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -78.35 152.41 32.36 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 113.34 -1.755 . . . . 0.0 112.28 -178.402 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.84 110.48 15.49 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.7 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 259' ' ' SER . . . . . 0.505 ' HB3' ' HD2' ' A' ' 183' ' ' LYS . 69.5 p . . . . . 0 C--N 1.327 -0.395 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.771 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.494 ' O ' ' HD3' ' A' ' 182' ' ' LYS . 40.0 t . . . . . 0 CA--C 1.503 -0.852 0 CA-C-O 121.35 0.595 . . . . 0.0 112.036 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.829 ' HB2' HG21 ' A' ' 236' ' ' VAL . 0.0 OUTLIER -144.89 112.17 6.06 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.841 177.36 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.886 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -130.85 151.51 51.19 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.954 178.973 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.859 HD13 ' HE2' ' A' ' 230' ' ' PHE . 0.4 OUTLIER -128.09 120.21 52.97 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.408 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.853 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -92.67 109.03 20.44 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.35 0.595 . . . . 0.0 110.57 -178.806 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 1.019 HG12 ' HB2' ' A' ' 252' ' ' CYS . 2.4 t -85.4 124.47 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 CA-C-N 114.781 -1.1 . . . . 0.0 109.327 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.59 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . -113.01 126.06 7.3 Favored Glycine 0 C--N 1.331 0.296 0 N-CA-C 114.555 0.582 . . . . 0.0 114.555 -176.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.464 ' O ' ' CB ' ' A' ' 252' ' ' CYS . . . 80.37 84.66 0.67 Allowed Glycine 0 C--N 1.331 0.266 0 C-N-CA 121.337 -0.458 . . . . 0.0 113.151 179.356 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.953 HD23 ' C ' ' A' ' 225' ' ' PHE . 0.7 OUTLIER -117.31 157.32 26.31 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.831 0.348 . . . . 0.0 111.154 -179.573 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.586 ' O ' HD12 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -49.34 -172.07 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.765 179.537 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 191' ' ' PRO . . . . . 0.583 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 94.7 Cg_endo -81.61 25.44 0.65 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.293 1.995 . . . . 0.0 113.598 -179.253 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.575 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 8.0 t70 150.78 79.77 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.778 0.323 . . . . 0.0 110.974 179.604 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.882 HG22 ' CD1' ' A' ' 198' ' ' ILE . 62.0 m -75.28 111.98 16.44 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.759 179.647 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.559 ' HG2' ' CG ' ' A' ' 197' ' ' LYS . 18.8 Cg_endo -60.1 112.2 1.22 Allowed 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.097 1.864 . . . . 0.0 110.812 178.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.821 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 7.4 pt-20 -51.85 -14.84 0.41 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.438 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 196' ' ' GLU . . . . . 0.459 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 1.3 mm-40 -67.12 -37.21 83.48 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.559 ' CG ' ' HG2' ' A' ' 194' ' ' PRO . 0.4 OUTLIER -74.97 -49.8 18.78 Favored 'General case' 0 CA--C 1.495 -1.139 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.193 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.882 ' CD1' HG22 ' A' ' 193' ' ' THR . 0.0 OUTLIER -47.26 -31.81 2.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.594 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.58 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 16.0 mtp180 -69.13 -33.61 73.73 Favored 'General case' 0 C--O 1.221 -0.44 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.177 178.633 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 200' ' ' GLU . . . . . 0.529 ' N ' ' O ' ' A' ' 197' ' ' LYS . 3.2 mt-10 -82.57 -59.35 2.55 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.452 0.644 . . . . 0.0 109.903 178.769 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.487 ' C ' ' CD1' ' A' ' 201' ' ' TYR . 0.6 OUTLIER -49.07 -54.36 16.33 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.931 179.083 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 1.068 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.2 OUTLIER -79.85 -30.99 40.45 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.597 -179.962 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.58 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -62.52 -56.79 19.54 Favored Glycine 0 CA--C 1.499 -0.965 0 N-CA-C 107.202 -2.359 . . . . 0.0 107.202 176.576 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -49.08 -28.93 8.37 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 176.216 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.78 ' CD2' HD11 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -58.38 -44.28 88.82 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 177.788 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 203' ' ' GLY . . . 169.65 -130.58 2.07 Favored Glycine 0 N--CA 1.443 -0.837 0 CA-C-N 113.708 -1.587 . . . . 0.0 110.579 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.478 ' C ' ' HG3' ' A' ' 231' ' ' LYS . 54.8 mm-40 -97.05 100.2 11.7 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.27 0.557 . . . . 0.0 111.256 178.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.451 HG21 ' HB2' ' A' ' 202' ' ' PHE . 2.9 t -77.64 137.64 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.056 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 209' ' ' GLU . . . . . 0.529 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 25.3 tp10 -92.84 -54.37 3.78 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 120.686 0.279 . . . . 0.0 110.341 178.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.443 ' C ' HG12 ' A' ' 211' ' ' ILE . 1.4 p -157.46 158.03 35.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.306 0.574 . . . . 0.0 112.182 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.743 HD12 ' HB ' ' A' ' 198' ' ' ILE . 0.1 OUTLIER -133.2 126.06 52.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.366 179.108 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -123.49 108.68 12.93 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 114.147 1.165 . . . . 0.0 114.147 -177.45 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.89 HD13 ' HB2' ' A' ' 226' ' ' CYS . 1.3 mm? . . . . . 0 CA--C 1.531 0.249 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 176.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.61 0 CA-C-O 121.003 0.224 . . . . 0.0 112.921 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 225' ' ' PHE . . . . . 0.953 ' C ' HD23 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -157.27 176.62 12.46 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -178.5 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 226' ' ' CYS . . . . . 0.89 ' HB2' HD13 ' A' ' 213' ' ' LEU . 2.7 p -140.22 151.91 45.56 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.336 -0.546 . . . . 0.0 112.154 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 1.101 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 4.2 m-85 -111.11 137.43 48.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.472 178.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 1.068 HD12 ' CE2' ' A' ' 202' ' ' PHE . 2.1 mt -131.32 141.84 44.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.131 0.491 . . . . 0.0 111.146 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 229' ' ' THR . . . . . 0.441 HG22 ' HB3' ' A' ' 209' ' ' GLU . 97.5 m -122.6 137.94 54.74 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.58 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.859 ' HE2' HD13 ' A' ' 184' ' ' ILE . 66.2 m-85 -111.83 126.44 55.09 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.93 -179.468 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.529 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -50.51 -37.77 40.74 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 106.622 -1.622 . . . . 0.0 106.622 177.696 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 232' ' ' GLU . . . . . 0.505 ' O ' ' HG3' ' A' ' 182' ' ' LYS . 15.2 mt-10 -89.86 -168.96 2.28 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 112.929 -1.941 . . . . 0.0 108.914 178.425 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 233' ' ' GLU . . . . . 0.509 ' CB ' ' HD2' ' A' ' 182' ' ' LYS . 2.3 pm0 -131.07 1.02 4.23 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.246 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.515 ' O ' ' N ' ' A' ' 237' ' ' LYS . 0.4 OUTLIER -75.13 -57.62 1.71 Allowed Pre-proline 0 C--N 1.331 -0.222 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -179.415 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.879 ' O ' HD12 ' A' ' 239' ' ' ILE . 98.5 Cg_exo -49.09 -31.83 22.3 Favored 'Trans proline' 0 CA--C 1.498 -1.275 0 N-CA-C 109.027 -1.182 . . . . 0.0 109.027 178.584 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.829 HG21 ' HB2' ' A' ' 182' ' ' LYS . 17.5 t -69.52 -41.57 80.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 113.883 -1.508 . . . . 0.0 108.855 178.149 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.515 ' N ' ' O ' ' A' ' 234' ' ' GLU . 22.7 mttt -59.47 -48.15 82.75 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.916 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.495 ' O ' ' HG3' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -76.86 -46.16 25.69 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.169 -179.238 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.879 HD12 ' O ' ' A' ' 235' ' ' PRO . 1.8 mt -49.04 -47.12 17.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.213 -0.449 . . . . 0.0 112.051 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 240' ' ' MET . . . . . 0.482 ' SD ' HG12 ' A' ' 236' ' ' VAL . 44.4 mtp -63.92 -17.73 63.52 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.022 -178.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.495 ' HG3' ' O ' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -86.97 -27.73 23.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.686 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.477 ' HG2' ' O ' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -86.79 92.7 9.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.438 179.503 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.505 ' N ' ' HD3' ' A' ' 243' ' ' LYS . 0.0 OUTLIER -36.28 -48.9 0.66 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.996 0.427 . . . . 0.0 110.31 -179.947 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 244' ' ' TYR . . . . . 0.575 ' CE1' ' HG3' ' A' ' 253' ' ' GLU . 22.1 m-85 -122.3 157.56 31.47 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.836 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 245' ' ' HIS . . . . . 0.777 ' CG ' HD12 ' A' ' 254' ' ' ILE . 29.8 m-70 -127.79 156.83 41.86 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.917 -179.657 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 246' ' ' ASN . . . . . 0.4 ' O ' ' CE2' ' A' ' 201' ' ' TYR . 6.2 m120 -129.15 105.15 7.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.124 0.487 . . . . 0.0 110.602 179.121 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.563 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.5 t -109.7 125.98 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.677 -179.583 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 248' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . 35.46 -89.19 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.504 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.563 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.1 OUTLIER -108.15 -35.88 6.45 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.777 0.798 . . . . 0.0 110.085 -179.679 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.506 ' HB3' ' HB2' ' A' ' 190' ' ' SER . 0.8 OUTLIER -77.92 154.46 31.63 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.322 -1.308 . . . . 0.0 112.959 -177.836 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.487 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -149.95 107.88 3.71 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.063 -0.972 . . . . 0.0 108.973 179.069 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 252' ' ' CYS . . . . . 1.019 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -128.78 153.33 47.5 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 -176.762 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 253' ' ' GLU . . . . . 0.575 ' HG3' ' CE1' ' A' ' 244' ' ' TYR . 31.7 tt0 -75.93 108.91 9.13 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.033 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 254' ' ' ILE . . . . . 0.894 HG12 HG13 ' A' ' 186' ' ' VAL . 19.1 mt -96.48 113.1 30.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 -178.309 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 255' ' ' LYS . . . . . 0.516 ' O ' ' C ' ' A' ' 256' ' ' VAL . 0.0 OUTLIER -119.6 133.37 55.69 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 176.516 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 183' ' ' LYS . 3.1 p -32.69 121.47 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 CA-C-O 122.218 1.009 . . . . 0.0 111.557 -177.524 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 1.101 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -76.52 153.71 35.23 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 113.353 -1.748 . . . . 0.0 112.07 -178.371 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -127.88 113.67 16.2 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.898 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 259' ' ' SER . . . . . 0.448 ' HB2' ' HD2' ' A' ' 183' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.519 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.073 -179.613 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.495 ' C ' ' CD ' ' A' ' 182' ' ' LYS . 55.2 t . . . . . 0 CA--C 1.501 -0.936 0 CA-C-O 121.11 0.481 . . . . 0.0 111.47 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.925 ' HB2' HG21 ' A' ' 236' ' ' VAL . 0.0 OUTLIER -152.68 111.78 3.83 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.088 177.346 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.915 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.5 OUTLIER -136.36 167.86 20.52 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.693 179.04 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.725 ' C ' ' HB2' ' A' ' 257' ' ' ALA . 0.3 OUTLIER -144.1 121.66 5.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.09 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.818 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.3 OUTLIER -96.36 108.97 21.57 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.454 -0.898 . . . . 0.0 109.679 -179.734 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 1.097 HG12 ' HB2' ' A' ' 252' ' ' CYS . 1.7 t -87.7 127.23 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.729 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.593 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . -114.71 124.54 6.42 Favored Glycine 0 C--N 1.331 0.282 0 N-CA-C 114.647 0.619 . . . . 0.0 114.647 -176.437 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.453 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . 82.12 85.83 0.75 Allowed Glycine 0 CA--C 1.518 0.28 0 C-N-CA 121.277 -0.487 . . . . 0.0 113.108 179.282 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.931 HD23 ' C ' ' A' ' 225' ' ' PHE . 0.8 OUTLIER -117.46 157.27 26.53 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.742 0.306 . . . . 0.0 111.367 -179.564 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.618 ' O ' HD12 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -49.83 -170.84 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.228 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.843 179.615 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 191' ' ' PRO . . . . . 0.607 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 95.7 Cg_endo -83.46 24.07 0.78 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.44 2.093 . . . . 0.0 113.381 -179.366 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.546 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 4.3 t0 154.67 77.19 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.72 0.295 . . . . 0.0 111.201 179.508 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.851 ' OG1' HD13 ' A' ' 189' ' ' LEU . 86.4 m -74.26 111.39 12.48 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 120.869 0.366 . . . . 0.0 110.957 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.527 ' HG2' ' HG2' ' A' ' 197' ' ' LYS . 19.3 Cg_endo -61.04 112.58 1.42 Allowed 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.248 1.965 . . . . 0.0 111.144 179.011 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.835 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 1.6 pm0 -51.9 -15.27 0.49 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.434 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 196' ' ' GLU . . . . . 0.498 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 40.6 mm-40 -66.94 -38.27 85.83 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.549 ' O ' ' N ' ' A' ' 200' ' ' GLU . 0.1 OUTLIER -74.04 -51.09 16.91 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.214 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.896 HG22 ' CE1' ' A' ' 202' ' ' PHE . 0.0 OUTLIER -47.52 -29.88 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.338 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.585 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 0.1 OUTLIER -70.9 -33.79 70.92 Favored 'General case' 0 C--O 1.22 -0.448 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.876 178.559 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 200' ' ' GLU . . . . . 0.578 ' CG ' ' N ' ' A' ' 201' ' ' TYR . 2.3 pt-20 -83.17 -56.47 3.76 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.857 0.361 . . . . 0.0 110.662 179.221 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.578 ' N ' ' CG ' ' A' ' 200' ' ' GLU . 0.2 OUTLIER -51.07 -53.5 33.31 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.427 0.632 . . . . 0.0 109.52 178.964 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 1.118 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.4 OUTLIER -79.65 -30.23 41.19 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.232 -179.913 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.585 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -62.11 -56.9 19.61 Favored Glycine 0 CA--C 1.498 -0.987 0 N-CA-C 106.763 -2.535 . . . . 0.0 106.763 176.234 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -49.41 -28.62 9.76 Favored Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 176.007 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.699 ' CD2' HD11 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -58.28 -42.4 86.5 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 177.99 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.493 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 166.96 -130.2 2.07 Favored Glycine 0 N--CA 1.441 -1.019 0 CA-C-N 113.709 -1.587 . . . . 0.0 109.895 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.533 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 9.4 mm-40 -96.82 100.85 12.37 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.322 0.582 . . . . 0.0 110.609 178.291 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.557 HG21 ' HB2' ' A' ' 202' ' ' PHE . 2.7 t -77.92 139.67 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.354 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 209' ' ' GLU . . . . . 0.539 ' HB3' HG22 ' A' ' 229' ' ' THR . 7.4 tp10 -89.75 -55.9 3.45 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 178.47 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 3.8 m -169.52 151.26 4.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.338 0.589 . . . . 0.0 112.069 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.882 HD12 ' HB ' ' A' ' 198' ' ' ILE . 0.4 OUTLIER -116.26 132.12 66.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.416 178.879 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -123.18 109.44 14.01 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -178.07 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.81 HD11 ' HB ' ' A' ' 193' ' ' THR . 1.6 mm? . . . . . 0 C--N 1.331 -0.231 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.873 177.6 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.554 0 CA-C-O 121.098 0.277 . . . . 0.0 112.744 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 225' ' ' PHE . . . . . 0.931 ' C ' HD23 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -157.38 176.63 12.42 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.054 -0.573 . . . . 0.0 109.781 -178.309 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 226' ' ' CYS . . . . . 0.7 ' HB3' HD13 ' A' ' 213' ' ' LEU . 30.5 p -140.96 146.86 37.88 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.276 -0.57 . . . . 0.0 112.425 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 1.113 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 4.7 m-85 -106.76 134.91 49.19 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.355 178.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 1.118 HD12 ' CE2' ' A' ' 202' ' ' PHE . 1.8 mt -128.66 136.35 60.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.146 0.498 . . . . 0.0 111.374 -179.305 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 229' ' ' THR . . . . . 0.539 HG22 ' HB3' ' A' ' 209' ' ' GLU . 52.5 m -117.02 138.02 51.85 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.529 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.611 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 75.6 m-85 -111.83 126.29 54.93 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.394 179.587 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.533 ' HG3' ' O ' ' A' ' 207' ' ' GLU . 0.0 OUTLIER -45.0 -40.33 6.37 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 178.56 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 232' ' ' GLU . . . . . 0.469 ' O ' ' HG3' ' A' ' 182' ' ' LYS . 69.5 mt-10 -99.12 173.05 7.0 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 113.442 -1.708 . . . . 0.0 108.779 178.426 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 233' ' ' GLU . . . . . 0.521 ' O ' ' HG3' ' A' ' 237' ' ' LYS . 0.8 OUTLIER -112.0 13.17 20.74 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.58 -179.633 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.551 ' O ' ' HB2' ' A' ' 237' ' ' LYS . 0.6 OUTLIER -80.84 -60.38 0.44 Allowed Pre-proline 0 C--N 1.331 -0.213 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.7 -179.628 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.658 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 90.8 Cg_exo -48.7 -36.76 33.56 Favored 'Trans proline' 0 CA--C 1.495 -1.456 0 N-CA-C 108.61 -1.342 . . . . 0.0 108.61 178.455 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.925 HG21 ' HB2' ' A' ' 182' ' ' LYS . 17.2 t -62.66 -40.27 87.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 114.204 -1.362 . . . . 0.0 109.773 178.523 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.551 ' HB2' ' O ' ' A' ' 234' ' ' GLU . 8.3 mtpt -54.24 -49.21 70.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.957 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.499 ' HA ' ' HG3' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -80.91 -45.83 16.13 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.615 -179.236 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.791 ' CG2' HG21 ' A' ' 254' ' ' ILE . 0.7 OUTLIER -39.48 -59.11 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.256 -0.883 . . . . 0.0 111.818 -179.549 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 240' ' ' MET . . . . . 0.476 ' SD ' HG12 ' A' ' 236' ' ' VAL . 2.6 mtp -55.53 -27.68 50.27 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.435 -178.693 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.499 ' HG3' ' HA ' ' A' ' 238' ' ' LYS . 1.1 mt-10 -84.43 -13.87 50.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.937 0.399 . . . . 0.0 110.642 179.659 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.463 ' HB2' ' NE2' ' A' ' 245' ' ' HIS . 1.9 mptt -79.42 105.86 11.04 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.725 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.509 ' HD3' ' CD2' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -37.52 -67.18 0.2 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.05 -179.869 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 244' ' ' TYR . . . . . 0.509 ' CD2' ' HD3' ' A' ' 243' ' ' LYS . 29.3 m-85 -132.71 143.28 49.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.971 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 245' ' ' HIS . . . . . 0.649 ' CD2' HD12 ' A' ' 254' ' ' ILE . 45.5 m-70 -108.81 127.93 54.45 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.354 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -102.25 105.28 15.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.034 0.445 . . . . 0.0 110.905 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.555 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.1 t -103.85 130.0 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.701 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 248' ' ' GLY . . . . . 0.451 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . 32.78 -89.91 0.01 OUTLIER Glycine 0 C--N 1.334 0.442 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.412 -179.633 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.555 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.1 OUTLIER -109.9 -34.74 6.34 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.843 0.83 . . . . 0.0 109.642 179.748 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.527 ' HB3' ' HB2' ' A' ' 190' ' ' SER . 1.9 p -77.16 152.44 34.85 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.172 -1.376 . . . . 0.0 112.65 -178.252 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -150.26 108.48 3.76 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.254 179.246 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 252' ' ' CYS . . . . . 1.097 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -127.54 153.15 46.71 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -177.381 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 253' ' ' GLU . . . . . 0.466 ' N ' ' O ' ' A' ' 187' ' ' GLY . 48.8 tt0 -76.07 113.68 13.87 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.552 -179.266 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 254' ' ' ILE . . . . . 0.97 HG12 HG13 ' A' ' 186' ' ' VAL . 6.3 mt -96.75 113.33 30.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 -178.343 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 255' ' ' LYS . . . . . 0.53 ' O ' ' C ' ' A' ' 256' ' ' VAL . 0.0 OUTLIER -122.67 128.15 50.22 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 105.569 -2.012 . . . . 0.0 105.569 176.346 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 183' ' ' LYS . 1.4 p -31.9 121.71 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 CA-C-O 122.244 1.021 . . . . 0.0 111.37 -176.807 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 1.113 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -75.85 153.85 36.53 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 113.27 -1.786 . . . . 0.0 111.768 -178.307 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.03 118.64 19.04 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.969 179.451 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 90.6 p . . . . . 0 C--N 1.326 -0.432 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.192 -179.514 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.507 HG12 ' N ' ' A' ' 182' ' ' LYS . 47.8 t . . . . . 0 CA--C 1.504 -0.805 0 CA-C-O 121.156 0.503 . . . . 0.0 111.671 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.56 ' HG2' ' CG ' ' A' ' 233' ' ' GLU . 0.0 OUTLIER -150.33 112.63 4.65 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.676 177.621 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.943 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.0 OUTLIER -138.51 148.27 44.08 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.218 178.484 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.906 HD13 ' HE2' ' A' ' 230' ' ' PHE . 0.3 OUTLIER -126.58 120.06 55.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.679 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.75 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.3 OUTLIER -92.98 109.6 21.06 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 121.44 0.638 . . . . 0.0 110.111 -179.164 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.765 HG13 HG12 ' A' ' 254' ' ' ILE . 5.8 t -88.72 118.49 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.161 -179.488 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.564 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . -62.11 -150.9 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 115.76 -0.654 . . . . 0.0 114.609 -178.004 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.48 ' O ' ' HB3' ' A' ' 252' ' ' CYS . . . -47.03 111.74 0.8 Allowed Glycine 0 C--N 1.33 0.234 0 CA-C-N 114.823 -0.688 . . . . 0.0 114.435 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.993 HD13 ' OG1' ' A' ' 193' ' ' THR . 3.3 pp -109.11 157.35 18.82 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.98 -0.61 . . . . 0.0 110.255 178.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.921 ' O ' HD12 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -42.74 178.13 0.01 OUTLIER Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 121.084 0.469 . . . . 0.0 111.034 179.726 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 191' ' ' PRO . . . . . 0.548 ' HD2' ' CB ' ' A' ' 190' ' ' SER . 74.5 Cg_endo -76.37 26.65 0.42 Allowed 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 122.637 2.225 . . . . 0.0 113.544 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.543 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 4.6 p30 157.48 73.88 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.113 0 N-CA-C 111.528 0.196 . . . . 0.0 111.528 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.993 ' OG1' HD13 ' A' ' 189' ' ' LEU . 87.6 m -77.93 111.22 16.58 Favored Pre-proline 0 CA--C 1.518 -0.26 0 CA-C-O 121.055 0.455 . . . . 0.0 110.742 179.268 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.609 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 57.7 Cg_endo -68.47 109.62 2.09 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.525 2.15 . . . . 0.0 111.686 179.27 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.612 ' HA ' ' CD1' ' A' ' 198' ' ' ILE . 0.6 OUTLIER -43.42 -19.81 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.47 179.752 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 196' ' ' GLU . . . . . 0.523 ' O ' ' HG2' ' A' ' 200' ' ' GLU . 0.1 OUTLIER -61.02 -44.49 97.33 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -179.158 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.609 ' CD ' ' HG2' ' A' ' 194' ' ' PRO . 1.4 mttp -76.17 -46.18 29.8 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 178.734 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.917 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.2 OUTLIER -48.56 -28.94 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-N 114.048 -1.433 . . . . 0.0 108.717 177.014 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.56 ' HG3' ' O ' ' A' ' 195' ' ' GLU . 12.9 mtp180 -75.75 -32.11 59.83 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.955 178.233 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 200' ' ' GLU . . . . . 0.523 ' HG2' ' O ' ' A' ' 196' ' ' GLU . 4.1 mm-40 -81.91 -57.48 3.4 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.226 0.536 . . . . 0.0 110.536 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.489 ' C ' ' CD1' ' A' ' 201' ' ' TYR . 0.3 OUTLIER -48.03 -53.94 14.65 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.678 179.308 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 1.005 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.9 OUTLIER -79.73 -31.95 41.12 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.571 179.93 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.53 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -61.88 -57.78 15.86 Favored Glycine 0 N--CA 1.444 -0.824 0 N-CA-C 107.378 -2.289 . . . . 0.0 107.378 176.814 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -49.33 -29.28 10.21 Favored Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 176.264 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.76 ' CE2' HG13 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -58.53 -43.49 89.25 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 122.115 0.959 . . . . 0.0 108.423 177.787 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 169.14 -131.29 2.25 Favored Glycine 0 N--CA 1.441 -1.002 0 CA-C-N 113.714 -1.584 . . . . 0.0 110.417 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.517 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 4.1 mt-10 -97.11 102.94 14.82 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.231 0.539 . . . . 0.0 111.364 178.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.498 ' O ' ' NZ ' ' A' ' 231' ' ' LYS . 2.5 t -77.84 138.9 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.049 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 209' ' ' GLU . . . . . 0.571 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 70.8 tt0 -93.35 -53.15 4.2 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.5 178.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.439 ' OG ' ' OE2' ' A' ' 212' ' ' GLU . 37.2 p -160.51 151.65 19.08 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.512 HG21 ' HB ' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -129.55 122.36 55.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.923 178.905 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 212' ' ' GLU . . . . . 0.439 ' OE2' ' OG ' ' A' ' 210' ' ' SER . 0.0 OUTLIER -123.86 115.29 21.07 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 -177.962 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.735 HD22 ' N ' ' A' ' 213' ' ' LEU . 0.3 OUTLIER . . . . . 0 CA--C 1.537 0.452 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 176.644 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 224' ' ' GLY . . . . . 0.453 ' O ' ' HG ' ' A' ' 189' ' ' LEU . . . . . . . . 0 N--CA 1.449 -0.488 0 N-CA-C 112.411 -0.276 . . . . 0.0 112.411 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 225' ' ' PHE . . . . . 0.887 ' C ' HD23 ' A' ' 189' ' ' LEU . 6.7 p90 -132.87 176.68 8.26 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 226' ' ' CYS . . . . . 0.583 ' N ' HD23 ' A' ' 189' ' ' LEU . 23.1 p -136.06 149.15 48.64 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 119.495 -0.882 . . . . 0.0 112.709 -179.311 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 1.162 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 3.1 m-85 -105.65 139.0 40.91 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 115.586 -0.733 . . . . 0.0 109.119 178.538 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 1.005 HD12 ' CE2' ' A' ' 202' ' ' PHE . 1.7 mt -133.83 118.29 29.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.414 0.626 . . . . 0.0 111.015 179.146 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 229' ' ' THR . . . . . 0.542 HG22 ' HB3' ' A' ' 209' ' ' GLU . 63.4 m -100.67 137.99 38.32 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.906 ' HE2' HD13 ' A' ' 184' ' ' ILE . 58.1 m-85 -111.8 126.49 55.14 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.465 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.571 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -49.46 -38.31 29.23 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 178.302 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 232' ' ' GLU . . . . . 0.419 ' OE1' ' CD ' ' A' ' 234' ' ' GLU . 0.7 OUTLIER -92.06 -165.37 1.33 Allowed 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 113.049 -1.887 . . . . 0.0 109.483 178.873 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 233' ' ' GLU . . . . . 0.56 ' CG ' ' HG2' ' A' ' 182' ' ' LYS . 0.5 OUTLIER -132.96 1.75 3.59 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.443 -179.914 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.493 ' O ' ' N ' ' A' ' 237' ' ' LYS . 0.2 OUTLIER -73.91 -59.53 1.79 Allowed Pre-proline 0 C--N 1.33 -0.264 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.622 -179.415 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.891 ' O ' HD12 ' A' ' 239' ' ' ILE . 98.5 Cg_exo -48.65 -33.61 24.74 Favored 'Trans proline' 0 CA--C 1.498 -1.299 0 N-CA-C 108.851 -1.25 . . . . 0.0 108.851 178.662 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.539 HG13 HG22 ' A' ' 184' ' ' ILE . 21.7 t -70.43 -40.74 77.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 113.856 -1.52 . . . . 0.0 109.502 178.288 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.524 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 19.9 mttt -56.68 -46.89 80.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.915 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.529 ' O ' ' CG ' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -81.14 -50.09 10.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.277 -179.754 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.891 HD12 ' O ' ' A' ' 235' ' ' PRO . 1.5 mt -40.74 -52.58 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.632 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 240' ' ' MET . . . . . 0.457 ' SD ' ' HB ' ' A' ' 256' ' ' VAL . 6.7 mtp -61.32 -21.92 64.42 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.025 -179.024 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.529 ' CG ' ' O ' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -80.05 -23.96 41.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.844 -179.834 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.418 ' N ' ' HG3' ' A' ' 241' ' ' GLU . 2.9 mmtp -79.11 137.59 37.56 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.034 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.553 ' HD2' ' CG ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -76.55 -41.96 44.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.447 179.588 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 244' ' ' TYR . . . . . 0.651 ' CD1' ' HB3' ' A' ' 253' ' ' GLU . 2.5 m-85 -140.51 140.88 35.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.277 178.837 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 245' ' ' HIS . . . . . 0.781 ' CE1' HD12 ' A' ' 254' ' ' ILE . 17.3 m-70 -106.39 157.8 17.36 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.675 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -133.77 105.27 6.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.97 0.414 . . . . 0.0 110.87 179.541 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.538 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.6 t -108.61 105.63 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.112 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 50.17 -85.21 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.421 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.538 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -107.1 -38.99 5.85 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.405 0.621 . . . . 0.0 110.602 179.806 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.495 ' O ' ' N ' ' A' ' 247' ' ' VAL . 4.4 p -77.63 150.28 34.64 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.984 -1.007 . . . . 0.0 112.105 -178.67 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.547 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -150.5 103.58 3.14 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.588 178.994 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 252' ' ' CYS . . . . . 0.612 ' SG ' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -130.59 154.69 47.59 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -177.515 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 253' ' ' GLU . . . . . 0.651 ' HB3' ' CD1' ' A' ' 244' ' ' TYR . 7.8 pt-20 -74.94 118.54 18.01 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.24 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 254' ' ' ILE . . . . . 0.781 HD12 ' CE1' ' A' ' 245' ' ' HIS . 24.0 mt -96.76 102.12 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 CA-C-O 121.809 0.814 . . . . 0.0 112.657 -178.525 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 255' ' ' LYS . . . . . 0.571 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -104.0 128.99 51.58 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 177.627 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 183' ' ' LYS . 3.8 p -32.41 125.06 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-O 122.15 0.976 . . . . 0.0 111.206 -176.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 1.162 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -76.23 152.82 36.46 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 113.522 -1.672 . . . . 0.0 112.166 -178.091 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.15 126.65 26.89 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.469 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 259' ' ' SER . . . . . 0.524 ' HB3' ' NZ ' ' A' ' 183' ' ' LYS . 53.9 p . . . . . 0 C--N 1.324 -0.508 0 CA-C-O 120.866 0.365 . . . . 0.0 111.097 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.515 ' CG1' ' N ' ' A' ' 182' ' ' LYS . 36.1 t . . . . . 0 CA--C 1.504 -0.808 0 CA-C-O 121.115 0.483 . . . . 0.0 111.247 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.943 ' HB3' HG21 ' A' ' 236' ' ' VAL . 2.8 mptt -148.45 112.95 5.32 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.447 178.038 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.851 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -134.14 143.88 48.2 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.846 179.08 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.853 HD13 ' HE1' ' A' ' 230' ' ' PHE . 1.0 OUTLIER -123.4 120.05 59.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.411 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.827 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -92.11 109.49 20.85 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.423 0.63 . . . . 0.0 109.992 -179.337 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.784 HG13 HG12 ' A' ' 254' ' ' ILE . 11.0 t -87.03 123.59 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.303 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.54 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . -68.67 -159.07 1.56 Allowed Glycine 0 CA--C 1.521 0.452 0 CA-C-N 115.743 -0.662 . . . . 0.0 114.477 -178.098 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.542 ' HA2' ' O ' ' A' ' 224' ' ' GLY . . . -39.13 107.55 0.07 OUTLIER Glycine 0 C--N 1.332 0.355 0 CA-C-N 114.918 -0.641 . . . . 0.0 114.37 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.932 HD13 ' OG1' ' A' ' 193' ' ' THR . 3.2 pp -107.98 157.14 18.47 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 122.537 0.335 . . . . 0.0 110.802 179.182 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.92 ' O ' HD12 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -40.28 173.44 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.392 0.615 . . . . 0.0 111.921 -179.947 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 191' ' ' PRO . . . . . 0.459 ' O ' ' HB2' ' A' ' 192' ' ' ASP . 32.9 Cg_exo -60.34 -3.65 2.62 Favored 'Trans proline' 0 CA--C 1.529 0.27 0 C-N-CA 123.293 2.662 . . . . 0.0 114.126 -179.373 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 191' ' ' PRO . 0.5 OUTLIER 172.01 74.02 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.69 -179.933 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.932 ' OG1' HD13 ' A' ' 189' ' ' LEU . 57.7 m -64.29 125.29 87.99 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.826 179.312 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.63 ' O ' HD11 ' A' ' 198' ' ' ILE . 83.5 Cg_endo -76.55 117.71 4.65 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.405 2.07 . . . . 0.0 110.381 178.37 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.809 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 12.4 pt-20 -51.62 -14.0 0.29 Allowed 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -178.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 196' ' ' GLU . . . . . 0.51 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 33.7 mt-10 -68.51 -44.0 75.6 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -179.397 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.621 ' CD ' ' HG2' ' A' ' 194' ' ' PRO . 0.9 OUTLIER -70.58 -47.41 60.34 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.444 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.809 ' CG1' ' HA ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -47.85 -30.84 2.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.423 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.579 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 1.5 mtp-105 -72.31 -32.35 66.48 Favored 'General case' 0 C--O 1.22 -0.456 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.105 178.818 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 200' ' ' GLU . . . . . 0.522 ' N ' ' O ' ' A' ' 197' ' ' LYS . 25.2 mt-10 -82.71 -59.16 2.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.137 0.494 . . . . 0.0 110.397 179.329 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.504 ' C ' ' CD1' ' A' ' 201' ' ' TYR . 0.4 OUTLIER -48.72 -53.61 18.21 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.767 -0.652 . . . . 0.0 109.718 179.118 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 1.135 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.5 OUTLIER -79.7 -31.36 41.26 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.538 -179.963 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.579 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -62.14 -56.34 22.78 Favored Glycine 0 CA--C 1.5 -0.855 0 N-CA-C 107.104 -2.398 . . . . 0.0 107.104 176.64 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -49.76 -28.4 11.15 Favored Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 176.114 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.77 ' CE2' HG13 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -58.64 -44.21 89.98 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 177.885 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 169.87 -130.66 2.07 Favored Glycine 0 N--CA 1.441 -0.985 0 CA-C-N 113.663 -1.608 . . . . 0.0 110.473 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.481 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 5.0 mt-10 -96.89 98.77 10.38 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.228 0.537 . . . . 0.0 110.923 178.694 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.452 HG21 ' HB2' ' A' ' 202' ' ' PHE . 2.7 t -75.76 141.26 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 CA-C-N 115.384 -0.825 . . . . 0.0 108.984 178.542 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 209' ' ' GLU . . . . . 0.508 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 45.6 tt0 -89.75 -57.72 2.77 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.141 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 10.4 p -167.58 151.41 6.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.298 0.571 . . . . 0.0 112.375 179.132 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.985 HD13 HG23 ' A' ' 228' ' ' ILE . 0.4 OUTLIER -117.71 132.29 67.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.497 178.657 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.45 111.46 16.35 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -178.293 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.931 HD11 ' HB ' ' A' ' 193' ' ' THR . 2.7 mm? . . . . . 0 CA--C 1.533 0.315 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.922 177.558 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 224' ' ' GLY . . . . . 0.542 ' O ' ' HA2' ' A' ' 188' ' ' GLY . . . . . . . . 0 C--O 1.222 -0.637 0 N-CA-C 113.635 0.214 . . . . 0.0 113.635 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 225' ' ' PHE . . . . . 0.842 ' C ' HD23 ' A' ' 189' ' ' LEU . 0.6 OUTLIER -156.05 176.08 13.12 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.743 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 226' ' ' CYS . . . . . 0.638 ' N ' HD23 ' A' ' 189' ' ' LEU . 27.3 p -140.7 150.92 44.08 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -179.376 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 1.126 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 4.5 m-85 -106.29 133.49 50.9 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.657 178.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 1.135 HD12 ' CE2' ' A' ' 202' ' ' PHE . 1.9 mt -127.75 128.05 68.99 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.393 0 CA-C-O 120.904 0.383 . . . . 0.0 111.108 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 229' ' ' THR . . . . . 0.496 ' OG1' ' HG2' ' A' ' 183' ' ' LYS . 51.5 m -111.62 137.95 48.81 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.214 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.853 ' HE1' HD13 ' A' ' 184' ' ' ILE . 83.2 m-85 -112.42 126.38 55.23 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.387 179.367 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.508 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -47.96 -38.38 16.66 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 178.018 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 232' ' ' GLU . . . . . 0.4 ' HG2' ' HB2' ' A' ' 207' ' ' GLU . 25.0 mm-40 -91.0 -165.33 1.33 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 113.397 -1.728 . . . . 0.0 110.186 179.388 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 233' ' ' GLU . . . . . 0.592 ' CB ' ' HG2' ' A' ' 182' ' ' LYS . 9.5 pt-20 -133.25 10.91 4.16 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.486 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.536 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.0 OUTLIER -83.43 -60.38 0.34 Allowed Pre-proline 0 C--N 1.326 -0.419 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.649 179.951 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.906 ' O ' HD12 ' A' ' 239' ' ' ILE . 80.2 Cg_exo -49.51 -30.45 21.26 Favored 'Trans proline' 0 CA--C 1.501 -1.145 0 N-CA-C 108.942 -1.215 . . . . 0.0 108.942 177.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.943 HG21 ' HB3' ' A' ' 182' ' ' LYS . 17.9 t -72.68 -45.28 58.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 113.88 -1.509 . . . . 0.0 110.323 178.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.536 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 1.5 ptpt -63.76 -35.09 79.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.791 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.526 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 0.0 OUTLIER -80.73 -50.39 9.94 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.128 0.489 . . . . 0.0 110.379 179.055 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.906 HD12 ' O ' ' A' ' 235' ' ' PRO . 1.7 mt -47.96 -49.74 10.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.433 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 240' ' ' MET . . . . . 0.458 ' HG2' ' HB ' ' A' ' 256' ' ' VAL . 36.8 mtp -58.16 -29.27 65.46 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.353 -178.456 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.514 ' CG ' ' O ' ' A' ' 237' ' ' LYS . 0.1 OUTLIER -86.38 -10.61 54.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.918 0.39 . . . . 0.0 110.566 179.447 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 239' ' ' ILE . 0.0 OUTLIER -81.6 102.52 10.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.2 -179.865 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.497 ' HE2' ' HB2' ' A' ' 244' ' ' TYR . 1.9 ttpt -38.18 -76.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.212 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 244' ' ' TYR . . . . . 0.667 ' CD1' ' HB3' ' A' ' 253' ' ' GLU . 8.9 m-85 -118.16 144.75 45.45 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.661 179.062 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 245' ' ' HIS . . . . . 0.678 ' CE1' HD12 ' A' ' 254' ' ' ILE . 24.9 m-70 -105.51 157.94 17.02 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.041 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 246' ' ' ASN . . . . . 0.443 ' O ' ' CE2' ' A' ' 201' ' ' TYR . 2.4 p-10 -133.15 105.21 6.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.527 179.582 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.548 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.5 t -110.9 101.34 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.688 -179.186 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 53.5 -79.62 0.01 OUTLIER Glycine 0 C--N 1.331 0.274 0 C-N-CA 121.062 -0.589 . . . . 0.0 112.521 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.548 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -113.44 -40.2 3.92 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.476 0.655 . . . . 0.0 110.234 179.762 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.48 ' HB3' ' HB2' ' A' ' 190' ' ' SER . 5.1 p -77.68 148.64 34.89 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.877 -179.021 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.532 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -151.25 103.22 2.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.84 178.807 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 252' ' ' CYS . . . . . 0.688 ' SG ' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -130.74 155.06 47.27 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -177.885 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 253' ' ' GLU . . . . . 0.667 ' HB3' ' CD1' ' A' ' 244' ' ' TYR . 8.4 pt-20 -74.69 119.51 18.98 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.196 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 254' ' ' ILE . . . . . 0.784 HG12 HG13 ' A' ' 186' ' ' VAL . 30.7 mt -96.97 102.59 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 CA-C-O 121.553 0.692 . . . . 0.0 112.385 -178.758 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 255' ' ' LYS . . . . . 0.554 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -103.52 130.36 50.89 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 177.812 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 183' ' ' LYS . 4.0 p -32.67 122.74 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.561 0 CA-C-O 122.3 1.048 . . . . 0.0 111.513 -176.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 1.126 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -76.25 152.02 36.64 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 113.262 -1.79 . . . . 0.0 111.776 -178.652 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.43 118.82 21.74 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.026 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 54.4 p . . . . . 0 C--N 1.325 -0.46 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.106 -179.567 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.491 ' CG1' ' N ' ' A' ' 182' ' ' LYS . 39.8 t . . . . . 0 CA--C 1.504 -0.815 0 CA-C-O 121.276 0.56 . . . . 0.0 111.589 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.87 ' HB2' HG21 ' A' ' 236' ' ' VAL . 0.0 OUTLIER -145.66 112.6 6.04 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.503 177.26 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 1.017 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.0 OUTLIER -133.62 164.82 26.34 Favored 'General case' 0 CA--C 1.507 -0.682 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.895 -179.891 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.862 HD13 ' HE1' ' A' ' 230' ' ' PHE . 1.4 pt -140.33 119.96 12.49 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 177.562 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.752 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.4 OUTLIER -95.94 108.77 21.19 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.424 -178.713 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 1.078 HG12 ' HB2' ' A' ' 252' ' ' CYS . 1.6 t -84.86 117.39 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.598 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 253' ' ' GLU . . . -104.7 134.14 11.87 Favored Glycine 0 N--CA 1.452 -0.248 0 N-CA-C 114.691 0.636 . . . . 0.0 114.691 -177.002 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.451 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . 72.73 84.48 0.24 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.147 -0.549 . . . . 0.0 112.746 179.178 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.928 HD23 ' CA ' ' A' ' 225' ' ' PHE . 0.6 OUTLIER -117.44 156.16 28.44 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.957 0.408 . . . . 0.0 111.085 -179.723 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.574 ' CB ' ' CD ' ' A' ' 191' ' ' PRO . 0.5 OUTLIER -47.25 -176.72 0.01 OUTLIER Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.316 179.917 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 191' ' ' PRO . . . . . 0.574 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 12.0 Cg_exo -71.86 5.73 2.4 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 123.391 2.727 . . . . 0.0 113.329 -179.286 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.464 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 0.8 OUTLIER 165.63 74.75 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.803 0.335 . . . . 0.0 111.43 -179.944 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.907 ' OG1' HD13 ' A' ' 189' ' ' LEU . 88.4 m -70.34 112.63 13.43 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.61 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.614 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 25.4 Cg_endo -60.32 107.38 0.41 Allowed 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.221 1.948 . . . . 0.0 111.163 179.098 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.814 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -48.53 -14.89 0.07 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.8 -179.618 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 196' ' ' GLU . . . . . 0.508 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 34.9 mt-10 -67.41 -40.46 85.57 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 -179.399 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.614 ' CD ' ' HG2' ' A' ' 194' ' ' PRO . 1.8 mttp -74.21 -47.51 34.97 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.903 HG22 ' CE1' ' A' ' 202' ' ' PHE . 0.0 OUTLIER -46.86 -30.2 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.104 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.566 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 7.1 mtp180 -71.5 -33.98 69.71 Favored 'General case' 0 C--O 1.221 -0.438 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.447 178.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 200' ' ' GLU . . . . . 0.512 ' N ' ' O ' ' A' ' 197' ' ' LYS . 0.4 OUTLIER -83.21 -46.3 12.86 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.157 0.503 . . . . 0.0 110.738 179.459 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.547 ' CD1' ' CD1' ' A' ' 202' ' ' PHE . 0.4 OUTLIER -61.25 -52.73 63.51 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.694 179.127 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 1.107 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -79.53 -31.25 42.06 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.663 179.483 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.566 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -63.86 -56.15 20.44 Favored Glycine 0 N--CA 1.443 -0.88 0 N-CA-C 106.73 -2.548 . . . . 0.0 106.73 175.824 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -50.25 -28.7 14.3 Favored Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 176.076 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.835 ' CD2' HD11 ' A' ' 239' ' ' ILE . 0.0 OUTLIER -58.82 -44.49 90.86 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 177.68 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.503 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 170.77 -130.88 2.08 Favored Glycine 0 N--CA 1.442 -0.955 0 CA-C-N 113.664 -1.607 . . . . 0.0 110.389 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.518 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 0.4 OUTLIER -97.11 101.93 13.6 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.156 0.503 . . . . 0.0 111.439 178.805 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.445 HG21 ' HB2' ' A' ' 202' ' ' PHE . 2.6 t -79.29 141.12 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 177.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 209' ' ' GLU . . . . . 0.539 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 38.2 tt0 -98.05 -51.91 3.88 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.202 178.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.428 ' C ' HG12 ' A' ' 211' ' ' ILE . 5.1 p -157.66 154.32 28.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.392 0.615 . . . . 0.0 112.471 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.733 HD13 HD13 ' A' ' 228' ' ' ILE . 0.2 OUTLIER -137.26 116.3 14.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.144 178.548 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -124.1 114.47 19.74 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 113.853 1.056 . . . . 0.0 113.853 -177.79 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.6 HD23 ' HB2' ' A' ' 226' ' ' CYS . 0.1 OUTLIER . . . . . 0 CA--C 1.533 0.326 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 177.034 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 224' ' ' GLY . . . . . 0.54 ' O ' ' HG ' ' A' ' 189' ' ' LEU . . . . . . . . 0 N--CA 1.443 -0.881 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 225' ' ' PHE . . . . . 0.928 ' CA ' HD23 ' A' ' 189' ' ' LEU . 19.4 p90 -133.42 177.31 7.79 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 -178.59 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 226' ' ' CYS . . . . . 0.6 ' HB2' HD23 ' A' ' 213' ' ' LEU . 3.6 p -136.22 150.1 48.84 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 119.507 -0.877 . . . . 0.0 112.682 -179.144 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 1.181 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 3.1 m-85 -106.12 141.14 37.98 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.06 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 1.107 HD12 ' CE2' ' A' ' 202' ' ' PHE . 1.4 mt -138.0 114.42 11.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.458 0.647 . . . . 0.0 111.018 179.454 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 229' ' ' THR . . . . . 0.522 ' OG1' ' CG ' ' A' ' 183' ' ' LYS . 69.3 m -100.58 138.15 38.03 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.33 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.862 ' HE1' HD13 ' A' ' 184' ' ' ILE . 74.3 m-85 -112.51 126.42 55.31 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.221 -0.591 . . . . 0.0 111.335 -179.533 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.539 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -47.49 -38.89 14.72 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 177.52 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 232' ' ' GLU . . . . . 0.496 ' O ' ' HG3' ' A' ' 182' ' ' LYS . 17.5 mm-40 -91.2 -171.25 2.9 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 113.078 -1.874 . . . . 0.0 109.431 178.661 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 233' ' ' GLU . . . . . 0.491 ' HG2' ' HD2' ' A' ' 182' ' ' LYS . 0.0 OUTLIER -130.32 14.25 5.59 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.476 179.92 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.528 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.3 OUTLIER -84.89 -60.84 0.29 Allowed Pre-proline 0 CA--C 1.517 -0.318 0 C-N-CA 120.644 -0.423 . . . . 0.0 110.928 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.893 ' O ' HD12 ' A' ' 239' ' ' ILE . 79.9 Cg_exo -49.3 -28.83 15.92 Favored 'Trans proline' 0 CA--C 1.499 -1.257 0 N-CA-C 108.719 -1.3 . . . . 0.0 108.719 178.208 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.87 HG21 ' HB2' ' A' ' 182' ' ' LYS . 14.5 t -73.29 -46.44 49.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 114.269 -1.332 . . . . 0.0 110.382 178.761 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.528 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 2.1 pttp -62.12 -35.9 80.13 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.552 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.628 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.1 OUTLIER -81.38 -55.44 4.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.301 179.43 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.893 HD12 ' O ' ' A' ' 235' ' ' PRO . 1.6 mt -42.04 -50.02 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.851 -179.018 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 240' ' ' MET . . . . . 0.442 ' CE ' ' HB ' ' A' ' 256' ' ' VAL . 46.7 mtp -59.82 -26.18 65.58 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.565 -178.707 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.5 ' CG ' ' O ' ' A' ' 237' ' ' LYS . 0.1 OUTLIER -82.24 -22.91 35.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.022 0.439 . . . . 0.0 110.742 179.875 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.414 ' HG2' ' O ' ' A' ' 238' ' ' LYS . 9.2 mmmt -79.11 107.06 11.59 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.662 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.577 ' HE2' ' CE1' ' A' ' 244' ' ' TYR . 0.3 OUTLIER -42.66 -46.66 5.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.997 -179.787 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 244' ' ' TYR . . . . . 0.577 ' CE1' ' HE2' ' A' ' 243' ' ' LYS . 14.0 m-85 -138.59 161.27 37.51 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.047 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 245' ' ' HIS . . . . . 0.763 ' CD2' HD12 ' A' ' 254' ' ' ILE . 39.2 m-70 -126.08 152.58 45.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.078 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -130.71 105.44 7.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.042 0.449 . . . . 0.0 110.579 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.727 HG11 HG23 ' A' ' 198' ' ' ILE . 2.6 t -106.14 105.74 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.189 -179.437 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 54.32 -86.84 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.229 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.465 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.1 OUTLIER -109.87 -39.19 5.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.697 0.761 . . . . 0.0 109.787 -179.829 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.567 ' CB ' ' HG1' ' A' ' 193' ' ' THR . 0.0 OUTLIER -77.82 153.97 32.29 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.373 -1.285 . . . . 0.0 112.349 -178.435 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.455 ' HD3' ' O ' ' A' ' 249' ' ' LEU . 0.0 OUTLIER -150.22 110.63 4.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.266 179.114 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 252' ' ' CYS . . . . . 1.078 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -127.91 153.16 46.99 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -177.709 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 253' ' ' GLU . . . . . 0.558 ' HG3' ' CD1' ' A' ' 244' ' ' TYR . 39.5 tt0 -75.98 110.34 10.36 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.149 -179.303 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 254' ' ' ILE . . . . . 1.006 HG12 HG13 ' A' ' 186' ' ' VAL . 11.5 mt -95.62 108.51 21.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -177.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 255' ' ' LYS . . . . . 0.523 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -112.03 129.86 56.06 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 105.488 -2.041 . . . . 0.0 105.488 176.066 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.763 HG23 ' O ' ' A' ' 183' ' ' LYS . 7.8 p -32.61 124.14 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 122.212 1.006 . . . . 0.0 111.459 -176.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 1.181 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -75.9 152.37 37.16 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 113.447 -1.706 . . . . 0.0 112.049 -177.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.5 123.59 21.62 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.216 179.538 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 259' ' ' SER . . . . . 0.488 ' OG ' ' NZ ' ' A' ' 183' ' ' LYS . 62.0 p . . . . . 0 C--N 1.326 -0.449 0 CA-C-O 120.903 0.382 . . . . 0.0 110.891 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.521 ' CG1' ' N ' ' A' ' 182' ' ' LYS . 40.9 t . . . . . 0 CA--C 1.502 -0.895 0 CA-C-O 121.217 0.532 . . . . 0.0 111.66 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.731 ' CB ' HG21 ' A' ' 236' ' ' VAL . 0.0 OUTLIER -149.18 112.52 4.97 Favored 'General case' 0 N--CA 1.432 -1.375 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.487 177.97 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.867 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -131.22 142.86 50.23 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-N 114.974 -1.012 . . . . 0.0 108.646 178.52 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.923 HD13 ' HE2' ' A' ' 230' ' ' PHE . 1.3 pt -123.85 119.75 57.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.82 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -92.5 109.81 21.21 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.494 0.664 . . . . 0.0 110.404 -178.982 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.689 HG13 HG12 ' A' ' 254' ' ' ILE . 6.3 t -85.97 129.84 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.886 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.597 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . -79.43 -153.73 8.07 Favored Glycine 0 CA--C 1.521 0.454 0 C-N-CA 121.034 -0.603 . . . . 0.0 114.209 -178.062 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.519 ' HA2' ' O ' ' A' ' 224' ' ' GLY . . . -34.56 109.61 0.06 OUTLIER Glycine 0 C--N 1.334 0.442 0 N-CA-C 114.255 0.462 . . . . 0.0 114.255 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.96 HD13 ' OG1' ' A' ' 193' ' ' THR . 1.7 pp -117.05 157.48 25.78 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.687 0.28 . . . . 0.0 110.819 179.406 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.789 ' O ' HD12 ' A' ' 189' ' ' LEU . 0.3 OUTLIER -42.25 -177.96 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.259 0 CA-C-O 121.463 0.649 . . . . 0.0 112.087 -179.709 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 191' ' ' PRO . . . . . 0.56 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 10.4 Cg_exo -70.82 1.52 5.05 Favored 'Trans proline' 0 CA--C 1.529 0.266 0 C-N-CA 123.232 2.621 . . . . 0.0 113.404 -179.403 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 192' ' ' ASP . 8.4 p-10 165.44 74.91 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.89 0.376 . . . . 0.0 111.415 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.96 ' OG1' HD13 ' A' ' 189' ' ' LEU . 11.9 m -68.9 116.85 45.6 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.125 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.528 ' HG2' ' HG2' ' A' ' 197' ' ' LYS . 36.5 Cg_endo -64.78 118.36 5.35 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.424 2.083 . . . . 0.0 111.438 179.037 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.783 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -52.06 -16.05 0.69 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.328 -179.607 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 196' ' ' GLU . . . . . 0.495 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 34.8 mt-10 -68.23 -37.85 81.24 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -179.685 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.528 ' HG2' ' HG2' ' A' ' 194' ' ' PRO . 18.0 mmmt -74.44 -50.08 19.81 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.318 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.818 ' CD1' HG22 ' A' ' 193' ' ' THR . 0.0 OUTLIER -48.13 -31.15 2.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 114.849 -1.069 . . . . 0.0 108.428 178.229 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.589 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 1.9 mtp85 -71.09 -32.73 69.44 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.296 178.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 200' ' ' GLU . . . . . 0.55 ' CG ' ' N ' ' A' ' 201' ' ' TYR . 4.2 pt-20 -81.71 -53.03 6.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.201 0.524 . . . . 0.0 109.894 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.55 ' N ' ' CG ' ' A' ' 200' ' ' GLU . 0.3 OUTLIER -55.35 -54.05 48.52 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.98 178.87 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 1.075 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.2 OUTLIER -79.58 -31.15 41.79 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.069 -0.968 . . . . 0.0 110.424 -179.67 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.589 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -65.1 -55.47 21.48 Favored Glycine 0 CA--C 1.499 -0.927 0 N-CA-C 106.928 -2.469 . . . . 0.0 106.928 176.349 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -49.97 -28.82 13.08 Favored Glycine 0 N--CA 1.442 -0.936 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 176.128 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.767 ' CE2' HG13 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -57.93 -46.18 85.44 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 122.145 0.974 . . . . 0.0 108.496 177.738 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 171.95 -130.89 2.03 Favored Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 113.542 -1.663 . . . . 0.0 110.247 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.487 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 5.2 mm-40 -97.01 100.7 12.2 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.245 0.545 . . . . 0.0 111.05 178.682 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.449 HG22 ' CE1' ' A' ' 230' ' ' PHE . 2.9 t -78.11 140.86 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.088 0 CA-C-N 115.235 -0.893 . . . . 0.0 108.653 178.295 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 209' ' ' GLU . . . . . 0.615 ' HB3' HG22 ' A' ' 229' ' ' THR . 10.1 tp10 -94.43 -53.83 3.76 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.771 0.32 . . . . 0.0 110.352 179.154 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.422 ' C ' HG12 ' A' ' 211' ' ' ILE . 24.0 p -159.83 156.85 28.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.21 0.528 . . . . 0.0 111.842 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.808 HD12 ' HB ' ' A' ' 198' ' ' ILE . 0.1 OUTLIER -131.84 124.57 53.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.528 178.959 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -123.07 103.26 8.46 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -178.16 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.766 HD13 ' O ' ' A' ' 193' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.323 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 177.357 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 224' ' ' GLY . . . . . 0.519 ' O ' ' HA2' ' A' ' 188' ' ' GLY . . . . . . . . 0 C--O 1.223 -0.583 0 N-CA-C 113.728 0.251 . . . . 0.0 113.728 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 225' ' ' PHE . . . . . 0.92 ' C ' HD23 ' A' ' 189' ' ' LEU . 0.4 OUTLIER -156.47 176.48 12.65 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.712 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 226' ' ' CYS . . . . . 0.542 ' N ' HD23 ' A' ' 189' ' ' LEU . 11.9 p -142.14 149.56 39.95 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.028 -0.669 . . . . 0.0 112.538 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 1.123 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 4.7 m-85 -106.24 138.86 41.67 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.592 178.804 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 1.075 HD12 ' CE2' ' A' ' 202' ' ' PHE . 2.2 mt -133.87 135.09 55.57 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.35 0 CA-C-O 120.962 0.41 . . . . 0.0 111.133 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 229' ' ' THR . . . . . 0.615 HG22 ' HB3' ' A' ' 209' ' ' GLU . 52.3 m -116.26 138.08 51.6 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.719 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.923 ' HE2' HD13 ' A' ' 184' ' ' ILE . 75.4 m-85 -112.9 126.29 55.3 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.271 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.505 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -49.36 -38.93 30.0 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 177.981 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 232' ' ' GLU . . . . . 0.459 ' O ' ' HD3' ' A' ' 182' ' ' LYS . 63.9 mt-10 -92.59 -170.86 2.59 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 113.362 -1.745 . . . . 0.0 109.304 178.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 233' ' ' GLU . . . . . 0.554 ' CB ' ' HG2' ' A' ' 182' ' ' LYS . 14.4 pt-20 -126.09 2.83 7.22 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.836 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.511 ' O ' ' HB2' ' A' ' 237' ' ' LYS . 0.2 OUTLIER -74.33 -59.25 1.69 Allowed Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.809 -179.169 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.893 ' O ' HD12 ' A' ' 239' ' ' ILE . 87.5 Cg_exo -49.15 -32.94 25.93 Favored 'Trans proline' 0 CA--C 1.5 -1.196 0 N-CA-C 108.814 -1.264 . . . . 0.0 108.814 178.641 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.731 HG21 ' CB ' ' A' ' 182' ' ' LYS . 22.9 t -70.41 -41.57 78.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 114.041 -1.436 . . . . 0.0 108.985 177.759 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.537 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 20.6 mtpt -55.78 -46.91 77.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.799 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.473 ' HA ' ' HG3' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -81.01 -48.76 11.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.144 -179.501 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.893 HD12 ' O ' ' A' ' 235' ' ' PRO . 1.7 mt -43.57 -49.49 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.841 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 240' ' ' MET . . . . . 0.458 ' SD ' HG12 ' A' ' 236' ' ' VAL . 52.9 mtp -61.22 -29.93 70.13 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.637 -178.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.473 ' HG3' ' HA ' ' A' ' 238' ' ' LYS . 0.2 OUTLIER -85.97 -12.17 51.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.794 0.33 . . . . 0.0 111.134 -179.56 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.425 ' O ' ' C ' ' A' ' 243' ' ' LYS . 11.5 mmmm -79.63 103.5 9.58 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.837 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.558 ' HD3' ' CD2' ' A' ' 244' ' ' TYR . 0.1 OUTLIER -37.46 -58.05 0.88 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.15 0.5 . . . . 0.0 110.325 179.75 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 244' ' ' TYR . . . . . 0.665 ' CD1' ' HB3' ' A' ' 253' ' ' GLU . 10.9 m-85 -135.51 153.27 51.78 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.239 179.372 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 245' ' ' HIS . . . . . 0.751 ' CE1' HD12 ' A' ' 254' ' ' ILE . 28.8 m-70 -111.91 157.43 20.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.116 -179.679 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -139.79 104.3 4.86 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.299 0.571 . . . . 0.0 109.979 178.525 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.659 HG12 ' H ' ' A' ' 248' ' ' GLY . 1.4 t -95.67 -173.65 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.874 -179.468 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 248' ' ' GLY . . . . . 0.659 ' H ' HG12 ' A' ' 247' ' ' VAL . . . -26.51 -56.69 0.08 OUTLIER Glycine 0 C--N 1.337 0.619 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.761 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.493 HD23 ' C ' ' A' ' 248' ' ' GLY . 0.0 OUTLIER -130.47 -40.03 1.27 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.443 0.639 . . . . 0.0 111.033 -179.826 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.51 ' O ' ' N ' ' A' ' 247' ' ' VAL . 57.2 p -77.59 150.01 34.75 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.094 -0.957 . . . . 0.0 112.794 -178.316 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -144.87 102.69 3.81 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.225 178.373 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 252' ' ' CYS . . . . . 0.597 ' HB3' ' C ' ' A' ' 187' ' ' GLY . 0.0 OUTLIER -130.11 154.86 47.05 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -177.448 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 253' ' ' GLU . . . . . 0.665 ' HB3' ' CD1' ' A' ' 244' ' ' TYR . 6.9 pt-20 -74.61 119.05 18.28 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 254' ' ' ILE . . . . . 0.751 HD12 ' CE1' ' A' ' 245' ' ' HIS . 39.8 mt -97.2 102.47 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 CA-C-O 121.621 0.724 . . . . 0.0 112.332 -178.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 255' ' ' LYS . . . . . 0.558 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -103.38 129.27 50.41 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 177.781 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 183' ' ' LYS . 5.7 p -32.32 123.62 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.509 -0.599 0 CA-C-O 122.307 1.051 . . . . 0.0 111.491 -176.772 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 1.123 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -76.26 152.57 36.46 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 113.319 -1.764 . . . . 0.0 111.982 -178.257 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.35 114.93 14.27 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.354 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.326 -0.452 0 CA-C-O 121.082 0.468 . . . . 0.0 111.518 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.511 ' CG1' ' N ' ' A' ' 182' ' ' LYS . 45.5 t . . . . . 0 CA--C 1.503 -0.85 0 CA-C-O 121.243 0.544 . . . . 0.0 111.612 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.879 ' HB2' HG21 ' A' ' 236' ' ' VAL . 0.5 OUTLIER -149.97 112.6 4.75 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.883 177.769 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.765 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.0 OUTLIER -135.46 155.85 49.86 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.55 179.242 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.87 HD13 ' HE2' ' A' ' 230' ' ' PHE . 0.4 OUTLIER -131.15 121.19 48.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 115.452 -0.794 . . . . 0.0 108.858 178.973 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.825 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.3 OUTLIER -93.82 109.25 20.94 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.287 0.565 . . . . 0.0 110.826 -178.981 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 1.012 HG12 ' HB2' ' A' ' 252' ' ' CYS . 2.5 t -86.08 126.4 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.586 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.589 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . -114.76 126.4 7.22 Favored Glycine 0 N--CA 1.452 -0.274 0 N-CA-C 114.602 0.601 . . . . 0.0 114.602 -176.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.466 ' HA3' ' C7 ' ' B' ' 2' ' ' ' DT' . . . 80.59 83.13 0.74 Allowed Glycine 0 CA--C 1.519 0.285 0 C-N-CA 121.245 -0.502 . . . . 0.0 113.361 179.119 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.966 HD23 ' C ' ' A' ' 225' ' ' PHE . 0.6 OUTLIER -117.25 157.77 25.47 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.816 0.341 . . . . 0.0 111.384 -179.394 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.615 ' N ' HD12 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -45.4 -177.41 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.197 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.557 179.503 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.555 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 11.4 Cg_exo -70.62 6.54 1.55 Allowed 'Trans proline' 0 CA--C 1.532 0.406 0 C-N-CA 123.255 2.637 . . . . 0.0 113.514 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.516 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 2.8 p30 160.55 77.65 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.013 0.435 . . . . 0.0 110.812 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.891 HG22 HD11 ' A' ' 198' ' ' ILE . 51.8 m -73.02 131.76 83.4 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.003 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.575 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 68.6 Cg_endo -80.96 114.34 2.88 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 122.945 2.43 . . . . 0.0 111.632 179.155 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.583 ' HA ' ' CD1' ' A' ' 198' ' ' ILE . 1.6 pm0 -48.1 -17.81 0.15 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.357 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' GLU . . . . . 0.474 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 27.4 mm-40 -61.36 -44.02 97.89 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -179.027 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.575 ' CD ' ' HG2' ' A' ' 194' ' ' PRO . 0.9 OUTLIER -76.38 -46.39 27.57 Favored 'General case' 0 CA--C 1.494 -1.207 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 178.826 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.959 ' CD1' HD21 ' A' ' 213' ' ' LEU . 0.2 OUTLIER -48.34 -29.01 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.373 0 CA-C-N 113.862 -1.517 . . . . 0.0 108.736 177.245 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.57 ' HG3' ' O ' ' A' ' 195' ' ' GLU . 2.3 mtt180 -76.12 -31.73 58.79 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-N 115.294 -0.867 . . . . 0.0 110.029 178.262 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' GLU . . . . . 0.58 ' CG ' ' N ' ' A' ' 201' ' ' TYR . 4.2 pt-20 -82.01 -55.17 4.74 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.098 0.475 . . . . 0.0 110.293 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.58 ' N ' ' CG ' ' A' ' 200' ' ' GLU . 0.3 OUTLIER -50.11 -53.88 24.4 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.484 0.659 . . . . 0.0 109.67 178.797 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 1.011 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.5 OUTLIER -79.66 -32.69 41.58 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.7 -179.836 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.539 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -62.82 -55.05 29.13 Favored Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 107.359 -2.296 . . . . 0.0 107.359 176.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -51.39 -27.84 18.36 Favored Glycine 0 N--CA 1.442 -0.949 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 176.36 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.764 ' CE2' HG13 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -59.17 -44.89 92.16 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 122.129 0.966 . . . . 0.0 108.601 177.849 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.493 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 172.42 -132.41 2.38 Favored Glycine 0 N--CA 1.442 -0.938 0 CA-C-N 113.698 -1.592 . . . . 0.0 110.482 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.486 ' HB2' ' HG3' ' A' ' 232' ' ' GLU . 1.8 mt-10 -97.22 97.13 8.92 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.21 0.529 . . . . 0.0 111.456 178.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 2.5 t -72.56 137.63 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' GLU . . . . . 0.669 ' HB3' HG22 ' A' ' 229' ' ' THR . 5.8 tp10 -89.54 -50.7 5.93 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 178.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.438 ' OG ' ' OE2' ' A' ' 212' ' ' GLU . 0.9 OUTLIER -165.15 159.02 17.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.31 0.576 . . . . 0.0 111.913 179.263 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.533 HD11 ' HA ' ' A' ' 199' ' ' ARG . 0.1 OUTLIER -131.59 120.72 46.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.212 179.156 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.438 ' OE2' ' OG ' ' A' ' 210' ' ' SER . 0.0 OUTLIER -123.43 102.64 8.01 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -179.066 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.959 HD21 ' CD1' ' A' ' 198' ' ' ILE . 1.7 mp -96.83 104.86 20.01 Favored Pre-proline 0 C--N 1.329 -0.284 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 177.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.546 ' HG3' ' CE1' ' A' ' 225' ' ' PHE . 64.3 Cg_endo -72.86 130.3 15.48 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.98 2.453 . . . . 0.0 113.321 -179.066 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 11.1 mtm -135.77 130.96 34.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.633 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.419 ' O ' ' HA ' ' A' ' 220' ' ' ASN . 0.5 OUTLIER -111.96 107.98 17.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.912 0.387 . . . . 0.0 110.666 179.849 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -81.97 -12.42 58.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.722 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.58 -47.29 12.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.671 0.272 . . . . 0.0 111.407 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 3.5 t -124.21 -19.74 5.47 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.664 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' ASN . . . . . 0.419 ' HA ' ' O ' ' A' ' 216' ' ' ASP . 13.8 m-80 51.74 58.45 5.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.746 0.308 . . . . 0.0 110.821 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 1.6 mtpp -51.92 -179.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.636 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.625 ' CD ' ' O ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -93.98 26.14 3.35 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 122.386 1.089 . . . . 0.0 109.957 179.992 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.583 ' O ' ' CD1' ' A' ' 225' ' ' PHE . 4.9 ptp85 -71.33 -25.96 62.63 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.516 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . -8.3 73.83 0.0 OUTLIER Glycine 0 C--N 1.345 1.07 0 O-C-N 124.506 1.129 . . . . 0.0 112.812 178.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.966 ' C ' HD23 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -157.15 176.93 12.08 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -178.29 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 226' ' ' CYS . . . . . 0.808 ' HB3' HD23 ' A' ' 213' ' ' LEU . 1.4 p -141.42 149.18 40.69 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.258 -0.577 . . . . 0.0 112.433 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 1.104 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 5.7 m-85 -107.21 146.45 31.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.351 178.306 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 1.011 HD12 ' CE2' ' A' ' 202' ' ' PHE . 1.8 mt -141.12 121.22 12.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.287 0.565 . . . . 0.0 111.667 179.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.669 HG22 ' HB3' ' A' ' 209' ' ' GLU . 31.2 m -102.39 137.91 40.01 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.235 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.87 ' HE2' HD13 ' A' ' 184' ' ' ILE . 72.4 m-85 -113.58 126.41 55.26 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.078 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.558 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -51.79 -37.31 51.03 Favored 'General case' 0 CA--C 1.505 -0.769 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 178.328 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 232' ' ' GLU . . . . . 0.49 ' O ' ' HG3' ' A' ' 182' ' ' LYS . 1.6 mm-40 -93.37 -175.28 3.76 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 113.39 -1.732 . . . . 0.0 109.3 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 233' ' ' GLU . . . . . 0.553 ' HB3' ' CE ' ' A' ' 182' ' ' LYS . 0.1 OUTLIER -124.67 11.37 8.49 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.912 -179.631 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.562 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.2 OUTLIER -80.74 -59.79 0.47 Allowed Pre-proline 0 C--N 1.328 -0.327 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.813 179.926 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.92 ' O ' HD12 ' A' ' 239' ' ' ILE . 84.0 Cg_exo -49.71 -31.87 26.92 Favored 'Trans proline' 0 CA--C 1.502 -1.087 0 N-CA-C 108.785 -1.275 . . . . 0.0 108.785 177.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.879 HG21 ' HB2' ' A' ' 182' ' ' LYS . 12.8 t -72.1 -44.93 64.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 114.059 -1.428 . . . . 0.0 110.566 178.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.562 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 19.4 pttt -62.33 -37.85 87.2 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.987 -179.153 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.48 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 0.0 OUTLIER -82.05 -49.99 9.6 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.856 0.36 . . . . 0.0 111.052 179.351 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.92 HD12 ' O ' ' A' ' 235' ' ' PRO . 1.4 mt -42.88 -53.08 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 24.7 mtp -56.23 -32.2 64.24 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.027 -179.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.477 ' CG ' ' O ' ' A' ' 237' ' ' LYS . 1.1 mt-10 -75.4 -21.19 58.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.13 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -79.57 109.92 14.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.849 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.406 ' HE2' ' HG3' ' A' ' 253' ' ' GLU . 0.0 OUTLIER -48.18 -47.57 35.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.755 179.951 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.561 ' CE1' ' HG3' ' A' ' 253' ' ' GLU . 8.5 m-85 -138.31 151.75 47.86 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.903 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 245' ' ' HIS . . . . . 0.807 ' CG ' HD12 ' A' ' 254' ' ' ILE . 29.7 m-70 -116.67 154.91 29.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.25 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 246' ' ' ASN . . . . . 0.406 ' O ' ' CE2' ' A' ' 201' ' ' TYR . 2.4 m-80 -134.34 105.23 6.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.276 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.545 ' N ' ' O ' ' A' ' 250' ' ' SER . 2.2 t -103.57 106.88 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.292 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 248' ' ' GLY . . . . . 0.457 ' C ' HD23 ' A' ' 249' ' ' LEU . . . 52.04 -83.06 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.186 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.544 HD23 ' N ' ' A' ' 249' ' ' LEU . 0.0 OUTLIER -111.11 -38.34 5.08 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.586 0.707 . . . . 0.0 110.267 179.727 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.545 ' O ' ' N ' ' A' ' 247' ' ' VAL . 0.6 OUTLIER -77.16 153.21 34.41 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.747 -1.115 . . . . 0.0 112.014 -178.627 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.498 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -146.97 107.08 4.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.959 179.159 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 252' ' ' CYS . . . . . 1.012 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -128.2 153.41 46.94 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -176.933 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 253' ' ' GLU . . . . . 0.561 ' HG3' ' CE1' ' A' ' 244' ' ' TYR . 29.2 tt0 -76.02 109.56 9.77 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.194 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.861 HG12 HG13 ' A' ' 186' ' ' VAL . 21.4 mt -96.54 115.23 35.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 -178.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.517 ' O ' ' C ' ' A' ' 256' ' ' VAL . 0.0 OUTLIER -121.01 131.8 54.51 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 106.144 -1.799 . . . . 0.0 106.144 176.628 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 183' ' ' LYS . 3.9 p -32.87 121.76 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.513 -0.472 0 CA-C-O 122.398 1.095 . . . . 0.0 111.446 -177.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 1.104 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -75.77 155.49 35.46 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 113.117 -1.856 . . . . 0.0 111.909 -178.53 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.91 125.16 27.71 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.426 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 259' ' ' SER . . . . . 0.568 ' HB3' ' CE ' ' A' ' 183' ' ' LYS . 83.3 p . . . . . 0 C--N 1.324 -0.516 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.232 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 2' ' ' ' DT' . . . . . 0.783 ' O2 ' " H2'" ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.427 -0.82 0 O4'-C1'-C2' 106.888 0.716 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 3' ' ' ' DA' . . . . . 0.602 H5'' ' CE1' ' A' ' 225' ' ' PHE . . . . . . . . 0 O4'--C1' 1.408 -0.954 0 C1'-O4'-C4' 107.639 -1.472 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 4' ' ' ' DG' . . . . . 0.641 H2'' " O5'" ' B' ' 5' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.428 -0.76 0 C4'-C3'-C2' 102.098 -1.102 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 5' ' ' ' DG' . . . . . 0.641 " O5'" H2'' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.428 -0.78 0 O4'-C1'-C2' 106.714 0.559 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.46 ' CG1' ' N ' ' A' ' 182' ' ' LYS . 45.8 t . . . . . 0 CA--C 1.502 -0.891 0 CA-C-O 121.46 0.648 . . . . 0.0 112.051 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.559 ' HB3' HG21 ' A' ' 236' ' ' VAL . 0.0 OUTLIER -148.91 111.56 4.78 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.117 176.733 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.829 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -138.57 146.1 41.44 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 114.979 -1.01 . . . . 0.0 109.623 179.39 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.877 HD13 ' HE1' ' A' ' 230' ' ' PHE . 0.4 OUTLIER -125.38 120.32 57.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.528 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.854 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -93.33 109.09 20.63 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.423 0.63 . . . . 0.0 110.459 -178.738 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 1.12 HG12 ' HB2' ' A' ' 252' ' ' CYS . 1.9 t -88.14 122.58 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.023 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.597 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . -108.23 125.79 8.0 Favored Glycine 0 N--CA 1.452 -0.239 0 CA-C-N 115.893 -0.594 . . . . 0.0 114.535 -176.52 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.549 ' HA3' ' C7 ' ' B' ' 2' ' ' ' DT' . . . 81.33 86.86 0.66 Allowed Glycine 0 C--N 1.333 0.414 0 C-N-CA 121.025 -0.607 . . . . 0.0 113.026 179.251 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.934 HD23 ' C ' ' A' ' 225' ' ' PHE . 0.7 OUTLIER -116.87 156.64 26.98 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.835 0.35 . . . . 0.0 111.258 -179.657 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.605 ' O ' HD12 ' A' ' 189' ' ' LEU . 0.2 OUTLIER -45.31 179.65 0.01 OUTLIER Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.16 179.56 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.53 ' CD ' ' OG ' ' A' ' 190' ' ' SER . 15.5 Cg_exo -68.33 4.98 1.35 Allowed 'Trans proline' 0 CA--C 1.531 0.346 0 C-N-CA 123.138 2.559 . . . . 0.0 113.575 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.505 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 0.3 OUTLIER 161.4 76.25 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.877 0.37 . . . . 0.0 110.954 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.847 ' OG1' HD13 ' A' ' 189' ' ' LEU . 35.7 m -70.86 132.41 86.88 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.469 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.626 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 83.9 Cg_endo -77.25 115.21 3.91 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.77 2.313 . . . . 0.0 110.955 178.324 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.803 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -51.61 -13.7 0.27 Allowed 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -179.36 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 196' ' ' GLU . . . . . 0.513 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 25.9 mt-10 -68.17 -41.34 81.63 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -179.411 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.626 ' CD ' ' HG2' ' A' ' 194' ' ' PRO . 1.5 mttp -72.5 -47.37 49.07 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.803 ' CG1' ' HA ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -47.05 -31.02 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.118 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.575 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 4.1 mtp85 -71.71 -33.46 68.77 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.247 179.121 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' GLU . . . . . 0.525 ' CG ' ' N ' ' A' ' 201' ' ' TYR . 3.1 pt-20 -82.49 -51.55 7.7 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.005 0.431 . . . . 0.0 110.601 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.525 ' N ' ' CG ' ' A' ' 200' ' ' GLU . 0.2 OUTLIER -54.84 -54.6 40.29 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.497 0.665 . . . . 0.0 109.835 178.964 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 1.107 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.4 OUTLIER -79.29 -31.0 43.19 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.079 -179.784 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.575 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -63.41 -55.47 25.43 Favored Glycine 0 CA--C 1.501 -0.841 0 N-CA-C 106.812 -2.515 . . . . 0.0 106.812 176.067 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -49.05 -29.35 8.62 Favored Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 176.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.803 ' CD2' HD11 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -59.18 -42.56 91.11 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 122.046 0.927 . . . . 0.0 108.587 177.704 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.489 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 167.69 -130.44 2.1 Favored Glycine 0 N--CA 1.442 -0.923 0 CA-C-N 113.666 -1.606 . . . . 0.0 110.318 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.526 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 13.1 mt-10 -97.02 101.91 13.58 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.157 0.503 . . . . 0.0 110.923 178.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.459 HG21 ' HB2' ' A' ' 202' ' ' PHE . 2.4 t -77.14 143.97 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 CA-C-N 115.449 -0.796 . . . . 0.0 108.931 178.362 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 209' ' ' GLU . . . . . 0.738 ' HB3' HG22 ' A' ' 229' ' ' THR . 18.8 tp10 -91.8 -55.13 3.58 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 178.412 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 3.3 m -170.55 150.88 3.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.765 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.959 HD13 HG23 ' A' ' 228' ' ' ILE . 0.4 OUTLIER -117.53 133.33 64.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.752 179.088 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -123.21 103.35 8.48 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -178.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.603 HD13 ' HB3' ' A' ' 226' ' ' CYS . 2.4 mm? -96.33 109.08 45.73 Favored Pre-proline 0 CA--C 1.531 0.226 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 177.173 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.603 ' HD2' ' O ' ' A' ' 225' ' ' PHE . 26.8 Cg_endo -92.36 130.78 1.04 Allowed 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 123.225 2.617 . . . . 0.0 112.567 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -134.88 130.89 36.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.587 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.481 ' O ' ' HA ' ' A' ' 220' ' ' ASN . 1.0 OUTLIER -115.22 106.51 14.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.979 -179.93 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -82.58 -12.79 57.46 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.994 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -87.67 -48.61 7.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.412 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 4.0 t -109.81 -26.89 9.58 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.348 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' ASN . . . . . 0.481 ' HA ' ' O ' ' A' ' 216' ' ' ASP . 42.3 m-20 52.44 47.27 25.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.833 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 3.9 ttpt -49.99 -178.67 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.946 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.625 ' CD ' ' O ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -101.35 21.85 13.46 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 122.444 1.116 . . . . 0.0 109.716 179.77 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.598 ' O ' ' N ' ' A' ' 225' ' ' PHE . 1.6 ptm180 -71.43 -20.83 62.06 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.321 178.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.514 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . -16.28 79.5 0.0 OUTLIER Glycine 0 C--N 1.343 0.964 0 O-C-N 124.4 1.062 . . . . 0.0 112.252 179.149 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.934 ' C ' HD23 ' A' ' 189' ' ' LEU . 0.0 OUTLIER -157.36 176.67 12.37 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.924 -0.638 . . . . 0.0 110.017 -177.773 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 226' ' ' CYS . . . . . 0.603 ' HB3' HD13 ' A' ' 213' ' ' LEU . 4.0 p -136.04 148.63 48.44 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.115 -0.634 . . . . 0.0 112.428 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 1.101 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 3.4 m-85 -109.81 132.79 53.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.111 -0.95 . . . . 0.0 108.446 178.254 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 1.107 HD12 ' CE2' ' A' ' 202' ' ' PHE . 1.8 mt -129.09 122.2 55.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.213 0.53 . . . . 0.0 111.785 -179.107 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.738 HG22 ' HB3' ' A' ' 209' ' ' GLU . 24.4 m -103.62 138.24 40.57 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.241 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.877 ' HE1' HD13 ' A' ' 184' ' ' ILE . 65.3 m-85 -110.97 126.38 54.71 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.55 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.559 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -48.22 -38.93 19.63 Favored 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 178.442 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 232' ' ' GLU . . . . . 0.452 ' O ' ' O ' ' A' ' 230' ' ' PHE . 0.3 OUTLIER -92.1 -166.18 1.5 Allowed 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 113.121 -1.854 . . . . 0.0 109.14 178.586 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 233' ' ' GLU . . . . . 0.517 ' O ' ' HG3' ' A' ' 237' ' ' LYS . 0.3 OUTLIER -131.27 -0.13 4.08 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.581 179.86 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.509 ' O ' ' N ' ' A' ' 237' ' ' LYS . 0.6 OUTLIER -72.57 -58.99 2.64 Favored Pre-proline 0 C--N 1.331 -0.234 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.835 -179.422 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.864 ' O ' HD12 ' A' ' 239' ' ' ILE . 96.5 Cg_exo -48.98 -32.91 24.59 Favored 'Trans proline' 0 CA--C 1.497 -1.373 0 N-CA-C 108.949 -1.212 . . . . 0.0 108.949 178.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.559 HG21 ' HB3' ' A' ' 182' ' ' LYS . 21.6 t -69.87 -40.84 79.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 113.834 -1.53 . . . . 0.0 109.075 178.118 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.517 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 8.7 mttt -58.81 -45.93 88.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.877 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.459 ' O ' ' HD3' ' A' ' 242' ' ' LYS . 0.0 OUTLIER -80.25 -47.42 14.63 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.064 -179.703 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.864 HD12 ' O ' ' A' ' 235' ' ' PRO . 1.6 mt -45.15 -50.82 2.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.7 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 240' ' ' MET . . . . . 0.501 ' SD ' HG12 ' A' ' 236' ' ' VAL . 23.0 mtp -58.13 -28.22 64.47 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.192 -179.073 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.465 ' N ' ' OE1' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -82.48 -20.76 36.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.224 0.535 . . . . 0.0 109.824 179.408 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.459 ' HD3' ' O ' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -80.55 100.13 8.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.019 179.729 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.61 ' HE2' ' CG ' ' A' ' 244' ' ' TYR . 1.8 ttpt -40.7 -67.43 0.24 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.24 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.61 ' CG ' ' HE2' ' A' ' 243' ' ' LYS . 7.1 m-30 -113.94 154.4 27.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.197 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 245' ' ' HIS . . . . . 0.699 ' CG ' HD12 ' A' ' 254' ' ' ILE . 24.3 m-70 -123.12 147.85 46.33 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.338 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 246' ' ' ASN . . . . . 0.448 ' HB3' ' HD2' ' A' ' 251' ' ' LYS . 0.4 OUTLIER -125.73 105.24 8.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.989 0.424 . . . . 0.0 110.938 179.712 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.662 HG11 HG23 ' A' ' 198' ' ' ILE . 1.9 t -102.64 108.98 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.235 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 48.76 -83.93 0.01 OUTLIER Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.271 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.556 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -110.48 -38.64 5.15 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.402 0.62 . . . . 0.0 110.497 179.639 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.522 ' HB3' ' HB2' ' A' ' 190' ' ' SER . 1.6 p -77.06 150.44 35.73 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.011 -0.995 . . . . 0.0 112.068 -178.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -144.88 108.05 4.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.307 178.984 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 252' ' ' CYS . . . . . 1.12 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -128.04 153.01 47.25 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -177.436 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 253' ' ' GLU . . . . . 0.515 ' HB2' ' O4 ' ' B' ' 2' ' ' ' DT' . 51.5 tt0 -76.17 113.14 13.38 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.221 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.92 HG12 HG13 ' A' ' 186' ' ' VAL . 10.1 mt -96.53 113.05 29.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 114.66 1.355 . . . . 0.0 114.66 -178.183 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.518 ' O ' ' C ' ' A' ' 256' ' ' VAL . 0.0 OUTLIER -119.5 129.57 54.77 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 176.207 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.674 HG23 ' O ' ' A' ' 183' ' ' LYS . 6.3 p -32.84 121.46 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.433 0 CA-C-O 122.264 1.031 . . . . 0.0 111.42 -177.157 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 1.101 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -76.01 154.1 36.0 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 113.207 -1.815 . . . . 0.0 112.132 -178.239 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 258' ' ' MET . . . . . 0.636 ' HE3' ' C6 ' ' B' ' 3' ' ' ' DA' . 0.0 OUTLIER -130.32 117.16 19.36 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.174 179.451 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.323 -0.558 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.716 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 2' ' ' ' DT' . . . . . 0.752 ' O2 ' " H2'" ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.428 -0.772 0 O4'-C1'-C2' 106.716 0.56 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 3' ' ' ' DA' . . . . . 0.636 ' C6 ' ' HE3' ' A' ' 258' ' ' MET . . . . . . . . 0 O4'--C1' 1.405 -1.118 0 C4'-C3'-C2' 104.602 1.402 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 4' ' ' ' DG' . . . . . 0.699 ' C2 ' ' CE1' ' A' ' 227' ' ' PHE . . . . . . . . 0 O5'--C5' 1.427 -0.831 0 C4'-C3'-C2' 102.178 -1.022 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 5' ' ' ' DG' . . . . . 0.685 " O5'" H2'' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.425 -0.913 0 O4'-C1'-C2' 106.962 0.783 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.543 ' CA ' ' HE3' ' A' ' 182' ' ' LYS . 55.7 t . . . . . 0 CA--C 1.506 -0.74 0 CA-C-O 121.02 0.438 . . . . 0.0 111.502 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 1.086 ' HB2' HG21 ' A' ' 236' ' ' VAL . 0.0 OUTLIER -154.37 112.41 3.52 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.185 177.293 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.829 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -134.62 153.72 51.84 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.76 179.207 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.783 HD13 ' HE1' ' A' ' 230' ' ' PHE . 0.1 OUTLIER -133.1 120.49 40.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 177.991 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.816 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -92.51 109.94 21.35 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 121.341 0.591 . . . . 0.0 110.309 -179.434 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.684 HG12 ' HB2' ' A' ' 252' ' ' CYS . 39.2 t -88.08 131.0 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.968 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.502 ' O ' ' HB3' ' A' ' 252' ' ' CYS . . . -85.16 -146.56 8.45 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 114.597 0.599 . . . . 0.0 114.597 -177.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.491 ' HA2' ' O ' ' A' ' 224' ' ' GLY . . . -35.56 103.29 0.02 OUTLIER Glycine 0 C--N 1.336 0.569 0 N-CA-C 114.505 0.562 . . . . 0.0 114.505 -179.25 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.924 HD13 ' OG1' ' A' ' 193' ' ' THR . 1.7 pp -117.78 157.07 27.22 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 122.453 0.301 . . . . 0.0 110.893 179.099 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.828 ' O ' HD12 ' A' ' 189' ' ' LEU . 0.0 OUTLIER -42.27 172.64 0.03 OUTLIER Pre-proline 0 N--CA 1.463 0.191 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.32 179.806 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.515 ' HD2' ' OG ' ' A' ' 190' ' ' SER . 31.7 Cg_exo -60.37 -5.24 3.92 Favored 'Trans proline' 0 CA--C 1.532 0.395 0 C-N-CA 122.891 2.394 . . . . 0.0 113.466 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 191' ' ' PRO . 0.1 OUTLIER 172.78 73.19 0.0 OUTLIER 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.924 0.392 . . . . 0.0 111.503 -179.943 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.924 ' OG1' HD13 ' A' ' 189' ' ' LEU . 57.4 m -61.36 114.31 10.51 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.471 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.538 ' HG2' ' HG2' ' A' ' 197' ' ' LYS . 13.3 Cg_endo -58.19 114.26 1.89 Allowed 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.166 1.911 . . . . 0.0 111.013 178.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.836 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 6.5 pt-20 -53.4 -14.67 0.81 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.501 -179.287 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' GLU . . . . . 0.514 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 51.7 mt-10 -68.34 -38.51 81.55 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.538 ' HG2' ' HG2' ' A' ' 194' ' ' PRO . 0.1 OUTLIER -73.85 -49.2 26.2 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.309 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 1.022 HG22 ' CE1' ' A' ' 202' ' ' PHE . 0.0 OUTLIER -48.48 -30.91 3.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.062 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.598 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 11.0 mtp180 -69.18 -33.43 73.35 Favored 'General case' 0 C--O 1.22 -0.494 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.639 178.367 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' GLU . . . . . 0.534 ' N ' ' O ' ' A' ' 197' ' ' LYS . 4.3 mt-10 -82.42 -59.58 2.49 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.422 178.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.52 ' C ' ' CD1' ' A' ' 201' ' ' TYR . 0.4 OUTLIER -49.0 -54.27 16.37 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.498 0.666 . . . . 0.0 109.839 179.119 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 1.074 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.6 OUTLIER -79.36 -30.83 42.76 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 114.92 -1.037 . . . . 0.0 110.244 -179.863 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.598 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -62.2 -57.53 16.58 Favored Glycine 0 N--CA 1.443 -0.879 0 N-CA-C 106.959 -2.456 . . . . 0.0 106.959 176.395 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -48.64 -28.49 6.92 Favored Glycine 0 N--CA 1.442 -0.919 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 176.199 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.776 ' CD2' HD11 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -58.65 -45.26 89.7 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 177.866 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.494 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 171.83 -132.75 2.51 Favored Glycine 0 N--CA 1.441 -0.975 0 CA-C-N 113.614 -1.63 . . . . 0.0 110.25 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.484 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 0.5 OUTLIER -96.87 98.02 9.77 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.278 0.561 . . . . 0.0 111.079 178.815 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.495 HG21 ' HB2' ' A' ' 202' ' ' PHE . 2.8 t -74.32 142.24 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.337 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 209' ' ' GLU . . . . . 0.669 ' HB3' HG22 ' A' ' 229' ' ' THR . 5.0 tp10 -94.13 -54.12 3.7 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.747 178.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.8 m -166.25 152.74 9.17 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.228 0.537 . . . . 0.0 112.073 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.886 HD13 HG23 ' A' ' 228' ' ' ILE . 0.4 OUTLIER -122.06 124.49 71.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.23 178.433 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.49 ' O ' ' HD3' ' A' ' 214' ' ' PRO . 0.9 OUTLIER -123.34 107.29 11.48 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -177.993 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.768 HD11 ' HB ' ' A' ' 193' ' ' THR . 0.1 OUTLIER -95.65 105.56 21.57 Favored Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 177.66 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.545 ' HD2' ' O ' ' A' ' 225' ' ' PHE . 11.4 Cg_exo -73.01 134.01 20.74 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.752 2.301 . . . . 0.0 112.521 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.87 130.94 38.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.358 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.427 ' OD2' ' CG2' ' A' ' 219' ' ' THR . 0.8 OUTLIER -113.75 107.19 15.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.963 0.411 . . . . 0.0 111.585 -179.356 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -82.62 -28.57 30.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.03 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.55 -42.72 9.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.928 -178.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.427 ' CG2' ' OD2' ' A' ' 216' ' ' ASP . 0.1 OUTLIER -91.51 -23.21 20.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.813 0.339 . . . . 0.0 111.279 -179.426 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 220' ' ' ASN . . . . . 0.405 ' HA ' ' O ' ' A' ' 216' ' ' ASP . 35.3 m-80 38.17 46.74 0.89 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.398 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 221' ' ' LYS . . . . . 0.444 ' HB2' ' NH1' ' A' ' 223' ' ' ARG . 2.0 mtmt -69.78 166.32 19.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.561 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.649 ' O ' ' CG ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -93.66 46.7 1.2 Allowed 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 122.93 1.348 . . . . 0.0 109.573 179.816 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.548 ' HB2' ' CE1' ' A' ' 225' ' ' PHE . 2.4 ptp85 -71.76 -31.87 67.11 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 178.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.498 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 13.56 60.57 0.01 OUTLIER Glycine 0 C--O 1.224 -0.518 0 CA-C-N 114.396 -1.275 . . . . 0.0 113.207 178.409 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.802 ' C ' HD23 ' A' ' 189' ' ' LEU . 1.1 p90 -156.24 176.38 12.76 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -179.218 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 226' ' ' CYS . . . . . 0.702 ' SG ' HD22 ' A' ' 189' ' ' LEU . 7.9 p -146.43 154.66 41.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.178 0.513 . . . . 0.0 112.118 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 1.121 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 7.3 m-85 -105.85 147.45 28.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.761 179.027 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 1.074 HD12 ' CE2' ' A' ' 202' ' ' PHE . 2.0 mt -139.51 131.18 34.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.042 0.448 . . . . 0.0 110.646 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.669 HG22 ' HB3' ' A' ' 209' ' ' GLU . 38.2 m -113.18 137.99 50.63 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.752 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.783 ' HE1' HD13 ' A' ' 184' ' ' ILE . 80.4 m-85 -113.92 126.51 55.24 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.719 -0.393 . . . . 0.0 110.187 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.541 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -48.88 -39.05 24.4 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 178.243 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 232' ' ' GLU . . . . . 0.473 ' O ' ' HG3' ' A' ' 182' ' ' LYS . 35.9 mm-40 -98.63 169.46 9.49 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 113.528 -1.669 . . . . 0.0 109.381 178.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 233' ' ' GLU . . . . . 0.552 ' HB3' ' CD ' ' A' ' 182' ' ' LYS . 1.4 pm0 -108.67 17.75 21.6 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.557 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.3 OUTLIER -83.73 -61.58 0.3 Allowed Pre-proline 0 C--N 1.33 -0.25 0 C-N-CA 120.059 -0.657 . . . . 0.0 110.847 179.918 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.885 ' O ' HD12 ' A' ' 239' ' ' ILE . 96.7 Cg_exo -49.18 -30.87 20.15 Favored 'Trans proline' 0 CA--C 1.498 -1.306 0 N-CA-C 108.982 -1.199 . . . . 0.0 108.982 177.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 1.086 HG21 ' HB2' ' A' ' 182' ' ' LYS . 15.7 t -72.25 -45.31 61.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 113.884 -1.507 . . . . 0.0 109.95 178.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.557 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 33.5 pttt -63.35 -35.86 81.78 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.921 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.515 ' HA ' ' HG3' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -81.01 -49.72 10.57 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.093 0.473 . . . . 0.0 110.729 179.293 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.885 HD12 ' O ' ' A' ' 235' ' ' PRO . 1.5 mt -46.67 -45.19 7.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.65 -0.704 . . . . 0.0 112.066 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 240' ' ' MET . . . . . 0.441 ' HG2' ' HB ' ' A' ' 256' ' ' VAL . 2.2 mtp -66.47 -20.03 65.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.766 -178.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.515 ' HG3' ' HA ' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -88.78 -27.32 21.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.909 0.385 . . . . 0.0 110.555 -179.883 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.536 ' N ' ' HD2' ' A' ' 242' ' ' LYS . 2.4 mmmm -80.36 106.8 12.65 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.316 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.414 ' C ' ' O ' ' A' ' 242' ' ' LYS . 0.0 OUTLIER -36.31 -62.37 0.45 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.221 -179.491 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.522 ' CE1' ' CG ' ' A' ' 253' ' ' GLU . 73.9 m-85 -125.57 170.13 11.78 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.633 -179.36 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 245' ' ' HIS . . . . . 0.796 ' CG ' HD12 ' A' ' 254' ' ' ILE . 37.4 m-70 -130.16 156.98 43.68 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.288 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -134.66 104.8 6.19 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.215 0.531 . . . . 0.0 110.059 178.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.635 HG12 ' H ' ' A' ' 248' ' ' GLY . 1.5 t -95.68 -179.63 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.992 -179.346 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 248' ' ' GLY . . . . . 0.635 ' H ' HG12 ' A' ' 247' ' ' VAL . . . -24.67 -58.06 0.05 OUTLIER Glycine 0 C--N 1.337 0.594 0 C-N-CA 121.377 -0.439 . . . . 0.0 112.991 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.37 -40.72 1.94 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.273 0.559 . . . . 0.0 111.063 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.555 ' HB3' ' HB3' ' A' ' 190' ' ' SER . 61.5 p -78.77 147.79 33.21 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.12 -0.945 . . . . 0.0 113.082 -178.148 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.1 OUTLIER -136.54 104.01 5.43 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 177.454 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 252' ' ' CYS . . . . . 0.684 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -128.49 153.89 46.68 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -175.684 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 253' ' ' GLU . . . . . 0.522 ' CG ' ' CE1' ' A' ' 244' ' ' TYR . 51.1 tt0 -76.01 109.54 9.73 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.27 179.311 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.796 HD12 ' CG ' ' A' ' 245' ' ' HIS . 21.7 mt -97.36 112.15 28.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -178.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.509 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -117.02 131.74 56.87 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 177.016 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.692 HG23 ' O ' ' A' ' 183' ' ' LYS . 4.0 p -33.38 123.52 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.485 0 CA-C-O 122.307 1.051 . . . . 0.0 111.225 -177.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 1.121 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -76.11 154.29 35.65 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 113.28 -1.782 . . . . 0.0 111.915 -178.447 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.44 112.23 15.37 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.012 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.507 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.432 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 2' ' ' ' DT' . . . . . 0.607 ' O2 ' " H2'" ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.428 -0.73 0 O4'-C1'-C2' 106.856 0.687 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 3' ' ' ' DA' . . . . . 0.892 " H4'" " O5'" ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.426 -0.903 0 C5'-C4'-O4' 108.429 -0.607 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 4' ' ' ' DG' . . . . . 0.892 " O5'" " H4'" ' B' ' 3' ' ' ' DA' . . . . . . . . 0 O5'--C5' 1.426 -0.877 0 C4'-C3'-C2' 102.032 -1.168 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 5' ' ' ' DG' . . . . . 0.728 ' N7 ' ' C5 ' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.428 -0.768 0 O4'-C1'-C2' 106.964 0.786 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.483 ' CG1' ' N ' ' A' ' 182' ' ' LYS . 47.7 t . . . . . 0 CA--C 1.503 -0.848 0 CA-C-O 121.229 0.538 . . . . 0.0 111.305 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.653 ' CB ' HG21 ' A' ' 236' ' ' VAL . 0.0 OUTLIER -151.38 112.31 4.27 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.481 177.463 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.851 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -132.35 152.01 51.61 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.607 179.228 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.792 HD13 ' HE1' ' A' ' 230' ' ' PHE . 0.2 OUTLIER -130.31 120.29 48.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.224 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.833 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -92.67 109.53 20.95 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 121.576 0.703 . . . . 0.0 109.814 -179.544 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.797 HG12 ' HB2' ' A' ' 252' ' ' CYS . 24.0 t -85.68 126.6 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.244 -179.199 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.544 ' O ' ' HB3' ' A' ' 252' ' ' CYS . . . -114.36 129.48 8.74 Favored Glycine 0 N--CA 1.453 -0.225 0 N-CA-C 115.014 0.766 . . . . 0.0 115.014 -177.016 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.556 ' HA3' ' H71' ' B' ' 2' ' ' ' DT' . . . 78.04 78.33 0.8 Allowed Glycine 0 C--N 1.331 0.264 0 C-N-CA 121.44 -0.409 . . . . 0.0 113.428 178.322 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.906 HD23 ' C ' ' A' ' 225' ' ' PHE . 0.6 OUTLIER -117.54 157.41 26.37 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 122.431 0.293 . . . . 0.0 110.726 -179.897 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.612 ' N ' HD12 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -46.7 -175.17 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.249 0 CA-C-O 121.102 0.477 . . . . 0.0 111.428 179.761 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.588 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 11.8 Cg_exo -70.83 -1.7 9.77 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 123.149 2.566 . . . . 0.0 113.707 -179.046 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.523 ' HB2' ' O ' ' A' ' 191' ' ' PRO . 25.9 t70 169.58 74.21 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.982 0.42 . . . . 0.0 111.24 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.854 ' OG1' HD13 ' A' ' 189' ' ' LEU . 55.1 m -66.3 114.58 17.6 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.939 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.583 ' O ' HD11 ' A' ' 198' ' ' ILE . 12.6 Cg_endo -56.72 115.41 2.46 Favored 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 122.478 2.119 . . . . 0.0 111.467 179.25 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.813 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.1 OUTLIER -53.11 -15.13 0.76 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.343 -179.641 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 196' ' ' GLU . . . . . 0.493 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 3.6 mt-10 -68.61 -38.96 81.0 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.552 ' HG2' ' HG2' ' A' ' 194' ' ' PRO . 19.0 mmmt -73.18 -48.93 31.1 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.406 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.843 ' CD1' HG22 ' A' ' 193' ' ' THR . 0.0 OUTLIER -48.49 -30.8 3.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.222 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.583 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 2.3 mtt180 -70.56 -32.52 69.97 Favored 'General case' 0 C--O 1.221 -0.447 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.662 178.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' GLU . . . . . 0.577 ' CG ' ' N ' ' A' ' 201' ' ' TYR . 4.2 pt-20 -83.03 -56.38 3.83 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.664 179.148 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.577 ' N ' ' CG ' ' A' ' 200' ' ' GLU . 0.4 OUTLIER -50.31 -53.93 25.15 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.62 0.724 . . . . 0.0 109.791 179.049 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 1.148 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.4 OUTLIER -79.43 -29.77 42.02 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.875 -179.915 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.583 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -62.72 -57.99 13.98 Favored Glycine 0 CA--C 1.499 -0.946 0 N-CA-C 107.044 -2.422 . . . . 0.0 107.044 176.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -48.81 -29.21 7.83 Favored Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 176.036 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.828 ' CD2' HD11 ' A' ' 239' ' ' ILE . 0.0 OUTLIER -58.36 -42.3 86.65 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.017 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.501 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 168.1 -131.1 2.23 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 113.733 -1.576 . . . . 0.0 110.212 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.529 ' HG3' ' CG ' ' A' ' 232' ' ' GLU . 1.3 mm-40 -96.8 100.64 12.17 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.239 0.542 . . . . 0.0 111.074 178.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.572 HG21 ' HB2' ' A' ' 202' ' ' PHE . 2.7 t -79.36 138.86 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 CA-C-N 115.336 -0.847 . . . . 0.0 108.813 178.229 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 209' ' ' GLU . . . . . 0.604 ' HB3' HG22 ' A' ' 229' ' ' THR . 3.0 tp10 -89.9 -56.94 3.04 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.766 178.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 3.5 m -166.39 150.86 7.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.278 0.561 . . . . 0.0 112.245 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 1.044 HD13 HG23 ' A' ' 228' ' ' ILE . 0.5 OUTLIER -119.04 123.36 71.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.561 178.638 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.487 ' O ' ' HD3' ' A' ' 214' ' ' PRO . 0.0 OUTLIER -122.73 103.19 8.49 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -178.834 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.527 HD23 ' CB ' ' A' ' 226' ' ' CYS . 0.0 OUTLIER -95.89 106.14 25.9 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.347 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.546 ' HD2' ' O ' ' A' ' 225' ' ' PHE . 13.0 Cg_exo -72.21 130.91 17.06 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 123.299 2.666 . . . . 0.0 113.282 -178.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 4.3 ptp -135.3 130.84 35.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.307 179.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.481 ' O ' ' HA ' ' A' ' 220' ' ' ASN . 0.5 OUTLIER -110.59 107.98 17.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.038 0.447 . . . . 0.0 111.24 -179.735 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -81.98 -8.7 59.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.045 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 4.4 mtpt -88.27 -51.68 5.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.454 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.427 ' O ' ' C ' ' A' ' 220' ' ' ASN . 0.0 OUTLIER -118.6 -9.98 10.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.278 -179.762 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 220' ' ' ASN . . . . . 0.481 ' HA ' ' O ' ' A' ' 216' ' ' ASP . 4.4 m120 37.35 59.01 1.22 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.652 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -57.26 -179.62 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.627 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.636 ' O ' ' CG ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -99.48 40.17 1.24 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 122.791 1.282 . . . . 0.0 110.139 -179.909 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.533 ' CB ' H5'' ' B' ' 3' ' ' ' DA' . 1.8 ptp85 -71.54 -31.59 67.19 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.059 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.498 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 11.94 63.7 0.01 OUTLIER Glycine 0 C--N 1.336 0.559 0 CA-C-N 114.292 -1.322 . . . . 0.0 113.245 178.423 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.906 ' C ' HD23 ' A' ' 189' ' ' LEU . 1.4 p90 -156.83 176.77 12.3 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 226' ' ' CYS . . . . . 0.527 ' CB ' HD23 ' A' ' 213' ' ' LEU . 30.5 p -145.78 156.38 43.55 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.505 -0.478 . . . . 0.0 112.255 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 1.12 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 5.4 m-85 -107.94 143.55 36.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.642 179.309 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 1.148 HD12 ' CE2' ' A' ' 202' ' ' PHE . 2.0 mt -137.13 128.34 41.26 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.401 0 CA-C-O 121.175 0.512 . . . . 0.0 111.495 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.604 HG22 ' HB3' ' A' ' 209' ' ' GLU . 54.9 m -110.88 138.15 47.63 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.834 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.792 ' HE1' HD13 ' A' ' 184' ' ' ILE . 67.9 m-85 -111.64 126.1 54.66 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.766 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.5 ' HG3' ' O ' ' A' ' 207' ' ' GLU . 0.1 OUTLIER -49.81 -38.52 34.95 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 177.711 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 232' ' ' GLU . . . . . 0.529 ' CG ' ' HG3' ' A' ' 207' ' ' GLU . 60.5 mm-40 -89.86 -167.8 1.95 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 113.154 -1.839 . . . . 0.0 109.274 178.543 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 233' ' ' GLU . . . . . 0.555 ' CB ' ' HG2' ' A' ' 182' ' ' LYS . 0.8 OUTLIER -131.32 -1.28 3.99 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -179.876 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.514 ' HB2' ' HD3' ' A' ' 235' ' ' PRO . 2.0 mt-10 -73.69 -58.14 2.32 Favored Pre-proline 0 C--N 1.329 -0.29 0 C-N-CA 120.433 -0.507 . . . . 0.0 112.141 -179.093 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.851 ' O ' HD12 ' A' ' 239' ' ' ILE . 79.8 Cg_exo -49.22 -31.07 20.96 Favored 'Trans proline' 0 CA--C 1.498 -1.303 0 N-CA-C 109.066 -1.167 . . . . 0.0 109.066 178.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.653 HG21 ' CB ' ' A' ' 182' ' ' LYS . 17.6 t -72.22 -44.07 64.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 114.019 -1.446 . . . . 0.0 109.189 178.255 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.497 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 2.1 mtpp -52.74 -47.95 67.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.396 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.666 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -80.61 -52.79 7.18 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.926 -179.268 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.851 HD12 ' O ' ' A' ' 235' ' ' PRO . 1.9 mt -38.49 -51.51 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.917 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 22.7 mtp -59.17 -26.78 65.08 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.052 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.529 ' HG3' ' CD ' ' A' ' 242' ' ' LYS . 0.2 OUTLIER -81.56 -27.91 34.13 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.676 179.89 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.529 ' CD ' ' HG3' ' A' ' 241' ' ' GLU . 0.6 OUTLIER -81.32 96.79 7.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.616 179.688 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.498 ' O ' ' HG3' ' A' ' 253' ' ' GLU . 0.0 OUTLIER -36.17 -55.0 0.8 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.867 -179.971 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.515 ' CE1' ' HG3' ' A' ' 253' ' ' GLU . 32.7 m-85 -126.26 158.4 35.82 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.299 0.571 . . . . 0.0 111.836 -179.127 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 245' ' ' HIS . . . . . 0.643 ' CG ' HD12 ' A' ' 254' ' ' ILE . 32.2 m-70 -127.85 157.46 40.42 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.531 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 246' ' ' ASN . . . . . 0.462 ' O ' ' CE2' ' A' ' 201' ' ' TYR . 5.6 m120 -127.82 104.69 7.97 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.211 0.529 . . . . 0.0 110.423 178.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.556 HG12 ' H ' ' A' ' 248' ' ' GLY . 1.4 t -95.31 174.92 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.253 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 248' ' ' GLY . . . . . 0.713 ' C ' HD23 ' A' ' 249' ' ' LEU . . . -14.66 -57.16 0.01 OUTLIER Glycine 0 C--N 1.34 0.759 0 O-C-N 123.662 0.601 . . . . 0.0 113.316 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.713 HD23 ' C ' ' A' ' 248' ' ' GLY . 0.0 OUTLIER -133.39 -39.8 0.91 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.959 -0.621 . . . . 0.0 110.939 -179.883 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.637 ' CB ' ' HG1' ' A' ' 193' ' ' THR . 6.0 p -78.24 152.2 32.7 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.159 -0.928 . . . . 0.0 113.192 -178.034 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -137.19 108.6 6.89 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.419 178.211 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 252' ' ' CYS . . . . . 0.797 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -128.63 153.73 46.97 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -176.357 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 253' ' ' GLU . . . . . 0.518 ' N ' ' O ' ' A' ' 187' ' ' GLY . 59.4 tt0 -76.08 108.11 8.75 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.832 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.651 HG21 ' CG2' ' A' ' 239' ' ' ILE . 13.2 mt -96.47 112.24 28.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 -178.237 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.514 ' O ' ' C ' ' A' ' 256' ' ' VAL . 0.0 OUTLIER -116.15 130.16 56.66 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 176.568 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 183' ' ' LYS . 3.6 p -32.78 123.54 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 122.136 0.969 . . . . 0.0 111.372 -177.529 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 1.12 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -76.67 153.71 34.92 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 113.522 -1.672 . . . . 0.0 111.716 -178.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.48 112.92 14.87 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.354 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 259' ' ' SER . . . . . 0.481 ' OG ' ' O6 ' ' B' ' 4' ' ' ' DG' . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.518 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.08 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 2' ' ' ' DT' . . . . . 0.816 ' O2 ' H5'' ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.427 -0.797 0 O4'-C1'-C2' 107.192 0.992 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 3' ' ' ' DA' . . . . . 0.893 " H4'" " O5'" ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.426 -0.854 0 C5'-C4'-O4' 108.251 -0.718 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 4' ' ' ' DG' . . . . . 0.893 " O5'" " H4'" ' B' ' 3' ' ' ' DA' . . . . . . . . 0 O5'--C5' 1.425 -0.908 0 C4'-C3'-C2' 101.493 -1.707 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 5' ' ' ' DG' . . . . . 0.737 ' C8 ' " H1'" ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.429 -0.667 0 C4'-C3'-C2' 102.571 -0.629 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.511 ' CG1' ' N ' ' A' ' 182' ' ' LYS . 42.8 t . . . . . 0 CA--C 1.504 -0.802 0 CA-C-O 121.181 0.515 . . . . 0.0 111.615 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.641 ' CB ' HG21 ' A' ' 236' ' ' VAL . 0.7 OUTLIER -149.99 112.67 4.76 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.488 177.731 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.818 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -134.15 142.57 47.51 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.747 179.838 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.789 HD12 HG21 ' A' ' 239' ' ' ILE . 0.2 OUTLIER -122.59 120.08 59.93 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.445 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.868 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.3 OUTLIER -91.73 109.44 20.76 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.68 0.752 . . . . 0.0 110.054 -179.135 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.706 HG22 HG12 ' A' ' 254' ' ' ILE . 48.7 t -85.53 126.43 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 CA-C-N 114.689 -1.141 . . . . 0.0 109.373 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.572 ' O ' ' HB3' ' A' ' 252' ' ' CYS . . . -112.99 134.8 12.18 Favored Glycine 0 C--N 1.331 0.288 0 N-CA-C 115.276 0.87 . . . . 0.0 115.276 -176.542 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.594 ' HA3' ' C5 ' ' B' ' 2' ' ' ' DT' . . . 64.51 84.09 0.08 OUTLIER Glycine 0 C--N 1.333 0.396 0 CA-C-N 115.516 -0.342 . . . . 0.0 112.675 178.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 1.016 HD13 ' OG1' ' A' ' 193' ' ' THR . 1.1 pp -117.36 157.83 25.46 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.045 0.45 . . . . 0.0 112.039 -178.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.643 ' O ' HD12 ' A' ' 189' ' ' LEU . 0.3 OUTLIER -44.68 -173.91 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.227 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.965 179.815 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.588 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 6.4 Cg_exo -74.75 9.48 1.93 Allowed 'Trans proline' 0 CA--C 1.53 0.289 0 C-N-CA 123.125 2.55 . . . . 0.0 113.507 -179.173 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.54 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 1.1 m-20 158.2 78.24 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 120.842 0.353 . . . . 0.0 111.534 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 193' ' ' THR . . . . . 1.016 ' OG1' HD13 ' A' ' 189' ' ' LEU . 19.2 m -68.78 112.17 10.55 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.633 179.343 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.587 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 54.9 Cg_endo -67.3 107.04 1.31 Allowed 'Trans proline' 0 N--CA 1.465 -0.158 0 C-N-CA 122.668 2.245 . . . . 0.0 111.767 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.609 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -41.06 -21.51 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.32 -0.4 . . . . 0.0 112.016 -179.964 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 196' ' ' GLU . . . . . 0.462 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 11.0 mt-10 -59.37 -43.71 92.84 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -178.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.587 ' CD ' ' HG2' ' A' ' 194' ' ' PRO . 0.6 OUTLIER -79.15 -46.21 18.42 Favored 'General case' 0 CA--C 1.494 -1.208 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 178.68 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.833 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.2 OUTLIER -49.07 -29.58 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-N 114.191 -1.368 . . . . 0.0 108.396 176.86 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.553 ' HG3' ' O ' ' A' ' 195' ' ' GLU . 4.6 mtp85 -74.16 -32.56 63.17 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.845 178.044 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' GLU . . . . . 0.536 ' O ' ' N ' ' A' ' 204' ' ' GLY . 5.4 mt-10 -82.61 -59.13 2.62 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.57 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.493 ' C ' ' CD1' ' A' ' 201' ' ' TYR . 0.4 OUTLIER -47.96 -52.16 20.77 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.136 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 1.065 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.4 OUTLIER -79.7 -31.69 41.26 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.301 179.459 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.542 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -61.84 -58.07 14.61 Favored Glycine 0 N--CA 1.442 -0.906 0 N-CA-C 107.613 -2.195 . . . . 0.0 107.613 176.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -49.76 -27.91 10.28 Favored Glycine 0 N--CA 1.441 -1.003 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 176.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.761 ' CE2' HG13 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -57.76 -46.05 85.08 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 177.826 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.505 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 173.56 -132.28 2.27 Favored Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 113.639 -1.618 . . . . 0.0 110.25 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.509 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 3.1 mm-40 -97.19 99.84 11.32 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.134 0.492 . . . . 0.0 111.08 178.581 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 2.6 t -74.76 139.08 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' GLU . . . . . 0.55 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 60.0 tt0 -91.03 -56.03 3.32 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 178.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -161.88 153.96 19.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.861 179.447 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.567 HD12 ' HB ' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -122.97 123.95 69.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.488 178.725 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.509 ' OE1' ' N7 ' ' B' ' 4' ' ' ' DG' . 1.0 OUTLIER -123.57 104.75 9.23 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -177.371 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.614 HD21 ' HB ' ' A' ' 193' ' ' THR . 0.7 OUTLIER -95.69 106.69 28.89 Favored Pre-proline 0 CA--C 1.531 0.233 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 176.545 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.562 ' HD2' ' O ' ' A' ' 225' ' ' PHE . 5.1 Cg_endo -85.38 133.98 4.77 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 123.197 2.598 . . . . 0.0 113.885 -178.151 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.39 134.84 40.14 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.288 179.052 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.461 ' O ' ' HA ' ' A' ' 220' ' ' ASN . 0.2 OUTLIER -110.2 107.19 16.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.912 0.387 . . . . 0.0 111.174 -179.834 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -81.88 -6.48 59.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.608 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -88.7 -51.7 5.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.837 0.351 . . . . 0.0 111.432 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.77 -22.3 7.46 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.03 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 220' ' ' ASN . . . . . 0.461 ' HA ' ' O ' ' A' ' 216' ' ' ASP . 2.2 m-80 57.02 55.99 5.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.278 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.4 177.16 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.347 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.75 ' HG3' ' O ' ' A' ' 222' ' ' ARG . 0.7 OUTLIER -100.01 38.27 1.5 Allowed 'General case' 0 N--CA 1.439 -0.991 0 CA-C-O 122.458 1.123 . . . . 0.0 109.713 -179.762 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.623 ' HB2' ' CE1' ' A' ' 225' ' ' PHE . 6.6 ptp85 -70.98 -28.89 64.78 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 179.052 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.535 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 4.99 64.77 0.01 OUTLIER Glycine 0 C--N 1.342 0.887 0 O-C-N 124.446 1.091 . . . . 0.0 112.863 177.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.883 ' C ' HD23 ' A' ' 189' ' ' LEU . 0.2 OUTLIER -156.49 176.48 12.65 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.985 -0.608 . . . . 0.0 109.406 -178.311 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 226' ' ' CYS . . . . . 0.536 ' O ' ' HB ' ' A' ' 186' ' ' VAL . 0.5 OUTLIER -139.77 156.89 46.52 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.033 -0.667 . . . . 0.0 112.225 -179.339 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 1.099 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 4.7 m-85 -114.24 132.26 56.2 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.428 -0.806 . . . . 0.0 108.968 179.196 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 1.065 HD12 ' CE2' ' A' ' 202' ' ' PHE . 2.2 mt -126.13 124.8 66.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.16 0.505 . . . . 0.0 111.41 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.525 HG22 ' HB3' ' A' ' 209' ' ' GLU . 85.1 m -106.1 138.08 42.9 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.496 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.767 ' HE2' HD13 ' A' ' 184' ' ' ILE . 74.7 m-85 -113.05 126.47 55.52 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.377 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.55 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -49.28 -38.4 27.03 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 178.334 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 232' ' ' GLU . . . . . 0.458 ' HB3' ' OE2' ' A' ' 234' ' ' GLU . 49.1 mt-10 -91.49 -168.57 2.07 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 113.399 -1.728 . . . . 0.0 109.673 179.177 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 233' ' ' GLU . . . . . 0.515 ' CB ' ' HG2' ' A' ' 182' ' ' LYS . 0.6 OUTLIER -131.34 14.04 5.06 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.834 -0.347 . . . . 0.0 111.372 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.582 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.4 OUTLIER -84.55 -60.06 0.32 Allowed Pre-proline 0 C--N 1.33 -0.263 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.702 179.873 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.889 ' O ' HD12 ' A' ' 239' ' ' ILE . 87.1 Cg_exo -49.31 -32.59 26.21 Favored 'Trans proline' 0 CA--C 1.502 -1.103 0 N-CA-C 109.089 -1.158 . . . . 0.0 109.089 178.193 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.641 HG21 ' CB ' ' A' ' 182' ' ' LYS . 21.7 t -72.51 -43.44 63.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 113.938 -1.483 . . . . 0.0 110.429 179.006 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.582 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 1.8 ptpt -64.07 -36.18 83.17 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.789 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.517 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 0.0 OUTLIER -82.19 -50.15 9.33 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.9 0.381 . . . . 0.0 111.269 179.279 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.889 HD12 ' O ' ' A' ' 235' ' ' PRO . 1.5 mt -44.6 -48.77 2.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.252 -179.196 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 240' ' ' MET . . . . . 0.459 ' HG2' ' HB ' ' A' ' 256' ' ' VAL . 22.3 mtp -61.97 -26.51 68.26 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.944 -178.561 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.45 ' CG ' ' O ' ' A' ' 237' ' ' LYS . 1.1 mt-10 -86.99 -16.73 34.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.826 0.346 . . . . 0.0 111.248 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.487 ' HG2' ' HA ' ' A' ' 239' ' ' ILE . 2.9 mmmt -80.55 118.42 22.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.138 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.456 ' HG2' ' N ' ' A' ' 244' ' ' TYR . 13.8 ttpt -41.9 -81.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.18 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.481 ' CD1' ' HG3' ' A' ' 253' ' ' GLU . 12.1 m-85 -114.74 157.15 23.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.407 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 245' ' ' HIS . . . . . 0.767 ' CG ' HD12 ' A' ' 254' ' ' ILE . 24.2 m-70 -113.68 150.23 33.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.241 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 246' ' ' ASN . . . . . 0.417 ' O ' ' CE2' ' A' ' 201' ' ' TYR . 0.2 OUTLIER -127.85 105.35 8.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.859 179.704 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.533 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.7 t -110.35 110.22 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.985 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 45.61 -87.71 0.01 OUTLIER Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.407 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.533 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -106.49 -39.97 5.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.363 0.601 . . . . 0.0 110.546 179.639 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.473 ' OG ' ' HB2' ' A' ' 190' ' ' SER . 1.5 m -77.43 147.42 35.98 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.033 -178.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -143.97 106.24 4.39 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.463 179.162 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 252' ' ' CYS . . . . . 0.68 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -128.21 153.12 47.27 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -176.541 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 253' ' ' GLU . . . . . 0.481 ' HG3' ' CD1' ' A' ' 244' ' ' TYR . 50.1 tt0 -76.29 107.57 8.62 Favored 'General case' 0 C--O 1.224 -0.27 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.172 178.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.767 HD12 ' CG ' ' A' ' 245' ' ' HIS . 29.2 mt -96.39 113.3 30.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -177.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.515 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -117.25 133.09 56.4 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 176.677 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 183' ' ' LYS . 5.5 p -33.23 124.94 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-O 122.251 1.024 . . . . 0.0 111.304 -177.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 1.099 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -78.27 152.95 32.24 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 113.423 -1.717 . . . . 0.0 112.48 -178.13 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.73 113.85 15.86 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.511 -1.222 . . . . 0.0 110.081 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 259' ' ' SER . . . . . 0.48 ' HB3' ' O6 ' ' B' ' 4' ' ' ' DG' . 83.6 p . . . . . 0 C--N 1.323 -0.586 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.859 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 2' ' ' ' DT' . . . . . 0.878 ' O2 ' " H2'" ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.427 -0.813 0 C4'-C3'-C2' 102.475 -0.725 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 3' ' ' ' DA' . . . . . 0.699 ' C2 ' ' CD2' ' A' ' 185' ' ' PHE . . . . . . . . 0 O5'--C5' 1.425 -0.947 0 C3'-C2'-C1' 99.718 -2.13 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 4' ' ' ' DG' . . . . . 0.709 ' C2 ' ' CE1' ' A' ' 227' ' ' PHE . . . . . . . . 0 O5'--C5' 1.427 -0.834 0 C4'-C3'-C2' 102.045 -1.155 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 5' ' ' ' DG' . . . . . 0.64 ' N7 ' ' C5 ' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.427 -0.801 0 O4'-C1'-C2' 106.799 0.635 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.485 ' O ' ' HD3' ' A' ' 182' ' ' LYS . 43.5 t . . . . . 0 CA--C 1.505 -0.765 0 CA-C-O 121.362 0.601 . . . . 0.0 112.328 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.549 ' CB ' HG21 ' A' ' 236' ' ' VAL . 8.0 mmtt -145.76 112.38 5.91 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.243 176.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.883 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.0 OUTLIER -130.62 162.45 29.33 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.965 179.775 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.846 HD11 ' HE2' ' A' ' 202' ' ' PHE . 0.3 OUTLIER -138.55 119.74 16.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 177.532 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.854 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -92.52 109.49 20.89 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.587 0.708 . . . . 0.0 110.195 -178.914 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.707 HG12 ' HB2' ' A' ' 252' ' ' CYS . 40.6 t -84.29 128.07 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.894 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.553 ' O ' ' HB3' ' A' ' 252' ' ' CYS . . . -116.5 132.76 10.32 Favored Glycine 0 N--CA 1.451 -0.319 0 N-CA-C 115.053 0.781 . . . . 0.0 115.053 -176.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.621 ' HA3' ' H71' ' B' ' 2' ' ' ' DT' . . . 71.39 80.11 0.36 Allowed Glycine 0 N--CA 1.452 -0.292 0 CA-C-N 115.442 -0.379 . . . . 0.0 113.397 178.171 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.934 HD13 ' OG1' ' A' ' 193' ' ' THR . 0.8 OUTLIER -117.26 157.57 25.82 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.701 0.286 . . . . 0.0 110.958 -179.796 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.593 ' CB ' ' CD ' ' A' ' 191' ' ' PRO . 0.2 OUTLIER -47.71 -173.66 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.934 179.585 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.593 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 5.7 Cg_exo -78.36 17.09 1.12 Allowed 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.956 2.437 . . . . 0.0 113.272 -179.373 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.538 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 1.2 m-20 159.73 76.89 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.117 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.635 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.934 ' OG1' HD13 ' A' ' 189' ' ' LEU . 50.1 m -71.45 114.55 28.94 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 120.855 0.36 . . . . 0.0 110.432 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.541 ' C ' HD11 ' A' ' 198' ' ' ILE . 16.3 Cg_endo -58.52 110.05 0.6 Allowed 'Trans proline' 0 N--CA 1.464 -0.243 0 C-N-CA 122.369 2.046 . . . . 0.0 111.748 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.803 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -50.9 -15.69 0.33 Allowed 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.143 -179.875 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 196' ' ' GLU . . . . . 0.482 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 23.1 mm-40 -71.94 -36.89 70.03 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' A' ' 200' ' ' GLU . 0.0 OUTLIER -73.92 -48.01 33.72 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.186 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.854 ' CD1' HG22 ' A' ' 193' ' ' THR . 0.0 OUTLIER -47.68 -30.73 2.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.225 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.603 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 6.5 mtt180 -71.72 -32.4 67.73 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.189 179.012 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' GLU . . . . . 0.53 ' N ' ' O ' ' A' ' 197' ' ' LYS . 0.4 OUTLIER -82.83 -46.19 13.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.023 0.44 . . . . 0.0 110.646 179.292 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.509 ' C ' ' CD1' ' A' ' 201' ' ' TYR . 0.5 OUTLIER -63.04 -53.55 52.11 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.004 179.407 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 1.122 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -79.88 -31.41 40.33 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 114.845 -1.07 . . . . 0.0 110.339 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.603 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -64.85 -54.36 28.7 Favored Glycine 0 CA--C 1.497 -1.071 0 N-CA-C 106.535 -2.626 . . . . 0.0 106.535 176.318 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -50.23 -29.3 15.54 Favored Glycine 0 N--CA 1.442 -0.928 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 175.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.811 ' CD2' HD11 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -58.34 -44.76 88.86 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 177.783 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 170.55 -129.89 1.89 Allowed Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 113.717 -1.583 . . . . 0.0 110.616 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.474 ' HB3' ' HE2' ' A' ' 231' ' ' LYS . 2.9 mm-40 -97.01 99.69 11.21 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.289 0.566 . . . . 0.0 111.321 178.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.413 HG22 ' CE1' ' A' ' 230' ' ' PHE . 2.6 t -77.5 143.39 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 CA-C-N 115.324 -0.853 . . . . 0.0 108.845 178.318 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 209' ' ' GLU . . . . . 0.525 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 5.8 tp10 -93.7 -56.78 2.78 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 4.4 m -166.94 149.92 6.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.959 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.903 HD13 HG23 ' A' ' 228' ' ' ILE . 0.4 OUTLIER -117.19 126.37 74.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.664 178.922 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -123.09 103.07 8.34 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -178.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.574 HD21 ' HB ' ' A' ' 193' ' ' THR . 0.1 OUTLIER -96.3 105.53 22.93 Favored Pre-proline 0 C--N 1.33 -0.241 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 177.917 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.52 ' HD2' ' O ' ' A' ' 225' ' ' PHE . 73.0 Cg_endo -75.31 127.44 10.47 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.75 2.3 . . . . 0.0 112.813 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.25 131.21 36.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.972 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.421 ' O ' ' OD1' ' A' ' 220' ' ' ASN . 0.3 OUTLIER -114.78 106.9 14.74 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.942 0.401 . . . . 0.0 110.945 179.931 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -82.02 -10.76 59.13 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.519 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.34 -50.89 9.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.867 0.365 . . . . 0.0 111.28 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.89 -30.17 5.12 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.171 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 220' ' ' ASN . . . . . 0.421 ' OD1' ' O ' ' A' ' 216' ' ' ASP . 39.6 m-20 62.47 71.72 0.52 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.956 0.407 . . . . 0.0 110.52 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.66 176.56 1.9 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.217 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.625 ' CD ' ' O ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -94.16 27.34 2.9 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 122.432 1.11 . . . . 0.0 110.104 179.993 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.572 ' O ' ' CD1' ' A' ' 225' ' ' PHE . 4.2 ptp85 -70.99 -28.47 64.45 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.364 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.528 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . -1.08 68.89 0.0 OUTLIER Glycine 0 C--N 1.343 0.93 0 O-C-N 124.611 1.194 . . . . 0.0 112.701 178.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.911 ' C ' HD23 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -156.79 176.7 12.39 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -178.339 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 226' ' ' CYS . . . . . 0.516 ' O ' ' HB ' ' A' ' 186' ' ' VAL . 1.3 p -139.48 156.32 47.01 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.016 -0.674 . . . . 0.0 112.544 -179.303 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 1.072 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 3.8 m-85 -113.95 133.44 55.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.495 -0.775 . . . . 0.0 108.965 178.438 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 1.122 HD12 ' CE2' ' A' ' 202' ' ' PHE . 2.0 mt -128.55 133.26 66.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.142 0.496 . . . . 0.0 111.475 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.457 HG22 ' HB3' ' A' ' 209' ' ' GLU . 97.7 m -113.03 138.05 50.48 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.155 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.817 ' HE2' HD13 ' A' ' 184' ' ' ILE . 67.9 m-85 -112.8 126.44 55.43 Favored 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.053 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.525 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -50.52 -37.83 41.25 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 177.737 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -90.1 -165.86 1.45 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 113.152 -1.84 . . . . 0.0 109.691 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' GLU . . . . . 0.528 ' HB2' ' HD2' ' A' ' 182' ' ' LYS . 0.4 OUTLIER -134.64 8.53 3.6 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.667 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.548 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.3 OUTLIER -82.14 -59.92 0.41 Allowed Pre-proline 0 C--N 1.328 -0.369 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.755 179.939 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.911 ' O ' HD12 ' A' ' 239' ' ' ILE . 80.2 Cg_exo -49.48 -30.91 22.27 Favored 'Trans proline' 0 CA--C 1.499 -1.27 0 N-CA-C 108.986 -1.198 . . . . 0.0 108.986 178.488 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.549 HG21 ' CB ' ' A' ' 182' ' ' LYS . 21.1 t -73.92 -45.69 48.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 114.473 -1.239 . . . . 0.0 110.272 178.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.548 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 1.2 ptpt -61.74 -36.23 80.38 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.606 -179.424 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.645 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -82.29 -54.89 4.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.172 178.918 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.911 HD12 ' O ' ' A' ' 235' ' ' PRO . 1.7 mt -40.33 -50.69 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.951 -179.132 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 240' ' ' MET . . . . . 0.472 ' HG2' ' HB ' ' A' ' 256' ' ' VAL . 17.3 mtp -60.06 -24.68 64.76 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.787 -178.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.487 ' CG ' ' O ' ' A' ' 237' ' ' LYS . 1.0 OUTLIER -87.91 -17.08 32.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.798 0.333 . . . . 0.0 111.261 -179.715 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.505 ' HG2' ' HA ' ' A' ' 239' ' ' ILE . 0.1 OUTLIER -79.68 123.77 27.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.352 -179.742 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.456 ' HE3' ' HB2' ' A' ' 244' ' ' TYR . 7.7 ttpt -50.38 -75.53 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 178.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.526 ' CD1' ' HG3' ' A' ' 253' ' ' GLU . 17.3 m-85 -121.02 144.81 48.33 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.932 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 245' ' ' HIS . . . . . 0.866 ' CG ' HD12 ' A' ' 254' ' ' ILE . 30.1 m-70 -104.55 150.63 24.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.096 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 246' ' ' ASN . . . . . 0.457 ' HB3' ' HD2' ' A' ' 251' ' ' LYS . 0.1 OUTLIER -129.58 104.68 7.59 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.221 0.534 . . . . 0.0 110.493 179.164 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.556 ' O ' ' C ' ' A' ' 248' ' ' GLY . 1.7 t -95.29 170.24 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.737 -179.481 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 248' ' ' GLY . . . . . 0.556 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . -8.3 -64.66 0.01 OUTLIER Glycine 0 C--N 1.341 0.825 0 O-C-N 123.669 0.606 . . . . 0.0 113.797 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.467 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -126.0 -39.82 2.07 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.509 0.671 . . . . 0.0 110.501 -179.282 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.663 ' CB ' ' HG1' ' A' ' 193' ' ' THR . 0.2 OUTLIER -77.3 157.33 30.79 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.745 -1.116 . . . . 0.0 112.734 -178.197 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -142.42 107.97 5.07 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.182 179.27 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 252' ' ' CYS . . . . . 0.707 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -128.67 152.96 47.79 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -177.255 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 253' ' ' GLU . . . . . 0.529 ' N ' ' O ' ' A' ' 187' ' ' GLY . 49.3 tt0 -76.61 108.48 9.64 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.581 179.056 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.866 HD12 ' CG ' ' A' ' 245' ' ' HIS . 30.6 mt -96.8 113.44 31.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 -178.261 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.518 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -115.94 133.25 56.22 Favored 'General case' 0 C--O 1.22 -0.448 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 176.508 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.633 HG23 ' O ' ' A' ' 183' ' ' LYS . 2.4 p -33.2 124.51 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-O 122.096 0.95 . . . . 0.0 111.324 -177.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 1.072 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -79.56 151.18 30.82 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 113.633 -1.621 . . . . 0.0 112.37 -178.406 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.62 115.85 19.41 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.089 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 29.7 p . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.057 -179.676 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 2' ' ' ' DT' . . . . . 0.637 ' O2 ' " H2'" ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.427 -0.803 0 O4'-C1'-C2' 106.874 0.703 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 3' ' ' ' DA' . . . . . 0.588 H5'' ' CE1' ' A' ' 225' ' ' PHE . . . . . . . . 0 O4'--C1' 1.407 -1.021 0 C4'-C3'-C2' 104.755 1.555 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 4' ' ' ' DG' . . . . . 0.958 H2'' " O5'" ' B' ' 5' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.428 -0.772 0 C4'-C3'-C2' 101.929 -1.271 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 5' ' ' ' DG' . . . . . 0.958 " O5'" H2'' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.427 -0.797 0 O4'-C1'-C2' 106.804 0.64 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.507 ' C ' ' CD ' ' A' ' 182' ' ' LYS . 45.3 t . . . . . 0 CA--C 1.503 -0.855 0 CA-C-O 121.044 0.449 . . . . 0.0 111.204 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 1.028 ' HB2' HG21 ' A' ' 236' ' ' VAL . 0.0 OUTLIER -151.14 112.34 4.34 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.103 177.66 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.817 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.0 OUTLIER -135.64 142.6 45.21 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.978 178.863 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.891 HD13 ' HE2' ' A' ' 230' ' ' PHE . 0.4 OUTLIER -122.04 120.91 62.7 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.183 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.787 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -94.14 109.34 21.13 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 121.553 0.692 . . . . 0.0 110.23 -179.195 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.992 HG12 ' HB2' ' A' ' 252' ' ' CYS . 4.9 t -85.03 128.86 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.802 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.564 ' HA2' ' HB2' ' A' ' 225' ' ' PHE . . . -115.6 127.87 7.78 Favored Glycine 0 C--N 1.332 0.316 0 N-CA-C 115.124 0.809 . . . . 0.0 115.124 -176.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.476 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . 76.26 82.04 0.53 Allowed Glycine 0 C--N 1.332 0.312 0 C-N-CA 121.354 -0.45 . . . . 0.0 113.419 178.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.949 HD13 ' OG1' ' A' ' 193' ' ' THR . 1.2 pp -117.43 157.18 26.67 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.778 0.323 . . . . 0.0 111.168 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.653 ' O ' HD12 ' A' ' 189' ' ' LEU . 0.2 OUTLIER -46.67 -177.45 0.01 OUTLIER Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.256 0.551 . . . . 0.0 111.592 -179.927 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.574 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 19.6 Cg_exo -67.31 -2.73 8.68 Favored 'Trans proline' 0 CA--C 1.53 0.291 0 C-N-CA 123.395 2.73 . . . . 0.0 113.908 -179.052 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 191' ' ' PRO . 0.8 OUTLIER 171.76 73.0 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.905 0.383 . . . . 0.0 111.667 -179.811 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.949 ' OG1' HD13 ' A' ' 189' ' ' LEU . 93.7 m -61.52 122.32 70.03 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.998 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.497 ' O ' HD11 ' A' ' 198' ' ' ILE . 55.7 Cg_endo -70.09 114.62 3.82 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.157 1.905 . . . . 0.0 111.103 178.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.817 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -51.61 -15.16 0.41 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 121.056 -0.257 . . . . 0.0 111.265 -179.439 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 196' ' ' GLU . . . . . 0.509 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 4.9 mt-10 -67.91 -40.42 83.41 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.521 ' O ' ' N ' ' A' ' 200' ' ' GLU . 0.4 OUTLIER -70.71 -50.95 30.92 Favored 'General case' 0 CA--C 1.5 -0.98 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.222 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.824 ' HB ' HD12 ' A' ' 211' ' ' ILE . 0.0 OUTLIER -47.59 -32.43 2.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 115.297 -0.865 . . . . 0.0 108.751 178.717 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.572 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 16.7 mtt85 -69.92 -33.4 72.12 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.975 178.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 200' ' ' GLU . . . . . 0.521 ' N ' ' O ' ' A' ' 197' ' ' LYS . 8.5 mm-40 -81.87 -60.13 2.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.278 0.561 . . . . 0.0 109.928 179.126 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.495 ' C ' ' CD1' ' A' ' 201' ' ' TYR . 0.3 OUTLIER -49.31 -54.19 18.29 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.025 178.932 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 1.104 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.2 OUTLIER -79.74 -31.5 41.04 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.991 -179.589 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.572 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -63.77 -56.47 18.81 Favored Glycine 0 CA--C 1.499 -0.95 0 N-CA-C 107.037 -2.425 . . . . 0.0 107.037 176.48 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -49.4 -28.44 9.47 Favored Glycine 0 N--CA 1.442 -0.937 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 176.237 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.771 ' CE2' HG13 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -57.19 -48.56 78.45 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 177.769 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 175.62 -130.15 1.67 Allowed Glycine 0 N--CA 1.44 -1.078 0 CA-C-N 113.65 -1.614 . . . . 0.0 110.31 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.505 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 20.7 mm-40 -96.96 100.96 12.45 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.144 0.497 . . . . 0.0 110.861 178.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.461 HG22 ' CE1' ' A' ' 230' ' ' PHE . 2.8 t -77.93 141.37 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.238 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 209' ' ' GLU . . . . . 0.588 ' HB3' HG22 ' A' ' 229' ' ' THR . 5.8 tp10 -91.9 -55.7 3.36 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.599 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 8.0 m -167.69 148.78 5.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.874 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.882 HD13 HG23 ' A' ' 228' ' ' ILE . 0.4 OUTLIER -115.72 125.67 72.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.882 178.931 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.519 ' O ' ' HD3' ' A' ' 214' ' ' PRO . 0.0 OUTLIER -123.28 105.01 9.49 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.334 -178.753 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.47 HD22 ' HB ' ' A' ' 193' ' ' THR . 0.1 OUTLIER -96.39 105.41 22.33 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-O 120.841 0.353 . . . . 0.0 110.822 178.55 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.578 ' HD2' ' O ' ' A' ' 225' ' ' PHE . 84.4 Cg_exo -49.72 -156.59 0.0 OUTLIER 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 123.444 2.762 . . . . 0.0 113.977 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.428 ' HB3' ' HB2' ' A' ' 220' ' ' ASN . 15.4 mmt -96.91 173.61 7.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.237 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.403 ' O ' ' N ' ' A' ' 220' ' ' ASN . 0.4 OUTLIER -112.01 149.98 31.26 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.341 -179.701 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 217' ' ' ASN . . . . . 0.578 ' N ' ' O ' ' A' ' 221' ' ' LYS . 13.6 t30 -56.97 -16.24 6.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.145 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.17 -27.08 69.12 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.155 0.502 . . . . 0.0 110.048 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 9.9 t -145.29 11.24 1.31 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.958 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' ASN . . . . . 0.49 ' HB3' ' NH1' ' A' ' 223' ' ' ARG . 3.6 m120 -148.8 -87.82 0.08 Allowed 'General case' 0 C--O 1.231 0.112 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 221' ' ' LYS . . . . . 0.578 ' O ' ' N ' ' A' ' 217' ' ' ASN . 34.7 mtpt -153.64 175.33 13.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.713 0.292 . . . . 0.0 111.299 -179.055 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.636 ' O ' ' CG ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -88.13 41.94 1.03 Allowed 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 122.928 1.347 . . . . 0.0 109.678 179.461 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.619 ' HB2' ' CE1' ' A' ' 225' ' ' PHE . 3.7 ptp85 -71.51 -31.12 66.73 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.335 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.491 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 16.57 61.26 0.01 OUTLIER Glycine 0 C--N 1.335 0.504 0 CA-C-N 114.43 -1.259 . . . . 0.0 112.922 178.301 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.88 ' C ' HD23 ' A' ' 189' ' ' LEU . 1.5 p90 -156.79 176.47 12.69 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 226' ' ' CYS . . . . . 0.469 ' O ' ' HB ' ' A' ' 186' ' ' VAL . 27.7 p -146.0 152.22 39.02 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.393 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 1.11 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 6.1 m-85 -106.21 139.43 40.74 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.082 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 1.104 HD12 ' CE2' ' A' ' 202' ' ' PHE . 2.0 mt -133.58 129.84 56.01 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.386 0 CA-C-O 120.879 0.371 . . . . 0.0 110.985 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.588 HG22 ' HB3' ' A' ' 209' ' ' GLU . 53.5 m -111.17 138.22 47.88 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.897 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.891 ' HE2' HD13 ' A' ' 184' ' ' ILE . 81.4 m-85 -114.51 126.44 54.94 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.445 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.505 ' HG3' ' O ' ' A' ' 207' ' ' GLU . 0.0 OUTLIER -47.77 -39.63 18.49 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 178.134 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 232' ' ' GLU . . . . . 0.479 ' O ' ' HG3' ' A' ' 182' ' ' LYS . 5.9 mm-40 -99.29 171.29 8.08 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 113.452 -1.704 . . . . 0.0 109.684 179.078 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 233' ' ' GLU . . . . . 0.44 ' HB3' ' CE ' ' A' ' 182' ' ' LYS . 0.0 OUTLIER -110.21 21.07 17.17 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.307 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.562 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.0 OUTLIER -85.18 -62.16 0.26 Allowed Pre-proline 0 C--N 1.331 -0.221 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.699 179.619 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.916 ' O ' HD12 ' A' ' 239' ' ' ILE . 87.3 Cg_exo -50.37 -29.69 24.54 Favored 'Trans proline' 0 CA--C 1.502 -1.101 0 N-CA-C 108.811 -1.265 . . . . 0.0 108.811 177.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 1.028 HG21 ' HB2' ' A' ' 182' ' ' LYS . 20.9 t -72.66 -42.96 62.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 113.768 -1.56 . . . . 0.0 110.324 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.562 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 9.3 pttp -64.26 -36.41 84.0 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.738 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.541 ' O ' ' CG ' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -81.43 -50.37 9.52 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.16 0.505 . . . . 0.0 110.92 179.183 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.916 HD12 ' O ' ' A' ' 235' ' ' PRO . 1.6 mt -45.53 -53.04 2.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.847 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 240' ' ' MET . . . . . 0.582 ' SD ' HG12 ' A' ' 236' ' ' VAL . 11.5 mtp -60.46 -17.1 42.59 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.263 -178.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.541 ' CG ' ' O ' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -88.37 -26.29 22.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.893 0.377 . . . . 0.0 111.0 -179.813 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.516 ' CD ' ' HG3' ' A' ' 241' ' ' GLU . 5.3 mmmt -79.58 109.8 14.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.01 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.483 ' HD3' ' CD1' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -40.18 -62.42 0.75 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.34 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.549 ' CD1' ' HG3' ' A' ' 253' ' ' GLU . 12.9 m-30 -122.01 161.7 22.48 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.897 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 245' ' ' HIS . . . . . 0.78 ' CE1' HD12 ' A' ' 254' ' ' ILE . 20.5 m-70 -122.82 156.76 33.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.822 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 246' ' ' ASN . . . . . 0.416 ' O ' ' CE2' ' A' ' 201' ' ' TYR . 6.0 m120 -133.24 105.15 6.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.172 0.511 . . . . 0.0 110.581 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.55 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.5 t -108.52 138.71 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.556 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 248' ' ' GLY . . . . . 0.479 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . 26.65 -87.57 0.01 OUTLIER Glycine 0 C--N 1.337 0.619 0 C-N-CA 121.163 -0.541 . . . . 0.0 113.017 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.55 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.1 OUTLIER -108.87 -34.63 6.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.774 0.797 . . . . 0.0 109.845 -179.861 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.516 ' O ' ' N ' ' A' ' 247' ' ' VAL . 3.0 p -77.25 152.92 34.46 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.248 -1.342 . . . . 0.0 113.176 -177.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -143.31 104.66 4.29 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 114.739 -1.118 . . . . 0.0 108.361 178.464 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 252' ' ' CYS . . . . . 0.992 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -128.34 152.77 47.76 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -176.399 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 253' ' ' GLU . . . . . 0.549 ' HG3' ' CD1' ' A' ' 244' ' ' TYR . 50.7 tt0 -76.93 107.79 9.52 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.982 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.854 HG12 HG13 ' A' ' 186' ' ' VAL . 26.1 mt -96.46 112.84 29.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -178.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.53 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -115.02 130.98 57.06 Favored 'General case' 0 C--O 1.221 -0.41 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 176.418 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.675 HG23 ' O ' ' A' ' 183' ' ' LYS . 10.0 p -33.16 124.46 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 122.156 0.979 . . . . 0.0 111.475 -177.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 1.11 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -76.68 153.93 34.68 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 113.501 -1.681 . . . . 0.0 111.448 -178.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.1 111.82 13.9 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.046 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 259' ' ' SER . . . . . 0.457 ' HB2' ' HD2' ' A' ' 183' ' ' LYS . 0.2 OUTLIER . . . . . 0 C--N 1.325 -0.459 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.7 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 2' ' ' ' DT' . . . . . 0.548 " C5'" ' O2 ' ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.427 -0.843 0 O4'-C1'-C2' 107.344 1.131 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 3' ' ' ' DA' . . . . . 0.88 " H4'" " O5'" ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.426 -0.857 0 C5'-C4'-O4' 108.419 -0.613 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 4' ' ' ' DG' . . . . . 0.89 H2'' " O5'" ' B' ' 5' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.426 -0.878 0 C4'-C3'-C2' 101.949 -1.251 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 5' ' ' ' DG' . . . . . 0.89 " O5'" H2'' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.426 -0.847 0 O4'-C1'-C2' 107.089 0.899 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.501 ' CG1' ' N ' ' A' ' 182' ' ' LYS . 40.6 t . . . . . 0 CA--C 1.506 -0.745 0 CA-C-O 121.261 0.553 . . . . 0.0 111.77 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.685 ' CB ' HG21 ' A' ' 236' ' ' VAL . 0.2 OUTLIER -148.02 112.5 5.31 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.029 177.442 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.863 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -130.5 145.45 51.86 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.382 179.271 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.873 HD13 ' HE2' ' A' ' 230' ' ' PHE . 0.3 OUTLIER -125.35 120.43 57.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.113 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.844 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -93.86 109.22 20.93 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.475 -178.875 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.995 HG12 ' HB2' ' A' ' 252' ' ' CYS . 2.8 t -84.44 124.65 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.196 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.551 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . -112.07 126.69 7.73 Favored Glycine 0 N--CA 1.451 -0.337 0 N-CA-C 114.932 0.733 . . . . 0.0 114.932 -176.429 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.464 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . 76.69 84.05 0.47 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 121.418 -0.42 . . . . 0.0 113.286 178.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.951 HD23 ' C ' ' A' ' 225' ' ' PHE . 0.9 OUTLIER -117.07 157.01 26.58 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.657 0.265 . . . . 0.0 110.788 179.843 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.655 ' O ' HD12 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -46.72 -175.15 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.061 179.818 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.586 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 4.0 Cg_exo -79.79 17.76 1.24 Allowed 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 123.024 2.483 . . . . 0.0 112.949 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.494 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 1.0 OUTLIER 161.86 74.72 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.126 0 CA-C-O 120.621 0.248 . . . . 0.0 111.363 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.933 ' OG1' HD13 ' A' ' 189' ' ' LEU . 55.2 m -74.59 112.86 19.27 Favored Pre-proline 0 C--N 1.332 -0.169 0 CA-C-O 120.912 0.387 . . . . 0.0 110.919 179.508 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.548 ' HG2' ' CG ' ' A' ' 197' ' ' LYS . 26.6 Cg_endo -62.65 109.03 0.8 Allowed 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 122.3 2.0 . . . . 0.0 111.485 179.163 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.851 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -48.0 -15.4 0.06 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 111.849 0.314 . . . . 0.0 111.849 -179.658 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 196' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 6.8 mm-40 -65.98 -37.06 84.99 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.548 ' CG ' ' HG2' ' A' ' 194' ' ' PRO . 0.8 OUTLIER -75.54 -50.95 14.08 Favored 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.258 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.851 ' CG1' ' HA ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -46.63 -31.19 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.314 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.552 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 5.2 mtp85 -70.16 -35.31 73.92 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.523 178.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' GLU . . . . . 0.513 ' N ' ' O ' ' A' ' 197' ' ' LYS . 12.1 mm-40 -82.4 -58.63 2.84 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.275 0.559 . . . . 0.0 110.233 179.187 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.497 ' C ' ' CD1' ' A' ' 201' ' ' TYR . 0.4 OUTLIER -48.28 -53.45 17.21 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.677 179.144 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 1.136 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.2 OUTLIER -79.78 -31.17 40.82 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.177 179.688 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.552 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -60.2 -57.88 16.92 Favored Glycine 0 CA--C 1.499 -0.91 0 N-CA-C 107.221 -2.352 . . . . 0.0 107.221 176.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -50.15 -27.65 11.32 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 176.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.814 ' CD2' HD11 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -58.24 -44.13 88.14 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 122.158 0.98 . . . . 0.0 108.383 178.003 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 169.49 -130.5 2.06 Favored Glycine 0 N--CA 1.442 -0.926 0 CA-C-N 113.465 -1.698 . . . . 0.0 110.26 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.5 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 46.1 mm-40 -96.72 101.64 13.28 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.258 0.551 . . . . 0.0 110.973 178.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.424 HG21 ' HB2' ' A' ' 202' ' ' PHE . 3.0 t -79.45 136.77 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 CA-C-N 115.25 -0.886 . . . . 0.0 108.814 178.343 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 209' ' ' GLU . . . . . 0.65 ' HB3' HG22 ' A' ' 229' ' ' THR . 6.1 tp10 -88.45 -56.56 3.26 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.399 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 3.4 m -166.29 150.37 7.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.342 0.591 . . . . 0.0 112.436 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.904 HD13 HG23 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -118.38 126.45 75.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.466 178.593 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.476 ' O ' ' HD3' ' A' ' 214' ' ' PRO . 0.5 OUTLIER -123.24 102.86 8.18 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -178.905 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.508 HD23 ' HB3' ' A' ' 226' ' ' CYS . 0.0 OUTLIER -97.18 105.13 22.5 Favored Pre-proline 0 C--N 1.33 -0.257 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 177.809 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.568 ' HD2' ' O ' ' A' ' 225' ' ' PHE . 6.3 Cg_exo -76.88 139.93 20.02 Favored 'Trans proline' 0 N--CA 1.465 -0.193 0 C-N-CA 123.022 2.481 . . . . 0.0 112.884 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.82 130.73 40.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.229 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.467 ' OD2' ' HD3' ' A' ' 223' ' ' ARG . 0.7 OUTLIER -101.31 106.62 17.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.838 0.352 . . . . 0.0 111.132 -179.716 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -83.14 -21.31 33.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.366 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 7.4 mttm -66.02 -51.99 53.25 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.44 -179.203 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.448 ' O ' ' O ' ' A' ' 220' ' ' ASN . 11.9 t -150.24 14.88 0.8 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.199 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 220' ' ' ASN . . . . . 0.455 ' OD1' ' O ' ' A' ' 216' ' ' ASP . 2.5 m120 37.7 96.76 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.241 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 221' ' ' LYS . . . . . 0.514 ' HB3' ' HG2' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -78.13 174.22 11.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.415 179.407 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.6 ' CD ' ' O ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -88.47 16.48 6.43 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 122.197 0.998 . . . . 0.0 109.609 179.242 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.611 ' O ' ' CD1' ' A' ' 225' ' ' PHE . 0.1 OUTLIER -71.71 -11.02 60.62 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.269 178.469 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.481 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . -23.67 82.46 0.0 OUTLIER Glycine 0 C--N 1.346 1.093 0 O-C-N 123.899 0.749 . . . . 0.0 112.232 179.149 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.951 ' C ' HD23 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -157.47 176.93 12.01 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.024 -0.588 . . . . 0.0 109.986 -177.879 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 226' ' ' CYS . . . . . 0.508 ' HB3' HD23 ' A' ' 213' ' ' LEU . 1.6 p -138.66 147.43 42.82 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.138 -0.625 . . . . 0.0 112.389 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 1.109 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 4.6 m-85 -107.44 133.49 51.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.161 178.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 1.136 HD12 ' CE2' ' A' ' 202' ' ' PHE . 1.8 mt -128.06 133.0 68.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.13 0.49 . . . . 0.0 111.686 -179.186 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.65 HG22 ' HB3' ' A' ' 209' ' ' GLU . 40.8 m -113.44 137.99 50.73 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.51 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.873 ' HE2' HD13 ' A' ' 184' ' ' ILE . 75.4 m-85 -113.62 126.3 55.12 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.298 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.5 ' HG3' ' O ' ' A' ' 207' ' ' GLU . 0.3 OUTLIER -47.94 -39.19 18.51 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 178.051 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 232' ' ' GLU . . . . . 0.44 ' O ' ' HD3' ' A' ' 182' ' ' LYS . 0.0 OUTLIER -91.47 -166.05 1.48 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 113.443 -1.708 . . . . 0.0 110.036 179.119 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 233' ' ' GLU . . . . . 0.544 ' HB3' ' HG2' ' A' ' 182' ' ' LYS . 0.6 OUTLIER -133.7 13.88 4.04 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.51 -179.92 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.578 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.3 OUTLIER -85.14 -59.52 0.32 Allowed Pre-proline 0 N--CA 1.452 -0.37 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 179.752 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.875 ' O ' HD12 ' A' ' 239' ' ' ILE . 83.4 Cg_exo -49.9 -31.0 25.39 Favored 'Trans proline' 0 CA--C 1.5 -1.214 0 N-CA-C 108.888 -1.235 . . . . 0.0 108.888 177.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.685 HG21 ' CB ' ' A' ' 182' ' ' LYS . 14.7 t -72.74 -45.16 57.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 113.892 -1.504 . . . . 0.0 110.179 179.001 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.578 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 1.6 ptpt -62.81 -36.36 82.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.721 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.503 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 0.0 OUTLIER -81.62 -50.3 9.49 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.903 0.382 . . . . 0.0 110.92 179.194 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.875 HD12 ' O ' ' A' ' 235' ' ' PRO . 1.6 mt -46.33 -49.84 5.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.54 -179.312 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 240' ' ' MET . . . . . 0.522 ' SD ' HG12 ' A' ' 236' ' ' VAL . 15.4 mtp -60.27 -28.33 67.98 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.877 -178.398 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.531 ' CG ' ' O ' ' A' ' 237' ' ' LYS . 0.0 OUTLIER -88.67 -9.67 51.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.752 0.31 . . . . 0.0 110.976 -179.927 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.484 ' HG2' ' HA ' ' A' ' 239' ' ' ILE . 4.5 mmmm -79.81 116.19 19.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.363 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.498 ' HG2' ' N ' ' A' ' 244' ' ' TYR . 5.0 ttpt -39.98 -74.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.546 ' CE1' ' HG3' ' A' ' 253' ' ' GLU . 21.6 m-85 -129.09 151.49 49.72 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.399 179.277 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 245' ' ' HIS . . . . . 0.787 ' CG ' HD12 ' A' ' 254' ' ' ILE . 45.0 m-70 -105.65 149.14 26.61 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.376 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -123.55 105.4 9.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.543 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.529 HG12 ' HB2' ' A' ' 197' ' ' LYS . 1.8 t -110.05 116.55 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.961 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 41.16 -90.67 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.676 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.511 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.1 OUTLIER -105.03 -35.99 7.46 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.747 0.784 . . . . 0.0 109.914 -179.538 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.477 ' HB3' ' HB2' ' A' ' 190' ' ' SER . 0.8 OUTLIER -77.87 153.61 32.5 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.317 -1.311 . . . . 0.0 112.633 -178.363 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.488 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -148.18 104.81 3.57 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.868 -1.06 . . . . 0.0 108.545 178.942 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 252' ' ' CYS . . . . . 0.995 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -127.59 152.32 47.8 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -177.074 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 253' ' ' GLU . . . . . 0.546 ' HG3' ' CE1' ' A' ' 244' ' ' TYR . 29.3 tt0 -77.17 110.05 11.54 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.047 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.877 HG12 HG13 ' A' ' 186' ' ' VAL . 25.3 mt -96.52 111.29 26.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 -178.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.514 ' O ' ' C ' ' A' ' 256' ' ' VAL . 0.0 OUTLIER -115.72 132.28 56.68 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 176.439 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.66 HG23 ' O ' ' A' ' 183' ' ' LYS . 5.2 p -32.8 121.78 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 CA-C-O 122.254 1.025 . . . . 0.0 111.356 -177.59 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 1.109 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -76.54 153.91 35.01 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 113.315 -1.766 . . . . 0.0 111.774 -178.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 2.0 mtm -128.81 113.6 15.49 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.761 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 259' ' ' SER . . . . . 0.411 ' HB3' ' HD2' ' A' ' 183' ' ' LYS . 86.9 p . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.537 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 2' ' ' ' DT' . . . . . 0.771 ' O2 ' " H2'" ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.428 -0.766 0 C1'-O4'-C4' 110.27 0.407 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 3' ' ' ' DA' . . . . . 0.576 H5'' ' CE1' ' A' ' 225' ' ' PHE . . . . . . . . 0 O5'--C5' 1.426 -0.899 0 C3'-C2'-C1' 104.965 1.618 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 4' ' ' ' DG' . . . . . 0.671 ' N1 ' ' CZ ' ' A' ' 227' ' ' PHE . . . . . . . . 0 O5'--C5' 1.426 -0.856 0 C4'-C3'-C2' 101.304 -1.896 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 5' ' ' ' DG' . . . . . 0.514 " O5'" H2'' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.426 -0.872 0 O4'-C1'-N19 108.214 0.517 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.527 ' CG1' ' N ' ' A' ' 182' ' ' LYS . 55.6 t . . . . . 0 CA--C 1.502 -0.865 0 CA-C-O 121.377 0.608 . . . . 0.0 111.961 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.75 ' CB ' HG21 ' A' ' 236' ' ' VAL . 0.0 OUTLIER -148.0 112.57 5.33 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.928 177.467 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.852 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -130.96 137.47 49.27 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.382 179.436 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.875 HD13 ' HE2' ' A' ' 230' ' ' PHE . 0.5 OUTLIER -119.67 120.73 64.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.814 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.813 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.3 OUTLIER -94.57 109.56 21.45 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.242 0.544 . . . . 0.0 111.003 -178.597 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 1.087 HG12 ' HB2' ' A' ' 252' ' ' CYS . 2.3 t -87.44 114.11 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.564 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.58 ' HA2' ' HB2' ' A' ' 225' ' ' PHE . . . -101.33 130.35 10.2 Favored Glycine 0 C--O 1.227 -0.288 0 N-CA-C 115.081 0.793 . . . . 0.0 115.081 -177.266 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.441 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . 78.36 79.73 0.75 Allowed Glycine 0 C--N 1.331 0.271 0 C-N-CA 121.01 -0.614 . . . . 0.0 113.472 178.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.939 HD23 ' C ' ' A' ' 225' ' ' PHE . 0.6 OUTLIER -117.69 157.56 26.26 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.693 0.282 . . . . 0.0 111.016 -179.916 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.587 ' N ' HD12 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -48.5 -173.48 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.792 179.305 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.585 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 5.5 Cg_exo -77.59 15.96 1.16 Allowed 'Trans proline' 0 CA--C 1.531 0.36 0 C-N-CA 122.965 2.444 . . . . 0.0 113.409 -179.429 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.553 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 0.6 OUTLIER 157.58 78.19 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.667 0.27 . . . . 0.0 111.482 179.84 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.93 ' OG1' HD13 ' A' ' 189' ' ' LEU . 76.1 m -71.89 115.44 38.14 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.095 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.602 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 21.0 Cg_endo -61.02 112.31 1.33 Allowed 'Trans proline' 0 C--N 1.332 -0.325 0 C-N-CA 122.226 1.95 . . . . 0.0 111.519 178.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.804 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -50.63 -14.92 0.22 Allowed 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.872 -179.668 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 196' ' ' GLU . . . . . 0.484 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 9.3 mm-40 -66.94 -40.32 87.52 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -179.167 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.602 ' CD ' ' HG2' ' A' ' 194' ' ' PRO . 1.4 mttp -75.29 -46.42 33.61 Favored 'General case' 0 CA--C 1.498 -1.055 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.269 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.891 ' CD1' HG22 ' A' ' 193' ' ' THR . 0.0 OUTLIER -47.74 -32.11 2.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.003 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.595 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 9.6 mtp180 -69.48 -33.48 72.94 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.091 178.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' GLU . . . . . 0.528 ' N ' ' O ' ' A' ' 197' ' ' LYS . 9.3 mm-40 -82.47 -59.06 2.66 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.207 0.527 . . . . 0.0 110.206 178.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.505 ' C ' ' CD1' ' A' ' 201' ' ' TYR . 0.2 OUTLIER -48.76 -54.67 14.07 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.797 179.005 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.965 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.2 OUTLIER -79.57 -30.69 41.74 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.376 -179.864 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.595 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -62.7 -57.1 17.64 Favored Glycine 0 CA--C 1.499 -0.931 0 N-CA-C 107.036 -2.426 . . . . 0.0 107.036 176.475 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -48.62 -29.33 7.6 Favored Glycine 0 N--CA 1.441 -1.022 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 176.165 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.805 ' CD2' HD11 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -58.22 -43.45 87.71 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 177.764 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.491 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 169.06 -130.81 2.14 Favored Glycine 0 N--CA 1.441 -1.02 0 CA-C-N 113.725 -1.579 . . . . 0.0 110.423 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.506 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 4.3 mt-10 -96.97 101.31 12.86 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.208 0.528 . . . . 0.0 111.027 178.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.433 HG21 ' HB2' ' A' ' 202' ' ' PHE . 2.9 t -78.77 138.22 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 178.404 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 209' ' ' GLU . . . . . 0.502 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 13.7 tp10 -91.46 -57.62 2.71 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.616 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 25.1 p -157.7 154.95 29.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.285 0.565 . . . . 0.0 112.207 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.742 HD12 ' HB ' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -129.64 124.3 59.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.411 179.516 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.53 ' O ' ' HD3' ' A' ' 214' ' ' PRO . 0.0 OUTLIER -123.15 112.96 18.34 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -179.093 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.903 HD13 ' HB2' ' A' ' 226' ' ' CYS . 1.7 mm? -96.27 105.16 20.36 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-O 120.836 0.35 . . . . 0.0 111.424 178.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.637 ' HD2' ' O ' ' A' ' 225' ' ' PHE . 65.6 Cg_exo -48.45 -159.99 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 123.672 2.915 . . . . 0.0 113.286 179.217 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.492 ' SD ' ' ND2' ' A' ' 220' ' ' ASN . 0.0 OUTLIER -107.57 173.32 6.37 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.15 179.861 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -109.14 150.13 28.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.618 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' ASN . . . . . 0.533 ' N ' ' O ' ' A' ' 221' ' ' LYS . 2.1 t30 -56.77 -14.76 3.64 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.171 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 29.9 mttp -62.79 -27.85 69.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.119 0.485 . . . . 0.0 109.929 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 2.3 t -146.99 13.31 1.13 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.718 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' ASN . . . . . 0.492 ' ND2' ' SD ' ' A' ' 215' ' ' MET . 6.4 m120 -149.27 -91.75 0.07 Allowed 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 120.751 0.31 . . . . 0.0 111.653 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 221' ' ' LYS . . . . . 0.535 ' HD2' ' NH2' ' A' ' 223' ' ' ARG . 0.7 OUTLIER -154.18 172.07 18.17 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.27 -179.815 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.651 ' O ' ' CG ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -85.94 39.57 0.81 Allowed 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 122.673 1.225 . . . . 0.0 110.802 -179.431 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.598 ' CB ' H5'' ' B' ' 3' ' ' ' DA' . 8.7 ptp85 -71.46 -31.02 66.69 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 177.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.51 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 16.01 64.18 0.01 OUTLIER Glycine 0 C--N 1.336 0.577 0 CA-C-N 114.501 -1.227 . . . . 0.0 113.052 178.432 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.939 ' C ' HD23 ' A' ' 189' ' ' LEU . 5.0 p90 -156.42 176.26 12.93 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -179.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 226' ' ' CYS . . . . . 0.903 ' HB2' HD13 ' A' ' 213' ' ' LEU . 7.2 p -143.87 154.89 43.83 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -179.245 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 1.137 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 6.1 m-85 -107.14 153.48 22.6 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.138 178.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.965 HD12 ' CE2' ' A' ' 202' ' ' PHE . 2.4 mt -147.87 135.11 13.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.869 0.366 . . . . 0.0 110.841 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.438 ' OG1' ' HG2' ' A' ' 183' ' ' LYS . 92.3 m -117.35 138.41 51.8 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.875 ' HE2' HD13 ' A' ' 184' ' ' ILE . 70.6 m-85 -111.89 126.25 54.9 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.564 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.506 ' HG3' ' O ' ' A' ' 207' ' ' GLU . 0.0 OUTLIER -49.55 -38.78 32.24 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 177.829 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 232' ' ' GLU . . . . . 0.483 ' O ' ' HD3' ' A' ' 182' ' ' LYS . 22.4 mt-10 -90.41 -171.49 3.1 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 113.276 -1.784 . . . . 0.0 109.019 178.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 233' ' ' GLU . . . . . 0.539 ' CB ' ' HG2' ' A' ' 182' ' ' LYS . 0.0 OUTLIER -127.47 0.5 6.26 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.55 179.965 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.485 ' O ' ' N ' ' A' ' 237' ' ' LYS . 0.2 OUTLIER -73.45 -57.61 2.63 Favored Pre-proline 0 C--N 1.329 -0.294 0 N-CA-C 112.0 0.371 . . . . 0.0 112.0 -179.075 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.887 ' O ' HD12 ' A' ' 239' ' ' ILE . 99.8 Cg_exo -49.24 -32.97 26.78 Favored 'Trans proline' 0 CA--C 1.498 -1.3 0 C-N-CA 121.124 1.216 . . . . 0.0 108.985 178.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.75 HG21 ' CB ' ' A' ' 182' ' ' LYS . 19.5 t -70.84 -41.62 77.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 113.646 -1.615 . . . . 0.0 109.189 178.297 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.524 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 23.5 mttm -57.18 -45.27 83.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.83 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.502 ' O ' ' HG3' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -81.03 -50.38 9.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.313 -179.396 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.887 HD12 ' O ' ' A' ' 235' ' ' PRO . 1.4 mt -41.78 -51.42 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.99 -179.298 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 240' ' ' MET . . . . . 0.61 ' SD ' HG12 ' A' ' 236' ' ' VAL . 4.9 mtp -64.23 -19.37 65.32 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.43 -178.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.502 ' HG3' ' O ' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -86.78 -22.1 26.12 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.063 0.458 . . . . 0.0 110.666 -179.916 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -78.49 118.26 20.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.667 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.447 ' HD3' ' CD2' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -48.68 -49.86 35.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.611 179.911 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.528 ' CD1' ' HG3' ' A' ' 253' ' ' GLU . 17.2 m-85 -138.74 163.91 30.96 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.945 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 245' ' ' HIS . . . . . 0.789 ' CE1' HD12 ' A' ' 254' ' ' ILE . 31.6 m-70 -125.07 156.05 38.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.028 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 246' ' ' ASN . . . . . 0.5 ' HA ' ' HA ' ' A' ' 251' ' ' LYS . 0.2 OUTLIER -137.99 105.08 5.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.093 0.473 . . . . 0.0 110.057 178.768 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.527 ' N ' ' O ' ' A' ' 250' ' ' SER . 1.8 t -103.09 106.7 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.424 -178.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 248' ' ' GLY . . . . . 0.407 ' HA3' ' HE3' ' A' ' 197' ' ' LYS . . . 54.84 -81.22 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.482 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.527 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -114.38 -39.23 3.88 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.424 0.631 . . . . 0.0 110.346 -179.983 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.527 ' O ' ' N ' ' A' ' 247' ' ' VAL . 0.2 OUTLIER -77.42 153.24 33.82 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.736 -178.952 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 246' ' ' ASN . 0.0 OUTLIER -145.12 108.7 4.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.408 -0.815 . . . . 0.0 108.869 179.143 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 252' ' ' CYS . . . . . 1.087 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -128.3 153.3 47.15 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -176.951 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 253' ' ' GLU . . . . . 0.56 ' N ' ' O ' ' A' ' 187' ' ' GLY . 39.0 tt0 -76.03 107.22 8.08 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.978 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.861 HG12 HG13 ' A' ' 186' ' ' VAL . 23.5 mt -95.76 113.7 30.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -178.398 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.519 ' O ' ' C ' ' A' ' 256' ' ' VAL . 0.0 OUTLIER -118.84 133.2 56.0 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 176.608 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 183' ' ' LYS . 6.8 p -33.37 123.8 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 CA-C-O 122.252 1.025 . . . . 0.0 111.294 -177.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 1.137 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -76.01 153.36 36.55 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 113.337 -1.756 . . . . 0.0 111.444 -178.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.33 113.54 15.09 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.52 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.323 -0.559 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.995 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 2' ' ' ' DT' . . . . . 0.896 ' O2 ' " H2'" ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O4'--C1' 1.409 -0.868 0 C3'-C2'-C1' 104.752 1.465 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 3' ' ' ' DA' . . . . . 0.961 " H4'" " O5'" ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.426 -0.9 0 O4'-C1'-C2' 106.721 0.565 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 4' ' ' ' DG' . . . . . 0.961 " O5'" " H4'" ' B' ' 3' ' ' ' DA' . . . . . . . . 0 C4'--C3' 1.52 -0.76 0 C4'-C3'-C2' 101.83 -1.37 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 5' ' ' ' DG' . . . . . 0.713 ' N7 ' ' C5 ' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 C2'--C1' 1.509 -0.828 0 C3'-C2'-C1' 101.461 -0.885 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.505 HG12 ' N ' ' A' ' 182' ' ' LYS . 55.0 t . . . . . 0 CA--C 1.502 -0.871 0 CA-C-O 121.099 0.476 . . . . 0.0 111.356 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 1.103 ' HB2' HG21 ' A' ' 236' ' ' VAL . 0.0 OUTLIER -155.0 112.43 3.37 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.328 177.601 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.817 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -136.68 144.13 43.77 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 115.113 -0.948 . . . . 0.0 109.345 178.84 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.866 HD13 ' HE2' ' A' ' 230' ' ' PHE . 0.2 OUTLIER -123.9 120.07 58.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.827 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.846 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.9 OUTLIER -91.03 109.39 20.63 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.434 0.635 . . . . 0.0 109.748 -179.709 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.954 HG12 ' HB2' ' A' ' 252' ' ' CYS . 4.1 t -88.75 104.9 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.484 -179.066 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.551 ' O ' ' N ' ' A' ' 253' ' ' GLU . . . -92.82 127.39 8.97 Favored Glycine 0 C--O 1.228 -0.28 0 CA-C-N 115.165 -0.925 . . . . 0.0 115.065 -177.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.619 ' HA3' ' C5 ' ' B' ' 2' ' ' ' DT' . . . 83.29 81.43 0.97 Allowed Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.893 -0.67 . . . . 0.0 113.531 178.3 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.951 HD23 ' C ' ' A' ' 225' ' ' PHE . 0.6 OUTLIER -117.26 156.96 26.86 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.803 0.335 . . . . 0.0 110.865 179.68 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.591 ' N ' HD12 ' A' ' 189' ' ' LEU . 0.2 OUTLIER -46.52 -178.16 0.01 OUTLIER Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.812 179.811 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.568 ' HD2' ' CB ' ' A' ' 190' ' ' SER . 72.1 Cg_endo -78.79 17.59 1.12 Allowed 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.563 2.175 . . . . 0.0 113.092 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.528 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 0.6 OUTLIER 159.86 66.17 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.497 0.189 . . . . 0.0 111.392 179.749 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.78 ' OG1' HD13 ' A' ' 189' ' ' LEU . 94.9 m -69.8 127.37 92.58 Favored Pre-proline 0 CA--C 1.518 -0.271 0 CA-C-O 120.963 0.411 . . . . 0.0 110.69 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.628 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 71.1 Cg_endo -71.15 109.49 2.58 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.378 2.052 . . . . 0.0 111.146 178.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.806 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -48.29 -14.07 0.05 Allowed 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -179.77 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 196' ' ' GLU . . . . . 0.524 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 2.9 mt-10 -67.44 -41.05 85.37 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.628 ' CD ' ' HG2' ' A' ' 194' ' ' PRO . 1.6 mttp -73.22 -46.87 47.84 Favored 'General case' 0 CA--C 1.503 -0.854 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.806 ' CG1' ' HA ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -47.5 -29.94 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.978 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 177.947 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.544 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 7.5 mtt180 -72.96 -32.69 65.38 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.294 178.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' GLU . . . . . 0.572 ' CG ' ' N ' ' A' ' 201' ' ' TYR . 3.6 pt-20 -83.0 -55.35 4.43 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.01 0.433 . . . . 0.0 110.337 179.053 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.572 ' N ' ' CG ' ' A' ' 200' ' ' GLU . 0.3 OUTLIER -50.01 -53.31 27.54 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.575 0.702 . . . . 0.0 109.511 178.761 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 1.132 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -79.64 -30.91 41.47 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.2 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.544 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -62.41 -56.72 20.14 Favored Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 107.048 -2.421 . . . . 0.0 107.048 176.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -50.67 -28.13 14.79 Favored Glycine 0 N--CA 1.443 -0.895 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 176.14 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.809 ' CD2' HD11 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -58.48 -43.9 89.13 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 177.805 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.502 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 170.69 -131.5 2.24 Favored Glycine 0 N--CA 1.441 -1.007 0 CA-C-N 113.615 -1.629 . . . . 0.0 110.271 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.513 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 2.1 mm-40 -97.1 100.82 12.3 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.238 0.542 . . . . 0.0 110.946 178.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.469 HG21 ' HB2' ' A' ' 202' ' ' PHE . 2.5 t -78.69 140.5 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.13 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.011 178.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 209' ' ' GLU . . . . . 0.718 ' HB3' HG22 ' A' ' 229' ' ' THR . 7.4 tp10 -89.53 -53.49 4.51 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 178.056 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.481 ' HB3' ' OE2' ' A' ' 212' ' ' GLU . 0.4 OUTLIER -170.89 156.69 5.09 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.451 179.256 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 1.022 HD13 HG23 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -125.1 117.28 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.611 179.375 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.556 ' C ' HD23 ' A' ' 213' ' ' LEU . 0.5 OUTLIER -123.5 104.43 9.06 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -179.422 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.987 HD22 ' CB ' ' A' ' 226' ' ' CYS . 0.1 OUTLIER -96.73 106.1 27.92 Favored Pre-proline 0 CA--C 1.533 0.31 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 179.207 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.593 ' CB ' " C4'" ' B' ' 4' ' ' ' DG' . 4.7 Cg_exo -79.65 135.28 11.47 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.121 2.548 . . . . 0.0 112.535 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 70.3 mtm -135.36 133.55 38.86 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.904 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.505 ' OD2' ' CG2' ' A' ' 219' ' ' THR . 0.7 OUTLIER -115.32 105.71 13.18 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.907 0.384 . . . . 0.0 110.936 179.781 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -84.73 -22.18 29.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.949 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 6.6 mttt -90.47 -51.7 5.28 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.505 ' CG2' ' OD2' ' A' ' 216' ' ' ASP . 3.4 t -90.78 -13.43 33.96 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -178.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 220' ' ' ASN . . . . . 0.411 ' C ' ' O ' ' A' ' 219' ' ' THR . 89.7 m-20 38.06 66.29 0.5 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.787 0.327 . . . . 0.0 110.812 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 221' ' ' LYS . . . . . 0.549 ' CD ' ' HB3' ' A' ' 223' ' ' ARG . 0.2 OUTLIER -95.01 31.45 1.87 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.032 0.444 . . . . 0.0 110.753 179.931 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.42 ' HD2' ' HA ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER 44.85 36.28 1.81 Allowed 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.179 -179.415 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.559 ' CD ' ' OP2' ' B' ' 5' ' ' ' DG' . 0.2 OUTLIER -87.83 17.33 4.9 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.684 178.794 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.485 ' O ' ' HG ' ' A' ' 189' ' ' LEU . . . -67.25 61.32 0.25 Allowed Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 178.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.951 ' C ' HD23 ' A' ' 189' ' ' LEU . 15.9 p90 -135.75 177.2 8.01 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -178.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 226' ' ' CYS . . . . . 0.987 ' CB ' HD22 ' A' ' 213' ' ' LEU . 1.5 p -135.9 149.69 49.07 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -178.573 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 1.117 ' CE1' ' HB1' ' A' ' 257' ' ' ALA . 3.9 m-85 -106.08 132.58 51.98 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.168 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 1.132 HD12 ' CE2' ' A' ' 202' ' ' PHE . 1.8 mt -128.61 118.54 47.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.292 0.567 . . . . 0.0 111.472 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.718 HG22 ' HB3' ' A' ' 209' ' ' GLU . 22.1 m -101.58 138.03 39.12 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.562 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.866 ' HE2' HD13 ' A' ' 184' ' ' ILE . 74.4 m-85 -114.87 126.46 54.83 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.095 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.513 ' HG3' ' O ' ' A' ' 207' ' ' GLU . 0.0 OUTLIER -48.17 -39.13 19.87 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 177.992 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 232' ' ' GLU . . . . . 0.485 ' O ' ' HG3' ' A' ' 182' ' ' LYS . 3.1 mt-10 -98.81 165.22 11.88 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 113.413 -1.721 . . . . 0.0 109.478 178.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 233' ' ' GLU . . . . . 0.458 ' HB3' ' CD ' ' A' ' 182' ' ' LYS . 0.9 OUTLIER -106.14 19.64 20.21 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -179.393 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.548 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.7 OUTLIER -85.34 -61.44 0.27 Allowed Pre-proline 0 C--N 1.334 -0.086 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.955 179.67 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.888 ' O ' HD12 ' A' ' 239' ' ' ILE . 85.5 Cg_exo -49.51 -29.53 18.85 Favored 'Trans proline' 0 CA--C 1.499 -1.256 0 N-CA-C 108.88 -1.238 . . . . 0.0 108.88 177.538 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 1.103 HG21 ' HB2' ' A' ' 182' ' ' LYS . 12.9 t -73.31 -46.15 50.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 113.786 -1.552 . . . . 0.0 110.719 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.548 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 13.6 pttt -59.94 -37.18 78.8 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.42 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.624 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.6 OUTLIER -80.75 -56.1 4.37 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.201 0.524 . . . . 0.0 110.753 178.858 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.888 HD12 ' O ' ' A' ' 235' ' ' PRO . 1.6 mt -39.28 -47.74 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.605 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 240' ' ' MET . . . . . 0.51 ' SD ' HG12 ' A' ' 236' ' ' VAL . 3.8 mtp -62.63 -27.7 69.39 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.782 -178.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.479 ' CG ' ' O ' ' A' ' 237' ' ' LYS . 1.8 mt-10 -83.41 -24.92 31.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.631 0.253 . . . . 0.0 111.553 -179.355 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.575 ' HD3' ' CE1' ' A' ' 245' ' ' HIS . 0.8 OUTLIER -79.22 109.31 13.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.019 0.437 . . . . 0.0 111.118 -179.461 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.504 ' HD2' ' CE2' ' A' ' 244' ' ' TYR . 0.6 OUTLIER -35.49 -61.19 0.46 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.094 -179.747 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.551 ' CE1' ' HG3' ' A' ' 253' ' ' GLU . 44.5 m-85 -129.28 167.72 17.28 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.583 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 245' ' ' HIS . . . . . 0.778 ' CG ' HD12 ' A' ' 254' ' ' ILE . 38.1 m-70 -128.47 153.36 47.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.758 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -127.93 105.57 8.51 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.001 0.429 . . . . 0.0 111.031 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.58 HG11 HG23 ' A' ' 198' ' ' ILE . 1.5 t -106.36 107.91 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.241 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 44.06 -86.67 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.582 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -101.41 -41.37 6.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.256 0.55 . . . . 0.0 110.829 179.75 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.504 ' HB3' ' HB2' ' A' ' 190' ' ' SER . 5.2 p -78.34 155.79 29.9 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.363 -0.835 . . . . 0.0 113.096 -178.054 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.508 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.1 OUTLIER -147.47 105.86 3.78 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 114.365 -1.288 . . . . 0.0 107.868 178.473 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 252' ' ' CYS . . . . . 0.954 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -127.52 153.32 46.49 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -176.199 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 253' ' ' GLU . . . . . 0.551 ' N ' ' O ' ' A' ' 187' ' ' GLY . 40.6 tt0 -76.21 107.03 8.16 Favored 'General case' 0 C--O 1.22 -0.464 0 CA-C-N 114.832 -1.076 . . . . 0.0 110.607 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.835 HG12 HG13 ' A' ' 186' ' ' VAL . 22.2 mt -95.62 111.85 26.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -178.171 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.537 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -116.42 130.24 56.65 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 113.349 -1.751 . . . . 0.0 106.327 177.035 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 183' ' ' LYS . 4.2 p -32.75 123.01 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.488 0 CA-C-O 122.265 1.031 . . . . 0.0 111.341 -177.386 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 1.117 ' HB1' ' CE1' ' A' ' 227' ' ' PHE . . . -76.31 153.98 35.44 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 113.39 -1.732 . . . . 0.0 110.974 -178.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.56 113.4 14.19 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.717 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 259' ' ' SER . . . . . 0.483 ' OG ' ' O6 ' ' B' ' 4' ' ' ' DG' . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.504 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.854 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 2' ' ' ' DT' . . . . . 0.626 ' O2 ' " H2'" ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.427 -0.82 0 C1'-O4'-C4' 110.625 0.66 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 3' ' ' ' DA' . . . . . 0.983 " H4'" " O5'" ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.424 -0.996 0 C3'-C2'-C1' 101.132 -1.12 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 4' ' ' ' DG' . . . . . 0.983 " O5'" " H4'" ' B' ' 3' ' ' ' DA' . . . . . . . . 0 O5'--C5' 1.427 -0.82 0 C4'-C3'-C2' 101.323 -1.877 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 5' ' ' ' DG' . . . . . 0.661 ' N7 ' ' C8 ' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.428 -0.773 0 O4'-C1'-C2' 106.847 0.679 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.501 ' CG1' ' N ' ' A' ' 182' ' ' LYS . 47.4 t . . . . . 0 CA--C 1.504 -0.808 0 CA-C-O 121.338 0.59 . . . . 0.0 111.608 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.696 ' CB ' HG21 ' A' ' 236' ' ' VAL . 0.0 OUTLIER -149.98 112.54 4.74 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.934 177.452 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.815 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.0 OUTLIER -133.21 141.78 48.25 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.444 179.254 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.816 HD12 HG21 ' A' ' 239' ' ' ILE . 0.5 OUTLIER -120.8 120.63 63.01 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 178.735 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.841 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -93.35 109.32 20.87 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.29 0.567 . . . . 0.0 110.327 -179.172 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.879 HG12 ' HB2' ' A' ' 252' ' ' CYS . 11.7 t -85.9 120.0 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.753 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.55 ' O ' ' N ' ' A' ' 253' ' ' GLU . . . -109.87 131.4 10.45 Favored Glycine 0 C--N 1.331 0.265 0 N-CA-C 115.221 0.849 . . . . 0.0 115.221 -176.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.606 ' HA3' ' C6 ' ' B' ' 2' ' ' ' DT' . . . 76.41 79.44 0.65 Allowed Glycine 0 C--N 1.331 0.255 0 C-N-CA 121.378 -0.439 . . . . 0.0 113.334 178.451 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.952 HD23 ' CA ' ' A' ' 225' ' ' PHE . 0.6 OUTLIER -117.54 157.48 26.26 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.605 0.241 . . . . 0.0 111.049 -179.776 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.619 ' N ' HD12 ' A' ' 189' ' ' LEU . 0.2 OUTLIER -46.88 -175.3 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.203 0 CA-C-O 121.046 0.45 . . . . 0.0 111.58 179.92 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.597 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 13.2 Cg_exo -70.59 6.35 1.63 Allowed 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 123.319 2.68 . . . . 0.0 113.721 -179.119 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.54 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 3.5 m-20 159.6 78.76 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.153 0.502 . . . . 0.0 110.834 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.911 ' OG1' HD13 ' A' ' 189' ' ' LEU . 52.8 m -71.01 116.0 42.02 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.999 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.603 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 20.5 Cg_endo -58.16 110.54 0.66 Allowed 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.319 2.013 . . . . 0.0 111.127 178.544 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.804 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.4 OUTLIER -50.77 -14.98 0.23 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.524 -179.56 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 196' ' ' GLU . . . . . 0.477 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 74.1 mt-10 -65.15 -41.14 95.0 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -179.28 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.603 ' CD ' ' HG2' ' A' ' 194' ' ' PRO . 1.4 mttp -73.79 -48.07 34.24 Favored 'General case' 0 CA--C 1.498 -1.048 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.41 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.855 ' CD1' HG22 ' A' ' 193' ' ' THR . 0.0 OUTLIER -47.69 -31.85 2.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.207 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.547 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 2.3 mtp-105 -69.82 -33.31 72.15 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.083 178.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 200' ' ' GLU . . . . . 0.514 ' N ' ' O ' ' A' ' 197' ' ' LYS . 7.9 mt-10 -82.49 -58.5 2.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.244 0.545 . . . . 0.0 110.095 178.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.555 ' CD1' ' CD1' ' A' ' 202' ' ' PHE . 0.2 OUTLIER -49.02 -53.54 19.65 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.677 178.895 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 1.094 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.1 OUTLIER -79.74 -31.39 41.02 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.583 -179.787 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.547 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -62.77 -55.25 28.02 Favored Glycine 0 CA--C 1.5 -0.896 0 N-CA-C 107.051 -2.42 . . . . 0.0 107.051 176.618 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -50.25 -27.6 11.58 Favored Glycine 0 N--CA 1.444 -0.815 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 176.163 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.75 ' CE2' HG13 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -59.2 -47.76 84.14 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 122.137 0.97 . . . . 0.0 108.528 177.984 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.493 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 176.5 -132.29 2.04 Favored Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 113.602 -1.635 . . . . 0.0 110.172 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.489 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 2.2 mt-10 -97.19 99.87 11.35 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.142 0.496 . . . . 0.0 111.128 178.515 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.464 HG22 ' CE1' ' A' ' 230' ' ' PHE . 2.7 t -76.17 138.71 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.274 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 209' ' ' GLU . . . . . 0.464 ' HB3' HG22 ' A' ' 229' ' ' THR . 3.7 tp10 -92.45 -54.66 3.7 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.062 178.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 3.3 m -161.5 151.92 17.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.248 0.547 . . . . 0.0 112.272 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.691 HD12 ' HB ' ' A' ' 198' ' ' ILE . 0.1 OUTLIER -126.39 119.19 53.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.809 179.037 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.476 ' O ' ' HD3' ' A' ' 214' ' ' PRO . 0.1 OUTLIER -123.46 103.71 8.63 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -177.895 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.773 HD23 ' CB ' ' A' ' 226' ' ' CYS . 0.0 OUTLIER -96.03 105.75 23.72 Favored Pre-proline 0 CA--C 1.531 0.225 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 176.84 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.625 ' HD2' ' O ' ' A' ' 225' ' ' PHE . 5.2 Cg_exo -77.63 131.77 11.63 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 123.041 2.494 . . . . 0.0 112.863 -178.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 2.8 ptm -132.12 130.57 41.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.027 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.482 ' O ' ' HA ' ' A' ' 220' ' ' ASN . 0.5 OUTLIER -110.94 106.73 15.94 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.866 0.365 . . . . 0.0 111.188 -179.577 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -81.9 -6.81 59.41 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.677 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 3.9 mttt -82.71 -48.82 10.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.158 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -127.8 -5.43 5.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.602 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 220' ' ' ASN . . . . . 0.482 ' HA ' ' O ' ' A' ' 216' ' ' ASP . 17.0 m120 40.58 61.03 1.73 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.823 0.344 . . . . 0.0 110.884 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.25 176.78 0.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.757 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.618 ' O ' ' CG ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -93.78 23.26 4.89 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 122.343 1.068 . . . . 0.0 109.792 179.755 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.589 ' O ' ' CD1' ' A' ' 225' ' ' PHE . 8.8 ptp85 -70.39 -31.64 68.96 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.092 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.562 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 0.92 70.92 0.0 OUTLIER Glycine 0 C--N 1.341 0.818 0 O-C-N 124.322 1.013 . . . . 0.0 112.542 178.497 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.952 ' CA ' HD23 ' A' ' 189' ' ' LEU . 0.5 OUTLIER -156.21 177.06 11.87 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.407 -0.396 . . . . 0.0 110.095 -177.852 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 226' ' ' CYS . . . . . 0.773 ' CB ' HD23 ' A' ' 213' ' ' LEU . 1.7 p -138.59 155.17 48.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.367 0.603 . . . . 0.0 112.609 -179.014 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 1.084 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 4.6 m-85 -111.17 133.3 53.63 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.338 178.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 1.094 HD12 ' CE2' ' A' ' 202' ' ' PHE . 2.0 mt -128.33 120.48 53.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.293 0.568 . . . . 0.0 111.679 -179.42 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.48 ' OG1' ' HG2' ' A' ' 183' ' ' LYS . 73.6 m -103.44 138.1 40.63 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.404 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.809 ' HE2' HD13 ' A' ' 184' ' ' ILE . 82.7 m-85 -114.12 126.59 55.26 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.514 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.489 ' HG3' ' O ' ' A' ' 207' ' ' GLU . 0.0 OUTLIER -49.19 -38.53 26.22 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 177.914 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 232' ' ' GLU . . . . . 0.451 ' O ' ' HD3' ' A' ' 182' ' ' LYS . 2.0 mm-40 -90.85 -166.79 1.66 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 113.42 -1.718 . . . . 0.0 109.923 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 233' ' ' GLU . . . . . 0.471 ' CB ' ' HG2' ' A' ' 182' ' ' LYS . 0.6 OUTLIER -132.64 13.09 4.47 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.689 -179.852 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.538 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.8 OUTLIER -85.12 -58.04 0.36 Allowed Pre-proline 0 N--CA 1.451 -0.39 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.609 179.829 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.931 ' O ' HD12 ' A' ' 239' ' ' ILE . 81.4 Cg_exo -50.65 -28.8 23.43 Favored 'Trans proline' 0 CA--C 1.502 -1.116 0 N-CA-C 109.238 -1.101 . . . . 0.0 109.238 178.139 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.696 HG21 ' CB ' ' A' ' 182' ' ' LYS . 13.9 t -73.14 -44.05 56.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 113.795 -1.548 . . . . 0.0 109.978 178.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.542 ' HG2' ' HD2' ' A' ' 238' ' ' LYS . 0.5 OUTLIER -67.95 -30.25 69.5 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.301 179.538 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.542 ' HD2' ' HG2' ' A' ' 237' ' ' LYS . 0.6 OUTLIER -78.74 -54.34 6.2 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.766 0.793 . . . . 0.0 110.369 179.36 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.931 HD12 ' O ' ' A' ' 235' ' ' PRO . 1.9 mt -51.67 -49.65 33.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 114.357 -1.292 . . . . 0.0 112.645 -178.702 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 240' ' ' MET . . . . . 0.528 ' SD ' HG12 ' A' ' 236' ' ' VAL . 8.1 mtp -59.35 -17.69 31.91 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.598 -178.572 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.541 ' CG ' ' O ' ' A' ' 237' ' ' LYS . 0.1 OUTLIER -84.25 -40.66 17.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.084 179.952 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.454 ' O ' ' C ' ' A' ' 243' ' ' LYS . 0.0 OUTLIER -80.3 87.15 5.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.722 179.898 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.56 ' N ' ' HD3' ' A' ' 243' ' ' LYS . 0.0 OUTLIER -31.48 -46.48 0.1 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.907 179.757 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.572 ' CE1' ' HG3' ' A' ' 253' ' ' GLU . 18.9 m-85 -120.62 148.94 43.23 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.799 -179.366 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 245' ' ' HIS . . . . . 0.875 ' CG ' HD12 ' A' ' 254' ' ' ILE . 24.7 m-70 -122.97 157.75 31.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.278 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 246' ' ' ASN . . . . . 0.404 ' O ' ' CE2' ' A' ' 201' ' ' TYR . 0.1 OUTLIER -129.54 104.8 7.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.114 178.815 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.575 HG11 HG23 ' A' ' 198' ' ' ILE . 1.6 t -106.89 111.02 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.069 -179.378 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 48.0 -86.48 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.248 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.525 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.1 OUTLIER -108.57 -39.56 5.36 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.436 0.636 . . . . 0.0 110.391 -179.722 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.509 ' HB3' ' HB2' ' A' ' 190' ' ' SER . 0.2 OUTLIER -77.75 154.96 31.52 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.85 -1.068 . . . . 0.0 112.626 -178.3 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.513 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.1 OUTLIER -146.61 108.87 4.45 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.065 178.86 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 252' ' ' CYS . . . . . 0.879 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -128.17 152.79 47.62 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -177.015 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 253' ' ' GLU . . . . . 0.572 ' HG3' ' CE1' ' A' ' 244' ' ' TYR . 29.6 tt0 -76.44 107.12 8.49 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.523 179.282 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.875 HD12 ' CG ' ' A' ' 245' ' ' HIS . 31.0 mt -96.15 111.07 25.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -178.291 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.521 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -113.63 133.36 55.34 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 176.656 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.537 ' CG2' ' O ' ' A' ' 183' ' ' LYS . 4.1 p -33.55 124.34 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-O 122.207 1.004 . . . . 0.0 111.26 -177.635 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 1.084 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -77.35 153.25 33.96 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 113.466 -1.697 . . . . 0.0 112.037 -178.538 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 258' ' ' MET . . . . . 0.441 ' HG3' ' C2 ' ' B' ' 3' ' ' ' DA' . 0.0 OUTLIER -131.18 117.56 19.21 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.298 179.186 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 259' ' ' SER . . . . . 0.492 ' OG ' ' O6 ' ' B' ' 4' ' ' ' DG' . 0.1 OUTLIER . . . . . 0 C--N 1.322 -0.624 0 CA-C-O 121.254 0.55 . . . . 0.0 111.45 -178.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 2' ' ' ' DT' . . . . . 0.881 ' O2 ' " H2'" ' B' ' 2' ' ' ' DT' . . . . . . . . 0 C2'--C1' 1.51 -0.79 0 C4'-C3'-C2' 104.404 1.204 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 3' ' ' ' DA' . . . . . 0.64 ' C8 ' ' OP1' ' B' ' 3' ' ' ' DA' . . . . . . . . 0 O5'--C5' 1.426 -0.873 0 C4'-C3'-C2' 104.231 1.031 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 4' ' ' ' DG' . . . . . 0.944 H2'' " O5'" ' B' ' 5' ' ' ' DG' . . . . . . . . 0 C4'--C3' 1.52 -0.765 0 C4'-C3'-C2' 101.867 -1.333 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 5' ' ' ' DG' . . . . . 0.944 " O5'" H2'' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.427 -0.811 0 O4'-C1'-C2' 106.636 0.487 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.476 ' CG1' ' N ' ' A' ' 182' ' ' LYS . 46.3 t . . . . . 0 CA--C 1.5 -0.949 0 CA-C-O 121.206 0.527 . . . . 0.0 111.422 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.873 ' HB2' HG21 ' A' ' 236' ' ' VAL . 0.1 OUTLIER -150.45 112.02 4.47 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.247 178.0 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.874 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -133.73 144.95 49.42 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-N 114.432 -1.258 . . . . 0.0 108.814 178.896 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.916 HD13 ' HE2' ' A' ' 230' ' ' PHE . 1.8 pt -124.37 119.86 57.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 178.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.837 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -93.92 109.02 20.75 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 121.471 0.653 . . . . 0.0 110.687 -178.574 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 1.131 HG12 ' HB2' ' A' ' 252' ' ' CYS . 1.9 t -86.34 126.67 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.135 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.566 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . -113.4 133.99 11.6 Favored Glycine 0 C--N 1.333 0.412 0 N-CA-C 114.313 0.485 . . . . 0.0 114.313 -176.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.538 ' HA3' ' C6 ' ' B' ' 2' ' ' ' DT' . . . 71.41 87.64 0.14 Allowed Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.692 -0.766 . . . . 0.0 111.893 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.938 HD13 ' OG1' ' A' ' 193' ' ' THR . 0.6 OUTLIER -115.86 156.56 25.9 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.026 0.441 . . . . 0.0 111.655 -178.469 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.604 ' CB ' ' CD ' ' A' ' 191' ' ' PRO . 0.3 OUTLIER -49.31 -172.64 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.888 179.77 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.604 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 3.1 Cg_exo -77.21 13.09 1.62 Allowed 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 123.004 2.469 . . . . 0.0 113.182 -179.3 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.535 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 1.6 p30 157.43 77.24 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 120.758 0.313 . . . . 0.0 111.375 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.938 ' OG1' HD13 ' A' ' 189' ' ' LEU . 16.8 m -70.91 114.24 25.4 Favored Pre-proline 0 CA--C 1.517 -0.309 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.258 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.61 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 97.6 Cg_endo -73.38 109.32 2.82 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.589 2.193 . . . . 0.0 111.211 178.701 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.606 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.3 OUTLIER -43.9 -19.69 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.831 -0.168 . . . . 0.0 111.447 -179.911 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 196' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' A' ' 194' ' ' PRO . 66.6 mt-10 -57.24 -43.14 82.64 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -179.355 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.61 ' CD ' ' HG2' ' A' ' 194' ' ' PRO . 0.5 OUTLIER -80.36 -47.11 14.96 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 178.619 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.893 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -49.0 -29.68 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 CA-C-N 114.382 -1.281 . . . . 0.0 108.445 176.728 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.565 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 0.0 OUTLIER -73.22 -32.54 64.82 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.656 178.104 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 200' ' ' GLU . . . . . 0.539 ' N ' ' O ' ' A' ' 197' ' ' LYS . 2.7 mt-10 -82.15 -58.33 3.0 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.642 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.492 ' C ' ' CD1' ' A' ' 201' ' ' TYR . 0.5 OUTLIER -48.43 -53.9 16.11 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.801 179.318 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 1.058 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.4 OUTLIER -79.59 -31.67 41.83 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.36 179.827 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.565 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -61.99 -57.12 18.71 Favored Glycine 0 CA--C 1.498 -1.001 0 N-CA-C 107.563 -2.215 . . . . 0.0 107.563 176.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -51.33 -28.12 18.84 Favored Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 176.479 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.771 ' CD2' HD11 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -57.07 -44.24 82.88 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.01 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.486 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 170.06 -129.11 1.76 Allowed Glycine 0 N--CA 1.441 -0.992 0 CA-C-N 113.518 -1.674 . . . . 0.0 110.221 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.516 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 21.8 mm-40 -97.16 101.52 13.1 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.153 0.502 . . . . 0.0 111.298 178.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 2.9 t -76.75 137.27 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 177.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' GLU . . . . . 0.509 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 5.7 tp10 -89.43 -56.58 3.2 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.954 179.078 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 15.5 m -164.38 149.49 10.11 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.278 0.561 . . . . 0.0 111.921 179.478 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.493 HD12 ' HB ' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -117.66 126.47 74.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.669 179.078 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.411 ' O ' ' HD3' ' A' ' 214' ' ' PRO . 0.2 OUTLIER -123.18 105.18 9.67 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -178.128 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.752 HD13 ' O ' ' A' ' 193' ' ' THR . 0.3 OUTLIER -96.34 105.85 25.13 Favored Pre-proline 0 C--N 1.33 -0.267 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 177.439 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.523 ' HD2' ' O ' ' A' ' 225' ' ' PHE . 96.0 Cg_endo -79.59 136.28 12.18 Favored 'Trans proline' 0 N--CA 1.464 -0.236 0 C-N-CA 122.746 2.297 . . . . 0.0 113.091 -179.398 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 25.1 mmm -130.2 135.1 47.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.963 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.522 ' HB2' ' N ' ' A' ' 220' ' ' ASN . 0.0 OUTLIER -113.74 106.5 14.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.224 -179.526 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -83.16 -42.21 17.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.335 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -91.05 -36.17 14.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.688 -179.242 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.436 ' O ' ' N ' ' A' ' 221' ' ' LYS . 0.7 OUTLIER -89.51 -21.95 22.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.841 0.353 . . . . 0.0 110.916 -179.741 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 220' ' ' ASN . . . . . 0.522 ' N ' ' HB2' ' A' ' 216' ' ' ASP . 0.6 OUTLIER 34.93 34.79 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.157 179.75 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 221' ' ' LYS . . . . . 0.436 ' N ' ' O ' ' A' ' 219' ' ' THR . 0.0 OUTLIER -57.41 168.28 0.82 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.795 0.331 . . . . 0.0 110.608 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.623 ' O ' ' CG ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -96.92 36.23 1.44 Allowed 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 122.526 1.155 . . . . 0.0 109.981 -179.758 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.536 ' O ' ' C ' ' A' ' 224' ' ' GLY . 8.0 ptp85 -71.87 -24.42 61.67 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.44 178.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.536 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . -2.77 72.17 0.0 OUTLIER Glycine 0 C--N 1.344 1.019 0 O-C-N 124.274 0.984 . . . . 0.0 112.706 179.029 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.92 ' C ' HD23 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -157.36 177.07 11.86 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -178.403 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 226' ' ' CYS . . . . . 0.425 ' SG ' ' HB ' ' A' ' 186' ' ' VAL . 6.0 p -139.75 151.35 45.74 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 1.095 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 4.6 m-85 -110.43 133.07 53.62 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.711 178.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 1.058 HD12 ' CE2' ' A' ' 202' ' ' PHE . 2.3 mt -127.68 131.75 69.69 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.342 0 CA-C-O 121.121 0.486 . . . . 0.0 111.245 179.592 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.482 ' HG1' ' HZ2' ' A' ' 183' ' ' LYS . 87.9 m -111.61 138.23 48.43 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.388 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.916 ' HE2' HD13 ' A' ' 184' ' ' ILE . 62.8 m-85 -112.8 126.29 55.27 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.686 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.516 ' HG3' ' O ' ' A' ' 207' ' ' GLU . 0.0 OUTLIER -50.85 -38.15 47.4 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 177.612 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 232' ' ' GLU . . . . . 0.511 ' O ' ' HG3' ' A' ' 182' ' ' LYS . 10.1 mt-10 -93.83 178.22 5.74 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 113.051 -1.886 . . . . 0.0 108.951 178.61 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 233' ' ' GLU . . . . . 0.547 ' O ' ' HG3' ' A' ' 237' ' ' LYS . 0.7 OUTLIER -117.7 1.98 12.24 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.878 -179.509 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.496 ' O ' ' N ' ' A' ' 237' ' ' LYS . 0.4 OUTLIER -73.06 -58.83 2.38 Favored Pre-proline 0 C--N 1.326 -0.435 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.864 -179.177 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.883 ' O ' HD12 ' A' ' 239' ' ' ILE . 82.2 Cg_exo -48.97 -32.72 23.97 Favored 'Trans proline' 0 CA--C 1.501 -1.134 0 N-CA-C 108.851 -1.25 . . . . 0.0 108.851 178.758 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.873 HG21 ' HB2' ' A' ' 182' ' ' LYS . 21.3 t -70.57 -42.05 78.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 113.928 -1.487 . . . . 0.0 109.034 178.068 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.547 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 13.5 mtpt -56.43 -45.93 80.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.798 179.619 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.489 ' HA ' ' HG3' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -81.25 -49.97 10.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.701 -179.163 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.883 HD12 ' O ' ' A' ' 235' ' ' PRO . 1.6 mt -42.74 -50.1 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.427 -178.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 240' ' ' MET . . . . . 0.543 ' SD ' HG12 ' A' ' 236' ' ' VAL . 12.2 mtp -62.42 -24.18 67.27 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.695 -178.613 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.489 ' HG3' ' HA ' ' A' ' 238' ' ' LYS . 0.7 OUTLIER -87.88 -16.66 33.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.534 -179.437 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.456 ' HG2' ' HA ' ' A' ' 239' ' ' ILE . 8.1 mmmt -83.93 116.3 22.72 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.57 -0.287 . . . . 0.0 111.153 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.518 ' HG2' ' N ' ' A' ' 244' ' ' TYR . 1.8 ttpm? -36.77 -80.7 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.082 0.468 . . . . 0.0 110.013 179.263 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.518 ' N ' ' HG2' ' A' ' 243' ' ' LYS . 10.3 m-85 -113.24 169.43 8.95 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.876 178.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 245' ' ' HIS . . . . . 0.697 ' CG ' HD12 ' A' ' 254' ' ' ILE . 17.0 m-70 -123.46 146.35 48.1 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.784 0.326 . . . . 0.0 110.935 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 246' ' ' ASN . . . . . 0.441 ' O ' ' CD2' ' A' ' 201' ' ' TYR . 0.1 OUTLIER -122.42 105.47 10.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.042 0.449 . . . . 0.0 110.519 179.595 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.523 HG11 HG23 ' A' ' 198' ' ' ILE . 2.4 t -111.6 102.41 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.824 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 51.2 -90.57 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.321 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.474 HD11 ' OG ' ' A' ' 190' ' ' SER . 0.1 OUTLIER -104.06 -40.36 6.21 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 121.594 0.711 . . . . 0.0 109.957 -179.931 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.57 ' CB ' ' HG1' ' A' ' 193' ' ' THR . 1.4 m -78.61 150.27 32.76 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.604 -1.18 . . . . 0.0 112.165 -178.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.519 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -149.98 107.61 3.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.47 179.36 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 252' ' ' CYS . . . . . 1.131 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -128.19 153.46 46.88 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -177.326 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 253' ' ' GLU . . . . . 0.542 ' N ' ' O ' ' A' ' 187' ' ' GLY . 71.4 tt0 -75.58 110.87 10.33 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.301 -178.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.964 HG12 HG13 ' A' ' 186' ' ' VAL . 11.5 mt -96.59 112.14 28.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 -178.036 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.526 ' O ' ' C ' ' A' ' 256' ' ' VAL . 0.0 OUTLIER -119.14 131.24 55.86 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 176.009 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.654 HG23 ' O ' ' A' ' 183' ' ' LYS . 6.0 p -32.32 122.58 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.586 0 CA-C-O 122.285 1.04 . . . . 0.0 111.551 -176.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 1.095 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -75.85 152.62 37.2 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 113.366 -1.743 . . . . 0.0 111.614 -178.425 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.86 110.18 12.33 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.717 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 259' ' ' SER . . . . . 0.525 ' HB2' ' HD2' ' A' ' 183' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--N 1.32 -0.677 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.805 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 2' ' ' ' DT' . . . . . 0.915 ' O2 ' " H2'" ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.427 -0.824 0 C3'-C2'-C1' 105.218 1.799 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 3' ' ' ' DA' . . . . . 0.592 " H4'" ' CZ ' ' A' ' 225' ' ' PHE . . . . . . . . 0 C2'--C1' 1.508 -0.924 0 C3'-C2'-C1' 100.272 -1.734 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 4' ' ' ' DG' . . . . . 0.713 ' C2 ' ' CE1' ' A' ' 227' ' ' PHE . . . . . . . . 0 O5'--C5' 1.427 -0.815 0 C4'-C3'-C2' 101.958 -1.242 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 5' ' ' ' DG' . . . . . 0.578 ' N7 ' ' C5 ' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.427 -0.801 0 O4'-C1'-C2' 107.121 0.928 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.416 ' CG1' ' N ' ' A' ' 182' ' ' LYS . 53.0 t . . . . . 0 CA--C 1.5 -0.946 0 CA-C-O 121.184 0.516 . . . . 0.0 111.314 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.963 ' HB2' HG21 ' A' ' 236' ' ' VAL . 0.0 OUTLIER -153.76 111.69 3.55 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.89 177.142 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.806 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -138.25 137.52 37.58 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 114.561 -1.199 . . . . 0.0 108.795 178.953 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.835 HD13 ' HE2' ' A' ' 230' ' ' PHE . 1.1 pt -117.99 120.37 64.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.064 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.824 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -94.59 109.77 21.65 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 121.543 0.687 . . . . 0.0 110.196 -179.026 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.692 HG22 ' CD1' ' A' ' 254' ' ' ILE . 45.5 t -84.44 133.89 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.036 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.536 ' O ' ' HB3' ' A' ' 252' ' ' CYS . . . -92.0 -149.74 24.64 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.961 -0.638 . . . . 0.0 114.686 -177.128 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.477 ' O ' ' HB3' ' A' ' 252' ' ' CYS . . . -33.15 102.31 0.01 OUTLIER Glycine 0 C--N 1.334 0.469 0 CA-C-N 114.971 -0.614 . . . . 0.0 113.564 -179.428 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 1.026 HD13 ' OG1' ' A' ' 193' ' ' THR . 1.4 pp -117.48 157.89 25.48 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 122.753 0.421 . . . . 0.0 111.186 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.63 ' O ' HD12 ' A' ' 189' ' ' LEU . 0.5 OUTLIER -43.84 -178.9 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.539 179.65 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.535 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 17.4 Cg_exo -67.62 4.05 1.54 Allowed 'Trans proline' 0 CA--C 1.533 0.458 0 C-N-CA 123.185 2.59 . . . . 0.0 114.019 -179.107 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.526 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 4.3 t0 161.76 76.04 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.896 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 193' ' ' THR . . . . . 1.026 ' OG1' HD13 ' A' ' 189' ' ' LEU . 17.6 m -64.65 109.78 3.25 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.483 179.156 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.505 ' HG2' ' HG2' ' A' ' 197' ' ' LYS . 11.5 Cg_endo -56.9 110.23 0.56 Allowed 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.243 1.962 . . . . 0.0 111.215 179.517 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.787 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.1 OUTLIER -47.23 -16.93 0.05 Allowed 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -179.278 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 196' ' ' GLU . . . . . 0.462 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 62.6 mt-10 -68.15 -38.05 81.71 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -179.584 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.505 ' HG2' ' HG2' ' A' ' 194' ' ' PRO . 1.5 mmmm -75.04 -47.78 27.23 Favored 'General case' 0 CA--C 1.5 -0.969 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.605 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.901 ' CD1' HG22 ' A' ' 193' ' ' THR . 0.0 OUTLIER -48.1 -30.9 2.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 115.1 -0.955 . . . . 0.0 108.679 178.326 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.579 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 12.9 mtp180 -71.47 -32.09 67.88 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.238 179.02 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 200' ' ' GLU . . . . . 0.501 ' N ' ' O ' ' A' ' 197' ' ' LYS . 0.4 OUTLIER -82.51 -45.66 14.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.086 0.469 . . . . 0.0 110.65 179.424 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.504 ' C ' ' CD1' ' A' ' 201' ' ' TYR . 0.2 OUTLIER -63.92 -52.91 57.67 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.006 179.2 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 1.029 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -79.68 -32.57 41.44 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.222 -179.799 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.579 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -64.98 -53.42 34.01 Favored Glycine 0 CA--C 1.498 -1.002 0 N-CA-C 106.579 -2.608 . . . . 0.0 106.579 175.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -51.18 -28.81 19.96 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 176.035 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.761 ' CE2' HG13 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -57.45 -47.69 81.15 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 122.268 1.033 . . . . 0.0 108.341 177.856 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.481 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 174.04 -129.25 1.6 Allowed Glycine 0 N--CA 1.441 -0.98 0 CA-C-N 113.36 -1.745 . . . . 0.0 110.12 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.518 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 5.0 mm-40 -97.14 100.42 11.9 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.274 0.559 . . . . 0.0 111.424 178.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.408 HG22 ' CE1' ' A' ' 230' ' ' PHE . 2.6 t -76.98 139.47 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.151 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 177.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 209' ' ' GLU . . . . . 0.765 ' HB3' HG22 ' A' ' 229' ' ' THR . 21.0 tp10 -91.73 -49.84 6.06 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 178.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 9.8 p -166.93 152.84 8.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.187 0.518 . . . . 0.0 112.09 179.407 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.736 HD12 ' HB ' ' A' ' 198' ' ' ILE . 0.1 OUTLIER -125.43 120.22 57.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.114 178.956 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.501 ' OE1' ' N7 ' ' B' ' 4' ' ' ' DG' . 0.4 OUTLIER -123.63 103.65 8.55 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -178.303 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.528 HD13 ' O ' ' A' ' 193' ' ' THR . 0.0 OUTLIER -95.67 105.78 22.99 Favored Pre-proline 0 C--N 1.332 -0.193 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 177.46 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.569 ' HD2' ' O ' ' A' ' 225' ' ' PHE . 7.0 Cg_exo -75.69 122.29 6.8 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 123.011 2.474 . . . . 0.0 112.968 -179.073 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 9.5 ptp -128.89 130.81 47.33 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.004 179.126 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.469 ' O ' ' HA ' ' A' ' 220' ' ' ASN . 2.1 t0 -111.42 106.01 14.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.974 0.416 . . . . 0.0 111.448 -179.552 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -83.43 -14.0 53.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.518 179.048 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -78.35 -50.88 10.95 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.435 -179.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.07 -28.46 6.6 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.375 -179.465 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 220' ' ' ASN . . . . . 0.469 ' HA ' ' O ' ' A' ' 216' ' ' ASP . 14.1 m-80 62.69 61.16 1.22 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.807 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -65.41 171.91 3.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.541 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.64 ' O ' ' CG ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -95.31 33.33 1.59 Allowed 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 122.684 1.231 . . . . 0.0 110.162 -179.899 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.572 ' HB2' ' CE1' ' A' ' 225' ' ' PHE . 8.1 ptp85 -71.06 -30.38 66.52 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.489 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.511 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 8.84 66.56 0.01 OUTLIER Glycine 0 C--N 1.335 0.496 0 CA-C-N 114.658 -1.156 . . . . 0.0 113.405 178.125 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.859 ' CA ' HD23 ' A' ' 189' ' ' LEU . 1.1 p90 -156.13 176.24 12.93 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 -179.484 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 226' ' ' CYS . . . . . 0.875 ' SG ' HD22 ' A' ' 189' ' ' LEU . 0.8 OUTLIER -144.46 154.62 43.13 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.439 -0.504 . . . . 0.0 112.137 -179.08 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 1.108 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 6.3 m-85 -108.52 139.91 42.61 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.167 179.289 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 1.029 HD12 ' CE2' ' A' ' 202' ' ' PHE . 2.2 mt -135.51 122.08 33.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.959 0.409 . . . . 0.0 110.923 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.765 HG22 ' HB3' ' A' ' 209' ' ' GLU . 28.8 m -103.33 138.32 40.25 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.674 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.835 ' HE2' HD13 ' A' ' 184' ' ' ILE . 71.4 m-85 -113.34 126.25 55.16 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.265 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.524 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -47.96 -39.11 18.4 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 178.404 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 232' ' ' GLU . . . . . 0.462 ' O ' ' HG3' ' A' ' 182' ' ' LYS . 3.3 mm-40 -100.95 171.43 7.65 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 113.414 -1.721 . . . . 0.0 109.202 178.76 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 233' ' ' GLU . . . . . 0.541 ' O ' ' HG3' ' A' ' 237' ' ' LYS . 4.2 pt-20 -107.97 12.01 27.38 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -179.099 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.538 ' O ' ' N ' ' A' ' 237' ' ' LYS . 0.1 OUTLIER -77.54 -60.71 0.7 Allowed Pre-proline 0 N--CA 1.465 0.283 0 C-N-CA 120.479 -0.488 . . . . 0.0 111.38 -179.787 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.914 ' O ' HD12 ' A' ' 239' ' ' ILE . 90.7 Cg_exo -49.45 -31.26 23.1 Favored 'Trans proline' 0 CA--C 1.499 -1.246 0 N-CA-C 108.671 -1.319 . . . . 0.0 108.671 178.279 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.963 HG21 ' HB2' ' A' ' 182' ' ' LYS . 21.5 t -69.25 -42.58 81.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 113.856 -1.52 . . . . 0.0 108.381 177.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.543 ' O ' ' CG ' ' A' ' 241' ' ' GLU . 2.8 mtpt -58.11 -45.4 87.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.529 178.473 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.537 ' CD ' ' O ' ' A' ' 234' ' ' GLU . 0.0 OUTLIER -73.47 -51.91 15.48 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.398 0.618 . . . . 0.0 111.22 -179.535 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.914 HD12 ' O ' ' A' ' 235' ' ' PRO . 1.9 mt -48.66 -49.46 14.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 114.79 -1.095 . . . . 0.0 112.911 -178.329 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 240' ' ' MET . . . . . 0.473 ' SD ' HG12 ' A' ' 236' ' ' VAL . 54.2 mtp -61.1 -29.03 69.51 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.699 -178.152 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.543 ' CG ' ' O ' ' A' ' 237' ' ' LYS . 0.3 OUTLIER -84.75 -13.15 52.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.87 0.367 . . . . 0.0 110.563 179.696 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.497 ' N ' ' HD3' ' A' ' 242' ' ' LYS . 0.7 OUTLIER -87.17 99.22 11.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.049 -179.934 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.593 ' HE3' ' CG ' ' A' ' 244' ' ' TYR . 8.1 ttpt -37.89 -73.51 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.23 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.593 ' CG ' ' HE3' ' A' ' 243' ' ' LYS . 8.7 m-30 -111.68 150.8 29.66 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.599 179.153 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 245' ' ' HIS . . . . . 0.803 ' CG ' HD12 ' A' ' 254' ' ' ILE . 17.6 m-70 -113.66 154.09 27.83 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.847 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -134.91 104.69 6.08 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.215 0.531 . . . . 0.0 110.01 178.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.694 HG12 ' H ' ' A' ' 248' ' ' GLY . 1.6 t -96.94 -173.42 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.728 -179.067 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 248' ' ' GLY . . . . . 0.694 ' H ' HG12 ' A' ' 247' ' ' VAL . . . -25.17 -62.27 0.06 OUTLIER Glycine 0 C--N 1.337 0.635 0 C-N-CA 121.2 -0.524 . . . . 0.0 112.964 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.633 HD23 ' C ' ' A' ' 248' ' ' GLY . 0.0 OUTLIER -126.89 -38.69 2.01 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.399 0.619 . . . . 0.0 110.726 179.796 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.467 ' OG ' ' OG1' ' A' ' 193' ' ' THR . 1.2 m -77.54 151.08 34.68 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.919 -1.037 . . . . 0.0 112.567 -178.183 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.5 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -140.01 105.89 5.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.922 -1.035 . . . . 0.0 108.722 179.135 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 252' ' ' CYS . . . . . 0.595 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -128.12 153.54 46.74 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -176.624 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 253' ' ' GLU . . . . . 0.581 ' HB2' ' CE1' ' A' ' 244' ' ' TYR . 64.1 tt0 -75.98 109.96 10.05 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.674 178.698 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.803 HD12 ' CG ' ' A' ' 245' ' ' HIS . 37.0 mt -97.02 113.03 30.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -178.089 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.519 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -114.1 131.94 56.23 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 176.89 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 183' ' ' LYS . 9.8 p -33.59 127.56 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-O 122.084 0.945 . . . . 0.0 111.328 -178.079 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 1.108 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -80.18 152.82 28.98 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 113.656 -1.611 . . . . 0.0 112.268 -178.446 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.47 116.8 16.43 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.595 -1.184 . . . . 0.0 110.416 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.323 -0.547 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.114 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 2' ' ' ' DT' . . . . . 0.88 ' O2 ' " H2'" ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.429 -0.712 0 C1'-O4'-C4' 110.443 0.531 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 3' ' ' ' DA' . . . . . 0.964 " H4'" " O5'" ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.424 -0.997 0 C4'-C3'-C2' 104.517 1.317 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 4' ' ' ' DG' . . . . . 0.964 " O5'" " H4'" ' B' ' 3' ' ' ' DA' . . . . . . . . 0 C4'--C3' 1.52 -0.844 0 C4'-C3'-C2' 101.668 -1.532 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 5' ' ' ' DG' . . . . . 0.618 ' N7 ' ' C5 ' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 C2'--C1' 1.509 -0.876 0 O4'-C1'-N19 108.107 0.383 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.508 ' CG1' ' N ' ' A' ' 182' ' ' LYS . 38.4 t . . . . . 0 CA--C 1.503 -0.84 0 CA-C-O 121.268 0.556 . . . . 0.0 112.04 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.595 ' CB ' HG21 ' A' ' 236' ' ' VAL . 4.6 mmtt -143.62 112.89 6.82 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.362 177.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.84 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.7 OUTLIER -130.59 152.44 49.96 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.343 179.438 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.904 HD13 ' HE1' ' A' ' 230' ' ' PHE . 0.5 OUTLIER -127.37 119.83 53.35 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.096 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.868 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -92.35 108.96 20.35 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.614 0.721 . . . . 0.0 110.156 -178.842 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 1.031 HG12 ' HB2' ' A' ' 252' ' ' CYS . 2.4 t -85.53 118.74 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.254 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.55 ' O ' ' HB3' ' A' ' 252' ' ' CYS . . . -104.97 131.14 10.52 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.271 -0.877 . . . . 0.0 115.026 -176.33 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.578 ' HA3' ' C6 ' ' B' ' 2' ' ' ' DT' . . . 71.73 85.15 0.2 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 121.352 -0.451 . . . . 0.0 112.764 178.736 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.963 HD13 ' OG1' ' A' ' 193' ' ' THR . 0.5 OUTLIER -115.47 157.29 24.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.941 0.401 . . . . 0.0 111.268 -179.534 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.625 ' N ' HD12 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -48.0 -169.26 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.751 179.347 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.619 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 17.7 Cg_endo -87.38 22.64 0.89 Allowed 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.403 2.068 . . . . 0.0 112.755 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.542 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 1.9 p30 157.05 76.26 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 111.623 0.231 . . . . 0.0 111.623 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.963 ' OG1' HD13 ' A' ' 189' ' ' LEU . 92.0 m -74.79 111.21 12.22 Favored Pre-proline 0 N--CA 1.464 0.236 0 CA-C-O 120.891 0.377 . . . . 0.0 110.908 179.31 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.572 ' HG2' ' CG ' ' A' ' 197' ' ' LYS . 16.6 Cg_endo -59.51 109.59 0.59 Allowed 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.367 2.045 . . . . 0.0 111.642 179.189 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.825 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.3 OUTLIER -50.84 -15.91 0.35 Allowed 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.754 -179.449 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 196' ' ' GLU . . . . . 0.512 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 5.6 mt-10 -69.0 -38.16 79.13 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.572 ' CG ' ' HG2' ' A' ' 194' ' ' PRO . 0.2 OUTLIER -73.25 -50.87 19.95 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.209 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.825 ' CG1' ' HA ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -46.77 -31.0 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.727 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.571 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 2.6 mtt180 -70.96 -33.9 70.92 Favored 'General case' 0 C--O 1.221 -0.441 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.373 178.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 200' ' ' GLU . . . . . 0.583 ' CG ' ' N ' ' A' ' 201' ' ' TYR . 3.2 pt-20 -82.14 -54.66 5.1 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.284 0.564 . . . . 0.0 110.162 179.421 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.583 ' N ' ' CG ' ' A' ' 200' ' ' GLU . 0.5 OUTLIER -53.69 -53.12 56.47 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.966 178.905 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 1.147 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.2 OUTLIER -79.84 -31.8 40.55 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.664 -179.933 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.571 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -63.81 -55.47 24.5 Favored Glycine 0 CA--C 1.498 -1.003 0 N-CA-C 106.799 -2.52 . . . . 0.0 106.799 176.441 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -50.16 -29.2 14.94 Favored Glycine 0 N--CA 1.443 -0.882 0 N-CA-C 109.694 -1.363 . . . . 0.0 109.694 176.076 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.765 ' CE2' HG13 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -57.18 -45.28 83.84 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 122.157 0.98 . . . . 0.0 108.456 177.849 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 171.02 -129.71 1.84 Allowed Glycine 0 N--CA 1.441 -0.976 0 CA-C-N 113.567 -1.651 . . . . 0.0 110.31 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.526 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 20.9 mm-40 -96.99 101.52 13.12 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.148 0.499 . . . . 0.0 111.081 178.722 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 2.5 t -77.94 142.54 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.25 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 209' ' ' GLU . . . . . 0.81 ' HB3' HG22 ' A' ' 229' ' ' THR . 5.5 tp10 -91.66 -52.23 4.86 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 178.403 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 2.6 m -175.16 149.72 1.1 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.985 178.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.901 HD13 HG23 ' A' ' 228' ' ' ILE . 0.4 OUTLIER -113.96 129.55 69.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.147 178.656 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.436 ' O ' ' HD3' ' A' ' 214' ' ' PRO . 0.0 OUTLIER -123.35 104.79 9.33 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -178.126 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.667 HD21 ' HB ' ' A' ' 193' ' ' THR . 0.1 OUTLIER -96.33 105.62 23.59 Favored Pre-proline 0 CA--C 1.531 0.238 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 177.634 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.611 ' HD2' ' O ' ' A' ' 225' ' ' PHE . 4.6 Cg_exo -82.93 131.1 5.92 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 123.362 2.708 . . . . 0.0 112.217 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 88.2 mmm -135.23 130.44 35.22 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.033 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.486 ' OD1' ' NH1' ' A' ' 223' ' ' ARG . 0.9 OUTLIER -114.94 105.86 13.48 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.981 0.419 . . . . 0.0 110.551 179.581 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -83.63 -14.63 51.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.548 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -90.03 -38.05 13.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.56 -179.283 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 5.0 t -112.35 -32.6 6.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.248 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 54.44 56.26 7.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.841 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 31.9 mtpt -63.88 173.66 1.74 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.98 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.633 ' CD ' ' O ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -92.21 22.23 4.59 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 122.271 1.034 . . . . 0.0 109.845 179.72 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.567 ' O ' ' N ' ' A' ' 225' ' ' PHE . 2.5 ptp85 -71.4 -25.09 62.2 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.36 178.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.529 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . -10.32 77.16 0.0 OUTLIER Glycine 0 C--N 1.344 1.015 0 O-C-N 124.459 1.099 . . . . 0.0 112.219 179.097 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.948 ' C ' HD23 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -156.85 176.71 12.39 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.703 -0.748 . . . . 0.0 109.652 -177.43 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 226' ' ' CYS . . . . . 0.483 ' O ' ' HB ' ' A' ' 186' ' ' VAL . 31.7 p -138.56 147.65 43.28 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.059 -0.656 . . . . 0.0 112.567 -179.32 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 1.122 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 4.0 m-85 -107.26 133.06 52.38 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.098 -0.956 . . . . 0.0 109.412 178.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 1.147 HD12 ' CE2' ' A' ' 202' ' ' PHE . 1.8 mt -127.32 123.91 62.89 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 CA-C-O 121.23 0.538 . . . . 0.0 111.395 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.81 HG22 ' HB3' ' A' ' 209' ' ' GLU . 19.8 m -105.15 138.39 41.43 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.344 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.904 ' HE1' HD13 ' A' ' 184' ' ' ILE . 72.6 m-85 -114.11 126.32 54.95 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.471 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.526 ' HG3' ' O ' ' A' ' 207' ' ' GLU . 0.0 OUTLIER -47.7 -39.12 16.67 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 178.139 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -94.34 -168.18 1.8 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 113.325 -1.762 . . . . 0.0 109.995 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 233' ' ' GLU . . . . . 0.539 ' HB3' ' CD ' ' A' ' 182' ' ' LYS . 1.1 pm0 -129.79 10.12 5.5 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.55 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.4 OUTLIER -80.0 -60.22 0.51 Allowed Pre-proline 0 C--N 1.328 -0.338 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.42 179.895 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.911 ' O ' HD12 ' A' ' 239' ' ' ILE . 87.5 Cg_exo -50.32 -29.67 24.19 Favored 'Trans proline' 0 CA--C 1.5 -1.19 0 N-CA-C 108.909 -1.227 . . . . 0.0 108.909 177.731 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.595 HG21 ' CB ' ' A' ' 182' ' ' LYS . 15.9 t -72.4 -44.7 62.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 113.971 -1.468 . . . . 0.0 109.905 178.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.55 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 0.2 OUTLIER -65.51 -35.52 81.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.84 -179.707 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.498 ' O ' ' CG ' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -80.99 -47.86 13.05 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.928 0.394 . . . . 0.0 110.857 179.14 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.911 HD12 ' O ' ' A' ' 235' ' ' PRO . 1.6 mt -49.33 -50.93 15.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.468 -179.392 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 240' ' ' MET . . . . . 0.436 ' SD ' ' O ' ' A' ' 236' ' ' VAL . 10.3 mtp -59.09 -29.1 67.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.795 0.331 . . . . 0.0 111.246 -178.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.498 ' CG ' ' O ' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -79.54 -21.26 45.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.063 0.459 . . . . 0.0 111.241 -179.734 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.411 ' HD3' ' HG3' ' A' ' 241' ' ' GLU . 5.5 mmtp -78.77 118.5 20.9 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.371 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.56 ' HE3' ' CD2' ' A' ' 244' ' ' TYR . 2.9 ttpt -44.81 -74.58 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.56 ' CD2' ' HE3' ' A' ' 243' ' ' LYS . 16.2 m-30 -121.95 153.92 37.85 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.072 178.586 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 245' ' ' HIS . . . . . 0.702 ' CD2' HD12 ' A' ' 254' ' ' ILE . 34.8 m-70 -109.9 146.56 34.94 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.03 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 34.0 m-20 -122.11 105.03 9.9 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.102 0.477 . . . . 0.0 110.149 178.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.557 ' O ' ' N ' ' A' ' 249' ' ' LEU . 2.2 t -107.71 127.42 63.73 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.631 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 248' ' ' GLY . . . . . 0.436 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . 34.77 -89.89 0.01 OUTLIER Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.431 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.557 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.1 OUTLIER -108.67 -37.77 5.82 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 121.706 0.765 . . . . 0.0 110.269 -179.887 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.433 ' HB3' ' H ' ' A' ' 190' ' ' SER . 1.4 m -77.8 154.17 32.15 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.494 -1.23 . . . . 0.0 112.547 -178.242 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -149.37 110.63 4.41 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.824 179.375 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 252' ' ' CYS . . . . . 1.031 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -129.38 152.84 48.49 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -177.619 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 253' ' ' GLU . . . . . 0.551 ' HB2' ' CE1' ' A' ' 244' ' ' TYR . 52.4 tt0 -76.41 110.86 11.29 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.917 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.919 HG12 HG13 ' A' ' 186' ' ' VAL . 14.9 mt -96.12 112.7 28.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 -177.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.513 ' O ' ' C ' ' A' ' 256' ' ' VAL . 0.0 OUTLIER -116.3 131.96 56.8 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 176.179 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 183' ' ' LYS . 3.4 p -32.87 123.07 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 CA-C-O 122.235 1.017 . . . . 0.0 111.555 -177.475 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 1.122 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -78.35 152.41 32.36 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 113.34 -1.755 . . . . 0.0 112.28 -178.402 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.84 110.48 15.49 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.7 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 259' ' ' SER . . . . . 0.505 ' HB3' ' HD2' ' A' ' 183' ' ' LYS . 69.5 p . . . . . 0 C--N 1.327 -0.395 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.771 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 2' ' ' ' DT' . . . . . 0.686 ' O2 ' " H2'" ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.427 -0.803 0 O4'-C1'-C2' 106.646 0.497 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 3' ' ' ' DA' . . . . . 0.531 " H4'" H5'' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.428 -0.773 0 C3'-C2'-C1' 105.368 1.906 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 4' ' ' ' DG' . . . . . 1.021 H2'' " O5'" ' B' ' 5' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.427 -0.796 0 C4'-C3'-C2' 101.994 -1.206 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 5' ' ' ' DG' . . . . . 1.021 " O5'" H2'' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.424 -1.024 0 O4'-C1'-C2' 107.112 0.92 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.494 ' O ' ' HD3' ' A' ' 182' ' ' LYS . 40.0 t . . . . . 0 CA--C 1.503 -0.852 0 CA-C-O 121.35 0.595 . . . . 0.0 112.036 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.829 ' HB2' HG21 ' A' ' 236' ' ' VAL . 0.0 OUTLIER -144.89 112.17 6.06 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.841 177.36 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.886 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -130.85 151.51 51.19 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.954 178.973 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.859 HD13 ' HE2' ' A' ' 230' ' ' PHE . 0.4 OUTLIER -128.09 120.21 52.97 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.408 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.853 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -92.67 109.03 20.44 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.35 0.595 . . . . 0.0 110.57 -178.806 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 1.019 HG12 ' HB2' ' A' ' 252' ' ' CYS . 2.4 t -85.4 124.47 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 CA-C-N 114.781 -1.1 . . . . 0.0 109.327 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.59 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . -113.01 126.06 7.3 Favored Glycine 0 C--N 1.331 0.296 0 N-CA-C 114.555 0.582 . . . . 0.0 114.555 -176.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.512 ' HA3' ' H71' ' B' ' 2' ' ' ' DT' . . . 80.37 84.66 0.67 Allowed Glycine 0 C--N 1.331 0.266 0 C-N-CA 121.337 -0.458 . . . . 0.0 113.151 179.356 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.953 HD23 ' C ' ' A' ' 225' ' ' PHE . 0.7 OUTLIER -117.31 157.32 26.31 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.831 0.348 . . . . 0.0 111.154 -179.573 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.586 ' O ' HD12 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -49.34 -172.07 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.765 179.537 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.583 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 94.7 Cg_endo -81.61 25.44 0.65 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.293 1.995 . . . . 0.0 113.598 -179.253 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.575 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 8.0 t70 150.78 79.77 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.778 0.323 . . . . 0.0 110.974 179.604 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.882 HG22 ' CD1' ' A' ' 198' ' ' ILE . 62.0 m -75.28 111.98 16.44 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.759 179.647 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.559 ' HG2' ' CG ' ' A' ' 197' ' ' LYS . 18.8 Cg_endo -60.1 112.2 1.22 Allowed 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.097 1.864 . . . . 0.0 110.812 178.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.821 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 7.4 pt-20 -51.85 -14.84 0.41 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.438 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 196' ' ' GLU . . . . . 0.459 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 1.3 mm-40 -67.12 -37.21 83.48 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.559 ' CG ' ' HG2' ' A' ' 194' ' ' PRO . 0.4 OUTLIER -74.97 -49.8 18.78 Favored 'General case' 0 CA--C 1.495 -1.139 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.193 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.882 ' CD1' HG22 ' A' ' 193' ' ' THR . 0.0 OUTLIER -47.26 -31.81 2.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.594 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.58 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 16.0 mtp180 -69.13 -33.61 73.73 Favored 'General case' 0 C--O 1.221 -0.44 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.177 178.633 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 200' ' ' GLU . . . . . 0.529 ' N ' ' O ' ' A' ' 197' ' ' LYS . 3.2 mt-10 -82.57 -59.35 2.55 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.452 0.644 . . . . 0.0 109.903 178.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.487 ' C ' ' CD1' ' A' ' 201' ' ' TYR . 0.6 OUTLIER -49.07 -54.36 16.33 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.931 179.083 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 1.068 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.2 OUTLIER -79.85 -30.99 40.45 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.597 -179.962 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.58 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -62.52 -56.79 19.54 Favored Glycine 0 CA--C 1.499 -0.965 0 N-CA-C 107.202 -2.359 . . . . 0.0 107.202 176.576 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -49.08 -28.93 8.37 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 176.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.78 ' CD2' HD11 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -58.38 -44.28 88.82 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 177.788 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 203' ' ' GLY . . . 169.65 -130.58 2.07 Favored Glycine 0 N--CA 1.443 -0.837 0 CA-C-N 113.708 -1.587 . . . . 0.0 110.579 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.478 ' C ' ' HG3' ' A' ' 231' ' ' LYS . 54.8 mm-40 -97.05 100.2 11.7 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.27 0.557 . . . . 0.0 111.256 178.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.451 HG21 ' HB2' ' A' ' 202' ' ' PHE . 2.9 t -77.64 137.64 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.056 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 209' ' ' GLU . . . . . 0.529 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 25.3 tp10 -92.84 -54.37 3.78 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 120.686 0.279 . . . . 0.0 110.341 178.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.443 ' C ' HG12 ' A' ' 211' ' ' ILE . 1.4 p -157.46 158.03 35.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.306 0.574 . . . . 0.0 112.182 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.743 HD12 ' HB ' ' A' ' 198' ' ' ILE . 0.1 OUTLIER -133.2 126.06 52.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.366 179.108 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.529 ' OE1' ' N7 ' ' B' ' 4' ' ' ' DG' . 0.7 OUTLIER -123.49 108.68 12.93 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 114.147 1.165 . . . . 0.0 114.147 -177.45 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.89 HD13 ' HB2' ' A' ' 226' ' ' CYS . 1.3 mm? -96.49 105.9 25.86 Favored Pre-proline 0 CA--C 1.531 0.249 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 176.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.512 ' HD2' ' O ' ' A' ' 225' ' ' PHE . 84.5 Cg_endo -82.43 136.02 8.51 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.881 2.388 . . . . 0.0 113.502 -178.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 4.1 mtp -135.43 133.46 38.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.379 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.508 ' HB2' ' NH1' ' A' ' 223' ' ' ARG . 3.3 t0 -113.21 106.54 14.76 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.988 0.423 . . . . 0.0 111.425 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -83.35 -22.7 32.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.575 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 10.1 mttm -84.14 -51.68 6.87 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -178.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -106.96 -25.2 11.73 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.498 -179.16 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 220' ' ' ASN . . . . . 0.439 ' HA ' ' O ' ' A' ' 216' ' ' ASP . 0.5 OUTLIER 49.25 60.13 3.98 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.791 0.329 . . . . 0.0 110.821 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 221' ' ' LYS . . . . . 0.53 ' HD3' ' CZ ' ' A' ' 223' ' ' ARG . 0.1 OUTLIER -67.21 175.22 2.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.116 -179.886 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.626 ' O ' ' CG ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -93.42 37.8 1.05 Allowed 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 122.755 1.264 . . . . 0.0 110.041 180.0 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.569 ' O ' ' N ' ' A' ' 225' ' ' PHE . 5.9 ptp85 -71.65 -27.08 62.83 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 121.569 -0.707 . . . . 0.0 109.134 178.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.521 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . -1.77 68.92 0.0 OUTLIER Glycine 0 C--N 1.341 0.834 0 O-C-N 124.619 1.199 . . . . 0.0 112.921 179.118 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.953 ' C ' HD23 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -157.27 176.62 12.46 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -178.5 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 226' ' ' CYS . . . . . 0.89 ' HB2' HD13 ' A' ' 213' ' ' LEU . 2.7 p -140.22 151.91 45.56 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.336 -0.546 . . . . 0.0 112.154 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 1.101 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 4.2 m-85 -111.11 137.43 48.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.472 178.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 1.068 HD12 ' CE2' ' A' ' 202' ' ' PHE . 2.1 mt -131.32 141.84 44.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.131 0.491 . . . . 0.0 111.146 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.441 HG22 ' HB3' ' A' ' 209' ' ' GLU . 97.5 m -122.6 137.94 54.74 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.58 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.859 ' HE2' HD13 ' A' ' 184' ' ' ILE . 66.2 m-85 -111.83 126.44 55.09 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.93 -179.468 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.529 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -50.51 -37.77 40.74 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 106.622 -1.622 . . . . 0.0 106.622 177.696 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 232' ' ' GLU . . . . . 0.505 ' O ' ' HG3' ' A' ' 182' ' ' LYS . 15.2 mt-10 -89.86 -168.96 2.28 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 112.929 -1.941 . . . . 0.0 108.914 178.425 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 233' ' ' GLU . . . . . 0.509 ' CB ' ' HD2' ' A' ' 182' ' ' LYS . 2.3 pm0 -131.07 1.02 4.23 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.246 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.515 ' O ' ' N ' ' A' ' 237' ' ' LYS . 0.4 OUTLIER -75.13 -57.62 1.71 Allowed Pre-proline 0 C--N 1.331 -0.222 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -179.415 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.879 ' O ' HD12 ' A' ' 239' ' ' ILE . 98.5 Cg_exo -49.09 -31.83 22.3 Favored 'Trans proline' 0 CA--C 1.498 -1.275 0 N-CA-C 109.027 -1.182 . . . . 0.0 109.027 178.584 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.829 HG21 ' HB2' ' A' ' 182' ' ' LYS . 17.5 t -69.52 -41.57 80.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 113.883 -1.508 . . . . 0.0 108.855 178.149 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.515 ' N ' ' O ' ' A' ' 234' ' ' GLU . 22.7 mttt -59.47 -48.15 82.75 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.916 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.495 ' O ' ' HG3' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -76.86 -46.16 25.69 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.169 -179.238 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.879 HD12 ' O ' ' A' ' 235' ' ' PRO . 1.8 mt -49.04 -47.12 17.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.213 -0.449 . . . . 0.0 112.051 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 240' ' ' MET . . . . . 0.482 ' SD ' HG12 ' A' ' 236' ' ' VAL . 44.4 mtp -63.92 -17.73 63.52 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.022 -178.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.495 ' HG3' ' O ' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -86.97 -27.73 23.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.686 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.477 ' HG2' ' O ' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -86.79 92.7 9.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.438 179.503 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.505 ' N ' ' HD3' ' A' ' 243' ' ' LYS . 0.0 OUTLIER -36.28 -48.9 0.66 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.996 0.427 . . . . 0.0 110.31 -179.947 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.575 ' CE1' ' HG3' ' A' ' 253' ' ' GLU . 22.1 m-85 -122.3 157.56 31.47 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.836 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 245' ' ' HIS . . . . . 0.777 ' CG ' HD12 ' A' ' 254' ' ' ILE . 29.8 m-70 -127.79 156.83 41.86 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.917 -179.657 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 246' ' ' ASN . . . . . 0.4 ' O ' ' CE2' ' A' ' 201' ' ' TYR . 6.2 m120 -129.15 105.15 7.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.124 0.487 . . . . 0.0 110.602 179.121 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.563 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.5 t -109.7 125.98 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.677 -179.583 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 248' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . 35.46 -89.19 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.504 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.563 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.1 OUTLIER -108.15 -35.88 6.45 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.777 0.798 . . . . 0.0 110.085 -179.679 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.506 ' HB3' ' HB2' ' A' ' 190' ' ' SER . 0.8 OUTLIER -77.92 154.46 31.63 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.322 -1.308 . . . . 0.0 112.959 -177.836 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.487 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -149.95 107.88 3.71 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.063 -0.972 . . . . 0.0 108.973 179.069 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 252' ' ' CYS . . . . . 1.019 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -128.78 153.33 47.5 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 -176.762 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 253' ' ' GLU . . . . . 0.575 ' HG3' ' CE1' ' A' ' 244' ' ' TYR . 31.7 tt0 -75.93 108.91 9.13 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.033 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.894 HG12 HG13 ' A' ' 186' ' ' VAL . 19.1 mt -96.48 113.1 30.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 -178.309 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.516 ' O ' ' C ' ' A' ' 256' ' ' VAL . 0.0 OUTLIER -119.6 133.37 55.69 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 176.516 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 183' ' ' LYS . 3.1 p -32.69 121.47 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 CA-C-O 122.218 1.009 . . . . 0.0 111.557 -177.524 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 1.101 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -76.52 153.71 35.23 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 113.353 -1.748 . . . . 0.0 112.07 -178.371 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -127.88 113.67 16.2 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.898 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 259' ' ' SER . . . . . 0.448 ' HB2' ' HD2' ' A' ' 183' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.519 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.073 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 2' ' ' ' DT' . . . . . 0.635 ' O2 ' " H2'" ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.427 -0.795 0 C1'-O4'-C4' 110.383 0.488 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 3' ' ' ' DA' . . . . . 0.608 H5'' ' CE1' ' A' ' 225' ' ' PHE . . . . . . . . 0 O4'--C1' 1.408 -0.949 0 C4'-C3'-C2' 104.736 1.536 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 4' ' ' ' DG' . . . . . 0.752 H2'' " O5'" ' B' ' 5' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.426 -0.874 0 C4'-C3'-C2' 101.976 -1.224 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 5' ' ' ' DG' . . . . . 0.752 " O5'" H2'' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.426 -0.871 0 O4'-C1'-C2' 106.934 0.758 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.495 ' C ' ' CD ' ' A' ' 182' ' ' LYS . 55.2 t . . . . . 0 CA--C 1.501 -0.936 0 CA-C-O 121.11 0.481 . . . . 0.0 111.47 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.925 ' HB2' HG21 ' A' ' 236' ' ' VAL . 0.0 OUTLIER -152.68 111.78 3.83 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.088 177.346 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.915 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.5 OUTLIER -136.36 167.86 20.52 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.693 179.04 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.725 ' C ' ' HB2' ' A' ' 257' ' ' ALA . 0.3 OUTLIER -144.1 121.66 5.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.09 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.818 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.3 OUTLIER -96.36 108.97 21.57 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.454 -0.898 . . . . 0.0 109.679 -179.734 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 1.097 HG12 ' HB2' ' A' ' 252' ' ' CYS . 1.7 t -87.7 127.23 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.729 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.593 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . -114.71 124.54 6.42 Favored Glycine 0 C--N 1.331 0.282 0 N-CA-C 114.647 0.619 . . . . 0.0 114.647 -176.437 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.453 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . 82.12 85.83 0.75 Allowed Glycine 0 CA--C 1.518 0.28 0 C-N-CA 121.277 -0.487 . . . . 0.0 113.108 179.282 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.931 HD23 ' C ' ' A' ' 225' ' ' PHE . 0.8 OUTLIER -117.46 157.27 26.53 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.742 0.306 . . . . 0.0 111.367 -179.564 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.618 ' O ' HD12 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -49.83 -170.84 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.228 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.843 179.615 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.607 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 95.7 Cg_endo -83.46 24.07 0.78 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.44 2.093 . . . . 0.0 113.381 -179.366 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.546 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 4.3 t0 154.67 77.19 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.72 0.295 . . . . 0.0 111.201 179.508 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.851 ' OG1' HD13 ' A' ' 189' ' ' LEU . 86.4 m -74.26 111.39 12.48 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 120.869 0.366 . . . . 0.0 110.957 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.527 ' HG2' ' HG2' ' A' ' 197' ' ' LYS . 19.3 Cg_endo -61.04 112.58 1.42 Allowed 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.248 1.965 . . . . 0.0 111.144 179.011 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.835 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 1.6 pm0 -51.9 -15.27 0.49 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.434 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 196' ' ' GLU . . . . . 0.498 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 40.6 mm-40 -66.94 -38.27 85.83 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.549 ' O ' ' N ' ' A' ' 200' ' ' GLU . 0.1 OUTLIER -74.04 -51.09 16.91 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.214 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.896 HG22 ' CE1' ' A' ' 202' ' ' PHE . 0.0 OUTLIER -47.52 -29.88 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.338 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.585 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 0.1 OUTLIER -70.9 -33.79 70.92 Favored 'General case' 0 C--O 1.22 -0.448 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.876 178.559 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 200' ' ' GLU . . . . . 0.578 ' CG ' ' N ' ' A' ' 201' ' ' TYR . 2.3 pt-20 -83.17 -56.47 3.76 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.857 0.361 . . . . 0.0 110.662 179.221 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.578 ' N ' ' CG ' ' A' ' 200' ' ' GLU . 0.2 OUTLIER -51.07 -53.5 33.31 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.427 0.632 . . . . 0.0 109.52 178.964 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 1.118 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.4 OUTLIER -79.65 -30.23 41.19 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.232 -179.913 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.585 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -62.11 -56.9 19.61 Favored Glycine 0 CA--C 1.498 -0.987 0 N-CA-C 106.763 -2.535 . . . . 0.0 106.763 176.234 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -49.41 -28.62 9.76 Favored Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 176.007 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.699 ' CD2' HD11 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -58.28 -42.4 86.5 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 177.99 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.493 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 166.96 -130.2 2.07 Favored Glycine 0 N--CA 1.441 -1.019 0 CA-C-N 113.709 -1.587 . . . . 0.0 109.895 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.533 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 9.4 mm-40 -96.82 100.85 12.37 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.322 0.582 . . . . 0.0 110.609 178.291 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.557 HG21 ' HB2' ' A' ' 202' ' ' PHE . 2.7 t -77.92 139.67 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.354 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 209' ' ' GLU . . . . . 0.539 ' HB3' HG22 ' A' ' 229' ' ' THR . 7.4 tp10 -89.75 -55.9 3.45 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 178.47 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 3.8 m -169.52 151.26 4.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.338 0.589 . . . . 0.0 112.069 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.882 HD12 ' HB ' ' A' ' 198' ' ' ILE . 0.4 OUTLIER -116.26 132.12 66.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.416 178.879 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.407 ' O ' ' HD3' ' A' ' 214' ' ' PRO . 1.0 OUTLIER -123.18 109.44 14.01 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -178.07 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.81 HD11 ' HB ' ' A' ' 193' ' ' THR . 1.6 mm? -96.59 106.37 29.36 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.873 177.6 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.565 ' HD2' ' O ' ' A' ' 225' ' ' PHE . 95.1 Cg_endo -86.27 129.97 3.35 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.736 2.291 . . . . 0.0 112.808 -179.665 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 2.2 mmt -135.25 132.92 38.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.609 179.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.51 ' O ' ' ND2' ' A' ' 220' ' ' ASN . 1.2 m-20 -107.6 106.23 16.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.878 0.371 . . . . 0.0 110.943 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -83.16 -10.56 58.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.171 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.35 -51.37 8.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.299 -179.611 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.9 -31.58 4.17 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.946 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 220' ' ' ASN . . . . . 0.51 ' ND2' ' O ' ' A' ' 216' ' ' ASP . 0.8 OUTLIER 70.78 56.7 0.23 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.969 179.835 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.4 -179.77 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.048 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.613 ' CD ' ' O ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -102.17 33.99 2.88 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 122.74 1.257 . . . . 0.0 109.668 179.783 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.557 ' O ' ' N ' ' A' ' 225' ' ' PHE . 4.7 ptp85 -71.98 -24.53 61.6 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.149 178.722 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.523 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . -4.29 72.35 0.0 OUTLIER Glycine 0 C--N 1.345 1.037 0 O-C-N 124.53 1.144 . . . . 0.0 112.744 179.327 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.931 ' C ' HD23 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -157.38 176.63 12.42 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.054 -0.573 . . . . 0.0 109.781 -178.309 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 226' ' ' CYS . . . . . 0.7 ' HB3' HD13 ' A' ' 213' ' ' LEU . 30.5 p -140.96 146.86 37.88 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.276 -0.57 . . . . 0.0 112.425 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 1.113 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 4.7 m-85 -106.76 134.91 49.19 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.355 178.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 1.118 HD12 ' CE2' ' A' ' 202' ' ' PHE . 1.8 mt -128.66 136.35 60.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.146 0.498 . . . . 0.0 111.374 -179.305 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.539 HG22 ' HB3' ' A' ' 209' ' ' GLU . 52.5 m -117.02 138.02 51.85 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.529 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.611 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 75.6 m-85 -111.83 126.29 54.93 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.394 179.587 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.533 ' HG3' ' O ' ' A' ' 207' ' ' GLU . 0.0 OUTLIER -45.0 -40.33 6.37 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 178.56 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 232' ' ' GLU . . . . . 0.469 ' O ' ' HG3' ' A' ' 182' ' ' LYS . 69.5 mt-10 -99.12 173.05 7.0 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 113.442 -1.708 . . . . 0.0 108.779 178.426 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 233' ' ' GLU . . . . . 0.521 ' O ' ' HG3' ' A' ' 237' ' ' LYS . 0.8 OUTLIER -112.0 13.17 20.74 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.58 -179.633 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.551 ' O ' ' HB2' ' A' ' 237' ' ' LYS . 0.6 OUTLIER -80.84 -60.38 0.44 Allowed Pre-proline 0 C--N 1.331 -0.213 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.7 -179.628 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.658 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 90.8 Cg_exo -48.7 -36.76 33.56 Favored 'Trans proline' 0 CA--C 1.495 -1.456 0 N-CA-C 108.61 -1.342 . . . . 0.0 108.61 178.455 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.925 HG21 ' HB2' ' A' ' 182' ' ' LYS . 17.2 t -62.66 -40.27 87.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 114.204 -1.362 . . . . 0.0 109.773 178.523 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.551 ' HB2' ' O ' ' A' ' 234' ' ' GLU . 8.3 mtpt -54.24 -49.21 70.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.957 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.499 ' HA ' ' HG3' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -80.91 -45.83 16.13 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.615 -179.236 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.791 ' CG2' HG21 ' A' ' 254' ' ' ILE . 0.7 OUTLIER -39.48 -59.11 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.256 -0.883 . . . . 0.0 111.818 -179.549 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 240' ' ' MET . . . . . 0.476 ' SD ' HG12 ' A' ' 236' ' ' VAL . 2.6 mtp -55.53 -27.68 50.27 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.435 -178.693 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.499 ' HG3' ' HA ' ' A' ' 238' ' ' LYS . 1.1 mt-10 -84.43 -13.87 50.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.937 0.399 . . . . 0.0 110.642 179.659 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.463 ' HB2' ' NE2' ' A' ' 245' ' ' HIS . 1.9 mptt -79.42 105.86 11.04 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.725 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.509 ' HD3' ' CD2' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -37.52 -67.18 0.2 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.05 -179.869 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.509 ' CD2' ' HD3' ' A' ' 243' ' ' LYS . 29.3 m-85 -132.71 143.28 49.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.971 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 245' ' ' HIS . . . . . 0.649 ' CD2' HD12 ' A' ' 254' ' ' ILE . 45.5 m-70 -108.81 127.93 54.45 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.354 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -102.25 105.28 15.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.034 0.445 . . . . 0.0 110.905 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.555 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.1 t -103.85 130.0 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.701 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 248' ' ' GLY . . . . . 0.451 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . 32.78 -89.91 0.01 OUTLIER Glycine 0 C--N 1.334 0.442 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.412 -179.633 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.555 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.1 OUTLIER -109.9 -34.74 6.34 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.843 0.83 . . . . 0.0 109.642 179.748 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.527 ' HB3' ' HB2' ' A' ' 190' ' ' SER . 1.9 p -77.16 152.44 34.85 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.172 -1.376 . . . . 0.0 112.65 -178.252 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -150.26 108.48 3.76 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.254 179.246 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 252' ' ' CYS . . . . . 1.097 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -127.54 153.15 46.71 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -177.381 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 253' ' ' GLU . . . . . 0.466 ' N ' ' O ' ' A' ' 187' ' ' GLY . 48.8 tt0 -76.07 113.68 13.87 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.552 -179.266 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.97 HG12 HG13 ' A' ' 186' ' ' VAL . 6.3 mt -96.75 113.33 30.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 -178.343 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.53 ' O ' ' C ' ' A' ' 256' ' ' VAL . 0.0 OUTLIER -122.67 128.15 50.22 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 105.569 -2.012 . . . . 0.0 105.569 176.346 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 183' ' ' LYS . 1.4 p -31.9 121.71 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 CA-C-O 122.244 1.021 . . . . 0.0 111.37 -176.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 1.113 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -75.85 153.85 36.53 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 113.27 -1.786 . . . . 0.0 111.768 -178.307 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.03 118.64 19.04 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.969 179.451 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 90.6 p . . . . . 0 C--N 1.326 -0.432 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.192 -179.514 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 2' ' ' ' DT' . . . . . 0.698 ' O2 ' " H2'" ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.427 -0.804 0 C3'-C2'-C1' 102.103 -0.427 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 3' ' ' ' DA' . . . . . 0.589 H5'' ' CE1' ' A' ' 225' ' ' PHE . . . . . . . . 0 O5'--C5' 1.427 -0.828 0 C4'-C3'-C2' 104.757 1.557 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 4' ' ' ' DG' . . . . . 0.852 H2'' " O5'" ' B' ' 5' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.427 -0.813 0 C4'-C3'-C2' 102.05 -1.15 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 5' ' ' ' DG' . . . . . 0.852 " O5'" H2'' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 C2'--C1' 1.508 -0.924 0 O4'-C1'-N19 108.146 0.432 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.507 HG12 ' N ' ' A' ' 182' ' ' LYS . 47.8 t . . . . . 0 CA--C 1.504 -0.805 0 CA-C-O 121.156 0.503 . . . . 0.0 111.671 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.56 ' HG2' ' CG ' ' A' ' 233' ' ' GLU . 0.0 OUTLIER -150.33 112.63 4.65 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.676 177.621 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.943 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.0 OUTLIER -138.51 148.27 44.08 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.218 178.484 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.906 HD13 ' HE2' ' A' ' 230' ' ' PHE . 0.3 OUTLIER -126.58 120.06 55.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.679 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.75 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.3 OUTLIER -92.98 109.6 21.06 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 121.44 0.638 . . . . 0.0 110.111 -179.164 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.765 HG13 HG12 ' A' ' 254' ' ' ILE . 5.8 t -88.72 118.49 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.161 -179.488 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.564 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . -62.11 -150.9 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 115.76 -0.654 . . . . 0.0 114.609 -178.004 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.48 ' O ' ' HB3' ' A' ' 252' ' ' CYS . . . -47.03 111.74 0.8 Allowed Glycine 0 C--N 1.33 0.234 0 CA-C-N 114.823 -0.688 . . . . 0.0 114.435 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.993 HD13 ' OG1' ' A' ' 193' ' ' THR . 3.3 pp -109.11 157.35 18.82 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.98 -0.61 . . . . 0.0 110.255 178.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.921 ' O ' HD12 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -42.74 178.13 0.01 OUTLIER Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 121.084 0.469 . . . . 0.0 111.034 179.726 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.548 ' HD2' ' CB ' ' A' ' 190' ' ' SER . 74.5 Cg_endo -76.37 26.65 0.42 Allowed 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 122.637 2.225 . . . . 0.0 113.544 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.543 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 4.6 p30 157.48 73.88 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.113 0 N-CA-C 111.528 0.196 . . . . 0.0 111.528 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.993 ' OG1' HD13 ' A' ' 189' ' ' LEU . 87.6 m -77.93 111.22 16.58 Favored Pre-proline 0 CA--C 1.518 -0.26 0 CA-C-O 121.055 0.455 . . . . 0.0 110.742 179.268 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.609 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 57.7 Cg_endo -68.47 109.62 2.09 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.525 2.15 . . . . 0.0 111.686 179.27 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.612 ' HA ' ' CD1' ' A' ' 198' ' ' ILE . 0.6 OUTLIER -43.42 -19.81 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.47 179.752 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 196' ' ' GLU . . . . . 0.523 ' O ' ' HG2' ' A' ' 200' ' ' GLU . 0.1 OUTLIER -61.02 -44.49 97.33 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -179.158 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.609 ' CD ' ' HG2' ' A' ' 194' ' ' PRO . 1.4 mttp -76.17 -46.18 29.8 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 178.734 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.917 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.2 OUTLIER -48.56 -28.94 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-N 114.048 -1.433 . . . . 0.0 108.717 177.014 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.56 ' HG3' ' O ' ' A' ' 195' ' ' GLU . 12.9 mtp180 -75.75 -32.11 59.83 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.955 178.233 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 200' ' ' GLU . . . . . 0.523 ' HG2' ' O ' ' A' ' 196' ' ' GLU . 4.1 mm-40 -81.91 -57.48 3.4 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.226 0.536 . . . . 0.0 110.536 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.489 ' C ' ' CD1' ' A' ' 201' ' ' TYR . 0.3 OUTLIER -48.03 -53.94 14.65 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.678 179.308 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 1.005 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.9 OUTLIER -79.73 -31.95 41.12 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.571 179.93 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.53 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -61.88 -57.78 15.86 Favored Glycine 0 N--CA 1.444 -0.824 0 N-CA-C 107.378 -2.289 . . . . 0.0 107.378 176.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -49.33 -29.28 10.21 Favored Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 176.264 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.76 ' CE2' HG13 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -58.53 -43.49 89.25 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 122.115 0.959 . . . . 0.0 108.423 177.787 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 169.14 -131.29 2.25 Favored Glycine 0 N--CA 1.441 -1.002 0 CA-C-N 113.714 -1.584 . . . . 0.0 110.417 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.517 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 4.1 mt-10 -97.11 102.94 14.82 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.231 0.539 . . . . 0.0 111.364 178.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.498 ' O ' ' NZ ' ' A' ' 231' ' ' LYS . 2.5 t -77.84 138.9 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.049 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 209' ' ' GLU . . . . . 0.571 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 70.8 tt0 -93.35 -53.15 4.2 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.5 178.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.439 ' OG ' ' OE2' ' A' ' 212' ' ' GLU . 37.2 p -160.51 151.65 19.08 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.512 HG21 ' HB ' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -129.55 122.36 55.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.923 178.905 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.439 ' OE2' ' OG ' ' A' ' 210' ' ' SER . 0.0 OUTLIER -123.86 115.29 21.07 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 -177.962 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.735 HD22 ' N ' ' A' ' 213' ' ' LEU . 0.3 OUTLIER -97.02 105.72 26.0 Favored Pre-proline 0 CA--C 1.537 0.452 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 176.644 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.673 ' HD2' ' O ' ' A' ' 225' ' ' PHE . 2.4 Cg_endo -86.75 123.69 2.13 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 123.583 2.855 . . . . 0.0 113.299 -178.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -135.29 130.18 34.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.283 178.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.429 ' CG ' ' NH1' ' A' ' 223' ' ' ARG . 1.2 m-20 -116.77 106.57 13.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.855 0.36 . . . . 0.0 111.407 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -82.82 -9.09 59.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.17 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 21.1 mmmt -91.18 -51.29 5.39 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.852 -179.232 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.418 ' CG2' ' HB3' ' A' ' 216' ' ' ASP . 0.8 OUTLIER -92.65 -35.13 13.68 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.321 -179.291 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 2.7 m120 70.07 36.9 1.81 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.91 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 221' ' ' LYS . . . . . 0.433 ' CD ' ' N ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -70.73 148.55 47.85 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.135 179.703 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.433 ' N ' ' CD ' ' A' ' 221' ' ' LYS . 0.0 OUTLIER -70.31 59.24 0.18 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.277 0.561 . . . . 0.0 110.568 179.632 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.429 ' NH1' ' CG ' ' A' ' 216' ' ' ASP . 4.0 ptp85 -102.13 18.94 19.57 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.651 179.223 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.453 ' O ' ' HG ' ' A' ' 189' ' ' LEU . . . -68.53 53.82 0.48 Allowed Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 115.162 -0.926 . . . . 0.0 112.411 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.887 ' C ' HD23 ' A' ' 189' ' ' LEU . 6.7 p90 -132.87 176.68 8.26 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 226' ' ' CYS . . . . . 0.583 ' N ' HD23 ' A' ' 189' ' ' LEU . 23.1 p -136.06 149.15 48.64 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 119.495 -0.882 . . . . 0.0 112.709 -179.311 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 1.162 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 3.1 m-85 -105.65 139.0 40.91 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 115.586 -0.733 . . . . 0.0 109.119 178.538 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 1.005 HD12 ' CE2' ' A' ' 202' ' ' PHE . 1.7 mt -133.83 118.29 29.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.414 0.626 . . . . 0.0 111.015 179.146 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.542 HG22 ' HB3' ' A' ' 209' ' ' GLU . 63.4 m -100.67 137.99 38.32 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.906 ' HE2' HD13 ' A' ' 184' ' ' ILE . 58.1 m-85 -111.8 126.49 55.14 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.465 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.571 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -49.46 -38.31 29.23 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 178.302 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 232' ' ' GLU . . . . . 0.419 ' OE1' ' CD ' ' A' ' 234' ' ' GLU . 0.7 OUTLIER -92.06 -165.37 1.33 Allowed 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 113.049 -1.887 . . . . 0.0 109.483 178.873 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 233' ' ' GLU . . . . . 0.56 ' CG ' ' HG2' ' A' ' 182' ' ' LYS . 0.5 OUTLIER -132.96 1.75 3.59 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.443 -179.914 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.493 ' O ' ' N ' ' A' ' 237' ' ' LYS . 0.2 OUTLIER -73.91 -59.53 1.79 Allowed Pre-proline 0 C--N 1.33 -0.264 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.622 -179.415 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.891 ' O ' HD12 ' A' ' 239' ' ' ILE . 98.5 Cg_exo -48.65 -33.61 24.74 Favored 'Trans proline' 0 CA--C 1.498 -1.299 0 N-CA-C 108.851 -1.25 . . . . 0.0 108.851 178.662 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.539 HG13 HG22 ' A' ' 184' ' ' ILE . 21.7 t -70.43 -40.74 77.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 113.856 -1.52 . . . . 0.0 109.502 178.288 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.524 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 19.9 mttt -56.68 -46.89 80.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.915 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.529 ' O ' ' CG ' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -81.14 -50.09 10.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.277 -179.754 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.891 HD12 ' O ' ' A' ' 235' ' ' PRO . 1.5 mt -40.74 -52.58 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.632 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 240' ' ' MET . . . . . 0.457 ' SD ' ' HB ' ' A' ' 256' ' ' VAL . 6.7 mtp -61.32 -21.92 64.42 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.025 -179.024 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.529 ' CG ' ' O ' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -80.05 -23.96 41.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.844 -179.834 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.418 ' N ' ' HG3' ' A' ' 241' ' ' GLU . 2.9 mmtp -79.11 137.59 37.56 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.034 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.553 ' HD2' ' CG ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -76.55 -41.96 44.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.447 179.588 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.651 ' CD1' ' HB3' ' A' ' 253' ' ' GLU . 2.5 m-85 -140.51 140.88 35.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.277 178.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 245' ' ' HIS . . . . . 0.781 ' CE1' HD12 ' A' ' 254' ' ' ILE . 17.3 m-70 -106.39 157.8 17.36 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.675 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -133.77 105.27 6.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.97 0.414 . . . . 0.0 110.87 179.541 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.538 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.6 t -108.61 105.63 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.112 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 50.17 -85.21 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.421 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.538 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -107.1 -38.99 5.85 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.405 0.621 . . . . 0.0 110.602 179.806 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.495 ' O ' ' N ' ' A' ' 247' ' ' VAL . 4.4 p -77.63 150.28 34.64 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.984 -1.007 . . . . 0.0 112.105 -178.67 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.547 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -150.5 103.58 3.14 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.588 178.994 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 252' ' ' CYS . . . . . 0.612 ' SG ' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -130.59 154.69 47.59 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -177.515 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 253' ' ' GLU . . . . . 0.651 ' HB3' ' CD1' ' A' ' 244' ' ' TYR . 7.8 pt-20 -74.94 118.54 18.01 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.24 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.781 HD12 ' CE1' ' A' ' 245' ' ' HIS . 24.0 mt -96.76 102.12 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 CA-C-O 121.809 0.814 . . . . 0.0 112.657 -178.525 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.571 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -104.0 128.99 51.58 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 177.627 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 183' ' ' LYS . 3.8 p -32.41 125.06 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-O 122.15 0.976 . . . . 0.0 111.206 -176.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 1.162 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -76.23 152.82 36.46 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 113.522 -1.672 . . . . 0.0 112.166 -178.091 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.15 126.65 26.89 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.469 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 259' ' ' SER . . . . . 0.524 ' HB3' ' NZ ' ' A' ' 183' ' ' LYS . 53.9 p . . . . . 0 C--N 1.324 -0.508 0 CA-C-O 120.866 0.365 . . . . 0.0 111.097 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 2' ' ' ' DT' . . . . . 0.876 ' O2 ' " H2'" ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.427 -0.81 0 O4'-C1'-C2' 107.067 0.879 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 3' ' ' ' DA' . . . . . 1.001 " H4'" " O5'" ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.426 -0.875 0 C4'-C3'-O3' 111.484 0.538 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 4' ' ' ' DG' . . . . . 1.001 " O5'" " H4'" ' B' ' 3' ' ' ' DA' . . . . . . . . 0 O5'--C5' 1.427 -0.826 0 C4'-C3'-C2' 102.194 -1.006 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 5' ' ' ' DG' . . . . . 0.731 ' N7 ' ' C5 ' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 C2'--C1' 1.507 -1.013 0 O4'-C1'-N19 108.182 0.478 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.515 ' CG1' ' N ' ' A' ' 182' ' ' LYS . 36.1 t . . . . . 0 CA--C 1.504 -0.808 0 CA-C-O 121.115 0.483 . . . . 0.0 111.247 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.943 ' HB3' HG21 ' A' ' 236' ' ' VAL . 2.8 mptt -148.45 112.95 5.32 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.447 178.038 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.851 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -134.14 143.88 48.2 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.846 179.08 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.853 HD13 ' HE1' ' A' ' 230' ' ' PHE . 1.0 OUTLIER -123.4 120.05 59.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.411 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.827 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -92.11 109.49 20.85 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.423 0.63 . . . . 0.0 109.992 -179.337 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.784 HG13 HG12 ' A' ' 254' ' ' ILE . 11.0 t -87.03 123.59 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.303 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.54 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . -68.67 -159.07 1.56 Allowed Glycine 0 CA--C 1.521 0.452 0 CA-C-N 115.743 -0.662 . . . . 0.0 114.477 -178.098 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.542 ' HA2' ' O ' ' A' ' 224' ' ' GLY . . . -39.13 107.55 0.07 OUTLIER Glycine 0 C--N 1.332 0.355 0 CA-C-N 114.918 -0.641 . . . . 0.0 114.37 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.932 HD13 ' OG1' ' A' ' 193' ' ' THR . 3.2 pp -107.98 157.14 18.47 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 122.537 0.335 . . . . 0.0 110.802 179.182 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.92 ' O ' HD12 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -40.28 173.44 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.392 0.615 . . . . 0.0 111.921 -179.947 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.459 ' O ' ' HB2' ' A' ' 192' ' ' ASP . 32.9 Cg_exo -60.34 -3.65 2.62 Favored 'Trans proline' 0 CA--C 1.529 0.27 0 C-N-CA 123.293 2.662 . . . . 0.0 114.126 -179.373 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 191' ' ' PRO . 0.5 OUTLIER 172.01 74.02 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.69 -179.933 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.932 ' OG1' HD13 ' A' ' 189' ' ' LEU . 57.7 m -64.29 125.29 87.99 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.826 179.312 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.63 ' O ' HD11 ' A' ' 198' ' ' ILE . 83.5 Cg_endo -76.55 117.71 4.65 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.405 2.07 . . . . 0.0 110.381 178.37 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.809 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 12.4 pt-20 -51.62 -14.0 0.29 Allowed 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -178.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 196' ' ' GLU . . . . . 0.51 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 33.7 mt-10 -68.51 -44.0 75.6 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -179.397 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.621 ' CD ' ' HG2' ' A' ' 194' ' ' PRO . 0.9 OUTLIER -70.58 -47.41 60.34 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.444 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.809 ' CG1' ' HA ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -47.85 -30.84 2.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.423 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.579 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 1.5 mtp-105 -72.31 -32.35 66.48 Favored 'General case' 0 C--O 1.22 -0.456 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.105 178.818 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 200' ' ' GLU . . . . . 0.522 ' N ' ' O ' ' A' ' 197' ' ' LYS . 25.2 mt-10 -82.71 -59.16 2.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.137 0.494 . . . . 0.0 110.397 179.329 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.504 ' C ' ' CD1' ' A' ' 201' ' ' TYR . 0.4 OUTLIER -48.72 -53.61 18.21 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.767 -0.652 . . . . 0.0 109.718 179.118 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 1.135 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.5 OUTLIER -79.7 -31.36 41.26 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.538 -179.963 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.579 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -62.14 -56.34 22.78 Favored Glycine 0 CA--C 1.5 -0.855 0 N-CA-C 107.104 -2.398 . . . . 0.0 107.104 176.64 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -49.76 -28.4 11.15 Favored Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 176.114 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.77 ' CE2' HG13 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -58.64 -44.21 89.98 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 177.885 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 169.87 -130.66 2.07 Favored Glycine 0 N--CA 1.441 -0.985 0 CA-C-N 113.663 -1.608 . . . . 0.0 110.473 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.481 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 5.0 mt-10 -96.89 98.77 10.38 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.228 0.537 . . . . 0.0 110.923 178.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.452 HG21 ' HB2' ' A' ' 202' ' ' PHE . 2.7 t -75.76 141.26 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 CA-C-N 115.384 -0.825 . . . . 0.0 108.984 178.542 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 209' ' ' GLU . . . . . 0.508 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 45.6 tt0 -89.75 -57.72 2.77 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.141 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 10.4 p -167.58 151.41 6.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.298 0.571 . . . . 0.0 112.375 179.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.985 HD13 HG23 ' A' ' 228' ' ' ILE . 0.4 OUTLIER -117.71 132.29 67.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.497 178.657 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.493 ' OE1' ' N7 ' ' B' ' 4' ' ' ' DG' . 0.0 OUTLIER -123.45 111.46 16.35 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -178.293 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.931 HD11 ' HB ' ' A' ' 193' ' ' THR . 2.7 mm? -96.21 109.02 45.12 Favored Pre-proline 0 CA--C 1.533 0.315 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.922 177.558 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.608 ' HD2' ' O ' ' A' ' 225' ' ' PHE . 22.3 Cg_exo -65.87 -157.36 0.03 OUTLIER 'Trans proline' 0 N--CA 1.472 0.223 0 C-N-CA 123.458 2.772 . . . . 0.0 113.427 -179.412 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.45 ' HB3' ' CG ' ' A' ' 220' ' ' ASN . 0.0 OUTLIER -92.86 173.49 7.72 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.608 -179.65 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.457 ' O ' ' HB2' ' A' ' 220' ' ' ASN . 1.0 OUTLIER -109.6 149.85 29.07 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.541 -179.668 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 217' ' ' ASN . . . . . 0.541 ' N ' ' O ' ' A' ' 221' ' ' LYS . 9.4 t30 -64.93 -9.44 21.32 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.029 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 7.0 mttp -67.29 -26.6 66.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.144 0.497 . . . . 0.0 110.481 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 2.6 t -150.15 15.42 0.82 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.876 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 220' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 216' ' ' ASP . 16.6 m120 -148.71 -92.13 0.08 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.689 0.28 . . . . 0.0 111.635 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 221' ' ' LYS . . . . . 0.541 ' O ' ' N ' ' A' ' 217' ' ' ASN . 23.1 mtpp -148.44 173.2 13.34 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.832 0.348 . . . . 0.0 111.253 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.636 ' O ' ' CG ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -92.39 40.23 1.04 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 123.066 1.412 . . . . 0.0 110.057 -179.993 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.544 ' HD3' ' CB ' ' A' ' 214' ' ' PRO . 2.1 ptp85 -71.7 -31.26 66.56 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.542 ' O ' ' HA2' ' A' ' 188' ' ' GLY . . . 10.98 62.36 0.01 OUTLIER Glycine 0 C--O 1.222 -0.637 0 CA-C-N 114.059 -1.428 . . . . 0.0 113.635 178.496 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.842 ' C ' HD23 ' A' ' 189' ' ' LEU . 0.6 OUTLIER -156.05 176.08 13.12 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.743 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 226' ' ' CYS . . . . . 0.638 ' N ' HD23 ' A' ' 189' ' ' LEU . 27.3 p -140.7 150.92 44.08 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -179.376 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 1.126 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 4.5 m-85 -106.29 133.49 50.9 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.657 178.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 1.135 HD12 ' CE2' ' A' ' 202' ' ' PHE . 1.9 mt -127.75 128.05 68.99 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.393 0 CA-C-O 120.904 0.383 . . . . 0.0 111.108 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.496 ' OG1' ' HG2' ' A' ' 183' ' ' LYS . 51.5 m -111.62 137.95 48.81 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.214 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.853 ' HE1' HD13 ' A' ' 184' ' ' ILE . 83.2 m-85 -112.42 126.38 55.23 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.387 179.367 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.508 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -47.96 -38.38 16.66 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 178.018 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 232' ' ' GLU . . . . . 0.4 ' HG2' ' HB2' ' A' ' 207' ' ' GLU . 25.0 mm-40 -91.0 -165.33 1.33 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 113.397 -1.728 . . . . 0.0 110.186 179.388 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 233' ' ' GLU . . . . . 0.592 ' CB ' ' HG2' ' A' ' 182' ' ' LYS . 9.5 pt-20 -133.25 10.91 4.16 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.486 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.536 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.0 OUTLIER -83.43 -60.38 0.34 Allowed Pre-proline 0 C--N 1.326 -0.419 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.649 179.951 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.906 ' O ' HD12 ' A' ' 239' ' ' ILE . 80.2 Cg_exo -49.51 -30.45 21.26 Favored 'Trans proline' 0 CA--C 1.501 -1.145 0 N-CA-C 108.942 -1.215 . . . . 0.0 108.942 177.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.943 HG21 ' HB3' ' A' ' 182' ' ' LYS . 17.9 t -72.68 -45.28 58.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 113.88 -1.509 . . . . 0.0 110.323 178.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.536 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 1.5 ptpt -63.76 -35.09 79.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.791 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.526 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 0.0 OUTLIER -80.73 -50.39 9.94 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.128 0.489 . . . . 0.0 110.379 179.055 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.906 HD12 ' O ' ' A' ' 235' ' ' PRO . 1.7 mt -47.96 -49.74 10.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.433 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 240' ' ' MET . . . . . 0.458 ' HG2' ' HB ' ' A' ' 256' ' ' VAL . 36.8 mtp -58.16 -29.27 65.46 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.353 -178.456 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.514 ' CG ' ' O ' ' A' ' 237' ' ' LYS . 0.1 OUTLIER -86.38 -10.61 54.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.918 0.39 . . . . 0.0 110.566 179.447 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 239' ' ' ILE . 0.0 OUTLIER -81.6 102.52 10.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.2 -179.865 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.497 ' HE2' ' HB2' ' A' ' 244' ' ' TYR . 1.9 ttpt -38.18 -76.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.212 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.667 ' CD1' ' HB3' ' A' ' 253' ' ' GLU . 8.9 m-85 -118.16 144.75 45.45 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.661 179.062 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 245' ' ' HIS . . . . . 0.678 ' CE1' HD12 ' A' ' 254' ' ' ILE . 24.9 m-70 -105.51 157.94 17.02 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.041 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 246' ' ' ASN . . . . . 0.443 ' O ' ' CE2' ' A' ' 201' ' ' TYR . 2.4 p-10 -133.15 105.21 6.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.527 179.582 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.548 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.5 t -110.9 101.34 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.688 -179.186 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 53.5 -79.62 0.01 OUTLIER Glycine 0 C--N 1.331 0.274 0 C-N-CA 121.062 -0.589 . . . . 0.0 112.521 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.548 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -113.44 -40.2 3.92 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.476 0.655 . . . . 0.0 110.234 179.762 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.48 ' HB3' ' HB2' ' A' ' 190' ' ' SER . 5.1 p -77.68 148.64 34.89 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.877 -179.021 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.532 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -151.25 103.22 2.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.84 178.807 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 252' ' ' CYS . . . . . 0.688 ' SG ' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -130.74 155.06 47.27 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -177.885 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 253' ' ' GLU . . . . . 0.667 ' HB3' ' CD1' ' A' ' 244' ' ' TYR . 8.4 pt-20 -74.69 119.51 18.98 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.196 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.784 HG12 HG13 ' A' ' 186' ' ' VAL . 30.7 mt -96.97 102.59 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 CA-C-O 121.553 0.692 . . . . 0.0 112.385 -178.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.554 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -103.52 130.36 50.89 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 177.812 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 183' ' ' LYS . 4.0 p -32.67 122.74 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.561 0 CA-C-O 122.3 1.048 . . . . 0.0 111.513 -176.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 1.126 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -76.25 152.02 36.64 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 113.262 -1.79 . . . . 0.0 111.776 -178.652 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 258' ' ' MET . . . . . 0.497 ' HE2' ' C6 ' ' B' ' 3' ' ' ' DA' . 0.0 OUTLIER -130.43 118.82 21.74 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.026 179.811 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 54.4 p . . . . . 0 C--N 1.325 -0.46 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.106 -179.567 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 2' ' ' ' DT' . . . . . 0.877 ' O2 ' " H2'" ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.428 -0.758 0 O4'-C1'-C2' 106.876 0.705 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 3' ' ' ' DA' . . . . . 0.608 " C5'" ' CE1' ' A' ' 225' ' ' PHE . . . . . . . . 0 O5'--C5' 1.426 -0.845 0 C4'-C3'-C2' 104.592 1.392 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 4' ' ' ' DG' . . . . . 0.72 ' C2 ' ' CE1' ' A' ' 227' ' ' PHE . . . . . . . . 0 O5'--C5' 1.428 -0.775 0 C4'-C3'-C2' 101.924 -1.276 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 5' ' ' ' DG' . . . . . 0.694 " O5'" H2'' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.426 -0.898 0 O4'-C1'-C2' 107.047 0.861 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.491 ' CG1' ' N ' ' A' ' 182' ' ' LYS . 39.8 t . . . . . 0 CA--C 1.504 -0.815 0 CA-C-O 121.276 0.56 . . . . 0.0 111.589 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.87 ' HB2' HG21 ' A' ' 236' ' ' VAL . 0.0 OUTLIER -145.66 112.6 6.04 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.503 177.26 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 1.017 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.0 OUTLIER -133.62 164.82 26.34 Favored 'General case' 0 CA--C 1.507 -0.682 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.895 -179.891 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.862 HD13 ' HE1' ' A' ' 230' ' ' PHE . 1.4 pt -140.33 119.96 12.49 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 177.562 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.752 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.4 OUTLIER -95.94 108.77 21.19 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.424 -178.713 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 1.078 HG12 ' HB2' ' A' ' 252' ' ' CYS . 1.6 t -84.86 117.39 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.598 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 253' ' ' GLU . . . -104.7 134.14 11.87 Favored Glycine 0 N--CA 1.452 -0.248 0 N-CA-C 114.691 0.636 . . . . 0.0 114.691 -177.002 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.602 ' HA3' ' C5 ' ' B' ' 2' ' ' ' DT' . . . 72.73 84.48 0.24 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.147 -0.549 . . . . 0.0 112.746 179.178 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.928 HD23 ' CA ' ' A' ' 225' ' ' PHE . 0.6 OUTLIER -117.44 156.16 28.44 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.957 0.408 . . . . 0.0 111.085 -179.723 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.574 ' CB ' ' CD ' ' A' ' 191' ' ' PRO . 0.5 OUTLIER -47.25 -176.72 0.01 OUTLIER Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.316 179.917 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.574 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 12.0 Cg_exo -71.86 5.73 2.4 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 123.391 2.727 . . . . 0.0 113.329 -179.286 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.464 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 0.8 OUTLIER 165.63 74.75 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.803 0.335 . . . . 0.0 111.43 -179.944 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.907 ' OG1' HD13 ' A' ' 189' ' ' LEU . 88.4 m -70.34 112.63 13.43 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.61 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.614 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 25.4 Cg_endo -60.32 107.38 0.41 Allowed 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.221 1.948 . . . . 0.0 111.163 179.098 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.814 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -48.53 -14.89 0.07 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.8 -179.618 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 196' ' ' GLU . . . . . 0.508 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 34.9 mt-10 -67.41 -40.46 85.57 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 -179.399 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.614 ' CD ' ' HG2' ' A' ' 194' ' ' PRO . 1.8 mttp -74.21 -47.51 34.97 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.903 HG22 ' CE1' ' A' ' 202' ' ' PHE . 0.0 OUTLIER -46.86 -30.2 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.104 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.566 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 7.1 mtp180 -71.5 -33.98 69.71 Favored 'General case' 0 C--O 1.221 -0.438 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.447 178.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 200' ' ' GLU . . . . . 0.512 ' N ' ' O ' ' A' ' 197' ' ' LYS . 0.4 OUTLIER -83.21 -46.3 12.86 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.157 0.503 . . . . 0.0 110.738 179.459 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.547 ' CD1' ' CD1' ' A' ' 202' ' ' PHE . 0.4 OUTLIER -61.25 -52.73 63.51 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.694 179.127 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 1.107 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -79.53 -31.25 42.06 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.663 179.483 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.566 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -63.86 -56.15 20.44 Favored Glycine 0 N--CA 1.443 -0.88 0 N-CA-C 106.73 -2.548 . . . . 0.0 106.73 175.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -50.25 -28.7 14.3 Favored Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 176.076 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.835 ' CD2' HD11 ' A' ' 239' ' ' ILE . 0.0 OUTLIER -58.82 -44.49 90.86 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 177.68 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.503 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 170.77 -130.88 2.08 Favored Glycine 0 N--CA 1.442 -0.955 0 CA-C-N 113.664 -1.607 . . . . 0.0 110.389 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.518 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 0.4 OUTLIER -97.11 101.93 13.6 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.156 0.503 . . . . 0.0 111.439 178.805 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.445 HG21 ' HB2' ' A' ' 202' ' ' PHE . 2.6 t -79.29 141.12 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 177.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 209' ' ' GLU . . . . . 0.539 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 38.2 tt0 -98.05 -51.91 3.88 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.202 178.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.428 ' C ' HG12 ' A' ' 211' ' ' ILE . 5.1 p -157.66 154.32 28.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.392 0.615 . . . . 0.0 112.471 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.733 HD13 HD13 ' A' ' 228' ' ' ILE . 0.2 OUTLIER -137.26 116.3 14.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.144 178.548 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.418 ' O ' ' HD3' ' A' ' 214' ' ' PRO . 0.3 OUTLIER -124.1 114.47 19.74 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 113.853 1.056 . . . . 0.0 113.853 -177.79 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.6 HD23 ' HB2' ' A' ' 226' ' ' CYS . 0.1 OUTLIER -96.45 105.97 26.28 Favored Pre-proline 0 CA--C 1.533 0.326 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 177.034 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.736 ' HD2' ' O ' ' A' ' 225' ' ' PHE . 13.4 Cg_exo -74.16 136.04 21.68 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 123.112 2.542 . . . . 0.0 113.181 -179.01 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -132.31 130.7 41.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.959 179.063 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.485 ' O ' ' HA ' ' A' ' 220' ' ' ASN . 3.7 t0 -116.32 106.64 13.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.819 0.342 . . . . 0.0 111.253 -179.546 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -82.89 -9.55 59.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.075 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.56 -51.18 20.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.251 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.432 ' O ' ' C ' ' A' ' 220' ' ' ASN . 0.0 OUTLIER -137.51 8.43 2.86 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.14 -179.676 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 220' ' ' ASN . . . . . 0.485 ' HA ' ' O ' ' A' ' 216' ' ' ASP . 72.4 m-80 33.01 58.73 0.45 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.634 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 1.9 mtpt -62.96 -174.5 0.07 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.464 ' O ' ' OP1' ' B' ' 3' ' ' ' DA' . 0.0 OUTLIER -85.0 33.87 0.54 Allowed 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 120.845 0.355 . . . . 0.0 111.123 179.17 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.476 ' HD3' ' HB2' ' A' ' 214' ' ' PRO . 1.9 ptp85 -86.75 17.33 4.06 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.722 178.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.54 ' O ' ' HG ' ' A' ' 189' ' ' LEU . . . -71.67 61.78 1.22 Allowed Glycine 0 N--CA 1.443 -0.881 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 177.682 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.928 ' CA ' HD23 ' A' ' 189' ' ' LEU . 19.4 p90 -133.42 177.31 7.79 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 -178.59 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 226' ' ' CYS . . . . . 0.6 ' HB2' HD23 ' A' ' 213' ' ' LEU . 3.6 p -136.22 150.1 48.84 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 119.507 -0.877 . . . . 0.0 112.682 -179.144 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 1.181 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 3.1 m-85 -106.12 141.14 37.98 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.06 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 1.107 HD12 ' CE2' ' A' ' 202' ' ' PHE . 1.4 mt -138.0 114.42 11.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.458 0.647 . . . . 0.0 111.018 179.454 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.522 ' OG1' ' CG ' ' A' ' 183' ' ' LYS . 69.3 m -100.58 138.15 38.03 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.33 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.862 ' HE1' HD13 ' A' ' 184' ' ' ILE . 74.3 m-85 -112.51 126.42 55.31 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.221 -0.591 . . . . 0.0 111.335 -179.533 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.539 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -47.49 -38.89 14.72 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 177.52 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 232' ' ' GLU . . . . . 0.496 ' O ' ' HG3' ' A' ' 182' ' ' LYS . 17.5 mm-40 -91.2 -171.25 2.9 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 113.078 -1.874 . . . . 0.0 109.431 178.661 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 233' ' ' GLU . . . . . 0.491 ' HG2' ' HD2' ' A' ' 182' ' ' LYS . 0.0 OUTLIER -130.32 14.25 5.59 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.476 179.92 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.528 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.3 OUTLIER -84.89 -60.84 0.29 Allowed Pre-proline 0 CA--C 1.517 -0.318 0 C-N-CA 120.644 -0.423 . . . . 0.0 110.928 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.893 ' O ' HD12 ' A' ' 239' ' ' ILE . 79.9 Cg_exo -49.3 -28.83 15.92 Favored 'Trans proline' 0 CA--C 1.499 -1.257 0 N-CA-C 108.719 -1.3 . . . . 0.0 108.719 178.208 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.87 HG21 ' HB2' ' A' ' 182' ' ' LYS . 14.5 t -73.29 -46.44 49.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 114.269 -1.332 . . . . 0.0 110.382 178.761 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.528 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 2.1 pttp -62.12 -35.9 80.13 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.552 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.628 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.1 OUTLIER -81.38 -55.44 4.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.301 179.43 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.893 HD12 ' O ' ' A' ' 235' ' ' PRO . 1.6 mt -42.04 -50.02 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.851 -179.018 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 240' ' ' MET . . . . . 0.442 ' CE ' ' HB ' ' A' ' 256' ' ' VAL . 46.7 mtp -59.82 -26.18 65.58 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.565 -178.707 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.5 ' CG ' ' O ' ' A' ' 237' ' ' LYS . 0.1 OUTLIER -82.24 -22.91 35.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.022 0.439 . . . . 0.0 110.742 179.875 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.414 ' HG2' ' O ' ' A' ' 238' ' ' LYS . 9.2 mmmt -79.11 107.06 11.59 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.662 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.577 ' HE2' ' CE1' ' A' ' 244' ' ' TYR . 0.3 OUTLIER -42.66 -46.66 5.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.997 -179.787 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.577 ' CE1' ' HE2' ' A' ' 243' ' ' LYS . 14.0 m-85 -138.59 161.27 37.51 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.047 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 245' ' ' HIS . . . . . 0.763 ' CD2' HD12 ' A' ' 254' ' ' ILE . 39.2 m-70 -126.08 152.58 45.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.078 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -130.71 105.44 7.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.042 0.449 . . . . 0.0 110.579 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.727 HG11 HG23 ' A' ' 198' ' ' ILE . 2.6 t -106.14 105.74 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.189 -179.437 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 54.32 -86.84 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.229 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.465 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.1 OUTLIER -109.87 -39.19 5.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.697 0.761 . . . . 0.0 109.787 -179.829 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.567 ' CB ' ' HG1' ' A' ' 193' ' ' THR . 0.0 OUTLIER -77.82 153.97 32.29 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.373 -1.285 . . . . 0.0 112.349 -178.435 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.455 ' HD3' ' O ' ' A' ' 249' ' ' LEU . 0.0 OUTLIER -150.22 110.63 4.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.266 179.114 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 252' ' ' CYS . . . . . 1.078 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -127.91 153.16 46.99 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -177.709 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 253' ' ' GLU . . . . . 0.558 ' HG3' ' CD1' ' A' ' 244' ' ' TYR . 39.5 tt0 -75.98 110.34 10.36 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.149 -179.303 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 1.006 HG12 HG13 ' A' ' 186' ' ' VAL . 11.5 mt -95.62 108.51 21.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -177.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.523 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -112.03 129.86 56.06 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 105.488 -2.041 . . . . 0.0 105.488 176.066 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.763 HG23 ' O ' ' A' ' 183' ' ' LYS . 7.8 p -32.61 124.14 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 122.212 1.006 . . . . 0.0 111.459 -176.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 1.181 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -75.9 152.37 37.16 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 113.447 -1.706 . . . . 0.0 112.049 -177.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.5 123.59 21.62 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.216 179.538 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 259' ' ' SER . . . . . 0.488 ' OG ' ' NZ ' ' A' ' 183' ' ' LYS . 62.0 p . . . . . 0 C--N 1.326 -0.449 0 CA-C-O 120.903 0.382 . . . . 0.0 110.891 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 2' ' ' ' DT' . . . . . 0.779 ' O2 ' " H2'" ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.428 -0.764 0 C3'-C2'-C1' 101.611 -0.778 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 3' ' ' ' DA' . . . . . 1.02 " H4'" " O5'" ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.424 -1.022 0 C3'-C2'-C1' 101.658 -0.744 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 4' ' ' ' DG' . . . . . 1.02 " O5'" " H4'" ' B' ' 3' ' ' ' DA' . . . . . . . . 0 O5'--C5' 1.426 -0.847 0 C4'-C3'-C2' 102.316 -0.884 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 5' ' ' ' DG' . . . . . 0.722 " O5'" " H1'" ' B' ' 4' ' ' ' DG' . . . . . . . . 0 C2'--C1' 1.507 -0.976 0 C4'-C3'-C2' 104.812 1.612 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.521 ' CG1' ' N ' ' A' ' 182' ' ' LYS . 40.9 t . . . . . 0 CA--C 1.502 -0.895 0 CA-C-O 121.217 0.532 . . . . 0.0 111.66 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.731 ' CB ' HG21 ' A' ' 236' ' ' VAL . 0.0 OUTLIER -149.18 112.52 4.97 Favored 'General case' 0 N--CA 1.432 -1.375 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.487 177.97 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.867 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -131.22 142.86 50.23 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-N 114.974 -1.012 . . . . 0.0 108.646 178.52 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.923 HD13 ' HE2' ' A' ' 230' ' ' PHE . 1.3 pt -123.85 119.75 57.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.82 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -92.5 109.81 21.21 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.494 0.664 . . . . 0.0 110.404 -178.982 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.689 HG13 HG12 ' A' ' 254' ' ' ILE . 6.3 t -85.97 129.84 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.886 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.597 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . -79.43 -153.73 8.07 Favored Glycine 0 CA--C 1.521 0.454 0 C-N-CA 121.034 -0.603 . . . . 0.0 114.209 -178.062 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.519 ' HA2' ' O ' ' A' ' 224' ' ' GLY . . . -34.56 109.61 0.06 OUTLIER Glycine 0 C--N 1.334 0.442 0 N-CA-C 114.255 0.462 . . . . 0.0 114.255 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.96 HD13 ' OG1' ' A' ' 193' ' ' THR . 1.7 pp -117.05 157.48 25.78 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.687 0.28 . . . . 0.0 110.819 179.406 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.789 ' O ' HD12 ' A' ' 189' ' ' LEU . 0.3 OUTLIER -42.25 -177.96 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.259 0 CA-C-O 121.463 0.649 . . . . 0.0 112.087 -179.709 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.56 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 10.4 Cg_exo -70.82 1.52 5.05 Favored 'Trans proline' 0 CA--C 1.529 0.266 0 C-N-CA 123.232 2.621 . . . . 0.0 113.404 -179.403 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 192' ' ' ASP . 8.4 p-10 165.44 74.91 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.89 0.376 . . . . 0.0 111.415 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.96 ' OG1' HD13 ' A' ' 189' ' ' LEU . 11.9 m -68.9 116.85 45.6 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.125 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.528 ' HG2' ' HG2' ' A' ' 197' ' ' LYS . 36.5 Cg_endo -64.78 118.36 5.35 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.424 2.083 . . . . 0.0 111.438 179.037 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.783 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -52.06 -16.05 0.69 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.328 -179.607 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 196' ' ' GLU . . . . . 0.495 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 34.8 mt-10 -68.23 -37.85 81.24 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -179.685 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.528 ' HG2' ' HG2' ' A' ' 194' ' ' PRO . 18.0 mmmt -74.44 -50.08 19.81 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.318 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.818 ' CD1' HG22 ' A' ' 193' ' ' THR . 0.0 OUTLIER -48.13 -31.15 2.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 114.849 -1.069 . . . . 0.0 108.428 178.229 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.589 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 1.9 mtp85 -71.09 -32.73 69.44 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.296 178.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 200' ' ' GLU . . . . . 0.55 ' CG ' ' N ' ' A' ' 201' ' ' TYR . 4.2 pt-20 -81.71 -53.03 6.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.201 0.524 . . . . 0.0 109.894 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.55 ' N ' ' CG ' ' A' ' 200' ' ' GLU . 0.3 OUTLIER -55.35 -54.05 48.52 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.98 178.87 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 1.075 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.2 OUTLIER -79.58 -31.15 41.79 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.069 -0.968 . . . . 0.0 110.424 -179.67 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.589 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -65.1 -55.47 21.48 Favored Glycine 0 CA--C 1.499 -0.927 0 N-CA-C 106.928 -2.469 . . . . 0.0 106.928 176.349 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -49.97 -28.82 13.08 Favored Glycine 0 N--CA 1.442 -0.936 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 176.128 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.767 ' CE2' HG13 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -57.93 -46.18 85.44 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 122.145 0.974 . . . . 0.0 108.496 177.738 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 171.95 -130.89 2.03 Favored Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 113.542 -1.663 . . . . 0.0 110.247 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.487 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 5.2 mm-40 -97.01 100.7 12.2 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.245 0.545 . . . . 0.0 111.05 178.682 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.449 HG22 ' CE1' ' A' ' 230' ' ' PHE . 2.9 t -78.11 140.86 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.088 0 CA-C-N 115.235 -0.893 . . . . 0.0 108.653 178.295 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 209' ' ' GLU . . . . . 0.615 ' HB3' HG22 ' A' ' 229' ' ' THR . 10.1 tp10 -94.43 -53.83 3.76 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.771 0.32 . . . . 0.0 110.352 179.154 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.422 ' C ' HG12 ' A' ' 211' ' ' ILE . 24.0 p -159.83 156.85 28.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.21 0.528 . . . . 0.0 111.842 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.808 HD12 ' HB ' ' A' ' 198' ' ' ILE . 0.1 OUTLIER -131.84 124.57 53.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.528 178.959 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.546 ' OE1' ' N7 ' ' B' ' 4' ' ' ' DG' . 0.6 OUTLIER -123.07 103.26 8.46 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -178.16 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.766 HD13 ' O ' ' A' ' 193' ' ' THR . 0.1 OUTLIER -96.72 105.91 26.52 Favored Pre-proline 0 C--N 1.329 -0.323 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 177.357 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.615 ' HD2' ' O ' ' A' ' 225' ' ' PHE . 31.3 Cg_exo -61.41 -158.22 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 123.272 2.648 . . . . 0.0 113.494 -179.103 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.493 ' HB2' ' CB ' ' A' ' 220' ' ' ASN . 5.5 mmt -97.13 173.56 7.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.455 -179.549 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -106.65 150.66 26.0 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.461 -179.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 217' ' ' ASN . . . . . 0.566 ' HA ' ' N ' ' A' ' 221' ' ' LYS . 21.8 t30 -52.92 -16.45 1.04 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.295 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.59 -32.37 73.35 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.47 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -137.76 5.5 2.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.155 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 220' ' ' ASN . . . . . 0.493 ' CB ' ' HB2' ' A' ' 215' ' ' MET . 3.7 m120 -143.71 -85.79 0.14 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.642 0.258 . . . . 0.0 111.537 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 221' ' ' LYS . . . . . 0.566 ' N ' ' HA ' ' A' ' 217' ' ' ASN . 0.2 OUTLIER -161.05 174.46 13.7 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.706 179.853 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.626 ' O ' ' CG ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -84.09 41.85 0.84 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 122.564 1.173 . . . . 0.0 111.102 -179.289 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.553 ' HB2' ' CE1' ' A' ' 225' ' ' PHE . 5.0 ptp85 -72.05 -29.05 63.76 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 177.44 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.519 ' O ' ' HA2' ' A' ' 188' ' ' GLY . . . 9.11 62.72 0.01 OUTLIER Glycine 0 C--N 1.337 0.592 0 CA-C-N 114.334 -1.303 . . . . 0.0 113.728 178.29 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.92 ' C ' HD23 ' A' ' 189' ' ' LEU . 0.4 OUTLIER -156.47 176.48 12.65 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.712 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 226' ' ' CYS . . . . . 0.542 ' N ' HD23 ' A' ' 189' ' ' LEU . 11.9 p -142.14 149.56 39.95 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.028 -0.669 . . . . 0.0 112.538 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 1.123 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 4.7 m-85 -106.24 138.86 41.67 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.592 178.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 1.075 HD12 ' CE2' ' A' ' 202' ' ' PHE . 2.2 mt -133.87 135.09 55.57 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.35 0 CA-C-O 120.962 0.41 . . . . 0.0 111.133 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.615 HG22 ' HB3' ' A' ' 209' ' ' GLU . 52.3 m -116.26 138.08 51.6 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.719 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.923 ' HE2' HD13 ' A' ' 184' ' ' ILE . 75.4 m-85 -112.9 126.29 55.3 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.271 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.505 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -49.36 -38.93 30.0 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 177.981 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 232' ' ' GLU . . . . . 0.459 ' O ' ' HD3' ' A' ' 182' ' ' LYS . 63.9 mt-10 -92.59 -170.86 2.59 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 113.362 -1.745 . . . . 0.0 109.304 178.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 233' ' ' GLU . . . . . 0.554 ' CB ' ' HG2' ' A' ' 182' ' ' LYS . 14.4 pt-20 -126.09 2.83 7.22 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.836 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.511 ' O ' ' HB2' ' A' ' 237' ' ' LYS . 0.2 OUTLIER -74.33 -59.25 1.69 Allowed Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.809 -179.169 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.893 ' O ' HD12 ' A' ' 239' ' ' ILE . 87.5 Cg_exo -49.15 -32.94 25.93 Favored 'Trans proline' 0 CA--C 1.5 -1.196 0 N-CA-C 108.814 -1.264 . . . . 0.0 108.814 178.641 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.731 HG21 ' CB ' ' A' ' 182' ' ' LYS . 22.9 t -70.41 -41.57 78.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 114.041 -1.436 . . . . 0.0 108.985 177.759 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.537 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 20.6 mtpt -55.78 -46.91 77.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.799 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.473 ' HA ' ' HG3' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -81.01 -48.76 11.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.144 -179.501 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.893 HD12 ' O ' ' A' ' 235' ' ' PRO . 1.7 mt -43.57 -49.49 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.841 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 240' ' ' MET . . . . . 0.458 ' SD ' HG12 ' A' ' 236' ' ' VAL . 52.9 mtp -61.22 -29.93 70.13 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.637 -178.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.473 ' HG3' ' HA ' ' A' ' 238' ' ' LYS . 0.2 OUTLIER -85.97 -12.17 51.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.794 0.33 . . . . 0.0 111.134 -179.56 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.425 ' O ' ' C ' ' A' ' 243' ' ' LYS . 11.5 mmmm -79.63 103.5 9.58 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.837 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.558 ' HD3' ' CD2' ' A' ' 244' ' ' TYR . 0.1 OUTLIER -37.46 -58.05 0.88 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.15 0.5 . . . . 0.0 110.325 179.75 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.665 ' CD1' ' HB3' ' A' ' 253' ' ' GLU . 10.9 m-85 -135.51 153.27 51.78 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.239 179.372 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 245' ' ' HIS . . . . . 0.751 ' CE1' HD12 ' A' ' 254' ' ' ILE . 28.8 m-70 -111.91 157.43 20.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.116 -179.679 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -139.79 104.3 4.86 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.299 0.571 . . . . 0.0 109.979 178.525 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.659 HG12 ' H ' ' A' ' 248' ' ' GLY . 1.4 t -95.67 -173.65 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.874 -179.468 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 248' ' ' GLY . . . . . 0.659 ' H ' HG12 ' A' ' 247' ' ' VAL . . . -26.51 -56.69 0.08 OUTLIER Glycine 0 C--N 1.337 0.619 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.761 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.493 HD23 ' C ' ' A' ' 248' ' ' GLY . 0.0 OUTLIER -130.47 -40.03 1.27 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.443 0.639 . . . . 0.0 111.033 -179.826 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.51 ' O ' ' N ' ' A' ' 247' ' ' VAL . 57.2 p -77.59 150.01 34.75 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.094 -0.957 . . . . 0.0 112.794 -178.316 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -144.87 102.69 3.81 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.225 178.373 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 252' ' ' CYS . . . . . 0.597 ' HB3' ' C ' ' A' ' 187' ' ' GLY . 0.0 OUTLIER -130.11 154.86 47.05 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -177.448 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 253' ' ' GLU . . . . . 0.665 ' HB3' ' CD1' ' A' ' 244' ' ' TYR . 6.9 pt-20 -74.61 119.05 18.28 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.751 HD12 ' CE1' ' A' ' 245' ' ' HIS . 39.8 mt -97.2 102.47 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 CA-C-O 121.621 0.724 . . . . 0.0 112.332 -178.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.558 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -103.38 129.27 50.41 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 177.781 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 183' ' ' LYS . 5.7 p -32.32 123.62 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.509 -0.599 0 CA-C-O 122.307 1.051 . . . . 0.0 111.491 -176.772 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 1.123 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -76.26 152.57 36.46 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 113.319 -1.764 . . . . 0.0 111.982 -178.257 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.35 114.93 14.27 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.354 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 259' ' ' SER . . . . . 0.414 ' OG ' ' C6 ' ' B' ' 4' ' ' ' DG' . 0.1 OUTLIER . . . . . 0 C--N 1.326 -0.452 0 CA-C-O 121.082 0.468 . . . . 0.0 111.518 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 2' ' ' ' DT' . . . . . 0.867 ' O2 ' " H2'" ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.427 -0.821 0 O4'-C1'-C2' 106.93 0.754 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 3' ' ' ' DA' . . . . . 0.533 H5'' ' CB ' ' A' ' 223' ' ' ARG . . . . . . . . 0 O5'--C5' 1.426 -0.893 0 C4'-C3'-C2' 103.929 0.729 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 4' ' ' ' DG' . . . . . 0.608 ' C8 ' ' N7 ' ' B' ' 5' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.428 -0.755 0 C4'-C3'-C2' 101.193 -2.007 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 5' ' ' ' DG' . . . . . 0.608 ' N7 ' ' C8 ' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 C2'--C1' 1.511 -0.7 0 C4'-C3'-C2' 102.392 -0.808 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.511 ' CG1' ' N ' ' A' ' 182' ' ' LYS . 45.5 t . . . . . 0 CA--C 1.503 -0.85 0 CA-C-O 121.243 0.544 . . . . 0.0 111.612 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.879 ' HB2' HG21 ' A' ' 236' ' ' VAL . 0.5 OUTLIER -149.97 112.6 4.75 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.883 177.769 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.765 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.0 OUTLIER -135.46 155.85 49.86 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.55 179.242 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.87 HD13 ' HE2' ' A' ' 230' ' ' PHE . 0.4 OUTLIER -131.15 121.19 48.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 115.452 -0.794 . . . . 0.0 108.858 178.973 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.825 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.3 OUTLIER -93.82 109.25 20.94 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.287 0.565 . . . . 0.0 110.826 -178.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 1.012 HG12 ' HB2' ' A' ' 252' ' ' CYS . 2.5 t -86.08 126.4 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.586 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.589 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . -114.76 126.4 7.22 Favored Glycine 0 N--CA 1.452 -0.274 0 N-CA-C 114.602 0.601 . . . . 0.0 114.602 -176.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.464 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . 80.59 83.13 0.74 Allowed Glycine 0 CA--C 1.519 0.285 0 C-N-CA 121.245 -0.502 . . . . 0.0 113.361 179.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.966 HD23 ' C ' ' A' ' 225' ' ' PHE . 0.6 OUTLIER -117.25 157.77 25.47 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.816 0.341 . . . . 0.0 111.384 -179.394 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.615 ' N ' HD12 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -45.4 -177.41 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.197 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.557 179.503 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . 0.555 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 11.4 Cg_exo -70.62 6.54 1.55 Allowed 'Trans proline' 0 CA--C 1.532 0.406 0 C-N-CA 123.255 2.637 . . . . 0.0 113.514 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.516 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 2.8 p30 160.55 77.65 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.013 0.435 . . . . 0.0 110.812 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.891 HG22 HD11 ' A' ' 198' ' ' ILE . 51.8 m -73.02 131.76 83.4 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.003 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.575 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 68.6 Cg_endo -80.96 114.34 2.88 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 122.945 2.43 . . . . 0.0 111.632 179.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.583 ' HA ' ' CD1' ' A' ' 198' ' ' ILE . 1.6 pm0 -48.1 -17.81 0.15 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.357 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . 0.474 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 27.4 mm-40 -61.36 -44.02 97.89 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -179.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.575 ' CD ' ' HG2' ' A' ' 194' ' ' PRO . 0.9 OUTLIER -76.38 -46.39 27.57 Favored 'General case' 0 CA--C 1.494 -1.207 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 178.826 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.959 ' CD1' HD21 ' A' ' 213' ' ' LEU . 0.2 OUTLIER -48.34 -29.01 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.373 0 CA-C-N 113.862 -1.517 . . . . 0.0 108.736 177.245 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.57 ' HG3' ' O ' ' A' ' 195' ' ' GLU . 2.3 mtt180 -76.12 -31.73 58.79 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-N 115.294 -0.867 . . . . 0.0 110.029 178.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . 0.58 ' CG ' ' N ' ' A' ' 201' ' ' TYR . 4.2 pt-20 -82.01 -55.17 4.74 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.098 0.475 . . . . 0.0 110.293 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.58 ' N ' ' CG ' ' A' ' 200' ' ' GLU . 0.3 OUTLIER -50.11 -53.88 24.4 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.484 0.659 . . . . 0.0 109.67 178.797 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 1.011 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.5 OUTLIER -79.66 -32.69 41.58 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.7 -179.836 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.539 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -62.82 -55.05 29.13 Favored Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 107.359 -2.296 . . . . 0.0 107.359 176.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -51.39 -27.84 18.36 Favored Glycine 0 N--CA 1.442 -0.949 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 176.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.764 ' CE2' HG13 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -59.17 -44.89 92.16 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 122.129 0.966 . . . . 0.0 108.601 177.849 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.493 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 172.42 -132.41 2.38 Favored Glycine 0 N--CA 1.442 -0.938 0 CA-C-N 113.698 -1.592 . . . . 0.0 110.482 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.486 ' HB2' ' HG3' ' A' ' 232' ' ' GLU . 1.8 mt-10 -97.22 97.13 8.92 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.21 0.529 . . . . 0.0 111.456 178.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 2.5 t -72.56 137.63 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . 0.669 ' HB3' HG22 ' A' ' 229' ' ' THR . 5.8 tp10 -89.54 -50.7 5.93 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 178.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.438 ' OG ' ' OE2' ' A' ' 212' ' ' GLU . 0.9 OUTLIER -165.15 159.02 17.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.31 0.576 . . . . 0.0 111.913 179.263 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.533 HD11 ' HA ' ' A' ' 199' ' ' ARG . 0.1 OUTLIER -131.59 120.72 46.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.212 179.156 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . 0.438 ' OE2' ' OG ' ' A' ' 210' ' ' SER . 0.0 OUTLIER -123.43 102.64 8.01 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -179.066 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.959 HD21 ' CD1' ' A' ' 198' ' ' ILE . 1.7 mp . . . . . 0 C--N 1.329 -0.284 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 177.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.676 0 CA-C-O 121.16 0.311 . . . . 0.0 112.812 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . 0.966 ' C ' HD23 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -157.15 176.93 12.08 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -178.29 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . 0.808 ' HB3' HD23 ' A' ' 213' ' ' LEU . 1.4 p -141.42 149.18 40.69 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.258 -0.577 . . . . 0.0 112.433 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 1.104 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 5.7 m-85 -107.21 146.45 31.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.351 178.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 1.011 HD12 ' CE2' ' A' ' 202' ' ' PHE . 1.8 mt -141.12 121.22 12.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.287 0.565 . . . . 0.0 111.667 179.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . 0.669 HG22 ' HB3' ' A' ' 209' ' ' GLU . 31.2 m -102.39 137.91 40.01 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.235 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.87 ' HE2' HD13 ' A' ' 184' ' ' ILE . 72.4 m-85 -113.58 126.41 55.26 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.078 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.558 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -51.79 -37.31 51.03 Favored 'General case' 0 CA--C 1.505 -0.769 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 178.328 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . 0.49 ' O ' ' HG3' ' A' ' 182' ' ' LYS . 1.6 mm-40 -93.37 -175.28 3.76 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 113.39 -1.732 . . . . 0.0 109.3 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . 0.553 ' HB3' ' CE ' ' A' ' 182' ' ' LYS . 0.1 OUTLIER -124.67 11.37 8.49 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.912 -179.631 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.562 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.2 OUTLIER -80.74 -59.79 0.47 Allowed Pre-proline 0 C--N 1.328 -0.327 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.813 179.926 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.92 ' O ' HD12 ' A' ' 239' ' ' ILE . 84.0 Cg_exo -49.71 -31.87 26.92 Favored 'Trans proline' 0 CA--C 1.502 -1.087 0 N-CA-C 108.785 -1.275 . . . . 0.0 108.785 177.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.879 HG21 ' HB2' ' A' ' 182' ' ' LYS . 12.8 t -72.1 -44.93 64.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 114.059 -1.428 . . . . 0.0 110.566 178.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.562 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 19.4 pttt -62.33 -37.85 87.2 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.987 -179.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.48 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 0.0 OUTLIER -82.05 -49.99 9.6 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.856 0.36 . . . . 0.0 111.052 179.351 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.92 HD12 ' O ' ' A' ' 235' ' ' PRO . 1.4 mt -42.88 -53.08 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 24.7 mtp -56.23 -32.2 64.24 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.027 -179.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.477 ' CG ' ' O ' ' A' ' 237' ' ' LYS . 1.1 mt-10 -75.4 -21.19 58.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.13 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -79.57 109.92 14.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.849 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.406 ' HE2' ' HG3' ' A' ' 253' ' ' GLU . 0.0 OUTLIER -48.18 -47.57 35.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.755 179.951 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . 0.561 ' CE1' ' HG3' ' A' ' 253' ' ' GLU . 8.5 m-85 -138.31 151.75 47.86 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.903 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' HIS . . . . . 0.807 ' CG ' HD12 ' A' ' 254' ' ' ILE . 29.7 m-70 -116.67 154.91 29.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.25 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . 0.406 ' O ' ' CE2' ' A' ' 201' ' ' TYR . 2.4 m-80 -134.34 105.23 6.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.276 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.545 ' N ' ' O ' ' A' ' 250' ' ' SER . 2.2 t -103.57 106.88 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.292 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . 0.457 ' C ' HD23 ' A' ' 249' ' ' LEU . . . 52.04 -83.06 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.186 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.544 HD23 ' N ' ' A' ' 249' ' ' LEU . 0.0 OUTLIER -111.11 -38.34 5.08 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.586 0.707 . . . . 0.0 110.267 179.727 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.545 ' O ' ' N ' ' A' ' 247' ' ' VAL . 0.6 OUTLIER -77.16 153.21 34.41 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.747 -1.115 . . . . 0.0 112.014 -178.627 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.498 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -146.97 107.08 4.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.959 179.159 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' CYS . . . . . 1.012 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -128.2 153.41 46.94 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -176.933 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . 0.561 ' HG3' ' CE1' ' A' ' 244' ' ' TYR . 29.2 tt0 -76.02 109.56 9.77 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.194 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . 0.861 HG12 HG13 ' A' ' 186' ' ' VAL . 21.4 mt -96.54 115.23 35.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 -178.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . 0.517 ' O ' ' C ' ' A' ' 256' ' ' VAL . 0.0 OUTLIER -121.01 131.8 54.51 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 106.144 -1.799 . . . . 0.0 106.144 176.628 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 183' ' ' LYS . 3.9 p -32.87 121.76 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.513 -0.472 0 CA-C-O 122.398 1.095 . . . . 0.0 111.446 -177.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 1.104 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -75.77 155.49 35.46 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 113.117 -1.856 . . . . 0.0 111.909 -178.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.91 125.16 27.71 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.426 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . 0.568 ' HB3' ' CE ' ' A' ' 183' ' ' LYS . 83.3 p . . . . . 0 C--N 1.324 -0.516 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.232 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.46 ' CG1' ' N ' ' A' ' 182' ' ' LYS . 45.8 t . . . . . 0 CA--C 1.502 -0.891 0 CA-C-O 121.46 0.648 . . . . 0.0 112.051 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.559 ' HB3' HG21 ' A' ' 236' ' ' VAL . 0.0 OUTLIER -148.91 111.56 4.78 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.117 176.733 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.829 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -138.57 146.1 41.44 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 114.979 -1.01 . . . . 0.0 109.623 179.39 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.877 HD13 ' HE1' ' A' ' 230' ' ' PHE . 0.4 OUTLIER -125.38 120.32 57.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.528 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.854 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -93.33 109.09 20.63 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.423 0.63 . . . . 0.0 110.459 -178.738 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 1.12 HG12 ' HB2' ' A' ' 252' ' ' CYS . 1.9 t -88.14 122.58 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.023 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.597 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . -108.23 125.79 8.0 Favored Glycine 0 N--CA 1.452 -0.239 0 CA-C-N 115.893 -0.594 . . . . 0.0 114.535 -176.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.476 ' O ' ' CB ' ' A' ' 252' ' ' CYS . . . 81.33 86.86 0.66 Allowed Glycine 0 C--N 1.333 0.414 0 C-N-CA 121.025 -0.607 . . . . 0.0 113.026 179.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.934 HD23 ' C ' ' A' ' 225' ' ' PHE . 0.7 OUTLIER -116.87 156.64 26.98 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.835 0.35 . . . . 0.0 111.258 -179.657 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.605 ' O ' HD12 ' A' ' 189' ' ' LEU . 0.2 OUTLIER -45.31 179.65 0.01 OUTLIER Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.16 179.56 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . 0.53 ' CD ' ' OG ' ' A' ' 190' ' ' SER . 15.5 Cg_exo -68.33 4.98 1.35 Allowed 'Trans proline' 0 CA--C 1.531 0.346 0 C-N-CA 123.138 2.559 . . . . 0.0 113.575 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.505 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 0.3 OUTLIER 161.4 76.25 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.877 0.37 . . . . 0.0 110.954 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.847 ' OG1' HD13 ' A' ' 189' ' ' LEU . 35.7 m -70.86 132.41 86.88 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.469 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.626 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 83.9 Cg_endo -77.25 115.21 3.91 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.77 2.313 . . . . 0.0 110.955 178.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.803 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -51.61 -13.7 0.27 Allowed 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -179.36 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . 0.513 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 25.9 mt-10 -68.17 -41.34 81.63 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -179.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.626 ' CD ' ' HG2' ' A' ' 194' ' ' PRO . 1.5 mttp -72.5 -47.37 49.07 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.803 ' CG1' ' HA ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -47.05 -31.02 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.118 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.575 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 4.1 mtp85 -71.71 -33.46 68.77 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.247 179.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . 0.525 ' CG ' ' N ' ' A' ' 201' ' ' TYR . 3.1 pt-20 -82.49 -51.55 7.7 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.005 0.431 . . . . 0.0 110.601 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.525 ' N ' ' CG ' ' A' ' 200' ' ' GLU . 0.2 OUTLIER -54.84 -54.6 40.29 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.497 0.665 . . . . 0.0 109.835 178.964 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 1.107 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.4 OUTLIER -79.29 -31.0 43.19 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.079 -179.784 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.575 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -63.41 -55.47 25.43 Favored Glycine 0 CA--C 1.501 -0.841 0 N-CA-C 106.812 -2.515 . . . . 0.0 106.812 176.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -49.05 -29.35 8.62 Favored Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 176.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.803 ' CD2' HD11 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -59.18 -42.56 91.11 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 122.046 0.927 . . . . 0.0 108.587 177.704 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.489 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 167.69 -130.44 2.1 Favored Glycine 0 N--CA 1.442 -0.923 0 CA-C-N 113.666 -1.606 . . . . 0.0 110.318 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.526 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 13.1 mt-10 -97.02 101.91 13.58 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.157 0.503 . . . . 0.0 110.923 178.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.459 HG21 ' HB2' ' A' ' 202' ' ' PHE . 2.4 t -77.14 143.97 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 CA-C-N 115.449 -0.796 . . . . 0.0 108.931 178.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . 0.738 ' HB3' HG22 ' A' ' 229' ' ' THR . 18.8 tp10 -91.8 -55.13 3.58 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 178.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 3.3 m -170.55 150.88 3.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.765 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.959 HD13 HG23 ' A' ' 228' ' ' ILE . 0.4 OUTLIER -117.53 133.33 64.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.752 179.088 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -123.21 103.35 8.48 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -178.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.603 HD13 ' HB3' ' A' ' 226' ' ' CYS . 2.4 mm? . . . . . 0 CA--C 1.531 0.226 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 177.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.458 0 N-CA-C 112.252 -0.339 . . . . 0.0 112.252 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . 0.934 ' C ' HD23 ' A' ' 189' ' ' LEU . 0.0 OUTLIER -157.36 176.67 12.37 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.924 -0.638 . . . . 0.0 110.017 -177.773 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . 0.603 ' HB3' HD13 ' A' ' 213' ' ' LEU . 4.0 p -136.04 148.63 48.44 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.115 -0.634 . . . . 0.0 112.428 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 1.101 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 3.4 m-85 -109.81 132.79 53.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.111 -0.95 . . . . 0.0 108.446 178.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 1.107 HD12 ' CE2' ' A' ' 202' ' ' PHE . 1.8 mt -129.09 122.2 55.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.213 0.53 . . . . 0.0 111.785 -179.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . 0.738 HG22 ' HB3' ' A' ' 209' ' ' GLU . 24.4 m -103.62 138.24 40.57 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.241 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.877 ' HE1' HD13 ' A' ' 184' ' ' ILE . 65.3 m-85 -110.97 126.38 54.71 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.55 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.559 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -48.22 -38.93 19.63 Favored 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 178.442 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . 0.452 ' O ' ' O ' ' A' ' 230' ' ' PHE . 0.3 OUTLIER -92.1 -166.18 1.5 Allowed 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 113.121 -1.854 . . . . 0.0 109.14 178.586 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . 0.517 ' O ' ' HG3' ' A' ' 237' ' ' LYS . 0.3 OUTLIER -131.27 -0.13 4.08 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.581 179.86 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.509 ' O ' ' N ' ' A' ' 237' ' ' LYS . 0.6 OUTLIER -72.57 -58.99 2.64 Favored Pre-proline 0 C--N 1.331 -0.234 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.835 -179.422 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.864 ' O ' HD12 ' A' ' 239' ' ' ILE . 96.5 Cg_exo -48.98 -32.91 24.59 Favored 'Trans proline' 0 CA--C 1.497 -1.373 0 N-CA-C 108.949 -1.212 . . . . 0.0 108.949 178.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.559 HG21 ' HB3' ' A' ' 182' ' ' LYS . 21.6 t -69.87 -40.84 79.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 113.834 -1.53 . . . . 0.0 109.075 178.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.517 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 8.7 mttt -58.81 -45.93 88.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.877 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.459 ' O ' ' HD3' ' A' ' 242' ' ' LYS . 0.0 OUTLIER -80.25 -47.42 14.63 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.064 -179.703 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.864 HD12 ' O ' ' A' ' 235' ' ' PRO . 1.6 mt -45.15 -50.82 2.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.7 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . 0.501 ' SD ' HG12 ' A' ' 236' ' ' VAL . 23.0 mtp -58.13 -28.22 64.47 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.192 -179.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.465 ' N ' ' OE1' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -82.48 -20.76 36.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.224 0.535 . . . . 0.0 109.824 179.408 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.459 ' HD3' ' O ' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -80.55 100.13 8.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.019 179.729 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.61 ' HE2' ' CG ' ' A' ' 244' ' ' TYR . 1.8 ttpt -40.7 -67.43 0.24 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.24 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . 0.61 ' CG ' ' HE2' ' A' ' 243' ' ' LYS . 7.1 m-30 -113.94 154.4 27.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.197 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' HIS . . . . . 0.699 ' CG ' HD12 ' A' ' 254' ' ' ILE . 24.3 m-70 -123.12 147.85 46.33 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.338 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . 0.448 ' HB3' ' HD2' ' A' ' 251' ' ' LYS . 0.4 OUTLIER -125.73 105.24 8.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.989 0.424 . . . . 0.0 110.938 179.712 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.662 HG11 HG23 ' A' ' 198' ' ' ILE . 1.9 t -102.64 108.98 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.235 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 48.76 -83.93 0.01 OUTLIER Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.271 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.556 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -110.48 -38.64 5.15 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.402 0.62 . . . . 0.0 110.497 179.639 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.522 ' HB3' ' HB2' ' A' ' 190' ' ' SER . 1.6 p -77.06 150.44 35.73 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.011 -0.995 . . . . 0.0 112.068 -178.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -144.88 108.05 4.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.307 178.984 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' CYS . . . . . 1.12 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -128.04 153.01 47.25 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -177.436 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . 0.492 ' HB2' ' CE1' ' A' ' 244' ' ' TYR . 51.5 tt0 -76.17 113.14 13.38 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.221 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . 0.92 HG12 HG13 ' A' ' 186' ' ' VAL . 10.1 mt -96.53 113.05 29.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 114.66 1.355 . . . . 0.0 114.66 -178.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . 0.518 ' O ' ' C ' ' A' ' 256' ' ' VAL . 0.0 OUTLIER -119.5 129.57 54.77 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 176.207 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.674 HG23 ' O ' ' A' ' 183' ' ' LYS . 6.3 p -32.84 121.46 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.433 0 CA-C-O 122.264 1.031 . . . . 0.0 111.42 -177.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 1.101 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -76.01 154.1 36.0 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 113.207 -1.815 . . . . 0.0 112.132 -178.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.32 117.16 19.36 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.174 179.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.323 -0.558 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.716 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.543 ' CA ' ' HE3' ' A' ' 182' ' ' LYS . 55.7 t . . . . . 0 CA--C 1.506 -0.74 0 CA-C-O 121.02 0.438 . . . . 0.0 111.502 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 1.086 ' HB2' HG21 ' A' ' 236' ' ' VAL . 0.0 OUTLIER -154.37 112.41 3.52 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.185 177.293 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.829 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -134.62 153.72 51.84 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.76 179.207 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.783 HD13 ' HE1' ' A' ' 230' ' ' PHE . 0.1 OUTLIER -133.1 120.49 40.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 177.991 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.816 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -92.51 109.94 21.35 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 121.341 0.591 . . . . 0.0 110.309 -179.434 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.684 HG12 ' HB2' ' A' ' 252' ' ' CYS . 39.2 t -88.08 131.0 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.968 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.502 ' O ' ' HB3' ' A' ' 252' ' ' CYS . . . -85.16 -146.56 8.45 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 114.597 0.599 . . . . 0.0 114.597 -177.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.491 ' HA2' ' O ' ' A' ' 224' ' ' GLY . . . -35.56 103.29 0.02 OUTLIER Glycine 0 C--N 1.336 0.569 0 N-CA-C 114.505 0.562 . . . . 0.0 114.505 -179.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.924 HD13 ' OG1' ' A' ' 193' ' ' THR . 1.7 pp -117.78 157.07 27.22 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 122.453 0.301 . . . . 0.0 110.893 179.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.828 ' O ' HD12 ' A' ' 189' ' ' LEU . 0.0 OUTLIER -42.27 172.64 0.03 OUTLIER Pre-proline 0 N--CA 1.463 0.191 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.32 179.806 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . 0.515 ' HD2' ' OG ' ' A' ' 190' ' ' SER . 31.7 Cg_exo -60.37 -5.24 3.92 Favored 'Trans proline' 0 CA--C 1.532 0.395 0 C-N-CA 122.891 2.394 . . . . 0.0 113.466 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 191' ' ' PRO . 0.1 OUTLIER 172.78 73.19 0.0 OUTLIER 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.924 0.392 . . . . 0.0 111.503 -179.943 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.924 ' OG1' HD13 ' A' ' 189' ' ' LEU . 57.4 m -61.36 114.31 10.51 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.471 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.538 ' HG2' ' HG2' ' A' ' 197' ' ' LYS . 13.3 Cg_endo -58.19 114.26 1.89 Allowed 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.166 1.911 . . . . 0.0 111.013 178.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.836 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 6.5 pt-20 -53.4 -14.67 0.81 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.501 -179.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . 0.514 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 51.7 mt-10 -68.34 -38.51 81.55 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.538 ' HG2' ' HG2' ' A' ' 194' ' ' PRO . 0.1 OUTLIER -73.85 -49.2 26.2 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.309 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 1.022 HG22 ' CE1' ' A' ' 202' ' ' PHE . 0.0 OUTLIER -48.48 -30.91 3.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.062 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.598 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 11.0 mtp180 -69.18 -33.43 73.35 Favored 'General case' 0 C--O 1.22 -0.494 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.639 178.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . 0.534 ' N ' ' O ' ' A' ' 197' ' ' LYS . 4.3 mt-10 -82.42 -59.58 2.49 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.422 178.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.52 ' C ' ' CD1' ' A' ' 201' ' ' TYR . 0.4 OUTLIER -49.0 -54.27 16.37 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.498 0.666 . . . . 0.0 109.839 179.119 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 1.074 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.6 OUTLIER -79.36 -30.83 42.76 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 114.92 -1.037 . . . . 0.0 110.244 -179.863 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.598 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -62.2 -57.53 16.58 Favored Glycine 0 N--CA 1.443 -0.879 0 N-CA-C 106.959 -2.456 . . . . 0.0 106.959 176.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -48.64 -28.49 6.92 Favored Glycine 0 N--CA 1.442 -0.919 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 176.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.776 ' CD2' HD11 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -58.65 -45.26 89.7 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 177.866 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.494 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 171.83 -132.75 2.51 Favored Glycine 0 N--CA 1.441 -0.975 0 CA-C-N 113.614 -1.63 . . . . 0.0 110.25 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.484 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 0.5 OUTLIER -96.87 98.02 9.77 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.278 0.561 . . . . 0.0 111.079 178.815 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.495 HG21 ' HB2' ' A' ' 202' ' ' PHE . 2.8 t -74.32 142.24 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . 0.669 ' HB3' HG22 ' A' ' 229' ' ' THR . 5.0 tp10 -94.13 -54.12 3.7 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.747 178.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.8 m -166.25 152.74 9.17 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.228 0.537 . . . . 0.0 112.073 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.886 HD13 HG23 ' A' ' 228' ' ' ILE . 0.4 OUTLIER -122.06 124.49 71.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.23 178.433 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -123.34 107.29 11.48 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -177.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.768 HD11 ' HB ' ' A' ' 193' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 177.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . 0.491 ' O ' ' HA2' ' A' ' 188' ' ' GLY . . . . . . . . 0 C--O 1.224 -0.518 0 CA-C-O 120.818 0.121 . . . . 0.0 113.207 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . 0.802 ' C ' HD23 ' A' ' 189' ' ' LEU . 1.1 p90 -156.24 176.38 12.76 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -179.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . 0.702 ' SG ' HD22 ' A' ' 189' ' ' LEU . 7.9 p -146.43 154.66 41.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.178 0.513 . . . . 0.0 112.118 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 1.121 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 7.3 m-85 -105.85 147.45 28.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.761 179.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 1.074 HD12 ' CE2' ' A' ' 202' ' ' PHE . 2.0 mt -139.51 131.18 34.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.042 0.448 . . . . 0.0 110.646 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . 0.669 HG22 ' HB3' ' A' ' 209' ' ' GLU . 38.2 m -113.18 137.99 50.63 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.752 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.783 ' HE1' HD13 ' A' ' 184' ' ' ILE . 80.4 m-85 -113.92 126.51 55.24 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.719 -0.393 . . . . 0.0 110.187 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.541 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -48.88 -39.05 24.4 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 178.243 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . 0.473 ' O ' ' HG3' ' A' ' 182' ' ' LYS . 35.9 mm-40 -98.63 169.46 9.49 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 113.528 -1.669 . . . . 0.0 109.381 178.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . 0.552 ' HB3' ' CD ' ' A' ' 182' ' ' LYS . 1.4 pm0 -108.67 17.75 21.6 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.557 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.3 OUTLIER -83.73 -61.58 0.3 Allowed Pre-proline 0 C--N 1.33 -0.25 0 C-N-CA 120.059 -0.657 . . . . 0.0 110.847 179.918 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.885 ' O ' HD12 ' A' ' 239' ' ' ILE . 96.7 Cg_exo -49.18 -30.87 20.15 Favored 'Trans proline' 0 CA--C 1.498 -1.306 0 N-CA-C 108.982 -1.199 . . . . 0.0 108.982 177.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 1.086 HG21 ' HB2' ' A' ' 182' ' ' LYS . 15.7 t -72.25 -45.31 61.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 113.884 -1.507 . . . . 0.0 109.95 178.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.557 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 33.5 pttt -63.35 -35.86 81.78 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.921 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.515 ' HA ' ' HG3' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -81.01 -49.72 10.57 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.093 0.473 . . . . 0.0 110.729 179.293 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.885 HD12 ' O ' ' A' ' 235' ' ' PRO . 1.5 mt -46.67 -45.19 7.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.65 -0.704 . . . . 0.0 112.066 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . 0.441 ' HG2' ' HB ' ' A' ' 256' ' ' VAL . 2.2 mtp -66.47 -20.03 65.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.766 -178.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.515 ' HG3' ' HA ' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -88.78 -27.32 21.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.909 0.385 . . . . 0.0 110.555 -179.883 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.536 ' N ' ' HD2' ' A' ' 242' ' ' LYS . 2.4 mmmm -80.36 106.8 12.65 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.316 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.414 ' C ' ' O ' ' A' ' 242' ' ' LYS . 0.0 OUTLIER -36.31 -62.37 0.45 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.221 -179.491 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . 0.522 ' CE1' ' CG ' ' A' ' 253' ' ' GLU . 73.9 m-85 -125.57 170.13 11.78 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.633 -179.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' HIS . . . . . 0.796 ' CG ' HD12 ' A' ' 254' ' ' ILE . 37.4 m-70 -130.16 156.98 43.68 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.288 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -134.66 104.8 6.19 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.215 0.531 . . . . 0.0 110.059 178.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.635 HG12 ' H ' ' A' ' 248' ' ' GLY . 1.5 t -95.68 -179.63 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.992 -179.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . 0.635 ' H ' HG12 ' A' ' 247' ' ' VAL . . . -24.67 -58.06 0.05 OUTLIER Glycine 0 C--N 1.337 0.594 0 C-N-CA 121.377 -0.439 . . . . 0.0 112.991 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.37 -40.72 1.94 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.273 0.559 . . . . 0.0 111.063 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.555 ' HB3' ' HB3' ' A' ' 190' ' ' SER . 61.5 p -78.77 147.79 33.21 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.12 -0.945 . . . . 0.0 113.082 -178.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.1 OUTLIER -136.54 104.01 5.43 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 177.454 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' CYS . . . . . 0.684 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -128.49 153.89 46.68 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -175.684 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . 0.522 ' CG ' ' CE1' ' A' ' 244' ' ' TYR . 51.1 tt0 -76.01 109.54 9.73 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.27 179.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . 0.796 HD12 ' CG ' ' A' ' 245' ' ' HIS . 21.7 mt -97.36 112.15 28.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -178.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . 0.509 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -117.02 131.74 56.87 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 177.016 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.692 HG23 ' O ' ' A' ' 183' ' ' LYS . 4.0 p -33.38 123.52 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.485 0 CA-C-O 122.307 1.051 . . . . 0.0 111.225 -177.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 1.121 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -76.11 154.29 35.65 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 113.28 -1.782 . . . . 0.0 111.915 -178.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.44 112.23 15.37 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.012 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.507 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.432 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.483 ' CG1' ' N ' ' A' ' 182' ' ' LYS . 47.7 t . . . . . 0 CA--C 1.503 -0.848 0 CA-C-O 121.229 0.538 . . . . 0.0 111.305 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.653 ' CB ' HG21 ' A' ' 236' ' ' VAL . 0.0 OUTLIER -151.38 112.31 4.27 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.481 177.463 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.851 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -132.35 152.01 51.61 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.607 179.228 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.792 HD13 ' HE1' ' A' ' 230' ' ' PHE . 0.2 OUTLIER -130.31 120.29 48.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.224 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.833 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -92.67 109.53 20.95 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 121.576 0.703 . . . . 0.0 109.814 -179.544 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.797 HG12 ' HB2' ' A' ' 252' ' ' CYS . 24.0 t -85.68 126.6 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.244 -179.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.544 ' O ' ' HB3' ' A' ' 252' ' ' CYS . . . -114.36 129.48 8.74 Favored Glycine 0 N--CA 1.453 -0.225 0 N-CA-C 115.014 0.766 . . . . 0.0 115.014 -177.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.476 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . 78.04 78.33 0.8 Allowed Glycine 0 C--N 1.331 0.264 0 C-N-CA 121.44 -0.409 . . . . 0.0 113.428 178.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.906 HD23 ' C ' ' A' ' 225' ' ' PHE . 0.6 OUTLIER -117.54 157.41 26.37 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 122.431 0.293 . . . . 0.0 110.726 -179.897 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.612 ' N ' HD12 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -46.7 -175.17 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.249 0 CA-C-O 121.102 0.477 . . . . 0.0 111.428 179.761 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . 0.588 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 11.8 Cg_exo -70.83 -1.7 9.77 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 123.149 2.566 . . . . 0.0 113.707 -179.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.523 ' HB2' ' O ' ' A' ' 191' ' ' PRO . 25.9 t70 169.58 74.21 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.982 0.42 . . . . 0.0 111.24 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.854 ' OG1' HD13 ' A' ' 189' ' ' LEU . 55.1 m -66.3 114.58 17.6 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.939 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.583 ' O ' HD11 ' A' ' 198' ' ' ILE . 12.6 Cg_endo -56.72 115.41 2.46 Favored 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 122.478 2.119 . . . . 0.0 111.467 179.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.813 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.1 OUTLIER -53.11 -15.13 0.76 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.343 -179.641 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . 0.493 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 3.6 mt-10 -68.61 -38.96 81.0 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.552 ' HG2' ' HG2' ' A' ' 194' ' ' PRO . 19.0 mmmt -73.18 -48.93 31.1 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.843 ' CD1' HG22 ' A' ' 193' ' ' THR . 0.0 OUTLIER -48.49 -30.8 3.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.222 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.583 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 2.3 mtt180 -70.56 -32.52 69.97 Favored 'General case' 0 C--O 1.221 -0.447 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.662 178.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . 0.577 ' CG ' ' N ' ' A' ' 201' ' ' TYR . 4.2 pt-20 -83.03 -56.38 3.83 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.664 179.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.577 ' N ' ' CG ' ' A' ' 200' ' ' GLU . 0.4 OUTLIER -50.31 -53.93 25.15 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.62 0.724 . . . . 0.0 109.791 179.049 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 1.148 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.4 OUTLIER -79.43 -29.77 42.02 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.875 -179.915 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.583 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -62.72 -57.99 13.98 Favored Glycine 0 CA--C 1.499 -0.946 0 N-CA-C 107.044 -2.422 . . . . 0.0 107.044 176.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -48.81 -29.21 7.83 Favored Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 176.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.828 ' CD2' HD11 ' A' ' 239' ' ' ILE . 0.0 OUTLIER -58.36 -42.3 86.65 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.017 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.501 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 168.1 -131.1 2.23 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 113.733 -1.576 . . . . 0.0 110.212 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.529 ' HG3' ' CG ' ' A' ' 232' ' ' GLU . 1.3 mm-40 -96.8 100.64 12.17 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.239 0.542 . . . . 0.0 111.074 178.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.572 HG21 ' HB2' ' A' ' 202' ' ' PHE . 2.7 t -79.36 138.86 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 CA-C-N 115.336 -0.847 . . . . 0.0 108.813 178.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . 0.604 ' HB3' HG22 ' A' ' 229' ' ' THR . 3.0 tp10 -89.9 -56.94 3.04 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.766 178.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 3.5 m -166.39 150.86 7.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.278 0.561 . . . . 0.0 112.245 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 1.044 HD13 HG23 ' A' ' 228' ' ' ILE . 0.5 OUTLIER -119.04 123.36 71.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.561 178.638 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.73 103.19 8.49 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -178.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.527 HD23 ' CB ' ' A' ' 226' ' ' CYS . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.362 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.226 -0.4 0 CA-C-O 120.756 0.087 . . . . 0.0 113.245 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . 0.906 ' C ' HD23 ' A' ' 189' ' ' LEU . 1.4 p90 -156.83 176.77 12.3 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . 0.527 ' CB ' HD23 ' A' ' 213' ' ' LEU . 30.5 p -145.78 156.38 43.55 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.505 -0.478 . . . . 0.0 112.255 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 1.12 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 5.4 m-85 -107.94 143.55 36.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.642 179.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 1.148 HD12 ' CE2' ' A' ' 202' ' ' PHE . 2.0 mt -137.13 128.34 41.26 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.401 0 CA-C-O 121.175 0.512 . . . . 0.0 111.495 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . 0.604 HG22 ' HB3' ' A' ' 209' ' ' GLU . 54.9 m -110.88 138.15 47.63 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.834 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.792 ' HE1' HD13 ' A' ' 184' ' ' ILE . 67.9 m-85 -111.64 126.1 54.66 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.766 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.5 ' HG3' ' O ' ' A' ' 207' ' ' GLU . 0.1 OUTLIER -49.81 -38.52 34.95 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 177.711 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . 0.529 ' CG ' ' HG3' ' A' ' 207' ' ' GLU . 60.5 mm-40 -89.86 -167.8 1.95 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 113.154 -1.839 . . . . 0.0 109.274 178.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . 0.555 ' CB ' ' HG2' ' A' ' 182' ' ' LYS . 0.8 OUTLIER -131.32 -1.28 3.99 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -179.876 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.514 ' HB2' ' HD3' ' A' ' 235' ' ' PRO . 2.0 mt-10 -73.69 -58.14 2.32 Favored Pre-proline 0 C--N 1.329 -0.29 0 C-N-CA 120.433 -0.507 . . . . 0.0 112.141 -179.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.851 ' O ' HD12 ' A' ' 239' ' ' ILE . 79.8 Cg_exo -49.22 -31.07 20.96 Favored 'Trans proline' 0 CA--C 1.498 -1.303 0 N-CA-C 109.066 -1.167 . . . . 0.0 109.066 178.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.653 HG21 ' CB ' ' A' ' 182' ' ' LYS . 17.6 t -72.22 -44.07 64.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 114.019 -1.446 . . . . 0.0 109.189 178.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.497 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 2.1 mtpp -52.74 -47.95 67.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.396 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.666 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -80.61 -52.79 7.18 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.926 -179.268 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.851 HD12 ' O ' ' A' ' 235' ' ' PRO . 1.9 mt -38.49 -51.51 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.917 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 22.7 mtp -59.17 -26.78 65.08 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.052 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.529 ' HG3' ' CD ' ' A' ' 242' ' ' LYS . 0.2 OUTLIER -81.56 -27.91 34.13 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.676 179.89 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.529 ' CD ' ' HG3' ' A' ' 241' ' ' GLU . 0.6 OUTLIER -81.32 96.79 7.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.616 179.688 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.498 ' O ' ' HG3' ' A' ' 253' ' ' GLU . 0.0 OUTLIER -36.17 -55.0 0.8 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.867 -179.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . 0.515 ' CE1' ' HG3' ' A' ' 253' ' ' GLU . 32.7 m-85 -126.26 158.4 35.82 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.299 0.571 . . . . 0.0 111.836 -179.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' HIS . . . . . 0.643 ' CG ' HD12 ' A' ' 254' ' ' ILE . 32.2 m-70 -127.85 157.46 40.42 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.531 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . 0.462 ' O ' ' CE2' ' A' ' 201' ' ' TYR . 2.2 m-80 -127.82 104.69 7.97 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.211 0.529 . . . . 0.0 110.423 178.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.556 HG12 ' H ' ' A' ' 248' ' ' GLY . 1.4 t -95.31 174.92 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.253 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . 0.713 ' C ' HD23 ' A' ' 249' ' ' LEU . . . -14.66 -57.16 0.01 OUTLIER Glycine 0 C--N 1.34 0.759 0 O-C-N 123.662 0.601 . . . . 0.0 113.316 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.713 HD23 ' C ' ' A' ' 248' ' ' GLY . 0.0 OUTLIER -133.39 -39.8 0.91 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.959 -0.621 . . . . 0.0 110.939 -179.883 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.637 ' CB ' ' HG1' ' A' ' 193' ' ' THR . 6.0 p -78.24 152.2 32.7 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.159 -0.928 . . . . 0.0 113.192 -178.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -137.19 108.6 6.89 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.419 178.211 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' CYS . . . . . 0.797 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -128.63 153.73 46.97 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -176.357 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . 0.518 ' N ' ' O ' ' A' ' 187' ' ' GLY . 59.4 tt0 -76.08 108.11 8.75 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.832 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . 0.651 HG21 ' CG2' ' A' ' 239' ' ' ILE . 13.2 mt -96.47 112.24 28.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 -178.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . 0.514 ' O ' ' C ' ' A' ' 256' ' ' VAL . 0.0 OUTLIER -116.15 130.16 56.66 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 176.568 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 183' ' ' LYS . 3.6 p -32.78 123.54 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 122.136 0.969 . . . . 0.0 111.372 -177.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 1.12 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -76.67 153.71 34.92 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 113.522 -1.672 . . . . 0.0 111.716 -178.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.48 112.92 14.87 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.354 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.518 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.08 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.511 ' CG1' ' N ' ' A' ' 182' ' ' LYS . 42.8 t . . . . . 0 CA--C 1.504 -0.802 0 CA-C-O 121.181 0.515 . . . . 0.0 111.615 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.641 ' CB ' HG21 ' A' ' 236' ' ' VAL . 0.7 OUTLIER -149.99 112.67 4.76 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.488 177.731 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.818 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -134.15 142.57 47.51 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.747 179.838 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.789 HD12 HG21 ' A' ' 239' ' ' ILE . 0.2 OUTLIER -122.59 120.08 59.93 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.445 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.868 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.3 OUTLIER -91.73 109.44 20.76 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.68 0.752 . . . . 0.0 110.054 -179.135 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.706 HG22 HG12 ' A' ' 254' ' ' ILE . 48.7 t -85.53 126.43 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 CA-C-N 114.689 -1.141 . . . . 0.0 109.373 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.572 ' O ' ' HB3' ' A' ' 252' ' ' CYS . . . -112.99 134.8 12.18 Favored Glycine 0 C--N 1.331 0.288 0 N-CA-C 115.276 0.87 . . . . 0.0 115.276 -176.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.493 ' O ' ' HB3' ' A' ' 252' ' ' CYS . . . 64.51 84.09 0.08 OUTLIER Glycine 0 C--N 1.333 0.396 0 CA-C-N 115.516 -0.342 . . . . 0.0 112.675 178.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 1.016 HD13 ' OG1' ' A' ' 193' ' ' THR . 1.1 pp -117.36 157.83 25.46 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.045 0.45 . . . . 0.0 112.039 -178.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.643 ' O ' HD12 ' A' ' 189' ' ' LEU . 0.3 OUTLIER -44.68 -173.91 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.227 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.965 179.815 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . 0.588 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 6.4 Cg_exo -74.75 9.48 1.93 Allowed 'Trans proline' 0 CA--C 1.53 0.289 0 C-N-CA 123.125 2.55 . . . . 0.0 113.507 -179.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.54 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 1.1 m-20 158.2 78.24 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 120.842 0.353 . . . . 0.0 111.534 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 1.016 ' OG1' HD13 ' A' ' 189' ' ' LEU . 19.2 m -68.78 112.17 10.55 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.633 179.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.587 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 54.9 Cg_endo -67.3 107.04 1.31 Allowed 'Trans proline' 0 N--CA 1.465 -0.158 0 C-N-CA 122.668 2.245 . . . . 0.0 111.767 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.609 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -41.06 -21.51 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.32 -0.4 . . . . 0.0 112.016 -179.964 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . 0.462 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 11.0 mt-10 -59.37 -43.71 92.84 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -178.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.587 ' CD ' ' HG2' ' A' ' 194' ' ' PRO . 0.6 OUTLIER -79.15 -46.21 18.42 Favored 'General case' 0 CA--C 1.494 -1.208 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 178.68 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.833 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.2 OUTLIER -49.07 -29.58 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-N 114.191 -1.368 . . . . 0.0 108.396 176.86 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.553 ' HG3' ' O ' ' A' ' 195' ' ' GLU . 4.6 mtp85 -74.16 -32.56 63.17 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.845 178.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . 0.536 ' O ' ' N ' ' A' ' 204' ' ' GLY . 5.4 mt-10 -82.61 -59.13 2.62 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.57 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.493 ' C ' ' CD1' ' A' ' 201' ' ' TYR . 0.4 OUTLIER -47.96 -52.16 20.77 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.136 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 1.065 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.4 OUTLIER -79.7 -31.69 41.26 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.301 179.459 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.542 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -61.84 -58.07 14.61 Favored Glycine 0 N--CA 1.442 -0.906 0 N-CA-C 107.613 -2.195 . . . . 0.0 107.613 176.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -49.76 -27.91 10.28 Favored Glycine 0 N--CA 1.441 -1.003 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 176.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.761 ' CE2' HG13 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -57.76 -46.05 85.08 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 177.826 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.505 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 173.56 -132.28 2.27 Favored Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 113.639 -1.618 . . . . 0.0 110.25 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.509 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 3.1 mm-40 -97.19 99.84 11.32 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.134 0.492 . . . . 0.0 111.08 178.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 2.6 t -74.76 139.08 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . 0.55 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 60.0 tt0 -91.03 -56.03 3.32 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 178.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -161.88 153.96 19.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.861 179.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.567 HD12 ' HB ' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -122.97 123.95 69.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.488 178.725 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -123.57 104.75 9.23 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -177.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.614 HD21 ' HB ' ' A' ' 193' ' ' THR . 0.7 OUTLIER . . . . . 0 CA--C 1.531 0.233 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 176.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.598 0 CA-C-O 121.264 0.369 . . . . 0.0 112.863 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . 0.883 ' C ' HD23 ' A' ' 189' ' ' LEU . 0.2 OUTLIER -156.49 176.48 12.65 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.985 -0.608 . . . . 0.0 109.406 -178.311 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . 0.536 ' O ' ' HB ' ' A' ' 186' ' ' VAL . 0.5 OUTLIER -139.77 156.89 46.52 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.033 -0.667 . . . . 0.0 112.225 -179.339 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 1.099 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 4.7 m-85 -114.24 132.26 56.2 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.428 -0.806 . . . . 0.0 108.968 179.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 1.065 HD12 ' CE2' ' A' ' 202' ' ' PHE . 2.2 mt -126.13 124.8 66.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.16 0.505 . . . . 0.0 111.41 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . 0.525 HG22 ' HB3' ' A' ' 209' ' ' GLU . 85.1 m -106.1 138.08 42.9 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.496 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.767 ' HE2' HD13 ' A' ' 184' ' ' ILE . 74.7 m-85 -113.05 126.47 55.52 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.377 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.55 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -49.28 -38.4 27.03 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 178.334 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . 0.458 ' HB3' ' OE2' ' A' ' 234' ' ' GLU . 49.1 mt-10 -91.49 -168.57 2.07 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 113.399 -1.728 . . . . 0.0 109.673 179.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . 0.515 ' CB ' ' HG2' ' A' ' 182' ' ' LYS . 0.6 OUTLIER -131.34 14.04 5.06 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.834 -0.347 . . . . 0.0 111.372 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.582 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.4 OUTLIER -84.55 -60.06 0.32 Allowed Pre-proline 0 C--N 1.33 -0.263 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.702 179.873 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.889 ' O ' HD12 ' A' ' 239' ' ' ILE . 87.1 Cg_exo -49.31 -32.59 26.21 Favored 'Trans proline' 0 CA--C 1.502 -1.103 0 N-CA-C 109.089 -1.158 . . . . 0.0 109.089 178.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.641 HG21 ' CB ' ' A' ' 182' ' ' LYS . 21.7 t -72.51 -43.44 63.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 113.938 -1.483 . . . . 0.0 110.429 179.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.582 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 1.8 ptpt -64.07 -36.18 83.17 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.789 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.517 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 0.0 OUTLIER -82.19 -50.15 9.33 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.9 0.381 . . . . 0.0 111.269 179.279 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.889 HD12 ' O ' ' A' ' 235' ' ' PRO . 1.5 mt -44.6 -48.77 2.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.252 -179.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . 0.459 ' HG2' ' HB ' ' A' ' 256' ' ' VAL . 22.3 mtp -61.97 -26.51 68.26 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.944 -178.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.45 ' CG ' ' O ' ' A' ' 237' ' ' LYS . 1.1 mt-10 -86.99 -16.73 34.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.826 0.346 . . . . 0.0 111.248 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.487 ' HG2' ' HA ' ' A' ' 239' ' ' ILE . 2.9 mmmt -80.55 118.42 22.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.138 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.456 ' HG2' ' N ' ' A' ' 244' ' ' TYR . 13.8 ttpt -41.9 -81.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . 0.481 ' CD1' ' HG3' ' A' ' 253' ' ' GLU . 12.1 m-85 -114.74 157.15 23.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.407 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' HIS . . . . . 0.767 ' CG ' HD12 ' A' ' 254' ' ' ILE . 24.2 m-70 -113.68 150.23 33.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.241 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . 0.417 ' O ' ' CE2' ' A' ' 201' ' ' TYR . 0.2 OUTLIER -127.85 105.35 8.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.859 179.704 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.533 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.7 t -110.35 110.22 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.985 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 45.61 -87.71 0.01 OUTLIER Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.407 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.533 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -106.49 -39.97 5.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.363 0.601 . . . . 0.0 110.546 179.639 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.473 ' OG ' ' HB2' ' A' ' 190' ' ' SER . 1.5 m -77.43 147.42 35.98 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.033 -178.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -143.97 106.24 4.39 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.463 179.162 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' CYS . . . . . 0.68 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -128.21 153.12 47.27 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -176.541 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . 0.481 ' HG3' ' CD1' ' A' ' 244' ' ' TYR . 50.1 tt0 -76.29 107.57 8.62 Favored 'General case' 0 C--O 1.224 -0.27 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.172 178.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . 0.767 HD12 ' CG ' ' A' ' 245' ' ' HIS . 29.2 mt -96.39 113.3 30.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -177.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . 0.515 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -117.25 133.09 56.4 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 176.677 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 183' ' ' LYS . 5.5 p -33.23 124.94 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-O 122.251 1.024 . . . . 0.0 111.304 -177.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 1.099 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -78.27 152.95 32.24 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 113.423 -1.717 . . . . 0.0 112.48 -178.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.73 113.85 15.86 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.511 -1.222 . . . . 0.0 110.081 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . 0.408 ' HB3' ' HD2' ' A' ' 183' ' ' LYS . 83.6 p . . . . . 0 C--N 1.323 -0.586 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.859 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.485 ' O ' ' HD3' ' A' ' 182' ' ' LYS . 43.5 t . . . . . 0 CA--C 1.505 -0.765 0 CA-C-O 121.362 0.601 . . . . 0.0 112.328 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.549 ' CB ' HG21 ' A' ' 236' ' ' VAL . 8.0 mmtt -145.76 112.38 5.91 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.243 176.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.883 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.0 OUTLIER -130.62 162.45 29.33 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.965 179.775 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.846 HD11 ' HE2' ' A' ' 202' ' ' PHE . 0.3 OUTLIER -138.55 119.74 16.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 177.532 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.854 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -92.52 109.49 20.89 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.587 0.708 . . . . 0.0 110.195 -178.914 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.707 HG12 ' HB2' ' A' ' 252' ' ' CYS . 40.6 t -84.29 128.07 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.894 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.553 ' O ' ' HB3' ' A' ' 252' ' ' CYS . . . -116.5 132.76 10.32 Favored Glycine 0 N--CA 1.451 -0.319 0 N-CA-C 115.053 0.781 . . . . 0.0 115.053 -176.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.483 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . 71.39 80.11 0.36 Allowed Glycine 0 N--CA 1.452 -0.292 0 CA-C-N 115.442 -0.379 . . . . 0.0 113.397 178.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.934 HD13 ' OG1' ' A' ' 193' ' ' THR . 0.8 OUTLIER -117.26 157.57 25.82 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.701 0.286 . . . . 0.0 110.958 -179.796 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.593 ' CB ' ' CD ' ' A' ' 191' ' ' PRO . 0.2 OUTLIER -47.71 -173.66 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.934 179.585 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . 0.593 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 5.7 Cg_exo -78.36 17.09 1.12 Allowed 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.956 2.437 . . . . 0.0 113.272 -179.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.538 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 1.2 m-20 159.73 76.89 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.117 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.635 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.934 ' OG1' HD13 ' A' ' 189' ' ' LEU . 50.1 m -71.45 114.55 28.94 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 120.855 0.36 . . . . 0.0 110.432 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.541 ' C ' HD11 ' A' ' 198' ' ' ILE . 16.3 Cg_endo -58.52 110.05 0.6 Allowed 'Trans proline' 0 N--CA 1.464 -0.243 0 C-N-CA 122.369 2.046 . . . . 0.0 111.748 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.803 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -50.9 -15.69 0.33 Allowed 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.143 -179.875 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . 0.482 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 23.1 mm-40 -71.94 -36.89 70.03 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' A' ' 200' ' ' GLU . 0.0 OUTLIER -73.92 -48.01 33.72 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.186 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.854 ' CD1' HG22 ' A' ' 193' ' ' THR . 0.0 OUTLIER -47.68 -30.73 2.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.225 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.603 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 6.5 mtt180 -71.72 -32.4 67.73 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.189 179.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . 0.53 ' N ' ' O ' ' A' ' 197' ' ' LYS . 0.4 OUTLIER -82.83 -46.19 13.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.023 0.44 . . . . 0.0 110.646 179.292 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.509 ' C ' ' CD1' ' A' ' 201' ' ' TYR . 0.5 OUTLIER -63.04 -53.55 52.11 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.004 179.407 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 1.122 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -79.88 -31.41 40.33 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 114.845 -1.07 . . . . 0.0 110.339 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.603 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -64.85 -54.36 28.7 Favored Glycine 0 CA--C 1.497 -1.071 0 N-CA-C 106.535 -2.626 . . . . 0.0 106.535 176.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -50.23 -29.3 15.54 Favored Glycine 0 N--CA 1.442 -0.928 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 175.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.811 ' CD2' HD11 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -58.34 -44.76 88.86 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 177.783 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 170.55 -129.89 1.89 Allowed Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 113.717 -1.583 . . . . 0.0 110.616 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.474 ' HB3' ' HE2' ' A' ' 231' ' ' LYS . 2.9 mm-40 -97.01 99.69 11.21 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.289 0.566 . . . . 0.0 111.321 178.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.413 HG22 ' CE1' ' A' ' 230' ' ' PHE . 2.6 t -77.5 143.39 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 CA-C-N 115.324 -0.853 . . . . 0.0 108.845 178.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . 0.525 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 5.8 tp10 -93.7 -56.78 2.78 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 4.4 m -166.94 149.92 6.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.959 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.903 HD13 HG23 ' A' ' 228' ' ' ILE . 0.4 OUTLIER -117.19 126.37 74.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.664 178.922 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -123.09 103.07 8.34 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -178.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.574 HD21 ' HB ' ' A' ' 193' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.241 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 177.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.615 0 CA-C-O 121.242 0.357 . . . . 0.0 112.701 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . 0.911 ' C ' HD23 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -156.79 176.7 12.39 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -178.339 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . 0.516 ' O ' ' HB ' ' A' ' 186' ' ' VAL . 1.3 p -139.48 156.32 47.01 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.016 -0.674 . . . . 0.0 112.544 -179.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 1.072 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 3.8 m-85 -113.95 133.44 55.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.495 -0.775 . . . . 0.0 108.965 178.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 1.122 HD12 ' CE2' ' A' ' 202' ' ' PHE . 2.0 mt -128.55 133.26 66.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.142 0.496 . . . . 0.0 111.475 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . 0.457 HG22 ' HB3' ' A' ' 209' ' ' GLU . 97.7 m -113.03 138.05 50.48 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.155 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.817 ' HE2' HD13 ' A' ' 184' ' ' ILE . 67.9 m-85 -112.8 126.44 55.43 Favored 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.053 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.525 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -50.52 -37.83 41.25 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 177.737 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -90.1 -165.86 1.45 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 113.152 -1.84 . . . . 0.0 109.691 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . 0.528 ' HB2' ' HD2' ' A' ' 182' ' ' LYS . 0.4 OUTLIER -134.64 8.53 3.6 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.667 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.548 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.3 OUTLIER -82.14 -59.92 0.41 Allowed Pre-proline 0 C--N 1.328 -0.369 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.755 179.939 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.911 ' O ' HD12 ' A' ' 239' ' ' ILE . 80.2 Cg_exo -49.48 -30.91 22.27 Favored 'Trans proline' 0 CA--C 1.499 -1.27 0 N-CA-C 108.986 -1.198 . . . . 0.0 108.986 178.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.549 HG21 ' CB ' ' A' ' 182' ' ' LYS . 21.1 t -73.92 -45.69 48.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 114.473 -1.239 . . . . 0.0 110.272 178.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.548 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 1.2 ptpt -61.74 -36.23 80.38 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.606 -179.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.645 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -82.29 -54.89 4.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.172 178.918 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.911 HD12 ' O ' ' A' ' 235' ' ' PRO . 1.7 mt -40.33 -50.69 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.951 -179.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . 0.472 ' HG2' ' HB ' ' A' ' 256' ' ' VAL . 17.3 mtp -60.06 -24.68 64.76 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.787 -178.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.487 ' CG ' ' O ' ' A' ' 237' ' ' LYS . 1.0 OUTLIER -87.91 -17.08 32.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.798 0.333 . . . . 0.0 111.261 -179.715 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.505 ' HG2' ' HA ' ' A' ' 239' ' ' ILE . 0.1 OUTLIER -79.68 123.77 27.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.352 -179.742 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.456 ' HE3' ' HB2' ' A' ' 244' ' ' TYR . 7.7 ttpt -50.38 -75.53 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 178.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . 0.526 ' CD1' ' HG3' ' A' ' 253' ' ' GLU . 17.3 m-85 -121.02 144.81 48.33 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.932 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' HIS . . . . . 0.866 ' CG ' HD12 ' A' ' 254' ' ' ILE . 30.1 m-70 -104.55 150.63 24.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.096 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . 0.457 ' HB3' ' HD2' ' A' ' 251' ' ' LYS . 0.0 OUTLIER -129.58 104.68 7.59 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.221 0.534 . . . . 0.0 110.493 179.164 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.556 ' O ' ' C ' ' A' ' 248' ' ' GLY . 1.7 t -95.29 170.24 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.737 -179.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . 0.556 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . -8.3 -64.66 0.01 OUTLIER Glycine 0 C--N 1.341 0.825 0 O-C-N 123.669 0.606 . . . . 0.0 113.797 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.467 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -126.0 -39.82 2.07 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.509 0.671 . . . . 0.0 110.501 -179.282 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.663 ' CB ' ' HG1' ' A' ' 193' ' ' THR . 0.2 OUTLIER -77.3 157.33 30.79 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.745 -1.116 . . . . 0.0 112.734 -178.197 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -142.42 107.97 5.07 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.182 179.27 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' CYS . . . . . 0.707 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -128.67 152.96 47.79 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -177.255 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . 0.529 ' N ' ' O ' ' A' ' 187' ' ' GLY . 49.3 tt0 -76.61 108.48 9.64 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.581 179.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . 0.866 HD12 ' CG ' ' A' ' 245' ' ' HIS . 30.6 mt -96.8 113.44 31.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 -178.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . 0.518 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -115.94 133.25 56.22 Favored 'General case' 0 C--O 1.22 -0.448 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 176.508 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.633 HG23 ' O ' ' A' ' 183' ' ' LYS . 2.4 p -33.2 124.51 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-O 122.096 0.95 . . . . 0.0 111.324 -177.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 1.072 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -79.56 151.18 30.82 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 113.633 -1.621 . . . . 0.0 112.37 -178.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.62 115.85 19.41 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.089 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 29.7 p . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.057 -179.676 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.507 ' C ' ' CD ' ' A' ' 182' ' ' LYS . 45.3 t . . . . . 0 CA--C 1.503 -0.855 0 CA-C-O 121.044 0.449 . . . . 0.0 111.204 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 1.028 ' HB2' HG21 ' A' ' 236' ' ' VAL . 0.0 OUTLIER -151.14 112.34 4.34 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.103 177.66 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.817 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.0 OUTLIER -135.64 142.6 45.21 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.978 178.863 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.891 HD13 ' HE2' ' A' ' 230' ' ' PHE . 0.4 OUTLIER -122.04 120.91 62.7 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.183 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.787 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -94.14 109.34 21.13 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 121.553 0.692 . . . . 0.0 110.23 -179.195 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.992 HG12 ' HB2' ' A' ' 252' ' ' CYS . 4.9 t -85.03 128.86 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.802 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.564 ' HA2' ' HB2' ' A' ' 225' ' ' PHE . . . -115.6 127.87 7.78 Favored Glycine 0 C--N 1.332 0.316 0 N-CA-C 115.124 0.809 . . . . 0.0 115.124 -176.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.476 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . 76.26 82.04 0.53 Allowed Glycine 0 C--N 1.332 0.312 0 C-N-CA 121.354 -0.45 . . . . 0.0 113.419 178.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.949 HD13 ' OG1' ' A' ' 193' ' ' THR . 1.2 pp -117.43 157.18 26.67 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.778 0.323 . . . . 0.0 111.168 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.653 ' O ' HD12 ' A' ' 189' ' ' LEU . 0.2 OUTLIER -46.67 -177.45 0.01 OUTLIER Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.256 0.551 . . . . 0.0 111.592 -179.927 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . 0.574 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 19.6 Cg_exo -67.31 -2.73 8.68 Favored 'Trans proline' 0 CA--C 1.53 0.291 0 C-N-CA 123.395 2.73 . . . . 0.0 113.908 -179.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 191' ' ' PRO . 0.8 OUTLIER 171.76 73.0 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.905 0.383 . . . . 0.0 111.667 -179.811 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.949 ' OG1' HD13 ' A' ' 189' ' ' LEU . 93.7 m -61.52 122.32 70.03 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.998 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.497 ' O ' HD11 ' A' ' 198' ' ' ILE . 55.7 Cg_endo -70.09 114.62 3.82 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.157 1.905 . . . . 0.0 111.103 178.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.817 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -51.61 -15.16 0.41 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 121.056 -0.257 . . . . 0.0 111.265 -179.439 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . 0.509 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 4.9 mt-10 -67.91 -40.42 83.41 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.521 ' O ' ' N ' ' A' ' 200' ' ' GLU . 0.4 OUTLIER -70.71 -50.95 30.92 Favored 'General case' 0 CA--C 1.5 -0.98 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.222 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.824 ' HB ' HD12 ' A' ' 211' ' ' ILE . 0.0 OUTLIER -47.59 -32.43 2.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 115.297 -0.865 . . . . 0.0 108.751 178.717 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.572 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 16.7 mtt85 -69.92 -33.4 72.12 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.975 178.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . 0.521 ' N ' ' O ' ' A' ' 197' ' ' LYS . 8.5 mm-40 -81.87 -60.13 2.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.278 0.561 . . . . 0.0 109.928 179.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.495 ' C ' ' CD1' ' A' ' 201' ' ' TYR . 0.3 OUTLIER -49.31 -54.19 18.29 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.025 178.932 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 1.104 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.2 OUTLIER -79.74 -31.5 41.04 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.991 -179.589 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.572 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -63.77 -56.47 18.81 Favored Glycine 0 CA--C 1.499 -0.95 0 N-CA-C 107.037 -2.425 . . . . 0.0 107.037 176.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -49.4 -28.44 9.47 Favored Glycine 0 N--CA 1.442 -0.937 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 176.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.771 ' CE2' HG13 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -57.19 -48.56 78.45 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 177.769 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 175.62 -130.15 1.67 Allowed Glycine 0 N--CA 1.44 -1.078 0 CA-C-N 113.65 -1.614 . . . . 0.0 110.31 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.505 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 20.7 mm-40 -96.96 100.96 12.45 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.144 0.497 . . . . 0.0 110.861 178.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.461 HG22 ' CE1' ' A' ' 230' ' ' PHE . 2.8 t -77.93 141.37 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . 0.588 ' HB3' HG22 ' A' ' 229' ' ' THR . 5.8 tp10 -91.9 -55.7 3.36 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 8.0 m -167.69 148.78 5.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.874 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.882 HD13 HG23 ' A' ' 228' ' ' ILE . 0.4 OUTLIER -115.72 125.67 72.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.882 178.931 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.28 105.01 9.49 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.334 -178.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.47 HD22 ' HB ' ' A' ' 193' ' ' THR . 0.1 OUTLIER . . . . . 0 CA--C 1.534 0.349 0 CA-C-O 120.841 0.353 . . . . 0.0 110.822 178.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.407 0 N-CA-C 112.922 -0.071 . . . . 0.0 112.922 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . 0.88 ' C ' HD23 ' A' ' 189' ' ' LEU . 1.5 p90 -156.79 176.47 12.69 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . 0.469 ' O ' ' HB ' ' A' ' 186' ' ' VAL . 27.7 p -146.0 152.22 39.02 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 1.11 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 6.1 m-85 -106.21 139.43 40.74 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.082 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 1.104 HD12 ' CE2' ' A' ' 202' ' ' PHE . 2.0 mt -133.58 129.84 56.01 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.386 0 CA-C-O 120.879 0.371 . . . . 0.0 110.985 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . 0.588 HG22 ' HB3' ' A' ' 209' ' ' GLU . 53.5 m -111.17 138.22 47.88 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.897 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.891 ' HE2' HD13 ' A' ' 184' ' ' ILE . 81.4 m-85 -114.51 126.44 54.94 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.445 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.505 ' HG3' ' O ' ' A' ' 207' ' ' GLU . 0.0 OUTLIER -47.77 -39.63 18.49 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 178.134 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . 0.479 ' O ' ' HG3' ' A' ' 182' ' ' LYS . 5.9 mm-40 -99.29 171.29 8.08 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 113.452 -1.704 . . . . 0.0 109.684 179.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . 0.44 ' HB3' ' CE ' ' A' ' 182' ' ' LYS . 0.0 OUTLIER -110.21 21.07 17.17 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.307 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.562 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.0 OUTLIER -85.18 -62.16 0.26 Allowed Pre-proline 0 C--N 1.331 -0.221 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.699 179.619 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.916 ' O ' HD12 ' A' ' 239' ' ' ILE . 87.3 Cg_exo -50.37 -29.69 24.54 Favored 'Trans proline' 0 CA--C 1.502 -1.101 0 N-CA-C 108.811 -1.265 . . . . 0.0 108.811 177.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 1.028 HG21 ' HB2' ' A' ' 182' ' ' LYS . 20.9 t -72.66 -42.96 62.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 113.768 -1.56 . . . . 0.0 110.324 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.562 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 9.3 pttp -64.26 -36.41 84.0 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.738 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.541 ' O ' ' CG ' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -81.43 -50.37 9.52 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.16 0.505 . . . . 0.0 110.92 179.183 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.916 HD12 ' O ' ' A' ' 235' ' ' PRO . 1.6 mt -45.53 -53.04 2.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.847 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . 0.582 ' SD ' HG12 ' A' ' 236' ' ' VAL . 11.5 mtp -60.46 -17.1 42.59 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.263 -178.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.541 ' CG ' ' O ' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -88.37 -26.29 22.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.893 0.377 . . . . 0.0 111.0 -179.813 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.516 ' CD ' ' HG3' ' A' ' 241' ' ' GLU . 5.3 mmmt -79.58 109.8 14.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.01 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.483 ' HD3' ' CD1' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -40.18 -62.42 0.75 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.34 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . 0.549 ' CD1' ' HG3' ' A' ' 253' ' ' GLU . 12.9 m-30 -122.01 161.7 22.48 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.897 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' HIS . . . . . 0.78 ' CE1' HD12 ' A' ' 254' ' ' ILE . 20.5 m-70 -122.82 156.76 33.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.822 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . 0.416 ' O ' ' CE2' ' A' ' 201' ' ' TYR . 1.3 m-80 -133.24 105.15 6.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.172 0.511 . . . . 0.0 110.581 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.55 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.5 t -108.52 138.71 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.556 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . 0.479 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . 26.65 -87.57 0.01 OUTLIER Glycine 0 C--N 1.337 0.619 0 C-N-CA 121.163 -0.541 . . . . 0.0 113.017 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.55 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.1 OUTLIER -108.87 -34.63 6.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.774 0.797 . . . . 0.0 109.845 -179.861 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.516 ' O ' ' N ' ' A' ' 247' ' ' VAL . 3.0 p -77.25 152.92 34.46 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.248 -1.342 . . . . 0.0 113.176 -177.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -143.31 104.66 4.29 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 114.739 -1.118 . . . . 0.0 108.361 178.464 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' CYS . . . . . 0.992 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -128.34 152.77 47.76 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -176.399 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . 0.549 ' HG3' ' CD1' ' A' ' 244' ' ' TYR . 50.7 tt0 -76.93 107.79 9.52 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.982 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . 0.854 HG12 HG13 ' A' ' 186' ' ' VAL . 26.1 mt -96.46 112.84 29.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -178.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . 0.53 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -115.02 130.98 57.06 Favored 'General case' 0 C--O 1.221 -0.41 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 176.418 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.675 HG23 ' O ' ' A' ' 183' ' ' LYS . 10.0 p -33.16 124.46 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 122.156 0.979 . . . . 0.0 111.475 -177.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 1.11 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -76.68 153.93 34.68 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 113.501 -1.681 . . . . 0.0 111.448 -178.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.1 111.82 13.9 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.046 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . 0.457 ' HB2' ' HD2' ' A' ' 183' ' ' LYS . 0.2 OUTLIER . . . . . 0 C--N 1.325 -0.459 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.7 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.501 ' CG1' ' N ' ' A' ' 182' ' ' LYS . 40.6 t . . . . . 0 CA--C 1.506 -0.745 0 CA-C-O 121.261 0.553 . . . . 0.0 111.77 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.685 ' CB ' HG21 ' A' ' 236' ' ' VAL . 0.2 OUTLIER -148.02 112.5 5.31 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.029 177.442 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.863 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -130.5 145.45 51.86 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.382 179.271 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.873 HD13 ' HE2' ' A' ' 230' ' ' PHE . 0.3 OUTLIER -125.35 120.43 57.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.113 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.844 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -93.86 109.22 20.93 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.475 -178.875 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.995 HG12 ' HB2' ' A' ' 252' ' ' CYS . 2.8 t -84.44 124.65 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.196 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.551 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . -112.07 126.69 7.73 Favored Glycine 0 N--CA 1.451 -0.337 0 N-CA-C 114.932 0.733 . . . . 0.0 114.932 -176.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.464 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . 76.69 84.05 0.47 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 121.418 -0.42 . . . . 0.0 113.286 178.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.951 HD23 ' C ' ' A' ' 225' ' ' PHE . 0.9 OUTLIER -117.07 157.01 26.58 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.657 0.265 . . . . 0.0 110.788 179.843 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.655 ' O ' HD12 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -46.72 -175.15 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.061 179.818 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . 0.586 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 4.0 Cg_exo -79.79 17.76 1.24 Allowed 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 123.024 2.483 . . . . 0.0 112.949 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.494 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 1.0 OUTLIER 161.86 74.72 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.126 0 CA-C-O 120.621 0.248 . . . . 0.0 111.363 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.933 ' OG1' HD13 ' A' ' 189' ' ' LEU . 55.2 m -74.59 112.86 19.27 Favored Pre-proline 0 C--N 1.332 -0.169 0 CA-C-O 120.912 0.387 . . . . 0.0 110.919 179.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.548 ' HG2' ' CG ' ' A' ' 197' ' ' LYS . 26.6 Cg_endo -62.65 109.03 0.8 Allowed 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 122.3 2.0 . . . . 0.0 111.485 179.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.851 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -48.0 -15.4 0.06 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 111.849 0.314 . . . . 0.0 111.849 -179.658 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 6.8 mm-40 -65.98 -37.06 84.99 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.548 ' CG ' ' HG2' ' A' ' 194' ' ' PRO . 0.8 OUTLIER -75.54 -50.95 14.08 Favored 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.258 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.851 ' CG1' ' HA ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -46.63 -31.19 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.314 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.552 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 5.2 mtp85 -70.16 -35.31 73.92 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.523 178.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . 0.513 ' N ' ' O ' ' A' ' 197' ' ' LYS . 12.1 mm-40 -82.4 -58.63 2.84 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.275 0.559 . . . . 0.0 110.233 179.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.497 ' C ' ' CD1' ' A' ' 201' ' ' TYR . 0.4 OUTLIER -48.28 -53.45 17.21 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.677 179.144 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 1.136 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.2 OUTLIER -79.78 -31.17 40.82 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.177 179.688 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.552 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -60.2 -57.88 16.92 Favored Glycine 0 CA--C 1.499 -0.91 0 N-CA-C 107.221 -2.352 . . . . 0.0 107.221 176.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -50.15 -27.65 11.32 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 176.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.814 ' CD2' HD11 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -58.24 -44.13 88.14 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 122.158 0.98 . . . . 0.0 108.383 178.003 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 169.49 -130.5 2.06 Favored Glycine 0 N--CA 1.442 -0.926 0 CA-C-N 113.465 -1.698 . . . . 0.0 110.26 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.5 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 46.1 mm-40 -96.72 101.64 13.28 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.258 0.551 . . . . 0.0 110.973 178.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.424 HG21 ' HB2' ' A' ' 202' ' ' PHE . 3.0 t -79.45 136.77 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 CA-C-N 115.25 -0.886 . . . . 0.0 108.814 178.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . 0.65 ' HB3' HG22 ' A' ' 229' ' ' THR . 6.1 tp10 -88.45 -56.56 3.26 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 3.4 m -166.29 150.37 7.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.342 0.591 . . . . 0.0 112.436 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.904 HD13 HG23 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -118.38 126.45 75.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.466 178.593 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -123.24 102.86 8.18 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -178.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.508 HD23 ' HB3' ' A' ' 226' ' ' CYS . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.257 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 177.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.421 0 N-CA-C 112.232 -0.347 . . . . 0.0 112.232 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . 0.951 ' C ' HD23 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -157.47 176.93 12.01 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.024 -0.588 . . . . 0.0 109.986 -177.879 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . 0.508 ' HB3' HD23 ' A' ' 213' ' ' LEU . 1.6 p -138.66 147.43 42.82 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.138 -0.625 . . . . 0.0 112.389 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 1.109 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 4.6 m-85 -107.44 133.49 51.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.161 178.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 1.136 HD12 ' CE2' ' A' ' 202' ' ' PHE . 1.8 mt -128.06 133.0 68.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.13 0.49 . . . . 0.0 111.686 -179.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . 0.65 HG22 ' HB3' ' A' ' 209' ' ' GLU . 40.8 m -113.44 137.99 50.73 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.51 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.873 ' HE2' HD13 ' A' ' 184' ' ' ILE . 75.4 m-85 -113.62 126.3 55.12 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.298 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.5 ' HG3' ' O ' ' A' ' 207' ' ' GLU . 0.3 OUTLIER -47.94 -39.19 18.51 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 178.051 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . 0.44 ' O ' ' HD3' ' A' ' 182' ' ' LYS . 0.0 OUTLIER -91.47 -166.05 1.48 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 113.443 -1.708 . . . . 0.0 110.036 179.119 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . 0.544 ' HB3' ' HG2' ' A' ' 182' ' ' LYS . 0.6 OUTLIER -133.7 13.88 4.04 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.51 -179.92 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.578 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.3 OUTLIER -85.14 -59.52 0.32 Allowed Pre-proline 0 N--CA 1.452 -0.37 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 179.752 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.875 ' O ' HD12 ' A' ' 239' ' ' ILE . 83.4 Cg_exo -49.9 -31.0 25.39 Favored 'Trans proline' 0 CA--C 1.5 -1.214 0 N-CA-C 108.888 -1.235 . . . . 0.0 108.888 177.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.685 HG21 ' CB ' ' A' ' 182' ' ' LYS . 14.7 t -72.74 -45.16 57.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 113.892 -1.504 . . . . 0.0 110.179 179.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.578 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 1.6 ptpt -62.81 -36.36 82.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.721 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.503 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 0.0 OUTLIER -81.62 -50.3 9.49 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.903 0.382 . . . . 0.0 110.92 179.194 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.875 HD12 ' O ' ' A' ' 235' ' ' PRO . 1.6 mt -46.33 -49.84 5.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.54 -179.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . 0.522 ' SD ' HG12 ' A' ' 236' ' ' VAL . 15.4 mtp -60.27 -28.33 67.98 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.877 -178.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.531 ' CG ' ' O ' ' A' ' 237' ' ' LYS . 0.0 OUTLIER -88.67 -9.67 51.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.752 0.31 . . . . 0.0 110.976 -179.927 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.484 ' HG2' ' HA ' ' A' ' 239' ' ' ILE . 4.5 mmmm -79.81 116.19 19.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.363 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.498 ' HG2' ' N ' ' A' ' 244' ' ' TYR . 5.0 ttpt -39.98 -74.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . 0.546 ' CE1' ' HG3' ' A' ' 253' ' ' GLU . 21.6 m-85 -129.09 151.49 49.72 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.399 179.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' HIS . . . . . 0.787 ' CG ' HD12 ' A' ' 254' ' ' ILE . 45.0 m-70 -105.65 149.14 26.61 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.376 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . 0.414 ' ND2' ' N ' ' A' ' 246' ' ' ASN . 0.0 OUTLIER -123.55 105.4 9.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.543 179.503 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.529 HG12 ' HB2' ' A' ' 197' ' ' LYS . 1.8 t -110.05 116.55 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.961 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 41.16 -90.67 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.676 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.511 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.1 OUTLIER -105.03 -35.99 7.46 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.747 0.784 . . . . 0.0 109.914 -179.538 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.477 ' HB3' ' HB2' ' A' ' 190' ' ' SER . 0.8 OUTLIER -77.87 153.61 32.5 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.317 -1.311 . . . . 0.0 112.633 -178.363 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.488 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -148.18 104.81 3.57 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.868 -1.06 . . . . 0.0 108.545 178.942 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' CYS . . . . . 0.995 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -127.59 152.32 47.8 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -177.074 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . 0.546 ' HG3' ' CE1' ' A' ' 244' ' ' TYR . 29.3 tt0 -77.17 110.05 11.54 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.047 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . 0.877 HG12 HG13 ' A' ' 186' ' ' VAL . 25.3 mt -96.52 111.29 26.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 -178.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . 0.514 ' O ' ' C ' ' A' ' 256' ' ' VAL . 0.0 OUTLIER -115.72 132.28 56.68 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 176.439 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.66 HG23 ' O ' ' A' ' 183' ' ' LYS . 5.2 p -32.8 121.78 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 CA-C-O 122.254 1.025 . . . . 0.0 111.356 -177.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 1.109 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -76.54 153.91 35.01 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 113.315 -1.766 . . . . 0.0 111.774 -178.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 2.0 mtm -128.81 113.6 15.49 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.761 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . 0.411 ' HB3' ' HD2' ' A' ' 183' ' ' LYS . 86.9 p . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.537 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.527 ' CG1' ' N ' ' A' ' 182' ' ' LYS . 55.6 t . . . . . 0 CA--C 1.502 -0.865 0 CA-C-O 121.377 0.608 . . . . 0.0 111.961 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.75 ' CB ' HG21 ' A' ' 236' ' ' VAL . 0.0 OUTLIER -148.0 112.57 5.33 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.928 177.467 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.852 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -130.96 137.47 49.27 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.382 179.436 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.875 HD13 ' HE2' ' A' ' 230' ' ' PHE . 0.5 OUTLIER -119.67 120.73 64.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.814 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.813 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.3 OUTLIER -94.57 109.56 21.45 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.242 0.544 . . . . 0.0 111.003 -178.597 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 1.087 HG12 ' HB2' ' A' ' 252' ' ' CYS . 2.3 t -87.44 114.11 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.564 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.58 ' HA2' ' HB2' ' A' ' 225' ' ' PHE . . . -101.33 130.35 10.2 Favored Glycine 0 C--O 1.227 -0.288 0 N-CA-C 115.081 0.793 . . . . 0.0 115.081 -177.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.441 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . 78.36 79.73 0.75 Allowed Glycine 0 C--N 1.331 0.271 0 C-N-CA 121.01 -0.614 . . . . 0.0 113.472 178.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.939 HD23 ' C ' ' A' ' 225' ' ' PHE . 0.6 OUTLIER -117.69 157.56 26.26 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.693 0.282 . . . . 0.0 111.016 -179.916 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.587 ' N ' HD12 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -48.5 -173.48 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.792 179.305 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . 0.585 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 5.5 Cg_exo -77.59 15.96 1.16 Allowed 'Trans proline' 0 CA--C 1.531 0.36 0 C-N-CA 122.965 2.444 . . . . 0.0 113.409 -179.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.553 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 0.6 OUTLIER 157.58 78.19 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.667 0.27 . . . . 0.0 111.482 179.84 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.93 ' OG1' HD13 ' A' ' 189' ' ' LEU . 76.1 m -71.89 115.44 38.14 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.095 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.602 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 21.0 Cg_endo -61.02 112.31 1.33 Allowed 'Trans proline' 0 C--N 1.332 -0.325 0 C-N-CA 122.226 1.95 . . . . 0.0 111.519 178.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.804 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -50.63 -14.92 0.22 Allowed 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.872 -179.668 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . 0.484 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 9.3 mm-40 -66.94 -40.32 87.52 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -179.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.602 ' CD ' ' HG2' ' A' ' 194' ' ' PRO . 1.4 mttp -75.29 -46.42 33.61 Favored 'General case' 0 CA--C 1.498 -1.055 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.891 ' CD1' HG22 ' A' ' 193' ' ' THR . 0.0 OUTLIER -47.74 -32.11 2.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.003 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.595 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 9.6 mtp180 -69.48 -33.48 72.94 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.091 178.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . 0.528 ' N ' ' O ' ' A' ' 197' ' ' LYS . 9.3 mm-40 -82.47 -59.06 2.66 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.207 0.527 . . . . 0.0 110.206 178.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.505 ' C ' ' CD1' ' A' ' 201' ' ' TYR . 0.2 OUTLIER -48.76 -54.67 14.07 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.797 179.005 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.965 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.2 OUTLIER -79.57 -30.69 41.74 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.376 -179.864 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.595 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -62.7 -57.1 17.64 Favored Glycine 0 CA--C 1.499 -0.931 0 N-CA-C 107.036 -2.426 . . . . 0.0 107.036 176.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -48.62 -29.33 7.6 Favored Glycine 0 N--CA 1.441 -1.022 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 176.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.805 ' CD2' HD11 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -58.22 -43.45 87.71 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 177.764 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.491 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 169.06 -130.81 2.14 Favored Glycine 0 N--CA 1.441 -1.02 0 CA-C-N 113.725 -1.579 . . . . 0.0 110.423 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.506 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 4.3 mt-10 -96.97 101.31 12.86 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.208 0.528 . . . . 0.0 111.027 178.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.433 HG21 ' HB2' ' A' ' 202' ' ' PHE . 2.9 t -78.77 138.22 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 178.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . 0.502 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 13.7 tp10 -91.46 -57.62 2.71 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.616 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 25.1 p -157.7 154.95 29.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.285 0.565 . . . . 0.0 112.207 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.742 HD12 ' HB ' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -129.64 124.3 59.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.411 179.516 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.15 112.96 18.34 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -179.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.903 HD13 ' HB2' ' A' ' 226' ' ' CYS . 1.7 mm? . . . . . 0 CA--C 1.532 0.277 0 CA-C-O 120.836 0.35 . . . . 0.0 111.424 178.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.437 0 CA-C-O 120.837 0.132 . . . . 0.0 113.052 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . 0.939 ' C ' HD23 ' A' ' 189' ' ' LEU . 5.0 p90 -156.42 176.26 12.93 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -179.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . 0.903 ' HB2' HD13 ' A' ' 213' ' ' LEU . 7.2 p -143.87 154.89 43.83 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -179.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 1.137 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 6.1 m-85 -107.14 153.48 22.6 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.138 178.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.965 HD12 ' CE2' ' A' ' 202' ' ' PHE . 2.4 mt -147.87 135.11 13.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.869 0.366 . . . . 0.0 110.841 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . 0.438 ' OG1' ' HG2' ' A' ' 183' ' ' LYS . 92.3 m -117.35 138.41 51.8 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.875 ' HE2' HD13 ' A' ' 184' ' ' ILE . 70.6 m-85 -111.89 126.25 54.9 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.564 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.506 ' HG3' ' O ' ' A' ' 207' ' ' GLU . 0.0 OUTLIER -49.55 -38.78 32.24 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 177.829 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . 0.483 ' O ' ' HD3' ' A' ' 182' ' ' LYS . 22.4 mt-10 -90.41 -171.49 3.1 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 113.276 -1.784 . . . . 0.0 109.019 178.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . 0.539 ' CB ' ' HG2' ' A' ' 182' ' ' LYS . 0.0 OUTLIER -127.47 0.5 6.26 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.55 179.965 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.485 ' O ' ' N ' ' A' ' 237' ' ' LYS . 0.2 OUTLIER -73.45 -57.61 2.63 Favored Pre-proline 0 C--N 1.329 -0.294 0 N-CA-C 112.0 0.371 . . . . 0.0 112.0 -179.075 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.887 ' O ' HD12 ' A' ' 239' ' ' ILE . 99.8 Cg_exo -49.24 -32.97 26.78 Favored 'Trans proline' 0 CA--C 1.498 -1.3 0 C-N-CA 121.124 1.216 . . . . 0.0 108.985 178.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.75 HG21 ' CB ' ' A' ' 182' ' ' LYS . 19.5 t -70.84 -41.62 77.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 113.646 -1.615 . . . . 0.0 109.189 178.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.524 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 23.5 mttm -57.18 -45.27 83.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.83 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.502 ' O ' ' HG3' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -81.03 -50.38 9.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.313 -179.396 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.887 HD12 ' O ' ' A' ' 235' ' ' PRO . 1.4 mt -41.78 -51.42 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.99 -179.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . 0.61 ' SD ' HG12 ' A' ' 236' ' ' VAL . 4.9 mtp -64.23 -19.37 65.32 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.43 -178.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.502 ' HG3' ' O ' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -86.78 -22.1 26.12 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.063 0.458 . . . . 0.0 110.666 -179.916 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -78.49 118.26 20.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.667 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.447 ' HD3' ' CD2' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -48.68 -49.86 35.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.611 179.911 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . 0.528 ' CD1' ' HG3' ' A' ' 253' ' ' GLU . 17.2 m-85 -138.74 163.91 30.96 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.945 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' HIS . . . . . 0.789 ' CE1' HD12 ' A' ' 254' ' ' ILE . 31.6 m-70 -125.07 156.05 38.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.028 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . 0.5 ' HA ' ' HA ' ' A' ' 251' ' ' LYS . 0.0 OUTLIER -137.99 105.08 5.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.093 0.473 . . . . 0.0 110.057 178.768 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.527 ' N ' ' O ' ' A' ' 250' ' ' SER . 1.8 t -103.09 106.7 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.424 -178.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . 0.407 ' HA3' ' HE3' ' A' ' 197' ' ' LYS . . . 54.84 -81.22 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.482 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.527 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -114.38 -39.23 3.88 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.424 0.631 . . . . 0.0 110.346 -179.983 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.527 ' O ' ' N ' ' A' ' 247' ' ' VAL . 0.2 OUTLIER -77.42 153.24 33.82 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.736 -178.952 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 246' ' ' ASN . 0.0 OUTLIER -145.12 108.7 4.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.408 -0.815 . . . . 0.0 108.869 179.143 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' CYS . . . . . 1.087 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -128.3 153.3 47.15 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -176.951 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . 0.56 ' N ' ' O ' ' A' ' 187' ' ' GLY . 39.0 tt0 -76.03 107.22 8.08 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.978 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . 0.861 HG12 HG13 ' A' ' 186' ' ' VAL . 23.5 mt -95.76 113.7 30.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -178.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . 0.519 ' O ' ' C ' ' A' ' 256' ' ' VAL . 0.0 OUTLIER -118.84 133.2 56.0 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 176.608 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 183' ' ' LYS . 6.8 p -33.37 123.8 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 CA-C-O 122.252 1.025 . . . . 0.0 111.294 -177.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 1.137 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -76.01 153.36 36.55 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 113.337 -1.756 . . . . 0.0 111.444 -178.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.33 113.54 15.09 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.52 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.323 -0.559 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.995 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.505 HG12 ' N ' ' A' ' 182' ' ' LYS . 55.0 t . . . . . 0 CA--C 1.502 -0.871 0 CA-C-O 121.099 0.476 . . . . 0.0 111.356 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 1.103 ' HB2' HG21 ' A' ' 236' ' ' VAL . 0.0 OUTLIER -155.0 112.43 3.37 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.328 177.601 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.817 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -136.68 144.13 43.77 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 115.113 -0.948 . . . . 0.0 109.345 178.84 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.866 HD13 ' HE2' ' A' ' 230' ' ' PHE . 0.2 OUTLIER -123.9 120.07 58.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.827 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.846 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.9 OUTLIER -91.03 109.39 20.63 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.434 0.635 . . . . 0.0 109.748 -179.709 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.954 HG12 ' HB2' ' A' ' 252' ' ' CYS . 4.1 t -88.75 104.9 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.484 -179.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.551 ' O ' ' N ' ' A' ' 253' ' ' GLU . . . -92.82 127.39 8.97 Favored Glycine 0 C--O 1.228 -0.28 0 CA-C-N 115.165 -0.925 . . . . 0.0 115.065 -177.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.522 ' O ' ' CB ' ' A' ' 252' ' ' CYS . . . 83.29 81.43 0.97 Allowed Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.893 -0.67 . . . . 0.0 113.531 178.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.951 HD23 ' C ' ' A' ' 225' ' ' PHE . 0.6 OUTLIER -117.26 156.96 26.86 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.803 0.335 . . . . 0.0 110.865 179.68 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.591 ' N ' HD12 ' A' ' 189' ' ' LEU . 0.2 OUTLIER -46.52 -178.16 0.01 OUTLIER Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.812 179.811 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . 0.568 ' HD2' ' CB ' ' A' ' 190' ' ' SER . 72.1 Cg_endo -78.79 17.59 1.12 Allowed 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.563 2.175 . . . . 0.0 113.092 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.528 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 0.6 OUTLIER 159.86 66.17 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.497 0.189 . . . . 0.0 111.392 179.749 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.78 ' OG1' HD13 ' A' ' 189' ' ' LEU . 94.9 m -69.8 127.37 92.58 Favored Pre-proline 0 CA--C 1.518 -0.271 0 CA-C-O 120.963 0.411 . . . . 0.0 110.69 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.628 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 71.1 Cg_endo -71.15 109.49 2.58 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.378 2.052 . . . . 0.0 111.146 178.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.806 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -48.29 -14.07 0.05 Allowed 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -179.77 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . 0.524 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 2.9 mt-10 -67.44 -41.05 85.37 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.628 ' CD ' ' HG2' ' A' ' 194' ' ' PRO . 1.6 mttp -73.22 -46.87 47.84 Favored 'General case' 0 CA--C 1.503 -0.854 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.806 ' CG1' ' HA ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -47.5 -29.94 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.978 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 177.947 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.544 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 7.5 mtt180 -72.96 -32.69 65.38 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.294 178.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . 0.572 ' CG ' ' N ' ' A' ' 201' ' ' TYR . 3.6 pt-20 -83.0 -55.35 4.43 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.01 0.433 . . . . 0.0 110.337 179.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.572 ' N ' ' CG ' ' A' ' 200' ' ' GLU . 0.3 OUTLIER -50.01 -53.31 27.54 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.575 0.702 . . . . 0.0 109.511 178.761 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 1.132 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -79.64 -30.91 41.47 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.2 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.544 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -62.41 -56.72 20.14 Favored Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 107.048 -2.421 . . . . 0.0 107.048 176.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -50.67 -28.13 14.79 Favored Glycine 0 N--CA 1.443 -0.895 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 176.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.809 ' CD2' HD11 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -58.48 -43.9 89.13 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 177.805 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.502 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 170.69 -131.5 2.24 Favored Glycine 0 N--CA 1.441 -1.007 0 CA-C-N 113.615 -1.629 . . . . 0.0 110.271 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.513 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 2.1 mm-40 -97.1 100.82 12.3 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.238 0.542 . . . . 0.0 110.946 178.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.469 HG21 ' HB2' ' A' ' 202' ' ' PHE . 2.5 t -78.69 140.5 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.13 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.011 178.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . 0.718 ' HB3' HG22 ' A' ' 229' ' ' THR . 7.4 tp10 -89.53 -53.49 4.51 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 178.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.481 ' HB3' ' OE2' ' A' ' 212' ' ' GLU . 0.4 OUTLIER -170.89 156.69 5.09 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.451 179.256 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 1.022 HD13 HG23 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -125.1 117.28 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.611 179.375 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . 0.556 ' C ' HD23 ' A' ' 213' ' ' LEU . 0.5 OUTLIER -123.5 104.43 9.06 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -179.422 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.987 HD22 ' CB ' ' A' ' 226' ' ' CYS . 0.1 OUTLIER . . . . . 0 CA--C 1.533 0.31 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 179.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . 0.485 ' O ' ' HG ' ' A' ' 189' ' ' LEU . . . . . . . . 0 N--CA 1.447 -0.617 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . 0.951 ' C ' HD23 ' A' ' 189' ' ' LEU . 15.9 p90 -135.75 177.2 8.01 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -178.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . 0.987 ' CB ' HD22 ' A' ' 213' ' ' LEU . 1.5 p -135.9 149.69 49.07 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -178.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 1.117 ' CE1' ' HB1' ' A' ' 257' ' ' ALA . 3.9 m-85 -106.08 132.58 51.98 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 1.132 HD12 ' CE2' ' A' ' 202' ' ' PHE . 1.8 mt -128.61 118.54 47.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.292 0.567 . . . . 0.0 111.472 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . 0.718 HG22 ' HB3' ' A' ' 209' ' ' GLU . 22.1 m -101.58 138.03 39.12 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.562 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.866 ' HE2' HD13 ' A' ' 184' ' ' ILE . 74.4 m-85 -114.87 126.46 54.83 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.095 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.513 ' HG3' ' O ' ' A' ' 207' ' ' GLU . 0.0 OUTLIER -48.17 -39.13 19.87 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 177.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . 0.485 ' O ' ' HG3' ' A' ' 182' ' ' LYS . 3.1 mt-10 -98.81 165.22 11.88 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 113.413 -1.721 . . . . 0.0 109.478 178.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . 0.458 ' HB3' ' CD ' ' A' ' 182' ' ' LYS . 0.9 OUTLIER -106.14 19.64 20.21 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -179.393 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.548 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.7 OUTLIER -85.34 -61.44 0.27 Allowed Pre-proline 0 C--N 1.334 -0.086 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.955 179.67 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.888 ' O ' HD12 ' A' ' 239' ' ' ILE . 85.5 Cg_exo -49.51 -29.53 18.85 Favored 'Trans proline' 0 CA--C 1.499 -1.256 0 N-CA-C 108.88 -1.238 . . . . 0.0 108.88 177.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 1.103 HG21 ' HB2' ' A' ' 182' ' ' LYS . 12.9 t -73.31 -46.15 50.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 113.786 -1.552 . . . . 0.0 110.719 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.548 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 13.6 pttt -59.94 -37.18 78.8 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.42 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.624 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.6 OUTLIER -80.75 -56.1 4.37 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.201 0.524 . . . . 0.0 110.753 178.858 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.888 HD12 ' O ' ' A' ' 235' ' ' PRO . 1.6 mt -39.28 -47.74 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.605 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . 0.51 ' SD ' HG12 ' A' ' 236' ' ' VAL . 3.8 mtp -62.63 -27.7 69.39 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.782 -178.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.479 ' CG ' ' O ' ' A' ' 237' ' ' LYS . 1.8 mt-10 -83.41 -24.92 31.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.631 0.253 . . . . 0.0 111.553 -179.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.575 ' HD3' ' CE1' ' A' ' 245' ' ' HIS . 0.8 OUTLIER -79.22 109.31 13.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.019 0.437 . . . . 0.0 111.118 -179.461 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.504 ' HD2' ' CE2' ' A' ' 244' ' ' TYR . 0.6 OUTLIER -35.49 -61.19 0.46 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.094 -179.747 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . 0.551 ' CE1' ' HG3' ' A' ' 253' ' ' GLU . 44.5 m-85 -129.28 167.72 17.28 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.583 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' HIS . . . . . 0.778 ' CG ' HD12 ' A' ' 254' ' ' ILE . 38.1 m-70 -128.47 153.36 47.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.758 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -127.93 105.57 8.51 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.001 0.429 . . . . 0.0 111.031 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.58 HG11 HG23 ' A' ' 198' ' ' ILE . 1.5 t -106.36 107.91 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.241 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 44.06 -86.67 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.582 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -101.41 -41.37 6.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.256 0.55 . . . . 0.0 110.829 179.75 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.504 ' HB3' ' HB2' ' A' ' 190' ' ' SER . 5.2 p -78.34 155.79 29.9 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.363 -0.835 . . . . 0.0 113.096 -178.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.508 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.1 OUTLIER -147.47 105.86 3.78 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 114.365 -1.288 . . . . 0.0 107.868 178.473 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' CYS . . . . . 0.954 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -127.52 153.32 46.49 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -176.199 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . 0.551 ' N ' ' O ' ' A' ' 187' ' ' GLY . 40.6 tt0 -76.21 107.03 8.16 Favored 'General case' 0 C--O 1.22 -0.464 0 CA-C-N 114.832 -1.076 . . . . 0.0 110.607 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . 0.835 HG12 HG13 ' A' ' 186' ' ' VAL . 22.2 mt -95.62 111.85 26.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -178.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . 0.537 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -116.42 130.24 56.65 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 113.349 -1.751 . . . . 0.0 106.327 177.035 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 183' ' ' LYS . 4.2 p -32.75 123.01 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.488 0 CA-C-O 122.265 1.031 . . . . 0.0 111.341 -177.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 1.117 ' HB1' ' CE1' ' A' ' 227' ' ' PHE . . . -76.31 153.98 35.44 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 113.39 -1.732 . . . . 0.0 110.974 -178.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.56 113.4 14.19 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.717 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.504 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.854 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.501 ' CG1' ' N ' ' A' ' 182' ' ' LYS . 47.4 t . . . . . 0 CA--C 1.504 -0.808 0 CA-C-O 121.338 0.59 . . . . 0.0 111.608 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.696 ' CB ' HG21 ' A' ' 236' ' ' VAL . 0.0 OUTLIER -149.98 112.54 4.74 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.934 177.452 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.815 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.0 OUTLIER -133.21 141.78 48.25 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.444 179.254 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.816 HD12 HG21 ' A' ' 239' ' ' ILE . 0.5 OUTLIER -120.8 120.63 63.01 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 178.735 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.841 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -93.35 109.32 20.87 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.29 0.567 . . . . 0.0 110.327 -179.172 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.879 HG12 ' HB2' ' A' ' 252' ' ' CYS . 11.7 t -85.9 120.0 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.753 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.55 ' O ' ' N ' ' A' ' 253' ' ' GLU . . . -109.87 131.4 10.45 Favored Glycine 0 C--N 1.331 0.265 0 N-CA-C 115.221 0.849 . . . . 0.0 115.221 -176.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.478 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . 76.41 79.44 0.65 Allowed Glycine 0 C--N 1.331 0.255 0 C-N-CA 121.378 -0.439 . . . . 0.0 113.334 178.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.952 HD23 ' CA ' ' A' ' 225' ' ' PHE . 0.6 OUTLIER -117.54 157.48 26.26 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.605 0.241 . . . . 0.0 111.049 -179.776 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.619 ' N ' HD12 ' A' ' 189' ' ' LEU . 0.2 OUTLIER -46.88 -175.3 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.203 0 CA-C-O 121.046 0.45 . . . . 0.0 111.58 179.92 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . 0.597 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 13.2 Cg_exo -70.59 6.35 1.63 Allowed 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 123.319 2.68 . . . . 0.0 113.721 -179.119 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.54 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 3.5 m-20 159.6 78.76 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.153 0.502 . . . . 0.0 110.834 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.911 ' OG1' HD13 ' A' ' 189' ' ' LEU . 52.8 m -71.01 116.0 42.02 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.999 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.603 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 20.5 Cg_endo -58.16 110.54 0.66 Allowed 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.319 2.013 . . . . 0.0 111.127 178.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.804 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.4 OUTLIER -50.77 -14.98 0.23 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.524 -179.56 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . 0.477 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 74.1 mt-10 -65.15 -41.14 95.0 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -179.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.603 ' CD ' ' HG2' ' A' ' 194' ' ' PRO . 1.4 mttp -73.79 -48.07 34.24 Favored 'General case' 0 CA--C 1.498 -1.048 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.855 ' CD1' HG22 ' A' ' 193' ' ' THR . 0.0 OUTLIER -47.69 -31.85 2.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.207 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.547 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 2.3 mtp-105 -69.82 -33.31 72.15 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.083 178.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . 0.514 ' N ' ' O ' ' A' ' 197' ' ' LYS . 7.9 mt-10 -82.49 -58.5 2.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.244 0.545 . . . . 0.0 110.095 178.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.555 ' CD1' ' CD1' ' A' ' 202' ' ' PHE . 0.2 OUTLIER -49.02 -53.54 19.65 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.677 178.895 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 1.094 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.1 OUTLIER -79.74 -31.39 41.02 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.583 -179.787 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.547 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -62.77 -55.25 28.02 Favored Glycine 0 CA--C 1.5 -0.896 0 N-CA-C 107.051 -2.42 . . . . 0.0 107.051 176.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -50.25 -27.6 11.58 Favored Glycine 0 N--CA 1.444 -0.815 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 176.163 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.75 ' CE2' HG13 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -59.2 -47.76 84.14 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 122.137 0.97 . . . . 0.0 108.528 177.984 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.493 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 176.5 -132.29 2.04 Favored Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 113.602 -1.635 . . . . 0.0 110.172 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.489 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 2.2 mt-10 -97.19 99.87 11.35 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.142 0.496 . . . . 0.0 111.128 178.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.464 HG22 ' CE1' ' A' ' 230' ' ' PHE . 2.7 t -76.17 138.71 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . 0.464 ' HB3' HG22 ' A' ' 229' ' ' THR . 3.7 tp10 -92.45 -54.66 3.7 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.062 178.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 3.3 m -161.5 151.92 17.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.248 0.547 . . . . 0.0 112.272 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.691 HD12 ' HB ' ' A' ' 198' ' ' ILE . 0.1 OUTLIER -126.39 119.19 53.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.809 179.037 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.46 103.71 8.63 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -177.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.773 HD23 ' CB ' ' A' ' 226' ' ' CYS . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.225 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 176.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.58 0 N-CA-C 112.542 -0.223 . . . . 0.0 112.542 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . 0.952 ' CA ' HD23 ' A' ' 189' ' ' LEU . 0.5 OUTLIER -156.21 177.06 11.87 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.407 -0.396 . . . . 0.0 110.095 -177.852 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . 0.773 ' CB ' HD23 ' A' ' 213' ' ' LEU . 1.7 p -138.59 155.17 48.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.367 0.603 . . . . 0.0 112.609 -179.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 1.084 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 4.6 m-85 -111.17 133.3 53.63 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.338 178.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 1.094 HD12 ' CE2' ' A' ' 202' ' ' PHE . 2.0 mt -128.33 120.48 53.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.293 0.568 . . . . 0.0 111.679 -179.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . 0.48 ' OG1' ' HG2' ' A' ' 183' ' ' LYS . 73.6 m -103.44 138.1 40.63 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.404 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.809 ' HE2' HD13 ' A' ' 184' ' ' ILE . 82.7 m-85 -114.12 126.59 55.26 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.514 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.489 ' HG3' ' O ' ' A' ' 207' ' ' GLU . 0.0 OUTLIER -49.19 -38.53 26.22 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 177.914 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . 0.451 ' O ' ' HD3' ' A' ' 182' ' ' LYS . 2.0 mm-40 -90.85 -166.79 1.66 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 113.42 -1.718 . . . . 0.0 109.923 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . 0.471 ' CB ' ' HG2' ' A' ' 182' ' ' LYS . 0.6 OUTLIER -132.64 13.09 4.47 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.689 -179.852 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.538 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.8 OUTLIER -85.12 -58.04 0.36 Allowed Pre-proline 0 N--CA 1.451 -0.39 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.609 179.829 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.931 ' O ' HD12 ' A' ' 239' ' ' ILE . 81.4 Cg_exo -50.65 -28.8 23.43 Favored 'Trans proline' 0 CA--C 1.502 -1.116 0 N-CA-C 109.238 -1.101 . . . . 0.0 109.238 178.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.696 HG21 ' CB ' ' A' ' 182' ' ' LYS . 13.9 t -73.14 -44.05 56.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 113.795 -1.548 . . . . 0.0 109.978 178.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.542 ' HG2' ' HD2' ' A' ' 238' ' ' LYS . 0.5 OUTLIER -67.95 -30.25 69.5 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.301 179.538 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.542 ' HD2' ' HG2' ' A' ' 237' ' ' LYS . 0.6 OUTLIER -78.74 -54.34 6.2 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.766 0.793 . . . . 0.0 110.369 179.36 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.931 HD12 ' O ' ' A' ' 235' ' ' PRO . 1.9 mt -51.67 -49.65 33.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 114.357 -1.292 . . . . 0.0 112.645 -178.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . 0.528 ' SD ' HG12 ' A' ' 236' ' ' VAL . 8.1 mtp -59.35 -17.69 31.91 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.598 -178.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.541 ' CG ' ' O ' ' A' ' 237' ' ' LYS . 0.1 OUTLIER -84.25 -40.66 17.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.084 179.952 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.454 ' O ' ' C ' ' A' ' 243' ' ' LYS . 0.0 OUTLIER -80.3 87.15 5.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.722 179.898 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.56 ' N ' ' HD3' ' A' ' 243' ' ' LYS . 0.0 OUTLIER -31.48 -46.48 0.1 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.907 179.757 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . 0.572 ' CE1' ' HG3' ' A' ' 253' ' ' GLU . 18.9 m-85 -120.62 148.94 43.23 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.799 -179.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' HIS . . . . . 0.875 ' CG ' HD12 ' A' ' 254' ' ' ILE . 24.7 m-70 -122.97 157.75 31.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.278 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . 0.404 ' O ' ' CE2' ' A' ' 201' ' ' TYR . 0.0 OUTLIER -129.54 104.8 7.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.114 178.815 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.575 HG11 HG23 ' A' ' 198' ' ' ILE . 1.6 t -106.89 111.02 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.069 -179.378 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 48.0 -86.48 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.248 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.525 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.1 OUTLIER -108.57 -39.56 5.36 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.436 0.636 . . . . 0.0 110.391 -179.722 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.509 ' HB3' ' HB2' ' A' ' 190' ' ' SER . 0.2 OUTLIER -77.75 154.96 31.52 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.85 -1.068 . . . . 0.0 112.626 -178.3 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.513 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.1 OUTLIER -146.61 108.87 4.45 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.065 178.86 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 252' ' ' CYS . . . . . 0.879 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -128.17 152.79 47.62 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -177.015 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . 0.572 ' HG3' ' CE1' ' A' ' 244' ' ' TYR . 29.6 tt0 -76.44 107.12 8.49 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.523 179.282 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . 0.875 HD12 ' CG ' ' A' ' 245' ' ' HIS . 31.0 mt -96.15 111.07 25.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -178.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . 0.521 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -113.63 133.36 55.34 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 176.656 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.537 ' CG2' ' O ' ' A' ' 183' ' ' LYS . 4.1 p -33.55 124.34 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-O 122.207 1.004 . . . . 0.0 111.26 -177.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 1.084 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -77.35 153.25 33.96 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 113.466 -1.697 . . . . 0.0 112.037 -178.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.18 117.56 19.21 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.298 179.186 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.322 -0.624 0 CA-C-O 121.254 0.55 . . . . 0.0 111.45 -178.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.476 ' CG1' ' N ' ' A' ' 182' ' ' LYS . 46.3 t . . . . . 0 CA--C 1.5 -0.949 0 CA-C-O 121.206 0.527 . . . . 0.0 111.422 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.873 ' HB2' HG21 ' A' ' 236' ' ' VAL . 0.1 OUTLIER -150.45 112.02 4.47 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.247 178.0 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.874 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -133.73 144.95 49.42 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-N 114.432 -1.258 . . . . 0.0 108.814 178.896 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.916 HD13 ' HE2' ' A' ' 230' ' ' PHE . 1.8 pt -124.37 119.86 57.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 178.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.837 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -93.92 109.02 20.75 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 121.471 0.653 . . . . 0.0 110.687 -178.574 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 1.131 HG12 ' HB2' ' A' ' 252' ' ' CYS . 1.9 t -86.34 126.67 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.135 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.566 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . -113.4 133.99 11.6 Favored Glycine 0 C--N 1.333 0.412 0 N-CA-C 114.313 0.485 . . . . 0.0 114.313 -176.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.455 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . 71.41 87.64 0.14 Allowed Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.692 -0.766 . . . . 0.0 111.893 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.938 HD13 ' OG1' ' A' ' 193' ' ' THR . 0.6 OUTLIER -115.86 156.56 25.9 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.026 0.441 . . . . 0.0 111.655 -178.469 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.604 ' CB ' ' CD ' ' A' ' 191' ' ' PRO . 0.3 OUTLIER -49.31 -172.64 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.888 179.77 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . 0.604 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 3.1 Cg_exo -77.21 13.09 1.62 Allowed 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 123.004 2.469 . . . . 0.0 113.182 -179.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.535 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 1.6 p30 157.43 77.24 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 120.758 0.313 . . . . 0.0 111.375 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.938 ' OG1' HD13 ' A' ' 189' ' ' LEU . 16.8 m -70.91 114.24 25.4 Favored Pre-proline 0 CA--C 1.517 -0.309 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.258 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.61 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 97.6 Cg_endo -73.38 109.32 2.82 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.589 2.193 . . . . 0.0 111.211 178.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.606 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.3 OUTLIER -43.9 -19.69 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.831 -0.168 . . . . 0.0 111.447 -179.911 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' A' ' 194' ' ' PRO . 66.6 mt-10 -57.24 -43.14 82.64 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -179.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.61 ' CD ' ' HG2' ' A' ' 194' ' ' PRO . 0.5 OUTLIER -80.36 -47.11 14.96 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 178.619 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.893 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -49.0 -29.68 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 CA-C-N 114.382 -1.281 . . . . 0.0 108.445 176.728 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.565 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 0.0 OUTLIER -73.22 -32.54 64.82 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.656 178.104 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . 0.539 ' N ' ' O ' ' A' ' 197' ' ' LYS . 2.7 mt-10 -82.15 -58.33 3.0 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.642 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.492 ' C ' ' CD1' ' A' ' 201' ' ' TYR . 0.5 OUTLIER -48.43 -53.9 16.11 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.801 179.318 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 1.058 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.4 OUTLIER -79.59 -31.67 41.83 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.36 179.827 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.565 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -61.99 -57.12 18.71 Favored Glycine 0 CA--C 1.498 -1.001 0 N-CA-C 107.563 -2.215 . . . . 0.0 107.563 176.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -51.33 -28.12 18.84 Favored Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 176.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.771 ' CD2' HD11 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -57.07 -44.24 82.88 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.01 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.486 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 170.06 -129.11 1.76 Allowed Glycine 0 N--CA 1.441 -0.992 0 CA-C-N 113.518 -1.674 . . . . 0.0 110.221 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.516 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 21.8 mm-40 -97.16 101.52 13.1 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.153 0.502 . . . . 0.0 111.298 178.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 2.9 t -76.75 137.27 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 177.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . 0.509 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 5.7 tp10 -89.43 -56.58 3.2 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.954 179.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 15.5 m -164.38 149.49 10.11 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.278 0.561 . . . . 0.0 111.921 179.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.493 HD12 ' HB ' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -117.66 126.47 74.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.669 179.078 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -123.18 105.18 9.67 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -178.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.752 HD13 ' O ' ' A' ' 193' ' ' THR . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.267 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 177.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.66 0 CA-C-O 121.041 0.245 . . . . 0.0 112.706 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . 0.92 ' C ' HD23 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -157.36 177.07 11.86 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -178.403 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . 0.425 ' SG ' ' HB ' ' A' ' 186' ' ' VAL . 6.0 p -139.75 151.35 45.74 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 1.095 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 4.6 m-85 -110.43 133.07 53.62 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.711 178.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 1.058 HD12 ' CE2' ' A' ' 202' ' ' PHE . 2.3 mt -127.68 131.75 69.69 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.342 0 CA-C-O 121.121 0.486 . . . . 0.0 111.245 179.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . 0.482 ' HG1' ' HZ2' ' A' ' 183' ' ' LYS . 87.9 m -111.61 138.23 48.43 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.388 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.916 ' HE2' HD13 ' A' ' 184' ' ' ILE . 62.8 m-85 -112.8 126.29 55.27 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.686 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.516 ' HG3' ' O ' ' A' ' 207' ' ' GLU . 0.0 OUTLIER -50.85 -38.15 47.4 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 177.612 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . 0.511 ' O ' ' HG3' ' A' ' 182' ' ' LYS . 10.1 mt-10 -93.83 178.22 5.74 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 113.051 -1.886 . . . . 0.0 108.951 178.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . 0.547 ' O ' ' HG3' ' A' ' 237' ' ' LYS . 0.7 OUTLIER -117.7 1.98 12.24 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.878 -179.509 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.496 ' O ' ' N ' ' A' ' 237' ' ' LYS . 0.4 OUTLIER -73.06 -58.83 2.38 Favored Pre-proline 0 C--N 1.326 -0.435 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.864 -179.177 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.883 ' O ' HD12 ' A' ' 239' ' ' ILE . 82.2 Cg_exo -48.97 -32.72 23.97 Favored 'Trans proline' 0 CA--C 1.501 -1.134 0 N-CA-C 108.851 -1.25 . . . . 0.0 108.851 178.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.873 HG21 ' HB2' ' A' ' 182' ' ' LYS . 21.3 t -70.57 -42.05 78.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 113.928 -1.487 . . . . 0.0 109.034 178.068 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.547 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 13.5 mtpt -56.43 -45.93 80.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.798 179.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.489 ' HA ' ' HG3' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -81.25 -49.97 10.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.701 -179.163 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.883 HD12 ' O ' ' A' ' 235' ' ' PRO . 1.6 mt -42.74 -50.1 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.427 -178.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . 0.543 ' SD ' HG12 ' A' ' 236' ' ' VAL . 12.2 mtp -62.42 -24.18 67.27 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.695 -178.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.489 ' HG3' ' HA ' ' A' ' 238' ' ' LYS . 0.7 OUTLIER -87.88 -16.66 33.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.534 -179.437 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.456 ' HG2' ' HA ' ' A' ' 239' ' ' ILE . 8.1 mmmt -83.93 116.3 22.72 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.57 -0.287 . . . . 0.0 111.153 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.518 ' HG2' ' N ' ' A' ' 244' ' ' TYR . 1.8 ttpm? -36.77 -80.7 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.082 0.468 . . . . 0.0 110.013 179.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . 0.518 ' N ' ' HG2' ' A' ' 243' ' ' LYS . 10.3 m-85 -113.24 169.43 8.95 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.876 178.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' HIS . . . . . 0.697 ' CG ' HD12 ' A' ' 254' ' ' ILE . 17.0 m-70 -123.46 146.35 48.1 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.784 0.326 . . . . 0.0 110.935 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . 0.441 ' O ' ' CD2' ' A' ' 201' ' ' TYR . 0.2 OUTLIER -122.42 105.47 10.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.042 0.449 . . . . 0.0 110.519 179.595 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.523 HG11 HG23 ' A' ' 198' ' ' ILE . 2.4 t -111.6 102.41 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.824 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 51.2 -90.57 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.321 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.474 HD11 ' OG ' ' A' ' 190' ' ' SER . 0.1 OUTLIER -104.06 -40.36 6.21 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 121.594 0.711 . . . . 0.0 109.957 -179.931 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.57 ' CB ' ' HG1' ' A' ' 193' ' ' THR . 1.4 m -78.61 150.27 32.76 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.604 -1.18 . . . . 0.0 112.165 -178.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.519 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -149.98 107.61 3.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.47 179.36 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 252' ' ' CYS . . . . . 1.131 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -128.19 153.46 46.88 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -177.326 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . 0.542 ' N ' ' O ' ' A' ' 187' ' ' GLY . 71.4 tt0 -75.58 110.87 10.33 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.301 -178.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . 0.964 HG12 HG13 ' A' ' 186' ' ' VAL . 11.5 mt -96.59 112.14 28.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 -178.036 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . 0.526 ' O ' ' C ' ' A' ' 256' ' ' VAL . 0.0 OUTLIER -119.14 131.24 55.86 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 176.009 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.654 HG23 ' O ' ' A' ' 183' ' ' LYS . 6.0 p -32.32 122.58 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.586 0 CA-C-O 122.285 1.04 . . . . 0.0 111.551 -176.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 1.095 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -75.85 152.62 37.2 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 113.366 -1.743 . . . . 0.0 111.614 -178.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.86 110.18 12.33 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.717 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . 0.525 ' HB2' ' HD2' ' A' ' 183' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--N 1.32 -0.677 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.805 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.416 ' CG1' ' N ' ' A' ' 182' ' ' LYS . 53.0 t . . . . . 0 CA--C 1.5 -0.946 0 CA-C-O 121.184 0.516 . . . . 0.0 111.314 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.963 ' HB2' HG21 ' A' ' 236' ' ' VAL . 0.0 OUTLIER -153.76 111.69 3.55 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.89 177.142 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.806 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -138.25 137.52 37.58 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 114.561 -1.199 . . . . 0.0 108.795 178.953 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.835 HD13 ' HE2' ' A' ' 230' ' ' PHE . 1.1 pt -117.99 120.37 64.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.824 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -94.59 109.77 21.65 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 121.543 0.687 . . . . 0.0 110.196 -179.026 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.692 HG22 ' CD1' ' A' ' 254' ' ' ILE . 45.5 t -84.44 133.89 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.036 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.536 ' O ' ' HB3' ' A' ' 252' ' ' CYS . . . -92.0 -149.74 24.64 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.961 -0.638 . . . . 0.0 114.686 -177.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.477 ' O ' ' HB3' ' A' ' 252' ' ' CYS . . . -33.15 102.31 0.01 OUTLIER Glycine 0 C--N 1.334 0.469 0 CA-C-N 114.971 -0.614 . . . . 0.0 113.564 -179.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 1.026 HD13 ' OG1' ' A' ' 193' ' ' THR . 1.4 pp -117.48 157.89 25.48 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 122.753 0.421 . . . . 0.0 111.186 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.63 ' O ' HD12 ' A' ' 189' ' ' LEU . 0.5 OUTLIER -43.84 -178.9 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.539 179.65 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . 0.535 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 17.4 Cg_exo -67.62 4.05 1.54 Allowed 'Trans proline' 0 CA--C 1.533 0.458 0 C-N-CA 123.185 2.59 . . . . 0.0 114.019 -179.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.526 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 4.3 t0 161.76 76.04 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.896 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 1.026 ' OG1' HD13 ' A' ' 189' ' ' LEU . 17.6 m -64.65 109.78 3.25 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.483 179.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.505 ' HG2' ' HG2' ' A' ' 197' ' ' LYS . 11.5 Cg_endo -56.9 110.23 0.56 Allowed 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.243 1.962 . . . . 0.0 111.215 179.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.787 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.1 OUTLIER -47.23 -16.93 0.05 Allowed 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -179.278 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . 0.462 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 62.6 mt-10 -68.15 -38.05 81.71 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -179.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.505 ' HG2' ' HG2' ' A' ' 194' ' ' PRO . 1.5 mmmm -75.04 -47.78 27.23 Favored 'General case' 0 CA--C 1.5 -0.969 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.901 ' CD1' HG22 ' A' ' 193' ' ' THR . 0.0 OUTLIER -48.1 -30.9 2.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 115.1 -0.955 . . . . 0.0 108.679 178.326 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.579 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 12.9 mtp180 -71.47 -32.09 67.88 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.238 179.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . 0.501 ' N ' ' O ' ' A' ' 197' ' ' LYS . 0.4 OUTLIER -82.51 -45.66 14.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.086 0.469 . . . . 0.0 110.65 179.424 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.504 ' C ' ' CD1' ' A' ' 201' ' ' TYR . 0.2 OUTLIER -63.92 -52.91 57.67 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.006 179.2 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 1.029 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -79.68 -32.57 41.44 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.222 -179.799 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.579 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -64.98 -53.42 34.01 Favored Glycine 0 CA--C 1.498 -1.002 0 N-CA-C 106.579 -2.608 . . . . 0.0 106.579 175.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -51.18 -28.81 19.96 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 176.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.761 ' CE2' HG13 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -57.45 -47.69 81.15 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 122.268 1.033 . . . . 0.0 108.341 177.856 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.481 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 174.04 -129.25 1.6 Allowed Glycine 0 N--CA 1.441 -0.98 0 CA-C-N 113.36 -1.745 . . . . 0.0 110.12 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.518 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 5.0 mm-40 -97.14 100.42 11.9 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.274 0.559 . . . . 0.0 111.424 178.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.408 HG22 ' CE1' ' A' ' 230' ' ' PHE . 2.6 t -76.98 139.47 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.151 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 177.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . 0.765 ' HB3' HG22 ' A' ' 229' ' ' THR . 21.0 tp10 -91.73 -49.84 6.06 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 178.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 9.8 p -166.93 152.84 8.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.187 0.518 . . . . 0.0 112.09 179.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.736 HD12 ' HB ' ' A' ' 198' ' ' ILE . 0.1 OUTLIER -125.43 120.22 57.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.114 178.956 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -123.63 103.65 8.55 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -178.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.528 HD13 ' O ' ' A' ' 193' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.332 -0.193 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 177.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.424 0 CA-C-O 120.892 0.162 . . . . 0.0 113.405 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . 0.859 ' CA ' HD23 ' A' ' 189' ' ' LEU . 1.1 p90 -156.13 176.24 12.93 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 -179.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . 0.875 ' SG ' HD22 ' A' ' 189' ' ' LEU . 0.8 OUTLIER -144.46 154.62 43.13 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.439 -0.504 . . . . 0.0 112.137 -179.08 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 1.108 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 6.3 m-85 -108.52 139.91 42.61 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.167 179.289 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 1.029 HD12 ' CE2' ' A' ' 202' ' ' PHE . 2.2 mt -135.51 122.08 33.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.959 0.409 . . . . 0.0 110.923 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . 0.765 HG22 ' HB3' ' A' ' 209' ' ' GLU . 28.8 m -103.33 138.32 40.25 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.674 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.835 ' HE2' HD13 ' A' ' 184' ' ' ILE . 71.4 m-85 -113.34 126.25 55.16 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.265 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.524 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -47.96 -39.11 18.4 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 178.404 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . 0.462 ' O ' ' HG3' ' A' ' 182' ' ' LYS . 3.3 mm-40 -100.95 171.43 7.65 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 113.414 -1.721 . . . . 0.0 109.202 178.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . 0.541 ' O ' ' HG3' ' A' ' 237' ' ' LYS . 4.2 pt-20 -107.97 12.01 27.38 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -179.099 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.538 ' O ' ' N ' ' A' ' 237' ' ' LYS . 0.1 OUTLIER -77.54 -60.71 0.7 Allowed Pre-proline 0 N--CA 1.465 0.283 0 C-N-CA 120.479 -0.488 . . . . 0.0 111.38 -179.787 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.914 ' O ' HD12 ' A' ' 239' ' ' ILE . 90.7 Cg_exo -49.45 -31.26 23.1 Favored 'Trans proline' 0 CA--C 1.499 -1.246 0 N-CA-C 108.671 -1.319 . . . . 0.0 108.671 178.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.963 HG21 ' HB2' ' A' ' 182' ' ' LYS . 21.5 t -69.25 -42.58 81.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 113.856 -1.52 . . . . 0.0 108.381 177.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.543 ' O ' ' CG ' ' A' ' 241' ' ' GLU . 2.8 mtpt -58.11 -45.4 87.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.529 178.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.537 ' CD ' ' O ' ' A' ' 234' ' ' GLU . 0.0 OUTLIER -73.47 -51.91 15.48 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.398 0.618 . . . . 0.0 111.22 -179.535 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.914 HD12 ' O ' ' A' ' 235' ' ' PRO . 1.9 mt -48.66 -49.46 14.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 114.79 -1.095 . . . . 0.0 112.911 -178.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . 0.473 ' SD ' HG12 ' A' ' 236' ' ' VAL . 54.2 mtp -61.1 -29.03 69.51 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.699 -178.152 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.543 ' CG ' ' O ' ' A' ' 237' ' ' LYS . 0.3 OUTLIER -84.75 -13.15 52.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.87 0.367 . . . . 0.0 110.563 179.696 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.497 ' N ' ' HD3' ' A' ' 242' ' ' LYS . 0.7 OUTLIER -87.17 99.22 11.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.049 -179.934 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.593 ' HE3' ' CG ' ' A' ' 244' ' ' TYR . 8.1 ttpt -37.89 -73.51 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.23 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . 0.593 ' CG ' ' HE3' ' A' ' 243' ' ' LYS . 8.7 m-30 -111.68 150.8 29.66 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.599 179.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' HIS . . . . . 0.803 ' CG ' HD12 ' A' ' 254' ' ' ILE . 17.6 m-70 -113.66 154.09 27.83 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.847 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -134.91 104.69 6.08 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.215 0.531 . . . . 0.0 110.01 178.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.694 HG12 ' H ' ' A' ' 248' ' ' GLY . 1.6 t -96.94 -173.42 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.728 -179.067 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . 0.694 ' H ' HG12 ' A' ' 247' ' ' VAL . . . -25.17 -62.27 0.06 OUTLIER Glycine 0 C--N 1.337 0.635 0 C-N-CA 121.2 -0.524 . . . . 0.0 112.964 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.633 HD23 ' C ' ' A' ' 248' ' ' GLY . 0.0 OUTLIER -126.89 -38.69 2.01 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.399 0.619 . . . . 0.0 110.726 179.796 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.467 ' OG ' ' OG1' ' A' ' 193' ' ' THR . 1.2 m -77.54 151.08 34.68 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.919 -1.037 . . . . 0.0 112.567 -178.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.5 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -140.01 105.89 5.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.922 -1.035 . . . . 0.0 108.722 179.135 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 252' ' ' CYS . . . . . 0.595 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -128.12 153.54 46.74 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -176.624 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . 0.581 ' HB2' ' CE1' ' A' ' 244' ' ' TYR . 64.1 tt0 -75.98 109.96 10.05 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.674 178.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . 0.803 HD12 ' CG ' ' A' ' 245' ' ' HIS . 37.0 mt -97.02 113.03 30.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -178.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . 0.519 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -114.1 131.94 56.23 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 176.89 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 183' ' ' LYS . 9.8 p -33.59 127.56 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-O 122.084 0.945 . . . . 0.0 111.328 -178.079 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 1.108 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -80.18 152.82 28.98 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 113.656 -1.611 . . . . 0.0 112.268 -178.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.47 116.8 16.43 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.595 -1.184 . . . . 0.0 110.416 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.323 -0.547 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.114 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.508 ' CG1' ' N ' ' A' ' 182' ' ' LYS . 38.4 t . . . . . 0 CA--C 1.503 -0.84 0 CA-C-O 121.268 0.556 . . . . 0.0 112.04 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.595 ' CB ' HG21 ' A' ' 236' ' ' VAL . 4.6 mmtt -143.62 112.89 6.82 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.362 177.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.84 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.7 OUTLIER -130.59 152.44 49.96 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.343 179.438 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.904 HD13 ' HE1' ' A' ' 230' ' ' PHE . 0.5 OUTLIER -127.37 119.83 53.35 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.096 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.868 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -92.35 108.96 20.35 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.614 0.721 . . . . 0.0 110.156 -178.842 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 1.031 HG12 ' HB2' ' A' ' 252' ' ' CYS . 2.4 t -85.53 118.74 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.254 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.55 ' O ' ' HB3' ' A' ' 252' ' ' CYS . . . -104.97 131.14 10.52 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.271 -0.877 . . . . 0.0 115.026 -176.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.458 ' O ' ' HB3' ' A' ' 252' ' ' CYS . . . 71.73 85.15 0.2 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 121.352 -0.451 . . . . 0.0 112.764 178.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.963 HD13 ' OG1' ' A' ' 193' ' ' THR . 0.5 OUTLIER -115.47 157.29 24.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.941 0.401 . . . . 0.0 111.268 -179.534 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.625 ' N ' HD12 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -48.0 -169.26 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.751 179.347 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . 0.619 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 17.7 Cg_endo -87.38 22.64 0.89 Allowed 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.403 2.068 . . . . 0.0 112.755 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.542 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 1.9 p30 157.05 76.26 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 111.623 0.231 . . . . 0.0 111.623 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.963 ' OG1' HD13 ' A' ' 189' ' ' LEU . 92.0 m -74.79 111.21 12.22 Favored Pre-proline 0 N--CA 1.464 0.236 0 CA-C-O 120.891 0.377 . . . . 0.0 110.908 179.31 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.572 ' HG2' ' CG ' ' A' ' 197' ' ' LYS . 16.6 Cg_endo -59.51 109.59 0.59 Allowed 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.367 2.045 . . . . 0.0 111.642 179.189 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.825 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.3 OUTLIER -50.84 -15.91 0.35 Allowed 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.754 -179.449 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . 0.512 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 5.6 mt-10 -69.0 -38.16 79.13 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.572 ' CG ' ' HG2' ' A' ' 194' ' ' PRO . 0.2 OUTLIER -73.25 -50.87 19.95 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.209 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.825 ' CG1' ' HA ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -46.77 -31.0 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.727 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.571 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 2.6 mtt180 -70.96 -33.9 70.92 Favored 'General case' 0 C--O 1.221 -0.441 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.373 178.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . 0.583 ' CG ' ' N ' ' A' ' 201' ' ' TYR . 3.2 pt-20 -82.14 -54.66 5.1 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.284 0.564 . . . . 0.0 110.162 179.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.583 ' N ' ' CG ' ' A' ' 200' ' ' GLU . 0.5 OUTLIER -53.69 -53.12 56.47 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.966 178.905 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 1.147 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.2 OUTLIER -79.84 -31.8 40.55 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.664 -179.933 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.571 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -63.81 -55.47 24.5 Favored Glycine 0 CA--C 1.498 -1.003 0 N-CA-C 106.799 -2.52 . . . . 0.0 106.799 176.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -50.16 -29.2 14.94 Favored Glycine 0 N--CA 1.443 -0.882 0 N-CA-C 109.694 -1.363 . . . . 0.0 109.694 176.076 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.765 ' CE2' HG13 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -57.18 -45.28 83.84 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 122.157 0.98 . . . . 0.0 108.456 177.849 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 171.02 -129.71 1.84 Allowed Glycine 0 N--CA 1.441 -0.976 0 CA-C-N 113.567 -1.651 . . . . 0.0 110.31 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.526 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 20.9 mm-40 -96.99 101.52 13.12 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.148 0.499 . . . . 0.0 111.081 178.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 2.5 t -77.94 142.54 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . 0.81 ' HB3' HG22 ' A' ' 229' ' ' THR . 5.5 tp10 -91.66 -52.23 4.86 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 178.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 2.6 m -175.16 149.72 1.1 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.985 178.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.901 HD13 HG23 ' A' ' 228' ' ' ILE . 0.4 OUTLIER -113.96 129.55 69.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.147 178.656 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.35 104.79 9.33 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -178.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.667 HD21 ' HB ' ' A' ' 193' ' ' THR . 0.1 OUTLIER . . . . . 0 CA--C 1.531 0.238 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 177.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.801 0 CA-C-O 121.375 0.431 . . . . 0.0 112.219 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . 0.948 ' C ' HD23 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -156.85 176.71 12.39 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.703 -0.748 . . . . 0.0 109.652 -177.43 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . 0.483 ' O ' ' HB ' ' A' ' 186' ' ' VAL . 31.7 p -138.56 147.65 43.28 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.059 -0.656 . . . . 0.0 112.567 -179.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 1.122 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 4.0 m-85 -107.26 133.06 52.38 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.098 -0.956 . . . . 0.0 109.412 178.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 1.147 HD12 ' CE2' ' A' ' 202' ' ' PHE . 1.8 mt -127.32 123.91 62.89 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 CA-C-O 121.23 0.538 . . . . 0.0 111.395 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . 0.81 HG22 ' HB3' ' A' ' 209' ' ' GLU . 19.8 m -105.15 138.39 41.43 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.344 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.904 ' HE1' HD13 ' A' ' 184' ' ' ILE . 72.6 m-85 -114.11 126.32 54.95 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.471 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.526 ' HG3' ' O ' ' A' ' 207' ' ' GLU . 0.0 OUTLIER -47.7 -39.12 16.67 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 178.139 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -94.34 -168.18 1.8 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 113.325 -1.762 . . . . 0.0 109.995 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . 0.539 ' HB3' ' CD ' ' A' ' 182' ' ' LYS . 1.1 pm0 -129.79 10.12 5.5 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.55 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.4 OUTLIER -80.0 -60.22 0.51 Allowed Pre-proline 0 C--N 1.328 -0.338 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.42 179.895 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.911 ' O ' HD12 ' A' ' 239' ' ' ILE . 87.5 Cg_exo -50.32 -29.67 24.19 Favored 'Trans proline' 0 CA--C 1.5 -1.19 0 N-CA-C 108.909 -1.227 . . . . 0.0 108.909 177.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.595 HG21 ' CB ' ' A' ' 182' ' ' LYS . 15.9 t -72.4 -44.7 62.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 113.971 -1.468 . . . . 0.0 109.905 178.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.55 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 0.2 OUTLIER -65.51 -35.52 81.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.84 -179.707 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.498 ' O ' ' CG ' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -80.99 -47.86 13.05 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.928 0.394 . . . . 0.0 110.857 179.14 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.911 HD12 ' O ' ' A' ' 235' ' ' PRO . 1.6 mt -49.33 -50.93 15.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.468 -179.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . 0.436 ' SD ' ' O ' ' A' ' 236' ' ' VAL . 10.3 mtp -59.09 -29.1 67.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.795 0.331 . . . . 0.0 111.246 -178.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.498 ' CG ' ' O ' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -79.54 -21.26 45.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.063 0.459 . . . . 0.0 111.241 -179.734 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.411 ' HD3' ' HG3' ' A' ' 241' ' ' GLU . 5.5 mmtp -78.77 118.5 20.9 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.371 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.56 ' HE3' ' CD2' ' A' ' 244' ' ' TYR . 2.9 ttpt -44.81 -74.58 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . 0.56 ' CD2' ' HE3' ' A' ' 243' ' ' LYS . 16.2 m-30 -121.95 153.92 37.85 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.072 178.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' HIS . . . . . 0.702 ' CD2' HD12 ' A' ' 254' ' ' ILE . 34.8 m-70 -109.9 146.56 34.94 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.03 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -122.11 105.03 9.9 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.102 0.477 . . . . 0.0 110.149 178.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.557 ' O ' ' N ' ' A' ' 249' ' ' LEU . 2.2 t -107.71 127.42 63.73 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.631 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . 0.436 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . 34.77 -89.89 0.01 OUTLIER Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.431 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.557 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.1 OUTLIER -108.67 -37.77 5.82 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 121.706 0.765 . . . . 0.0 110.269 -179.887 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.433 ' HB3' ' H ' ' A' ' 190' ' ' SER . 1.4 m -77.8 154.17 32.15 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.494 -1.23 . . . . 0.0 112.547 -178.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -149.37 110.63 4.41 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.824 179.375 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 252' ' ' CYS . . . . . 1.031 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -129.38 152.84 48.49 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -177.619 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . 0.551 ' HB2' ' CE1' ' A' ' 244' ' ' TYR . 52.4 tt0 -76.41 110.86 11.29 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.917 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . 0.919 HG12 HG13 ' A' ' 186' ' ' VAL . 14.9 mt -96.12 112.7 28.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 -177.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . 0.513 ' O ' ' C ' ' A' ' 256' ' ' VAL . 0.0 OUTLIER -116.3 131.96 56.8 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 176.179 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 183' ' ' LYS . 3.4 p -32.87 123.07 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 CA-C-O 122.235 1.017 . . . . 0.0 111.555 -177.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 1.122 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -78.35 152.41 32.36 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 113.34 -1.755 . . . . 0.0 112.28 -178.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.84 110.48 15.49 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.7 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . 0.505 ' HB3' ' HD2' ' A' ' 183' ' ' LYS . 69.5 p . . . . . 0 C--N 1.327 -0.395 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.771 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.494 ' O ' ' HD3' ' A' ' 182' ' ' LYS . 40.0 t . . . . . 0 CA--C 1.503 -0.852 0 CA-C-O 121.35 0.595 . . . . 0.0 112.036 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.829 ' HB2' HG21 ' A' ' 236' ' ' VAL . 0.0 OUTLIER -144.89 112.17 6.06 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.841 177.36 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.886 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -130.85 151.51 51.19 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.954 178.973 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.859 HD13 ' HE2' ' A' ' 230' ' ' PHE . 0.4 OUTLIER -128.09 120.21 52.97 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.408 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.853 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -92.67 109.03 20.44 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.35 0.595 . . . . 0.0 110.57 -178.806 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 1.019 HG12 ' HB2' ' A' ' 252' ' ' CYS . 2.4 t -85.4 124.47 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 CA-C-N 114.781 -1.1 . . . . 0.0 109.327 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.59 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . -113.01 126.06 7.3 Favored Glycine 0 C--N 1.331 0.296 0 N-CA-C 114.555 0.582 . . . . 0.0 114.555 -176.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.464 ' O ' ' CB ' ' A' ' 252' ' ' CYS . . . 80.37 84.66 0.67 Allowed Glycine 0 C--N 1.331 0.266 0 C-N-CA 121.337 -0.458 . . . . 0.0 113.151 179.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.953 HD23 ' C ' ' A' ' 225' ' ' PHE . 0.7 OUTLIER -117.31 157.32 26.31 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.831 0.348 . . . . 0.0 111.154 -179.573 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.586 ' O ' HD12 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -49.34 -172.07 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.765 179.537 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . 0.583 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 94.7 Cg_endo -81.61 25.44 0.65 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.293 1.995 . . . . 0.0 113.598 -179.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.575 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 8.0 t70 150.78 79.77 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.778 0.323 . . . . 0.0 110.974 179.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.882 HG22 ' CD1' ' A' ' 198' ' ' ILE . 62.0 m -75.28 111.98 16.44 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.759 179.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.559 ' HG2' ' CG ' ' A' ' 197' ' ' LYS . 18.8 Cg_endo -60.1 112.2 1.22 Allowed 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.097 1.864 . . . . 0.0 110.812 178.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.821 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 7.4 pt-20 -51.85 -14.84 0.41 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.438 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . 0.459 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 1.3 mm-40 -67.12 -37.21 83.48 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.559 ' CG ' ' HG2' ' A' ' 194' ' ' PRO . 0.4 OUTLIER -74.97 -49.8 18.78 Favored 'General case' 0 CA--C 1.495 -1.139 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.193 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.882 ' CD1' HG22 ' A' ' 193' ' ' THR . 0.0 OUTLIER -47.26 -31.81 2.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.594 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.58 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 16.0 mtp180 -69.13 -33.61 73.73 Favored 'General case' 0 C--O 1.221 -0.44 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.177 178.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . 0.529 ' N ' ' O ' ' A' ' 197' ' ' LYS . 3.2 mt-10 -82.57 -59.35 2.55 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.452 0.644 . . . . 0.0 109.903 178.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.487 ' C ' ' CD1' ' A' ' 201' ' ' TYR . 0.6 OUTLIER -49.07 -54.36 16.33 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.931 179.083 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 1.068 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.2 OUTLIER -79.85 -30.99 40.45 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.597 -179.962 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.58 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -62.52 -56.79 19.54 Favored Glycine 0 CA--C 1.499 -0.965 0 N-CA-C 107.202 -2.359 . . . . 0.0 107.202 176.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -49.08 -28.93 8.37 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 176.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.78 ' CD2' HD11 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -58.38 -44.28 88.82 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 177.788 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 203' ' ' GLY . . . 169.65 -130.58 2.07 Favored Glycine 0 N--CA 1.443 -0.837 0 CA-C-N 113.708 -1.587 . . . . 0.0 110.579 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.478 ' C ' ' HG3' ' A' ' 231' ' ' LYS . 54.8 mm-40 -97.05 100.2 11.7 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.27 0.557 . . . . 0.0 111.256 178.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.451 HG21 ' HB2' ' A' ' 202' ' ' PHE . 2.9 t -77.64 137.64 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . 0.529 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 25.3 tp10 -92.84 -54.37 3.78 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 120.686 0.279 . . . . 0.0 110.341 178.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.443 ' C ' HG12 ' A' ' 211' ' ' ILE . 1.4 p -157.46 158.03 35.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.306 0.574 . . . . 0.0 112.182 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.743 HD12 ' HB ' ' A' ' 198' ' ' ILE . 0.1 OUTLIER -133.2 126.06 52.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.366 179.108 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -123.49 108.68 12.93 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 114.147 1.165 . . . . 0.0 114.147 -177.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.89 HD13 ' HB2' ' A' ' 226' ' ' CYS . 1.3 mm? . . . . . 0 CA--C 1.531 0.249 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 176.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.61 0 CA-C-O 121.003 0.224 . . . . 0.0 112.921 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . 0.953 ' C ' HD23 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -157.27 176.62 12.46 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -178.5 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . 0.89 ' HB2' HD13 ' A' ' 213' ' ' LEU . 2.7 p -140.22 151.91 45.56 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.336 -0.546 . . . . 0.0 112.154 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 1.101 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 4.2 m-85 -111.11 137.43 48.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.472 178.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 1.068 HD12 ' CE2' ' A' ' 202' ' ' PHE . 2.1 mt -131.32 141.84 44.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.131 0.491 . . . . 0.0 111.146 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . 0.441 HG22 ' HB3' ' A' ' 209' ' ' GLU . 97.5 m -122.6 137.94 54.74 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.859 ' HE2' HD13 ' A' ' 184' ' ' ILE . 66.2 m-85 -111.83 126.44 55.09 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.93 -179.468 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.529 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -50.51 -37.77 40.74 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 106.622 -1.622 . . . . 0.0 106.622 177.696 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . 0.505 ' O ' ' HG3' ' A' ' 182' ' ' LYS . 15.2 mt-10 -89.86 -168.96 2.28 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 112.929 -1.941 . . . . 0.0 108.914 178.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . 0.509 ' CB ' ' HD2' ' A' ' 182' ' ' LYS . 2.3 pm0 -131.07 1.02 4.23 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.246 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.515 ' O ' ' N ' ' A' ' 237' ' ' LYS . 0.4 OUTLIER -75.13 -57.62 1.71 Allowed Pre-proline 0 C--N 1.331 -0.222 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -179.415 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.879 ' O ' HD12 ' A' ' 239' ' ' ILE . 98.5 Cg_exo -49.09 -31.83 22.3 Favored 'Trans proline' 0 CA--C 1.498 -1.275 0 N-CA-C 109.027 -1.182 . . . . 0.0 109.027 178.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.829 HG21 ' HB2' ' A' ' 182' ' ' LYS . 17.5 t -69.52 -41.57 80.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 113.883 -1.508 . . . . 0.0 108.855 178.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.515 ' N ' ' O ' ' A' ' 234' ' ' GLU . 22.7 mttt -59.47 -48.15 82.75 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.916 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.495 ' O ' ' HG3' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -76.86 -46.16 25.69 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.169 -179.238 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.879 HD12 ' O ' ' A' ' 235' ' ' PRO . 1.8 mt -49.04 -47.12 17.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.213 -0.449 . . . . 0.0 112.051 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . 0.482 ' SD ' HG12 ' A' ' 236' ' ' VAL . 44.4 mtp -63.92 -17.73 63.52 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.022 -178.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.495 ' HG3' ' O ' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -86.97 -27.73 23.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.686 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.477 ' HG2' ' O ' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -86.79 92.7 9.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.438 179.503 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.505 ' N ' ' HD3' ' A' ' 243' ' ' LYS . 0.0 OUTLIER -36.28 -48.9 0.66 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.996 0.427 . . . . 0.0 110.31 -179.947 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . 0.575 ' CE1' ' HG3' ' A' ' 253' ' ' GLU . 22.1 m-85 -122.3 157.56 31.47 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.836 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' HIS . . . . . 0.777 ' CG ' HD12 ' A' ' 254' ' ' ILE . 29.8 m-70 -127.79 156.83 41.86 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.917 -179.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . 0.4 ' O ' ' CE2' ' A' ' 201' ' ' TYR . 2.1 m-80 -129.15 105.15 7.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.124 0.487 . . . . 0.0 110.602 179.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.563 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.5 t -109.7 125.98 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.677 -179.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . 35.46 -89.19 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.504 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.563 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.1 OUTLIER -108.15 -35.88 6.45 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.777 0.798 . . . . 0.0 110.085 -179.679 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.506 ' HB3' ' HB2' ' A' ' 190' ' ' SER . 0.8 OUTLIER -77.92 154.46 31.63 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.322 -1.308 . . . . 0.0 112.959 -177.836 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.487 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -149.95 107.88 3.71 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.063 -0.972 . . . . 0.0 108.973 179.069 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 252' ' ' CYS . . . . . 1.019 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -128.78 153.33 47.5 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 -176.762 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . 0.575 ' HG3' ' CE1' ' A' ' 244' ' ' TYR . 31.7 tt0 -75.93 108.91 9.13 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.033 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . 0.894 HG12 HG13 ' A' ' 186' ' ' VAL . 19.1 mt -96.48 113.1 30.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 -178.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . 0.516 ' O ' ' C ' ' A' ' 256' ' ' VAL . 0.0 OUTLIER -119.6 133.37 55.69 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 176.516 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 183' ' ' LYS . 3.1 p -32.69 121.47 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 CA-C-O 122.218 1.009 . . . . 0.0 111.557 -177.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 1.101 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -76.52 153.71 35.23 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 113.353 -1.748 . . . . 0.0 112.07 -178.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -127.88 113.67 16.2 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.898 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . 0.448 ' HB2' ' HD2' ' A' ' 183' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.519 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.073 -179.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.495 ' C ' ' CD ' ' A' ' 182' ' ' LYS . 55.2 t . . . . . 0 CA--C 1.501 -0.936 0 CA-C-O 121.11 0.481 . . . . 0.0 111.47 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.925 ' HB2' HG21 ' A' ' 236' ' ' VAL . 0.0 OUTLIER -152.68 111.78 3.83 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.088 177.346 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.915 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.5 OUTLIER -136.36 167.86 20.52 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.693 179.04 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.725 ' C ' ' HB2' ' A' ' 257' ' ' ALA . 0.3 OUTLIER -144.1 121.66 5.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.09 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.818 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.3 OUTLIER -96.36 108.97 21.57 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.454 -0.898 . . . . 0.0 109.679 -179.734 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 1.097 HG12 ' HB2' ' A' ' 252' ' ' CYS . 1.7 t -87.7 127.23 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.729 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.593 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . -114.71 124.54 6.42 Favored Glycine 0 C--N 1.331 0.282 0 N-CA-C 114.647 0.619 . . . . 0.0 114.647 -176.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.453 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . 82.12 85.83 0.75 Allowed Glycine 0 CA--C 1.518 0.28 0 C-N-CA 121.277 -0.487 . . . . 0.0 113.108 179.282 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.931 HD23 ' C ' ' A' ' 225' ' ' PHE . 0.8 OUTLIER -117.46 157.27 26.53 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.742 0.306 . . . . 0.0 111.367 -179.564 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.618 ' O ' HD12 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -49.83 -170.84 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.228 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.843 179.615 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . 0.607 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 95.7 Cg_endo -83.46 24.07 0.78 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.44 2.093 . . . . 0.0 113.381 -179.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.546 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 4.3 t0 154.67 77.19 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.72 0.295 . . . . 0.0 111.201 179.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.851 ' OG1' HD13 ' A' ' 189' ' ' LEU . 86.4 m -74.26 111.39 12.48 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 120.869 0.366 . . . . 0.0 110.957 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.527 ' HG2' ' HG2' ' A' ' 197' ' ' LYS . 19.3 Cg_endo -61.04 112.58 1.42 Allowed 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.248 1.965 . . . . 0.0 111.144 179.011 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.835 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 1.6 pm0 -51.9 -15.27 0.49 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.434 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . 0.498 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 40.6 mm-40 -66.94 -38.27 85.83 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.549 ' O ' ' N ' ' A' ' 200' ' ' GLU . 0.1 OUTLIER -74.04 -51.09 16.91 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.214 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.896 HG22 ' CE1' ' A' ' 202' ' ' PHE . 0.0 OUTLIER -47.52 -29.88 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.338 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.585 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 0.1 OUTLIER -70.9 -33.79 70.92 Favored 'General case' 0 C--O 1.22 -0.448 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.876 178.559 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . 0.578 ' CG ' ' N ' ' A' ' 201' ' ' TYR . 2.3 pt-20 -83.17 -56.47 3.76 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.857 0.361 . . . . 0.0 110.662 179.221 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.578 ' N ' ' CG ' ' A' ' 200' ' ' GLU . 0.2 OUTLIER -51.07 -53.5 33.31 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.427 0.632 . . . . 0.0 109.52 178.964 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 1.118 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.4 OUTLIER -79.65 -30.23 41.19 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.232 -179.913 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.585 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -62.11 -56.9 19.61 Favored Glycine 0 CA--C 1.498 -0.987 0 N-CA-C 106.763 -2.535 . . . . 0.0 106.763 176.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -49.41 -28.62 9.76 Favored Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 176.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.699 ' CD2' HD11 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -58.28 -42.4 86.5 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 177.99 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.493 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 166.96 -130.2 2.07 Favored Glycine 0 N--CA 1.441 -1.019 0 CA-C-N 113.709 -1.587 . . . . 0.0 109.895 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.533 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 9.4 mm-40 -96.82 100.85 12.37 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.322 0.582 . . . . 0.0 110.609 178.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.557 HG21 ' HB2' ' A' ' 202' ' ' PHE . 2.7 t -77.92 139.67 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.354 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . 0.539 ' HB3' HG22 ' A' ' 229' ' ' THR . 7.4 tp10 -89.75 -55.9 3.45 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 178.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 3.8 m -169.52 151.26 4.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.338 0.589 . . . . 0.0 112.069 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.882 HD12 ' HB ' ' A' ' 198' ' ' ILE . 0.4 OUTLIER -116.26 132.12 66.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.416 178.879 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -123.18 109.44 14.01 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -178.07 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.81 HD11 ' HB ' ' A' ' 193' ' ' THR . 1.6 mm? . . . . . 0 C--N 1.331 -0.231 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.873 177.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.554 0 CA-C-O 121.098 0.277 . . . . 0.0 112.744 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . 0.931 ' C ' HD23 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -157.38 176.63 12.42 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.054 -0.573 . . . . 0.0 109.781 -178.309 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . 0.7 ' HB3' HD13 ' A' ' 213' ' ' LEU . 30.5 p -140.96 146.86 37.88 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.276 -0.57 . . . . 0.0 112.425 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 1.113 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 4.7 m-85 -106.76 134.91 49.19 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.355 178.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 1.118 HD12 ' CE2' ' A' ' 202' ' ' PHE . 1.8 mt -128.66 136.35 60.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.146 0.498 . . . . 0.0 111.374 -179.305 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . 0.539 HG22 ' HB3' ' A' ' 209' ' ' GLU . 52.5 m -117.02 138.02 51.85 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.529 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.611 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 75.6 m-85 -111.83 126.29 54.93 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.394 179.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.533 ' HG3' ' O ' ' A' ' 207' ' ' GLU . 0.0 OUTLIER -45.0 -40.33 6.37 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 178.56 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . 0.469 ' O ' ' HG3' ' A' ' 182' ' ' LYS . 69.5 mt-10 -99.12 173.05 7.0 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 113.442 -1.708 . . . . 0.0 108.779 178.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . 0.521 ' O ' ' HG3' ' A' ' 237' ' ' LYS . 0.8 OUTLIER -112.0 13.17 20.74 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.58 -179.633 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.551 ' O ' ' HB2' ' A' ' 237' ' ' LYS . 0.6 OUTLIER -80.84 -60.38 0.44 Allowed Pre-proline 0 C--N 1.331 -0.213 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.7 -179.628 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.658 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 90.8 Cg_exo -48.7 -36.76 33.56 Favored 'Trans proline' 0 CA--C 1.495 -1.456 0 N-CA-C 108.61 -1.342 . . . . 0.0 108.61 178.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.925 HG21 ' HB2' ' A' ' 182' ' ' LYS . 17.2 t -62.66 -40.27 87.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 114.204 -1.362 . . . . 0.0 109.773 178.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.551 ' HB2' ' O ' ' A' ' 234' ' ' GLU . 8.3 mtpt -54.24 -49.21 70.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.957 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.499 ' HA ' ' HG3' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -80.91 -45.83 16.13 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.615 -179.236 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.791 ' CG2' HG21 ' A' ' 254' ' ' ILE . 0.7 OUTLIER -39.48 -59.11 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.256 -0.883 . . . . 0.0 111.818 -179.549 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . 0.476 ' SD ' HG12 ' A' ' 236' ' ' VAL . 2.6 mtp -55.53 -27.68 50.27 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.435 -178.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.499 ' HG3' ' HA ' ' A' ' 238' ' ' LYS . 1.1 mt-10 -84.43 -13.87 50.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.937 0.399 . . . . 0.0 110.642 179.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.463 ' HB2' ' NE2' ' A' ' 245' ' ' HIS . 1.9 mptt -79.42 105.86 11.04 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.725 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.509 ' HD3' ' CD2' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -37.52 -67.18 0.2 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.05 -179.869 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . 0.509 ' CD2' ' HD3' ' A' ' 243' ' ' LYS . 29.3 m-85 -132.71 143.28 49.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.971 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' HIS . . . . . 0.649 ' CD2' HD12 ' A' ' 254' ' ' ILE . 45.5 m-70 -108.81 127.93 54.45 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.354 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -102.25 105.28 15.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.034 0.445 . . . . 0.0 110.905 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.555 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.1 t -103.85 130.0 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.701 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . 0.451 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . 32.78 -89.91 0.01 OUTLIER Glycine 0 C--N 1.334 0.442 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.412 -179.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.555 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.1 OUTLIER -109.9 -34.74 6.34 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.843 0.83 . . . . 0.0 109.642 179.748 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.527 ' HB3' ' HB2' ' A' ' 190' ' ' SER . 1.9 p -77.16 152.44 34.85 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.172 -1.376 . . . . 0.0 112.65 -178.252 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -150.26 108.48 3.76 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.254 179.246 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 252' ' ' CYS . . . . . 1.097 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -127.54 153.15 46.71 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -177.381 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . 0.466 ' N ' ' O ' ' A' ' 187' ' ' GLY . 48.8 tt0 -76.07 113.68 13.87 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.552 -179.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . 0.97 HG12 HG13 ' A' ' 186' ' ' VAL . 6.3 mt -96.75 113.33 30.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 -178.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . 0.53 ' O ' ' C ' ' A' ' 256' ' ' VAL . 0.0 OUTLIER -122.67 128.15 50.22 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 105.569 -2.012 . . . . 0.0 105.569 176.346 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 183' ' ' LYS . 1.4 p -31.9 121.71 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 CA-C-O 122.244 1.021 . . . . 0.0 111.37 -176.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 1.113 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -75.85 153.85 36.53 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 113.27 -1.786 . . . . 0.0 111.768 -178.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.03 118.64 19.04 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.969 179.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 90.6 p . . . . . 0 C--N 1.326 -0.432 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.192 -179.514 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.507 HG12 ' N ' ' A' ' 182' ' ' LYS . 47.8 t . . . . . 0 CA--C 1.504 -0.805 0 CA-C-O 121.156 0.503 . . . . 0.0 111.671 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.56 ' HG2' ' CG ' ' A' ' 233' ' ' GLU . 0.0 OUTLIER -150.33 112.63 4.65 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.676 177.621 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.943 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.0 OUTLIER -138.51 148.27 44.08 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.218 178.484 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.906 HD13 ' HE2' ' A' ' 230' ' ' PHE . 0.3 OUTLIER -126.58 120.06 55.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.679 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.75 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.3 OUTLIER -92.98 109.6 21.06 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 121.44 0.638 . . . . 0.0 110.111 -179.164 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.765 HG13 HG12 ' A' ' 254' ' ' ILE . 5.8 t -88.72 118.49 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.161 -179.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.564 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . -62.11 -150.9 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 115.76 -0.654 . . . . 0.0 114.609 -178.004 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.48 ' O ' ' HB3' ' A' ' 252' ' ' CYS . . . -47.03 111.74 0.8 Allowed Glycine 0 C--N 1.33 0.234 0 CA-C-N 114.823 -0.688 . . . . 0.0 114.435 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.993 HD13 ' OG1' ' A' ' 193' ' ' THR . 3.3 pp -109.11 157.35 18.82 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.98 -0.61 . . . . 0.0 110.255 178.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.921 ' O ' HD12 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -42.74 178.13 0.01 OUTLIER Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 121.084 0.469 . . . . 0.0 111.034 179.726 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . 0.548 ' HD2' ' CB ' ' A' ' 190' ' ' SER . 74.5 Cg_endo -76.37 26.65 0.42 Allowed 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 122.637 2.225 . . . . 0.0 113.544 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.543 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 4.6 p30 157.48 73.88 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.113 0 N-CA-C 111.528 0.196 . . . . 0.0 111.528 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.993 ' OG1' HD13 ' A' ' 189' ' ' LEU . 87.6 m -77.93 111.22 16.58 Favored Pre-proline 0 CA--C 1.518 -0.26 0 CA-C-O 121.055 0.455 . . . . 0.0 110.742 179.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.609 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 57.7 Cg_endo -68.47 109.62 2.09 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.525 2.15 . . . . 0.0 111.686 179.27 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.612 ' HA ' ' CD1' ' A' ' 198' ' ' ILE . 0.6 OUTLIER -43.42 -19.81 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.47 179.752 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . 0.523 ' O ' ' HG2' ' A' ' 200' ' ' GLU . 0.1 OUTLIER -61.02 -44.49 97.33 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -179.158 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.609 ' CD ' ' HG2' ' A' ' 194' ' ' PRO . 1.4 mttp -76.17 -46.18 29.8 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 178.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.917 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.2 OUTLIER -48.56 -28.94 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-N 114.048 -1.433 . . . . 0.0 108.717 177.014 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.56 ' HG3' ' O ' ' A' ' 195' ' ' GLU . 12.9 mtp180 -75.75 -32.11 59.83 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.955 178.233 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . 0.523 ' HG2' ' O ' ' A' ' 196' ' ' GLU . 4.1 mm-40 -81.91 -57.48 3.4 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.226 0.536 . . . . 0.0 110.536 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.489 ' C ' ' CD1' ' A' ' 201' ' ' TYR . 0.3 OUTLIER -48.03 -53.94 14.65 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.678 179.308 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 1.005 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.9 OUTLIER -79.73 -31.95 41.12 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.571 179.93 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.53 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -61.88 -57.78 15.86 Favored Glycine 0 N--CA 1.444 -0.824 0 N-CA-C 107.378 -2.289 . . . . 0.0 107.378 176.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -49.33 -29.28 10.21 Favored Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 176.264 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.76 ' CE2' HG13 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -58.53 -43.49 89.25 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 122.115 0.959 . . . . 0.0 108.423 177.787 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 169.14 -131.29 2.25 Favored Glycine 0 N--CA 1.441 -1.002 0 CA-C-N 113.714 -1.584 . . . . 0.0 110.417 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.517 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 4.1 mt-10 -97.11 102.94 14.82 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.231 0.539 . . . . 0.0 111.364 178.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.498 ' O ' ' NZ ' ' A' ' 231' ' ' LYS . 2.5 t -77.84 138.9 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.049 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . 0.571 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 70.8 tt0 -93.35 -53.15 4.2 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.5 178.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.439 ' OG ' ' OE2' ' A' ' 212' ' ' GLU . 37.2 p -160.51 151.65 19.08 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.512 HG21 ' HB ' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -129.55 122.36 55.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.923 178.905 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . 0.439 ' OE2' ' OG ' ' A' ' 210' ' ' SER . 0.0 OUTLIER -123.86 115.29 21.07 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 -177.962 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.735 HD22 ' N ' ' A' ' 213' ' ' LEU . 0.3 OUTLIER . . . . . 0 CA--C 1.537 0.452 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 176.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . 0.453 ' O ' ' HG ' ' A' ' 189' ' ' LEU . . . . . . . . 0 N--CA 1.449 -0.488 0 N-CA-C 112.411 -0.276 . . . . 0.0 112.411 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . 0.887 ' C ' HD23 ' A' ' 189' ' ' LEU . 6.7 p90 -132.87 176.68 8.26 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . 0.583 ' N ' HD23 ' A' ' 189' ' ' LEU . 23.1 p -136.06 149.15 48.64 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 119.495 -0.882 . . . . 0.0 112.709 -179.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 1.162 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 3.1 m-85 -105.65 139.0 40.91 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 115.586 -0.733 . . . . 0.0 109.119 178.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 1.005 HD12 ' CE2' ' A' ' 202' ' ' PHE . 1.7 mt -133.83 118.29 29.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.414 0.626 . . . . 0.0 111.015 179.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . 0.542 HG22 ' HB3' ' A' ' 209' ' ' GLU . 63.4 m -100.67 137.99 38.32 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.906 ' HE2' HD13 ' A' ' 184' ' ' ILE . 58.1 m-85 -111.8 126.49 55.14 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.465 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.571 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -49.46 -38.31 29.23 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 178.302 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . 0.419 ' OE1' ' CD ' ' A' ' 234' ' ' GLU . 0.7 OUTLIER -92.06 -165.37 1.33 Allowed 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 113.049 -1.887 . . . . 0.0 109.483 178.873 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . 0.56 ' CG ' ' HG2' ' A' ' 182' ' ' LYS . 0.5 OUTLIER -132.96 1.75 3.59 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.443 -179.914 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.493 ' O ' ' N ' ' A' ' 237' ' ' LYS . 0.2 OUTLIER -73.91 -59.53 1.79 Allowed Pre-proline 0 C--N 1.33 -0.264 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.622 -179.415 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.891 ' O ' HD12 ' A' ' 239' ' ' ILE . 98.5 Cg_exo -48.65 -33.61 24.74 Favored 'Trans proline' 0 CA--C 1.498 -1.299 0 N-CA-C 108.851 -1.25 . . . . 0.0 108.851 178.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.539 HG13 HG22 ' A' ' 184' ' ' ILE . 21.7 t -70.43 -40.74 77.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 113.856 -1.52 . . . . 0.0 109.502 178.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.524 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 19.9 mttt -56.68 -46.89 80.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.915 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.529 ' O ' ' CG ' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -81.14 -50.09 10.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.277 -179.754 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.891 HD12 ' O ' ' A' ' 235' ' ' PRO . 1.5 mt -40.74 -52.58 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.632 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . 0.457 ' SD ' ' HB ' ' A' ' 256' ' ' VAL . 6.7 mtp -61.32 -21.92 64.42 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.025 -179.024 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.529 ' CG ' ' O ' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -80.05 -23.96 41.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.844 -179.834 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.418 ' N ' ' HG3' ' A' ' 241' ' ' GLU . 2.9 mmtp -79.11 137.59 37.56 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.034 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.553 ' HD2' ' CG ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -76.55 -41.96 44.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.447 179.588 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . 0.651 ' CD1' ' HB3' ' A' ' 253' ' ' GLU . 2.5 m-85 -140.51 140.88 35.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.277 178.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' HIS . . . . . 0.781 ' CE1' HD12 ' A' ' 254' ' ' ILE . 17.3 m-70 -106.39 157.8 17.36 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.675 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . 0.404 ' ND2' ' N ' ' A' ' 246' ' ' ASN . 0.1 OUTLIER -133.77 105.27 6.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.97 0.414 . . . . 0.0 110.87 179.541 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.538 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.6 t -108.61 105.63 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.112 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 50.17 -85.21 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.421 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.538 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -107.1 -38.99 5.85 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.405 0.621 . . . . 0.0 110.602 179.806 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.495 ' O ' ' N ' ' A' ' 247' ' ' VAL . 4.4 p -77.63 150.28 34.64 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.984 -1.007 . . . . 0.0 112.105 -178.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.547 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -150.5 103.58 3.14 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.588 178.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 252' ' ' CYS . . . . . 0.612 ' SG ' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -130.59 154.69 47.59 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -177.515 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . 0.651 ' HB3' ' CD1' ' A' ' 244' ' ' TYR . 7.8 pt-20 -74.94 118.54 18.01 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.24 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . 0.781 HD12 ' CE1' ' A' ' 245' ' ' HIS . 24.0 mt -96.76 102.12 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 CA-C-O 121.809 0.814 . . . . 0.0 112.657 -178.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . 0.571 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -104.0 128.99 51.58 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 177.627 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 183' ' ' LYS . 3.8 p -32.41 125.06 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-O 122.15 0.976 . . . . 0.0 111.206 -176.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 1.162 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -76.23 152.82 36.46 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 113.522 -1.672 . . . . 0.0 112.166 -178.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.15 126.65 26.89 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.469 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . 0.524 ' HB3' ' NZ ' ' A' ' 183' ' ' LYS . 53.9 p . . . . . 0 C--N 1.324 -0.508 0 CA-C-O 120.866 0.365 . . . . 0.0 111.097 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.515 ' CG1' ' N ' ' A' ' 182' ' ' LYS . 36.1 t . . . . . 0 CA--C 1.504 -0.808 0 CA-C-O 121.115 0.483 . . . . 0.0 111.247 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.943 ' HB3' HG21 ' A' ' 236' ' ' VAL . 2.8 mptt -148.45 112.95 5.32 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.447 178.038 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.851 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -134.14 143.88 48.2 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.846 179.08 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.853 HD13 ' HE1' ' A' ' 230' ' ' PHE . 1.0 OUTLIER -123.4 120.05 59.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.411 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.827 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -92.11 109.49 20.85 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.423 0.63 . . . . 0.0 109.992 -179.337 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.784 HG13 HG12 ' A' ' 254' ' ' ILE . 11.0 t -87.03 123.59 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.303 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.54 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . -68.67 -159.07 1.56 Allowed Glycine 0 CA--C 1.521 0.452 0 CA-C-N 115.743 -0.662 . . . . 0.0 114.477 -178.098 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.542 ' HA2' ' O ' ' A' ' 224' ' ' GLY . . . -39.13 107.55 0.07 OUTLIER Glycine 0 C--N 1.332 0.355 0 CA-C-N 114.918 -0.641 . . . . 0.0 114.37 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.932 HD13 ' OG1' ' A' ' 193' ' ' THR . 3.2 pp -107.98 157.14 18.47 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 122.537 0.335 . . . . 0.0 110.802 179.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.92 ' O ' HD12 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -40.28 173.44 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.392 0.615 . . . . 0.0 111.921 -179.947 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . 0.459 ' O ' ' HB2' ' A' ' 192' ' ' ASP . 32.9 Cg_exo -60.34 -3.65 2.62 Favored 'Trans proline' 0 CA--C 1.529 0.27 0 C-N-CA 123.293 2.662 . . . . 0.0 114.126 -179.373 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 191' ' ' PRO . 0.5 OUTLIER 172.01 74.02 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.69 -179.933 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.932 ' OG1' HD13 ' A' ' 189' ' ' LEU . 57.7 m -64.29 125.29 87.99 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.826 179.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.63 ' O ' HD11 ' A' ' 198' ' ' ILE . 83.5 Cg_endo -76.55 117.71 4.65 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.405 2.07 . . . . 0.0 110.381 178.37 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.809 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 12.4 pt-20 -51.62 -14.0 0.29 Allowed 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -178.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . 0.51 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 33.7 mt-10 -68.51 -44.0 75.6 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -179.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.621 ' CD ' ' HG2' ' A' ' 194' ' ' PRO . 0.9 OUTLIER -70.58 -47.41 60.34 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.444 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.809 ' CG1' ' HA ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -47.85 -30.84 2.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.423 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.579 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 1.5 mtp-105 -72.31 -32.35 66.48 Favored 'General case' 0 C--O 1.22 -0.456 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.105 178.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . 0.522 ' N ' ' O ' ' A' ' 197' ' ' LYS . 25.2 mt-10 -82.71 -59.16 2.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.137 0.494 . . . . 0.0 110.397 179.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.504 ' C ' ' CD1' ' A' ' 201' ' ' TYR . 0.4 OUTLIER -48.72 -53.61 18.21 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.767 -0.652 . . . . 0.0 109.718 179.118 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 1.135 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.5 OUTLIER -79.7 -31.36 41.26 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.538 -179.963 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.579 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -62.14 -56.34 22.78 Favored Glycine 0 CA--C 1.5 -0.855 0 N-CA-C 107.104 -2.398 . . . . 0.0 107.104 176.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -49.76 -28.4 11.15 Favored Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 176.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.77 ' CE2' HG13 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -58.64 -44.21 89.98 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 177.885 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 169.87 -130.66 2.07 Favored Glycine 0 N--CA 1.441 -0.985 0 CA-C-N 113.663 -1.608 . . . . 0.0 110.473 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.481 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 5.0 mt-10 -96.89 98.77 10.38 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.228 0.537 . . . . 0.0 110.923 178.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.452 HG21 ' HB2' ' A' ' 202' ' ' PHE . 2.7 t -75.76 141.26 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 CA-C-N 115.384 -0.825 . . . . 0.0 108.984 178.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . 0.508 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 45.6 tt0 -89.75 -57.72 2.77 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.141 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 10.4 p -167.58 151.41 6.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.298 0.571 . . . . 0.0 112.375 179.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.985 HD13 HG23 ' A' ' 228' ' ' ILE . 0.4 OUTLIER -117.71 132.29 67.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.497 178.657 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.45 111.46 16.35 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -178.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.931 HD11 ' HB ' ' A' ' 193' ' ' THR . 2.7 mm? . . . . . 0 CA--C 1.533 0.315 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.922 177.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . 0.542 ' O ' ' HA2' ' A' ' 188' ' ' GLY . . . . . . . . 0 C--O 1.222 -0.637 0 N-CA-C 113.635 0.214 . . . . 0.0 113.635 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . 0.842 ' C ' HD23 ' A' ' 189' ' ' LEU . 0.6 OUTLIER -156.05 176.08 13.12 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.743 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . 0.638 ' N ' HD23 ' A' ' 189' ' ' LEU . 27.3 p -140.7 150.92 44.08 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -179.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 1.126 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 4.5 m-85 -106.29 133.49 50.9 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.657 178.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 1.135 HD12 ' CE2' ' A' ' 202' ' ' PHE . 1.9 mt -127.75 128.05 68.99 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.393 0 CA-C-O 120.904 0.383 . . . . 0.0 111.108 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . 0.496 ' OG1' ' HG2' ' A' ' 183' ' ' LYS . 51.5 m -111.62 137.95 48.81 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.214 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.853 ' HE1' HD13 ' A' ' 184' ' ' ILE . 83.2 m-85 -112.42 126.38 55.23 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.387 179.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.508 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -47.96 -38.38 16.66 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 178.018 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . 0.4 ' HG2' ' HB2' ' A' ' 207' ' ' GLU . 25.0 mm-40 -91.0 -165.33 1.33 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 113.397 -1.728 . . . . 0.0 110.186 179.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . 0.592 ' CB ' ' HG2' ' A' ' 182' ' ' LYS . 9.5 pt-20 -133.25 10.91 4.16 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.486 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.536 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.0 OUTLIER -83.43 -60.38 0.34 Allowed Pre-proline 0 C--N 1.326 -0.419 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.649 179.951 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.906 ' O ' HD12 ' A' ' 239' ' ' ILE . 80.2 Cg_exo -49.51 -30.45 21.26 Favored 'Trans proline' 0 CA--C 1.501 -1.145 0 N-CA-C 108.942 -1.215 . . . . 0.0 108.942 177.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.943 HG21 ' HB3' ' A' ' 182' ' ' LYS . 17.9 t -72.68 -45.28 58.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 113.88 -1.509 . . . . 0.0 110.323 178.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.536 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 1.5 ptpt -63.76 -35.09 79.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.791 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.526 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 0.0 OUTLIER -80.73 -50.39 9.94 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.128 0.489 . . . . 0.0 110.379 179.055 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.906 HD12 ' O ' ' A' ' 235' ' ' PRO . 1.7 mt -47.96 -49.74 10.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.433 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . 0.458 ' HG2' ' HB ' ' A' ' 256' ' ' VAL . 36.8 mtp -58.16 -29.27 65.46 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.353 -178.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.514 ' CG ' ' O ' ' A' ' 237' ' ' LYS . 0.1 OUTLIER -86.38 -10.61 54.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.918 0.39 . . . . 0.0 110.566 179.447 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 239' ' ' ILE . 0.0 OUTLIER -81.6 102.52 10.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.2 -179.865 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.497 ' HE2' ' HB2' ' A' ' 244' ' ' TYR . 1.9 ttpt -38.18 -76.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.212 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . 0.667 ' CD1' ' HB3' ' A' ' 253' ' ' GLU . 8.9 m-85 -118.16 144.75 45.45 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.661 179.062 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' HIS . . . . . 0.678 ' CE1' HD12 ' A' ' 254' ' ' ILE . 24.9 m-70 -105.51 157.94 17.02 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.041 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . 0.464 ' ND2' ' N ' ' A' ' 246' ' ' ASN . 0.0 OUTLIER -133.15 105.21 6.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.527 179.582 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.548 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.5 t -110.9 101.34 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.688 -179.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 53.5 -79.62 0.01 OUTLIER Glycine 0 C--N 1.331 0.274 0 C-N-CA 121.062 -0.589 . . . . 0.0 112.521 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.548 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -113.44 -40.2 3.92 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.476 0.655 . . . . 0.0 110.234 179.762 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.48 ' HB3' ' HB2' ' A' ' 190' ' ' SER . 5.1 p -77.68 148.64 34.89 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.877 -179.021 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.532 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -151.25 103.22 2.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.84 178.807 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 252' ' ' CYS . . . . . 0.688 ' SG ' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -130.74 155.06 47.27 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -177.885 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . 0.667 ' HB3' ' CD1' ' A' ' 244' ' ' TYR . 8.4 pt-20 -74.69 119.51 18.98 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . 0.784 HG12 HG13 ' A' ' 186' ' ' VAL . 30.7 mt -96.97 102.59 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 CA-C-O 121.553 0.692 . . . . 0.0 112.385 -178.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . 0.554 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -103.52 130.36 50.89 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 177.812 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 183' ' ' LYS . 4.0 p -32.67 122.74 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.561 0 CA-C-O 122.3 1.048 . . . . 0.0 111.513 -176.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 1.126 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -76.25 152.02 36.64 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 113.262 -1.79 . . . . 0.0 111.776 -178.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.43 118.82 21.74 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.026 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 54.4 p . . . . . 0 C--N 1.325 -0.46 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.106 -179.567 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.491 ' CG1' ' N ' ' A' ' 182' ' ' LYS . 39.8 t . . . . . 0 CA--C 1.504 -0.815 0 CA-C-O 121.276 0.56 . . . . 0.0 111.589 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.87 ' HB2' HG21 ' A' ' 236' ' ' VAL . 0.0 OUTLIER -145.66 112.6 6.04 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.503 177.26 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 1.017 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.0 OUTLIER -133.62 164.82 26.34 Favored 'General case' 0 CA--C 1.507 -0.682 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.895 -179.891 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.862 HD13 ' HE1' ' A' ' 230' ' ' PHE . 1.4 pt -140.33 119.96 12.49 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 177.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.752 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.4 OUTLIER -95.94 108.77 21.19 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.424 -178.713 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 1.078 HG12 ' HB2' ' A' ' 252' ' ' CYS . 1.6 t -84.86 117.39 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.598 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 253' ' ' GLU . . . -104.7 134.14 11.87 Favored Glycine 0 N--CA 1.452 -0.248 0 N-CA-C 114.691 0.636 . . . . 0.0 114.691 -177.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.451 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . 72.73 84.48 0.24 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.147 -0.549 . . . . 0.0 112.746 179.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.928 HD23 ' CA ' ' A' ' 225' ' ' PHE . 0.6 OUTLIER -117.44 156.16 28.44 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.957 0.408 . . . . 0.0 111.085 -179.723 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.574 ' CB ' ' CD ' ' A' ' 191' ' ' PRO . 0.5 OUTLIER -47.25 -176.72 0.01 OUTLIER Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.316 179.917 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . 0.574 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 12.0 Cg_exo -71.86 5.73 2.4 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 123.391 2.727 . . . . 0.0 113.329 -179.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.464 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 0.8 OUTLIER 165.63 74.75 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.803 0.335 . . . . 0.0 111.43 -179.944 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.907 ' OG1' HD13 ' A' ' 189' ' ' LEU . 88.4 m -70.34 112.63 13.43 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.61 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.614 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 25.4 Cg_endo -60.32 107.38 0.41 Allowed 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.221 1.948 . . . . 0.0 111.163 179.098 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.814 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -48.53 -14.89 0.07 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.8 -179.618 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . 0.508 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 34.9 mt-10 -67.41 -40.46 85.57 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 -179.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.614 ' CD ' ' HG2' ' A' ' 194' ' ' PRO . 1.8 mttp -74.21 -47.51 34.97 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.903 HG22 ' CE1' ' A' ' 202' ' ' PHE . 0.0 OUTLIER -46.86 -30.2 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.104 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.566 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 7.1 mtp180 -71.5 -33.98 69.71 Favored 'General case' 0 C--O 1.221 -0.438 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.447 178.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . 0.512 ' N ' ' O ' ' A' ' 197' ' ' LYS . 0.4 OUTLIER -83.21 -46.3 12.86 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.157 0.503 . . . . 0.0 110.738 179.459 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.547 ' CD1' ' CD1' ' A' ' 202' ' ' PHE . 0.4 OUTLIER -61.25 -52.73 63.51 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.694 179.127 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 1.107 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -79.53 -31.25 42.06 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.663 179.483 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.566 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -63.86 -56.15 20.44 Favored Glycine 0 N--CA 1.443 -0.88 0 N-CA-C 106.73 -2.548 . . . . 0.0 106.73 175.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -50.25 -28.7 14.3 Favored Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 176.076 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.835 ' CD2' HD11 ' A' ' 239' ' ' ILE . 0.0 OUTLIER -58.82 -44.49 90.86 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 177.68 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.503 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 170.77 -130.88 2.08 Favored Glycine 0 N--CA 1.442 -0.955 0 CA-C-N 113.664 -1.607 . . . . 0.0 110.389 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.518 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 0.4 OUTLIER -97.11 101.93 13.6 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.156 0.503 . . . . 0.0 111.439 178.805 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.445 HG21 ' HB2' ' A' ' 202' ' ' PHE . 2.6 t -79.29 141.12 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 177.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . 0.539 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 38.2 tt0 -98.05 -51.91 3.88 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.202 178.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.428 ' C ' HG12 ' A' ' 211' ' ' ILE . 5.1 p -157.66 154.32 28.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.392 0.615 . . . . 0.0 112.471 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.733 HD13 HD13 ' A' ' 228' ' ' ILE . 0.2 OUTLIER -137.26 116.3 14.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.144 178.548 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -124.1 114.47 19.74 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 113.853 1.056 . . . . 0.0 113.853 -177.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.6 HD23 ' HB2' ' A' ' 226' ' ' CYS . 0.1 OUTLIER . . . . . 0 CA--C 1.533 0.326 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 177.034 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . 0.54 ' O ' ' HG ' ' A' ' 189' ' ' LEU . . . . . . . . 0 N--CA 1.443 -0.881 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . 0.928 ' CA ' HD23 ' A' ' 189' ' ' LEU . 19.4 p90 -133.42 177.31 7.79 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 -178.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . 0.6 ' HB2' HD23 ' A' ' 213' ' ' LEU . 3.6 p -136.22 150.1 48.84 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 119.507 -0.877 . . . . 0.0 112.682 -179.144 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 1.181 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 3.1 m-85 -106.12 141.14 37.98 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.06 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 1.107 HD12 ' CE2' ' A' ' 202' ' ' PHE . 1.4 mt -138.0 114.42 11.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.458 0.647 . . . . 0.0 111.018 179.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . 0.522 ' OG1' ' CG ' ' A' ' 183' ' ' LYS . 69.3 m -100.58 138.15 38.03 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.33 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.862 ' HE1' HD13 ' A' ' 184' ' ' ILE . 74.3 m-85 -112.51 126.42 55.31 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.221 -0.591 . . . . 0.0 111.335 -179.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.539 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -47.49 -38.89 14.72 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 177.52 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . 0.496 ' O ' ' HG3' ' A' ' 182' ' ' LYS . 17.5 mm-40 -91.2 -171.25 2.9 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 113.078 -1.874 . . . . 0.0 109.431 178.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . 0.491 ' HG2' ' HD2' ' A' ' 182' ' ' LYS . 0.0 OUTLIER -130.32 14.25 5.59 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.476 179.92 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.528 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.3 OUTLIER -84.89 -60.84 0.29 Allowed Pre-proline 0 CA--C 1.517 -0.318 0 C-N-CA 120.644 -0.423 . . . . 0.0 110.928 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.893 ' O ' HD12 ' A' ' 239' ' ' ILE . 79.9 Cg_exo -49.3 -28.83 15.92 Favored 'Trans proline' 0 CA--C 1.499 -1.257 0 N-CA-C 108.719 -1.3 . . . . 0.0 108.719 178.208 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.87 HG21 ' HB2' ' A' ' 182' ' ' LYS . 14.5 t -73.29 -46.44 49.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 114.269 -1.332 . . . . 0.0 110.382 178.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.528 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 2.1 pttp -62.12 -35.9 80.13 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.552 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.628 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.1 OUTLIER -81.38 -55.44 4.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.301 179.43 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.893 HD12 ' O ' ' A' ' 235' ' ' PRO . 1.6 mt -42.04 -50.02 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.851 -179.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . 0.442 ' CE ' ' HB ' ' A' ' 256' ' ' VAL . 46.7 mtp -59.82 -26.18 65.58 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.565 -178.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.5 ' CG ' ' O ' ' A' ' 237' ' ' LYS . 0.1 OUTLIER -82.24 -22.91 35.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.022 0.439 . . . . 0.0 110.742 179.875 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.414 ' HG2' ' O ' ' A' ' 238' ' ' LYS . 9.2 mmmt -79.11 107.06 11.59 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.662 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.577 ' HE2' ' CE1' ' A' ' 244' ' ' TYR . 0.3 OUTLIER -42.66 -46.66 5.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.997 -179.787 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . 0.577 ' CE1' ' HE2' ' A' ' 243' ' ' LYS . 14.0 m-85 -138.59 161.27 37.51 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.047 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 245' ' ' HIS . . . . . 0.763 ' CD2' HD12 ' A' ' 254' ' ' ILE . 39.2 m-70 -126.08 152.58 45.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.078 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -130.71 105.44 7.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.042 0.449 . . . . 0.0 110.579 179.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.727 HG11 HG23 ' A' ' 198' ' ' ILE . 2.6 t -106.14 105.74 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.189 -179.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 54.32 -86.84 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.229 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.465 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.1 OUTLIER -109.87 -39.19 5.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.697 0.761 . . . . 0.0 109.787 -179.829 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.567 ' CB ' ' HG1' ' A' ' 193' ' ' THR . 0.0 OUTLIER -77.82 153.97 32.29 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.373 -1.285 . . . . 0.0 112.349 -178.435 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.455 ' HD3' ' O ' ' A' ' 249' ' ' LEU . 0.0 OUTLIER -150.22 110.63 4.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.266 179.114 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 252' ' ' CYS . . . . . 1.078 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -127.91 153.16 46.99 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -177.709 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . 0.558 ' HG3' ' CD1' ' A' ' 244' ' ' TYR . 39.5 tt0 -75.98 110.34 10.36 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.149 -179.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . 1.006 HG12 HG13 ' A' ' 186' ' ' VAL . 11.5 mt -95.62 108.51 21.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -177.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . 0.523 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -112.03 129.86 56.06 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 105.488 -2.041 . . . . 0.0 105.488 176.066 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.763 HG23 ' O ' ' A' ' 183' ' ' LYS . 7.8 p -32.61 124.14 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 122.212 1.006 . . . . 0.0 111.459 -176.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 1.181 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -75.9 152.37 37.16 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 113.447 -1.706 . . . . 0.0 112.049 -177.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.5 123.59 21.62 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.216 179.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . 0.488 ' OG ' ' NZ ' ' A' ' 183' ' ' LYS . 62.0 p . . . . . 0 C--N 1.326 -0.449 0 CA-C-O 120.903 0.382 . . . . 0.0 110.891 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.521 ' CG1' ' N ' ' A' ' 182' ' ' LYS . 40.9 t . . . . . 0 CA--C 1.502 -0.895 0 CA-C-O 121.217 0.532 . . . . 0.0 111.66 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.731 ' CB ' HG21 ' A' ' 236' ' ' VAL . 0.0 OUTLIER -149.18 112.52 4.97 Favored 'General case' 0 N--CA 1.432 -1.375 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.487 177.97 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.867 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -131.22 142.86 50.23 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-N 114.974 -1.012 . . . . 0.0 108.646 178.52 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.923 HD13 ' HE2' ' A' ' 230' ' ' PHE . 1.3 pt -123.85 119.75 57.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.82 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -92.5 109.81 21.21 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.494 0.664 . . . . 0.0 110.404 -178.982 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.689 HG13 HG12 ' A' ' 254' ' ' ILE . 6.3 t -85.97 129.84 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.886 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.597 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . -79.43 -153.73 8.07 Favored Glycine 0 CA--C 1.521 0.454 0 C-N-CA 121.034 -0.603 . . . . 0.0 114.209 -178.062 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.519 ' HA2' ' O ' ' A' ' 224' ' ' GLY . . . -34.56 109.61 0.06 OUTLIER Glycine 0 C--N 1.334 0.442 0 N-CA-C 114.255 0.462 . . . . 0.0 114.255 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.96 HD13 ' OG1' ' A' ' 193' ' ' THR . 1.7 pp -117.05 157.48 25.78 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.687 0.28 . . . . 0.0 110.819 179.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.789 ' O ' HD12 ' A' ' 189' ' ' LEU . 0.3 OUTLIER -42.25 -177.96 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.259 0 CA-C-O 121.463 0.649 . . . . 0.0 112.087 -179.709 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . 0.56 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 10.4 Cg_exo -70.82 1.52 5.05 Favored 'Trans proline' 0 CA--C 1.529 0.266 0 C-N-CA 123.232 2.621 . . . . 0.0 113.404 -179.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 192' ' ' ASP . 8.4 p-10 165.44 74.91 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.89 0.376 . . . . 0.0 111.415 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.96 ' OG1' HD13 ' A' ' 189' ' ' LEU . 11.9 m -68.9 116.85 45.6 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.125 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.528 ' HG2' ' HG2' ' A' ' 197' ' ' LYS . 36.5 Cg_endo -64.78 118.36 5.35 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.424 2.083 . . . . 0.0 111.438 179.037 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.783 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -52.06 -16.05 0.69 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.328 -179.607 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . 0.495 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 34.8 mt-10 -68.23 -37.85 81.24 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -179.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.528 ' HG2' ' HG2' ' A' ' 194' ' ' PRO . 18.0 mmmt -74.44 -50.08 19.81 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.818 ' CD1' HG22 ' A' ' 193' ' ' THR . 0.0 OUTLIER -48.13 -31.15 2.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 114.849 -1.069 . . . . 0.0 108.428 178.229 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.589 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 1.9 mtp85 -71.09 -32.73 69.44 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.296 178.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . 0.55 ' CG ' ' N ' ' A' ' 201' ' ' TYR . 4.2 pt-20 -81.71 -53.03 6.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.201 0.524 . . . . 0.0 109.894 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.55 ' N ' ' CG ' ' A' ' 200' ' ' GLU . 0.3 OUTLIER -55.35 -54.05 48.52 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.98 178.87 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 1.075 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.2 OUTLIER -79.58 -31.15 41.79 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.069 -0.968 . . . . 0.0 110.424 -179.67 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.589 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -65.1 -55.47 21.48 Favored Glycine 0 CA--C 1.499 -0.927 0 N-CA-C 106.928 -2.469 . . . . 0.0 106.928 176.349 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -49.97 -28.82 13.08 Favored Glycine 0 N--CA 1.442 -0.936 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 176.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.767 ' CE2' HG13 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -57.93 -46.18 85.44 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 122.145 0.974 . . . . 0.0 108.496 177.738 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 171.95 -130.89 2.03 Favored Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 113.542 -1.663 . . . . 0.0 110.247 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.487 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 5.2 mm-40 -97.01 100.7 12.2 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.245 0.545 . . . . 0.0 111.05 178.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.449 HG22 ' CE1' ' A' ' 230' ' ' PHE . 2.9 t -78.11 140.86 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.088 0 CA-C-N 115.235 -0.893 . . . . 0.0 108.653 178.295 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . 0.615 ' HB3' HG22 ' A' ' 229' ' ' THR . 10.1 tp10 -94.43 -53.83 3.76 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.771 0.32 . . . . 0.0 110.352 179.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.422 ' C ' HG12 ' A' ' 211' ' ' ILE . 24.0 p -159.83 156.85 28.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.21 0.528 . . . . 0.0 111.842 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.808 HD12 ' HB ' ' A' ' 198' ' ' ILE . 0.1 OUTLIER -131.84 124.57 53.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.528 178.959 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -123.07 103.26 8.46 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -178.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.766 HD13 ' O ' ' A' ' 193' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.323 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 177.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . 0.519 ' O ' ' HA2' ' A' ' 188' ' ' GLY . . . . . . . . 0 C--O 1.223 -0.583 0 N-CA-C 113.728 0.251 . . . . 0.0 113.728 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . 0.92 ' C ' HD23 ' A' ' 189' ' ' LEU . 0.4 OUTLIER -156.47 176.48 12.65 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.712 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . 0.542 ' N ' HD23 ' A' ' 189' ' ' LEU . 11.9 p -142.14 149.56 39.95 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.028 -0.669 . . . . 0.0 112.538 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 1.123 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 4.7 m-85 -106.24 138.86 41.67 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.592 178.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 1.075 HD12 ' CE2' ' A' ' 202' ' ' PHE . 2.2 mt -133.87 135.09 55.57 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.35 0 CA-C-O 120.962 0.41 . . . . 0.0 111.133 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . 0.615 HG22 ' HB3' ' A' ' 209' ' ' GLU . 52.3 m -116.26 138.08 51.6 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.719 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.923 ' HE2' HD13 ' A' ' 184' ' ' ILE . 75.4 m-85 -112.9 126.29 55.3 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.271 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.505 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -49.36 -38.93 30.0 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 177.981 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . 0.459 ' O ' ' HD3' ' A' ' 182' ' ' LYS . 63.9 mt-10 -92.59 -170.86 2.59 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 113.362 -1.745 . . . . 0.0 109.304 178.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . 0.554 ' CB ' ' HG2' ' A' ' 182' ' ' LYS . 14.4 pt-20 -126.09 2.83 7.22 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.836 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.511 ' O ' ' HB2' ' A' ' 237' ' ' LYS . 0.2 OUTLIER -74.33 -59.25 1.69 Allowed Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.809 -179.169 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.893 ' O ' HD12 ' A' ' 239' ' ' ILE . 87.5 Cg_exo -49.15 -32.94 25.93 Favored 'Trans proline' 0 CA--C 1.5 -1.196 0 N-CA-C 108.814 -1.264 . . . . 0.0 108.814 178.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.731 HG21 ' CB ' ' A' ' 182' ' ' LYS . 22.9 t -70.41 -41.57 78.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 114.041 -1.436 . . . . 0.0 108.985 177.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.537 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 20.6 mtpt -55.78 -46.91 77.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.799 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.473 ' HA ' ' HG3' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -81.01 -48.76 11.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.144 -179.501 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.893 HD12 ' O ' ' A' ' 235' ' ' PRO . 1.7 mt -43.57 -49.49 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.841 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . 0.458 ' SD ' HG12 ' A' ' 236' ' ' VAL . 52.9 mtp -61.22 -29.93 70.13 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.637 -178.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.473 ' HG3' ' HA ' ' A' ' 238' ' ' LYS . 0.2 OUTLIER -85.97 -12.17 51.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.794 0.33 . . . . 0.0 111.134 -179.56 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.425 ' O ' ' C ' ' A' ' 243' ' ' LYS . 11.5 mmmm -79.63 103.5 9.58 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.837 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.558 ' HD3' ' CD2' ' A' ' 244' ' ' TYR . 0.1 OUTLIER -37.46 -58.05 0.88 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.15 0.5 . . . . 0.0 110.325 179.75 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . 0.665 ' CD1' ' HB3' ' A' ' 253' ' ' GLU . 10.9 m-85 -135.51 153.27 51.78 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.239 179.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 245' ' ' HIS . . . . . 0.751 ' CE1' HD12 ' A' ' 254' ' ' ILE . 28.8 m-70 -111.91 157.43 20.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.116 -179.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . 0.447 ' ND2' ' C ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -139.79 104.3 4.86 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.299 0.571 . . . . 0.0 109.979 178.525 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.659 HG12 ' H ' ' A' ' 248' ' ' GLY . 1.4 t -95.67 -173.65 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.874 -179.468 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . 0.659 ' H ' HG12 ' A' ' 247' ' ' VAL . . . -26.51 -56.69 0.08 OUTLIER Glycine 0 C--N 1.337 0.619 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.761 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.493 HD23 ' C ' ' A' ' 248' ' ' GLY . 0.0 OUTLIER -130.47 -40.03 1.27 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.443 0.639 . . . . 0.0 111.033 -179.826 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.51 ' O ' ' N ' ' A' ' 247' ' ' VAL . 57.2 p -77.59 150.01 34.75 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.094 -0.957 . . . . 0.0 112.794 -178.316 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -144.87 102.69 3.81 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.225 178.373 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 252' ' ' CYS . . . . . 0.597 ' HB3' ' C ' ' A' ' 187' ' ' GLY . 0.0 OUTLIER -130.11 154.86 47.05 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -177.448 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . 0.665 ' HB3' ' CD1' ' A' ' 244' ' ' TYR . 6.9 pt-20 -74.61 119.05 18.28 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . 0.751 HD12 ' CE1' ' A' ' 245' ' ' HIS . 39.8 mt -97.2 102.47 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 CA-C-O 121.621 0.724 . . . . 0.0 112.332 -178.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . 0.558 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -103.38 129.27 50.41 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 177.781 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 183' ' ' LYS . 5.7 p -32.32 123.62 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.509 -0.599 0 CA-C-O 122.307 1.051 . . . . 0.0 111.491 -176.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 1.123 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -76.26 152.57 36.46 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 113.319 -1.764 . . . . 0.0 111.982 -178.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.35 114.93 14.27 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.354 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.326 -0.452 0 CA-C-O 121.082 0.468 . . . . 0.0 111.518 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.511 ' CG1' ' N ' ' A' ' 182' ' ' LYS . 45.5 t . . . . . 0 CA--C 1.503 -0.85 0 CA-C-O 121.243 0.544 . . . . 0.0 111.612 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.879 ' HB2' HG21 ' A' ' 236' ' ' VAL . 0.5 OUTLIER -149.97 112.6 4.75 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.883 177.769 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.765 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.0 OUTLIER -135.46 155.85 49.86 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.55 179.242 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.87 HD13 ' HE2' ' A' ' 230' ' ' PHE . 0.4 OUTLIER -131.15 121.19 48.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 115.452 -0.794 . . . . 0.0 108.858 178.973 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.825 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.3 OUTLIER -93.82 109.25 20.94 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.287 0.565 . . . . 0.0 110.826 -178.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 1.012 HG12 ' HB2' ' A' ' 252' ' ' CYS . 2.5 t -86.08 126.4 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.586 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.589 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . -114.76 126.4 7.22 Favored Glycine 0 N--CA 1.452 -0.274 0 N-CA-C 114.602 0.601 . . . . 0.0 114.602 -176.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.466 ' HA3' ' C7 ' ' B' ' 2' ' ' ' DT' . . . 80.59 83.13 0.74 Allowed Glycine 0 CA--C 1.519 0.285 0 C-N-CA 121.245 -0.502 . . . . 0.0 113.361 179.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.966 HD23 ' C ' ' A' ' 225' ' ' PHE . 0.6 OUTLIER -117.25 157.77 25.47 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.816 0.341 . . . . 0.0 111.384 -179.394 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.615 ' N ' HD12 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -45.4 -177.41 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.197 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.557 179.503 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.555 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 11.4 Cg_exo -70.62 6.54 1.55 Allowed 'Trans proline' 0 CA--C 1.532 0.406 0 C-N-CA 123.255 2.637 . . . . 0.0 113.514 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.516 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 2.8 p30 160.55 77.65 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.013 0.435 . . . . 0.0 110.812 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.891 HG22 HD11 ' A' ' 198' ' ' ILE . 51.8 m -73.02 131.76 83.4 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.003 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.575 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 68.6 Cg_endo -80.96 114.34 2.88 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 122.945 2.43 . . . . 0.0 111.632 179.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.583 ' HA ' ' CD1' ' A' ' 198' ' ' ILE . 1.6 pm0 -48.1 -17.81 0.15 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.357 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . 0.474 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 27.4 mm-40 -61.36 -44.02 97.89 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -179.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.575 ' CD ' ' HG2' ' A' ' 194' ' ' PRO . 0.9 OUTLIER -76.38 -46.39 27.57 Favored 'General case' 0 CA--C 1.494 -1.207 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 178.826 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.959 ' CD1' HD21 ' A' ' 213' ' ' LEU . 0.2 OUTLIER -48.34 -29.01 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.373 0 CA-C-N 113.862 -1.517 . . . . 0.0 108.736 177.245 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.57 ' HG3' ' O ' ' A' ' 195' ' ' GLU . 2.3 mtt180 -76.12 -31.73 58.79 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-N 115.294 -0.867 . . . . 0.0 110.029 178.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . 0.58 ' CG ' ' N ' ' A' ' 201' ' ' TYR . 4.2 pt-20 -82.01 -55.17 4.74 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.098 0.475 . . . . 0.0 110.293 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.58 ' N ' ' CG ' ' A' ' 200' ' ' GLU . 0.3 OUTLIER -50.11 -53.88 24.4 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.484 0.659 . . . . 0.0 109.67 178.797 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 1.011 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.5 OUTLIER -79.66 -32.69 41.58 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.7 -179.836 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.539 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -62.82 -55.05 29.13 Favored Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 107.359 -2.296 . . . . 0.0 107.359 176.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -51.39 -27.84 18.36 Favored Glycine 0 N--CA 1.442 -0.949 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 176.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.764 ' CE2' HG13 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -59.17 -44.89 92.16 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 122.129 0.966 . . . . 0.0 108.601 177.849 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.493 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 172.42 -132.41 2.38 Favored Glycine 0 N--CA 1.442 -0.938 0 CA-C-N 113.698 -1.592 . . . . 0.0 110.482 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.486 ' HB2' ' HG3' ' A' ' 232' ' ' GLU . 1.8 mt-10 -97.22 97.13 8.92 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.21 0.529 . . . . 0.0 111.456 178.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 2.5 t -72.56 137.63 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . 0.669 ' HB3' HG22 ' A' ' 229' ' ' THR . 5.8 tp10 -89.54 -50.7 5.93 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 178.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.438 ' OG ' ' OE2' ' A' ' 212' ' ' GLU . 0.9 OUTLIER -165.15 159.02 17.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.31 0.576 . . . . 0.0 111.913 179.263 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.533 HD11 ' HA ' ' A' ' 199' ' ' ARG . 0.1 OUTLIER -131.59 120.72 46.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.212 179.156 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.438 ' OE2' ' OG ' ' A' ' 210' ' ' SER . 0.0 OUTLIER -123.43 102.64 8.01 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -179.066 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.959 HD21 ' CD1' ' A' ' 198' ' ' ILE . 1.7 mp -96.83 104.86 20.01 Favored Pre-proline 0 C--N 1.329 -0.284 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 177.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.546 ' HG3' ' CE1' ' A' ' 225' ' ' PHE . 64.3 Cg_endo -72.86 130.3 15.48 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.98 2.453 . . . . 0.0 113.321 -179.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 11.1 mtm -135.77 130.96 34.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.633 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.419 ' O ' ' HA ' ' A' ' 220' ' ' ASN . 0.5 OUTLIER -111.96 107.98 17.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.912 0.387 . . . . 0.0 110.666 179.849 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -81.97 -12.42 58.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.722 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.58 -47.29 12.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.671 0.272 . . . . 0.0 111.407 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 3.5 t -124.21 -19.74 5.47 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.664 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . 0.419 ' HA ' ' O ' ' A' ' 216' ' ' ASP . 13.8 m-80 51.74 58.45 5.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.746 0.308 . . . . 0.0 110.821 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 1.6 mtpp -51.92 -179.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.636 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.625 ' CD ' ' O ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -93.98 26.14 3.35 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 122.386 1.089 . . . . 0.0 109.957 179.992 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.583 ' O ' ' CD1' ' A' ' 225' ' ' PHE . 4.9 ptp85 -71.33 -25.96 62.63 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.516 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . -8.3 73.83 0.0 OUTLIER Glycine 0 C--N 1.345 1.07 0 O-C-N 124.506 1.129 . . . . 0.0 112.812 178.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.966 ' C ' HD23 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -157.15 176.93 12.08 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -178.29 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . 0.808 ' HB3' HD23 ' A' ' 213' ' ' LEU . 1.4 p -141.42 149.18 40.69 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.258 -0.577 . . . . 0.0 112.433 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 1.104 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 5.7 m-85 -107.21 146.45 31.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.351 178.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 1.011 HD12 ' CE2' ' A' ' 202' ' ' PHE . 1.8 mt -141.12 121.22 12.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.287 0.565 . . . . 0.0 111.667 179.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.669 HG22 ' HB3' ' A' ' 209' ' ' GLU . 31.2 m -102.39 137.91 40.01 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.235 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.87 ' HE2' HD13 ' A' ' 184' ' ' ILE . 72.4 m-85 -113.58 126.41 55.26 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.078 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.558 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -51.79 -37.31 51.03 Favored 'General case' 0 CA--C 1.505 -0.769 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 178.328 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . 0.49 ' O ' ' HG3' ' A' ' 182' ' ' LYS . 1.6 mm-40 -93.37 -175.28 3.76 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 113.39 -1.732 . . . . 0.0 109.3 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . 0.553 ' HB3' ' CE ' ' A' ' 182' ' ' LYS . 0.1 OUTLIER -124.67 11.37 8.49 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.912 -179.631 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.562 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.2 OUTLIER -80.74 -59.79 0.47 Allowed Pre-proline 0 C--N 1.328 -0.327 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.813 179.926 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.92 ' O ' HD12 ' A' ' 239' ' ' ILE . 84.0 Cg_exo -49.71 -31.87 26.92 Favored 'Trans proline' 0 CA--C 1.502 -1.087 0 N-CA-C 108.785 -1.275 . . . . 0.0 108.785 177.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.879 HG21 ' HB2' ' A' ' 182' ' ' LYS . 12.8 t -72.1 -44.93 64.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 114.059 -1.428 . . . . 0.0 110.566 178.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.562 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 19.4 pttt -62.33 -37.85 87.2 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.987 -179.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.48 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 0.0 OUTLIER -82.05 -49.99 9.6 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.856 0.36 . . . . 0.0 111.052 179.351 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.92 HD12 ' O ' ' A' ' 235' ' ' PRO . 1.4 mt -42.88 -53.08 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 24.7 mtp -56.23 -32.2 64.24 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.027 -179.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.477 ' CG ' ' O ' ' A' ' 237' ' ' LYS . 1.1 mt-10 -75.4 -21.19 58.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.13 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -79.57 109.92 14.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.849 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.406 ' HE2' ' HG3' ' A' ' 253' ' ' GLU . 0.0 OUTLIER -48.18 -47.57 35.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.755 179.951 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.561 ' CE1' ' HG3' ' A' ' 253' ' ' GLU . 8.5 m-85 -138.31 151.75 47.86 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.903 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' HIS . . . . . 0.807 ' CG ' HD12 ' A' ' 254' ' ' ILE . 29.7 m-70 -116.67 154.91 29.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.25 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . 0.406 ' O ' ' CE2' ' A' ' 201' ' ' TYR . 2.4 m-80 -134.34 105.23 6.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.276 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.545 ' N ' ' O ' ' A' ' 250' ' ' SER . 2.2 t -103.57 106.88 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.292 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . 0.457 ' C ' HD23 ' A' ' 249' ' ' LEU . . . 52.04 -83.06 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.186 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.544 HD23 ' N ' ' A' ' 249' ' ' LEU . 0.0 OUTLIER -111.11 -38.34 5.08 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.586 0.707 . . . . 0.0 110.267 179.727 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.545 ' O ' ' N ' ' A' ' 247' ' ' VAL . 0.6 OUTLIER -77.16 153.21 34.41 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.747 -1.115 . . . . 0.0 112.014 -178.627 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.498 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -146.97 107.08 4.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.959 179.159 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' CYS . . . . . 1.012 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -128.2 153.41 46.94 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -176.933 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . 0.561 ' HG3' ' CE1' ' A' ' 244' ' ' TYR . 29.2 tt0 -76.02 109.56 9.77 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.194 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.861 HG12 HG13 ' A' ' 186' ' ' VAL . 21.4 mt -96.54 115.23 35.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 -178.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.517 ' O ' ' C ' ' A' ' 256' ' ' VAL . 0.0 OUTLIER -121.01 131.8 54.51 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 106.144 -1.799 . . . . 0.0 106.144 176.628 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 183' ' ' LYS . 3.9 p -32.87 121.76 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.513 -0.472 0 CA-C-O 122.398 1.095 . . . . 0.0 111.446 -177.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 1.104 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -75.77 155.49 35.46 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 113.117 -1.856 . . . . 0.0 111.909 -178.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.91 125.16 27.71 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.426 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . 0.568 ' HB3' ' CE ' ' A' ' 183' ' ' LYS . 83.3 p . . . . . 0 C--N 1.324 -0.516 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.232 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' ' DT' . . . . . 0.783 ' O2 ' " H2'" ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.427 -0.82 0 O4'-C1'-C2' 106.888 0.716 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' ' DA' . . . . . 0.602 H5'' ' CE1' ' A' ' 225' ' ' PHE . . . . . . . . 0 O4'--C1' 1.408 -0.954 0 C1'-O4'-C4' 107.639 -1.472 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' ' DG' . . . . . 0.641 H2'' " O5'" ' B' ' 5' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.428 -0.76 0 C4'-C3'-C2' 102.098 -1.102 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' ' DG' . . . . . 0.641 " O5'" H2'' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.428 -0.78 0 O4'-C1'-C2' 106.714 0.559 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.46 ' CG1' ' N ' ' A' ' 182' ' ' LYS . 45.8 t . . . . . 0 CA--C 1.502 -0.891 0 CA-C-O 121.46 0.648 . . . . 0.0 112.051 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.559 ' HB3' HG21 ' A' ' 236' ' ' VAL . 0.0 OUTLIER -148.91 111.56 4.78 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.117 176.733 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.829 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -138.57 146.1 41.44 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 114.979 -1.01 . . . . 0.0 109.623 179.39 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.877 HD13 ' HE1' ' A' ' 230' ' ' PHE . 0.4 OUTLIER -125.38 120.32 57.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.528 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.854 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -93.33 109.09 20.63 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.423 0.63 . . . . 0.0 110.459 -178.738 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 1.12 HG12 ' HB2' ' A' ' 252' ' ' CYS . 1.9 t -88.14 122.58 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.023 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.597 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . -108.23 125.79 8.0 Favored Glycine 0 N--CA 1.452 -0.239 0 CA-C-N 115.893 -0.594 . . . . 0.0 114.535 -176.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.549 ' HA3' ' C7 ' ' B' ' 2' ' ' ' DT' . . . 81.33 86.86 0.66 Allowed Glycine 0 C--N 1.333 0.414 0 C-N-CA 121.025 -0.607 . . . . 0.0 113.026 179.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.934 HD23 ' C ' ' A' ' 225' ' ' PHE . 0.7 OUTLIER -116.87 156.64 26.98 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.835 0.35 . . . . 0.0 111.258 -179.657 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.605 ' O ' HD12 ' A' ' 189' ' ' LEU . 0.2 OUTLIER -45.31 179.65 0.01 OUTLIER Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.16 179.56 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.53 ' CD ' ' OG ' ' A' ' 190' ' ' SER . 15.5 Cg_exo -68.33 4.98 1.35 Allowed 'Trans proline' 0 CA--C 1.531 0.346 0 C-N-CA 123.138 2.559 . . . . 0.0 113.575 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.505 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 0.3 OUTLIER 161.4 76.25 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.877 0.37 . . . . 0.0 110.954 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.847 ' OG1' HD13 ' A' ' 189' ' ' LEU . 35.7 m -70.86 132.41 86.88 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.469 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.626 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 83.9 Cg_endo -77.25 115.21 3.91 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.77 2.313 . . . . 0.0 110.955 178.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.803 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -51.61 -13.7 0.27 Allowed 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -179.36 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . 0.513 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 25.9 mt-10 -68.17 -41.34 81.63 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -179.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.626 ' CD ' ' HG2' ' A' ' 194' ' ' PRO . 1.5 mttp -72.5 -47.37 49.07 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.803 ' CG1' ' HA ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -47.05 -31.02 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.118 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.575 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 4.1 mtp85 -71.71 -33.46 68.77 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.247 179.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . 0.525 ' CG ' ' N ' ' A' ' 201' ' ' TYR . 3.1 pt-20 -82.49 -51.55 7.7 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.005 0.431 . . . . 0.0 110.601 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.525 ' N ' ' CG ' ' A' ' 200' ' ' GLU . 0.2 OUTLIER -54.84 -54.6 40.29 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.497 0.665 . . . . 0.0 109.835 178.964 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 1.107 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.4 OUTLIER -79.29 -31.0 43.19 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.079 -179.784 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.575 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -63.41 -55.47 25.43 Favored Glycine 0 CA--C 1.501 -0.841 0 N-CA-C 106.812 -2.515 . . . . 0.0 106.812 176.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -49.05 -29.35 8.62 Favored Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 176.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.803 ' CD2' HD11 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -59.18 -42.56 91.11 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 122.046 0.927 . . . . 0.0 108.587 177.704 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.489 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 167.69 -130.44 2.1 Favored Glycine 0 N--CA 1.442 -0.923 0 CA-C-N 113.666 -1.606 . . . . 0.0 110.318 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.526 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 13.1 mt-10 -97.02 101.91 13.58 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.157 0.503 . . . . 0.0 110.923 178.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.459 HG21 ' HB2' ' A' ' 202' ' ' PHE . 2.4 t -77.14 143.97 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 CA-C-N 115.449 -0.796 . . . . 0.0 108.931 178.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . 0.738 ' HB3' HG22 ' A' ' 229' ' ' THR . 18.8 tp10 -91.8 -55.13 3.58 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 178.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 3.3 m -170.55 150.88 3.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.765 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.959 HD13 HG23 ' A' ' 228' ' ' ILE . 0.4 OUTLIER -117.53 133.33 64.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.752 179.088 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -123.21 103.35 8.48 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -178.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.603 HD13 ' HB3' ' A' ' 226' ' ' CYS . 2.4 mm? -96.33 109.08 45.73 Favored Pre-proline 0 CA--C 1.531 0.226 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 177.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.603 ' HD2' ' O ' ' A' ' 225' ' ' PHE . 26.8 Cg_endo -92.36 130.78 1.04 Allowed 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 123.225 2.617 . . . . 0.0 112.567 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -134.88 130.89 36.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.587 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.503 ' O ' ' ND2' ' A' ' 220' ' ' ASN . 1.0 OUTLIER -115.22 106.51 14.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.979 -179.93 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -82.58 -12.79 57.46 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.994 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -87.67 -48.61 7.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.412 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 4.0 t -109.81 -26.89 9.58 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.348 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . 0.503 ' ND2' ' O ' ' A' ' 216' ' ' ASP . 9.5 m120 52.44 47.27 25.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.833 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 3.9 ttpt -49.99 -178.67 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.946 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.625 ' CD ' ' O ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -101.35 21.85 13.46 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 122.444 1.116 . . . . 0.0 109.716 179.77 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.598 ' O ' ' N ' ' A' ' 225' ' ' PHE . 1.6 ptm180 -71.43 -20.83 62.06 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.321 178.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.514 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . -16.28 79.5 0.0 OUTLIER Glycine 0 C--N 1.343 0.964 0 O-C-N 124.4 1.062 . . . . 0.0 112.252 179.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.934 ' C ' HD23 ' A' ' 189' ' ' LEU . 0.0 OUTLIER -157.36 176.67 12.37 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.924 -0.638 . . . . 0.0 110.017 -177.773 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . 0.603 ' HB3' HD13 ' A' ' 213' ' ' LEU . 4.0 p -136.04 148.63 48.44 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.115 -0.634 . . . . 0.0 112.428 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 1.101 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 3.4 m-85 -109.81 132.79 53.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.111 -0.95 . . . . 0.0 108.446 178.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 1.107 HD12 ' CE2' ' A' ' 202' ' ' PHE . 1.8 mt -129.09 122.2 55.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.213 0.53 . . . . 0.0 111.785 -179.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.738 HG22 ' HB3' ' A' ' 209' ' ' GLU . 24.4 m -103.62 138.24 40.57 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.241 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.877 ' HE1' HD13 ' A' ' 184' ' ' ILE . 65.3 m-85 -110.97 126.38 54.71 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.55 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.559 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -48.22 -38.93 19.63 Favored 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 178.442 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . 0.452 ' O ' ' O ' ' A' ' 230' ' ' PHE . 0.3 OUTLIER -92.1 -166.18 1.5 Allowed 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 113.121 -1.854 . . . . 0.0 109.14 178.586 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . 0.517 ' O ' ' HG3' ' A' ' 237' ' ' LYS . 0.3 OUTLIER -131.27 -0.13 4.08 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.581 179.86 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.509 ' O ' ' N ' ' A' ' 237' ' ' LYS . 0.6 OUTLIER -72.57 -58.99 2.64 Favored Pre-proline 0 C--N 1.331 -0.234 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.835 -179.422 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.864 ' O ' HD12 ' A' ' 239' ' ' ILE . 96.5 Cg_exo -48.98 -32.91 24.59 Favored 'Trans proline' 0 CA--C 1.497 -1.373 0 N-CA-C 108.949 -1.212 . . . . 0.0 108.949 178.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.559 HG21 ' HB3' ' A' ' 182' ' ' LYS . 21.6 t -69.87 -40.84 79.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 113.834 -1.53 . . . . 0.0 109.075 178.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.517 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 8.7 mttt -58.81 -45.93 88.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.877 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.459 ' O ' ' HD3' ' A' ' 242' ' ' LYS . 0.0 OUTLIER -80.25 -47.42 14.63 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.064 -179.703 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.864 HD12 ' O ' ' A' ' 235' ' ' PRO . 1.6 mt -45.15 -50.82 2.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.7 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . 0.501 ' SD ' HG12 ' A' ' 236' ' ' VAL . 23.0 mtp -58.13 -28.22 64.47 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.192 -179.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.465 ' N ' ' OE1' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -82.48 -20.76 36.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.224 0.535 . . . . 0.0 109.824 179.408 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.459 ' HD3' ' O ' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -80.55 100.13 8.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.019 179.729 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.61 ' HE2' ' CG ' ' A' ' 244' ' ' TYR . 1.8 ttpt -40.7 -67.43 0.24 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.24 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.61 ' CG ' ' HE2' ' A' ' 243' ' ' LYS . 7.1 m-30 -113.94 154.4 27.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.197 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' HIS . . . . . 0.699 ' CG ' HD12 ' A' ' 254' ' ' ILE . 24.3 m-70 -123.12 147.85 46.33 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.338 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . 0.448 ' HB3' ' HD2' ' A' ' 251' ' ' LYS . 0.4 OUTLIER -125.73 105.24 8.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.989 0.424 . . . . 0.0 110.938 179.712 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.662 HG11 HG23 ' A' ' 198' ' ' ILE . 1.9 t -102.64 108.98 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.235 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 48.76 -83.93 0.01 OUTLIER Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.271 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.556 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -110.48 -38.64 5.15 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.402 0.62 . . . . 0.0 110.497 179.639 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.522 ' HB3' ' HB2' ' A' ' 190' ' ' SER . 1.6 p -77.06 150.44 35.73 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.011 -0.995 . . . . 0.0 112.068 -178.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -144.88 108.05 4.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.307 178.984 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' CYS . . . . . 1.12 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -128.04 153.01 47.25 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -177.436 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . 0.515 ' HB2' ' O4 ' ' B' ' 2' ' ' ' DT' . 51.5 tt0 -76.17 113.14 13.38 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.221 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.92 HG12 HG13 ' A' ' 186' ' ' VAL . 10.1 mt -96.53 113.05 29.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 114.66 1.355 . . . . 0.0 114.66 -178.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.518 ' O ' ' C ' ' A' ' 256' ' ' VAL . 0.0 OUTLIER -119.5 129.57 54.77 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 176.207 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.674 HG23 ' O ' ' A' ' 183' ' ' LYS . 6.3 p -32.84 121.46 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.433 0 CA-C-O 122.264 1.031 . . . . 0.0 111.42 -177.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 1.101 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -76.01 154.1 36.0 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 113.207 -1.815 . . . . 0.0 112.132 -178.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' MET . . . . . 0.636 ' HE3' ' C6 ' ' B' ' 3' ' ' ' DA' . 0.0 OUTLIER -130.32 117.16 19.36 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.174 179.451 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.323 -0.558 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.716 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' ' DT' . . . . . 0.752 ' O2 ' " H2'" ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.428 -0.772 0 O4'-C1'-C2' 106.716 0.56 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' ' DA' . . . . . 0.636 ' C6 ' ' HE3' ' A' ' 258' ' ' MET . . . . . . . . 0 O4'--C1' 1.405 -1.118 0 C4'-C3'-C2' 104.602 1.402 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' ' DG' . . . . . 0.699 ' C2 ' ' CE1' ' A' ' 227' ' ' PHE . . . . . . . . 0 O5'--C5' 1.427 -0.831 0 C4'-C3'-C2' 102.178 -1.022 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' ' DG' . . . . . 0.685 " O5'" H2'' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.425 -0.913 0 O4'-C1'-C2' 106.962 0.783 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.543 ' CA ' ' HE3' ' A' ' 182' ' ' LYS . 55.7 t . . . . . 0 CA--C 1.506 -0.74 0 CA-C-O 121.02 0.438 . . . . 0.0 111.502 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 1.086 ' HB2' HG21 ' A' ' 236' ' ' VAL . 0.0 OUTLIER -154.37 112.41 3.52 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.185 177.293 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.829 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -134.62 153.72 51.84 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.76 179.207 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.783 HD13 ' HE1' ' A' ' 230' ' ' PHE . 0.1 OUTLIER -133.1 120.49 40.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 177.991 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.816 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -92.51 109.94 21.35 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 121.341 0.591 . . . . 0.0 110.309 -179.434 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.684 HG12 ' HB2' ' A' ' 252' ' ' CYS . 39.2 t -88.08 131.0 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.968 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.502 ' O ' ' HB3' ' A' ' 252' ' ' CYS . . . -85.16 -146.56 8.45 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 114.597 0.599 . . . . 0.0 114.597 -177.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.491 ' HA2' ' O ' ' A' ' 224' ' ' GLY . . . -35.56 103.29 0.02 OUTLIER Glycine 0 C--N 1.336 0.569 0 N-CA-C 114.505 0.562 . . . . 0.0 114.505 -179.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.924 HD13 ' OG1' ' A' ' 193' ' ' THR . 1.7 pp -117.78 157.07 27.22 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 122.453 0.301 . . . . 0.0 110.893 179.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.828 ' O ' HD12 ' A' ' 189' ' ' LEU . 0.0 OUTLIER -42.27 172.64 0.03 OUTLIER Pre-proline 0 N--CA 1.463 0.191 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.32 179.806 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.515 ' HD2' ' OG ' ' A' ' 190' ' ' SER . 31.7 Cg_exo -60.37 -5.24 3.92 Favored 'Trans proline' 0 CA--C 1.532 0.395 0 C-N-CA 122.891 2.394 . . . . 0.0 113.466 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 191' ' ' PRO . 0.1 OUTLIER 172.78 73.19 0.0 OUTLIER 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.924 0.392 . . . . 0.0 111.503 -179.943 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.924 ' OG1' HD13 ' A' ' 189' ' ' LEU . 57.4 m -61.36 114.31 10.51 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.471 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.538 ' HG2' ' HG2' ' A' ' 197' ' ' LYS . 13.3 Cg_endo -58.19 114.26 1.89 Allowed 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.166 1.911 . . . . 0.0 111.013 178.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.836 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 6.5 pt-20 -53.4 -14.67 0.81 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.501 -179.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . 0.514 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 51.7 mt-10 -68.34 -38.51 81.55 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.538 ' HG2' ' HG2' ' A' ' 194' ' ' PRO . 0.1 OUTLIER -73.85 -49.2 26.2 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.309 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 1.022 HG22 ' CE1' ' A' ' 202' ' ' PHE . 0.0 OUTLIER -48.48 -30.91 3.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.062 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.598 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 11.0 mtp180 -69.18 -33.43 73.35 Favored 'General case' 0 C--O 1.22 -0.494 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.639 178.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . 0.534 ' N ' ' O ' ' A' ' 197' ' ' LYS . 4.3 mt-10 -82.42 -59.58 2.49 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.422 178.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.52 ' C ' ' CD1' ' A' ' 201' ' ' TYR . 0.4 OUTLIER -49.0 -54.27 16.37 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.498 0.666 . . . . 0.0 109.839 179.119 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 1.074 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.6 OUTLIER -79.36 -30.83 42.76 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 114.92 -1.037 . . . . 0.0 110.244 -179.863 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.598 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -62.2 -57.53 16.58 Favored Glycine 0 N--CA 1.443 -0.879 0 N-CA-C 106.959 -2.456 . . . . 0.0 106.959 176.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -48.64 -28.49 6.92 Favored Glycine 0 N--CA 1.442 -0.919 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 176.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.776 ' CD2' HD11 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -58.65 -45.26 89.7 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 177.866 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.494 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 171.83 -132.75 2.51 Favored Glycine 0 N--CA 1.441 -0.975 0 CA-C-N 113.614 -1.63 . . . . 0.0 110.25 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.484 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 0.5 OUTLIER -96.87 98.02 9.77 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.278 0.561 . . . . 0.0 111.079 178.815 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.495 HG21 ' HB2' ' A' ' 202' ' ' PHE . 2.8 t -74.32 142.24 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . 0.669 ' HB3' HG22 ' A' ' 229' ' ' THR . 5.0 tp10 -94.13 -54.12 3.7 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.747 178.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.8 m -166.25 152.74 9.17 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.228 0.537 . . . . 0.0 112.073 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.886 HD13 HG23 ' A' ' 228' ' ' ILE . 0.4 OUTLIER -122.06 124.49 71.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.23 178.433 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.49 ' O ' ' HD3' ' A' ' 214' ' ' PRO . 0.9 OUTLIER -123.34 107.29 11.48 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -177.993 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.768 HD11 ' HB ' ' A' ' 193' ' ' THR . 0.1 OUTLIER -95.65 105.56 21.57 Favored Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 177.66 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.545 ' HD2' ' O ' ' A' ' 225' ' ' PHE . 11.4 Cg_exo -73.01 134.01 20.74 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.752 2.301 . . . . 0.0 112.521 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.87 130.94 38.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.358 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.427 ' OD2' ' CG2' ' A' ' 219' ' ' THR . 0.8 OUTLIER -113.75 107.19 15.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.963 0.411 . . . . 0.0 111.585 -179.356 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -82.62 -28.57 30.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.03 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.55 -42.72 9.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.928 -178.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.427 ' CG2' ' OD2' ' A' ' 216' ' ' ASP . 0.1 OUTLIER -91.51 -23.21 20.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.813 0.339 . . . . 0.0 111.279 -179.426 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . 0.405 ' HA ' ' O ' ' A' ' 216' ' ' ASP . 17.1 m120 38.17 46.74 0.89 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.398 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . 0.444 ' HB2' ' NH1' ' A' ' 223' ' ' ARG . 2.0 mtmt -69.78 166.32 19.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.561 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.649 ' O ' ' CG ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -93.66 46.7 1.2 Allowed 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 122.93 1.348 . . . . 0.0 109.573 179.816 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.548 ' HB2' ' CE1' ' A' ' 225' ' ' PHE . 2.4 ptp85 -71.76 -31.87 67.11 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 178.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.498 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 13.56 60.57 0.01 OUTLIER Glycine 0 C--O 1.224 -0.518 0 CA-C-N 114.396 -1.275 . . . . 0.0 113.207 178.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.802 ' C ' HD23 ' A' ' 189' ' ' LEU . 1.1 p90 -156.24 176.38 12.76 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -179.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . 0.702 ' SG ' HD22 ' A' ' 189' ' ' LEU . 7.9 p -146.43 154.66 41.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.178 0.513 . . . . 0.0 112.118 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 1.121 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 7.3 m-85 -105.85 147.45 28.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.761 179.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 1.074 HD12 ' CE2' ' A' ' 202' ' ' PHE . 2.0 mt -139.51 131.18 34.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.042 0.448 . . . . 0.0 110.646 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.669 HG22 ' HB3' ' A' ' 209' ' ' GLU . 38.2 m -113.18 137.99 50.63 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.752 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.783 ' HE1' HD13 ' A' ' 184' ' ' ILE . 80.4 m-85 -113.92 126.51 55.24 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.719 -0.393 . . . . 0.0 110.187 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.541 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -48.88 -39.05 24.4 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 178.243 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . 0.473 ' O ' ' HG3' ' A' ' 182' ' ' LYS . 35.9 mm-40 -98.63 169.46 9.49 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 113.528 -1.669 . . . . 0.0 109.381 178.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . 0.552 ' HB3' ' CD ' ' A' ' 182' ' ' LYS . 1.4 pm0 -108.67 17.75 21.6 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.557 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.3 OUTLIER -83.73 -61.58 0.3 Allowed Pre-proline 0 C--N 1.33 -0.25 0 C-N-CA 120.059 -0.657 . . . . 0.0 110.847 179.918 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.885 ' O ' HD12 ' A' ' 239' ' ' ILE . 96.7 Cg_exo -49.18 -30.87 20.15 Favored 'Trans proline' 0 CA--C 1.498 -1.306 0 N-CA-C 108.982 -1.199 . . . . 0.0 108.982 177.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 1.086 HG21 ' HB2' ' A' ' 182' ' ' LYS . 15.7 t -72.25 -45.31 61.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 113.884 -1.507 . . . . 0.0 109.95 178.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.557 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 33.5 pttt -63.35 -35.86 81.78 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.921 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.515 ' HA ' ' HG3' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -81.01 -49.72 10.57 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.093 0.473 . . . . 0.0 110.729 179.293 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.885 HD12 ' O ' ' A' ' 235' ' ' PRO . 1.5 mt -46.67 -45.19 7.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.65 -0.704 . . . . 0.0 112.066 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . 0.441 ' HG2' ' HB ' ' A' ' 256' ' ' VAL . 2.2 mtp -66.47 -20.03 65.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.766 -178.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.515 ' HG3' ' HA ' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -88.78 -27.32 21.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.909 0.385 . . . . 0.0 110.555 -179.883 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.536 ' N ' ' HD2' ' A' ' 242' ' ' LYS . 2.4 mmmm -80.36 106.8 12.65 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.316 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.414 ' C ' ' O ' ' A' ' 242' ' ' LYS . 0.0 OUTLIER -36.31 -62.37 0.45 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.221 -179.491 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.522 ' CE1' ' CG ' ' A' ' 253' ' ' GLU . 73.9 m-85 -125.57 170.13 11.78 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.633 -179.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' HIS . . . . . 0.796 ' CG ' HD12 ' A' ' 254' ' ' ILE . 37.4 m-70 -130.16 156.98 43.68 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.288 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -134.66 104.8 6.19 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.215 0.531 . . . . 0.0 110.059 178.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.635 HG12 ' H ' ' A' ' 248' ' ' GLY . 1.5 t -95.68 -179.63 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.992 -179.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . 0.635 ' H ' HG12 ' A' ' 247' ' ' VAL . . . -24.67 -58.06 0.05 OUTLIER Glycine 0 C--N 1.337 0.594 0 C-N-CA 121.377 -0.439 . . . . 0.0 112.991 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.37 -40.72 1.94 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.273 0.559 . . . . 0.0 111.063 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.555 ' HB3' ' HB3' ' A' ' 190' ' ' SER . 61.5 p -78.77 147.79 33.21 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.12 -0.945 . . . . 0.0 113.082 -178.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.1 OUTLIER -136.54 104.01 5.43 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 177.454 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' CYS . . . . . 0.684 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -128.49 153.89 46.68 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -175.684 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . 0.522 ' CG ' ' CE1' ' A' ' 244' ' ' TYR . 51.1 tt0 -76.01 109.54 9.73 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.27 179.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.796 HD12 ' CG ' ' A' ' 245' ' ' HIS . 21.7 mt -97.36 112.15 28.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -178.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.509 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -117.02 131.74 56.87 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 177.016 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.692 HG23 ' O ' ' A' ' 183' ' ' LYS . 4.0 p -33.38 123.52 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.485 0 CA-C-O 122.307 1.051 . . . . 0.0 111.225 -177.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 1.121 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -76.11 154.29 35.65 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 113.28 -1.782 . . . . 0.0 111.915 -178.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.44 112.23 15.37 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.012 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.507 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.432 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' ' DT' . . . . . 0.607 ' O2 ' " H2'" ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.428 -0.73 0 O4'-C1'-C2' 106.856 0.687 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' ' DA' . . . . . 0.892 " H4'" " O5'" ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.426 -0.903 0 C5'-C4'-O4' 108.429 -0.607 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' ' DG' . . . . . 0.892 " O5'" " H4'" ' B' ' 3' ' ' ' DA' . . . . . . . . 0 O5'--C5' 1.426 -0.877 0 C4'-C3'-C2' 102.032 -1.168 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' ' DG' . . . . . 0.728 ' N7 ' ' C5 ' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.428 -0.768 0 O4'-C1'-C2' 106.964 0.786 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.483 ' CG1' ' N ' ' A' ' 182' ' ' LYS . 47.7 t . . . . . 0 CA--C 1.503 -0.848 0 CA-C-O 121.229 0.538 . . . . 0.0 111.305 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.653 ' CB ' HG21 ' A' ' 236' ' ' VAL . 0.0 OUTLIER -151.38 112.31 4.27 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.481 177.463 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.851 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -132.35 152.01 51.61 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.607 179.228 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.792 HD13 ' HE1' ' A' ' 230' ' ' PHE . 0.2 OUTLIER -130.31 120.29 48.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.224 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.833 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -92.67 109.53 20.95 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 121.576 0.703 . . . . 0.0 109.814 -179.544 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.797 HG12 ' HB2' ' A' ' 252' ' ' CYS . 24.0 t -85.68 126.6 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.244 -179.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.544 ' O ' ' HB3' ' A' ' 252' ' ' CYS . . . -114.36 129.48 8.74 Favored Glycine 0 N--CA 1.453 -0.225 0 N-CA-C 115.014 0.766 . . . . 0.0 115.014 -177.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.556 ' HA3' ' H71' ' B' ' 2' ' ' ' DT' . . . 78.04 78.33 0.8 Allowed Glycine 0 C--N 1.331 0.264 0 C-N-CA 121.44 -0.409 . . . . 0.0 113.428 178.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.906 HD23 ' C ' ' A' ' 225' ' ' PHE . 0.6 OUTLIER -117.54 157.41 26.37 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 122.431 0.293 . . . . 0.0 110.726 -179.897 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.612 ' N ' HD12 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -46.7 -175.17 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.249 0 CA-C-O 121.102 0.477 . . . . 0.0 111.428 179.761 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.588 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 11.8 Cg_exo -70.83 -1.7 9.77 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 123.149 2.566 . . . . 0.0 113.707 -179.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.523 ' HB2' ' O ' ' A' ' 191' ' ' PRO . 25.9 t70 169.58 74.21 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.982 0.42 . . . . 0.0 111.24 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.854 ' OG1' HD13 ' A' ' 189' ' ' LEU . 55.1 m -66.3 114.58 17.6 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.939 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.583 ' O ' HD11 ' A' ' 198' ' ' ILE . 12.6 Cg_endo -56.72 115.41 2.46 Favored 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 122.478 2.119 . . . . 0.0 111.467 179.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.813 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.1 OUTLIER -53.11 -15.13 0.76 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.343 -179.641 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . 0.493 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 3.6 mt-10 -68.61 -38.96 81.0 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.552 ' HG2' ' HG2' ' A' ' 194' ' ' PRO . 19.0 mmmt -73.18 -48.93 31.1 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.843 ' CD1' HG22 ' A' ' 193' ' ' THR . 0.0 OUTLIER -48.49 -30.8 3.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.222 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.583 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 2.3 mtt180 -70.56 -32.52 69.97 Favored 'General case' 0 C--O 1.221 -0.447 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.662 178.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . 0.577 ' CG ' ' N ' ' A' ' 201' ' ' TYR . 4.2 pt-20 -83.03 -56.38 3.83 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.664 179.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.577 ' N ' ' CG ' ' A' ' 200' ' ' GLU . 0.4 OUTLIER -50.31 -53.93 25.15 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.62 0.724 . . . . 0.0 109.791 179.049 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 1.148 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.4 OUTLIER -79.43 -29.77 42.02 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.875 -179.915 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.583 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -62.72 -57.99 13.98 Favored Glycine 0 CA--C 1.499 -0.946 0 N-CA-C 107.044 -2.422 . . . . 0.0 107.044 176.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -48.81 -29.21 7.83 Favored Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 176.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.828 ' CD2' HD11 ' A' ' 239' ' ' ILE . 0.0 OUTLIER -58.36 -42.3 86.65 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.017 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.501 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 168.1 -131.1 2.23 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 113.733 -1.576 . . . . 0.0 110.212 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.529 ' HG3' ' CG ' ' A' ' 232' ' ' GLU . 1.3 mm-40 -96.8 100.64 12.17 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.239 0.542 . . . . 0.0 111.074 178.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.572 HG21 ' HB2' ' A' ' 202' ' ' PHE . 2.7 t -79.36 138.86 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 CA-C-N 115.336 -0.847 . . . . 0.0 108.813 178.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . 0.604 ' HB3' HG22 ' A' ' 229' ' ' THR . 3.0 tp10 -89.9 -56.94 3.04 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.766 178.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 3.5 m -166.39 150.86 7.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.278 0.561 . . . . 0.0 112.245 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 1.044 HD13 HG23 ' A' ' 228' ' ' ILE . 0.5 OUTLIER -119.04 123.36 71.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.561 178.638 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.487 ' O ' ' HD3' ' A' ' 214' ' ' PRO . 0.0 OUTLIER -122.73 103.19 8.49 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -178.834 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.527 HD23 ' CB ' ' A' ' 226' ' ' CYS . 0.0 OUTLIER -95.89 106.14 25.9 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.347 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.546 ' HD2' ' O ' ' A' ' 225' ' ' PHE . 13.0 Cg_exo -72.21 130.91 17.06 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 123.299 2.666 . . . . 0.0 113.282 -178.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 4.3 ptp -135.3 130.84 35.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.307 179.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.481 ' O ' ' HA ' ' A' ' 220' ' ' ASN . 0.5 OUTLIER -110.59 107.98 17.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.038 0.447 . . . . 0.0 111.24 -179.735 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -81.98 -8.7 59.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.045 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 4.4 mtpt -88.27 -51.68 5.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.454 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.427 ' O ' ' C ' ' A' ' 220' ' ' ASN . 0.0 OUTLIER -118.6 -9.98 10.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.278 -179.762 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . 0.481 ' HA ' ' O ' ' A' ' 216' ' ' ASP . 4.4 m120 37.35 59.01 1.22 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.652 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -57.26 -179.62 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.627 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.636 ' O ' ' CG ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -99.48 40.17 1.24 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 122.791 1.282 . . . . 0.0 110.139 -179.909 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.533 ' CB ' H5'' ' B' ' 3' ' ' ' DA' . 1.8 ptp85 -71.54 -31.59 67.19 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.498 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 11.94 63.7 0.01 OUTLIER Glycine 0 C--N 1.336 0.559 0 CA-C-N 114.292 -1.322 . . . . 0.0 113.245 178.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.906 ' C ' HD23 ' A' ' 189' ' ' LEU . 1.4 p90 -156.83 176.77 12.3 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . 0.527 ' CB ' HD23 ' A' ' 213' ' ' LEU . 30.5 p -145.78 156.38 43.55 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.505 -0.478 . . . . 0.0 112.255 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 1.12 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 5.4 m-85 -107.94 143.55 36.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.642 179.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 1.148 HD12 ' CE2' ' A' ' 202' ' ' PHE . 2.0 mt -137.13 128.34 41.26 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.401 0 CA-C-O 121.175 0.512 . . . . 0.0 111.495 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.604 HG22 ' HB3' ' A' ' 209' ' ' GLU . 54.9 m -110.88 138.15 47.63 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.834 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.792 ' HE1' HD13 ' A' ' 184' ' ' ILE . 67.9 m-85 -111.64 126.1 54.66 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.766 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.5 ' HG3' ' O ' ' A' ' 207' ' ' GLU . 0.1 OUTLIER -49.81 -38.52 34.95 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 177.711 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . 0.529 ' CG ' ' HG3' ' A' ' 207' ' ' GLU . 60.5 mm-40 -89.86 -167.8 1.95 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 113.154 -1.839 . . . . 0.0 109.274 178.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . 0.555 ' CB ' ' HG2' ' A' ' 182' ' ' LYS . 0.8 OUTLIER -131.32 -1.28 3.99 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -179.876 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.514 ' HB2' ' HD3' ' A' ' 235' ' ' PRO . 2.0 mt-10 -73.69 -58.14 2.32 Favored Pre-proline 0 C--N 1.329 -0.29 0 C-N-CA 120.433 -0.507 . . . . 0.0 112.141 -179.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.851 ' O ' HD12 ' A' ' 239' ' ' ILE . 79.8 Cg_exo -49.22 -31.07 20.96 Favored 'Trans proline' 0 CA--C 1.498 -1.303 0 N-CA-C 109.066 -1.167 . . . . 0.0 109.066 178.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.653 HG21 ' CB ' ' A' ' 182' ' ' LYS . 17.6 t -72.22 -44.07 64.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 114.019 -1.446 . . . . 0.0 109.189 178.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.497 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 2.1 mtpp -52.74 -47.95 67.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.396 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.666 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -80.61 -52.79 7.18 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.926 -179.268 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.851 HD12 ' O ' ' A' ' 235' ' ' PRO . 1.9 mt -38.49 -51.51 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.917 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 22.7 mtp -59.17 -26.78 65.08 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.052 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.529 ' HG3' ' CD ' ' A' ' 242' ' ' LYS . 0.2 OUTLIER -81.56 -27.91 34.13 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.676 179.89 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.529 ' CD ' ' HG3' ' A' ' 241' ' ' GLU . 0.6 OUTLIER -81.32 96.79 7.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.616 179.688 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.498 ' O ' ' HG3' ' A' ' 253' ' ' GLU . 0.0 OUTLIER -36.17 -55.0 0.8 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.867 -179.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.515 ' CE1' ' HG3' ' A' ' 253' ' ' GLU . 32.7 m-85 -126.26 158.4 35.82 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.299 0.571 . . . . 0.0 111.836 -179.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' HIS . . . . . 0.643 ' CG ' HD12 ' A' ' 254' ' ' ILE . 32.2 m-70 -127.85 157.46 40.42 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.531 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . 0.462 ' O ' ' CE2' ' A' ' 201' ' ' TYR . 2.2 m-80 -127.82 104.69 7.97 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.211 0.529 . . . . 0.0 110.423 178.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.556 HG12 ' H ' ' A' ' 248' ' ' GLY . 1.4 t -95.31 174.92 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.253 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . 0.713 ' C ' HD23 ' A' ' 249' ' ' LEU . . . -14.66 -57.16 0.01 OUTLIER Glycine 0 C--N 1.34 0.759 0 O-C-N 123.662 0.601 . . . . 0.0 113.316 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.713 HD23 ' C ' ' A' ' 248' ' ' GLY . 0.0 OUTLIER -133.39 -39.8 0.91 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.959 -0.621 . . . . 0.0 110.939 -179.883 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.637 ' CB ' ' HG1' ' A' ' 193' ' ' THR . 6.0 p -78.24 152.2 32.7 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.159 -0.928 . . . . 0.0 113.192 -178.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -137.19 108.6 6.89 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.419 178.211 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' CYS . . . . . 0.797 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -128.63 153.73 46.97 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -176.357 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . 0.518 ' N ' ' O ' ' A' ' 187' ' ' GLY . 59.4 tt0 -76.08 108.11 8.75 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.832 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.651 HG21 ' CG2' ' A' ' 239' ' ' ILE . 13.2 mt -96.47 112.24 28.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 -178.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.514 ' O ' ' C ' ' A' ' 256' ' ' VAL . 0.0 OUTLIER -116.15 130.16 56.66 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 176.568 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 183' ' ' LYS . 3.6 p -32.78 123.54 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 122.136 0.969 . . . . 0.0 111.372 -177.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 1.12 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -76.67 153.71 34.92 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 113.522 -1.672 . . . . 0.0 111.716 -178.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.48 112.92 14.87 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.354 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . 0.481 ' OG ' ' O6 ' ' B' ' 4' ' ' ' DG' . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.518 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.08 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' ' DT' . . . . . 0.816 ' O2 ' H5'' ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.427 -0.797 0 O4'-C1'-C2' 107.192 0.992 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' ' DA' . . . . . 0.893 " H4'" " O5'" ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.426 -0.854 0 C5'-C4'-O4' 108.251 -0.718 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' ' DG' . . . . . 0.893 " O5'" " H4'" ' B' ' 3' ' ' ' DA' . . . . . . . . 0 O5'--C5' 1.425 -0.908 0 C4'-C3'-C2' 101.493 -1.707 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' ' DG' . . . . . 0.737 ' C8 ' " H1'" ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.429 -0.667 0 C4'-C3'-C2' 102.571 -0.629 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.511 ' CG1' ' N ' ' A' ' 182' ' ' LYS . 42.8 t . . . . . 0 CA--C 1.504 -0.802 0 CA-C-O 121.181 0.515 . . . . 0.0 111.615 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.641 ' CB ' HG21 ' A' ' 236' ' ' VAL . 0.7 OUTLIER -149.99 112.67 4.76 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.488 177.731 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.818 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -134.15 142.57 47.51 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.747 179.838 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.789 HD12 HG21 ' A' ' 239' ' ' ILE . 0.2 OUTLIER -122.59 120.08 59.93 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.445 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.868 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.3 OUTLIER -91.73 109.44 20.76 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.68 0.752 . . . . 0.0 110.054 -179.135 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.706 HG22 HG12 ' A' ' 254' ' ' ILE . 48.7 t -85.53 126.43 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 CA-C-N 114.689 -1.141 . . . . 0.0 109.373 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.572 ' O ' ' HB3' ' A' ' 252' ' ' CYS . . . -112.99 134.8 12.18 Favored Glycine 0 C--N 1.331 0.288 0 N-CA-C 115.276 0.87 . . . . 0.0 115.276 -176.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.594 ' HA3' ' C5 ' ' B' ' 2' ' ' ' DT' . . . 64.51 84.09 0.08 OUTLIER Glycine 0 C--N 1.333 0.396 0 CA-C-N 115.516 -0.342 . . . . 0.0 112.675 178.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 1.016 HD13 ' OG1' ' A' ' 193' ' ' THR . 1.1 pp -117.36 157.83 25.46 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.045 0.45 . . . . 0.0 112.039 -178.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.643 ' O ' HD12 ' A' ' 189' ' ' LEU . 0.3 OUTLIER -44.68 -173.91 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.227 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.965 179.815 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.588 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 6.4 Cg_exo -74.75 9.48 1.93 Allowed 'Trans proline' 0 CA--C 1.53 0.289 0 C-N-CA 123.125 2.55 . . . . 0.0 113.507 -179.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.54 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 1.1 m-20 158.2 78.24 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 120.842 0.353 . . . . 0.0 111.534 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 1.016 ' OG1' HD13 ' A' ' 189' ' ' LEU . 19.2 m -68.78 112.17 10.55 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.633 179.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.587 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 54.9 Cg_endo -67.3 107.04 1.31 Allowed 'Trans proline' 0 N--CA 1.465 -0.158 0 C-N-CA 122.668 2.245 . . . . 0.0 111.767 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.609 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -41.06 -21.51 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.32 -0.4 . . . . 0.0 112.016 -179.964 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . 0.462 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 11.0 mt-10 -59.37 -43.71 92.84 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -178.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.587 ' CD ' ' HG2' ' A' ' 194' ' ' PRO . 0.6 OUTLIER -79.15 -46.21 18.42 Favored 'General case' 0 CA--C 1.494 -1.208 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 178.68 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.833 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.2 OUTLIER -49.07 -29.58 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-N 114.191 -1.368 . . . . 0.0 108.396 176.86 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.553 ' HG3' ' O ' ' A' ' 195' ' ' GLU . 4.6 mtp85 -74.16 -32.56 63.17 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.845 178.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . 0.536 ' O ' ' N ' ' A' ' 204' ' ' GLY . 5.4 mt-10 -82.61 -59.13 2.62 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.57 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.493 ' C ' ' CD1' ' A' ' 201' ' ' TYR . 0.4 OUTLIER -47.96 -52.16 20.77 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.136 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 1.065 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.4 OUTLIER -79.7 -31.69 41.26 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.301 179.459 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.542 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -61.84 -58.07 14.61 Favored Glycine 0 N--CA 1.442 -0.906 0 N-CA-C 107.613 -2.195 . . . . 0.0 107.613 176.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -49.76 -27.91 10.28 Favored Glycine 0 N--CA 1.441 -1.003 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 176.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.761 ' CE2' HG13 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -57.76 -46.05 85.08 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 177.826 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.505 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 173.56 -132.28 2.27 Favored Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 113.639 -1.618 . . . . 0.0 110.25 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.509 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 3.1 mm-40 -97.19 99.84 11.32 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.134 0.492 . . . . 0.0 111.08 178.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 2.6 t -74.76 139.08 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . 0.55 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 60.0 tt0 -91.03 -56.03 3.32 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 178.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -161.88 153.96 19.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.861 179.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.567 HD12 ' HB ' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -122.97 123.95 69.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.488 178.725 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.509 ' OE1' ' N7 ' ' B' ' 4' ' ' ' DG' . 1.0 OUTLIER -123.57 104.75 9.23 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -177.371 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.614 HD21 ' HB ' ' A' ' 193' ' ' THR . 0.7 OUTLIER -95.69 106.69 28.89 Favored Pre-proline 0 CA--C 1.531 0.233 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 176.545 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.562 ' HD2' ' O ' ' A' ' 225' ' ' PHE . 5.1 Cg_endo -85.38 133.98 4.77 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 123.197 2.598 . . . . 0.0 113.885 -178.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.39 134.84 40.14 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.288 179.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.461 ' O ' ' HA ' ' A' ' 220' ' ' ASN . 0.2 OUTLIER -110.2 107.19 16.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.912 0.387 . . . . 0.0 111.174 -179.834 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -81.88 -6.48 59.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.608 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -88.7 -51.7 5.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.837 0.351 . . . . 0.0 111.432 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.77 -22.3 7.46 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.03 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . 0.461 ' HA ' ' O ' ' A' ' 216' ' ' ASP . 2.2 m-80 57.02 55.99 5.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.278 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.4 177.16 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.347 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.75 ' HG3' ' O ' ' A' ' 222' ' ' ARG . 0.7 OUTLIER -100.01 38.27 1.5 Allowed 'General case' 0 N--CA 1.439 -0.991 0 CA-C-O 122.458 1.123 . . . . 0.0 109.713 -179.762 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.623 ' HB2' ' CE1' ' A' ' 225' ' ' PHE . 6.6 ptp85 -70.98 -28.89 64.78 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 179.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.535 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 4.99 64.77 0.01 OUTLIER Glycine 0 C--N 1.342 0.887 0 O-C-N 124.446 1.091 . . . . 0.0 112.863 177.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.883 ' C ' HD23 ' A' ' 189' ' ' LEU . 0.2 OUTLIER -156.49 176.48 12.65 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.985 -0.608 . . . . 0.0 109.406 -178.311 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . 0.536 ' O ' ' HB ' ' A' ' 186' ' ' VAL . 0.5 OUTLIER -139.77 156.89 46.52 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.033 -0.667 . . . . 0.0 112.225 -179.339 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 1.099 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 4.7 m-85 -114.24 132.26 56.2 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.428 -0.806 . . . . 0.0 108.968 179.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 1.065 HD12 ' CE2' ' A' ' 202' ' ' PHE . 2.2 mt -126.13 124.8 66.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.16 0.505 . . . . 0.0 111.41 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.525 HG22 ' HB3' ' A' ' 209' ' ' GLU . 85.1 m -106.1 138.08 42.9 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.496 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.767 ' HE2' HD13 ' A' ' 184' ' ' ILE . 74.7 m-85 -113.05 126.47 55.52 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.377 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.55 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -49.28 -38.4 27.03 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 178.334 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . 0.458 ' HB3' ' OE2' ' A' ' 234' ' ' GLU . 49.1 mt-10 -91.49 -168.57 2.07 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 113.399 -1.728 . . . . 0.0 109.673 179.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . 0.515 ' CB ' ' HG2' ' A' ' 182' ' ' LYS . 0.6 OUTLIER -131.34 14.04 5.06 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.834 -0.347 . . . . 0.0 111.372 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.582 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.4 OUTLIER -84.55 -60.06 0.32 Allowed Pre-proline 0 C--N 1.33 -0.263 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.702 179.873 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.889 ' O ' HD12 ' A' ' 239' ' ' ILE . 87.1 Cg_exo -49.31 -32.59 26.21 Favored 'Trans proline' 0 CA--C 1.502 -1.103 0 N-CA-C 109.089 -1.158 . . . . 0.0 109.089 178.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.641 HG21 ' CB ' ' A' ' 182' ' ' LYS . 21.7 t -72.51 -43.44 63.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 113.938 -1.483 . . . . 0.0 110.429 179.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.582 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 1.8 ptpt -64.07 -36.18 83.17 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.789 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.517 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 0.0 OUTLIER -82.19 -50.15 9.33 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.9 0.381 . . . . 0.0 111.269 179.279 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.889 HD12 ' O ' ' A' ' 235' ' ' PRO . 1.5 mt -44.6 -48.77 2.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.252 -179.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . 0.459 ' HG2' ' HB ' ' A' ' 256' ' ' VAL . 22.3 mtp -61.97 -26.51 68.26 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.944 -178.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.45 ' CG ' ' O ' ' A' ' 237' ' ' LYS . 1.1 mt-10 -86.99 -16.73 34.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.826 0.346 . . . . 0.0 111.248 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.487 ' HG2' ' HA ' ' A' ' 239' ' ' ILE . 2.9 mmmt -80.55 118.42 22.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.138 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.456 ' HG2' ' N ' ' A' ' 244' ' ' TYR . 13.8 ttpt -41.9 -81.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.481 ' CD1' ' HG3' ' A' ' 253' ' ' GLU . 12.1 m-85 -114.74 157.15 23.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.407 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' HIS . . . . . 0.767 ' CG ' HD12 ' A' ' 254' ' ' ILE . 24.2 m-70 -113.68 150.23 33.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.241 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . 0.417 ' O ' ' CE2' ' A' ' 201' ' ' TYR . 0.2 OUTLIER -127.85 105.35 8.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.859 179.704 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.533 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.7 t -110.35 110.22 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.985 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 45.61 -87.71 0.01 OUTLIER Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.407 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.533 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -106.49 -39.97 5.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.363 0.601 . . . . 0.0 110.546 179.639 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.473 ' OG ' ' HB2' ' A' ' 190' ' ' SER . 1.5 m -77.43 147.42 35.98 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.033 -178.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -143.97 106.24 4.39 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.463 179.162 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' CYS . . . . . 0.68 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -128.21 153.12 47.27 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -176.541 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . 0.481 ' HG3' ' CD1' ' A' ' 244' ' ' TYR . 50.1 tt0 -76.29 107.57 8.62 Favored 'General case' 0 C--O 1.224 -0.27 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.172 178.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.767 HD12 ' CG ' ' A' ' 245' ' ' HIS . 29.2 mt -96.39 113.3 30.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -177.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.515 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -117.25 133.09 56.4 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 176.677 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 183' ' ' LYS . 5.5 p -33.23 124.94 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-O 122.251 1.024 . . . . 0.0 111.304 -177.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 1.099 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -78.27 152.95 32.24 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 113.423 -1.717 . . . . 0.0 112.48 -178.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.73 113.85 15.86 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.511 -1.222 . . . . 0.0 110.081 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . 0.48 ' HB3' ' O6 ' ' B' ' 4' ' ' ' DG' . 83.6 p . . . . . 0 C--N 1.323 -0.586 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.859 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' ' DT' . . . . . 0.878 ' O2 ' " H2'" ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.427 -0.813 0 C4'-C3'-C2' 102.475 -0.725 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' ' DA' . . . . . 0.699 ' C2 ' ' CD2' ' A' ' 185' ' ' PHE . . . . . . . . 0 O5'--C5' 1.425 -0.947 0 C3'-C2'-C1' 99.718 -2.13 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' ' DG' . . . . . 0.709 ' C2 ' ' CE1' ' A' ' 227' ' ' PHE . . . . . . . . 0 O5'--C5' 1.427 -0.834 0 C4'-C3'-C2' 102.045 -1.155 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' ' DG' . . . . . 0.64 ' N7 ' ' C5 ' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.427 -0.801 0 O4'-C1'-C2' 106.799 0.635 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.485 ' O ' ' HD3' ' A' ' 182' ' ' LYS . 43.5 t . . . . . 0 CA--C 1.505 -0.765 0 CA-C-O 121.362 0.601 . . . . 0.0 112.328 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.549 ' CB ' HG21 ' A' ' 236' ' ' VAL . 8.0 mmtt -145.76 112.38 5.91 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.243 176.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.883 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.0 OUTLIER -130.62 162.45 29.33 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.965 179.775 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.846 HD11 ' HE2' ' A' ' 202' ' ' PHE . 0.3 OUTLIER -138.55 119.74 16.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 177.532 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.854 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -92.52 109.49 20.89 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.587 0.708 . . . . 0.0 110.195 -178.914 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.707 HG12 ' HB2' ' A' ' 252' ' ' CYS . 40.6 t -84.29 128.07 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.894 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.553 ' O ' ' HB3' ' A' ' 252' ' ' CYS . . . -116.5 132.76 10.32 Favored Glycine 0 N--CA 1.451 -0.319 0 N-CA-C 115.053 0.781 . . . . 0.0 115.053 -176.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.621 ' HA3' ' H71' ' B' ' 2' ' ' ' DT' . . . 71.39 80.11 0.36 Allowed Glycine 0 N--CA 1.452 -0.292 0 CA-C-N 115.442 -0.379 . . . . 0.0 113.397 178.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.934 HD13 ' OG1' ' A' ' 193' ' ' THR . 0.8 OUTLIER -117.26 157.57 25.82 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.701 0.286 . . . . 0.0 110.958 -179.796 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.593 ' CB ' ' CD ' ' A' ' 191' ' ' PRO . 0.2 OUTLIER -47.71 -173.66 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.934 179.585 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.593 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 5.7 Cg_exo -78.36 17.09 1.12 Allowed 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.956 2.437 . . . . 0.0 113.272 -179.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.538 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 1.2 m-20 159.73 76.89 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.117 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.635 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.934 ' OG1' HD13 ' A' ' 189' ' ' LEU . 50.1 m -71.45 114.55 28.94 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 120.855 0.36 . . . . 0.0 110.432 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.541 ' C ' HD11 ' A' ' 198' ' ' ILE . 16.3 Cg_endo -58.52 110.05 0.6 Allowed 'Trans proline' 0 N--CA 1.464 -0.243 0 C-N-CA 122.369 2.046 . . . . 0.0 111.748 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.803 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -50.9 -15.69 0.33 Allowed 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.143 -179.875 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . 0.482 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 23.1 mm-40 -71.94 -36.89 70.03 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' A' ' 200' ' ' GLU . 0.0 OUTLIER -73.92 -48.01 33.72 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.186 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.854 ' CD1' HG22 ' A' ' 193' ' ' THR . 0.0 OUTLIER -47.68 -30.73 2.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.225 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.603 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 6.5 mtt180 -71.72 -32.4 67.73 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.189 179.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . 0.53 ' N ' ' O ' ' A' ' 197' ' ' LYS . 0.4 OUTLIER -82.83 -46.19 13.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.023 0.44 . . . . 0.0 110.646 179.292 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.509 ' C ' ' CD1' ' A' ' 201' ' ' TYR . 0.5 OUTLIER -63.04 -53.55 52.11 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.004 179.407 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 1.122 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -79.88 -31.41 40.33 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 114.845 -1.07 . . . . 0.0 110.339 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.603 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -64.85 -54.36 28.7 Favored Glycine 0 CA--C 1.497 -1.071 0 N-CA-C 106.535 -2.626 . . . . 0.0 106.535 176.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -50.23 -29.3 15.54 Favored Glycine 0 N--CA 1.442 -0.928 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 175.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.811 ' CD2' HD11 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -58.34 -44.76 88.86 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 177.783 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 170.55 -129.89 1.89 Allowed Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 113.717 -1.583 . . . . 0.0 110.616 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.474 ' HB3' ' HE2' ' A' ' 231' ' ' LYS . 2.9 mm-40 -97.01 99.69 11.21 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.289 0.566 . . . . 0.0 111.321 178.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.413 HG22 ' CE1' ' A' ' 230' ' ' PHE . 2.6 t -77.5 143.39 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 CA-C-N 115.324 -0.853 . . . . 0.0 108.845 178.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . 0.525 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 5.8 tp10 -93.7 -56.78 2.78 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 4.4 m -166.94 149.92 6.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.959 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.903 HD13 HG23 ' A' ' 228' ' ' ILE . 0.4 OUTLIER -117.19 126.37 74.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.664 178.922 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -123.09 103.07 8.34 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -178.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.574 HD21 ' HB ' ' A' ' 193' ' ' THR . 0.1 OUTLIER -96.3 105.53 22.93 Favored Pre-proline 0 C--N 1.33 -0.241 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 177.917 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.52 ' HD2' ' O ' ' A' ' 225' ' ' PHE . 73.0 Cg_endo -75.31 127.44 10.47 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.75 2.3 . . . . 0.0 112.813 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.25 131.21 36.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.972 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.421 ' O ' ' OD1' ' A' ' 220' ' ' ASN . 0.3 OUTLIER -114.78 106.9 14.74 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.942 0.401 . . . . 0.0 110.945 179.931 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -82.02 -10.76 59.13 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.519 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.34 -50.89 9.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.867 0.365 . . . . 0.0 111.28 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.89 -30.17 5.12 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.171 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . 0.421 ' OD1' ' O ' ' A' ' 216' ' ' ASP . 39.6 m-20 62.47 71.72 0.52 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.956 0.407 . . . . 0.0 110.52 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.66 176.56 1.9 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.217 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.625 ' CD ' ' O ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -94.16 27.34 2.9 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 122.432 1.11 . . . . 0.0 110.104 179.993 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.572 ' O ' ' CD1' ' A' ' 225' ' ' PHE . 4.2 ptp85 -70.99 -28.47 64.45 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.528 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . -1.08 68.89 0.0 OUTLIER Glycine 0 C--N 1.343 0.93 0 O-C-N 124.611 1.194 . . . . 0.0 112.701 178.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.911 ' C ' HD23 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -156.79 176.7 12.39 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -178.339 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . 0.516 ' O ' ' HB ' ' A' ' 186' ' ' VAL . 1.3 p -139.48 156.32 47.01 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.016 -0.674 . . . . 0.0 112.544 -179.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 1.072 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 3.8 m-85 -113.95 133.44 55.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.495 -0.775 . . . . 0.0 108.965 178.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 1.122 HD12 ' CE2' ' A' ' 202' ' ' PHE . 2.0 mt -128.55 133.26 66.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.142 0.496 . . . . 0.0 111.475 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.457 HG22 ' HB3' ' A' ' 209' ' ' GLU . 97.7 m -113.03 138.05 50.48 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.155 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.817 ' HE2' HD13 ' A' ' 184' ' ' ILE . 67.9 m-85 -112.8 126.44 55.43 Favored 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.053 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.525 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -50.52 -37.83 41.25 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 177.737 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -90.1 -165.86 1.45 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 113.152 -1.84 . . . . 0.0 109.691 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . 0.528 ' HB2' ' HD2' ' A' ' 182' ' ' LYS . 0.4 OUTLIER -134.64 8.53 3.6 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.667 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.548 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.3 OUTLIER -82.14 -59.92 0.41 Allowed Pre-proline 0 C--N 1.328 -0.369 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.755 179.939 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.911 ' O ' HD12 ' A' ' 239' ' ' ILE . 80.2 Cg_exo -49.48 -30.91 22.27 Favored 'Trans proline' 0 CA--C 1.499 -1.27 0 N-CA-C 108.986 -1.198 . . . . 0.0 108.986 178.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.549 HG21 ' CB ' ' A' ' 182' ' ' LYS . 21.1 t -73.92 -45.69 48.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 114.473 -1.239 . . . . 0.0 110.272 178.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.548 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 1.2 ptpt -61.74 -36.23 80.38 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.606 -179.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.645 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -82.29 -54.89 4.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.172 178.918 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.911 HD12 ' O ' ' A' ' 235' ' ' PRO . 1.7 mt -40.33 -50.69 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.951 -179.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . 0.472 ' HG2' ' HB ' ' A' ' 256' ' ' VAL . 17.3 mtp -60.06 -24.68 64.76 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.787 -178.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.487 ' CG ' ' O ' ' A' ' 237' ' ' LYS . 1.0 OUTLIER -87.91 -17.08 32.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.798 0.333 . . . . 0.0 111.261 -179.715 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.505 ' HG2' ' HA ' ' A' ' 239' ' ' ILE . 0.1 OUTLIER -79.68 123.77 27.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.352 -179.742 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.456 ' HE3' ' HB2' ' A' ' 244' ' ' TYR . 7.7 ttpt -50.38 -75.53 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 178.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.526 ' CD1' ' HG3' ' A' ' 253' ' ' GLU . 17.3 m-85 -121.02 144.81 48.33 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.932 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' HIS . . . . . 0.866 ' CG ' HD12 ' A' ' 254' ' ' ILE . 30.1 m-70 -104.55 150.63 24.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.096 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . 0.457 ' HB3' ' HD2' ' A' ' 251' ' ' LYS . 0.0 OUTLIER -129.58 104.68 7.59 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.221 0.534 . . . . 0.0 110.493 179.164 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.556 ' O ' ' C ' ' A' ' 248' ' ' GLY . 1.7 t -95.29 170.24 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.737 -179.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . 0.556 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . -8.3 -64.66 0.01 OUTLIER Glycine 0 C--N 1.341 0.825 0 O-C-N 123.669 0.606 . . . . 0.0 113.797 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.467 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -126.0 -39.82 2.07 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.509 0.671 . . . . 0.0 110.501 -179.282 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.663 ' CB ' ' HG1' ' A' ' 193' ' ' THR . 0.2 OUTLIER -77.3 157.33 30.79 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.745 -1.116 . . . . 0.0 112.734 -178.197 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -142.42 107.97 5.07 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.182 179.27 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' CYS . . . . . 0.707 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -128.67 152.96 47.79 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -177.255 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . 0.529 ' N ' ' O ' ' A' ' 187' ' ' GLY . 49.3 tt0 -76.61 108.48 9.64 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.581 179.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.866 HD12 ' CG ' ' A' ' 245' ' ' HIS . 30.6 mt -96.8 113.44 31.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 -178.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.518 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -115.94 133.25 56.22 Favored 'General case' 0 C--O 1.22 -0.448 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 176.508 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.633 HG23 ' O ' ' A' ' 183' ' ' LYS . 2.4 p -33.2 124.51 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-O 122.096 0.95 . . . . 0.0 111.324 -177.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 1.072 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -79.56 151.18 30.82 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 113.633 -1.621 . . . . 0.0 112.37 -178.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.62 115.85 19.41 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.089 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 29.7 p . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.057 -179.676 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' ' DT' . . . . . 0.637 ' O2 ' " H2'" ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.427 -0.803 0 O4'-C1'-C2' 106.874 0.703 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' ' DA' . . . . . 0.588 H5'' ' CE1' ' A' ' 225' ' ' PHE . . . . . . . . 0 O4'--C1' 1.407 -1.021 0 C4'-C3'-C2' 104.755 1.555 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' ' DG' . . . . . 0.958 H2'' " O5'" ' B' ' 5' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.428 -0.772 0 C4'-C3'-C2' 101.929 -1.271 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' ' DG' . . . . . 0.958 " O5'" H2'' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.427 -0.797 0 O4'-C1'-C2' 106.804 0.64 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.507 ' C ' ' CD ' ' A' ' 182' ' ' LYS . 45.3 t . . . . . 0 CA--C 1.503 -0.855 0 CA-C-O 121.044 0.449 . . . . 0.0 111.204 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 1.028 ' HB2' HG21 ' A' ' 236' ' ' VAL . 0.0 OUTLIER -151.14 112.34 4.34 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.103 177.66 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.817 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.0 OUTLIER -135.64 142.6 45.21 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.978 178.863 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.891 HD13 ' HE2' ' A' ' 230' ' ' PHE . 0.4 OUTLIER -122.04 120.91 62.7 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.183 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.787 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -94.14 109.34 21.13 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 121.553 0.692 . . . . 0.0 110.23 -179.195 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.992 HG12 ' HB2' ' A' ' 252' ' ' CYS . 4.9 t -85.03 128.86 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.802 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.564 ' HA2' ' HB2' ' A' ' 225' ' ' PHE . . . -115.6 127.87 7.78 Favored Glycine 0 C--N 1.332 0.316 0 N-CA-C 115.124 0.809 . . . . 0.0 115.124 -176.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.476 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . 76.26 82.04 0.53 Allowed Glycine 0 C--N 1.332 0.312 0 C-N-CA 121.354 -0.45 . . . . 0.0 113.419 178.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.949 HD13 ' OG1' ' A' ' 193' ' ' THR . 1.2 pp -117.43 157.18 26.67 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.778 0.323 . . . . 0.0 111.168 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.653 ' O ' HD12 ' A' ' 189' ' ' LEU . 0.2 OUTLIER -46.67 -177.45 0.01 OUTLIER Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.256 0.551 . . . . 0.0 111.592 -179.927 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.574 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 19.6 Cg_exo -67.31 -2.73 8.68 Favored 'Trans proline' 0 CA--C 1.53 0.291 0 C-N-CA 123.395 2.73 . . . . 0.0 113.908 -179.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 191' ' ' PRO . 0.8 OUTLIER 171.76 73.0 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.905 0.383 . . . . 0.0 111.667 -179.811 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.949 ' OG1' HD13 ' A' ' 189' ' ' LEU . 93.7 m -61.52 122.32 70.03 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.998 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.497 ' O ' HD11 ' A' ' 198' ' ' ILE . 55.7 Cg_endo -70.09 114.62 3.82 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.157 1.905 . . . . 0.0 111.103 178.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.817 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -51.61 -15.16 0.41 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 121.056 -0.257 . . . . 0.0 111.265 -179.439 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . 0.509 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 4.9 mt-10 -67.91 -40.42 83.41 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.521 ' O ' ' N ' ' A' ' 200' ' ' GLU . 0.4 OUTLIER -70.71 -50.95 30.92 Favored 'General case' 0 CA--C 1.5 -0.98 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.222 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.824 ' HB ' HD12 ' A' ' 211' ' ' ILE . 0.0 OUTLIER -47.59 -32.43 2.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 115.297 -0.865 . . . . 0.0 108.751 178.717 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.572 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 16.7 mtt85 -69.92 -33.4 72.12 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.975 178.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . 0.521 ' N ' ' O ' ' A' ' 197' ' ' LYS . 8.5 mm-40 -81.87 -60.13 2.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.278 0.561 . . . . 0.0 109.928 179.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.495 ' C ' ' CD1' ' A' ' 201' ' ' TYR . 0.3 OUTLIER -49.31 -54.19 18.29 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.025 178.932 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 1.104 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.2 OUTLIER -79.74 -31.5 41.04 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.991 -179.589 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.572 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -63.77 -56.47 18.81 Favored Glycine 0 CA--C 1.499 -0.95 0 N-CA-C 107.037 -2.425 . . . . 0.0 107.037 176.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -49.4 -28.44 9.47 Favored Glycine 0 N--CA 1.442 -0.937 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 176.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.771 ' CE2' HG13 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -57.19 -48.56 78.45 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 177.769 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 175.62 -130.15 1.67 Allowed Glycine 0 N--CA 1.44 -1.078 0 CA-C-N 113.65 -1.614 . . . . 0.0 110.31 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.505 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 20.7 mm-40 -96.96 100.96 12.45 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.144 0.497 . . . . 0.0 110.861 178.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.461 HG22 ' CE1' ' A' ' 230' ' ' PHE . 2.8 t -77.93 141.37 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . 0.588 ' HB3' HG22 ' A' ' 229' ' ' THR . 5.8 tp10 -91.9 -55.7 3.36 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 8.0 m -167.69 148.78 5.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.874 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.882 HD13 HG23 ' A' ' 228' ' ' ILE . 0.4 OUTLIER -115.72 125.67 72.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.882 178.931 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.519 ' O ' ' HD3' ' A' ' 214' ' ' PRO . 0.0 OUTLIER -123.28 105.01 9.49 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.334 -178.753 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.47 HD22 ' HB ' ' A' ' 193' ' ' THR . 0.1 OUTLIER -96.39 105.41 22.33 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-O 120.841 0.353 . . . . 0.0 110.822 178.55 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.578 ' HD2' ' O ' ' A' ' 225' ' ' PHE . 84.4 Cg_exo -49.72 -156.59 0.0 OUTLIER 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 123.444 2.762 . . . . 0.0 113.977 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.428 ' HB3' ' HB2' ' A' ' 220' ' ' ASN . 15.4 mmt -96.91 173.61 7.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.237 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.403 ' O ' ' N ' ' A' ' 220' ' ' ASN . 0.4 OUTLIER -112.01 149.98 31.26 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.341 -179.701 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . 0.578 ' N ' ' O ' ' A' ' 221' ' ' LYS . 13.6 t30 -56.97 -16.24 6.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.145 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.17 -27.08 69.12 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.155 0.502 . . . . 0.0 110.048 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 9.9 t -145.29 11.24 1.31 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.958 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . 0.49 ' HB3' ' NH1' ' A' ' 223' ' ' ARG . 3.6 m120 -148.8 -87.82 0.08 Allowed 'General case' 0 C--O 1.231 0.112 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . 0.578 ' O ' ' N ' ' A' ' 217' ' ' ASN . 34.7 mtpt -153.64 175.33 13.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.713 0.292 . . . . 0.0 111.299 -179.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.636 ' O ' ' CG ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -88.13 41.94 1.03 Allowed 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 122.928 1.347 . . . . 0.0 109.678 179.461 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.619 ' HB2' ' CE1' ' A' ' 225' ' ' PHE . 3.7 ptp85 -71.51 -31.12 66.73 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.491 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 16.57 61.26 0.01 OUTLIER Glycine 0 C--N 1.335 0.504 0 CA-C-N 114.43 -1.259 . . . . 0.0 112.922 178.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.88 ' C ' HD23 ' A' ' 189' ' ' LEU . 1.5 p90 -156.79 176.47 12.69 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . 0.469 ' O ' ' HB ' ' A' ' 186' ' ' VAL . 27.7 p -146.0 152.22 39.02 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 1.11 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 6.1 m-85 -106.21 139.43 40.74 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.082 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 1.104 HD12 ' CE2' ' A' ' 202' ' ' PHE . 2.0 mt -133.58 129.84 56.01 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.386 0 CA-C-O 120.879 0.371 . . . . 0.0 110.985 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.588 HG22 ' HB3' ' A' ' 209' ' ' GLU . 53.5 m -111.17 138.22 47.88 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.897 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.891 ' HE2' HD13 ' A' ' 184' ' ' ILE . 81.4 m-85 -114.51 126.44 54.94 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.445 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.505 ' HG3' ' O ' ' A' ' 207' ' ' GLU . 0.0 OUTLIER -47.77 -39.63 18.49 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 178.134 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . 0.479 ' O ' ' HG3' ' A' ' 182' ' ' LYS . 5.9 mm-40 -99.29 171.29 8.08 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 113.452 -1.704 . . . . 0.0 109.684 179.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . 0.44 ' HB3' ' CE ' ' A' ' 182' ' ' LYS . 0.0 OUTLIER -110.21 21.07 17.17 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.307 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.562 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.0 OUTLIER -85.18 -62.16 0.26 Allowed Pre-proline 0 C--N 1.331 -0.221 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.699 179.619 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.916 ' O ' HD12 ' A' ' 239' ' ' ILE . 87.3 Cg_exo -50.37 -29.69 24.54 Favored 'Trans proline' 0 CA--C 1.502 -1.101 0 N-CA-C 108.811 -1.265 . . . . 0.0 108.811 177.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 1.028 HG21 ' HB2' ' A' ' 182' ' ' LYS . 20.9 t -72.66 -42.96 62.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 113.768 -1.56 . . . . 0.0 110.324 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.562 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 9.3 pttp -64.26 -36.41 84.0 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.738 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.541 ' O ' ' CG ' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -81.43 -50.37 9.52 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.16 0.505 . . . . 0.0 110.92 179.183 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.916 HD12 ' O ' ' A' ' 235' ' ' PRO . 1.6 mt -45.53 -53.04 2.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.847 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . 0.582 ' SD ' HG12 ' A' ' 236' ' ' VAL . 11.5 mtp -60.46 -17.1 42.59 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.263 -178.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.541 ' CG ' ' O ' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -88.37 -26.29 22.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.893 0.377 . . . . 0.0 111.0 -179.813 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.516 ' CD ' ' HG3' ' A' ' 241' ' ' GLU . 5.3 mmmt -79.58 109.8 14.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.01 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.483 ' HD3' ' CD1' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -40.18 -62.42 0.75 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.34 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.549 ' CD1' ' HG3' ' A' ' 253' ' ' GLU . 12.9 m-30 -122.01 161.7 22.48 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.897 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' HIS . . . . . 0.78 ' CE1' HD12 ' A' ' 254' ' ' ILE . 20.5 m-70 -122.82 156.76 33.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.822 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . 0.416 ' O ' ' CE2' ' A' ' 201' ' ' TYR . 1.3 m-80 -133.24 105.15 6.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.172 0.511 . . . . 0.0 110.581 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.55 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.5 t -108.52 138.71 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.556 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . 0.479 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . 26.65 -87.57 0.01 OUTLIER Glycine 0 C--N 1.337 0.619 0 C-N-CA 121.163 -0.541 . . . . 0.0 113.017 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.55 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.1 OUTLIER -108.87 -34.63 6.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.774 0.797 . . . . 0.0 109.845 -179.861 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.516 ' O ' ' N ' ' A' ' 247' ' ' VAL . 3.0 p -77.25 152.92 34.46 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.248 -1.342 . . . . 0.0 113.176 -177.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -143.31 104.66 4.29 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 114.739 -1.118 . . . . 0.0 108.361 178.464 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' CYS . . . . . 0.992 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -128.34 152.77 47.76 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -176.399 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . 0.549 ' HG3' ' CD1' ' A' ' 244' ' ' TYR . 50.7 tt0 -76.93 107.79 9.52 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.982 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.854 HG12 HG13 ' A' ' 186' ' ' VAL . 26.1 mt -96.46 112.84 29.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -178.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.53 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -115.02 130.98 57.06 Favored 'General case' 0 C--O 1.221 -0.41 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 176.418 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.675 HG23 ' O ' ' A' ' 183' ' ' LYS . 10.0 p -33.16 124.46 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 122.156 0.979 . . . . 0.0 111.475 -177.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 1.11 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -76.68 153.93 34.68 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 113.501 -1.681 . . . . 0.0 111.448 -178.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.1 111.82 13.9 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.046 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . 0.457 ' HB2' ' HD2' ' A' ' 183' ' ' LYS . 0.2 OUTLIER . . . . . 0 C--N 1.325 -0.459 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.7 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' ' DT' . . . . . 0.548 " C5'" ' O2 ' ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.427 -0.843 0 O4'-C1'-C2' 107.344 1.131 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' ' DA' . . . . . 0.88 " H4'" " O5'" ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.426 -0.857 0 C5'-C4'-O4' 108.419 -0.613 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' ' DG' . . . . . 0.89 H2'' " O5'" ' B' ' 5' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.426 -0.878 0 C4'-C3'-C2' 101.949 -1.251 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' ' DG' . . . . . 0.89 " O5'" H2'' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.426 -0.847 0 O4'-C1'-C2' 107.089 0.899 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.501 ' CG1' ' N ' ' A' ' 182' ' ' LYS . 40.6 t . . . . . 0 CA--C 1.506 -0.745 0 CA-C-O 121.261 0.553 . . . . 0.0 111.77 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.685 ' CB ' HG21 ' A' ' 236' ' ' VAL . 0.2 OUTLIER -148.02 112.5 5.31 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.029 177.442 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.863 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -130.5 145.45 51.86 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.382 179.271 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.873 HD13 ' HE2' ' A' ' 230' ' ' PHE . 0.3 OUTLIER -125.35 120.43 57.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.113 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.844 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -93.86 109.22 20.93 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.475 -178.875 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.995 HG12 ' HB2' ' A' ' 252' ' ' CYS . 2.8 t -84.44 124.65 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.196 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.551 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . -112.07 126.69 7.73 Favored Glycine 0 N--CA 1.451 -0.337 0 N-CA-C 114.932 0.733 . . . . 0.0 114.932 -176.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.464 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . 76.69 84.05 0.47 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 121.418 -0.42 . . . . 0.0 113.286 178.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.951 HD23 ' C ' ' A' ' 225' ' ' PHE . 0.9 OUTLIER -117.07 157.01 26.58 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.657 0.265 . . . . 0.0 110.788 179.843 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.655 ' O ' HD12 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -46.72 -175.15 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.061 179.818 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.586 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 4.0 Cg_exo -79.79 17.76 1.24 Allowed 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 123.024 2.483 . . . . 0.0 112.949 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.494 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 1.0 OUTLIER 161.86 74.72 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.126 0 CA-C-O 120.621 0.248 . . . . 0.0 111.363 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.933 ' OG1' HD13 ' A' ' 189' ' ' LEU . 55.2 m -74.59 112.86 19.27 Favored Pre-proline 0 C--N 1.332 -0.169 0 CA-C-O 120.912 0.387 . . . . 0.0 110.919 179.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.548 ' HG2' ' CG ' ' A' ' 197' ' ' LYS . 26.6 Cg_endo -62.65 109.03 0.8 Allowed 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 122.3 2.0 . . . . 0.0 111.485 179.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.851 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -48.0 -15.4 0.06 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 111.849 0.314 . . . . 0.0 111.849 -179.658 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 6.8 mm-40 -65.98 -37.06 84.99 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.548 ' CG ' ' HG2' ' A' ' 194' ' ' PRO . 0.8 OUTLIER -75.54 -50.95 14.08 Favored 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.258 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.851 ' CG1' ' HA ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -46.63 -31.19 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.314 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.552 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 5.2 mtp85 -70.16 -35.31 73.92 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.523 178.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . 0.513 ' N ' ' O ' ' A' ' 197' ' ' LYS . 12.1 mm-40 -82.4 -58.63 2.84 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.275 0.559 . . . . 0.0 110.233 179.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.497 ' C ' ' CD1' ' A' ' 201' ' ' TYR . 0.4 OUTLIER -48.28 -53.45 17.21 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.677 179.144 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 1.136 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.2 OUTLIER -79.78 -31.17 40.82 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.177 179.688 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.552 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -60.2 -57.88 16.92 Favored Glycine 0 CA--C 1.499 -0.91 0 N-CA-C 107.221 -2.352 . . . . 0.0 107.221 176.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -50.15 -27.65 11.32 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 176.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.814 ' CD2' HD11 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -58.24 -44.13 88.14 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 122.158 0.98 . . . . 0.0 108.383 178.003 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 169.49 -130.5 2.06 Favored Glycine 0 N--CA 1.442 -0.926 0 CA-C-N 113.465 -1.698 . . . . 0.0 110.26 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.5 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 46.1 mm-40 -96.72 101.64 13.28 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.258 0.551 . . . . 0.0 110.973 178.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.424 HG21 ' HB2' ' A' ' 202' ' ' PHE . 3.0 t -79.45 136.77 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 CA-C-N 115.25 -0.886 . . . . 0.0 108.814 178.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . 0.65 ' HB3' HG22 ' A' ' 229' ' ' THR . 6.1 tp10 -88.45 -56.56 3.26 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 3.4 m -166.29 150.37 7.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.342 0.591 . . . . 0.0 112.436 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.904 HD13 HG23 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -118.38 126.45 75.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.466 178.593 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.476 ' O ' ' HD3' ' A' ' 214' ' ' PRO . 0.5 OUTLIER -123.24 102.86 8.18 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -178.905 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.508 HD23 ' HB3' ' A' ' 226' ' ' CYS . 0.0 OUTLIER -97.18 105.13 22.5 Favored Pre-proline 0 C--N 1.33 -0.257 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 177.809 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.568 ' HD2' ' O ' ' A' ' 225' ' ' PHE . 6.3 Cg_exo -76.88 139.93 20.02 Favored 'Trans proline' 0 N--CA 1.465 -0.193 0 C-N-CA 123.022 2.481 . . . . 0.0 112.884 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.82 130.73 40.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.229 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.467 ' OD2' ' HD3' ' A' ' 223' ' ' ARG . 0.7 OUTLIER -101.31 106.62 17.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.838 0.352 . . . . 0.0 111.132 -179.716 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -83.14 -21.31 33.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.366 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 7.4 mttm -66.02 -51.99 53.25 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.44 -179.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.448 ' O ' ' O ' ' A' ' 220' ' ' ASN . 11.9 t -150.24 14.88 0.8 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.199 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . 0.455 ' OD1' ' O ' ' A' ' 216' ' ' ASP . 2.5 m120 37.7 96.76 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.241 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . 0.514 ' HB3' ' HG2' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -78.13 174.22 11.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.415 179.407 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.6 ' CD ' ' O ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -88.47 16.48 6.43 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 122.197 0.998 . . . . 0.0 109.609 179.242 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.611 ' O ' ' CD1' ' A' ' 225' ' ' PHE . 0.1 OUTLIER -71.71 -11.02 60.62 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.269 178.469 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.481 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . -23.67 82.46 0.0 OUTLIER Glycine 0 C--N 1.346 1.093 0 O-C-N 123.899 0.749 . . . . 0.0 112.232 179.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.951 ' C ' HD23 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -157.47 176.93 12.01 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.024 -0.588 . . . . 0.0 109.986 -177.879 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . 0.508 ' HB3' HD23 ' A' ' 213' ' ' LEU . 1.6 p -138.66 147.43 42.82 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.138 -0.625 . . . . 0.0 112.389 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 1.109 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 4.6 m-85 -107.44 133.49 51.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.161 178.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 1.136 HD12 ' CE2' ' A' ' 202' ' ' PHE . 1.8 mt -128.06 133.0 68.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.13 0.49 . . . . 0.0 111.686 -179.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.65 HG22 ' HB3' ' A' ' 209' ' ' GLU . 40.8 m -113.44 137.99 50.73 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.51 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.873 ' HE2' HD13 ' A' ' 184' ' ' ILE . 75.4 m-85 -113.62 126.3 55.12 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.298 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.5 ' HG3' ' O ' ' A' ' 207' ' ' GLU . 0.3 OUTLIER -47.94 -39.19 18.51 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 178.051 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . 0.44 ' O ' ' HD3' ' A' ' 182' ' ' LYS . 0.0 OUTLIER -91.47 -166.05 1.48 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 113.443 -1.708 . . . . 0.0 110.036 179.119 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . 0.544 ' HB3' ' HG2' ' A' ' 182' ' ' LYS . 0.6 OUTLIER -133.7 13.88 4.04 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.51 -179.92 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.578 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.3 OUTLIER -85.14 -59.52 0.32 Allowed Pre-proline 0 N--CA 1.452 -0.37 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 179.752 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.875 ' O ' HD12 ' A' ' 239' ' ' ILE . 83.4 Cg_exo -49.9 -31.0 25.39 Favored 'Trans proline' 0 CA--C 1.5 -1.214 0 N-CA-C 108.888 -1.235 . . . . 0.0 108.888 177.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.685 HG21 ' CB ' ' A' ' 182' ' ' LYS . 14.7 t -72.74 -45.16 57.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 113.892 -1.504 . . . . 0.0 110.179 179.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.578 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 1.6 ptpt -62.81 -36.36 82.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.721 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.503 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 0.0 OUTLIER -81.62 -50.3 9.49 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.903 0.382 . . . . 0.0 110.92 179.194 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.875 HD12 ' O ' ' A' ' 235' ' ' PRO . 1.6 mt -46.33 -49.84 5.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.54 -179.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . 0.522 ' SD ' HG12 ' A' ' 236' ' ' VAL . 15.4 mtp -60.27 -28.33 67.98 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.877 -178.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.531 ' CG ' ' O ' ' A' ' 237' ' ' LYS . 0.0 OUTLIER -88.67 -9.67 51.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.752 0.31 . . . . 0.0 110.976 -179.927 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.484 ' HG2' ' HA ' ' A' ' 239' ' ' ILE . 4.5 mmmm -79.81 116.19 19.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.363 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.498 ' HG2' ' N ' ' A' ' 244' ' ' TYR . 5.0 ttpt -39.98 -74.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.546 ' CE1' ' HG3' ' A' ' 253' ' ' GLU . 21.6 m-85 -129.09 151.49 49.72 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.399 179.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' HIS . . . . . 0.787 ' CG ' HD12 ' A' ' 254' ' ' ILE . 45.0 m-70 -105.65 149.14 26.61 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.376 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . 0.414 ' ND2' ' N ' ' A' ' 246' ' ' ASN . 0.0 OUTLIER -123.55 105.4 9.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.543 179.503 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.529 HG12 ' HB2' ' A' ' 197' ' ' LYS . 1.8 t -110.05 116.55 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.961 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 41.16 -90.67 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.676 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.511 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.1 OUTLIER -105.03 -35.99 7.46 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.747 0.784 . . . . 0.0 109.914 -179.538 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.477 ' HB3' ' HB2' ' A' ' 190' ' ' SER . 0.8 OUTLIER -77.87 153.61 32.5 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.317 -1.311 . . . . 0.0 112.633 -178.363 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.488 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -148.18 104.81 3.57 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.868 -1.06 . . . . 0.0 108.545 178.942 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' CYS . . . . . 0.995 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -127.59 152.32 47.8 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -177.074 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . 0.546 ' HG3' ' CE1' ' A' ' 244' ' ' TYR . 29.3 tt0 -77.17 110.05 11.54 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.047 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.877 HG12 HG13 ' A' ' 186' ' ' VAL . 25.3 mt -96.52 111.29 26.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 -178.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.514 ' O ' ' C ' ' A' ' 256' ' ' VAL . 0.0 OUTLIER -115.72 132.28 56.68 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 176.439 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.66 HG23 ' O ' ' A' ' 183' ' ' LYS . 5.2 p -32.8 121.78 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 CA-C-O 122.254 1.025 . . . . 0.0 111.356 -177.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 1.109 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -76.54 153.91 35.01 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 113.315 -1.766 . . . . 0.0 111.774 -178.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 2.0 mtm -128.81 113.6 15.49 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.761 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . 0.411 ' HB3' ' HD2' ' A' ' 183' ' ' LYS . 86.9 p . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.537 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' ' DT' . . . . . 0.771 ' O2 ' " H2'" ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.428 -0.766 0 C1'-O4'-C4' 110.27 0.407 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' ' DA' . . . . . 0.576 H5'' ' CE1' ' A' ' 225' ' ' PHE . . . . . . . . 0 O5'--C5' 1.426 -0.899 0 C3'-C2'-C1' 104.965 1.618 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' ' DG' . . . . . 0.671 ' N1 ' ' CZ ' ' A' ' 227' ' ' PHE . . . . . . . . 0 O5'--C5' 1.426 -0.856 0 C4'-C3'-C2' 101.304 -1.896 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' ' DG' . . . . . 0.514 " O5'" H2'' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.426 -0.872 0 O4'-C1'-N19 108.214 0.517 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.527 ' CG1' ' N ' ' A' ' 182' ' ' LYS . 55.6 t . . . . . 0 CA--C 1.502 -0.865 0 CA-C-O 121.377 0.608 . . . . 0.0 111.961 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.75 ' CB ' HG21 ' A' ' 236' ' ' VAL . 0.0 OUTLIER -148.0 112.57 5.33 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.928 177.467 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.852 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -130.96 137.47 49.27 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.382 179.436 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.875 HD13 ' HE2' ' A' ' 230' ' ' PHE . 0.5 OUTLIER -119.67 120.73 64.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.814 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.813 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.3 OUTLIER -94.57 109.56 21.45 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.242 0.544 . . . . 0.0 111.003 -178.597 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 1.087 HG12 ' HB2' ' A' ' 252' ' ' CYS . 2.3 t -87.44 114.11 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.564 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.58 ' HA2' ' HB2' ' A' ' 225' ' ' PHE . . . -101.33 130.35 10.2 Favored Glycine 0 C--O 1.227 -0.288 0 N-CA-C 115.081 0.793 . . . . 0.0 115.081 -177.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.441 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . 78.36 79.73 0.75 Allowed Glycine 0 C--N 1.331 0.271 0 C-N-CA 121.01 -0.614 . . . . 0.0 113.472 178.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.939 HD23 ' C ' ' A' ' 225' ' ' PHE . 0.6 OUTLIER -117.69 157.56 26.26 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.693 0.282 . . . . 0.0 111.016 -179.916 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.587 ' N ' HD12 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -48.5 -173.48 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.792 179.305 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.585 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 5.5 Cg_exo -77.59 15.96 1.16 Allowed 'Trans proline' 0 CA--C 1.531 0.36 0 C-N-CA 122.965 2.444 . . . . 0.0 113.409 -179.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.553 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 0.6 OUTLIER 157.58 78.19 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.667 0.27 . . . . 0.0 111.482 179.84 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.93 ' OG1' HD13 ' A' ' 189' ' ' LEU . 76.1 m -71.89 115.44 38.14 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.095 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.602 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 21.0 Cg_endo -61.02 112.31 1.33 Allowed 'Trans proline' 0 C--N 1.332 -0.325 0 C-N-CA 122.226 1.95 . . . . 0.0 111.519 178.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.804 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -50.63 -14.92 0.22 Allowed 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.872 -179.668 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . 0.484 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 9.3 mm-40 -66.94 -40.32 87.52 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -179.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.602 ' CD ' ' HG2' ' A' ' 194' ' ' PRO . 1.4 mttp -75.29 -46.42 33.61 Favored 'General case' 0 CA--C 1.498 -1.055 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.891 ' CD1' HG22 ' A' ' 193' ' ' THR . 0.0 OUTLIER -47.74 -32.11 2.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.003 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.595 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 9.6 mtp180 -69.48 -33.48 72.94 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.091 178.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . 0.528 ' N ' ' O ' ' A' ' 197' ' ' LYS . 9.3 mm-40 -82.47 -59.06 2.66 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.207 0.527 . . . . 0.0 110.206 178.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.505 ' C ' ' CD1' ' A' ' 201' ' ' TYR . 0.2 OUTLIER -48.76 -54.67 14.07 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.797 179.005 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.965 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.2 OUTLIER -79.57 -30.69 41.74 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.376 -179.864 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.595 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -62.7 -57.1 17.64 Favored Glycine 0 CA--C 1.499 -0.931 0 N-CA-C 107.036 -2.426 . . . . 0.0 107.036 176.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -48.62 -29.33 7.6 Favored Glycine 0 N--CA 1.441 -1.022 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 176.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.805 ' CD2' HD11 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -58.22 -43.45 87.71 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 177.764 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.491 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 169.06 -130.81 2.14 Favored Glycine 0 N--CA 1.441 -1.02 0 CA-C-N 113.725 -1.579 . . . . 0.0 110.423 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.506 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 4.3 mt-10 -96.97 101.31 12.86 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.208 0.528 . . . . 0.0 111.027 178.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.433 HG21 ' HB2' ' A' ' 202' ' ' PHE . 2.9 t -78.77 138.22 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 178.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . 0.502 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 13.7 tp10 -91.46 -57.62 2.71 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.616 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 25.1 p -157.7 154.95 29.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.285 0.565 . . . . 0.0 112.207 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.742 HD12 ' HB ' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -129.64 124.3 59.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.411 179.516 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.53 ' O ' ' HD3' ' A' ' 214' ' ' PRO . 0.0 OUTLIER -123.15 112.96 18.34 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -179.093 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.903 HD13 ' HB2' ' A' ' 226' ' ' CYS . 1.7 mm? -96.27 105.16 20.36 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-O 120.836 0.35 . . . . 0.0 111.424 178.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.637 ' HD2' ' O ' ' A' ' 225' ' ' PHE . 65.6 Cg_exo -48.45 -159.99 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 123.672 2.915 . . . . 0.0 113.286 179.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.492 ' SD ' ' ND2' ' A' ' 220' ' ' ASN . 0.0 OUTLIER -107.57 173.32 6.37 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.15 179.861 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -109.14 150.13 28.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.618 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . 0.533 ' N ' ' O ' ' A' ' 221' ' ' LYS . 2.1 t30 -56.77 -14.76 3.64 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.171 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 29.9 mttp -62.79 -27.85 69.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.119 0.485 . . . . 0.0 109.929 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 2.3 t -146.99 13.31 1.13 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.718 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . 0.492 ' ND2' ' SD ' ' A' ' 215' ' ' MET . 6.4 m120 -149.27 -91.75 0.07 Allowed 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 120.751 0.31 . . . . 0.0 111.653 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . 0.535 ' HD2' ' NH2' ' A' ' 223' ' ' ARG . 0.7 OUTLIER -154.18 172.07 18.17 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.27 -179.815 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.651 ' O ' ' CG ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -85.94 39.57 0.81 Allowed 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 122.673 1.225 . . . . 0.0 110.802 -179.431 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.598 ' CB ' H5'' ' B' ' 3' ' ' ' DA' . 8.7 ptp85 -71.46 -31.02 66.69 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 177.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.51 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 16.01 64.18 0.01 OUTLIER Glycine 0 C--N 1.336 0.577 0 CA-C-N 114.501 -1.227 . . . . 0.0 113.052 178.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.939 ' C ' HD23 ' A' ' 189' ' ' LEU . 5.0 p90 -156.42 176.26 12.93 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -179.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . 0.903 ' HB2' HD13 ' A' ' 213' ' ' LEU . 7.2 p -143.87 154.89 43.83 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -179.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 1.137 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 6.1 m-85 -107.14 153.48 22.6 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.138 178.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.965 HD12 ' CE2' ' A' ' 202' ' ' PHE . 2.4 mt -147.87 135.11 13.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.869 0.366 . . . . 0.0 110.841 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.438 ' OG1' ' HG2' ' A' ' 183' ' ' LYS . 92.3 m -117.35 138.41 51.8 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.875 ' HE2' HD13 ' A' ' 184' ' ' ILE . 70.6 m-85 -111.89 126.25 54.9 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.564 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.506 ' HG3' ' O ' ' A' ' 207' ' ' GLU . 0.0 OUTLIER -49.55 -38.78 32.24 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 177.829 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . 0.483 ' O ' ' HD3' ' A' ' 182' ' ' LYS . 22.4 mt-10 -90.41 -171.49 3.1 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 113.276 -1.784 . . . . 0.0 109.019 178.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . 0.539 ' CB ' ' HG2' ' A' ' 182' ' ' LYS . 0.0 OUTLIER -127.47 0.5 6.26 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.55 179.965 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.485 ' O ' ' N ' ' A' ' 237' ' ' LYS . 0.2 OUTLIER -73.45 -57.61 2.63 Favored Pre-proline 0 C--N 1.329 -0.294 0 N-CA-C 112.0 0.371 . . . . 0.0 112.0 -179.075 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.887 ' O ' HD12 ' A' ' 239' ' ' ILE . 99.8 Cg_exo -49.24 -32.97 26.78 Favored 'Trans proline' 0 CA--C 1.498 -1.3 0 C-N-CA 121.124 1.216 . . . . 0.0 108.985 178.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.75 HG21 ' CB ' ' A' ' 182' ' ' LYS . 19.5 t -70.84 -41.62 77.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 113.646 -1.615 . . . . 0.0 109.189 178.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.524 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 23.5 mttm -57.18 -45.27 83.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.83 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.502 ' O ' ' HG3' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -81.03 -50.38 9.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.313 -179.396 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.887 HD12 ' O ' ' A' ' 235' ' ' PRO . 1.4 mt -41.78 -51.42 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.99 -179.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . 0.61 ' SD ' HG12 ' A' ' 236' ' ' VAL . 4.9 mtp -64.23 -19.37 65.32 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.43 -178.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.502 ' HG3' ' O ' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -86.78 -22.1 26.12 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.063 0.458 . . . . 0.0 110.666 -179.916 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -78.49 118.26 20.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.667 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.447 ' HD3' ' CD2' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -48.68 -49.86 35.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.611 179.911 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.528 ' CD1' ' HG3' ' A' ' 253' ' ' GLU . 17.2 m-85 -138.74 163.91 30.96 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.945 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' HIS . . . . . 0.789 ' CE1' HD12 ' A' ' 254' ' ' ILE . 31.6 m-70 -125.07 156.05 38.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.028 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . 0.5 ' HA ' ' HA ' ' A' ' 251' ' ' LYS . 0.0 OUTLIER -137.99 105.08 5.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.093 0.473 . . . . 0.0 110.057 178.768 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.527 ' N ' ' O ' ' A' ' 250' ' ' SER . 1.8 t -103.09 106.7 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.424 -178.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . 0.407 ' HA3' ' HE3' ' A' ' 197' ' ' LYS . . . 54.84 -81.22 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.482 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.527 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -114.38 -39.23 3.88 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.424 0.631 . . . . 0.0 110.346 -179.983 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.527 ' O ' ' N ' ' A' ' 247' ' ' VAL . 0.2 OUTLIER -77.42 153.24 33.82 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.736 -178.952 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 246' ' ' ASN . 0.0 OUTLIER -145.12 108.7 4.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.408 -0.815 . . . . 0.0 108.869 179.143 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' CYS . . . . . 1.087 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -128.3 153.3 47.15 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -176.951 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . 0.56 ' N ' ' O ' ' A' ' 187' ' ' GLY . 39.0 tt0 -76.03 107.22 8.08 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.978 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.861 HG12 HG13 ' A' ' 186' ' ' VAL . 23.5 mt -95.76 113.7 30.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -178.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.519 ' O ' ' C ' ' A' ' 256' ' ' VAL . 0.0 OUTLIER -118.84 133.2 56.0 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 176.608 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 183' ' ' LYS . 6.8 p -33.37 123.8 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 CA-C-O 122.252 1.025 . . . . 0.0 111.294 -177.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 1.137 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -76.01 153.36 36.55 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 113.337 -1.756 . . . . 0.0 111.444 -178.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.33 113.54 15.09 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.52 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.323 -0.559 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.995 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' ' DT' . . . . . 0.896 ' O2 ' " H2'" ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O4'--C1' 1.409 -0.868 0 C3'-C2'-C1' 104.752 1.465 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' ' DA' . . . . . 0.961 " H4'" " O5'" ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.426 -0.9 0 O4'-C1'-C2' 106.721 0.565 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' ' DG' . . . . . 0.961 " O5'" " H4'" ' B' ' 3' ' ' ' DA' . . . . . . . . 0 C4'--C3' 1.52 -0.76 0 C4'-C3'-C2' 101.83 -1.37 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' ' DG' . . . . . 0.713 ' N7 ' ' C5 ' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 C2'--C1' 1.509 -0.828 0 C3'-C2'-C1' 101.461 -0.885 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.505 HG12 ' N ' ' A' ' 182' ' ' LYS . 55.0 t . . . . . 0 CA--C 1.502 -0.871 0 CA-C-O 121.099 0.476 . . . . 0.0 111.356 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 1.103 ' HB2' HG21 ' A' ' 236' ' ' VAL . 0.0 OUTLIER -155.0 112.43 3.37 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.328 177.601 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.817 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -136.68 144.13 43.77 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 115.113 -0.948 . . . . 0.0 109.345 178.84 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.866 HD13 ' HE2' ' A' ' 230' ' ' PHE . 0.2 OUTLIER -123.9 120.07 58.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.827 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.846 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.9 OUTLIER -91.03 109.39 20.63 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.434 0.635 . . . . 0.0 109.748 -179.709 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.954 HG12 ' HB2' ' A' ' 252' ' ' CYS . 4.1 t -88.75 104.9 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.484 -179.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.551 ' O ' ' N ' ' A' ' 253' ' ' GLU . . . -92.82 127.39 8.97 Favored Glycine 0 C--O 1.228 -0.28 0 CA-C-N 115.165 -0.925 . . . . 0.0 115.065 -177.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.619 ' HA3' ' C5 ' ' B' ' 2' ' ' ' DT' . . . 83.29 81.43 0.97 Allowed Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.893 -0.67 . . . . 0.0 113.531 178.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.951 HD23 ' C ' ' A' ' 225' ' ' PHE . 0.6 OUTLIER -117.26 156.96 26.86 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.803 0.335 . . . . 0.0 110.865 179.68 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.591 ' N ' HD12 ' A' ' 189' ' ' LEU . 0.2 OUTLIER -46.52 -178.16 0.01 OUTLIER Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.812 179.811 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.568 ' HD2' ' CB ' ' A' ' 190' ' ' SER . 72.1 Cg_endo -78.79 17.59 1.12 Allowed 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.563 2.175 . . . . 0.0 113.092 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.528 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 0.6 OUTLIER 159.86 66.17 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.497 0.189 . . . . 0.0 111.392 179.749 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.78 ' OG1' HD13 ' A' ' 189' ' ' LEU . 94.9 m -69.8 127.37 92.58 Favored Pre-proline 0 CA--C 1.518 -0.271 0 CA-C-O 120.963 0.411 . . . . 0.0 110.69 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.628 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 71.1 Cg_endo -71.15 109.49 2.58 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.378 2.052 . . . . 0.0 111.146 178.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.806 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -48.29 -14.07 0.05 Allowed 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -179.77 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . 0.524 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 2.9 mt-10 -67.44 -41.05 85.37 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.628 ' CD ' ' HG2' ' A' ' 194' ' ' PRO . 1.6 mttp -73.22 -46.87 47.84 Favored 'General case' 0 CA--C 1.503 -0.854 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.806 ' CG1' ' HA ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -47.5 -29.94 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.978 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 177.947 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.544 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 7.5 mtt180 -72.96 -32.69 65.38 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.294 178.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . 0.572 ' CG ' ' N ' ' A' ' 201' ' ' TYR . 3.6 pt-20 -83.0 -55.35 4.43 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.01 0.433 . . . . 0.0 110.337 179.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.572 ' N ' ' CG ' ' A' ' 200' ' ' GLU . 0.3 OUTLIER -50.01 -53.31 27.54 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.575 0.702 . . . . 0.0 109.511 178.761 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 1.132 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -79.64 -30.91 41.47 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.2 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.544 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -62.41 -56.72 20.14 Favored Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 107.048 -2.421 . . . . 0.0 107.048 176.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -50.67 -28.13 14.79 Favored Glycine 0 N--CA 1.443 -0.895 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 176.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.809 ' CD2' HD11 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -58.48 -43.9 89.13 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 177.805 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.502 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 170.69 -131.5 2.24 Favored Glycine 0 N--CA 1.441 -1.007 0 CA-C-N 113.615 -1.629 . . . . 0.0 110.271 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.513 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 2.1 mm-40 -97.1 100.82 12.3 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.238 0.542 . . . . 0.0 110.946 178.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.469 HG21 ' HB2' ' A' ' 202' ' ' PHE . 2.5 t -78.69 140.5 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.13 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.011 178.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . 0.718 ' HB3' HG22 ' A' ' 229' ' ' THR . 7.4 tp10 -89.53 -53.49 4.51 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 178.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.481 ' HB3' ' OE2' ' A' ' 212' ' ' GLU . 0.4 OUTLIER -170.89 156.69 5.09 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.451 179.256 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 1.022 HD13 HG23 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -125.1 117.28 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.611 179.375 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.556 ' C ' HD23 ' A' ' 213' ' ' LEU . 0.5 OUTLIER -123.5 104.43 9.06 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -179.422 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.987 HD22 ' CB ' ' A' ' 226' ' ' CYS . 0.1 OUTLIER -96.73 106.1 27.92 Favored Pre-proline 0 CA--C 1.533 0.31 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 179.207 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.593 ' CB ' " C4'" ' B' ' 4' ' ' ' DG' . 4.7 Cg_exo -79.65 135.28 11.47 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.121 2.548 . . . . 0.0 112.535 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 70.3 mtm -135.36 133.55 38.86 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.904 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.505 ' OD2' ' CG2' ' A' ' 219' ' ' THR . 0.7 OUTLIER -115.32 105.71 13.18 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.907 0.384 . . . . 0.0 110.936 179.781 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -84.73 -22.18 29.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.949 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 6.6 mttt -90.47 -51.7 5.28 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.505 ' CG2' ' OD2' ' A' ' 216' ' ' ASP . 3.4 t -90.78 -13.43 33.96 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -178.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . 0.411 ' C ' ' O ' ' A' ' 219' ' ' THR . 89.7 m-20 38.06 66.29 0.5 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.787 0.327 . . . . 0.0 110.812 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . 0.549 ' CD ' ' HB3' ' A' ' 223' ' ' ARG . 0.2 OUTLIER -95.01 31.45 1.87 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.032 0.444 . . . . 0.0 110.753 179.931 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.42 ' HD2' ' HA ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER 44.85 36.28 1.81 Allowed 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.179 -179.415 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.559 ' CD ' ' OP2' ' B' ' 5' ' ' ' DG' . 0.2 OUTLIER -87.83 17.33 4.9 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.684 178.794 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.485 ' O ' ' HG ' ' A' ' 189' ' ' LEU . . . -67.25 61.32 0.25 Allowed Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 178.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.951 ' C ' HD23 ' A' ' 189' ' ' LEU . 15.9 p90 -135.75 177.2 8.01 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -178.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . 0.987 ' CB ' HD22 ' A' ' 213' ' ' LEU . 1.5 p -135.9 149.69 49.07 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -178.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 1.117 ' CE1' ' HB1' ' A' ' 257' ' ' ALA . 3.9 m-85 -106.08 132.58 51.98 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 1.132 HD12 ' CE2' ' A' ' 202' ' ' PHE . 1.8 mt -128.61 118.54 47.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.292 0.567 . . . . 0.0 111.472 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.718 HG22 ' HB3' ' A' ' 209' ' ' GLU . 22.1 m -101.58 138.03 39.12 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.562 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.866 ' HE2' HD13 ' A' ' 184' ' ' ILE . 74.4 m-85 -114.87 126.46 54.83 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.095 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.513 ' HG3' ' O ' ' A' ' 207' ' ' GLU . 0.0 OUTLIER -48.17 -39.13 19.87 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 177.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . 0.485 ' O ' ' HG3' ' A' ' 182' ' ' LYS . 3.1 mt-10 -98.81 165.22 11.88 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 113.413 -1.721 . . . . 0.0 109.478 178.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . 0.458 ' HB3' ' CD ' ' A' ' 182' ' ' LYS . 0.9 OUTLIER -106.14 19.64 20.21 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -179.393 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.548 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.7 OUTLIER -85.34 -61.44 0.27 Allowed Pre-proline 0 C--N 1.334 -0.086 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.955 179.67 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.888 ' O ' HD12 ' A' ' 239' ' ' ILE . 85.5 Cg_exo -49.51 -29.53 18.85 Favored 'Trans proline' 0 CA--C 1.499 -1.256 0 N-CA-C 108.88 -1.238 . . . . 0.0 108.88 177.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 1.103 HG21 ' HB2' ' A' ' 182' ' ' LYS . 12.9 t -73.31 -46.15 50.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 113.786 -1.552 . . . . 0.0 110.719 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.548 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 13.6 pttt -59.94 -37.18 78.8 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.42 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.624 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.6 OUTLIER -80.75 -56.1 4.37 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.201 0.524 . . . . 0.0 110.753 178.858 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.888 HD12 ' O ' ' A' ' 235' ' ' PRO . 1.6 mt -39.28 -47.74 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.605 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . 0.51 ' SD ' HG12 ' A' ' 236' ' ' VAL . 3.8 mtp -62.63 -27.7 69.39 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.782 -178.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.479 ' CG ' ' O ' ' A' ' 237' ' ' LYS . 1.8 mt-10 -83.41 -24.92 31.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.631 0.253 . . . . 0.0 111.553 -179.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.575 ' HD3' ' CE1' ' A' ' 245' ' ' HIS . 0.8 OUTLIER -79.22 109.31 13.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.019 0.437 . . . . 0.0 111.118 -179.461 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.504 ' HD2' ' CE2' ' A' ' 244' ' ' TYR . 0.6 OUTLIER -35.49 -61.19 0.46 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.094 -179.747 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.551 ' CE1' ' HG3' ' A' ' 253' ' ' GLU . 44.5 m-85 -129.28 167.72 17.28 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.583 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' HIS . . . . . 0.778 ' CG ' HD12 ' A' ' 254' ' ' ILE . 38.1 m-70 -128.47 153.36 47.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.758 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -127.93 105.57 8.51 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.001 0.429 . . . . 0.0 111.031 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.58 HG11 HG23 ' A' ' 198' ' ' ILE . 1.5 t -106.36 107.91 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.241 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 44.06 -86.67 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.582 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -101.41 -41.37 6.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.256 0.55 . . . . 0.0 110.829 179.75 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.504 ' HB3' ' HB2' ' A' ' 190' ' ' SER . 5.2 p -78.34 155.79 29.9 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.363 -0.835 . . . . 0.0 113.096 -178.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.508 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.1 OUTLIER -147.47 105.86 3.78 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 114.365 -1.288 . . . . 0.0 107.868 178.473 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' CYS . . . . . 0.954 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -127.52 153.32 46.49 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -176.199 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . 0.551 ' N ' ' O ' ' A' ' 187' ' ' GLY . 40.6 tt0 -76.21 107.03 8.16 Favored 'General case' 0 C--O 1.22 -0.464 0 CA-C-N 114.832 -1.076 . . . . 0.0 110.607 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.835 HG12 HG13 ' A' ' 186' ' ' VAL . 22.2 mt -95.62 111.85 26.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -178.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.537 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -116.42 130.24 56.65 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 113.349 -1.751 . . . . 0.0 106.327 177.035 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 183' ' ' LYS . 4.2 p -32.75 123.01 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.488 0 CA-C-O 122.265 1.031 . . . . 0.0 111.341 -177.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 1.117 ' HB1' ' CE1' ' A' ' 227' ' ' PHE . . . -76.31 153.98 35.44 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 113.39 -1.732 . . . . 0.0 110.974 -178.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.56 113.4 14.19 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.717 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . 0.483 ' OG ' ' O6 ' ' B' ' 4' ' ' ' DG' . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.504 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.854 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' ' DT' . . . . . 0.626 ' O2 ' " H2'" ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.427 -0.82 0 C1'-O4'-C4' 110.625 0.66 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' ' DA' . . . . . 0.983 " H4'" " O5'" ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.424 -0.996 0 C3'-C2'-C1' 101.132 -1.12 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' ' DG' . . . . . 0.983 " O5'" " H4'" ' B' ' 3' ' ' ' DA' . . . . . . . . 0 O5'--C5' 1.427 -0.82 0 C4'-C3'-C2' 101.323 -1.877 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' ' DG' . . . . . 0.661 ' N7 ' ' C8 ' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.428 -0.773 0 O4'-C1'-C2' 106.847 0.679 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.501 ' CG1' ' N ' ' A' ' 182' ' ' LYS . 47.4 t . . . . . 0 CA--C 1.504 -0.808 0 CA-C-O 121.338 0.59 . . . . 0.0 111.608 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.696 ' CB ' HG21 ' A' ' 236' ' ' VAL . 0.0 OUTLIER -149.98 112.54 4.74 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.934 177.452 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.815 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.0 OUTLIER -133.21 141.78 48.25 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.444 179.254 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.816 HD12 HG21 ' A' ' 239' ' ' ILE . 0.5 OUTLIER -120.8 120.63 63.01 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 178.735 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.841 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -93.35 109.32 20.87 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.29 0.567 . . . . 0.0 110.327 -179.172 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.879 HG12 ' HB2' ' A' ' 252' ' ' CYS . 11.7 t -85.9 120.0 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.753 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.55 ' O ' ' N ' ' A' ' 253' ' ' GLU . . . -109.87 131.4 10.45 Favored Glycine 0 C--N 1.331 0.265 0 N-CA-C 115.221 0.849 . . . . 0.0 115.221 -176.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.606 ' HA3' ' C6 ' ' B' ' 2' ' ' ' DT' . . . 76.41 79.44 0.65 Allowed Glycine 0 C--N 1.331 0.255 0 C-N-CA 121.378 -0.439 . . . . 0.0 113.334 178.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.952 HD23 ' CA ' ' A' ' 225' ' ' PHE . 0.6 OUTLIER -117.54 157.48 26.26 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.605 0.241 . . . . 0.0 111.049 -179.776 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.619 ' N ' HD12 ' A' ' 189' ' ' LEU . 0.2 OUTLIER -46.88 -175.3 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.203 0 CA-C-O 121.046 0.45 . . . . 0.0 111.58 179.92 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.597 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 13.2 Cg_exo -70.59 6.35 1.63 Allowed 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 123.319 2.68 . . . . 0.0 113.721 -179.119 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.54 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 3.5 m-20 159.6 78.76 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.153 0.502 . . . . 0.0 110.834 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.911 ' OG1' HD13 ' A' ' 189' ' ' LEU . 52.8 m -71.01 116.0 42.02 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.999 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.603 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 20.5 Cg_endo -58.16 110.54 0.66 Allowed 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.319 2.013 . . . . 0.0 111.127 178.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.804 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.4 OUTLIER -50.77 -14.98 0.23 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.524 -179.56 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . 0.477 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 74.1 mt-10 -65.15 -41.14 95.0 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -179.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.603 ' CD ' ' HG2' ' A' ' 194' ' ' PRO . 1.4 mttp -73.79 -48.07 34.24 Favored 'General case' 0 CA--C 1.498 -1.048 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.855 ' CD1' HG22 ' A' ' 193' ' ' THR . 0.0 OUTLIER -47.69 -31.85 2.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.207 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.547 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 2.3 mtp-105 -69.82 -33.31 72.15 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.083 178.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . 0.514 ' N ' ' O ' ' A' ' 197' ' ' LYS . 7.9 mt-10 -82.49 -58.5 2.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.244 0.545 . . . . 0.0 110.095 178.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.555 ' CD1' ' CD1' ' A' ' 202' ' ' PHE . 0.2 OUTLIER -49.02 -53.54 19.65 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.677 178.895 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 1.094 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.1 OUTLIER -79.74 -31.39 41.02 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.583 -179.787 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.547 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -62.77 -55.25 28.02 Favored Glycine 0 CA--C 1.5 -0.896 0 N-CA-C 107.051 -2.42 . . . . 0.0 107.051 176.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -50.25 -27.6 11.58 Favored Glycine 0 N--CA 1.444 -0.815 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 176.163 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.75 ' CE2' HG13 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -59.2 -47.76 84.14 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 122.137 0.97 . . . . 0.0 108.528 177.984 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.493 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 176.5 -132.29 2.04 Favored Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 113.602 -1.635 . . . . 0.0 110.172 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.489 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 2.2 mt-10 -97.19 99.87 11.35 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.142 0.496 . . . . 0.0 111.128 178.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.464 HG22 ' CE1' ' A' ' 230' ' ' PHE . 2.7 t -76.17 138.71 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . 0.464 ' HB3' HG22 ' A' ' 229' ' ' THR . 3.7 tp10 -92.45 -54.66 3.7 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.062 178.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 3.3 m -161.5 151.92 17.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.248 0.547 . . . . 0.0 112.272 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.691 HD12 ' HB ' ' A' ' 198' ' ' ILE . 0.1 OUTLIER -126.39 119.19 53.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.809 179.037 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.476 ' O ' ' HD3' ' A' ' 214' ' ' PRO . 0.1 OUTLIER -123.46 103.71 8.63 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -177.895 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.773 HD23 ' CB ' ' A' ' 226' ' ' CYS . 0.0 OUTLIER -96.03 105.75 23.72 Favored Pre-proline 0 CA--C 1.531 0.225 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 176.84 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.625 ' HD2' ' O ' ' A' ' 225' ' ' PHE . 5.2 Cg_exo -77.63 131.77 11.63 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 123.041 2.494 . . . . 0.0 112.863 -178.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 2.8 ptm -132.12 130.57 41.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.027 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.482 ' O ' ' HA ' ' A' ' 220' ' ' ASN . 0.5 OUTLIER -110.94 106.73 15.94 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.866 0.365 . . . . 0.0 111.188 -179.577 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -81.9 -6.81 59.41 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.677 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 3.9 mttt -82.71 -48.82 10.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.158 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -127.8 -5.43 5.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.602 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . 0.482 ' HA ' ' O ' ' A' ' 216' ' ' ASP . 17.0 m120 40.58 61.03 1.73 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.823 0.344 . . . . 0.0 110.884 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.25 176.78 0.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.757 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.618 ' O ' ' CG ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -93.78 23.26 4.89 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 122.343 1.068 . . . . 0.0 109.792 179.755 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.589 ' O ' ' CD1' ' A' ' 225' ' ' PHE . 8.8 ptp85 -70.39 -31.64 68.96 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.562 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 0.92 70.92 0.0 OUTLIER Glycine 0 C--N 1.341 0.818 0 O-C-N 124.322 1.013 . . . . 0.0 112.542 178.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.952 ' CA ' HD23 ' A' ' 189' ' ' LEU . 0.5 OUTLIER -156.21 177.06 11.87 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.407 -0.396 . . . . 0.0 110.095 -177.852 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . 0.773 ' CB ' HD23 ' A' ' 213' ' ' LEU . 1.7 p -138.59 155.17 48.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.367 0.603 . . . . 0.0 112.609 -179.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 1.084 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 4.6 m-85 -111.17 133.3 53.63 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.338 178.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 1.094 HD12 ' CE2' ' A' ' 202' ' ' PHE . 2.0 mt -128.33 120.48 53.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.293 0.568 . . . . 0.0 111.679 -179.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.48 ' OG1' ' HG2' ' A' ' 183' ' ' LYS . 73.6 m -103.44 138.1 40.63 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.404 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.809 ' HE2' HD13 ' A' ' 184' ' ' ILE . 82.7 m-85 -114.12 126.59 55.26 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.514 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.489 ' HG3' ' O ' ' A' ' 207' ' ' GLU . 0.0 OUTLIER -49.19 -38.53 26.22 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 177.914 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . 0.451 ' O ' ' HD3' ' A' ' 182' ' ' LYS . 2.0 mm-40 -90.85 -166.79 1.66 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 113.42 -1.718 . . . . 0.0 109.923 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . 0.471 ' CB ' ' HG2' ' A' ' 182' ' ' LYS . 0.6 OUTLIER -132.64 13.09 4.47 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.689 -179.852 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.538 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.8 OUTLIER -85.12 -58.04 0.36 Allowed Pre-proline 0 N--CA 1.451 -0.39 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.609 179.829 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.931 ' O ' HD12 ' A' ' 239' ' ' ILE . 81.4 Cg_exo -50.65 -28.8 23.43 Favored 'Trans proline' 0 CA--C 1.502 -1.116 0 N-CA-C 109.238 -1.101 . . . . 0.0 109.238 178.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.696 HG21 ' CB ' ' A' ' 182' ' ' LYS . 13.9 t -73.14 -44.05 56.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 113.795 -1.548 . . . . 0.0 109.978 178.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.542 ' HG2' ' HD2' ' A' ' 238' ' ' LYS . 0.5 OUTLIER -67.95 -30.25 69.5 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.301 179.538 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.542 ' HD2' ' HG2' ' A' ' 237' ' ' LYS . 0.6 OUTLIER -78.74 -54.34 6.2 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.766 0.793 . . . . 0.0 110.369 179.36 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.931 HD12 ' O ' ' A' ' 235' ' ' PRO . 1.9 mt -51.67 -49.65 33.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 114.357 -1.292 . . . . 0.0 112.645 -178.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . 0.528 ' SD ' HG12 ' A' ' 236' ' ' VAL . 8.1 mtp -59.35 -17.69 31.91 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.598 -178.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.541 ' CG ' ' O ' ' A' ' 237' ' ' LYS . 0.1 OUTLIER -84.25 -40.66 17.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.084 179.952 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.454 ' O ' ' C ' ' A' ' 243' ' ' LYS . 0.0 OUTLIER -80.3 87.15 5.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.722 179.898 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.56 ' N ' ' HD3' ' A' ' 243' ' ' LYS . 0.0 OUTLIER -31.48 -46.48 0.1 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.907 179.757 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.572 ' CE1' ' HG3' ' A' ' 253' ' ' GLU . 18.9 m-85 -120.62 148.94 43.23 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.799 -179.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' HIS . . . . . 0.875 ' CG ' HD12 ' A' ' 254' ' ' ILE . 24.7 m-70 -122.97 157.75 31.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.278 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . 0.404 ' O ' ' CE2' ' A' ' 201' ' ' TYR . 0.0 OUTLIER -129.54 104.8 7.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.114 178.815 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.575 HG11 HG23 ' A' ' 198' ' ' ILE . 1.6 t -106.89 111.02 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.069 -179.378 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 48.0 -86.48 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.248 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.525 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.1 OUTLIER -108.57 -39.56 5.36 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.436 0.636 . . . . 0.0 110.391 -179.722 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.509 ' HB3' ' HB2' ' A' ' 190' ' ' SER . 0.2 OUTLIER -77.75 154.96 31.52 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.85 -1.068 . . . . 0.0 112.626 -178.3 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.513 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.1 OUTLIER -146.61 108.87 4.45 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.065 178.86 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' CYS . . . . . 0.879 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -128.17 152.79 47.62 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -177.015 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . 0.572 ' HG3' ' CE1' ' A' ' 244' ' ' TYR . 29.6 tt0 -76.44 107.12 8.49 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.523 179.282 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.875 HD12 ' CG ' ' A' ' 245' ' ' HIS . 31.0 mt -96.15 111.07 25.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -178.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.521 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -113.63 133.36 55.34 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 176.656 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.537 ' CG2' ' O ' ' A' ' 183' ' ' LYS . 4.1 p -33.55 124.34 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-O 122.207 1.004 . . . . 0.0 111.26 -177.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 1.084 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -77.35 153.25 33.96 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 113.466 -1.697 . . . . 0.0 112.037 -178.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' MET . . . . . 0.441 ' HG3' ' C2 ' ' B' ' 3' ' ' ' DA' . 0.0 OUTLIER -131.18 117.56 19.21 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.298 179.186 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . 0.492 ' OG ' ' O6 ' ' B' ' 4' ' ' ' DG' . 0.1 OUTLIER . . . . . 0 C--N 1.322 -0.624 0 CA-C-O 121.254 0.55 . . . . 0.0 111.45 -178.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' ' DT' . . . . . 0.881 ' O2 ' " H2'" ' B' ' 2' ' ' ' DT' . . . . . . . . 0 C2'--C1' 1.51 -0.79 0 C4'-C3'-C2' 104.404 1.204 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' ' DA' . . . . . 0.64 ' C8 ' ' OP1' ' B' ' 3' ' ' ' DA' . . . . . . . . 0 O5'--C5' 1.426 -0.873 0 C4'-C3'-C2' 104.231 1.031 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' ' DG' . . . . . 0.944 H2'' " O5'" ' B' ' 5' ' ' ' DG' . . . . . . . . 0 C4'--C3' 1.52 -0.765 0 C4'-C3'-C2' 101.867 -1.333 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' ' DG' . . . . . 0.944 " O5'" H2'' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.427 -0.811 0 O4'-C1'-C2' 106.636 0.487 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.476 ' CG1' ' N ' ' A' ' 182' ' ' LYS . 46.3 t . . . . . 0 CA--C 1.5 -0.949 0 CA-C-O 121.206 0.527 . . . . 0.0 111.422 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.873 ' HB2' HG21 ' A' ' 236' ' ' VAL . 0.1 OUTLIER -150.45 112.02 4.47 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.247 178.0 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.874 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -133.73 144.95 49.42 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-N 114.432 -1.258 . . . . 0.0 108.814 178.896 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.916 HD13 ' HE2' ' A' ' 230' ' ' PHE . 1.8 pt -124.37 119.86 57.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 178.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.837 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -93.92 109.02 20.75 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 121.471 0.653 . . . . 0.0 110.687 -178.574 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 1.131 HG12 ' HB2' ' A' ' 252' ' ' CYS . 1.9 t -86.34 126.67 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.135 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.566 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . -113.4 133.99 11.6 Favored Glycine 0 C--N 1.333 0.412 0 N-CA-C 114.313 0.485 . . . . 0.0 114.313 -176.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.538 ' HA3' ' C6 ' ' B' ' 2' ' ' ' DT' . . . 71.41 87.64 0.14 Allowed Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.692 -0.766 . . . . 0.0 111.893 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.938 HD13 ' OG1' ' A' ' 193' ' ' THR . 0.6 OUTLIER -115.86 156.56 25.9 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.026 0.441 . . . . 0.0 111.655 -178.469 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.604 ' CB ' ' CD ' ' A' ' 191' ' ' PRO . 0.3 OUTLIER -49.31 -172.64 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.888 179.77 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.604 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 3.1 Cg_exo -77.21 13.09 1.62 Allowed 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 123.004 2.469 . . . . 0.0 113.182 -179.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.535 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 1.6 p30 157.43 77.24 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 120.758 0.313 . . . . 0.0 111.375 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.938 ' OG1' HD13 ' A' ' 189' ' ' LEU . 16.8 m -70.91 114.24 25.4 Favored Pre-proline 0 CA--C 1.517 -0.309 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.258 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.61 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 97.6 Cg_endo -73.38 109.32 2.82 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.589 2.193 . . . . 0.0 111.211 178.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.606 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.3 OUTLIER -43.9 -19.69 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.831 -0.168 . . . . 0.0 111.447 -179.911 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' A' ' 194' ' ' PRO . 66.6 mt-10 -57.24 -43.14 82.64 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -179.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.61 ' CD ' ' HG2' ' A' ' 194' ' ' PRO . 0.5 OUTLIER -80.36 -47.11 14.96 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 178.619 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.893 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -49.0 -29.68 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 CA-C-N 114.382 -1.281 . . . . 0.0 108.445 176.728 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.565 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 0.0 OUTLIER -73.22 -32.54 64.82 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.656 178.104 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . 0.539 ' N ' ' O ' ' A' ' 197' ' ' LYS . 2.7 mt-10 -82.15 -58.33 3.0 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.642 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.492 ' C ' ' CD1' ' A' ' 201' ' ' TYR . 0.5 OUTLIER -48.43 -53.9 16.11 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.801 179.318 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 1.058 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.4 OUTLIER -79.59 -31.67 41.83 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.36 179.827 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.565 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -61.99 -57.12 18.71 Favored Glycine 0 CA--C 1.498 -1.001 0 N-CA-C 107.563 -2.215 . . . . 0.0 107.563 176.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -51.33 -28.12 18.84 Favored Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 176.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.771 ' CD2' HD11 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -57.07 -44.24 82.88 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.01 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.486 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 170.06 -129.11 1.76 Allowed Glycine 0 N--CA 1.441 -0.992 0 CA-C-N 113.518 -1.674 . . . . 0.0 110.221 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.516 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 21.8 mm-40 -97.16 101.52 13.1 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.153 0.502 . . . . 0.0 111.298 178.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 2.9 t -76.75 137.27 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 177.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . 0.509 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 5.7 tp10 -89.43 -56.58 3.2 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.954 179.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 15.5 m -164.38 149.49 10.11 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.278 0.561 . . . . 0.0 111.921 179.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.493 HD12 ' HB ' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -117.66 126.47 74.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.669 179.078 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.411 ' O ' ' HD3' ' A' ' 214' ' ' PRO . 0.2 OUTLIER -123.18 105.18 9.67 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -178.128 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.752 HD13 ' O ' ' A' ' 193' ' ' THR . 0.3 OUTLIER -96.34 105.85 25.13 Favored Pre-proline 0 C--N 1.33 -0.267 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 177.439 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.523 ' HD2' ' O ' ' A' ' 225' ' ' PHE . 96.0 Cg_endo -79.59 136.28 12.18 Favored 'Trans proline' 0 N--CA 1.464 -0.236 0 C-N-CA 122.746 2.297 . . . . 0.0 113.091 -179.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 25.1 mmm -130.2 135.1 47.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.963 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.522 ' HB2' ' N ' ' A' ' 220' ' ' ASN . 0.0 OUTLIER -113.74 106.5 14.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.224 -179.526 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -83.16 -42.21 17.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.335 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -91.05 -36.17 14.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.688 -179.242 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.436 ' O ' ' N ' ' A' ' 221' ' ' LYS . 0.7 OUTLIER -89.51 -21.95 22.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.841 0.353 . . . . 0.0 110.916 -179.741 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . 0.522 ' N ' ' HB2' ' A' ' 216' ' ' ASP . 0.6 OUTLIER 34.93 34.79 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.157 179.75 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . 0.436 ' N ' ' O ' ' A' ' 219' ' ' THR . 0.0 OUTLIER -57.41 168.28 0.82 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.795 0.331 . . . . 0.0 110.608 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.623 ' O ' ' CG ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -96.92 36.23 1.44 Allowed 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 122.526 1.155 . . . . 0.0 109.981 -179.758 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.536 ' O ' ' C ' ' A' ' 224' ' ' GLY . 8.0 ptp85 -71.87 -24.42 61.67 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.44 178.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.536 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . -2.77 72.17 0.0 OUTLIER Glycine 0 C--N 1.344 1.019 0 O-C-N 124.274 0.984 . . . . 0.0 112.706 179.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.92 ' C ' HD23 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -157.36 177.07 11.86 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -178.403 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . 0.425 ' SG ' ' HB ' ' A' ' 186' ' ' VAL . 6.0 p -139.75 151.35 45.74 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 1.095 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 4.6 m-85 -110.43 133.07 53.62 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.711 178.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 1.058 HD12 ' CE2' ' A' ' 202' ' ' PHE . 2.3 mt -127.68 131.75 69.69 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.342 0 CA-C-O 121.121 0.486 . . . . 0.0 111.245 179.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.482 ' HG1' ' HZ2' ' A' ' 183' ' ' LYS . 87.9 m -111.61 138.23 48.43 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.388 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.916 ' HE2' HD13 ' A' ' 184' ' ' ILE . 62.8 m-85 -112.8 126.29 55.27 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.686 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.516 ' HG3' ' O ' ' A' ' 207' ' ' GLU . 0.0 OUTLIER -50.85 -38.15 47.4 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 177.612 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . 0.511 ' O ' ' HG3' ' A' ' 182' ' ' LYS . 10.1 mt-10 -93.83 178.22 5.74 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 113.051 -1.886 . . . . 0.0 108.951 178.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . 0.547 ' O ' ' HG3' ' A' ' 237' ' ' LYS . 0.7 OUTLIER -117.7 1.98 12.24 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.878 -179.509 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.496 ' O ' ' N ' ' A' ' 237' ' ' LYS . 0.4 OUTLIER -73.06 -58.83 2.38 Favored Pre-proline 0 C--N 1.326 -0.435 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.864 -179.177 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.883 ' O ' HD12 ' A' ' 239' ' ' ILE . 82.2 Cg_exo -48.97 -32.72 23.97 Favored 'Trans proline' 0 CA--C 1.501 -1.134 0 N-CA-C 108.851 -1.25 . . . . 0.0 108.851 178.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.873 HG21 ' HB2' ' A' ' 182' ' ' LYS . 21.3 t -70.57 -42.05 78.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 113.928 -1.487 . . . . 0.0 109.034 178.068 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.547 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 13.5 mtpt -56.43 -45.93 80.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.798 179.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.489 ' HA ' ' HG3' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -81.25 -49.97 10.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.701 -179.163 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.883 HD12 ' O ' ' A' ' 235' ' ' PRO . 1.6 mt -42.74 -50.1 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.427 -178.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . 0.543 ' SD ' HG12 ' A' ' 236' ' ' VAL . 12.2 mtp -62.42 -24.18 67.27 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.695 -178.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.489 ' HG3' ' HA ' ' A' ' 238' ' ' LYS . 0.7 OUTLIER -87.88 -16.66 33.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.534 -179.437 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.456 ' HG2' ' HA ' ' A' ' 239' ' ' ILE . 8.1 mmmt -83.93 116.3 22.72 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.57 -0.287 . . . . 0.0 111.153 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.518 ' HG2' ' N ' ' A' ' 244' ' ' TYR . 1.8 ttpm? -36.77 -80.7 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.082 0.468 . . . . 0.0 110.013 179.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.518 ' N ' ' HG2' ' A' ' 243' ' ' LYS . 10.3 m-85 -113.24 169.43 8.95 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.876 178.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' HIS . . . . . 0.697 ' CG ' HD12 ' A' ' 254' ' ' ILE . 17.0 m-70 -123.46 146.35 48.1 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.784 0.326 . . . . 0.0 110.935 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . 0.441 ' O ' ' CD2' ' A' ' 201' ' ' TYR . 0.2 OUTLIER -122.42 105.47 10.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.042 0.449 . . . . 0.0 110.519 179.595 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.523 HG11 HG23 ' A' ' 198' ' ' ILE . 2.4 t -111.6 102.41 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.824 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 51.2 -90.57 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.321 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.474 HD11 ' OG ' ' A' ' 190' ' ' SER . 0.1 OUTLIER -104.06 -40.36 6.21 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 121.594 0.711 . . . . 0.0 109.957 -179.931 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.57 ' CB ' ' HG1' ' A' ' 193' ' ' THR . 1.4 m -78.61 150.27 32.76 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.604 -1.18 . . . . 0.0 112.165 -178.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.519 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -149.98 107.61 3.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.47 179.36 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' CYS . . . . . 1.131 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -128.19 153.46 46.88 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -177.326 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . 0.542 ' N ' ' O ' ' A' ' 187' ' ' GLY . 71.4 tt0 -75.58 110.87 10.33 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.301 -178.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.964 HG12 HG13 ' A' ' 186' ' ' VAL . 11.5 mt -96.59 112.14 28.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 -178.036 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.526 ' O ' ' C ' ' A' ' 256' ' ' VAL . 0.0 OUTLIER -119.14 131.24 55.86 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 176.009 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.654 HG23 ' O ' ' A' ' 183' ' ' LYS . 6.0 p -32.32 122.58 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.586 0 CA-C-O 122.285 1.04 . . . . 0.0 111.551 -176.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 1.095 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -75.85 152.62 37.2 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 113.366 -1.743 . . . . 0.0 111.614 -178.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.86 110.18 12.33 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.717 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . 0.525 ' HB2' ' HD2' ' A' ' 183' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--N 1.32 -0.677 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.805 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' ' DT' . . . . . 0.915 ' O2 ' " H2'" ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.427 -0.824 0 C3'-C2'-C1' 105.218 1.799 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' ' DA' . . . . . 0.592 " H4'" ' CZ ' ' A' ' 225' ' ' PHE . . . . . . . . 0 C2'--C1' 1.508 -0.924 0 C3'-C2'-C1' 100.272 -1.734 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' ' DG' . . . . . 0.713 ' C2 ' ' CE1' ' A' ' 227' ' ' PHE . . . . . . . . 0 O5'--C5' 1.427 -0.815 0 C4'-C3'-C2' 101.958 -1.242 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' ' DG' . . . . . 0.578 ' N7 ' ' C5 ' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.427 -0.801 0 O4'-C1'-C2' 107.121 0.928 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.416 ' CG1' ' N ' ' A' ' 182' ' ' LYS . 53.0 t . . . . . 0 CA--C 1.5 -0.946 0 CA-C-O 121.184 0.516 . . . . 0.0 111.314 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.963 ' HB2' HG21 ' A' ' 236' ' ' VAL . 0.0 OUTLIER -153.76 111.69 3.55 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.89 177.142 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.806 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -138.25 137.52 37.58 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 114.561 -1.199 . . . . 0.0 108.795 178.953 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.835 HD13 ' HE2' ' A' ' 230' ' ' PHE . 1.1 pt -117.99 120.37 64.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.824 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -94.59 109.77 21.65 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 121.543 0.687 . . . . 0.0 110.196 -179.026 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.692 HG22 ' CD1' ' A' ' 254' ' ' ILE . 45.5 t -84.44 133.89 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.036 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.536 ' O ' ' HB3' ' A' ' 252' ' ' CYS . . . -92.0 -149.74 24.64 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.961 -0.638 . . . . 0.0 114.686 -177.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.477 ' O ' ' HB3' ' A' ' 252' ' ' CYS . . . -33.15 102.31 0.01 OUTLIER Glycine 0 C--N 1.334 0.469 0 CA-C-N 114.971 -0.614 . . . . 0.0 113.564 -179.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 1.026 HD13 ' OG1' ' A' ' 193' ' ' THR . 1.4 pp -117.48 157.89 25.48 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 122.753 0.421 . . . . 0.0 111.186 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.63 ' O ' HD12 ' A' ' 189' ' ' LEU . 0.5 OUTLIER -43.84 -178.9 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.539 179.65 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.535 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 17.4 Cg_exo -67.62 4.05 1.54 Allowed 'Trans proline' 0 CA--C 1.533 0.458 0 C-N-CA 123.185 2.59 . . . . 0.0 114.019 -179.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.526 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 4.3 t0 161.76 76.04 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.896 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 1.026 ' OG1' HD13 ' A' ' 189' ' ' LEU . 17.6 m -64.65 109.78 3.25 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.483 179.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.505 ' HG2' ' HG2' ' A' ' 197' ' ' LYS . 11.5 Cg_endo -56.9 110.23 0.56 Allowed 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.243 1.962 . . . . 0.0 111.215 179.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.787 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.1 OUTLIER -47.23 -16.93 0.05 Allowed 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -179.278 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . 0.462 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 62.6 mt-10 -68.15 -38.05 81.71 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -179.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.505 ' HG2' ' HG2' ' A' ' 194' ' ' PRO . 1.5 mmmm -75.04 -47.78 27.23 Favored 'General case' 0 CA--C 1.5 -0.969 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.901 ' CD1' HG22 ' A' ' 193' ' ' THR . 0.0 OUTLIER -48.1 -30.9 2.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 115.1 -0.955 . . . . 0.0 108.679 178.326 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.579 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 12.9 mtp180 -71.47 -32.09 67.88 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.238 179.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . 0.501 ' N ' ' O ' ' A' ' 197' ' ' LYS . 0.4 OUTLIER -82.51 -45.66 14.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.086 0.469 . . . . 0.0 110.65 179.424 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.504 ' C ' ' CD1' ' A' ' 201' ' ' TYR . 0.2 OUTLIER -63.92 -52.91 57.67 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.006 179.2 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 1.029 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -79.68 -32.57 41.44 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.222 -179.799 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.579 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -64.98 -53.42 34.01 Favored Glycine 0 CA--C 1.498 -1.002 0 N-CA-C 106.579 -2.608 . . . . 0.0 106.579 175.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -51.18 -28.81 19.96 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 176.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.761 ' CE2' HG13 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -57.45 -47.69 81.15 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 122.268 1.033 . . . . 0.0 108.341 177.856 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.481 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 174.04 -129.25 1.6 Allowed Glycine 0 N--CA 1.441 -0.98 0 CA-C-N 113.36 -1.745 . . . . 0.0 110.12 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.518 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 5.0 mm-40 -97.14 100.42 11.9 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.274 0.559 . . . . 0.0 111.424 178.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.408 HG22 ' CE1' ' A' ' 230' ' ' PHE . 2.6 t -76.98 139.47 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.151 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 177.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . 0.765 ' HB3' HG22 ' A' ' 229' ' ' THR . 21.0 tp10 -91.73 -49.84 6.06 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 178.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 9.8 p -166.93 152.84 8.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.187 0.518 . . . . 0.0 112.09 179.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.736 HD12 ' HB ' ' A' ' 198' ' ' ILE . 0.1 OUTLIER -125.43 120.22 57.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.114 178.956 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.501 ' OE1' ' N7 ' ' B' ' 4' ' ' ' DG' . 0.4 OUTLIER -123.63 103.65 8.55 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -178.303 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.528 HD13 ' O ' ' A' ' 193' ' ' THR . 0.0 OUTLIER -95.67 105.78 22.99 Favored Pre-proline 0 C--N 1.332 -0.193 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 177.46 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.569 ' HD2' ' O ' ' A' ' 225' ' ' PHE . 7.0 Cg_exo -75.69 122.29 6.8 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 123.011 2.474 . . . . 0.0 112.968 -179.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 9.5 ptp -128.89 130.81 47.33 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.004 179.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.469 ' O ' ' HA ' ' A' ' 220' ' ' ASN . 2.1 t0 -111.42 106.01 14.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.974 0.416 . . . . 0.0 111.448 -179.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -83.43 -14.0 53.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.518 179.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -78.35 -50.88 10.95 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.435 -179.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.07 -28.46 6.6 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.375 -179.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . 0.469 ' HA ' ' O ' ' A' ' 216' ' ' ASP . 14.1 m-80 62.69 61.16 1.22 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.807 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -65.41 171.91 3.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.541 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.64 ' O ' ' CG ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -95.31 33.33 1.59 Allowed 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 122.684 1.231 . . . . 0.0 110.162 -179.899 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.572 ' HB2' ' CE1' ' A' ' 225' ' ' PHE . 8.1 ptp85 -71.06 -30.38 66.52 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.511 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 8.84 66.56 0.01 OUTLIER Glycine 0 C--N 1.335 0.496 0 CA-C-N 114.658 -1.156 . . . . 0.0 113.405 178.125 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.859 ' CA ' HD23 ' A' ' 189' ' ' LEU . 1.1 p90 -156.13 176.24 12.93 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 -179.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . 0.875 ' SG ' HD22 ' A' ' 189' ' ' LEU . 0.8 OUTLIER -144.46 154.62 43.13 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.439 -0.504 . . . . 0.0 112.137 -179.08 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 1.108 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 6.3 m-85 -108.52 139.91 42.61 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.167 179.289 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 1.029 HD12 ' CE2' ' A' ' 202' ' ' PHE . 2.2 mt -135.51 122.08 33.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.959 0.409 . . . . 0.0 110.923 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.765 HG22 ' HB3' ' A' ' 209' ' ' GLU . 28.8 m -103.33 138.32 40.25 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.674 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.835 ' HE2' HD13 ' A' ' 184' ' ' ILE . 71.4 m-85 -113.34 126.25 55.16 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.265 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.524 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -47.96 -39.11 18.4 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 178.404 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . 0.462 ' O ' ' HG3' ' A' ' 182' ' ' LYS . 3.3 mm-40 -100.95 171.43 7.65 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 113.414 -1.721 . . . . 0.0 109.202 178.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . 0.541 ' O ' ' HG3' ' A' ' 237' ' ' LYS . 4.2 pt-20 -107.97 12.01 27.38 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -179.099 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.538 ' O ' ' N ' ' A' ' 237' ' ' LYS . 0.1 OUTLIER -77.54 -60.71 0.7 Allowed Pre-proline 0 N--CA 1.465 0.283 0 C-N-CA 120.479 -0.488 . . . . 0.0 111.38 -179.787 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.914 ' O ' HD12 ' A' ' 239' ' ' ILE . 90.7 Cg_exo -49.45 -31.26 23.1 Favored 'Trans proline' 0 CA--C 1.499 -1.246 0 N-CA-C 108.671 -1.319 . . . . 0.0 108.671 178.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.963 HG21 ' HB2' ' A' ' 182' ' ' LYS . 21.5 t -69.25 -42.58 81.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 113.856 -1.52 . . . . 0.0 108.381 177.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.543 ' O ' ' CG ' ' A' ' 241' ' ' GLU . 2.8 mtpt -58.11 -45.4 87.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.529 178.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.537 ' CD ' ' O ' ' A' ' 234' ' ' GLU . 0.0 OUTLIER -73.47 -51.91 15.48 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.398 0.618 . . . . 0.0 111.22 -179.535 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.914 HD12 ' O ' ' A' ' 235' ' ' PRO . 1.9 mt -48.66 -49.46 14.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 114.79 -1.095 . . . . 0.0 112.911 -178.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . 0.473 ' SD ' HG12 ' A' ' 236' ' ' VAL . 54.2 mtp -61.1 -29.03 69.51 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.699 -178.152 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.543 ' CG ' ' O ' ' A' ' 237' ' ' LYS . 0.3 OUTLIER -84.75 -13.15 52.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.87 0.367 . . . . 0.0 110.563 179.696 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.497 ' N ' ' HD3' ' A' ' 242' ' ' LYS . 0.7 OUTLIER -87.17 99.22 11.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.049 -179.934 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.593 ' HE3' ' CG ' ' A' ' 244' ' ' TYR . 8.1 ttpt -37.89 -73.51 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.23 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.593 ' CG ' ' HE3' ' A' ' 243' ' ' LYS . 8.7 m-30 -111.68 150.8 29.66 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.599 179.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' HIS . . . . . 0.803 ' CG ' HD12 ' A' ' 254' ' ' ILE . 17.6 m-70 -113.66 154.09 27.83 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.847 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -134.91 104.69 6.08 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.215 0.531 . . . . 0.0 110.01 178.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.694 HG12 ' H ' ' A' ' 248' ' ' GLY . 1.6 t -96.94 -173.42 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.728 -179.067 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . 0.694 ' H ' HG12 ' A' ' 247' ' ' VAL . . . -25.17 -62.27 0.06 OUTLIER Glycine 0 C--N 1.337 0.635 0 C-N-CA 121.2 -0.524 . . . . 0.0 112.964 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.633 HD23 ' C ' ' A' ' 248' ' ' GLY . 0.0 OUTLIER -126.89 -38.69 2.01 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.399 0.619 . . . . 0.0 110.726 179.796 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.467 ' OG ' ' OG1' ' A' ' 193' ' ' THR . 1.2 m -77.54 151.08 34.68 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.919 -1.037 . . . . 0.0 112.567 -178.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.5 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -140.01 105.89 5.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.922 -1.035 . . . . 0.0 108.722 179.135 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' CYS . . . . . 0.595 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -128.12 153.54 46.74 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -176.624 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . 0.581 ' HB2' ' CE1' ' A' ' 244' ' ' TYR . 64.1 tt0 -75.98 109.96 10.05 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.674 178.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.803 HD12 ' CG ' ' A' ' 245' ' ' HIS . 37.0 mt -97.02 113.03 30.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -178.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.519 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -114.1 131.94 56.23 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 176.89 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 183' ' ' LYS . 9.8 p -33.59 127.56 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-O 122.084 0.945 . . . . 0.0 111.328 -178.079 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 1.108 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -80.18 152.82 28.98 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 113.656 -1.611 . . . . 0.0 112.268 -178.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.47 116.8 16.43 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.595 -1.184 . . . . 0.0 110.416 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.323 -0.547 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.114 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' ' DT' . . . . . 0.88 ' O2 ' " H2'" ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.429 -0.712 0 C1'-O4'-C4' 110.443 0.531 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' ' DA' . . . . . 0.964 " H4'" " O5'" ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.424 -0.997 0 C4'-C3'-C2' 104.517 1.317 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' ' DG' . . . . . 0.964 " O5'" " H4'" ' B' ' 3' ' ' ' DA' . . . . . . . . 0 C4'--C3' 1.52 -0.844 0 C4'-C3'-C2' 101.668 -1.532 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' ' DG' . . . . . 0.618 ' N7 ' ' C5 ' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 C2'--C1' 1.509 -0.876 0 O4'-C1'-N19 108.107 0.383 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.508 ' CG1' ' N ' ' A' ' 182' ' ' LYS . 38.4 t . . . . . 0 CA--C 1.503 -0.84 0 CA-C-O 121.268 0.556 . . . . 0.0 112.04 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.595 ' CB ' HG21 ' A' ' 236' ' ' VAL . 4.6 mmtt -143.62 112.89 6.82 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.362 177.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.84 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.7 OUTLIER -130.59 152.44 49.96 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.343 179.438 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.904 HD13 ' HE1' ' A' ' 230' ' ' PHE . 0.5 OUTLIER -127.37 119.83 53.35 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.096 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.868 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -92.35 108.96 20.35 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.614 0.721 . . . . 0.0 110.156 -178.842 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 1.031 HG12 ' HB2' ' A' ' 252' ' ' CYS . 2.4 t -85.53 118.74 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.254 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.55 ' O ' ' HB3' ' A' ' 252' ' ' CYS . . . -104.97 131.14 10.52 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.271 -0.877 . . . . 0.0 115.026 -176.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.578 ' HA3' ' C6 ' ' B' ' 2' ' ' ' DT' . . . 71.73 85.15 0.2 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 121.352 -0.451 . . . . 0.0 112.764 178.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.963 HD13 ' OG1' ' A' ' 193' ' ' THR . 0.5 OUTLIER -115.47 157.29 24.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.941 0.401 . . . . 0.0 111.268 -179.534 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.625 ' N ' HD12 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -48.0 -169.26 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.751 179.347 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.619 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 17.7 Cg_endo -87.38 22.64 0.89 Allowed 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.403 2.068 . . . . 0.0 112.755 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.542 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 1.9 p30 157.05 76.26 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 111.623 0.231 . . . . 0.0 111.623 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.963 ' OG1' HD13 ' A' ' 189' ' ' LEU . 92.0 m -74.79 111.21 12.22 Favored Pre-proline 0 N--CA 1.464 0.236 0 CA-C-O 120.891 0.377 . . . . 0.0 110.908 179.31 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.572 ' HG2' ' CG ' ' A' ' 197' ' ' LYS . 16.6 Cg_endo -59.51 109.59 0.59 Allowed 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.367 2.045 . . . . 0.0 111.642 179.189 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.825 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.3 OUTLIER -50.84 -15.91 0.35 Allowed 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.754 -179.449 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . 0.512 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 5.6 mt-10 -69.0 -38.16 79.13 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.572 ' CG ' ' HG2' ' A' ' 194' ' ' PRO . 0.2 OUTLIER -73.25 -50.87 19.95 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.209 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.825 ' CG1' ' HA ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -46.77 -31.0 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.727 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.571 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 2.6 mtt180 -70.96 -33.9 70.92 Favored 'General case' 0 C--O 1.221 -0.441 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.373 178.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . 0.583 ' CG ' ' N ' ' A' ' 201' ' ' TYR . 3.2 pt-20 -82.14 -54.66 5.1 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.284 0.564 . . . . 0.0 110.162 179.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.583 ' N ' ' CG ' ' A' ' 200' ' ' GLU . 0.5 OUTLIER -53.69 -53.12 56.47 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.966 178.905 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 1.147 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.2 OUTLIER -79.84 -31.8 40.55 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.664 -179.933 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.571 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -63.81 -55.47 24.5 Favored Glycine 0 CA--C 1.498 -1.003 0 N-CA-C 106.799 -2.52 . . . . 0.0 106.799 176.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -50.16 -29.2 14.94 Favored Glycine 0 N--CA 1.443 -0.882 0 N-CA-C 109.694 -1.363 . . . . 0.0 109.694 176.076 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.765 ' CE2' HG13 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -57.18 -45.28 83.84 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 122.157 0.98 . . . . 0.0 108.456 177.849 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 171.02 -129.71 1.84 Allowed Glycine 0 N--CA 1.441 -0.976 0 CA-C-N 113.567 -1.651 . . . . 0.0 110.31 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.526 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 20.9 mm-40 -96.99 101.52 13.12 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.148 0.499 . . . . 0.0 111.081 178.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 2.5 t -77.94 142.54 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . 0.81 ' HB3' HG22 ' A' ' 229' ' ' THR . 5.5 tp10 -91.66 -52.23 4.86 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 178.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 2.6 m -175.16 149.72 1.1 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.985 178.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.901 HD13 HG23 ' A' ' 228' ' ' ILE . 0.4 OUTLIER -113.96 129.55 69.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.147 178.656 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.436 ' O ' ' HD3' ' A' ' 214' ' ' PRO . 0.0 OUTLIER -123.35 104.79 9.33 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -178.126 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.667 HD21 ' HB ' ' A' ' 193' ' ' THR . 0.1 OUTLIER -96.33 105.62 23.59 Favored Pre-proline 0 CA--C 1.531 0.238 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 177.634 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.611 ' HD2' ' O ' ' A' ' 225' ' ' PHE . 4.6 Cg_exo -82.93 131.1 5.92 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 123.362 2.708 . . . . 0.0 112.217 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 88.2 mmm -135.23 130.44 35.22 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.033 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.486 ' OD1' ' NH1' ' A' ' 223' ' ' ARG . 0.9 OUTLIER -114.94 105.86 13.48 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.981 0.419 . . . . 0.0 110.551 179.581 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -83.63 -14.63 51.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.548 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -90.03 -38.05 13.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.56 -179.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 5.0 t -112.35 -32.6 6.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.248 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 54.44 56.26 7.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.841 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 31.9 mtpt -63.88 173.66 1.74 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.98 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.633 ' CD ' ' O ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -92.21 22.23 4.59 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 122.271 1.034 . . . . 0.0 109.845 179.72 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.567 ' O ' ' N ' ' A' ' 225' ' ' PHE . 2.5 ptp85 -71.4 -25.09 62.2 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.36 178.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.529 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . -10.32 77.16 0.0 OUTLIER Glycine 0 C--N 1.344 1.015 0 O-C-N 124.459 1.099 . . . . 0.0 112.219 179.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.948 ' C ' HD23 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -156.85 176.71 12.39 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.703 -0.748 . . . . 0.0 109.652 -177.43 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . 0.483 ' O ' ' HB ' ' A' ' 186' ' ' VAL . 31.7 p -138.56 147.65 43.28 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.059 -0.656 . . . . 0.0 112.567 -179.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 1.122 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 4.0 m-85 -107.26 133.06 52.38 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.098 -0.956 . . . . 0.0 109.412 178.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 1.147 HD12 ' CE2' ' A' ' 202' ' ' PHE . 1.8 mt -127.32 123.91 62.89 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 CA-C-O 121.23 0.538 . . . . 0.0 111.395 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.81 HG22 ' HB3' ' A' ' 209' ' ' GLU . 19.8 m -105.15 138.39 41.43 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.344 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.904 ' HE1' HD13 ' A' ' 184' ' ' ILE . 72.6 m-85 -114.11 126.32 54.95 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.471 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.526 ' HG3' ' O ' ' A' ' 207' ' ' GLU . 0.0 OUTLIER -47.7 -39.12 16.67 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 178.139 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -94.34 -168.18 1.8 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 113.325 -1.762 . . . . 0.0 109.995 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . 0.539 ' HB3' ' CD ' ' A' ' 182' ' ' LYS . 1.1 pm0 -129.79 10.12 5.5 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.55 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.4 OUTLIER -80.0 -60.22 0.51 Allowed Pre-proline 0 C--N 1.328 -0.338 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.42 179.895 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.911 ' O ' HD12 ' A' ' 239' ' ' ILE . 87.5 Cg_exo -50.32 -29.67 24.19 Favored 'Trans proline' 0 CA--C 1.5 -1.19 0 N-CA-C 108.909 -1.227 . . . . 0.0 108.909 177.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.595 HG21 ' CB ' ' A' ' 182' ' ' LYS . 15.9 t -72.4 -44.7 62.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 113.971 -1.468 . . . . 0.0 109.905 178.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.55 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 0.2 OUTLIER -65.51 -35.52 81.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.84 -179.707 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.498 ' O ' ' CG ' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -80.99 -47.86 13.05 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.928 0.394 . . . . 0.0 110.857 179.14 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.911 HD12 ' O ' ' A' ' 235' ' ' PRO . 1.6 mt -49.33 -50.93 15.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.468 -179.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . 0.436 ' SD ' ' O ' ' A' ' 236' ' ' VAL . 10.3 mtp -59.09 -29.1 67.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.795 0.331 . . . . 0.0 111.246 -178.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.498 ' CG ' ' O ' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -79.54 -21.26 45.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.063 0.459 . . . . 0.0 111.241 -179.734 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.411 ' HD3' ' HG3' ' A' ' 241' ' ' GLU . 5.5 mmtp -78.77 118.5 20.9 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.371 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.56 ' HE3' ' CD2' ' A' ' 244' ' ' TYR . 2.9 ttpt -44.81 -74.58 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.56 ' CD2' ' HE3' ' A' ' 243' ' ' LYS . 16.2 m-30 -121.95 153.92 37.85 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.072 178.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' HIS . . . . . 0.702 ' CD2' HD12 ' A' ' 254' ' ' ILE . 34.8 m-70 -109.9 146.56 34.94 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.03 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -122.11 105.03 9.9 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.102 0.477 . . . . 0.0 110.149 178.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.557 ' O ' ' N ' ' A' ' 249' ' ' LEU . 2.2 t -107.71 127.42 63.73 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.631 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . 0.436 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . 34.77 -89.89 0.01 OUTLIER Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.431 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.557 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.1 OUTLIER -108.67 -37.77 5.82 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 121.706 0.765 . . . . 0.0 110.269 -179.887 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.433 ' HB3' ' H ' ' A' ' 190' ' ' SER . 1.4 m -77.8 154.17 32.15 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.494 -1.23 . . . . 0.0 112.547 -178.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -149.37 110.63 4.41 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.824 179.375 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' CYS . . . . . 1.031 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -129.38 152.84 48.49 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -177.619 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . 0.551 ' HB2' ' CE1' ' A' ' 244' ' ' TYR . 52.4 tt0 -76.41 110.86 11.29 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.917 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.919 HG12 HG13 ' A' ' 186' ' ' VAL . 14.9 mt -96.12 112.7 28.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 -177.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.513 ' O ' ' C ' ' A' ' 256' ' ' VAL . 0.0 OUTLIER -116.3 131.96 56.8 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 176.179 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 183' ' ' LYS . 3.4 p -32.87 123.07 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 CA-C-O 122.235 1.017 . . . . 0.0 111.555 -177.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 1.122 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -78.35 152.41 32.36 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 113.34 -1.755 . . . . 0.0 112.28 -178.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.84 110.48 15.49 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.7 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . 0.505 ' HB3' ' HD2' ' A' ' 183' ' ' LYS . 69.5 p . . . . . 0 C--N 1.327 -0.395 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.771 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' ' DT' . . . . . 0.686 ' O2 ' " H2'" ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.427 -0.803 0 O4'-C1'-C2' 106.646 0.497 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' ' DA' . . . . . 0.531 " H4'" H5'' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.428 -0.773 0 C3'-C2'-C1' 105.368 1.906 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' ' DG' . . . . . 1.021 H2'' " O5'" ' B' ' 5' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.427 -0.796 0 C4'-C3'-C2' 101.994 -1.206 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' ' DG' . . . . . 1.021 " O5'" H2'' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.424 -1.024 0 O4'-C1'-C2' 107.112 0.92 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.494 ' O ' ' HD3' ' A' ' 182' ' ' LYS . 40.0 t . . . . . 0 CA--C 1.503 -0.852 0 CA-C-O 121.35 0.595 . . . . 0.0 112.036 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.829 ' HB2' HG21 ' A' ' 236' ' ' VAL . 0.0 OUTLIER -144.89 112.17 6.06 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.841 177.36 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.886 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -130.85 151.51 51.19 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.954 178.973 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.859 HD13 ' HE2' ' A' ' 230' ' ' PHE . 0.4 OUTLIER -128.09 120.21 52.97 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.408 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.853 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -92.67 109.03 20.44 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.35 0.595 . . . . 0.0 110.57 -178.806 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 1.019 HG12 ' HB2' ' A' ' 252' ' ' CYS . 2.4 t -85.4 124.47 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 CA-C-N 114.781 -1.1 . . . . 0.0 109.327 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.59 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . -113.01 126.06 7.3 Favored Glycine 0 C--N 1.331 0.296 0 N-CA-C 114.555 0.582 . . . . 0.0 114.555 -176.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.512 ' HA3' ' H71' ' B' ' 2' ' ' ' DT' . . . 80.37 84.66 0.67 Allowed Glycine 0 C--N 1.331 0.266 0 C-N-CA 121.337 -0.458 . . . . 0.0 113.151 179.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.953 HD23 ' C ' ' A' ' 225' ' ' PHE . 0.7 OUTLIER -117.31 157.32 26.31 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.831 0.348 . . . . 0.0 111.154 -179.573 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.586 ' O ' HD12 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -49.34 -172.07 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.765 179.537 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.583 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 94.7 Cg_endo -81.61 25.44 0.65 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.293 1.995 . . . . 0.0 113.598 -179.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.575 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 8.0 t70 150.78 79.77 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.778 0.323 . . . . 0.0 110.974 179.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.882 HG22 ' CD1' ' A' ' 198' ' ' ILE . 62.0 m -75.28 111.98 16.44 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.759 179.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.559 ' HG2' ' CG ' ' A' ' 197' ' ' LYS . 18.8 Cg_endo -60.1 112.2 1.22 Allowed 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.097 1.864 . . . . 0.0 110.812 178.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.821 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 7.4 pt-20 -51.85 -14.84 0.41 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.438 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . 0.459 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 1.3 mm-40 -67.12 -37.21 83.48 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.559 ' CG ' ' HG2' ' A' ' 194' ' ' PRO . 0.4 OUTLIER -74.97 -49.8 18.78 Favored 'General case' 0 CA--C 1.495 -1.139 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.193 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.882 ' CD1' HG22 ' A' ' 193' ' ' THR . 0.0 OUTLIER -47.26 -31.81 2.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.594 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.58 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 16.0 mtp180 -69.13 -33.61 73.73 Favored 'General case' 0 C--O 1.221 -0.44 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.177 178.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . 0.529 ' N ' ' O ' ' A' ' 197' ' ' LYS . 3.2 mt-10 -82.57 -59.35 2.55 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.452 0.644 . . . . 0.0 109.903 178.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.487 ' C ' ' CD1' ' A' ' 201' ' ' TYR . 0.6 OUTLIER -49.07 -54.36 16.33 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.931 179.083 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 1.068 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.2 OUTLIER -79.85 -30.99 40.45 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.597 -179.962 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.58 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -62.52 -56.79 19.54 Favored Glycine 0 CA--C 1.499 -0.965 0 N-CA-C 107.202 -2.359 . . . . 0.0 107.202 176.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -49.08 -28.93 8.37 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 176.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.78 ' CD2' HD11 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -58.38 -44.28 88.82 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 177.788 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 203' ' ' GLY . . . 169.65 -130.58 2.07 Favored Glycine 0 N--CA 1.443 -0.837 0 CA-C-N 113.708 -1.587 . . . . 0.0 110.579 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.478 ' C ' ' HG3' ' A' ' 231' ' ' LYS . 54.8 mm-40 -97.05 100.2 11.7 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.27 0.557 . . . . 0.0 111.256 178.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.451 HG21 ' HB2' ' A' ' 202' ' ' PHE . 2.9 t -77.64 137.64 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . 0.529 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 25.3 tp10 -92.84 -54.37 3.78 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 120.686 0.279 . . . . 0.0 110.341 178.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.443 ' C ' HG12 ' A' ' 211' ' ' ILE . 1.4 p -157.46 158.03 35.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.306 0.574 . . . . 0.0 112.182 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.743 HD12 ' HB ' ' A' ' 198' ' ' ILE . 0.1 OUTLIER -133.2 126.06 52.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.366 179.108 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.529 ' OE1' ' N7 ' ' B' ' 4' ' ' ' DG' . 0.7 OUTLIER -123.49 108.68 12.93 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 114.147 1.165 . . . . 0.0 114.147 -177.45 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.89 HD13 ' HB2' ' A' ' 226' ' ' CYS . 1.3 mm? -96.49 105.9 25.86 Favored Pre-proline 0 CA--C 1.531 0.249 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 176.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.512 ' HD2' ' O ' ' A' ' 225' ' ' PHE . 84.5 Cg_endo -82.43 136.02 8.51 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.881 2.388 . . . . 0.0 113.502 -178.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 4.1 mtp -135.43 133.46 38.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.379 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.508 ' HB2' ' NH1' ' A' ' 223' ' ' ARG . 3.3 t0 -113.21 106.54 14.76 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.988 0.423 . . . . 0.0 111.425 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -83.35 -22.7 32.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.575 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 10.1 mttm -84.14 -51.68 6.87 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -178.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -106.96 -25.2 11.73 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.498 -179.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . 0.439 ' HA ' ' O ' ' A' ' 216' ' ' ASP . 0.5 OUTLIER 49.25 60.13 3.98 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.791 0.329 . . . . 0.0 110.821 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . 0.53 ' HD3' ' CZ ' ' A' ' 223' ' ' ARG . 0.1 OUTLIER -67.21 175.22 2.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.116 -179.886 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.626 ' O ' ' CG ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -93.42 37.8 1.05 Allowed 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 122.755 1.264 . . . . 0.0 110.041 180.0 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.569 ' O ' ' N ' ' A' ' 225' ' ' PHE . 5.9 ptp85 -71.65 -27.08 62.83 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 121.569 -0.707 . . . . 0.0 109.134 178.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.521 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . -1.77 68.92 0.0 OUTLIER Glycine 0 C--N 1.341 0.834 0 O-C-N 124.619 1.199 . . . . 0.0 112.921 179.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.953 ' C ' HD23 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -157.27 176.62 12.46 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -178.5 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . 0.89 ' HB2' HD13 ' A' ' 213' ' ' LEU . 2.7 p -140.22 151.91 45.56 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.336 -0.546 . . . . 0.0 112.154 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 1.101 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 4.2 m-85 -111.11 137.43 48.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.472 178.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 1.068 HD12 ' CE2' ' A' ' 202' ' ' PHE . 2.1 mt -131.32 141.84 44.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.131 0.491 . . . . 0.0 111.146 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.441 HG22 ' HB3' ' A' ' 209' ' ' GLU . 97.5 m -122.6 137.94 54.74 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.859 ' HE2' HD13 ' A' ' 184' ' ' ILE . 66.2 m-85 -111.83 126.44 55.09 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.93 -179.468 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.529 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -50.51 -37.77 40.74 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 106.622 -1.622 . . . . 0.0 106.622 177.696 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . 0.505 ' O ' ' HG3' ' A' ' 182' ' ' LYS . 15.2 mt-10 -89.86 -168.96 2.28 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 112.929 -1.941 . . . . 0.0 108.914 178.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . 0.509 ' CB ' ' HD2' ' A' ' 182' ' ' LYS . 2.3 pm0 -131.07 1.02 4.23 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.246 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.515 ' O ' ' N ' ' A' ' 237' ' ' LYS . 0.4 OUTLIER -75.13 -57.62 1.71 Allowed Pre-proline 0 C--N 1.331 -0.222 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -179.415 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.879 ' O ' HD12 ' A' ' 239' ' ' ILE . 98.5 Cg_exo -49.09 -31.83 22.3 Favored 'Trans proline' 0 CA--C 1.498 -1.275 0 N-CA-C 109.027 -1.182 . . . . 0.0 109.027 178.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.829 HG21 ' HB2' ' A' ' 182' ' ' LYS . 17.5 t -69.52 -41.57 80.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 113.883 -1.508 . . . . 0.0 108.855 178.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.515 ' N ' ' O ' ' A' ' 234' ' ' GLU . 22.7 mttt -59.47 -48.15 82.75 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.916 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.495 ' O ' ' HG3' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -76.86 -46.16 25.69 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.169 -179.238 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.879 HD12 ' O ' ' A' ' 235' ' ' PRO . 1.8 mt -49.04 -47.12 17.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.213 -0.449 . . . . 0.0 112.051 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . 0.482 ' SD ' HG12 ' A' ' 236' ' ' VAL . 44.4 mtp -63.92 -17.73 63.52 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.022 -178.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.495 ' HG3' ' O ' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -86.97 -27.73 23.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.686 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.477 ' HG2' ' O ' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -86.79 92.7 9.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.438 179.503 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.505 ' N ' ' HD3' ' A' ' 243' ' ' LYS . 0.0 OUTLIER -36.28 -48.9 0.66 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.996 0.427 . . . . 0.0 110.31 -179.947 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.575 ' CE1' ' HG3' ' A' ' 253' ' ' GLU . 22.1 m-85 -122.3 157.56 31.47 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.836 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' HIS . . . . . 0.777 ' CG ' HD12 ' A' ' 254' ' ' ILE . 29.8 m-70 -127.79 156.83 41.86 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.917 -179.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . 0.4 ' O ' ' CE2' ' A' ' 201' ' ' TYR . 2.1 m-80 -129.15 105.15 7.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.124 0.487 . . . . 0.0 110.602 179.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.563 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.5 t -109.7 125.98 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.677 -179.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . 35.46 -89.19 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.504 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.563 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.1 OUTLIER -108.15 -35.88 6.45 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.777 0.798 . . . . 0.0 110.085 -179.679 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.506 ' HB3' ' HB2' ' A' ' 190' ' ' SER . 0.8 OUTLIER -77.92 154.46 31.63 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.322 -1.308 . . . . 0.0 112.959 -177.836 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.487 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -149.95 107.88 3.71 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.063 -0.972 . . . . 0.0 108.973 179.069 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' CYS . . . . . 1.019 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -128.78 153.33 47.5 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 -176.762 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . 0.575 ' HG3' ' CE1' ' A' ' 244' ' ' TYR . 31.7 tt0 -75.93 108.91 9.13 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.033 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.894 HG12 HG13 ' A' ' 186' ' ' VAL . 19.1 mt -96.48 113.1 30.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 -178.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.516 ' O ' ' C ' ' A' ' 256' ' ' VAL . 0.0 OUTLIER -119.6 133.37 55.69 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 176.516 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 183' ' ' LYS . 3.1 p -32.69 121.47 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 CA-C-O 122.218 1.009 . . . . 0.0 111.557 -177.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 1.101 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -76.52 153.71 35.23 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 113.353 -1.748 . . . . 0.0 112.07 -178.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -127.88 113.67 16.2 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.898 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . 0.448 ' HB2' ' HD2' ' A' ' 183' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.519 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.073 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' ' DT' . . . . . 0.635 ' O2 ' " H2'" ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.427 -0.795 0 C1'-O4'-C4' 110.383 0.488 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' ' DA' . . . . . 0.608 H5'' ' CE1' ' A' ' 225' ' ' PHE . . . . . . . . 0 O4'--C1' 1.408 -0.949 0 C4'-C3'-C2' 104.736 1.536 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' ' DG' . . . . . 0.752 H2'' " O5'" ' B' ' 5' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.426 -0.874 0 C4'-C3'-C2' 101.976 -1.224 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' ' DG' . . . . . 0.752 " O5'" H2'' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.426 -0.871 0 O4'-C1'-C2' 106.934 0.758 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.495 ' C ' ' CD ' ' A' ' 182' ' ' LYS . 55.2 t . . . . . 0 CA--C 1.501 -0.936 0 CA-C-O 121.11 0.481 . . . . 0.0 111.47 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.925 ' HB2' HG21 ' A' ' 236' ' ' VAL . 0.0 OUTLIER -152.68 111.78 3.83 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.088 177.346 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.915 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.5 OUTLIER -136.36 167.86 20.52 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.693 179.04 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.725 ' C ' ' HB2' ' A' ' 257' ' ' ALA . 0.3 OUTLIER -144.1 121.66 5.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.09 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.818 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.3 OUTLIER -96.36 108.97 21.57 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.454 -0.898 . . . . 0.0 109.679 -179.734 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 1.097 HG12 ' HB2' ' A' ' 252' ' ' CYS . 1.7 t -87.7 127.23 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.729 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.593 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . -114.71 124.54 6.42 Favored Glycine 0 C--N 1.331 0.282 0 N-CA-C 114.647 0.619 . . . . 0.0 114.647 -176.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.453 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . 82.12 85.83 0.75 Allowed Glycine 0 CA--C 1.518 0.28 0 C-N-CA 121.277 -0.487 . . . . 0.0 113.108 179.282 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.931 HD23 ' C ' ' A' ' 225' ' ' PHE . 0.8 OUTLIER -117.46 157.27 26.53 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.742 0.306 . . . . 0.0 111.367 -179.564 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.618 ' O ' HD12 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -49.83 -170.84 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.228 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.843 179.615 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.607 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 95.7 Cg_endo -83.46 24.07 0.78 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.44 2.093 . . . . 0.0 113.381 -179.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.546 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 4.3 t0 154.67 77.19 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.72 0.295 . . . . 0.0 111.201 179.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.851 ' OG1' HD13 ' A' ' 189' ' ' LEU . 86.4 m -74.26 111.39 12.48 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 120.869 0.366 . . . . 0.0 110.957 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.527 ' HG2' ' HG2' ' A' ' 197' ' ' LYS . 19.3 Cg_endo -61.04 112.58 1.42 Allowed 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.248 1.965 . . . . 0.0 111.144 179.011 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.835 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 1.6 pm0 -51.9 -15.27 0.49 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.434 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . 0.498 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 40.6 mm-40 -66.94 -38.27 85.83 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.549 ' O ' ' N ' ' A' ' 200' ' ' GLU . 0.1 OUTLIER -74.04 -51.09 16.91 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.214 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.896 HG22 ' CE1' ' A' ' 202' ' ' PHE . 0.0 OUTLIER -47.52 -29.88 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.338 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.585 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 0.1 OUTLIER -70.9 -33.79 70.92 Favored 'General case' 0 C--O 1.22 -0.448 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.876 178.559 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . 0.578 ' CG ' ' N ' ' A' ' 201' ' ' TYR . 2.3 pt-20 -83.17 -56.47 3.76 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.857 0.361 . . . . 0.0 110.662 179.221 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.578 ' N ' ' CG ' ' A' ' 200' ' ' GLU . 0.2 OUTLIER -51.07 -53.5 33.31 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.427 0.632 . . . . 0.0 109.52 178.964 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 1.118 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.4 OUTLIER -79.65 -30.23 41.19 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.232 -179.913 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.585 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -62.11 -56.9 19.61 Favored Glycine 0 CA--C 1.498 -0.987 0 N-CA-C 106.763 -2.535 . . . . 0.0 106.763 176.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -49.41 -28.62 9.76 Favored Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 176.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.699 ' CD2' HD11 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -58.28 -42.4 86.5 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 177.99 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.493 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 166.96 -130.2 2.07 Favored Glycine 0 N--CA 1.441 -1.019 0 CA-C-N 113.709 -1.587 . . . . 0.0 109.895 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.533 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 9.4 mm-40 -96.82 100.85 12.37 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.322 0.582 . . . . 0.0 110.609 178.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.557 HG21 ' HB2' ' A' ' 202' ' ' PHE . 2.7 t -77.92 139.67 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.354 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . 0.539 ' HB3' HG22 ' A' ' 229' ' ' THR . 7.4 tp10 -89.75 -55.9 3.45 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 178.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 3.8 m -169.52 151.26 4.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.338 0.589 . . . . 0.0 112.069 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.882 HD12 ' HB ' ' A' ' 198' ' ' ILE . 0.4 OUTLIER -116.26 132.12 66.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.416 178.879 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.407 ' O ' ' HD3' ' A' ' 214' ' ' PRO . 1.0 OUTLIER -123.18 109.44 14.01 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -178.07 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.81 HD11 ' HB ' ' A' ' 193' ' ' THR . 1.6 mm? -96.59 106.37 29.36 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.873 177.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.565 ' HD2' ' O ' ' A' ' 225' ' ' PHE . 95.1 Cg_endo -86.27 129.97 3.35 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.736 2.291 . . . . 0.0 112.808 -179.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 2.2 mmt -135.25 132.92 38.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.609 179.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.424 ' O ' ' HA ' ' A' ' 220' ' ' ASN . 1.2 m-20 -107.6 106.23 16.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.878 0.371 . . . . 0.0 110.943 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -83.16 -10.56 58.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.171 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.35 -51.37 8.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.299 -179.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.9 -31.58 4.17 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.946 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . 0.424 ' HA ' ' O ' ' A' ' 216' ' ' ASP . 1.0 OUTLIER 70.78 56.7 0.23 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.969 179.835 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.4 -179.77 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.048 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.613 ' CD ' ' O ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -102.17 33.99 2.88 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 122.74 1.257 . . . . 0.0 109.668 179.783 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.557 ' O ' ' N ' ' A' ' 225' ' ' PHE . 4.7 ptp85 -71.98 -24.53 61.6 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.149 178.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.523 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . -4.29 72.35 0.0 OUTLIER Glycine 0 C--N 1.345 1.037 0 O-C-N 124.53 1.144 . . . . 0.0 112.744 179.327 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.931 ' C ' HD23 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -157.38 176.63 12.42 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.054 -0.573 . . . . 0.0 109.781 -178.309 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . 0.7 ' HB3' HD13 ' A' ' 213' ' ' LEU . 30.5 p -140.96 146.86 37.88 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.276 -0.57 . . . . 0.0 112.425 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 1.113 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 4.7 m-85 -106.76 134.91 49.19 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.355 178.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 1.118 HD12 ' CE2' ' A' ' 202' ' ' PHE . 1.8 mt -128.66 136.35 60.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.146 0.498 . . . . 0.0 111.374 -179.305 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.539 HG22 ' HB3' ' A' ' 209' ' ' GLU . 52.5 m -117.02 138.02 51.85 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.529 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.611 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 75.6 m-85 -111.83 126.29 54.93 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.394 179.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.533 ' HG3' ' O ' ' A' ' 207' ' ' GLU . 0.0 OUTLIER -45.0 -40.33 6.37 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 178.56 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . 0.469 ' O ' ' HG3' ' A' ' 182' ' ' LYS . 69.5 mt-10 -99.12 173.05 7.0 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 113.442 -1.708 . . . . 0.0 108.779 178.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . 0.521 ' O ' ' HG3' ' A' ' 237' ' ' LYS . 0.8 OUTLIER -112.0 13.17 20.74 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.58 -179.633 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.551 ' O ' ' HB2' ' A' ' 237' ' ' LYS . 0.6 OUTLIER -80.84 -60.38 0.44 Allowed Pre-proline 0 C--N 1.331 -0.213 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.7 -179.628 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.658 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 90.8 Cg_exo -48.7 -36.76 33.56 Favored 'Trans proline' 0 CA--C 1.495 -1.456 0 N-CA-C 108.61 -1.342 . . . . 0.0 108.61 178.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.925 HG21 ' HB2' ' A' ' 182' ' ' LYS . 17.2 t -62.66 -40.27 87.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 114.204 -1.362 . . . . 0.0 109.773 178.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.551 ' HB2' ' O ' ' A' ' 234' ' ' GLU . 8.3 mtpt -54.24 -49.21 70.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.957 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.499 ' HA ' ' HG3' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -80.91 -45.83 16.13 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.615 -179.236 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.791 ' CG2' HG21 ' A' ' 254' ' ' ILE . 0.7 OUTLIER -39.48 -59.11 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.256 -0.883 . . . . 0.0 111.818 -179.549 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . 0.476 ' SD ' HG12 ' A' ' 236' ' ' VAL . 2.6 mtp -55.53 -27.68 50.27 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.435 -178.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.499 ' HG3' ' HA ' ' A' ' 238' ' ' LYS . 1.1 mt-10 -84.43 -13.87 50.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.937 0.399 . . . . 0.0 110.642 179.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.463 ' HB2' ' NE2' ' A' ' 245' ' ' HIS . 1.9 mptt -79.42 105.86 11.04 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.725 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.509 ' HD3' ' CD2' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -37.52 -67.18 0.2 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.05 -179.869 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.509 ' CD2' ' HD3' ' A' ' 243' ' ' LYS . 29.3 m-85 -132.71 143.28 49.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.971 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' HIS . . . . . 0.649 ' CD2' HD12 ' A' ' 254' ' ' ILE . 45.5 m-70 -108.81 127.93 54.45 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.354 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -102.25 105.28 15.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.034 0.445 . . . . 0.0 110.905 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.555 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.1 t -103.85 130.0 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.701 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . 0.451 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . 32.78 -89.91 0.01 OUTLIER Glycine 0 C--N 1.334 0.442 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.412 -179.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.555 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.1 OUTLIER -109.9 -34.74 6.34 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.843 0.83 . . . . 0.0 109.642 179.748 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.527 ' HB3' ' HB2' ' A' ' 190' ' ' SER . 1.9 p -77.16 152.44 34.85 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.172 -1.376 . . . . 0.0 112.65 -178.252 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -150.26 108.48 3.76 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.254 179.246 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' CYS . . . . . 1.097 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -127.54 153.15 46.71 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -177.381 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . 0.466 ' N ' ' O ' ' A' ' 187' ' ' GLY . 48.8 tt0 -76.07 113.68 13.87 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.552 -179.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.97 HG12 HG13 ' A' ' 186' ' ' VAL . 6.3 mt -96.75 113.33 30.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 -178.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.53 ' O ' ' C ' ' A' ' 256' ' ' VAL . 0.0 OUTLIER -122.67 128.15 50.22 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 105.569 -2.012 . . . . 0.0 105.569 176.346 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 183' ' ' LYS . 1.4 p -31.9 121.71 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 CA-C-O 122.244 1.021 . . . . 0.0 111.37 -176.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 1.113 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -75.85 153.85 36.53 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 113.27 -1.786 . . . . 0.0 111.768 -178.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.03 118.64 19.04 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.969 179.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 90.6 p . . . . . 0 C--N 1.326 -0.432 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.192 -179.514 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 2' ' ' ' DT' . . . . . 0.698 ' O2 ' " H2'" ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.427 -0.804 0 C3'-C2'-C1' 102.103 -0.427 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 3' ' ' ' DA' . . . . . 0.589 H5'' ' CE1' ' A' ' 225' ' ' PHE . . . . . . . . 0 O5'--C5' 1.427 -0.828 0 C4'-C3'-C2' 104.757 1.557 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 4' ' ' ' DG' . . . . . 0.852 H2'' " O5'" ' B' ' 5' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.427 -0.813 0 C4'-C3'-C2' 102.05 -1.15 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 5' ' ' ' DG' . . . . . 0.852 " O5'" H2'' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 C2'--C1' 1.508 -0.924 0 O4'-C1'-N19 108.146 0.432 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.507 HG12 ' N ' ' A' ' 182' ' ' LYS . 47.8 t . . . . . 0 CA--C 1.504 -0.805 0 CA-C-O 121.156 0.503 . . . . 0.0 111.671 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.56 ' HG2' ' CG ' ' A' ' 233' ' ' GLU . 0.0 OUTLIER -150.33 112.63 4.65 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.676 177.621 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.943 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.0 OUTLIER -138.51 148.27 44.08 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.218 178.484 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.906 HD13 ' HE2' ' A' ' 230' ' ' PHE . 0.3 OUTLIER -126.58 120.06 55.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.679 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.75 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.3 OUTLIER -92.98 109.6 21.06 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 121.44 0.638 . . . . 0.0 110.111 -179.164 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.765 HG13 HG12 ' A' ' 254' ' ' ILE . 5.8 t -88.72 118.49 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.161 -179.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.564 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . -62.11 -150.9 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 115.76 -0.654 . . . . 0.0 114.609 -178.004 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.48 ' O ' ' HB3' ' A' ' 252' ' ' CYS . . . -47.03 111.74 0.8 Allowed Glycine 0 C--N 1.33 0.234 0 CA-C-N 114.823 -0.688 . . . . 0.0 114.435 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.993 HD13 ' OG1' ' A' ' 193' ' ' THR . 3.3 pp -109.11 157.35 18.82 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.98 -0.61 . . . . 0.0 110.255 178.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.921 ' O ' HD12 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -42.74 178.13 0.01 OUTLIER Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 121.084 0.469 . . . . 0.0 111.034 179.726 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.548 ' HD2' ' CB ' ' A' ' 190' ' ' SER . 74.5 Cg_endo -76.37 26.65 0.42 Allowed 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 122.637 2.225 . . . . 0.0 113.544 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.543 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 4.6 p30 157.48 73.88 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.113 0 N-CA-C 111.528 0.196 . . . . 0.0 111.528 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.993 ' OG1' HD13 ' A' ' 189' ' ' LEU . 87.6 m -77.93 111.22 16.58 Favored Pre-proline 0 CA--C 1.518 -0.26 0 CA-C-O 121.055 0.455 . . . . 0.0 110.742 179.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.609 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 57.7 Cg_endo -68.47 109.62 2.09 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.525 2.15 . . . . 0.0 111.686 179.27 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.612 ' HA ' ' CD1' ' A' ' 198' ' ' ILE . 0.6 OUTLIER -43.42 -19.81 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.47 179.752 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . 0.523 ' O ' ' HG2' ' A' ' 200' ' ' GLU . 0.1 OUTLIER -61.02 -44.49 97.33 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -179.158 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.609 ' CD ' ' HG2' ' A' ' 194' ' ' PRO . 1.4 mttp -76.17 -46.18 29.8 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 178.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.917 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.2 OUTLIER -48.56 -28.94 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-N 114.048 -1.433 . . . . 0.0 108.717 177.014 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.56 ' HG3' ' O ' ' A' ' 195' ' ' GLU . 12.9 mtp180 -75.75 -32.11 59.83 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.955 178.233 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . 0.523 ' HG2' ' O ' ' A' ' 196' ' ' GLU . 4.1 mm-40 -81.91 -57.48 3.4 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.226 0.536 . . . . 0.0 110.536 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.489 ' C ' ' CD1' ' A' ' 201' ' ' TYR . 0.3 OUTLIER -48.03 -53.94 14.65 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.678 179.308 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 1.005 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.9 OUTLIER -79.73 -31.95 41.12 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.571 179.93 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.53 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -61.88 -57.78 15.86 Favored Glycine 0 N--CA 1.444 -0.824 0 N-CA-C 107.378 -2.289 . . . . 0.0 107.378 176.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -49.33 -29.28 10.21 Favored Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 176.264 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.76 ' CE2' HG13 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -58.53 -43.49 89.25 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 122.115 0.959 . . . . 0.0 108.423 177.787 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 169.14 -131.29 2.25 Favored Glycine 0 N--CA 1.441 -1.002 0 CA-C-N 113.714 -1.584 . . . . 0.0 110.417 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.517 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 4.1 mt-10 -97.11 102.94 14.82 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.231 0.539 . . . . 0.0 111.364 178.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.498 ' O ' ' NZ ' ' A' ' 231' ' ' LYS . 2.5 t -77.84 138.9 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.049 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . 0.571 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 70.8 tt0 -93.35 -53.15 4.2 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.5 178.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.439 ' OG ' ' OE2' ' A' ' 212' ' ' GLU . 37.2 p -160.51 151.65 19.08 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.512 HG21 ' HB ' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -129.55 122.36 55.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.923 178.905 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.439 ' OE2' ' OG ' ' A' ' 210' ' ' SER . 0.0 OUTLIER -123.86 115.29 21.07 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 -177.962 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.735 HD22 ' N ' ' A' ' 213' ' ' LEU . 0.3 OUTLIER -97.02 105.72 26.0 Favored Pre-proline 0 CA--C 1.537 0.452 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 176.644 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.673 ' HD2' ' O ' ' A' ' 225' ' ' PHE . 2.4 Cg_endo -86.75 123.69 2.13 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 123.583 2.855 . . . . 0.0 113.299 -178.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -135.29 130.18 34.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.283 178.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.429 ' CG ' ' NH1' ' A' ' 223' ' ' ARG . 1.2 m-20 -116.77 106.57 13.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.855 0.36 . . . . 0.0 111.407 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -82.82 -9.09 59.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.17 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 21.1 mmmt -91.18 -51.29 5.39 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.852 -179.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.418 ' CG2' ' HB3' ' A' ' 216' ' ' ASP . 0.8 OUTLIER -92.65 -35.13 13.68 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.321 -179.291 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 2.7 m120 70.07 36.9 1.81 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.91 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . 0.433 ' CD ' ' N ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -70.73 148.55 47.85 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.135 179.703 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.433 ' N ' ' CD ' ' A' ' 221' ' ' LYS . 0.0 OUTLIER -70.31 59.24 0.18 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.277 0.561 . . . . 0.0 110.568 179.632 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.429 ' NH1' ' CG ' ' A' ' 216' ' ' ASP . 4.0 ptp85 -102.13 18.94 19.57 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.651 179.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.453 ' O ' ' HG ' ' A' ' 189' ' ' LEU . . . -68.53 53.82 0.48 Allowed Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 115.162 -0.926 . . . . 0.0 112.411 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.887 ' C ' HD23 ' A' ' 189' ' ' LEU . 6.7 p90 -132.87 176.68 8.26 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . 0.583 ' N ' HD23 ' A' ' 189' ' ' LEU . 23.1 p -136.06 149.15 48.64 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 119.495 -0.882 . . . . 0.0 112.709 -179.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 1.162 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 3.1 m-85 -105.65 139.0 40.91 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 115.586 -0.733 . . . . 0.0 109.119 178.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 1.005 HD12 ' CE2' ' A' ' 202' ' ' PHE . 1.7 mt -133.83 118.29 29.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.414 0.626 . . . . 0.0 111.015 179.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.542 HG22 ' HB3' ' A' ' 209' ' ' GLU . 63.4 m -100.67 137.99 38.32 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.906 ' HE2' HD13 ' A' ' 184' ' ' ILE . 58.1 m-85 -111.8 126.49 55.14 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.465 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.571 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -49.46 -38.31 29.23 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 178.302 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . 0.419 ' OE1' ' CD ' ' A' ' 234' ' ' GLU . 0.7 OUTLIER -92.06 -165.37 1.33 Allowed 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 113.049 -1.887 . . . . 0.0 109.483 178.873 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . 0.56 ' CG ' ' HG2' ' A' ' 182' ' ' LYS . 0.5 OUTLIER -132.96 1.75 3.59 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.443 -179.914 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.493 ' O ' ' N ' ' A' ' 237' ' ' LYS . 0.2 OUTLIER -73.91 -59.53 1.79 Allowed Pre-proline 0 C--N 1.33 -0.264 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.622 -179.415 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.891 ' O ' HD12 ' A' ' 239' ' ' ILE . 98.5 Cg_exo -48.65 -33.61 24.74 Favored 'Trans proline' 0 CA--C 1.498 -1.299 0 N-CA-C 108.851 -1.25 . . . . 0.0 108.851 178.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.539 HG13 HG22 ' A' ' 184' ' ' ILE . 21.7 t -70.43 -40.74 77.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 113.856 -1.52 . . . . 0.0 109.502 178.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.524 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 19.9 mttt -56.68 -46.89 80.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.915 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.529 ' O ' ' CG ' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -81.14 -50.09 10.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.277 -179.754 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.891 HD12 ' O ' ' A' ' 235' ' ' PRO . 1.5 mt -40.74 -52.58 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.632 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . 0.457 ' SD ' ' HB ' ' A' ' 256' ' ' VAL . 6.7 mtp -61.32 -21.92 64.42 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.025 -179.024 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.529 ' CG ' ' O ' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -80.05 -23.96 41.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.844 -179.834 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.418 ' N ' ' HG3' ' A' ' 241' ' ' GLU . 2.9 mmtp -79.11 137.59 37.56 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.034 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.553 ' HD2' ' CG ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -76.55 -41.96 44.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.447 179.588 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.651 ' CD1' ' HB3' ' A' ' 253' ' ' GLU . 2.5 m-85 -140.51 140.88 35.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.277 178.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' HIS . . . . . 0.781 ' CE1' HD12 ' A' ' 254' ' ' ILE . 17.3 m-70 -106.39 157.8 17.36 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.675 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . 0.404 ' ND2' ' N ' ' A' ' 246' ' ' ASN . 0.1 OUTLIER -133.77 105.27 6.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.97 0.414 . . . . 0.0 110.87 179.541 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.538 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.6 t -108.61 105.63 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.112 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 50.17 -85.21 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.421 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.538 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -107.1 -38.99 5.85 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.405 0.621 . . . . 0.0 110.602 179.806 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.495 ' O ' ' N ' ' A' ' 247' ' ' VAL . 4.4 p -77.63 150.28 34.64 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.984 -1.007 . . . . 0.0 112.105 -178.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.547 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -150.5 103.58 3.14 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.588 178.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' CYS . . . . . 0.612 ' SG ' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -130.59 154.69 47.59 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -177.515 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . 0.651 ' HB3' ' CD1' ' A' ' 244' ' ' TYR . 7.8 pt-20 -74.94 118.54 18.01 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.24 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.781 HD12 ' CE1' ' A' ' 245' ' ' HIS . 24.0 mt -96.76 102.12 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 CA-C-O 121.809 0.814 . . . . 0.0 112.657 -178.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.571 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -104.0 128.99 51.58 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 177.627 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 183' ' ' LYS . 3.8 p -32.41 125.06 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-O 122.15 0.976 . . . . 0.0 111.206 -176.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 1.162 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -76.23 152.82 36.46 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 113.522 -1.672 . . . . 0.0 112.166 -178.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.15 126.65 26.89 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.469 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . 0.524 ' HB3' ' NZ ' ' A' ' 183' ' ' LYS . 53.9 p . . . . . 0 C--N 1.324 -0.508 0 CA-C-O 120.866 0.365 . . . . 0.0 111.097 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 2' ' ' ' DT' . . . . . 0.876 ' O2 ' " H2'" ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.427 -0.81 0 O4'-C1'-C2' 107.067 0.879 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 3' ' ' ' DA' . . . . . 1.001 " H4'" " O5'" ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.426 -0.875 0 C4'-C3'-O3' 111.484 0.538 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 4' ' ' ' DG' . . . . . 1.001 " O5'" " H4'" ' B' ' 3' ' ' ' DA' . . . . . . . . 0 O5'--C5' 1.427 -0.826 0 C4'-C3'-C2' 102.194 -1.006 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 5' ' ' ' DG' . . . . . 0.731 ' N7 ' ' C5 ' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 C2'--C1' 1.507 -1.013 0 O4'-C1'-N19 108.182 0.478 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.515 ' CG1' ' N ' ' A' ' 182' ' ' LYS . 36.1 t . . . . . 0 CA--C 1.504 -0.808 0 CA-C-O 121.115 0.483 . . . . 0.0 111.247 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.943 ' HB3' HG21 ' A' ' 236' ' ' VAL . 2.8 mptt -148.45 112.95 5.32 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.447 178.038 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.851 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -134.14 143.88 48.2 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.846 179.08 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.853 HD13 ' HE1' ' A' ' 230' ' ' PHE . 1.0 OUTLIER -123.4 120.05 59.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.411 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.827 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -92.11 109.49 20.85 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.423 0.63 . . . . 0.0 109.992 -179.337 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.784 HG13 HG12 ' A' ' 254' ' ' ILE . 11.0 t -87.03 123.59 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.303 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.54 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . -68.67 -159.07 1.56 Allowed Glycine 0 CA--C 1.521 0.452 0 CA-C-N 115.743 -0.662 . . . . 0.0 114.477 -178.098 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.542 ' HA2' ' O ' ' A' ' 224' ' ' GLY . . . -39.13 107.55 0.07 OUTLIER Glycine 0 C--N 1.332 0.355 0 CA-C-N 114.918 -0.641 . . . . 0.0 114.37 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.932 HD13 ' OG1' ' A' ' 193' ' ' THR . 3.2 pp -107.98 157.14 18.47 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 122.537 0.335 . . . . 0.0 110.802 179.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.92 ' O ' HD12 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -40.28 173.44 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.392 0.615 . . . . 0.0 111.921 -179.947 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.459 ' O ' ' HB2' ' A' ' 192' ' ' ASP . 32.9 Cg_exo -60.34 -3.65 2.62 Favored 'Trans proline' 0 CA--C 1.529 0.27 0 C-N-CA 123.293 2.662 . . . . 0.0 114.126 -179.373 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 191' ' ' PRO . 0.5 OUTLIER 172.01 74.02 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.69 -179.933 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.932 ' OG1' HD13 ' A' ' 189' ' ' LEU . 57.7 m -64.29 125.29 87.99 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.826 179.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.63 ' O ' HD11 ' A' ' 198' ' ' ILE . 83.5 Cg_endo -76.55 117.71 4.65 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.405 2.07 . . . . 0.0 110.381 178.37 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.809 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 12.4 pt-20 -51.62 -14.0 0.29 Allowed 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -178.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . 0.51 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 33.7 mt-10 -68.51 -44.0 75.6 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -179.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.621 ' CD ' ' HG2' ' A' ' 194' ' ' PRO . 0.9 OUTLIER -70.58 -47.41 60.34 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.444 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.809 ' CG1' ' HA ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -47.85 -30.84 2.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.423 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.579 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 1.5 mtp-105 -72.31 -32.35 66.48 Favored 'General case' 0 C--O 1.22 -0.456 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.105 178.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . 0.522 ' N ' ' O ' ' A' ' 197' ' ' LYS . 25.2 mt-10 -82.71 -59.16 2.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.137 0.494 . . . . 0.0 110.397 179.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.504 ' C ' ' CD1' ' A' ' 201' ' ' TYR . 0.4 OUTLIER -48.72 -53.61 18.21 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.767 -0.652 . . . . 0.0 109.718 179.118 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 1.135 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.5 OUTLIER -79.7 -31.36 41.26 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.538 -179.963 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.579 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -62.14 -56.34 22.78 Favored Glycine 0 CA--C 1.5 -0.855 0 N-CA-C 107.104 -2.398 . . . . 0.0 107.104 176.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -49.76 -28.4 11.15 Favored Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 176.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.77 ' CE2' HG13 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -58.64 -44.21 89.98 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 177.885 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 169.87 -130.66 2.07 Favored Glycine 0 N--CA 1.441 -0.985 0 CA-C-N 113.663 -1.608 . . . . 0.0 110.473 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.481 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 5.0 mt-10 -96.89 98.77 10.38 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.228 0.537 . . . . 0.0 110.923 178.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.452 HG21 ' HB2' ' A' ' 202' ' ' PHE . 2.7 t -75.76 141.26 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 CA-C-N 115.384 -0.825 . . . . 0.0 108.984 178.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . 0.508 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 45.6 tt0 -89.75 -57.72 2.77 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.141 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 10.4 p -167.58 151.41 6.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.298 0.571 . . . . 0.0 112.375 179.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.985 HD13 HG23 ' A' ' 228' ' ' ILE . 0.4 OUTLIER -117.71 132.29 67.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.497 178.657 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.493 ' OE1' ' N7 ' ' B' ' 4' ' ' ' DG' . 0.0 OUTLIER -123.45 111.46 16.35 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -178.293 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.931 HD11 ' HB ' ' A' ' 193' ' ' THR . 2.7 mm? -96.21 109.02 45.12 Favored Pre-proline 0 CA--C 1.533 0.315 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.922 177.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.608 ' HD2' ' O ' ' A' ' 225' ' ' PHE . 22.3 Cg_exo -65.87 -157.36 0.03 OUTLIER 'Trans proline' 0 N--CA 1.472 0.223 0 C-N-CA 123.458 2.772 . . . . 0.0 113.427 -179.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.45 ' HB3' ' CG ' ' A' ' 220' ' ' ASN . 0.0 OUTLIER -92.86 173.49 7.72 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.608 -179.65 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.457 ' O ' ' HB2' ' A' ' 220' ' ' ASN . 1.0 OUTLIER -109.6 149.85 29.07 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.541 -179.668 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . 0.541 ' N ' ' O ' ' A' ' 221' ' ' LYS . 9.4 t30 -64.93 -9.44 21.32 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.029 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 7.0 mttp -67.29 -26.6 66.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.144 0.497 . . . . 0.0 110.481 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 2.6 t -150.15 15.42 0.82 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.876 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 216' ' ' ASP . 16.6 m120 -148.71 -92.13 0.08 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.689 0.28 . . . . 0.0 111.635 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . 0.541 ' O ' ' N ' ' A' ' 217' ' ' ASN . 23.1 mtpp -148.44 173.2 13.34 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.832 0.348 . . . . 0.0 111.253 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.636 ' O ' ' CG ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -92.39 40.23 1.04 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 123.066 1.412 . . . . 0.0 110.057 -179.993 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.544 ' HD3' ' CB ' ' A' ' 214' ' ' PRO . 2.1 ptp85 -71.7 -31.26 66.56 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.542 ' O ' ' HA2' ' A' ' 188' ' ' GLY . . . 10.98 62.36 0.01 OUTLIER Glycine 0 C--O 1.222 -0.637 0 CA-C-N 114.059 -1.428 . . . . 0.0 113.635 178.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.842 ' C ' HD23 ' A' ' 189' ' ' LEU . 0.6 OUTLIER -156.05 176.08 13.12 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.743 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . 0.638 ' N ' HD23 ' A' ' 189' ' ' LEU . 27.3 p -140.7 150.92 44.08 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -179.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 1.126 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 4.5 m-85 -106.29 133.49 50.9 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.657 178.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 1.135 HD12 ' CE2' ' A' ' 202' ' ' PHE . 1.9 mt -127.75 128.05 68.99 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.393 0 CA-C-O 120.904 0.383 . . . . 0.0 111.108 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.496 ' OG1' ' HG2' ' A' ' 183' ' ' LYS . 51.5 m -111.62 137.95 48.81 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.214 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.853 ' HE1' HD13 ' A' ' 184' ' ' ILE . 83.2 m-85 -112.42 126.38 55.23 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.387 179.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.508 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -47.96 -38.38 16.66 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 178.018 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . 0.4 ' HG2' ' HB2' ' A' ' 207' ' ' GLU . 25.0 mm-40 -91.0 -165.33 1.33 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 113.397 -1.728 . . . . 0.0 110.186 179.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . 0.592 ' CB ' ' HG2' ' A' ' 182' ' ' LYS . 9.5 pt-20 -133.25 10.91 4.16 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.486 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.536 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.0 OUTLIER -83.43 -60.38 0.34 Allowed Pre-proline 0 C--N 1.326 -0.419 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.649 179.951 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.906 ' O ' HD12 ' A' ' 239' ' ' ILE . 80.2 Cg_exo -49.51 -30.45 21.26 Favored 'Trans proline' 0 CA--C 1.501 -1.145 0 N-CA-C 108.942 -1.215 . . . . 0.0 108.942 177.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.943 HG21 ' HB3' ' A' ' 182' ' ' LYS . 17.9 t -72.68 -45.28 58.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 113.88 -1.509 . . . . 0.0 110.323 178.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.536 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 1.5 ptpt -63.76 -35.09 79.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.791 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.526 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 0.0 OUTLIER -80.73 -50.39 9.94 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.128 0.489 . . . . 0.0 110.379 179.055 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.906 HD12 ' O ' ' A' ' 235' ' ' PRO . 1.7 mt -47.96 -49.74 10.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.433 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . 0.458 ' HG2' ' HB ' ' A' ' 256' ' ' VAL . 36.8 mtp -58.16 -29.27 65.46 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.353 -178.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.514 ' CG ' ' O ' ' A' ' 237' ' ' LYS . 0.1 OUTLIER -86.38 -10.61 54.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.918 0.39 . . . . 0.0 110.566 179.447 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 239' ' ' ILE . 0.0 OUTLIER -81.6 102.52 10.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.2 -179.865 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.497 ' HE2' ' HB2' ' A' ' 244' ' ' TYR . 1.9 ttpt -38.18 -76.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.212 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.667 ' CD1' ' HB3' ' A' ' 253' ' ' GLU . 8.9 m-85 -118.16 144.75 45.45 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.661 179.062 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' HIS . . . . . 0.678 ' CE1' HD12 ' A' ' 254' ' ' ILE . 24.9 m-70 -105.51 157.94 17.02 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.041 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . 0.464 ' ND2' ' N ' ' A' ' 246' ' ' ASN . 0.0 OUTLIER -133.15 105.21 6.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.527 179.582 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.548 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.5 t -110.9 101.34 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.688 -179.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 53.5 -79.62 0.01 OUTLIER Glycine 0 C--N 1.331 0.274 0 C-N-CA 121.062 -0.589 . . . . 0.0 112.521 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.548 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -113.44 -40.2 3.92 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.476 0.655 . . . . 0.0 110.234 179.762 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.48 ' HB3' ' HB2' ' A' ' 190' ' ' SER . 5.1 p -77.68 148.64 34.89 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.877 -179.021 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.532 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -151.25 103.22 2.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.84 178.807 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' CYS . . . . . 0.688 ' SG ' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -130.74 155.06 47.27 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -177.885 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . 0.667 ' HB3' ' CD1' ' A' ' 244' ' ' TYR . 8.4 pt-20 -74.69 119.51 18.98 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.784 HG12 HG13 ' A' ' 186' ' ' VAL . 30.7 mt -96.97 102.59 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 CA-C-O 121.553 0.692 . . . . 0.0 112.385 -178.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.554 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -103.52 130.36 50.89 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 177.812 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 183' ' ' LYS . 4.0 p -32.67 122.74 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.561 0 CA-C-O 122.3 1.048 . . . . 0.0 111.513 -176.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 1.126 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -76.25 152.02 36.64 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 113.262 -1.79 . . . . 0.0 111.776 -178.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 258' ' ' MET . . . . . 0.497 ' HE2' ' C6 ' ' B' ' 3' ' ' ' DA' . 0.0 OUTLIER -130.43 118.82 21.74 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.026 179.811 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 54.4 p . . . . . 0 C--N 1.325 -0.46 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.106 -179.567 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 2' ' ' ' DT' . . . . . 0.877 ' O2 ' " H2'" ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.428 -0.758 0 O4'-C1'-C2' 106.876 0.705 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 3' ' ' ' DA' . . . . . 0.608 " C5'" ' CE1' ' A' ' 225' ' ' PHE . . . . . . . . 0 O5'--C5' 1.426 -0.845 0 C4'-C3'-C2' 104.592 1.392 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 4' ' ' ' DG' . . . . . 0.72 ' C2 ' ' CE1' ' A' ' 227' ' ' PHE . . . . . . . . 0 O5'--C5' 1.428 -0.775 0 C4'-C3'-C2' 101.924 -1.276 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 5' ' ' ' DG' . . . . . 0.694 " O5'" H2'' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.426 -0.898 0 O4'-C1'-C2' 107.047 0.861 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.491 ' CG1' ' N ' ' A' ' 182' ' ' LYS . 39.8 t . . . . . 0 CA--C 1.504 -0.815 0 CA-C-O 121.276 0.56 . . . . 0.0 111.589 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.87 ' HB2' HG21 ' A' ' 236' ' ' VAL . 0.0 OUTLIER -145.66 112.6 6.04 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.503 177.26 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 1.017 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.0 OUTLIER -133.62 164.82 26.34 Favored 'General case' 0 CA--C 1.507 -0.682 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.895 -179.891 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.862 HD13 ' HE1' ' A' ' 230' ' ' PHE . 1.4 pt -140.33 119.96 12.49 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 177.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.752 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.4 OUTLIER -95.94 108.77 21.19 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.424 -178.713 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 1.078 HG12 ' HB2' ' A' ' 252' ' ' CYS . 1.6 t -84.86 117.39 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.598 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 253' ' ' GLU . . . -104.7 134.14 11.87 Favored Glycine 0 N--CA 1.452 -0.248 0 N-CA-C 114.691 0.636 . . . . 0.0 114.691 -177.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.602 ' HA3' ' C5 ' ' B' ' 2' ' ' ' DT' . . . 72.73 84.48 0.24 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.147 -0.549 . . . . 0.0 112.746 179.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.928 HD23 ' CA ' ' A' ' 225' ' ' PHE . 0.6 OUTLIER -117.44 156.16 28.44 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.957 0.408 . . . . 0.0 111.085 -179.723 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.574 ' CB ' ' CD ' ' A' ' 191' ' ' PRO . 0.5 OUTLIER -47.25 -176.72 0.01 OUTLIER Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.316 179.917 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.574 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 12.0 Cg_exo -71.86 5.73 2.4 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 123.391 2.727 . . . . 0.0 113.329 -179.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.464 ' CB ' ' O ' ' A' ' 191' ' ' PRO . 0.8 OUTLIER 165.63 74.75 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.803 0.335 . . . . 0.0 111.43 -179.944 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.907 ' OG1' HD13 ' A' ' 189' ' ' LEU . 88.4 m -70.34 112.63 13.43 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.61 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.614 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 25.4 Cg_endo -60.32 107.38 0.41 Allowed 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.221 1.948 . . . . 0.0 111.163 179.098 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.814 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -48.53 -14.89 0.07 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.8 -179.618 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . 0.508 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 34.9 mt-10 -67.41 -40.46 85.57 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 -179.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.614 ' CD ' ' HG2' ' A' ' 194' ' ' PRO . 1.8 mttp -74.21 -47.51 34.97 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.903 HG22 ' CE1' ' A' ' 202' ' ' PHE . 0.0 OUTLIER -46.86 -30.2 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.104 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.566 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 7.1 mtp180 -71.5 -33.98 69.71 Favored 'General case' 0 C--O 1.221 -0.438 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.447 178.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . 0.512 ' N ' ' O ' ' A' ' 197' ' ' LYS . 0.4 OUTLIER -83.21 -46.3 12.86 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.157 0.503 . . . . 0.0 110.738 179.459 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.547 ' CD1' ' CD1' ' A' ' 202' ' ' PHE . 0.4 OUTLIER -61.25 -52.73 63.51 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.694 179.127 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 1.107 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -79.53 -31.25 42.06 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.663 179.483 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.566 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -63.86 -56.15 20.44 Favored Glycine 0 N--CA 1.443 -0.88 0 N-CA-C 106.73 -2.548 . . . . 0.0 106.73 175.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -50.25 -28.7 14.3 Favored Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 176.076 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.835 ' CD2' HD11 ' A' ' 239' ' ' ILE . 0.0 OUTLIER -58.82 -44.49 90.86 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 177.68 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.503 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 170.77 -130.88 2.08 Favored Glycine 0 N--CA 1.442 -0.955 0 CA-C-N 113.664 -1.607 . . . . 0.0 110.389 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.518 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 0.4 OUTLIER -97.11 101.93 13.6 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.156 0.503 . . . . 0.0 111.439 178.805 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.445 HG21 ' HB2' ' A' ' 202' ' ' PHE . 2.6 t -79.29 141.12 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 177.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . 0.539 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 38.2 tt0 -98.05 -51.91 3.88 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.202 178.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.428 ' C ' HG12 ' A' ' 211' ' ' ILE . 5.1 p -157.66 154.32 28.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.392 0.615 . . . . 0.0 112.471 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.733 HD13 HD13 ' A' ' 228' ' ' ILE . 0.2 OUTLIER -137.26 116.3 14.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.144 178.548 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.418 ' O ' ' HD3' ' A' ' 214' ' ' PRO . 0.3 OUTLIER -124.1 114.47 19.74 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 113.853 1.056 . . . . 0.0 113.853 -177.79 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.6 HD23 ' HB2' ' A' ' 226' ' ' CYS . 0.1 OUTLIER -96.45 105.97 26.28 Favored Pre-proline 0 CA--C 1.533 0.326 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 177.034 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.736 ' HD2' ' O ' ' A' ' 225' ' ' PHE . 13.4 Cg_exo -74.16 136.04 21.68 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 123.112 2.542 . . . . 0.0 113.181 -179.01 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -132.31 130.7 41.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.959 179.063 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.485 ' O ' ' HA ' ' A' ' 220' ' ' ASN . 3.7 t0 -116.32 106.64 13.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.819 0.342 . . . . 0.0 111.253 -179.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -82.89 -9.55 59.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.075 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.56 -51.18 20.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.251 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.432 ' O ' ' C ' ' A' ' 220' ' ' ASN . 0.0 OUTLIER -137.51 8.43 2.86 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.14 -179.676 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . 0.485 ' HA ' ' O ' ' A' ' 216' ' ' ASP . 72.4 m-80 33.01 58.73 0.45 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.634 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 1.9 mtpt -62.96 -174.5 0.07 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.464 ' O ' ' OP1' ' B' ' 3' ' ' ' DA' . 0.0 OUTLIER -85.0 33.87 0.54 Allowed 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 120.845 0.355 . . . . 0.0 111.123 179.17 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.476 ' HD3' ' HB2' ' A' ' 214' ' ' PRO . 1.9 ptp85 -86.75 17.33 4.06 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.722 178.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.54 ' O ' ' HG ' ' A' ' 189' ' ' LEU . . . -71.67 61.78 1.22 Allowed Glycine 0 N--CA 1.443 -0.881 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 177.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.928 ' CA ' HD23 ' A' ' 189' ' ' LEU . 19.4 p90 -133.42 177.31 7.79 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 -178.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . 0.6 ' HB2' HD23 ' A' ' 213' ' ' LEU . 3.6 p -136.22 150.1 48.84 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 119.507 -0.877 . . . . 0.0 112.682 -179.144 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 1.181 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 3.1 m-85 -106.12 141.14 37.98 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.06 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 1.107 HD12 ' CE2' ' A' ' 202' ' ' PHE . 1.4 mt -138.0 114.42 11.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.458 0.647 . . . . 0.0 111.018 179.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.522 ' OG1' ' CG ' ' A' ' 183' ' ' LYS . 69.3 m -100.58 138.15 38.03 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.33 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.862 ' HE1' HD13 ' A' ' 184' ' ' ILE . 74.3 m-85 -112.51 126.42 55.31 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.221 -0.591 . . . . 0.0 111.335 -179.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.539 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -47.49 -38.89 14.72 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 177.52 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . 0.496 ' O ' ' HG3' ' A' ' 182' ' ' LYS . 17.5 mm-40 -91.2 -171.25 2.9 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 113.078 -1.874 . . . . 0.0 109.431 178.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . 0.491 ' HG2' ' HD2' ' A' ' 182' ' ' LYS . 0.0 OUTLIER -130.32 14.25 5.59 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.476 179.92 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.528 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.3 OUTLIER -84.89 -60.84 0.29 Allowed Pre-proline 0 CA--C 1.517 -0.318 0 C-N-CA 120.644 -0.423 . . . . 0.0 110.928 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.893 ' O ' HD12 ' A' ' 239' ' ' ILE . 79.9 Cg_exo -49.3 -28.83 15.92 Favored 'Trans proline' 0 CA--C 1.499 -1.257 0 N-CA-C 108.719 -1.3 . . . . 0.0 108.719 178.208 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.87 HG21 ' HB2' ' A' ' 182' ' ' LYS . 14.5 t -73.29 -46.44 49.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 114.269 -1.332 . . . . 0.0 110.382 178.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.528 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 2.1 pttp -62.12 -35.9 80.13 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.552 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.628 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.1 OUTLIER -81.38 -55.44 4.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.301 179.43 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.893 HD12 ' O ' ' A' ' 235' ' ' PRO . 1.6 mt -42.04 -50.02 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.851 -179.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . 0.442 ' CE ' ' HB ' ' A' ' 256' ' ' VAL . 46.7 mtp -59.82 -26.18 65.58 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.565 -178.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.5 ' CG ' ' O ' ' A' ' 237' ' ' LYS . 0.1 OUTLIER -82.24 -22.91 35.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.022 0.439 . . . . 0.0 110.742 179.875 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.414 ' HG2' ' O ' ' A' ' 238' ' ' LYS . 9.2 mmmt -79.11 107.06 11.59 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.662 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.577 ' HE2' ' CE1' ' A' ' 244' ' ' TYR . 0.3 OUTLIER -42.66 -46.66 5.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.997 -179.787 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.577 ' CE1' ' HE2' ' A' ' 243' ' ' LYS . 14.0 m-85 -138.59 161.27 37.51 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.047 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' HIS . . . . . 0.763 ' CD2' HD12 ' A' ' 254' ' ' ILE . 39.2 m-70 -126.08 152.58 45.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.078 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -130.71 105.44 7.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.042 0.449 . . . . 0.0 110.579 179.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.727 HG11 HG23 ' A' ' 198' ' ' ILE . 2.6 t -106.14 105.74 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.189 -179.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 54.32 -86.84 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.229 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.465 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.1 OUTLIER -109.87 -39.19 5.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.697 0.761 . . . . 0.0 109.787 -179.829 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.567 ' CB ' ' HG1' ' A' ' 193' ' ' THR . 0.0 OUTLIER -77.82 153.97 32.29 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.373 -1.285 . . . . 0.0 112.349 -178.435 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.455 ' HD3' ' O ' ' A' ' 249' ' ' LEU . 0.0 OUTLIER -150.22 110.63 4.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.266 179.114 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' CYS . . . . . 1.078 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -127.91 153.16 46.99 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -177.709 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . 0.558 ' HG3' ' CD1' ' A' ' 244' ' ' TYR . 39.5 tt0 -75.98 110.34 10.36 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.149 -179.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 1.006 HG12 HG13 ' A' ' 186' ' ' VAL . 11.5 mt -95.62 108.51 21.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -177.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.523 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -112.03 129.86 56.06 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 105.488 -2.041 . . . . 0.0 105.488 176.066 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.763 HG23 ' O ' ' A' ' 183' ' ' LYS . 7.8 p -32.61 124.14 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 122.212 1.006 . . . . 0.0 111.459 -176.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 1.181 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -75.9 152.37 37.16 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 113.447 -1.706 . . . . 0.0 112.049 -177.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.5 123.59 21.62 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.216 179.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . 0.488 ' OG ' ' NZ ' ' A' ' 183' ' ' LYS . 62.0 p . . . . . 0 C--N 1.326 -0.449 0 CA-C-O 120.903 0.382 . . . . 0.0 110.891 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 2' ' ' ' DT' . . . . . 0.779 ' O2 ' " H2'" ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.428 -0.764 0 C3'-C2'-C1' 101.611 -0.778 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 3' ' ' ' DA' . . . . . 1.02 " H4'" " O5'" ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.424 -1.022 0 C3'-C2'-C1' 101.658 -0.744 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 4' ' ' ' DG' . . . . . 1.02 " O5'" " H4'" ' B' ' 3' ' ' ' DA' . . . . . . . . 0 O5'--C5' 1.426 -0.847 0 C4'-C3'-C2' 102.316 -0.884 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 5' ' ' ' DG' . . . . . 0.722 " O5'" " H1'" ' B' ' 4' ' ' ' DG' . . . . . . . . 0 C2'--C1' 1.507 -0.976 0 C4'-C3'-C2' 104.812 1.612 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.521 ' CG1' ' N ' ' A' ' 182' ' ' LYS . 40.9 t . . . . . 0 CA--C 1.502 -0.895 0 CA-C-O 121.217 0.532 . . . . 0.0 111.66 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.731 ' CB ' HG21 ' A' ' 236' ' ' VAL . 0.0 OUTLIER -149.18 112.52 4.97 Favored 'General case' 0 N--CA 1.432 -1.375 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.487 177.97 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.867 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -131.22 142.86 50.23 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-N 114.974 -1.012 . . . . 0.0 108.646 178.52 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.923 HD13 ' HE2' ' A' ' 230' ' ' PHE . 1.3 pt -123.85 119.75 57.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.82 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -92.5 109.81 21.21 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.494 0.664 . . . . 0.0 110.404 -178.982 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.689 HG13 HG12 ' A' ' 254' ' ' ILE . 6.3 t -85.97 129.84 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.886 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.597 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . -79.43 -153.73 8.07 Favored Glycine 0 CA--C 1.521 0.454 0 C-N-CA 121.034 -0.603 . . . . 0.0 114.209 -178.062 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.519 ' HA2' ' O ' ' A' ' 224' ' ' GLY . . . -34.56 109.61 0.06 OUTLIER Glycine 0 C--N 1.334 0.442 0 N-CA-C 114.255 0.462 . . . . 0.0 114.255 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.96 HD13 ' OG1' ' A' ' 193' ' ' THR . 1.7 pp -117.05 157.48 25.78 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.687 0.28 . . . . 0.0 110.819 179.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.789 ' O ' HD12 ' A' ' 189' ' ' LEU . 0.3 OUTLIER -42.25 -177.96 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.259 0 CA-C-O 121.463 0.649 . . . . 0.0 112.087 -179.709 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.56 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 10.4 Cg_exo -70.82 1.52 5.05 Favored 'Trans proline' 0 CA--C 1.529 0.266 0 C-N-CA 123.232 2.621 . . . . 0.0 113.404 -179.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 192' ' ' ASP . 8.4 p-10 165.44 74.91 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.89 0.376 . . . . 0.0 111.415 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.96 ' OG1' HD13 ' A' ' 189' ' ' LEU . 11.9 m -68.9 116.85 45.6 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.125 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.528 ' HG2' ' HG2' ' A' ' 197' ' ' LYS . 36.5 Cg_endo -64.78 118.36 5.35 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.424 2.083 . . . . 0.0 111.438 179.037 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.783 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -52.06 -16.05 0.69 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.328 -179.607 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . 0.495 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 34.8 mt-10 -68.23 -37.85 81.24 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -179.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.528 ' HG2' ' HG2' ' A' ' 194' ' ' PRO . 18.0 mmmt -74.44 -50.08 19.81 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.818 ' CD1' HG22 ' A' ' 193' ' ' THR . 0.0 OUTLIER -48.13 -31.15 2.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 114.849 -1.069 . . . . 0.0 108.428 178.229 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.589 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 1.9 mtp85 -71.09 -32.73 69.44 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.296 178.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . 0.55 ' CG ' ' N ' ' A' ' 201' ' ' TYR . 4.2 pt-20 -81.71 -53.03 6.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.201 0.524 . . . . 0.0 109.894 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.55 ' N ' ' CG ' ' A' ' 200' ' ' GLU . 0.3 OUTLIER -55.35 -54.05 48.52 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.98 178.87 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 1.075 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.2 OUTLIER -79.58 -31.15 41.79 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.069 -0.968 . . . . 0.0 110.424 -179.67 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.589 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -65.1 -55.47 21.48 Favored Glycine 0 CA--C 1.499 -0.927 0 N-CA-C 106.928 -2.469 . . . . 0.0 106.928 176.349 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -49.97 -28.82 13.08 Favored Glycine 0 N--CA 1.442 -0.936 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 176.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.767 ' CE2' HG13 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -57.93 -46.18 85.44 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 122.145 0.974 . . . . 0.0 108.496 177.738 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 171.95 -130.89 2.03 Favored Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 113.542 -1.663 . . . . 0.0 110.247 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.487 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 5.2 mm-40 -97.01 100.7 12.2 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.245 0.545 . . . . 0.0 111.05 178.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.449 HG22 ' CE1' ' A' ' 230' ' ' PHE . 2.9 t -78.11 140.86 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.088 0 CA-C-N 115.235 -0.893 . . . . 0.0 108.653 178.295 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . 0.615 ' HB3' HG22 ' A' ' 229' ' ' THR . 10.1 tp10 -94.43 -53.83 3.76 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.771 0.32 . . . . 0.0 110.352 179.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.422 ' C ' HG12 ' A' ' 211' ' ' ILE . 24.0 p -159.83 156.85 28.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.21 0.528 . . . . 0.0 111.842 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.808 HD12 ' HB ' ' A' ' 198' ' ' ILE . 0.1 OUTLIER -131.84 124.57 53.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.528 178.959 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.546 ' OE1' ' N7 ' ' B' ' 4' ' ' ' DG' . 0.6 OUTLIER -123.07 103.26 8.46 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -178.16 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.766 HD13 ' O ' ' A' ' 193' ' ' THR . 0.1 OUTLIER -96.72 105.91 26.52 Favored Pre-proline 0 C--N 1.329 -0.323 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 177.357 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.615 ' HD2' ' O ' ' A' ' 225' ' ' PHE . 31.3 Cg_exo -61.41 -158.22 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 123.272 2.648 . . . . 0.0 113.494 -179.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.493 ' HB2' ' CB ' ' A' ' 220' ' ' ASN . 5.5 mmt -97.13 173.56 7.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.455 -179.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -106.65 150.66 26.0 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.461 -179.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . 0.566 ' HA ' ' N ' ' A' ' 221' ' ' LYS . 21.8 t30 -52.92 -16.45 1.04 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.295 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.59 -32.37 73.35 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.47 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -137.76 5.5 2.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.155 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . 0.493 ' CB ' ' HB2' ' A' ' 215' ' ' MET . 6.8 m-80 -143.71 -85.79 0.14 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.642 0.258 . . . . 0.0 111.537 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . 0.566 ' N ' ' HA ' ' A' ' 217' ' ' ASN . 0.2 OUTLIER -161.05 174.46 13.7 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.706 179.853 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.626 ' O ' ' CG ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -84.09 41.85 0.84 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 122.564 1.173 . . . . 0.0 111.102 -179.289 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.553 ' HB2' ' CE1' ' A' ' 225' ' ' PHE . 5.0 ptp85 -72.05 -29.05 63.76 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 177.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.519 ' O ' ' HA2' ' A' ' 188' ' ' GLY . . . 9.11 62.72 0.01 OUTLIER Glycine 0 C--N 1.337 0.592 0 CA-C-N 114.334 -1.303 . . . . 0.0 113.728 178.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.92 ' C ' HD23 ' A' ' 189' ' ' LEU . 0.4 OUTLIER -156.47 176.48 12.65 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.712 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . 0.542 ' N ' HD23 ' A' ' 189' ' ' LEU . 11.9 p -142.14 149.56 39.95 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.028 -0.669 . . . . 0.0 112.538 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 1.123 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 4.7 m-85 -106.24 138.86 41.67 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.592 178.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 1.075 HD12 ' CE2' ' A' ' 202' ' ' PHE . 2.2 mt -133.87 135.09 55.57 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.35 0 CA-C-O 120.962 0.41 . . . . 0.0 111.133 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.615 HG22 ' HB3' ' A' ' 209' ' ' GLU . 52.3 m -116.26 138.08 51.6 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.719 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.923 ' HE2' HD13 ' A' ' 184' ' ' ILE . 75.4 m-85 -112.9 126.29 55.3 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.271 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.505 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -49.36 -38.93 30.0 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 177.981 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . 0.459 ' O ' ' HD3' ' A' ' 182' ' ' LYS . 63.9 mt-10 -92.59 -170.86 2.59 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 113.362 -1.745 . . . . 0.0 109.304 178.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . 0.554 ' CB ' ' HG2' ' A' ' 182' ' ' LYS . 14.4 pt-20 -126.09 2.83 7.22 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.836 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.511 ' O ' ' HB2' ' A' ' 237' ' ' LYS . 0.2 OUTLIER -74.33 -59.25 1.69 Allowed Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.809 -179.169 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.893 ' O ' HD12 ' A' ' 239' ' ' ILE . 87.5 Cg_exo -49.15 -32.94 25.93 Favored 'Trans proline' 0 CA--C 1.5 -1.196 0 N-CA-C 108.814 -1.264 . . . . 0.0 108.814 178.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.731 HG21 ' CB ' ' A' ' 182' ' ' LYS . 22.9 t -70.41 -41.57 78.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 114.041 -1.436 . . . . 0.0 108.985 177.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.537 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 20.6 mtpt -55.78 -46.91 77.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.799 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.473 ' HA ' ' HG3' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -81.01 -48.76 11.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.144 -179.501 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.893 HD12 ' O ' ' A' ' 235' ' ' PRO . 1.7 mt -43.57 -49.49 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.841 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . 0.458 ' SD ' HG12 ' A' ' 236' ' ' VAL . 52.9 mtp -61.22 -29.93 70.13 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.637 -178.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.473 ' HG3' ' HA ' ' A' ' 238' ' ' LYS . 0.2 OUTLIER -85.97 -12.17 51.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.794 0.33 . . . . 0.0 111.134 -179.56 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.425 ' O ' ' C ' ' A' ' 243' ' ' LYS . 11.5 mmmm -79.63 103.5 9.58 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.837 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.558 ' HD3' ' CD2' ' A' ' 244' ' ' TYR . 0.1 OUTLIER -37.46 -58.05 0.88 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.15 0.5 . . . . 0.0 110.325 179.75 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.665 ' CD1' ' HB3' ' A' ' 253' ' ' GLU . 10.9 m-85 -135.51 153.27 51.78 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.239 179.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' HIS . . . . . 0.751 ' CE1' HD12 ' A' ' 254' ' ' ILE . 28.8 m-70 -111.91 157.43 20.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.116 -179.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . 0.447 ' ND2' ' C ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -139.79 104.3 4.86 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.299 0.571 . . . . 0.0 109.979 178.525 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.659 HG12 ' H ' ' A' ' 248' ' ' GLY . 1.4 t -95.67 -173.65 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.874 -179.468 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . 0.659 ' H ' HG12 ' A' ' 247' ' ' VAL . . . -26.51 -56.69 0.08 OUTLIER Glycine 0 C--N 1.337 0.619 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.761 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.493 HD23 ' C ' ' A' ' 248' ' ' GLY . 0.0 OUTLIER -130.47 -40.03 1.27 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.443 0.639 . . . . 0.0 111.033 -179.826 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.51 ' O ' ' N ' ' A' ' 247' ' ' VAL . 57.2 p -77.59 150.01 34.75 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.094 -0.957 . . . . 0.0 112.794 -178.316 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -144.87 102.69 3.81 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.225 178.373 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' CYS . . . . . 0.597 ' HB3' ' C ' ' A' ' 187' ' ' GLY . 0.0 OUTLIER -130.11 154.86 47.05 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -177.448 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . 0.665 ' HB3' ' CD1' ' A' ' 244' ' ' TYR . 6.9 pt-20 -74.61 119.05 18.28 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.751 HD12 ' CE1' ' A' ' 245' ' ' HIS . 39.8 mt -97.2 102.47 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 CA-C-O 121.621 0.724 . . . . 0.0 112.332 -178.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.558 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -103.38 129.27 50.41 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 177.781 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 183' ' ' LYS . 5.7 p -32.32 123.62 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.509 -0.599 0 CA-C-O 122.307 1.051 . . . . 0.0 111.491 -176.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 1.123 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -76.26 152.57 36.46 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 113.319 -1.764 . . . . 0.0 111.982 -178.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.35 114.93 14.27 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.354 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . 0.414 ' OG ' ' C6 ' ' B' ' 4' ' ' ' DG' . 0.1 OUTLIER . . . . . 0 C--N 1.326 -0.452 0 CA-C-O 121.082 0.468 . . . . 0.0 111.518 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 2' ' ' ' DT' . . . . . 0.867 ' O2 ' " H2'" ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.427 -0.821 0 O4'-C1'-C2' 106.93 0.754 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 3' ' ' ' DA' . . . . . 0.533 H5'' ' CB ' ' A' ' 223' ' ' ARG . . . . . . . . 0 O5'--C5' 1.426 -0.893 0 C4'-C3'-C2' 103.929 0.729 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 4' ' ' ' DG' . . . . . 0.608 ' C8 ' ' N7 ' ' B' ' 5' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.428 -0.755 0 C4'-C3'-C2' 101.193 -2.007 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 5' ' ' ' DG' . . . . . 0.608 ' N7 ' ' C8 ' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 C2'--C1' 1.511 -0.7 0 C4'-C3'-C2' 102.392 -0.808 . . . . 0.0 . . . . . . . . . . 1 1 . 1 stop_ save_